data_2azh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2azh _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 . . . . . 0 C--O 1.236 0.391 0 CA-C-O 121.125 0.488 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.68 HD13 ' O ' ' A' ' 115' ' ' ALA . 22.7 tp 177.32 -39.09 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 175.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.685 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.4 t70 -49.31 -63.03 1.22 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.505 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 p -59.58 -37.76 79.35 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.003 0.43 . . . . 0.0 112.043 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 mp -56.25 -50.58 70.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.898 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.75 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 5.8 p90 -85.59 -18.72 32.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.115 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 16' ' ' MET . 19.1 tpp180 -63.82 -51.99 62.21 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -63.89 -27.5 69.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.37 0.605 . . . . 0.0 109.453 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.75 ' HB ' ' HA ' ' A' ' 11' ' ' TYR . 2.1 t -70.56 -51.7 35.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.891 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 tt -72.19 -23.12 21.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.512 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -82.01 -42.68 18.99 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.261 0.351 . . . . 0.0 111.28 -178.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.532 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 20.9 t70 -69.11 -33.41 73.44 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.185 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.644 ' CE1' ' HB2' ' A' ' 74' ' ' SER . 86.2 t60 -74.4 -19.72 60.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.005 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -66.45 -40.63 89.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.532 ' HE3' ' HA ' ' A' ' 17' ' ' ASP . 70.9 mttt -49.98 -34.67 21.73 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.488 169.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.73 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 10.8 m120 -82.03 -179.6 1.54 Allowed Pre-proline 0 N--CA 1.465 0.298 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.73 ' HD2' ' HB3' ' A' ' 21' ' ' ASN . 11.1 Cg_endo -58.29 164.55 8.59 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.654 1.569 . . . . 0.0 111.215 164.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -85.83 -140.18 0.08 Allowed 'General case' 0 C--N 1.31 -1.137 0 O-C-N 122.038 -0.414 . . . . 0.0 111.072 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -116.91 52.46 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.981 0.419 . . . . 0.0 110.322 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.71 ' HD3' ' HG2' ' A' ' 62' ' ' GLU . 41.8 mmtm -144.03 83.68 1.75 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.587 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.28 137.14 5.23 Favored Glycine 0 C--O 1.228 -0.259 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.501 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 3.0 m -155.56 135.76 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.96 0.409 . . . . 0.0 110.171 -175.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.604 HD11 ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -144.09 170.28 16.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.363 0.602 . . . . 0.0 111.013 173.254 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -135.14 41.31 2.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.67 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.455 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 25.0 t70 -84.85 -9.73 57.85 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.88 0.371 . . . . 0.0 110.535 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.6 m -153.39 -85.45 0.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.301 0.572 . . . . 0.0 110.181 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.55 HD13 HD21 ' A' ' 51' ' ' LEU . 16.2 pt -127.66 141.77 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.783 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.938 HG13 HG23 ' A' ' 48' ' ' THR . 58.6 t -121.02 107.11 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.507 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.62 HG21 ' HA2' ' A' ' 139' ' ' GLY . 97.0 t -101.45 124.52 55.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 O-C-N 123.577 0.548 . . . . 0.0 110.413 -176.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -126.77 137.65 53.25 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.9 tpt -148.43 126.19 11.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -129.03 146.98 50.86 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.988 0.805 . . . . 0.0 111.368 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.954 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 20.2 t-20 -108.23 98.24 25.94 Favored Pre-proline 0 C--O 1.248 0.988 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.2 -23.73 70.78 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 123.623 2.882 . . . . 0.0 112.353 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.6 m -62.2 -31.87 72.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.085 0.865 . . . . 0.0 111.79 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 81.2 m -113.31 -51.58 2.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.47 -6.75 10.6 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 118.995 -1.574 . . . . 0.0 110.131 -156.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.954 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 24.4 m-20 -60.02 121.58 12.2 Favored 'General case' 0 C--O 1.213 -0.856 0 C-N-CA 123.742 0.817 . . . . 0.0 109.665 173.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -150.2 136.75 19.02 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 121.524 -0.735 . . . . 0.0 110.536 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 132' ' ' SER . 26.2 pt -138.75 145.02 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 81.0 mtm180 -125.86 105.21 8.78 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.509 0.671 . . . . 0.0 110.936 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.632 HD11 ' HE3' ' A' ' 49' ' ' MET . 1.3 tm? -89.7 98.49 11.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.918 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.938 HG23 HG13 ' A' ' 33' ' ' VAL . 71.7 p -100.48 120.16 39.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.632 ' HE3' HD11 ' A' ' 47' ' ' LEU . 35.7 mtt -111.2 -179.87 3.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.769 0.795 . . . . 0.0 112.591 -173.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HG3' ' OD2' ' A' ' 30' ' ' ASP . 60.7 tttm -149.53 93.68 2.09 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.55 HD21 HD13 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -124.23 101.98 7.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.62 -174.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -91.75 57.19 3.15 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.381 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.61 -99.55 0.22 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.445 ' C ' HD11 ' A' ' 85' ' ' ILE . 11.6 m-20 -131.2 25.9 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.675 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.472 HD11 ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -132.52 143.72 38.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.22 114.64 30.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -100.09 -24.9 14.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -169.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 11.6 t70 -153.21 155.5 36.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.693 171.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.58 ' H ' ' HE2' ' A' ' 81' ' ' LYS . . . -157.24 117.52 3.5 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -114.43 138.59 50.39 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 123.195 0.309 . . . . 0.0 110.219 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 5.4 p90 -129.5 137.88 51.06 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -169.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.71 ' HG2' ' HD3' ' A' ' 25' ' ' LYS . 3.6 tm-20 -120.04 135.04 55.08 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.86 138.57 7.0 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.202 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -150.93 142.44 23.51 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 43' ' ' ASP . . . 146.49 -134.75 5.46 Favored Glycine 0 CA--C 1.508 -0.386 0 C-N-CA 118.811 -1.661 . . . . 0.0 111.54 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 64.0 m -75.15 153.96 37.96 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 p -66.5 -27.12 67.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.892 0.377 . . . . 0.0 110.752 -170.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.687 HD13 HG22 ' A' ' 119' ' ' VAL . 2.7 pp -82.19 -32.1 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 121.568 0.699 . . . . 0.0 111.648 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.583 ' N ' HD11 ' A' ' 68' ' ' ILE . 6.7 m -73.17 -52.95 12.23 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.3 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.5 ptm -65.83 -17.82 64.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.979 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.527 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -86.67 -46.75 9.76 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.671 0.272 . . . . 0.0 111.633 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.2 p -69.88 -42.17 73.8 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.246 0.545 . . . . 0.0 110.304 -172.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.17 -56.05 26.27 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.204 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.644 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 60.4 p -63.88 -30.05 71.18 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.616 ' HG3' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -75.09 -53.0 9.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.028 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.566 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 11.9 tpt -70.04 -22.3 63.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.984 -177.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 8.5 p -72.93 -40.47 65.41 Favored 'General case' 0 C--O 1.212 -0.902 0 O-C-N 121.654 -0.654 . . . . 0.0 110.406 174.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -57.28 -31.14 65.3 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.41 172.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.86 -34.47 19.45 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.858 0.837 . . . . 0.0 110.25 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.5 OUTLIER -75.19 -32.25 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.685 -177.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.58 ' HE2' ' H ' ' A' ' 59' ' ' ALA . 46.2 tttm -49.88 -18.31 0.49 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.887 1.275 . . . . 0.0 111.838 175.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.1 46.99 1.05 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.427 ' HB2' HD11 ' A' ' 80' ' ' ILE . 42.8 mmtm -132.64 -175.69 3.85 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -118.09 -178.42 3.5 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 172.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.68 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -72.85 -44.16 58.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.143 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.87 -42.55 99.8 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.082 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 m -61.64 -45.47 93.93 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.565 0.698 . . . . 0.0 111.499 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.423 ' HB1' HD13 ' A' ' 80' ' ' ILE . . . -70.54 -32.46 69.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.529 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 83.1 mt -63.01 -35.73 81.2 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.166 0.984 . . . . 0.0 108.501 172.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.7 m -70.65 -33.91 71.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.489 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -63.65 -26.04 68.49 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.163 0.506 . . . . 0.0 110.926 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.499 ' HB3' ' HB1' ' A' ' 141' ' ' ALA . 0.9 OUTLIER -89.63 -34.35 16.33 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -178.177 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 143' ' ' GLU . 14.0 tmtt? -68.38 -37.22 80.2 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.545 HD11 ' HA ' ' A' ' 105' ' ' ASP . 21.8 mt -66.18 -46.47 87.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 123.558 0.743 . . . . 0.0 109.74 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.442 ' HD2' HG12 ' A' ' 113' ' ' ILE . 27.6 t80 -53.25 -30.18 36.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.697 0.76 . . . . 0.0 111.451 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.3 t -85.28 -39.03 18.18 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.626 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.95 -28.52 63.5 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.825 0.85 . . . . 0.0 111.672 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.633 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -57.8 -58.03 10.15 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.246 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.692 ' HE1' ' HA ' ' A' ' 99' ' ' MET . 3.4 mmt -64.7 -7.09 9.41 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -174.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -116.52 -35.94 4.11 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.375 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -94.69 -24.18 18.75 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.08 -173.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 23.7 ttmm 85.71 -21.87 0.2 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.046 0.927 . . . . 0.0 110.484 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 98' ' ' MET . 44.8 mt-10 -92.02 167.83 11.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.521 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 1.4 p90 -137.27 -110.75 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.02 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.817 ' HB3' HD12 ' A' ' 110' ' ' LEU . 13.9 t70 -93.93 110.54 22.21 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.498 0.666 . . . . 0.0 110.186 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -46.72 -11.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.527 -1.67 . . . . 0.0 113.027 172.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 105' ' ' ASP . 27.2 m -105.2 -15.37 15.08 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 121.678 -0.639 . . . . 0.0 110.495 177.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 108' ' ' ILE . 24.6 mm 70.77 19.15 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 124.049 0.843 . . . . 0.0 111.483 174.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -97.94 93.67 6.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.817 HD12 ' HB3' ' A' ' 105' ' ' ASP . 9.0 mp -124.07 31.82 5.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.249 -164.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -36.76 -43.75 0.85 Allowed Glycine 0 CA--C 1.534 1.219 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 6.9 p-10 -86.81 -44.73 11.51 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 117.657 0.728 . . . . 0.0 110.95 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.477 HD12 ' HG ' ' A' ' 110' ' ' LEU . 55.3 mt -62.74 -38.16 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.503 0.668 . . . . 0.0 110.58 -174.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.523 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 39.8 mt-10 -63.51 -53.69 48.07 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.028 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.68 ' O ' HD13 ' A' ' 7' ' ' LEU . . . -68.55 -37.73 80.2 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 124.527 1.142 . . . . 0.0 114.028 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.712 HD12 HG22 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -92.0 -11.3 36.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -173.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 114' ' ' GLU . 4.7 pp0? -60.32 -31.37 70.22 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.267 -0.895 . . . . 0.0 110.733 177.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.462 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -84.47 -18.1 62.87 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.461 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.712 HG22 HD12 ' A' ' 116' ' ' LEU . 72.9 t -86.69 -55.66 6.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.396 0.617 . . . . 0.0 110.368 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.766 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 23.5 t -41.22 -14.69 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.068 -1.878 . . . . 0.0 115.391 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 119' ' ' VAL . 55.0 mttm -131.56 7.6 4.51 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -163.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -103.01 136.39 19.24 Favored Pre-proline 0 CA--C 1.507 -0.71 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.83 -22.18 28.75 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.785 2.323 . . . . 0.0 111.621 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.53 -8.0 33.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.467 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.692 ' HB3' HG12 ' A' ' 119' ' ' VAL . 84.1 mtt180 -126.03 5.33 7.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 O-C-N 121.714 -0.616 . . . . 0.0 110.363 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 tt -84.53 -33.03 8.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.148 0.975 . . . . 0.0 108.954 -168.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.45 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 75.9 mmtt -72.72 -24.45 60.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.027 174.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.509 ' HA ' ' HB3' ' A' ' 131' ' ' LEU . 71.2 m -84.92 -17.76 36.77 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.582 0.706 . . . . 0.0 110.249 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.766 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -82.29 -21.54 36.11 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.557 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 65.5 m -83.63 -40.19 19.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.625 HD23 ' HB3' ' A' ' 43' ' ' ASP . 2.0 tp -50.51 -63.07 1.24 Allowed 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 113.459 -1.7 . . . . 0.0 111.185 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.554 ' HB2' HD22 ' A' ' 116' ' ' LEU . 20.5 m -76.44 -63.17 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -172.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.446 ' HB2' HD23 ' A' ' 116' ' ' LEU . 66.4 t90 -66.16 -49.84 66.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.145 -173.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.557 ' HB3' ' O ' ' A' ' 130' ' ' THR . 51.6 tttm -62.67 -35.69 80.48 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.134 -176.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.92 93.6 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.838 170.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.0 tp -66.46 -35.17 79.62 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.961 ' HA ' ' HB2' ' A' ' 141' ' ' ALA . 30.3 tt0 -69.04 -35.48 76.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.672 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -79.91 6.28 11.62 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 122.003 0.906 . . . . 0.0 110.023 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.62 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -103.71 -36.94 3.11 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.697 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.508 HG21 HG13 ' A' ' 85' ' ' ILE . 11.0 p -172.67 41.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.156 0.979 . . . . 0.0 109.698 -176.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.961 ' HB2' ' HA ' ' A' ' 137' ' ' GLU . . . -148.9 167.62 25.23 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.876 -172.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 143' ' ' GLU . 37.4 ttmt -171.02 -10.46 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.547 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 27.1 tt0 71.19 -67.29 0.26 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.887 0.742 . . . . 0.0 110.698 -175.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--N 1.315 -0.925 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.524 -178.78 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.432 ' CG ' ' H ' ' A' ' 7' ' ' LEU . 2.2 p30 . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.432 ' H ' ' CG ' ' A' ' 6' ' ' ASN . 47.1 tp -143.99 -25.76 0.54 Allowed 'General case' 0 C--O 1.212 -0.899 0 C-N-CA 122.43 0.292 . . . . 0.0 111.687 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.415 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 14.6 t70 -49.17 -59.79 3.35 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.23 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -45.6 89.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.188 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.445 ' O ' HG21 ' A' ' 14' ' ' VAL . 74.7 mt -54.19 -51.67 63.64 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.481 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.415 ' CE1' ' HA ' ' A' ' 8' ' ' ASP . 2.2 p90 -85.14 -18.24 34.8 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.368 -175.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -60.52 -40.75 92.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.997 0.427 . . . . 0.0 110.128 169.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.616 ' HG3' ' HE3' ' A' ' 16' ' ' MET . 10.4 tt0 -73.1 -24.66 60.67 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.714 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 10' ' ' LEU . 90.0 t -73.17 -34.93 46.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.331 175.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.4 mt -73.9 -32.34 33.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.635 172.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.616 ' HE3' ' HG3' ' A' ' 13' ' ' GLN . 56.2 ttp -68.77 -46.27 69.2 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.899 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -38.2 89.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.702 -177.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.426 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -83.0 -14.24 54.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -69.09 -50.06 51.61 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.479 -1.388 . . . . 0.0 109.04 167.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -52.58 -37.39 57.92 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.391 0.676 . . . . 0.0 110.511 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.86 84.68 32.44 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.93 39.21 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.99 3.127 . . . . 0.0 114.408 -163.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -85.69 57.82 4.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.799 0.809 . . . . 0.0 110.868 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.426 ' OD1' ' HD2' ' A' ' 18' ' ' HIS . 4.6 m-20 -102.03 19.63 18.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.925 0.869 . . . . 0.0 109.496 172.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -136.99 143.96 43.05 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.002 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.793 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 157.96 139.74 2.77 Favored Glycine 0 C--O 1.21 -1.351 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.792 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.597 HG23 HG21 ' A' ' 48' ' ' THR . 4.0 p -167.18 120.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.465 0.65 . . . . 0.0 109.347 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.744 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -138.97 154.07 48.25 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.51 0.671 . . . . 0.0 110.533 175.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -102.2 79.64 1.88 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.841 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.472 ' OD1' ' HG3' ' A' ' 50' ' ' LYS . 6.5 t70 -115.8 -130.61 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.478 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 m -52.08 -71.71 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.976 0.798 . . . . 0.0 111.746 -172.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.731 HD13 HD22 ' A' ' 51' ' ' LEU . 10.4 pt -132.59 140.36 47.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.458 0.647 . . . . 0.0 110.978 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.683 HG13 HG23 ' A' ' 48' ' ' THR . 44.5 t -120.48 107.7 21.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.078 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 1.034 HG22 ' HA2' ' A' ' 139' ' ' GLY . 89.9 t -101.11 128.27 53.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.104 -172.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 1.5 p-10 -132.06 149.0 52.53 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.812 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.8 ' HE1' ' HA ' ' A' ' 36' ' ' MET . 3.5 mmt -143.08 122.77 13.33 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.341 1.026 . . . . 0.0 110.22 176.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.691 ' HB3' ' HB3' ' A' ' 44' ' ' ARG . 3.7 p-10 -118.44 134.2 55.26 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.131 0.894 . . . . 0.0 110.768 -176.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.43 ' N ' HD11 ' A' ' 131' ' ' LEU . 22.4 t30 -156.84 138.87 10.18 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -45.28 -35.61 11.56 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 124.447 3.431 . . . . 0.0 113.807 -178.367 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.587 HG21 ' O ' ' A' ' 124' ' ' ALA . 3.2 m -74.91 23.76 0.1 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 122.148 0.975 . . . . 0.0 111.427 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.629 ' SG ' HD13 ' A' ' 131' ' ' LEU . 72.3 m -136.22 -52.73 0.73 Allowed 'General case' 0 C--N 1.312 -1.06 0 O-C-N 121.463 -0.773 . . . . 0.0 110.335 167.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.29 -29.11 2.31 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.478 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 24.9 t0 -157.28 -88.45 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.82 0 CA-C-N 114.621 -0.79 . . . . 0.0 111.258 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.691 ' HB3' ' HB3' ' A' ' 37' ' ' ASN . 7.7 ptp85 179.63 -179.35 0.43 Allowed 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.036 0.446 . . . . 0.0 110.897 -169.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.644 HG23 ' HE1' ' A' ' 61' ' ' PHE . 19.5 pt -137.65 139.61 42.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.821 177.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.507 ' HD3' ' HD3' ' A' ' 44' ' ' ARG . 37.2 mmm-85 -114.03 100.69 8.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.494 0.664 . . . . 0.0 110.342 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.881 HD21 ' HG3' ' A' ' 49' ' ' MET . 0.8 OUTLIER -82.86 92.44 7.28 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.744 ' HB ' HD12 ' A' ' 28' ' ' LEU . 68.3 p -84.0 111.97 19.76 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.881 ' HG3' HD21 ' A' ' 47' ' ' LEU . 22.9 mtt -107.21 178.25 4.61 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.826 0.822 . . . . 0.0 111.298 -170.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.472 ' HG3' ' OD1' ' A' ' 30' ' ' ASP . 62.8 tttp -160.79 95.82 1.1 Allowed 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.731 HD22 HD13 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -119.56 84.52 2.22 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.852 -177.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.89 59.35 4.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.511 -164.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.92 -99.48 0.2 Allowed Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.804 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.415 ' C ' HG12 ' A' ' 85' ' ' ILE . 11.6 p-10 -133.37 24.47 4.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.466 0.65 . . . . 0.0 109.795 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.676 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.2 pp -139.66 152.91 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -99.83 121.17 50.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -104.15 -33.25 8.8 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.335 -169.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 6.9 t70 -140.17 143.02 35.9 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.417 -0.811 . . . . 0.0 108.86 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.572 ' HB2' HD22 ' A' ' 47' ' ' LEU . . . -167.74 101.74 0.48 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.793 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 47.7 mttp -115.32 167.53 10.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.058 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.644 ' HE1' HG23 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -124.41 131.28 53.5 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.627 0.727 . . . . 0.0 111.18 -174.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 10.3 tp10 -128.79 110.81 12.48 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.15 174.86 34.0 Favored Glycine 0 CA--C 1.493 -1.317 0 C-N-CA 119.325 -1.417 . . . . 0.0 113.486 -174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 1.3 tm-20 -147.74 132.25 17.7 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.95 -133.59 2.76 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.581 -171.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.2 p -110.03 172.81 6.64 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.662 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.7 t -74.16 -31.08 62.56 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.177 -165.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.711 HD11 ' SG ' ' A' ' 128' ' ' CYS . 2.7 pp -75.66 -24.57 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.148 0.499 . . . . 0.0 109.937 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.435 ' N ' HD13 ' A' ' 68' ' ' ILE . 13.1 m -78.86 -37.79 39.44 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 65.0 mtt -58.41 -33.0 69.17 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.779 0.799 . . . . 0.0 109.687 167.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.579 ' O ' ' HB3' ' A' ' 74' ' ' SER . . . -71.62 -38.1 70.83 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.999 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.794 ' HB2' HD13 ' A' ' 116' ' ' LEU . 41.7 t -59.98 -48.47 81.56 Favored 'General case' 0 C--O 1.219 -0.538 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.12 -41.33 78.81 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.815 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 71' ' ' ALA . 30.7 t -47.8 -67.59 0.26 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.242 173.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.466 ' SD ' ' HA3' ' A' ' 111' ' ' GLY . 25.5 mmt -65.15 -32.42 74.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.925 0.393 . . . . 0.0 110.518 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.752 ' SD ' ' HG ' ' A' ' 47' ' ' LEU . 31.9 ttm -56.66 -61.72 2.23 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.593 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 p -60.08 -27.62 67.14 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -90.02 -31.63 17.11 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.308 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.11 -41.22 15.92 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.299 0.571 . . . . 0.0 111.059 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.552 HG21 ' HE1' ' A' ' 49' ' ' MET . 14.7 mm -76.66 -39.71 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.443 -174.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.585 ' HZ1' ' HB3' ' A' ' 81' ' ' LYS . 3.0 mmmp? -52.56 -18.74 1.87 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.217 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.01 54.9 0.78 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.014 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.423 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 12.0 tppt? -133.3 169.45 16.89 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -114.28 -174.03 2.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 173.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.476 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 18.4 mm -85.49 -33.31 7.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.963 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -63.4 -46.42 86.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.198 0.523 . . . . 0.0 110.92 175.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 83' ' ' LYS . 0.9 OUTLIER -67.96 -37.61 81.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.352 178.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.885 ' HB2' HG21 ' A' ' 140' ' ' VAL . . . -64.18 -43.21 95.84 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.101 0.477 . . . . 0.0 111.37 175.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 70.9 mt -67.1 -35.54 80.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.318 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 p -73.03 -35.2 66.72 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.933 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.0 ttt -70.03 -22.58 63.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.875 0.845 . . . . 0.0 111.718 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.502 ' OG ' ' HA ' ' A' ' 142' ' ' LYS . 49.4 p -89.06 -36.59 15.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.859 ' HB2' ' HA ' ' A' ' 143' ' ' GLU . 87.1 tttt -66.8 -37.02 83.73 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 1.03 HD11 ' HA ' ' A' ' 105' ' ' ASP . 12.8 mt -67.74 -47.27 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.355 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.529 ' CE2' HG12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -55.95 -24.88 40.88 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 123.934 0.771 . . . . 0.0 110.04 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.4 m -81.71 -43.07 18.97 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.993 -0.442 . . . . 0.0 110.824 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 99' ' ' MET . 6.2 t70 -75.96 -29.19 58.2 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -173.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.8 ptm -54.31 -10.0 0.34 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.956 0.902 . . . . 0.0 112.307 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.49 ' H ' ' C ' ' A' ' 97' ' ' ASP . 95.6 mmm -100.1 -7.77 24.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.926 0.87 . . . . 0.0 109.241 -166.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -134.68 -22.74 1.65 Allowed 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.688 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.54 -23.49 6.87 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 119.207 -0.774 . . . . 0.0 112.302 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.3 tptm 81.48 -18.54 0.48 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.08 1.352 . . . . 0.0 109.692 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -77.91 149.15 34.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -137.03 -134.03 0.14 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -171.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 1.03 ' HA ' HD11 ' A' ' 94' ' ' ILE . 9.0 t70 -90.66 108.79 20.04 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.125 0.964 . . . . 0.0 109.33 -169.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -58.5 -2.86 0.23 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.284 173.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.538 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 1.5 m -89.79 -24.82 21.37 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 170.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.447 HG21 ' O ' ' A' ' 108' ' ' ILE . 22.7 mm 72.91 25.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-O 122.421 1.105 . . . . 0.0 110.703 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -94.89 70.03 3.36 Favored 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 121.618 -0.676 . . . . 0.0 109.952 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.798 ' HG ' HD13 ' A' ' 113' ' ' ILE . 6.1 mp -104.35 14.11 30.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.285 -169.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.466 ' HA3' ' SD ' ' A' ' 75' ' ' MET . . . -44.78 -39.26 6.07 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 119.857 -0.413 . . . . 0.0 113.849 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.09 -45.42 23.49 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-O 122.367 1.08 . . . . 0.0 109.906 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.798 HD13 ' HG ' ' A' ' 110' ' ' LEU . 36.8 mt -58.25 -28.95 36.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.902 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -76.27 -54.5 6.7 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.282 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.45 -41.45 69.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.3 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.794 HD13 ' HB2' ' A' ' 72' ' ' SER . 6.6 mp -96.04 -6.77 37.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 6.4 tt0 -45.53 -51.44 11.82 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.178 0.923 . . . . 0.0 110.853 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.48 -18.79 77.32 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.375 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.538 HG23 HD12 ' A' ' 68' ' ' ILE . 60.2 t -78.29 -60.25 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 O-C-N 122.056 -0.673 . . . . 0.0 111.606 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.518 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 14.5 p -50.93 -16.06 0.38 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.338 -1.301 . . . . 0.0 114.141 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.962 ' HA ' ' HE2' ' A' ' 121' ' ' LYS . 8.9 mmpt? -99.66 -16.73 18.09 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.492 -0.755 . . . . 0.0 110.822 -163.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -90.4 135.14 29.9 Favored Pre-proline 0 N--CA 1.443 -0.794 0 O-C-N 123.833 0.708 . . . . 0.0 109.819 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.0 -27.48 21.36 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.323 2.682 . . . . 0.0 111.78 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.587 ' O ' HG21 ' A' ' 40' ' ' THR . . . -84.34 -27.75 27.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.556 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 119' ' ' VAL . 30.5 mtm180 -113.9 17.76 17.75 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.775 -166.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.7 tt -84.9 -29.74 6.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.03 -17.78 45.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.778 -1.556 . . . . 0.0 107.999 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.711 ' SG ' HD11 ' A' ' 68' ' ' ILE . 54.1 t -84.34 -19.62 33.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.757 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.568 ' O ' ' HB3' ' A' ' 133' ' ' TRP . . . -85.78 -27.73 25.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.533 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.618 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 16.6 p -78.31 -35.84 47.26 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.629 HD13 ' SG ' ' A' ' 41' ' ' CYS . 10.0 tt -51.42 -54.17 29.43 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.225 172.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.508 ' HB2' HD22 ' A' ' 116' ' ' LEU . 35.9 m -81.88 -62.25 1.69 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.568 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 1.2 t90 -62.49 -50.43 71.44 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 120.943 0.401 . . . . 0.0 111.849 -175.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.618 ' HB3' ' O ' ' A' ' 130' ' ' THR . 37.7 ttpt -62.65 -29.34 70.56 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.608 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 131' ' ' LEU . . . -56.89 -31.02 64.45 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 169.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.5 mp -80.55 -35.17 34.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.4 ' OE1' ' HD2' ' A' ' 142' ' ' LYS . 7.5 mm-40 -61.65 -43.85 98.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.422 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -91.25 5.51 48.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.361 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 1.034 ' HA2' HG22 ' A' ' 34' ' ' VAL . . . -85.79 -39.99 7.87 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.885 HG21 ' HB2' ' A' ' 88' ' ' ALA . 20.1 m -127.06 -9.45 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 O-C-N 122.091 -0.653 . . . . 0.0 110.543 -177.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 140' ' ' VAL . . . 91.78 152.39 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.184 1.393 . . . . 0.0 108.425 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.502 ' HA ' ' OG ' ' A' ' 92' ' ' SER . 14.9 pttp -114.44 142.66 46.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -171.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.859 ' HA ' ' HB2' ' A' ' 93' ' ' LYS . 33.4 mt-10 65.81 -88.66 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.242 0.964 . . . . 0.0 111.861 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 C--N 1.311 -1.068 0 O-C-N 123.587 0.554 . . . . 0.0 110.585 -178.227 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.516 -0.358 0 CA-C-O 121.104 0.478 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 115' ' ' ALA . 12.7 tp -137.54 0.28 2.25 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.983 0.897 . . . . 0.0 109.116 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.495 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -55.81 -63.53 1.14 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 125.348 1.459 . . . . 0.0 111.467 -178.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -62.7 -35.14 78.73 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.718 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.487 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 4.1 mm? -53.97 -39.52 66.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.103 174.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.858 ' HE1' HG22 ' A' ' 68' ' ' ILE . 22.7 m-85 -63.08 -57.71 9.71 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 121.52 0.676 . . . . 0.0 109.848 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.632 ' HA ' HG22 ' A' ' 15' ' ' ILE . 47.3 mtm180 -69.44 -18.92 63.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.03 -169.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -86.62 -35.86 19.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.685 1.231 . . . . 0.0 108.02 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.631 HG23 ' HB2' ' A' ' 115' ' ' ALA . 0.3 OUTLIER -80.1 -34.19 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.964 -175.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.632 HG22 ' HA ' ' A' ' 12' ' ' ARG . 10.5 tt -82.62 -19.1 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.683 175.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.604 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 17.2 tpt -61.73 -43.87 98.02 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.859 0.838 . . . . 0.0 110.388 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.02 -41.71 63.95 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.059 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -61.82 -28.23 69.33 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.774 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -66.84 -55.64 13.93 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.104 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -48.57 -38.35 20.38 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 124.039 0.837 . . . . 0.0 110.812 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -114.08 86.3 11.32 Favored Pre-proline 0 C--N 1.32 -0.676 0 O-C-N 123.426 0.454 . . . . 0.0 110.478 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.57 45.97 2.01 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.529 2.153 . . . . 0.0 114.038 -172.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.33 102.15 11.58 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.083 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -142.24 25.93 1.86 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.151 0.977 . . . . 0.0 108.366 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -132.09 124.46 29.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.224 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.767 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 155.28 146.94 4.56 Favored Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.713 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -165.39 93.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.873 0 O-C-N 124.619 0.835 . . . . 0.0 109.25 177.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.587 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -116.75 139.2 50.84 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 120.68 -1.263 . . . . 0.0 111.721 -175.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.495 ' HA ' HG23 ' A' ' 33' ' ' VAL . 58.1 t30 -81.24 81.34 7.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.627 172.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.507 ' HB2' HD11 ' A' ' 28' ' ' LEU . 10.3 t70 -101.48 -125.86 0.19 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.667 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.4 t -66.66 -64.92 0.75 Allowed 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.668 -0.645 . . . . 0.0 110.376 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.567 HG13 ' HB2' ' A' ' 49' ' ' MET . 34.4 pt -125.65 135.28 64.43 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.713 176.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.962 HG12 HG22 ' A' ' 48' ' ' THR . 84.9 t -116.16 138.11 47.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.917 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.735 HG23 ' HA2' ' A' ' 139' ' ' GLY . 98.1 t -127.95 124.65 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -120.41 136.91 54.58 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.35 0.119 . . . . 0.0 111.061 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.546 ' HG3' HD12 ' A' ' 131' ' ' LEU . 47.9 tpp -151.55 123.48 8.09 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 110.98 175.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -127.64 150.35 49.78 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.573 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -109.93 98.2 33.05 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.51 -11.62 32.79 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.596 2.864 . . . . 0.0 113.278 -171.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.4 m -75.85 -30.9 59.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.544 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.478 ' SG ' ' OD2' ' A' ' 43' ' ' ASP . 6.2 p -131.12 -12.67 3.59 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.43 3.78 58.49 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.317 -1.42 . . . . 0.0 113.538 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.478 ' OD2' ' SG ' ' A' ' 41' ' ' CYS . 21.7 m-20 -70.15 115.5 9.42 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -127.83 141.08 51.67 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.907 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 31.6 pt -141.34 149.84 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.287 0.565 . . . . 0.0 110.172 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.728 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 50.5 mtt180 -140.51 107.64 5.48 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.957 -0.464 . . . . 0.0 111.525 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.705 HD23 ' HG3' ' A' ' 49' ' ' MET . 0.7 OUTLIER -93.66 89.67 6.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.962 HG22 HG12 ' A' ' 33' ' ' VAL . 67.4 p -88.02 128.5 35.4 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 173.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.705 ' HG3' HD23 ' A' ' 47' ' ' LEU . 30.5 mtt -113.67 -179.21 3.57 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.275 1.036 . . . . 0.0 112.92 -170.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.833 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 45.3 tttp -159.87 98.7 1.36 Allowed 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.539 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.3 pt? -126.48 93.12 3.71 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -172.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -99.17 59.92 1.17 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.731 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 148.77 -96.21 0.17 Allowed Glycine 0 C--N 1.316 -0.548 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.43 18.93 6.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -176.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 2.4 pp -140.54 167.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 p -116.2 116.81 53.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 168.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -106.58 -27.63 10.75 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.033 0.921 . . . . 0.0 109.95 -166.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.833 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 28.0 t70 -140.73 144.68 35.7 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.36 118.04 2.53 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.767 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 34.2 mmtp -107.25 130.41 54.75 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.728 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.7 p90 -129.01 147.28 50.86 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.35 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 42.2 tt0 -107.16 138.46 43.29 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.42 120.13 1.54 Allowed Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.637 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -163.15 106.63 1.04 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.15 -131.4 1.87 Allowed Glycine 0 C--O 1.236 0.24 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.904 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.454 ' SG ' ' OD2' ' A' ' 43' ' ' ASP . 74.7 m -77.21 173.67 11.6 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.8 m -89.87 17.31 6.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.795 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.858 HG22 ' HE1' ' A' ' 11' ' ' TYR . 2.7 pp -119.05 -45.13 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.393 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.502 ' N ' HD13 ' A' ' 68' ' ' ILE . 13.8 p -73.27 -46.18 51.34 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.798 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -27.25 64.43 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.172 177.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.0 -59.26 2.39 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.632 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.648 ' CB ' ' HB2' ' A' ' 116' ' ' LEU . 21.7 p -67.62 -45.84 74.22 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.437 -168.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.04 -53.81 50.33 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 120.901 0.381 . . . . 0.0 110.345 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.1 t -60.16 -35.33 75.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.414 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.402 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 17.9 tpt -67.78 -54.82 16.17 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.551 0.691 . . . . 0.0 110.349 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.443 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -62.98 -33.52 75.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.205 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.618 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 24.3 p -72.61 -39.43 67.3 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.348 0.594 . . . . 0.0 110.651 177.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' A' ' 75' ' ' MET . 28.1 tt0 -53.25 -38.05 62.65 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.586 171.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.98 -27.83 24.61 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.762 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.618 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -73.56 -36.83 48.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 O-C-N 124.359 1.037 . . . . 0.0 110.152 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -56.35 -17.51 8.07 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.848 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.95 42.59 1.79 Allowed Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.29 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.46 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 20.6 mmtm -134.53 -153.04 0.5 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.698 0.761 . . . . 0.0 111.875 -176.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.46 ' H ' ' HB3' ' A' ' 83' ' ' LYS . 4.4 m-20 -145.78 155.88 43.23 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 -167.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.627 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.6 mp -63.31 -49.75 81.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 O-C-N 123.342 0.401 . . . . 0.0 110.079 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.26 -38.73 82.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.863 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.508 ' O ' ' HG2' ' A' ' 91' ' ' MET . 4.8 m -68.35 -35.04 77.16 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 121.497 0.665 . . . . 0.0 110.428 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 141' ' ' ALA . . . -60.5 -41.88 95.21 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 173.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 32.8 mt -67.36 -31.83 72.35 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.287 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.426 ' OG ' ' HA ' ' A' ' 87' ' ' THR . 5.1 p -77.96 -29.63 49.93 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 121.66 -0.65 . . . . 0.0 111.76 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 87' ' ' THR . 22.1 mmt -75.66 -18.91 59.5 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.09 0.948 . . . . 0.0 110.846 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p -90.08 -31.47 17.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.377 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.85 -37.96 79.46 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.66 172.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.434 HD11 ' HB2' ' A' ' 105' ' ' ASP . 35.9 mt -62.23 -48.85 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 171.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.472 ' HD1' HG12 ' A' ' 113' ' ' ILE . 49.9 t80 -43.39 -35.91 1.73 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.471 0.653 . . . . 0.0 111.745 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.2 m -85.08 -35.51 21.78 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 121.686 -0.634 . . . . 0.0 111.454 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -84.3 -20.09 32.69 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.05 0.929 . . . . 0.0 112.3 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.446 ' CG ' ' HB3' ' A' ' 104' ' ' TYR . 2.1 tmt? -73.34 -13.07 61.04 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.233 -174.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.1 mmt -95.24 6.15 49.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.556 -160.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -103.97 16.85 25.35 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.5 30.25 74.85 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.509 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -102.7 -170.92 1.87 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.816 0.308 . . . . 0.0 110.211 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.59 156.86 33.87 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.456 ' HD2' ' H ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -124.64 -101.2 0.39 Allowed 'General case' 0 C--N 1.316 -0.883 0 O-C-N 123.717 0.636 . . . . 0.0 111.035 -178.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.625 ' HB3' HD11 ' A' ' 110' ' ' LEU . 15.4 t0 -116.14 107.26 14.67 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 123.742 0.651 . . . . 0.0 109.373 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.76 -2.01 1.6 Allowed 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.959 0.787 . . . . 0.0 111.531 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.59 ' O ' HG21 ' A' ' 108' ' ' ILE . 2.1 m -89.34 -15.8 32.54 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 172.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.59 HG21 ' O ' ' A' ' 107' ' ' SER . 4.3 tp 68.59 15.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.068 0.947 . . . . 0.0 113.512 165.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.442 ' C ' HD13 ' A' ' 110' ' ' LEU . 29.0 t0 -92.73 88.68 6.34 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.625 HD11 ' HB3' ' A' ' 105' ' ' ASP . 10.8 mp -127.0 43.75 3.05 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.037 -168.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -38.64 -44.87 1.89 Allowed Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.579 -0.737 . . . . 0.0 114.91 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.606 ' O ' ' HB3' ' A' ' 116' ' ' LEU . 16.1 p-10 -90.45 -41.53 11.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.52 1.152 . . . . 0.0 109.99 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.725 ' O ' ' HB2' ' A' ' 117' ' ' GLN . 50.7 mt -69.47 -27.49 34.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.591 -172.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -86.98 -69.59 0.67 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.396 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.631 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -63.52 -39.39 94.31 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -172.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.648 ' HB2' ' CB ' ' A' ' 72' ' ' SER . 48.4 tp -99.74 3.08 44.77 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.648 0.737 . . . . 0.0 111.17 -169.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.725 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 8.2 tt0 -63.48 -45.79 89.15 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.536 0.684 . . . . 0.0 110.445 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.95 -17.23 65.14 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 113.91 -1.495 . . . . 0.0 113.014 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.931 HG13 ' HG2' ' A' ' 125' ' ' ARG . 97.9 t -82.09 -40.78 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 121.765 0.793 . . . . 0.0 110.186 -169.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.511 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 16.4 t -42.98 -13.23 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.561 -1.654 . . . . 0.0 115.393 174.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.466 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 10.2 ptmt -142.93 -0.37 1.16 Allowed 'General case' 0 C--O 1.243 0.725 0 O-C-N 121.003 -1.061 . . . . 0.0 113.041 -162.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.63 ' HB2' ' HB3' ' A' ' 125' ' ' ARG . 30.0 m-85 -81.09 123.6 81.75 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 168.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -51.05 -28.79 25.76 Favored 'Trans proline' 0 C--O 1.218 -0.514 0 C-N-CA 123.347 2.698 . . . . 0.0 112.652 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.49 -0.11 32.81 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.216 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.931 ' HG2' HG13 ' A' ' 119' ' ' VAL . 33.0 ttm180 -126.08 6.02 7.19 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.393 -175.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.7 tt -80.73 -25.34 11.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.244 -171.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -76.8 -20.11 56.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.389 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.0 m -86.3 -19.33 30.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.228 174.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.562 ' HB2' HG11 ' A' ' 119' ' ' VAL . . . -72.62 -46.9 51.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.147 176.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.671 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 7.5 p -69.99 -37.58 75.76 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.546 HD12 ' HG3' ' A' ' 36' ' ' MET . 18.0 tp -46.38 -55.68 6.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.077 -0.389 . . . . 0.0 111.494 171.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.45 ' HB2' HD23 ' A' ' 116' ' ' LEU . 6.7 m -83.42 -55.87 4.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.812 0.339 . . . . 0.0 111.203 -171.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.411 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 6.4 t90 -63.47 -50.56 69.21 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.746 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.671 ' HB3' ' O ' ' A' ' 130' ' ' THR . 3.1 tppp? -60.65 -42.31 96.7 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.19 -41.13 78.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.937 0.399 . . . . 0.0 111.581 173.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.0 tp -73.97 -32.43 63.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.416 0.627 . . . . 0.0 110.173 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.681 ' HA ' ' O ' ' A' ' 141' ' ' ALA . 39.4 tt0 -69.55 -37.37 77.03 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.5 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.68 ' HB3' ' HZ2' ' A' ' 138' ' ' LYS . 9.6 mtpm? -87.64 10.63 17.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.695 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.735 ' HA2' HG23 ' A' ' 34' ' ' VAL . . . -94.82 -40.96 4.23 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.491 ' CG1' ' HE2' ' A' ' 49' ' ' MET . 14.8 p -178.13 -44.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.681 ' O ' ' HA ' ' A' ' 137' ' ' GLU . . . -82.97 100.61 10.54 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.409 ' HA ' ' HG3' ' A' ' 137' ' ' GLU . 13.4 ptmm? -142.91 28.29 1.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.102 0.477 . . . . 0.0 110.587 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 59.12 -167.28 0.16 Allowed 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.9 -171.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.493 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.657 HD12 ' HB2' ' A' ' 10' ' ' LEU . 28.3 tp -105.5 -16.6 14.68 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.008 -0.433 . . . . 0.0 110.443 -168.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 30.4 t70 -56.53 -54.18 48.84 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.825 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.3 m -59.93 -42.25 93.58 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.536 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.657 ' HB2' HD12 ' A' ' 7' ' ' LEU . 70.0 mt -59.08 -36.41 75.04 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.835 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.544 ' O ' HG12 ' A' ' 15' ' ' ILE . 8.3 m-85 -63.92 -54.75 29.77 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.194 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.502 ' O ' ' HB2' ' A' ' 16' ' ' MET . 28.0 mtt85 -56.23 -37.33 69.58 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.86 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -75.49 -37.61 60.07 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.261 0.35 . . . . 0.0 110.868 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 t -76.93 -34.62 22.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.937 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 11' ' ' TYR . 29.0 pt -77.91 -18.44 13.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 121.813 -0.555 . . . . 0.0 109.804 174.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 45.7 ttm -69.04 -47.41 65.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -61.05 -46.41 90.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.733 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 58.9 t-80 -51.61 -45.86 63.37 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.251 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -66.72 -49.12 67.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.387 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -44.61 -41.38 6.54 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.238 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -131.73 81.05 64.6 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-O 121.407 0.622 . . . . 0.0 109.505 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -88.72 94.99 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.078 2.519 . . . . 0.0 112.875 -171.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -161.17 115.05 2.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.009 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.612 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 13.8 m120 -113.16 24.76 11.99 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.32 101.04 10.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.972 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.653 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -168.65 120.44 0.89 Allowed Glycine 0 CA--C 1.494 -1.237 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.755 HG22 ' HE ' ' A' ' 46' ' ' ARG . 2.4 p -167.88 105.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 O-C-N 121.185 -1.186 . . . . 0.0 110.982 -174.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.457 ' H ' ' CB ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -87.55 -155.36 0.29 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.396 0.617 . . . . 0.0 110.155 173.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.566 ' HA ' HG22 ' A' ' 33' ' ' VAL . 3.8 p-10 -166.42 13.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.357 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -99.42 -71.18 0.7 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.804 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.693 ' HB3' ' O ' ' A' ' 49' ' ' MET . 11.3 t -73.19 -143.98 0.02 OUTLIER 'General case' 0 C--O 1.238 0.486 0 O-C-N 123.157 0.286 . . . . 0.0 110.649 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.789 HG13 ' HB2' ' A' ' 49' ' ' MET . 27.9 pt -78.78 119.98 28.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.683 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.984 HG11 HG23 ' A' ' 48' ' ' THR . 79.9 t -119.2 135.02 60.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.257 -177.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.755 HG22 ' HA2' ' A' ' 139' ' ' GLY . 78.9 t -123.52 119.63 57.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -120.65 118.71 30.82 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.051 0.219 . . . . 0.0 110.766 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.774 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 3.4 mmt -144.51 121.17 11.15 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.15 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.498 ' HB3' ' HG3' ' A' ' 44' ' ' ARG . 3.1 p30 -120.09 158.65 26.43 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 172.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.624 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 25.9 t30 -114.46 100.07 52.38 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 121.384 0.611 . . . . 0.0 109.816 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.12 -19.34 40.87 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 123.157 2.571 . . . . 0.0 113.113 -173.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 60.1 m -62.91 -43.92 97.49 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.8 p -133.0 8.67 4.09 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.06 6.9 78.33 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.477 163.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.624 ' OD1' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -82.3 146.4 29.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.216 0.531 . . . . 0.0 110.153 176.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.498 ' HG3' ' HB3' ' A' ' 37' ' ' ASN . 52.3 ttt180 -139.71 148.32 42.16 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.622 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.7 tt -140.18 146.61 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 123.536 0.523 . . . . 0.0 110.12 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.755 ' HE ' HG22 ' A' ' 27' ' ' VAL . 75.4 mtp85 -141.17 100.38 3.79 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.241 0.543 . . . . 0.0 110.326 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.704 HD22 ' HG3' ' A' ' 49' ' ' MET . 0.3 OUTLIER -89.99 92.17 8.88 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.48 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.984 HG23 HG11 ' A' ' 33' ' ' VAL . 77.7 p -93.23 130.64 38.86 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.553 -0.717 . . . . 0.0 109.79 174.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.789 ' HB2' HG13 ' A' ' 32' ' ' ILE . 36.9 mtt -126.92 -177.7 4.13 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 121.819 -0.55 . . . . 0.0 110.815 -172.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.797 ' HZ1' ' HB2' ' A' ' 52' ' ' ASP . 10.5 tmtt? -160.61 110.93 1.78 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.5 pt? -128.57 94.3 3.84 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.942 0.877 . . . . 0.0 108.939 -170.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.797 ' HB2' ' HZ1' ' A' ' 50' ' ' LYS . 37.4 t70 -101.89 59.84 0.85 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.759 0.79 . . . . 0.0 109.951 -171.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.83 -94.82 0.16 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 170.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -133.77 24.71 4.0 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.408 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -139.48 160.13 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -173.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -95.68 97.12 6.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 123.485 1.612 . . . . 0.0 106.999 165.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 50' ' ' LYS . 37.8 tt0 -66.44 -41.88 88.46 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 112.509 -2.132 . . . . 0.0 110.189 -167.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -148.72 146.53 28.14 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.561 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.33 121.93 11.11 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.653 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 89.4 mttt -126.06 140.86 52.25 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.704 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.651 ' CZ ' ' HA ' ' A' ' 74' ' ' SER . 31.2 p90 -128.22 143.39 51.03 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.972 0.415 . . . . 0.0 110.575 -172.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.612 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 45.7 tt0 -117.05 114.02 23.16 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -121.38 128.66 7.42 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.265 -173.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -148.21 108.45 4.1 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 43' ' ' ASP . . . 170.84 -132.4 2.47 Favored Glycine 0 C--N 1.317 -0.523 0 C-N-CA 119.363 -1.398 . . . . 0.0 112.584 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 70' ' ' MET . 1.4 p -95.37 159.25 15.09 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 120.753 0.311 . . . . 0.0 110.261 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.9 t -78.75 24.9 0.28 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.467 -167.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.487 HD12 HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -118.19 -52.67 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 122.386 1.089 . . . . 0.0 109.652 179.022 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.613 ' HB3' HD21 ' A' ' 131' ' ' LEU . 1.2 m -77.23 -44.29 30.49 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 121.781 0.801 . . . . 0.0 111.098 -170.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 66' ' ' CYS . 26.9 ptm -72.16 -12.84 61.37 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.392 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.81 -45.98 11.08 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.071 -0.393 . . . . 0.0 111.379 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 p -62.62 -28.36 69.85 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 121.41 0.624 . . . . 0.0 109.849 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.61 -50.38 67.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.463 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.651 ' HA ' ' CZ ' ' A' ' 61' ' ' PHE . 24.3 m -59.64 -39.25 83.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -76.49 -58.61 3.18 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.829 -174.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.6 ' SD ' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -59.34 -34.0 71.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.817 -177.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 1.059 ' HA ' HG23 ' A' ' 80' ' ' ILE . 98.9 m -61.97 -43.18 99.37 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.088 0.858 . . . . 0.0 110.1 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 75' ' ' MET . 77.5 mt-30 -49.45 -37.01 24.34 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.773 0.797 . . . . 0.0 110.535 172.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.489 ' HB1' ' OD2' ' A' ' 109' ' ' ASP . . . -86.26 -31.84 21.44 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.682 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 1.059 HG23 ' HA ' ' A' ' 77' ' ' THR . 9.9 tp -83.24 -40.17 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.054 -173.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -54.34 -17.29 2.84 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.927 0.87 . . . . 0.0 111.346 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.26 40.88 2.12 Favored Glycine 0 C--N 1.31 -0.895 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -132.78 167.05 20.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -103.98 -177.06 3.26 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.678 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.4 mp -81.77 -45.37 20.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.21 -176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -58.36 -43.45 88.4 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.37 0.419 . . . . 0.0 111.099 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.522 ' HA ' ' OG ' ' A' ' 90' ' ' SER . 2.7 p -68.84 -37.65 79.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.389 0.614 . . . . 0.0 111.508 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.4 ' HB2' HG13 ' A' ' 140' ' ' VAL . . . -60.89 -40.52 93.37 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.863 175.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.835 HD21 ' HB3' ' A' ' 142' ' ' LYS . 34.0 mt -69.58 -37.5 76.97 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 110.819 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.522 ' OG ' ' HA ' ' A' ' 87' ' ' THR . 2.3 p -75.43 -35.24 61.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.072 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.533 ' HA ' HG23 ' A' ' 94' ' ' ILE . 11.2 tmm? -64.94 -20.85 66.68 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.778 0.799 . . . . 0.0 109.185 173.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.795 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 43.6 t -85.35 -42.96 14.1 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.297 -1.319 . . . . 0.0 107.577 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.637 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 54.3 tttp -67.42 -36.25 80.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.329 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.533 HG23 ' HA ' ' A' ' 91' ' ' MET . 9.1 tt -79.73 -39.77 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.087 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -46.19 -38.63 8.57 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.44 0.638 . . . . 0.0 111.247 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.5 m -86.66 -28.23 23.29 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.44 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -71.77 -21.57 61.71 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.052 0.541 . . . . 0.0 111.0 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -41.94 -47.27 4.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.673 0.789 . . . . 0.0 112.513 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.1 ttt -55.08 -18.24 5.14 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -129.3 -26.46 2.56 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.492 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.47 -40.17 4.26 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.512 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp 87.85 37.48 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.427 ' HB3' HD11 ' A' ' 94' ' ' ILE . 39.7 mt-10 -132.45 126.96 34.27 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.562 -2.108 . . . . 0.0 107.219 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.58 ' CD1' HD21 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -94.59 -89.73 0.23 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 107' ' ' SER . 5.3 t70 -115.02 112.64 22.96 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 156.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.491 ' H ' HD12 ' A' ' 94' ' ' ILE . 30.9 t70 -49.89 -21.81 1.29 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.775 173.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.462 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 1.3 m -80.11 -17.13 53.4 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.48 ' HA ' HD13 ' A' ' 110' ' ' LEU . 21.9 mm 72.23 24.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 122.507 1.146 . . . . 0.0 110.492 174.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.489 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 27.6 t70 -95.17 66.77 2.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.055 177.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.793 ' HG ' ' HB ' ' A' ' 113' ' ' ILE . 7.8 mp -95.94 40.32 1.12 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.127 -165.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.443 ' HA2' ' SD ' ' A' ' 75' ' ' MET . . . -38.31 -50.75 2.28 Favored Glycine 0 C--O 1.242 0.594 0 O-C-N 124.066 0.854 . . . . 0.0 114.145 177.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.63 ' HB2' HD21 ' A' ' 116' ' ' LEU . 8.5 p-10 -91.59 -43.38 9.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.8 -0.824 . . . . 0.0 110.238 176.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.793 ' HB ' ' HG ' ' A' ' 110' ' ' LEU . 16.4 mt -62.93 -33.3 59.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.575 -166.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.466 ' HG2' HD21 ' A' ' 10' ' ' LEU . 31.8 tt0 -61.98 -50.83 70.52 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.423 ' O ' HG21 ' A' ' 119' ' ' VAL . . . -69.68 -53.37 18.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.933 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 112' ' ' ASP . 3.9 mp -82.72 -2.7 54.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -164.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -62.79 -39.32 93.87 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.52 -17.19 64.62 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.864 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.85 HG13 ' HB3' ' A' ' 125' ' ' ARG . 91.8 t -86.17 -46.94 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -171.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.6 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 9.4 t -49.56 -10.16 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.63 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.824 ' HA ' ' HE3' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -134.0 -17.41 2.15 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.365 -160.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -88.63 130.06 46.63 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.56 -30.61 55.44 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 122.433 2.089 . . . . 0.0 112.276 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.25 1.75 56.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.255 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.85 ' HB3' HG13 ' A' ' 119' ' ' VAL . 27.9 mmt180 -134.92 8.01 3.49 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 118.61 0.641 . . . . 0.0 110.422 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.2 tt -84.34 -30.07 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -165.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.489 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 31.8 mmtp -74.99 -30.49 61.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.999 174.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.2 m -78.62 -17.64 55.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.023 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.6 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -78.38 -31.4 48.38 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.92 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.756 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 25.3 m -72.11 -44.47 63.15 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.613 HD21 ' HB3' ' A' ' 69' ' ' SER . 9.5 tt -50.2 -63.59 1.07 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.636 174.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.52 ' HB2' HD22 ' A' ' 116' ' ' LEU . 13.5 p -74.59 -63.49 1.23 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.985 -171.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.49 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 4.7 t90 -66.38 -56.34 11.54 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 122.58 0.352 . . . . 0.0 111.219 -175.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.756 ' HB3' ' O ' ' A' ' 130' ' ' THR . 24.1 tptm -56.6 -40.08 74.66 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 123.992 0.808 . . . . 0.0 110.184 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.1 -32.95 73.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.555 HD22 ' SD ' ' A' ' 76' ' ' MET . 15.7 tp -78.22 -33.8 49.65 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.018 0.914 . . . . 0.0 109.217 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.422 ' HA ' ' HB2' ' A' ' 141' ' ' ALA . 3.5 tp10 -68.82 -41.11 79.03 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 122.844 1.307 . . . . 0.0 109.395 175.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -85.37 13.71 6.29 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 113.965 -1.47 . . . . 0.0 109.907 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.755 ' HA2' HG22 ' A' ' 34' ' ' VAL . . . -95.87 -32.95 6.57 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.569 -177.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 88' ' ' ALA . 9.3 p -171.34 -28.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.795 ' HB1' ' HB2' ' A' ' 92' ' ' SER . . . -63.76 177.3 0.75 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 123.713 0.633 . . . . 0.0 110.438 173.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.835 ' HB3' HD21 ' A' ' 89' ' ' LEU . 86.0 tttt 177.76 -29.84 0.0 OUTLIER 'General case' 0 C--O 1.237 0.421 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -170.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.637 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 26.1 tt0 65.76 -76.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.816 0.341 . . . . 0.0 110.605 -172.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--N 1.318 -0.791 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.929 -172.888 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 C--O 1.241 0.631 0 CA-C-O 122.071 0.939 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.796 HD21 HG23 ' A' ' 68' ' ' ILE . 15.8 tp -102.11 -20.18 14.84 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.426 -171.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 18.6 t70 -52.76 -54.51 32.91 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.59 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -49.64 -40.49 39.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.545 175.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.509 HD12 ' HB3' ' A' ' 114' ' ' GLU . 2.7 mm? -65.74 -39.19 90.85 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.895 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.524 ' HE1' ' HB2' ' A' ' 67' ' ' SER . 41.3 m-85 -64.83 -47.92 76.25 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.428 176.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 8' ' ' ASP . 43.4 mtp180 -56.14 -47.06 78.92 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.056 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -72.01 -43.69 64.65 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 120.586 0.232 . . . . 0.0 111.58 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.9 t -81.21 -33.38 12.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.096 0.474 . . . . 0.0 111.809 -170.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 11' ' ' TYR . 1.7 mp -73.37 -24.54 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 O-C-N 121.932 -0.48 . . . . 0.0 110.195 173.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ttt -67.69 -51.0 54.77 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.593 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.24 -38.32 81.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.112 0.482 . . . . 0.0 110.369 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -54.49 -41.76 69.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.28 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -56.41 -59.09 5.47 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.924 0.393 . . . . 0.0 111.163 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -66.94 -18.83 65.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -137.49 82.12 28.73 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.394 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -90.93 73.61 0.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 123.476 2.784 . . . . 0.0 112.763 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -109.61 62.48 0.6 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.182 0.515 . . . . 0.0 111.008 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -136.64 37.2 2.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.608 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -145.53 43.51 1.28 Allowed 'General case' 0 C--N 1.315 -0.907 0 O-C-N 123.526 0.516 . . . . 0.0 109.631 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.25 167.31 29.02 Favored Glycine 0 C--O 1.222 -0.632 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.533 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.718 HG21 HG21 ' A' ' 48' ' ' THR . 3.1 p -165.87 130.68 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 117.212 0.506 . . . . 0.0 109.906 -174.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.733 HD11 ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -150.72 164.59 35.78 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.731 178.239 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -117.84 28.05 8.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.593 0.711 . . . . 0.0 110.739 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.27 2.48 9.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.898 -173.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.681 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 4.8 t -165.4 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.07 0.462 . . . . 0.0 110.543 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.46 HG13 ' SD ' ' A' ' 49' ' ' MET . 15.7 pt -127.37 146.66 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.962 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.938 HG11 HG23 ' A' ' 48' ' ' THR . 36.6 t -125.86 116.21 45.36 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.001 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.865 HG23 ' HA2' ' A' ' 139' ' ' GLY . 18.1 t -102.56 118.34 49.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.313 0.578 . . . . 0.0 110.478 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 9.2 t70 -119.28 127.95 53.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.023 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.609 ' SD ' ' HA ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -130.73 117.11 18.94 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.804 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 4.6 p30 -117.39 125.76 51.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.49 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -129.64 90.24 44.26 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -33.19 118.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.33 -0.403 1 C-N-CA 125.59 4.193 . . . . 0.0 114.773 -168.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.1 m 79.17 -35.68 0.16 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 171.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.413 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 32.5 t -94.98 -14.2 24.6 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 122.312 1.053 . . . . 0.0 109.217 -174.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.646 ' HA3' HD21 ' A' ' 131' ' ' LEU . . . 179.59 64.42 0.07 OUTLIER Glycine 0 N--CA 1.414 -2.781 0 N-CA-C 105.836 -2.906 . . . . 0.0 105.836 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 24.1 t70 -49.63 -47.26 49.89 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.33 1.052 . . . . 0.0 111.528 -159.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.804 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 12.8 ptm180 -164.66 151.88 11.37 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.914 169.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.48 HG22 ' HE1' ' A' ' 61' ' ' PHE . 43.8 pt -139.16 141.17 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.637 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 93.0 mtt180 -123.06 105.83 10.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.106 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.689 HD23 ' HE2' ' A' ' 49' ' ' MET . 1.3 tt -89.66 102.85 15.53 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.938 HG23 HG11 ' A' ' 33' ' ' VAL . 82.4 p -99.13 117.58 33.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.893 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.689 ' HE2' HD23 ' A' ' 47' ' ' LEU . 2.0 mpt? -105.82 178.65 4.5 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.243 0.544 . . . . 0.0 110.812 -172.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 31' ' ' SER . 14.5 tmtt? -152.29 97.93 2.35 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 10.0 mt -115.48 89.45 3.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.607 -171.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -113.02 94.31 4.84 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.445 1.117 . . . . 0.0 109.593 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.67 -104.24 0.45 Allowed Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.763 -173.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -151.74 22.34 0.69 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 111.813 -2.193 . . . . 0.0 108.439 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 2.0 pp -132.19 160.38 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.007 -170.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.442 ' HA ' HD23 ' A' ' 51' ' ' LEU . 3.0 p -97.92 109.06 22.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 166.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.582 ' HB2' HD13 ' A' ' 55' ' ' ILE . 2.5 tm-20 -97.68 -34.16 11.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -164.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.571 ' OD2' HD21 ' A' ' 28' ' ' LEU . 19.6 t70 -143.4 147.2 34.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.947 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 48' ' ' THR . . . -167.85 134.33 2.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.552 0.215 . . . . 0.0 110.524 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -136.85 175.56 9.5 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.637 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -127.57 133.83 49.75 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 123.972 0.795 . . . . 0.0 111.067 176.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -128.89 132.09 47.67 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.21 -177.96 48.58 Favored Glycine 0 C--N 1.31 -0.901 0 C-N-CA 118.695 -1.717 . . . . 0.0 113.804 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -139.82 125.47 19.33 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.96 -131.48 1.35 Allowed Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -171.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.413 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 5.4 p -131.48 174.5 10.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 118.187 0.994 . . . . 0.0 111.653 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.524 ' HB2' ' HE1' ' A' ' 11' ' ' TYR . 6.3 p -52.89 -49.3 66.14 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -168.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.796 HG23 HD21 ' A' ' 7' ' ' LEU . 2.5 pp -77.28 -24.62 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.704 -171.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.638 ' HG ' HD11 ' A' ' 68' ' ' ILE . 1.7 m -68.95 -45.69 70.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.381 0.61 . . . . 0.0 109.59 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.429 ' HG2' ' CZ ' ' A' ' 61' ' ' PHE . 55.2 mtt -67.08 -35.23 79.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.813 173.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 74' ' ' SER . . . -69.25 -44.36 72.12 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -172.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 50.5 m -62.89 -50.28 71.49 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.6 -40.54 72.19 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 114.59 -1.187 . . . . 0.0 111.414 174.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 71' ' ' ALA . 64.1 m -47.95 -55.94 8.78 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 175.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.765 ' HG3' ' HA3' ' A' ' 111' ' ' GLY . 1.3 tmt? -71.08 -37.4 72.45 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -172.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.658 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 6.6 mmt -77.0 -34.98 57.43 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.638 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 30.1 m -62.95 -21.12 65.86 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.946 -1.096 . . . . 0.0 109.393 169.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -85.81 -38.69 17.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.572 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.0 -44.41 11.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.626 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.658 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -76.61 -38.5 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 122.886 0.474 . . . . 0.0 111.084 -171.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.638 ' HB2' ' O ' ' A' ' 77' ' ' THR . 8.3 ttpp -49.77 -17.02 0.29 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.6 37.84 3.16 Favored Glycine 0 C--O 1.218 -0.86 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -133.32 -166.74 1.81 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.8 p-10 -123.78 -163.61 1.15 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.734 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -81.66 -44.74 20.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.267 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -66.09 -39.77 90.28 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.879 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.4 p -64.14 -38.76 92.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.701 0.286 . . . . 0.0 110.563 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.449 ' HB1' HG11 ' A' ' 140' ' ' VAL . . . -60.2 -46.49 89.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 122.011 0.91 . . . . 0.0 110.346 174.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 48.1 mt -63.3 -34.26 77.31 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.77 0.795 . . . . 0.0 109.797 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.401 ' O ' HG13 ' A' ' 94' ' ' ILE . 49.0 m -64.01 -25.63 68.21 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.731 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.493 ' HE3' ' HE3' ' A' ' 76' ' ' MET . 94.6 mmm -71.48 -38.64 71.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.3 0.571 . . . . 0.0 110.263 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.517 ' CB ' ' H ' ' A' ' 143' ' ' GLU . 15.1 t -64.41 -39.81 94.56 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.889 171.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.98 -45.33 86.93 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 121.954 0.883 . . . . 0.0 109.533 172.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 104' ' ' TYR . 44.9 mt -59.5 -51.31 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.563 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -57.6 -37.81 73.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.396 0.617 . . . . 0.0 112.233 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.2 p -72.62 -34.56 67.42 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.776 -0.578 . . . . 0.0 110.824 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.1 -42.71 72.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.497 0.665 . . . . 0.0 110.777 172.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.2 tmt? -56.1 -15.29 3.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.008 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 57.7 ttp -85.38 -22.21 28.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.857 0.837 . . . . 0.0 109.577 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -77.49 2.63 15.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.309 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.39 44.35 51.76 Favored Glycine 0 CA--C 1.503 -0.717 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.976 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.685 ' HG2' ' H ' ' A' ' 103' ' ' GLU . 78.2 tttt -123.3 -136.94 0.3 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.685 ' H ' ' HG2' ' A' ' 102' ' ' LYS . 51.0 mt-10 -75.25 -158.07 0.08 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.381 0.61 . . . . 0.0 110.207 172.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.518 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -146.73 -102.12 0.09 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.149 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' A' ' 107' ' ' SER . 8.0 t70 -108.7 105.94 15.76 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.29 20.65 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.505 0.722 . . . . 0.0 112.4 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 105' ' ' ASP . 1.7 m -109.59 -20.09 12.98 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 166.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.488 HG21 ' O ' ' A' ' 108' ' ' ILE . 22.3 mm 70.42 28.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.018 171.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -97.03 90.67 5.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.516 ' HB3' ' HG3' ' A' ' 114' ' ' GLU . 4.3 mp -127.23 17.34 7.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.978 -169.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.765 ' HA3' ' HG3' ' A' ' 75' ' ' MET . . . -46.58 -36.64 8.16 Favored Glycine 0 C--N 1.34 0.805 0 O-C-N 124.448 1.092 . . . . 0.0 114.192 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 16.7 p-10 -75.68 -58.48 3.25 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 122.582 -0.363 . . . . 0.0 111.271 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.725 ' HA ' ' HB2' ' A' ' 116' ' ' LEU . 53.1 mt -63.14 -24.94 37.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 C-N-CA 124.706 1.203 . . . . 0.0 111.299 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 16.8 mt-10 -62.74 -48.97 76.89 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.36 -47.07 71.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.708 171.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.725 ' HB2' ' HA ' ' A' ' 113' ' ' ILE . 8.1 mt -58.67 -34.32 71.12 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.026 0.441 . . . . 0.0 111.188 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 8.4 tt0 -42.97 -53.06 4.94 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.622 1.569 . . . . 0.0 112.386 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.38 -17.68 70.75 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.601 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.735 HG11 ' HB3' ' A' ' 125' ' ' ARG . 48.9 t -84.8 -46.24 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 117.224 0.512 . . . . 0.0 111.18 -173.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.692 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 24.5 m -42.49 -16.14 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -127.8 -3.25 5.91 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -162.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.702 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 6.6 m-85 -83.17 145.59 49.36 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -46.98 -39.15 24.79 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.424 2.75 . . . . 0.0 112.874 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.21 5.38 19.93 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.735 ' HB3' HG11 ' A' ' 119' ' ' VAL . 22.1 mtm180 -112.68 2.15 16.0 Favored 'General case' 0 C--O 1.202 -1.42 0 CA-C-O 122.303 1.049 . . . . 0.0 109.93 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -78.96 -37.65 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 113.989 -1.459 . . . . 0.0 108.912 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -74.79 -21.53 59.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.027 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.493 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 5.9 t -85.77 -16.91 37.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.582 -1.645 . . . . 0.0 109.248 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.692 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -85.65 -27.55 25.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 124.582 1.176 . . . . 0.0 108.988 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.72 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 3.0 m -70.67 -39.26 73.66 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 175.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.646 HD21 ' HA3' ' A' ' 42' ' ' GLY . 16.7 tp -49.62 -60.86 2.49 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.823 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.448 ' HB2' ' CD2' ' A' ' 116' ' ' LEU . 10.5 m -78.03 -60.67 2.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -171.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.502 ' HB2' HD22 ' A' ' 116' ' ' LEU . 67.0 t90 -66.42 -52.59 44.86 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.72 ' HB3' ' O ' ' A' ' 130' ' ' THR . 21.9 ttmt -58.94 -36.48 74.84 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.047 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.17 77.97 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.173 172.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.561 ' CD2' ' HG3' ' A' ' 76' ' ' MET . 13.5 tp -76.37 -35.87 58.45 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.74 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -71.18 -32.95 69.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.966 0.889 . . . . 0.0 109.073 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -81.44 4.99 19.04 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.403 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.865 ' HA2' HG23 ' A' ' 34' ' ' VAL . . . -91.86 -44.65 4.13 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.705 -0.679 . . . . 0.0 113.734 -171.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.449 HG11 ' HB1' ' A' ' 88' ' ' ALA . 12.4 p -166.95 -27.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 122.156 -0.614 . . . . 0.0 111.056 -174.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.713 ' HA ' HD23 ' A' ' 89' ' ' LEU . . . -78.94 160.73 27.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.484 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 141' ' ' ALA . 87.0 tttt 170.0 76.6 0.0 OUTLIER 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.372 0.669 . . . . 0.0 110.703 173.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.517 ' H ' ' CB ' ' A' ' 92' ' ' SER . 17.8 tp10 -81.62 -48.43 11.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 170.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 . . . . . 0 N--CA 1.441 -0.916 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.647 175.113 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.525 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 26.6 p-10 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 115' ' ' ALA . 22.0 tp -93.57 -19.71 20.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.827 -170.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -58.92 -56.99 15.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 124.042 0.838 . . . . 0.0 109.71 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.1 t -65.03 -37.66 88.33 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 6' ' ' ASN . 58.7 mt -53.1 -35.86 60.08 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.627 0.727 . . . . 0.0 111.039 173.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.423 ' O ' HG13 ' A' ' 15' ' ' ILE . 13.2 m-85 -70.92 -39.22 72.82 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -65.8 -35.21 80.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.659 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -65.84 -28.27 68.86 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 123.998 0.811 . . . . 0.0 109.988 174.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.984 HG12 ' HB1' ' A' ' 71' ' ' ALA . 66.6 t -84.0 -41.72 16.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.221 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 11' ' ' TYR . 76.0 mt -61.7 -29.51 46.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 CA-C-O 121.54 0.685 . . . . 0.0 110.15 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -62.08 -51.17 69.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.386 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 11.4 t70 -72.48 -40.35 67.0 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -54.26 -45.24 72.35 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.443 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -59.03 -52.14 67.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.341 0.256 . . . . 0.0 111.432 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 17' ' ' ASP . 32.7 ttpt -42.89 -34.15 0.91 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 173.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.514 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.0 OUTLIER -154.34 84.58 3.93 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-O 122.032 0.92 . . . . 0.0 111.952 177.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -86.1 65.91 5.22 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.319 2.679 . . . . 0.0 111.807 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 25' ' ' LYS . 62.8 mtt180 -73.27 -77.53 0.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.769 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 5.9 m120 67.24 -22.95 0.11 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 23' ' ' ARG . 30.6 mmtp -114.97 85.7 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.812 0.339 . . . . 0.0 111.24 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -139.75 146.17 17.57 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 121.087 -0.577 . . . . 0.0 112.284 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.504 HG22 HG21 ' A' ' 48' ' ' THR . 7.4 p -168.16 134.59 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 122.689 0.396 . . . . 0.0 110.193 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.655 HD11 ' HB ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -151.62 140.37 20.85 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.69 172.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.456 ' HA ' HG21 ' A' ' 33' ' ' VAL . 3.1 p-10 -100.51 39.33 1.38 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.367 -174.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.73 -104.06 0.03 OUTLIER 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.559 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.532 ' CB ' ' HG ' ' A' ' 51' ' ' LEU . 13.0 m -72.05 -76.18 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.317 0.579 . . . . 0.0 112.031 -174.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.888 HG13 ' HB2' ' A' ' 49' ' ' MET . 6.8 pt -119.58 131.05 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-O 121.411 0.624 . . . . 0.0 111.99 -176.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.875 HG13 HG23 ' A' ' 48' ' ' THR . 89.5 t -124.74 129.08 73.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 123.543 0.737 . . . . 0.0 109.762 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.771 HG21 ' HA2' ' A' ' 139' ' ' GLY . 7.1 t -134.25 127.84 51.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.329 0.585 . . . . 0.0 110.386 -173.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.571 ' OD2' ' HD2' ' A' ' 46' ' ' ARG . 2.0 m-20 -117.23 134.45 54.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.249 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.782 ' HA ' ' HE3' ' A' ' 36' ' ' MET . 0.7 OUTLIER -142.22 122.53 13.94 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -125.0 140.79 52.6 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.709 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 51.1 t30 -135.11 119.35 13.41 Favored Pre-proline 0 C--O 1.253 1.263 0 O-C-N 121.316 -0.865 . . . . 0.0 109.295 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.48 ' HD2' ' OD1' ' A' ' 38' ' ' ASN . 59.6 Cg_exo -25.5 105.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 1 C-N-CA 126.685 4.923 . . . . 0.0 116.417 -175.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.8 m 74.32 -34.52 0.28 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 165.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 127' ' ' LYS . 33.1 t -79.01 -49.23 13.03 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.604 -167.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.636 ' HA3' HD22 ' A' ' 131' ' ' LEU . . . -130.9 24.01 4.34 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.157 -1.021 . . . . 0.0 112.103 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.646 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 34.3 t70 40.77 -96.21 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.137 0 O-C-N 124.85 0.971 . . . . 0.0 111.936 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -136.44 146.38 46.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.356 0.598 . . . . 0.0 111.933 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 tt -131.98 125.18 54.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 170.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.571 ' HD2' ' OD2' ' A' ' 35' ' ' ASP . 24.4 mtm180 -130.36 109.22 10.57 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.189 -174.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.749 HD12 ' HE1' ' A' ' 49' ' ' MET . 0.7 OUTLIER -103.16 100.74 10.67 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 124.33 1.019 . . . . 0.0 108.934 -176.022 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.875 HG23 HG13 ' A' ' 33' ' ' VAL . 57.4 p -97.3 131.42 44.02 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 172.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.888 ' HB2' HG13 ' A' ' 32' ' ' ILE . 55.9 mtt -121.38 -178.56 3.82 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.584 0.707 . . . . 0.0 110.292 -176.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 45.2 tttm -157.63 111.66 2.59 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.541 HD23 HD12 ' A' ' 85' ' ' ILE . 6.3 mt -92.45 140.24 29.77 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.342 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.902 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . 2.4 m-20 -134.18 64.86 1.59 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 140.5 -133.25 5.85 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -164.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -121.11 31.79 6.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 168.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.48 HD11 ' HG2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -127.44 178.22 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.571 -172.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -107.61 112.93 42.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.902 ' HG3' ' HB2' ' A' ' 52' ' ' ASP . 4.3 mm-40 -101.8 -31.35 10.79 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 122.03 0.919 . . . . 0.0 109.414 -169.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 33.2 t0 -141.53 144.95 34.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.643 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.02 134.39 15.24 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.416 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 73.4 mmtt -124.96 129.82 51.12 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.514 ' HB3' HG23 ' A' ' 77' ' ' THR . 47.6 p90 -116.02 141.21 48.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.199 0.524 . . . . 0.0 111.203 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 26.4 tt0 -116.6 121.79 42.74 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.92 128.29 5.24 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.544 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.646 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 10.3 tp10 -150.8 128.02 11.25 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.65 -131.68 2.57 Favored Glycine 0 C--O 1.227 -0.284 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 -171.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.4 p -99.47 159.57 14.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.461 0.63 . . . . 0.0 109.787 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 p -59.22 -38.71 80.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.838 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.787 HD11 HG21 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -61.4 -48.37 89.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.7 m -68.93 -47.35 65.94 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 110.785 -173.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.2 ptp -61.61 -29.91 70.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.452 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.984 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -66.14 -53.17 41.08 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.29 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.47 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 16.2 m -56.42 -40.02 74.02 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 123.9 0.75 . . . . 0.0 109.651 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.7 -57.21 10.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.582 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.459 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 49.2 m -55.76 -48.62 74.96 Favored 'General case' 0 CA--C 1.493 -1.246 0 O-C-N 123.873 0.733 . . . . 0.0 112.266 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.8 tpt -70.65 -54.96 9.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 120.933 0.397 . . . . 0.0 110.551 -174.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.676 ' HG3' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -59.95 -44.76 94.19 Favored 'General case' 0 C--O 1.205 -1.252 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.556 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.66 ' HA ' HG23 ' A' ' 80' ' ' ILE . 32.0 m -63.03 -36.99 85.42 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.16 0.891 . . . . 0.0 109.784 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -52.41 -47.85 66.07 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.002 174.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.84 -23.97 25.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.453 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.66 HG23 ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -77.48 -30.75 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -174.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.544 ' HZ3' ' HB3' ' A' ' 81' ' ' LYS . 7.0 ttpm? -52.93 -18.64 2.06 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.483 170.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.78 44.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.638 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 8.3 mttp -132.61 -162.4 1.23 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.019 0.438 . . . . 0.0 110.508 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.9 m-20 -140.83 164.56 29.91 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mp -68.09 -51.25 50.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 119.239 0.927 . . . . 0.0 110.573 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.91 -36.45 79.3 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.776 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.4 m -66.77 -41.83 87.1 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.614 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.85 82.0 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.57 0.544 . . . . 0.0 111.325 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 83.2 mt -63.59 -39.15 93.65 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.863 0.84 . . . . 0.0 109.028 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.7 t -59.14 -41.9 89.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.411 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.52 ' HE3' ' HE2' ' A' ' 76' ' ' MET . 12.3 ttt -65.63 -38.35 89.14 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.069 0.461 . . . . 0.0 110.586 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.741 ' HB3' ' HD2' ' A' ' 142' ' ' LYS . 16.3 m -60.34 -48.49 81.52 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.045 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -59.85 -40.74 89.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.603 0.716 . . . . 0.0 109.471 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' A' ' 104' ' ' TYR . 29.8 mt -61.62 -47.83 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.966 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -56.65 -34.49 67.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.818 0.342 . . . . 0.0 110.57 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.3 m -71.58 -44.39 64.57 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.869 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.92 -52.02 53.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.779 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.1 tpt -38.95 -63.51 0.52 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.5 mmm -49.2 -17.13 0.2 Allowed 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -128.07 -4.1 5.67 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.892 0.315 . . . . 0.0 111.193 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -116.44 -32.25 1.67 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.947 -1.121 . . . . 0.0 113.871 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 88.41 -13.93 0.4 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.245 1.418 . . . . 0.0 110.075 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -98.59 134.85 40.95 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.667 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.492 ' HA ' HG22 ' A' ' 94' ' ' ILE . 3.2 p90 -124.75 -121.93 0.26 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.826 -176.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.471 ' O ' HD13 ' A' ' 108' ' ' ILE . 24.8 t70 -94.44 107.15 19.13 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 120.914 0.387 . . . . 0.0 110.342 -174.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -48.29 -19.06 0.26 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.205 -1.361 . . . . 0.0 113.049 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.7 t -92.8 -22.69 19.17 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.613 ' HA ' HD12 ' A' ' 110' ' ' LEU . 23.4 mm 67.56 39.14 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 122.164 0.983 . . . . 0.0 109.855 175.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -99.21 81.93 2.63 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.613 HD12 ' HA ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -144.57 51.34 1.27 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -174.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -39.65 -18.76 0.01 OUTLIER Glycine 0 CA--C 1.54 1.605 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.536 ' HB3' ' HG3' ' A' ' 76' ' ' MET . 14.0 p-10 -85.27 -43.4 13.78 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 117.692 0.746 . . . . 0.0 109.522 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.875 ' O ' ' HB2' ' A' ' 117' ' ' GLN . 5.0 tt -70.12 -16.81 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.47 -171.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -56.11 -64.78 0.75 Allowed 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.771 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -76.51 -44.77 33.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.918 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.651 HD11 HG21 ' A' ' 119' ' ' VAL . 14.2 tp -92.64 1.67 57.14 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -163.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.875 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 7.1 tt0 -58.44 -52.12 66.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.385 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.06 -13.6 72.91 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.933 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.787 HG21 HD11 ' A' ' 68' ' ' ILE . 93.3 t -78.83 -46.95 23.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 CA-C-N 117.093 0.446 . . . . 0.0 110.423 -162.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 125' ' ' ARG . 14.3 m -42.45 -15.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.59 1.556 . . . . 0.0 115.135 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 125' ' ' ARG . 63.9 pttt -131.3 13.81 5.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.528 -0.733 . . . . 0.0 112.47 -171.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.689 ' HD2' ' HA ' ' A' ' 119' ' ' VAL . 15.4 m-85 -76.43 170.03 18.08 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.199 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.421 ' HD2' ' HD1' ' A' ' 122' ' ' PHE . 30.5 Cg_endo -65.43 -18.95 61.16 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.207 1.938 . . . . 0.0 109.966 166.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.487 ' HB3' ' HD2' ' A' ' 127' ' ' LYS . . . -113.38 17.14 18.69 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.984 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.602 ' HG3' ' N ' ' A' ' 126' ' ' ILE . 18.6 ptp180 -44.05 -61.18 1.55 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.127 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.602 ' N ' ' HG3' ' A' ' 125' ' ' ARG . 39.9 pt -59.48 -22.97 24.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.184 -172.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.709 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 99.5 mttt -68.34 -63.25 1.1 Allowed 'General case' 0 C--N 1.313 -1.003 0 O-C-N 122.247 -0.283 . . . . 0.0 110.402 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.8 m -85.67 -35.2 21.05 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.451 0.644 . . . . 0.0 110.675 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.689 ' HB3' HG12 ' A' ' 119' ' ' VAL . . . -73.85 -51.28 16.8 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.618 -173.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.544 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 36.7 m -63.83 -45.87 87.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.183 -177.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.636 HD22 ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -56.63 -50.09 73.06 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.163 -0.961 . . . . 0.0 110.567 179.382 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.462 ' N ' ' HG ' ' A' ' 131' ' ' LEU . 7.1 m -76.7 -61.53 1.94 Allowed 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -174.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -61.51 -53.46 56.04 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 123.852 0.72 . . . . 0.0 111.139 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 130' ' ' THR . 88.0 tttt -55.33 -42.91 74.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 36' ' ' MET . . . -61.17 -50.29 73.74 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.549 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.676 HD23 ' HG3' ' A' ' 76' ' ' MET . 11.8 tp -65.2 -31.69 72.99 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.461 0.648 . . . . 0.0 110.338 -175.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.703 ' CG ' ' HD3' ' A' ' 142' ' ' LYS . 2.9 tp10 -83.52 -32.33 25.96 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.79 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -71.09 -47.15 59.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.771 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -41.36 -34.68 1.07 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.395 -0.82 . . . . 0.0 114.35 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.481 ' O ' HD23 ' A' ' 89' ' ' LEU . 27.2 m -108.12 -1.09 9.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.147 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 90.09 3.43 0.16 Allowed 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 168.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.741 ' HD2' ' HB3' ' A' ' 92' ' ' SER . 43.0 tptt 55.18 87.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 171.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 69.3 -52.69 0.6 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.956 0.903 . . . . 0.0 112.228 172.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 C--O 1.24 0.602 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.297 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--O 1.214 -0.79 0 CA-C-O 121.079 0.466 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.486 HD22 HG23 ' A' ' 119' ' ' VAL . 21.5 tp -70.46 -42.75 71.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.022 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.799 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 17.8 t70 -54.5 -53.76 50.04 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.417 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 m -57.29 -54.39 47.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.337 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.617 ' O ' HG12 ' A' ' 14' ' ' VAL . 4.3 mp -47.33 -52.42 16.48 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.419 1.074 . . . . 0.0 111.862 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.799 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 0.6 OUTLIER -79.19 -19.42 50.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.488 -175.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -66.6 -35.67 80.74 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-O 121.412 0.625 . . . . 0.0 109.358 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -75.65 -35.23 60.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.081 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.755 HG21 ' HA ' ' A' ' 11' ' ' TYR . 3.2 m -72.48 -35.34 51.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.961 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.558 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 14.5 tt -77.41 -22.67 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.929 174.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 17.2 tpt -84.9 -38.78 18.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.323 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.763 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 20.3 t70 -77.9 -37.13 48.63 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.441 ' CD2' ' HB3' ' A' ' 24' ' ' ASN . 26.1 t60 -71.43 -16.46 62.38 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.068 171.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.558 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 46.4 t80 -73.57 -48.22 34.55 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.333 0.587 . . . . 0.0 110.014 171.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.763 ' HD3' ' HA ' ' A' ' 17' ' ' ASP . 41.4 mtpt -48.61 -45.79 38.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.846 171.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -114.81 78.41 5.22 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 18' ' ' HIS . 72.7 Cg_endo -77.62 51.11 3.44 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 122.999 2.466 . . . . 0.0 113.414 -165.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -83.72 50.41 1.8 Allowed 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 121.801 -0.562 . . . . 0.0 109.57 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.441 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . 20.0 p-10 -114.2 24.77 11.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.9 0.857 . . . . 0.0 109.044 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -133.15 139.44 47.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.835 -1.53 . . . . 0.0 108.868 173.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 142.67 141.89 3.94 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.103 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.635 HG11 ' HB2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -159.27 127.93 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.774 HD11 ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -136.11 147.68 47.9 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.491 0.663 . . . . 0.0 110.56 176.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -93.26 44.08 1.13 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.23 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 31' ' ' SER . 1.2 m-20 -85.67 -130.37 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.031 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.449 ' H ' ' HB3' ' A' ' 30' ' ' ASP . 14.9 m -52.12 -77.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.784 HG13 ' HB2' ' A' ' 49' ' ' MET . 12.8 pt -127.02 137.86 56.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.622 0.725 . . . . 0.0 110.394 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.596 HG12 HG22 ' A' ' 48' ' ' THR . 95.7 t -123.09 114.69 43.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.617 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.913 HG21 ' HA2' ' A' ' 139' ' ' GLY . 93.9 t -106.88 119.3 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.074 -176.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 2.0 p-10 -127.85 149.57 50.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.504 0.669 . . . . 0.0 110.141 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.462 ' O ' HG22 ' A' ' 45' ' ' ILE . 27.3 ttt -157.37 132.11 8.66 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.173 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 7.0 p30 -127.28 135.62 50.83 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -113.63 88.33 13.43 Favored Pre-proline 0 N--CA 1.439 -0.983 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 167.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -60.08 -6.26 4.8 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.386 2.058 . . . . 0.0 113.889 -169.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.7 p -98.6 -51.03 4.06 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.294 0.568 . . . . 0.0 111.784 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 51.6 t -135.23 17.99 3.42 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -169.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.22 -3.37 0.37 Allowed Glycine 0 N--CA 1.47 0.956 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.406 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.629 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 11.5 m-20 53.79 -110.7 0.56 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 118.394 -0.812 . . . . 0.0 111.117 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 31.3 ptt180 -158.67 148.83 19.69 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.652 1.115 . . . . 0.0 112.549 -176.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.572 HG13 ' CE1' ' A' ' 61' ' ' PHE . 5.0 tt -130.4 133.26 64.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.571 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -121.56 103.44 8.92 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.246 0.341 . . . . 0.0 111.695 173.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.672 HD23 ' HG3' ' A' ' 49' ' ' MET . 1.9 tt -92.6 106.63 18.58 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 172.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.774 ' HB ' HD11 ' A' ' 28' ' ' LEU . 44.9 p -99.27 123.5 43.6 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.784 ' HB2' HG13 ' A' ' 32' ' ' ILE . 52.2 mtt -113.26 178.7 4.19 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 123.741 0.651 . . . . 0.0 111.73 -175.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HA ' ' OG ' ' A' ' 31' ' ' SER . 86.9 tttt -160.24 100.56 1.37 Allowed 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -116.72 92.16 3.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.065 0.936 . . . . 0.0 111.501 -175.503 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -103.36 89.36 3.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.466 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.31 -100.88 0.32 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-O 122.985 1.325 . . . . 0.0 111.821 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -159.6 35.85 0.19 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 111.375 -2.412 . . . . 0.0 106.681 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.666 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.3 pp -140.13 143.58 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.187 -171.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.489 HG12 HG23 ' A' ' 80' ' ' ILE . 1.3 p -92.59 113.35 27.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -102.1 -32.01 10.34 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 113.978 -1.465 . . . . 0.0 107.941 -163.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -136.48 129.51 31.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.65 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.63 104.49 3.75 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.429 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 29.0 mmtp -120.75 151.95 38.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.922 -175.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CE1' HG13 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -130.53 135.75 48.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.635 ' HB2' HG11 ' A' ' 27' ' ' VAL . 1.1 tm-20 -142.09 114.56 8.39 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.76 -177.49 39.16 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.004 -172.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -139.85 157.71 45.28 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.629 ' HA2' ' HB2' ' A' ' 43' ' ' ASP . . . 157.26 -143.17 9.27 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 119.253 -1.451 . . . . 0.0 112.502 176.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 61.1 m -76.31 164.57 25.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.271 0.558 . . . . 0.0 110.828 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -63.41 -35.47 80.52 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.008 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.639 HG13 HG21 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -82.81 -29.02 8.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.05 -177.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.52 ' N ' HD11 ' A' ' 68' ' ' ILE . 8.3 m -66.92 -55.0 16.52 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.699 -0.625 . . . . 0.0 110.729 -174.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.445 ' HE2' HD12 ' A' ' 15' ' ' ILE . 24.7 ptt? -69.55 -16.25 63.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.656 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.492 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -85.84 -53.3 5.2 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.553 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.3 t -74.1 -51.21 16.39 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.746 0.654 . . . . 0.0 109.818 -171.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.36 -51.91 65.25 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.219 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.478 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . 30.3 t -66.16 -38.46 88.14 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.915 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.568 ' SD ' ' HB ' ' A' ' 14' ' ' VAL . 28.7 ttt -59.32 -46.83 87.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.352 0.596 . . . . 0.0 110.671 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -23.28 56.78 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.175 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.593 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 99.6 m -67.97 -43.72 78.33 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-O 122.389 1.09 . . . . 0.0 110.008 172.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.8 tm0? -58.8 -27.03 64.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.835 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.74 -33.6 23.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.63 HG22 ' HE1' ' A' ' 49' ' ' MET . 2.3 mm -67.83 -36.24 75.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.616 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -56.8 -18.87 14.39 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.716 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.94 38.39 2.95 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.737 ' HE3' ' HB ' ' A' ' 87' ' ' THR . 27.3 tptt -131.45 164.33 25.97 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -172.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.596 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.4 p-10 -111.65 -175.2 2.64 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 169.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.752 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.1 mp -76.3 -39.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.267 -173.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -60.67 -48.59 81.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.002 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.737 ' HB ' ' HE3' ' A' ' 83' ' ' LYS . 18.6 p -71.7 -36.12 70.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.535 ' HB2' HG23 ' A' ' 140' ' ' VAL . . . -56.42 -40.5 74.84 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.429 0.633 . . . . 0.0 111.466 172.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 66.3 mt -62.62 -33.82 75.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.367 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -80.45 -25.2 39.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.631 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -65.0 -27.31 68.73 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 121.844 0.83 . . . . 0.0 109.362 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.4 m -88.59 -23.53 23.08 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.366 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 143' ' ' GLU . 83.5 tttt -79.01 -30.17 44.08 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.626 177.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.8 tt -82.21 -33.6 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -50.47 -33.34 20.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.166 163.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.7 m -81.65 -27.82 33.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.484 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 99' ' ' MET . 20.6 t70 -66.11 -35.79 81.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.707 ' HA ' ' CE1' ' A' ' 104' ' ' TYR . 59.7 ttp -48.15 -16.71 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.252 0.621 . . . . 0.0 112.609 169.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.451 ' H ' ' C ' ' A' ' 97' ' ' ASP . 73.7 mtm -117.96 -36.38 3.64 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.066 -0.396 . . . . 0.0 111.259 -173.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.33 -43.43 4.78 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.063 0.459 . . . . 0.0 110.457 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.419 ' HA3' ' OD1' ' A' ' 97' ' ' ASP . . . -81.5 -57.14 2.82 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.872 -174.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 61.28 81.4 0.19 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.538 0.685 . . . . 0.0 111.242 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -178.9 31.82 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.558 0.695 . . . . 0.0 110.335 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.707 ' CE1' ' HA ' ' A' ' 98' ' ' MET . 15.6 p90 -103.82 113.1 26.38 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.483 0.658 . . . . 0.0 110.045 -176.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -137.71 70.43 1.39 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.038 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.773 ' H ' HD21 ' A' ' 110' ' ' LEU . 32.1 t70 60.67 6.62 1.17 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.613 0.72 . . . . 0.0 111.202 168.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.2 m -111.9 3.74 17.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.703 -173.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.402 ' HB ' ' H ' ' A' ' 109' ' ' ASP . 1.9 mp -131.99 -77.69 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -144.79 166.72 24.43 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 167.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.773 HD21 ' H ' ' A' ' 106' ' ' ASP . 3.1 tp 173.11 -7.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -39.04 -46.39 2.38 Favored Glycine 0 C--N 1.355 1.589 0 C-N-CA 121.155 -0.545 . . . . 0.0 114.282 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.468 ' OD2' HG13 ' A' ' 113' ' ' ILE . 2.8 p-10 -70.69 -59.61 2.72 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.976 HG21 ' HB3' ' A' ' 117' ' ' GLN . 41.0 mt -50.9 -40.7 20.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.995 0.918 . . . . 0.0 112.57 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 10' ' ' LEU . 12.2 mm-40 -61.75 -12.22 15.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.462 0.649 . . . . 0.0 111.57 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.581 ' CB ' HG22 ' A' ' 14' ' ' VAL . . . -138.37 19.4 2.75 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.753 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.565 HD13 HG21 ' A' ' 119' ' ' VAL . 10.0 tp -161.88 -20.78 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -169.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.976 ' HB3' HG21 ' A' ' 113' ' ' ILE . 22.4 pt20 -60.09 -31.32 69.91 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.794 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.554 ' HA2' ' HE2' ' A' ' 121' ' ' LYS . . . -80.62 -16.96 74.34 Favored Glycine 0 CA--C 1.504 -0.597 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.656 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 125' ' ' ARG . 79.7 t -81.6 -43.86 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 123.291 0.636 . . . . 0.0 110.36 -171.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.535 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 4.8 m -36.09 -16.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.554 ' HE2' ' HA2' ' A' ' 118' ' ' GLY . 0.3 OUTLIER -146.66 0.47 0.77 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 119.969 1.258 . . . . 0.0 113.626 -166.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.747 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 12.9 m-30 -75.18 136.22 72.71 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 172.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.05 -26.63 50.91 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.682 2.255 . . . . 0.0 111.971 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.38 -0.29 35.69 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.825 ' HB3' HG13 ' A' ' 119' ' ' VAL . 64.0 mtt180 -129.26 12.77 6.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.165 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -80.22 -32.24 13.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 122.796 1.284 . . . . 0.0 108.033 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -83.24 -20.91 33.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.606 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.481 ' HG ' ' HA ' ' A' ' 125' ' ' ARG . 57.4 m -82.57 -18.6 40.77 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.921 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.567 ' HB2' HG11 ' A' ' 119' ' ' VAL . . . -84.54 -36.43 22.16 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.972 -176.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.631 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 3.9 m -75.01 -40.45 60.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 69' ' ' SER . 8.2 tt -50.7 -51.14 52.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.105 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 t -80.24 -60.89 2.16 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.066 -174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -62.87 -53.27 56.78 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.854 0.359 . . . . 0.0 111.751 -175.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.631 ' HB3' ' O ' ' A' ' 130' ' ' THR . 19.9 tptm -59.39 -34.8 72.88 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.913 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 131' ' ' LEU . . . -53.89 -34.5 59.66 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.073 171.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.2 mt -84.24 -39.43 19.29 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.34 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -70.47 -39.74 74.06 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.64 0.733 . . . . 0.0 110.905 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.759 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -84.88 12.38 7.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.094 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.913 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -102.86 -29.72 5.74 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.196 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.675 HG12 ' HE2' ' A' ' 49' ' ' MET . 29.3 m -131.56 -23.49 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -174.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 140' ' ' VAL . . . 90.46 175.29 0.02 OUTLIER 'General case' 0 C--N 1.351 0.663 0 C-N-CA 125.093 1.357 . . . . 0.0 109.759 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -123.95 149.15 46.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.241 -0.912 . . . . 0.0 112.405 -169.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -92.48 104.83 17.11 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 162.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.133 -166.499 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.1 m120 . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 120.956 0.408 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.763 ' HA ' HD12 ' A' ' 10' ' ' LEU . 55.8 tp 169.47 -36.55 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 17.3 t70 -61.56 -57.03 13.72 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.32 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.545 ' HA ' ' HG2' ' A' ' 12' ' ' ARG . 29.1 p -51.02 -43.05 60.8 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.751 0.786 . . . . 0.0 111.729 173.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.763 HD12 ' HA ' ' A' ' 7' ' ' LEU . 88.2 mt -51.79 -48.01 63.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.81 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.498 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.8 m-85 -67.64 -35.55 79.1 Favored 'General case' 0 CA--C 1.5 -0.981 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.415 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.545 ' HG2' ' HA ' ' A' ' 9' ' ' THR . 21.6 mmm-85 -59.91 -30.76 69.26 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.739 -0.601 . . . . 0.0 110.075 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -82.32 -34.79 28.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.612 HG13 ' HB2' ' A' ' 75' ' ' MET . 94.9 t -76.96 -30.77 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.594 -176.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 11' ' ' TYR . 30.9 pt -83.84 -19.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.1 ttt -64.15 -44.65 91.48 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.838 0.828 . . . . 0.0 109.242 175.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.18 -33.9 63.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.481 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -62.11 -26.56 68.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.174 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -68.63 -54.35 16.93 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.566 -0.709 . . . . 0.0 110.557 168.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -48.68 -38.23 20.72 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.235 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -112.84 81.31 4.37 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.48 -16.39 23.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.422 3.415 . . . . 0.0 115.475 -159.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -148.48 164.74 33.27 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.286 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -151.03 81.02 1.32 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.114 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.635 ' HG3' ' HG3' ' A' ' 62' ' ' GLU . 58.7 tttm -141.82 93.79 2.6 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.363 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.78 152.63 24.75 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.754 HG23 HG22 ' A' ' 48' ' ' THR . 2.9 p -150.29 132.61 6.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.197 0.522 . . . . 0.0 110.141 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.757 HD11 ' HB ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -153.71 146.32 24.17 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 176.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -111.49 139.34 47.01 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.804 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t70 172.21 -79.74 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.603 0.761 . . . . 0.0 109.188 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.526 ' HB3' ' HG ' ' A' ' 51' ' ' LEU . 14.1 m -72.01 -86.49 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.519 -175.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.631 HG13 ' HB2' ' A' ' 49' ' ' MET . 4.3 pt -138.23 134.31 44.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.299 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.581 HG12 HG21 ' A' ' 48' ' ' THR . 61.4 t -125.62 121.93 61.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.728 0.775 . . . . 0.0 110.201 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 1.063 HG22 ' HA2' ' A' ' 139' ' ' GLY . 2.8 t -117.36 124.83 73.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.352 -176.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.5 p-10 -126.43 138.98 53.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.826 0.346 . . . . 0.0 110.395 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.915 ' HA ' ' HE3' ' A' ' 36' ' ' MET . 2.0 tpt -147.1 131.26 17.36 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -109.77 132.29 54.28 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.223 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -121.96 98.88 44.59 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 161.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -32.33 109.0 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 125.171 3.914 . . . . 0.0 115.147 -168.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 m 71.73 -20.49 0.24 Allowed 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.095 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 51.6 t -95.42 -33.19 12.57 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.37 1.081 . . . . 0.0 109.142 -175.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.463 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . -157.61 60.9 0.33 Allowed Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 104.714 -3.354 . . . . 0.0 104.714 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.68 -43.04 89.84 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.594 -1.303 . . . . 0.0 112.048 -156.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -148.44 132.41 17.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 118.246 -1.382 . . . . 0.0 109.926 168.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 36' ' ' MET . 8.7 tt -124.33 116.15 46.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 20.4 ttt180 -121.36 102.79 8.5 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.649 -0.657 . . . . 0.0 111.924 -172.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.927 HD23 ' HE3' ' A' ' 49' ' ' MET . 28.1 tp -87.82 102.58 14.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.342 173.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.757 ' HB ' HD11 ' A' ' 28' ' ' LEU . 31.6 p -98.4 112.35 24.39 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 171.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.927 ' HE3' HD23 ' A' ' 47' ' ' LEU . 24.9 mtt -100.87 178.88 4.56 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.117 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.892 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 56.3 tttp -157.28 93.4 1.31 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 2.2 pp -117.72 108.95 16.02 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 113.183 -1.826 . . . . 0.0 106.848 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -98.84 60.46 1.25 Allowed 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.931 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.28 -98.58 0.19 Allowed Glycine 0 N--CA 1.424 -2.152 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.195 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -128.78 22.47 5.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.75 HD11 ' O ' ' A' ' 55' ' ' ILE . 2.4 pp -135.77 144.8 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -98.28 122.77 50.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -115.94 -21.21 9.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.998 0.904 . . . . 0.0 109.099 -170.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.892 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 17.1 t70 -141.35 149.11 40.74 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.885 174.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -161.75 108.06 1.34 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.769 0.795 . . . . 0.0 109.124 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.428 ' HZ3' ' CD2' ' A' ' 28' ' ' LEU . 64.2 mttp -107.3 147.72 29.9 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.328 0.585 . . . . 0.0 109.57 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.9 t80 -121.38 129.01 52.79 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.998 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.635 ' HG3' ' HG3' ' A' ' 25' ' ' LYS . 27.8 tt0 -128.26 124.44 36.63 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.72 -177.72 48.28 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 119.132 -1.508 . . . . 0.0 112.72 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -141.71 128.95 21.02 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.463 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . -169.49 -132.1 1.4 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.5 -1.334 . . . . 0.0 110.81 -175.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 7.3 p -123.35 -163.98 1.17 Allowed 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 p -55.77 -26.5 46.22 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.762 HG13 ' HB3' ' A' ' 128' ' ' CYS . 7.3 mm -62.48 -66.62 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.649 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 p -55.43 -32.57 62.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.225 1.012 . . . . 0.0 109.909 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -61.7 -60.86 3.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.286 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 115' ' ' ALA . . . -71.68 -43.3 66.25 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -172.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.494 ' HB3' HD11 ' A' ' 116' ' ' LEU . 49.4 p -59.0 -39.61 82.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 110.632 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.768 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -75.01 -48.93 21.63 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.232 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 27.6 m -55.35 -61.04 2.6 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.802 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.612 ' HB2' HG13 ' A' ' 14' ' ' VAL . 12.6 tpt -83.1 -57.63 3.2 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.543 ' CG ' HD11 ' A' ' 136' ' ' LEU . 10.5 tpt -74.02 -27.9 61.18 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -171.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.768 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 85.6 m -73.32 -40.99 64.05 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 74' ' ' SER . 8.3 tt0 -59.54 -26.22 65.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.183 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.26 -33.58 22.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.67 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -67.6 -42.96 87.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.11 178.389 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 65.2 tttm -56.45 -16.28 5.57 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.686 0.794 . . . . 0.0 111.694 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.89 38.59 2.95 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.419 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -135.25 179.09 6.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.741 0.27 . . . . 0.0 111.597 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.631 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.0 m-20 -100.41 176.94 5.18 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.686 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 12.6 mm -84.41 -43.11 17.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.548 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -63.36 -38.27 90.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.02 0.438 . . . . 0.0 110.318 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -61.62 -41.3 97.27 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 121.72 0.772 . . . . 0.0 110.866 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.44 ' HB1' HG22 ' A' ' 140' ' ' VAL . . . -66.11 -34.98 79.28 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 121.927 -0.483 . . . . 0.0 110.605 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 70.7 mt -64.71 -39.72 94.12 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.453 1.121 . . . . 0.0 109.735 175.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.55 ' O ' HG12 ' A' ' 94' ' ' ILE . 26.9 t -67.09 -41.66 85.94 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.827 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.474 ' HE3' HD21 ' A' ' 110' ' ' LEU . 16.9 tpt -62.85 -22.42 66.66 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 122.287 1.041 . . . . 0.0 110.854 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.495 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 27.5 t -89.03 -35.95 16.07 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.499 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -66.58 -51.51 55.63 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.813 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 105' ' ' ASP . 22.1 pt -65.1 -39.83 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.838 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 91' ' ' MET . 39.2 t80 -53.51 -35.93 61.19 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.411 0.624 . . . . 0.0 111.143 174.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.6 m -86.31 -35.85 19.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.134 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.54 -35.96 75.92 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.096 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 1.3 tmt? -39.22 -49.75 1.9 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 124.127 0.892 . . . . 0.0 111.689 178.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.2 mtt -57.21 -10.63 1.32 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -124.46 -35.24 2.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.773 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.723 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -88.69 -32.07 11.92 Favored Glycine 0 C--O 1.239 0.448 0 C-N-CA 119.511 -1.328 . . . . 0.0 114.168 -173.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.723 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 22.4 tttm 97.64 -29.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.758 1.223 . . . . 0.0 109.699 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' MET . 0.7 OUTLIER -82.09 163.21 22.19 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.65 -106.34 0.24 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.7 ' HA ' HD12 ' A' ' 94' ' ' ILE . 31.7 t70 -95.34 101.73 13.48 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 172.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.27 8.87 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 105' ' ' ASP . 65.3 m -105.78 -16.95 14.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 169.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 108' ' ' ILE . 32.0 mm 65.37 27.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-O 121.816 0.817 . . . . 0.0 110.949 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -95.41 86.93 4.63 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 170.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.532 ' HB3' ' HB ' ' A' ' 113' ' ' ILE . 6.7 mt -123.75 43.94 2.84 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.393 -165.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -40.47 -33.21 0.53 Allowed Glycine 0 CA--C 1.538 1.51 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.674 168.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 3.8 p-10 -58.32 -72.78 0.09 Allowed 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 123.448 0.699 . . . . 0.0 109.989 171.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 110' ' ' LEU . 1.1 mp -46.2 -37.88 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.827 0.851 . . . . 0.0 110.313 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.608 ' O ' ' HB3' ' A' ' 10' ' ' LEU . 29.4 tt0 -61.57 -18.89 61.22 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.681 0.753 . . . . 0.0 111.704 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.556 ' C ' HD13 ' A' ' 116' ' ' LEU . . . -136.77 16.85 3.08 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.824 -0.548 . . . . 0.0 111.796 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.556 HD13 ' C ' ' A' ' 115' ' ' ALA . 5.7 mp -151.03 -24.39 0.21 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -167.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.42 ' HB2' HG21 ' A' ' 113' ' ' ILE . 7.7 tt0 -43.53 -52.32 6.26 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.41 0.443 . . . . 0.0 112.121 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.799 ' HA2' ' HE3' ' A' ' 121' ' ' LYS . . . -75.76 -17.36 80.13 Favored Glycine 0 CA--C 1.512 -0.155 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.489 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.778 HG13 ' HB3' ' A' ' 125' ' ' ARG . 65.8 t -74.92 -54.62 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 117.202 0.501 . . . . 0.0 111.397 -169.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.671 ' HB3' ' HZ2' ' A' ' 133' ' ' TRP . 16.9 m -44.77 -15.0 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 O-C-N 125.231 1.582 . . . . 0.0 114.621 -175.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.799 ' HE3' ' HA2' ' A' ' 118' ' ' GLY . 20.0 pttp -127.96 -4.7 5.68 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.71 -162.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.482 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 27.6 m-85 -86.7 133.98 38.57 Favored Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.109 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.64 -22.92 37.99 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 122.034 1.823 . . . . 0.0 111.55 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.68 -2.99 43.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.226 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.778 ' HB3' HG13 ' A' ' 119' ' ' VAL . 66.1 mtt85 -129.34 16.58 6.04 Favored 'General case' 0 C--O 1.213 -0.83 0 O-C-N 121.831 -0.543 . . . . 0.0 109.556 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.2 tt -87.36 -31.23 5.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.623 -171.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -78.38 -20.76 50.56 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.762 ' HB3' HG13 ' A' ' 68' ' ' ILE . 77.5 m -82.91 -18.5 39.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.286 176.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.653 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -84.99 -32.8 22.77 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.998 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.475 ' O ' ' HG3' ' A' ' 134' ' ' LYS . 16.9 p -74.9 -43.58 53.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.615 ' HA ' ' HG2' ' A' ' 36' ' ' MET . 4.6 pp -58.45 -34.88 71.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.456 ' HB3' HD22 ' A' ' 116' ' ' LEU . 49.1 m -69.95 -55.03 10.72 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.447 0.467 . . . . 0.0 111.853 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.671 ' HZ2' ' HB3' ' A' ' 120' ' ' SER . 25.6 m0 -55.56 -38.64 69.59 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.695 1.236 . . . . 0.0 111.194 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.627 ' HA ' ' HB3' ' A' ' 138' ' ' LYS . 50.0 mtpt -70.35 -42.41 71.89 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.605 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.544 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -58.4 -61.95 2.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.012 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.543 HD11 ' CG ' ' A' ' 76' ' ' MET . 72.6 mt -87.21 -43.59 12.1 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.054 -169.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.649 ' OE1' ' HA ' ' A' ' 133' ' ' TRP . 3.0 mp0 -84.8 -39.89 17.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -173.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.627 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 7.8 tmtm? -88.68 12.22 15.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.395 1.093 . . . . 0.0 109.051 176.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 1.063 ' HA2' HG22 ' A' ' 34' ' ' VAL . . . -88.13 -24.46 34.51 Favored Glycine 0 C--O 1.221 -0.658 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.114 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.458 ' O ' ' HB1' ' A' ' 141' ' ' ALA . 29.6 m -114.23 -0.98 9.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.899 -0.65 . . . . 0.0 110.438 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 140' ' ' VAL . . . 86.7 110.91 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.935 1.397 . . . . 0.0 108.403 -173.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -68.69 136.86 53.56 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.207 -169.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.787 ' HG3' ' H ' ' A' ' 144' ' ' GLU . 13.7 pt-20 41.01 -89.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 125.261 1.6 . . . . 0.0 113.58 176.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.787 ' H ' ' HG3' ' A' ' 143' ' ' GLU . 6.2 mm-40 . . . . . 0 N--CA 1.45 -0.453 0 CA-C-N 118.401 0.546 . . . . 0.0 109.836 172.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 C--O 1.24 0.588 0 CA-C-O 120.113 0.006 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' A' ' 10' ' ' LEU . 29.9 tp -126.57 -13.5 5.95 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.375 0.422 . . . . 0.0 110.154 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.69 -58.26 9.35 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.155 0.502 . . . . 0.0 111.427 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.3 m -55.14 -41.63 72.02 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.631 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.573 ' HB2' HD13 ' A' ' 7' ' ' LEU . 44.1 mt -55.56 -45.61 77.29 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.441 177.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.415 ' O ' HG22 ' A' ' 15' ' ' ILE . 15.7 m-85 -59.56 -46.37 89.11 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.367 0.604 . . . . 0.0 109.473 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -57.38 -45.27 84.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.599 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -67.31 -32.29 73.17 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.101 0.25 . . . . 0.0 110.682 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.626 HG13 ' HB2' ' A' ' 75' ' ' MET . 72.9 t -80.43 -47.99 20.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.833 -175.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 11' ' ' TYR . 18.2 tt -69.58 -25.53 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.2 ttt -78.29 -45.97 21.39 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.126 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.98 -42.77 76.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.489 0.662 . . . . 0.0 110.09 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.482 ' CG ' ' HB3' ' A' ' 74' ' ' SER . 85.9 t60 -66.95 -29.19 68.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.465 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -64.33 -45.48 87.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.941 -0.475 . . . . 0.0 110.615 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -47.52 -33.15 5.99 Favored 'General case' 0 C--O 1.247 0.937 0 O-C-N 124.197 0.936 . . . . 0.0 111.202 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -87.05 155.85 55.03 Favored Pre-proline 0 C--O 1.22 -0.492 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.146 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.24 -68.16 0.11 Allowed 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 123.606 2.871 . . . . 0.0 113.825 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.615 ' HG2' ' H ' ' A' ' 24' ' ' ASN . 25.0 ttm-85 176.61 -167.29 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.615 ' H ' ' HG2' ' A' ' 23' ' ' ARG . 18.6 p-10 -144.52 8.54 1.35 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.148 -0.345 . . . . 0.0 110.725 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 61' ' ' PHE . 60.6 tttp -99.91 115.32 29.37 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.633 0.73 . . . . 0.0 111.212 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.845 ' HA3' ' HE2' ' A' ' 60' ' ' LYS . . . -172.25 -177.83 42.03 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.457 HG21 HG23 ' A' ' 48' ' ' THR . 7.4 p -166.33 125.61 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 118.119 0.959 . . . . 0.0 110.655 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.745 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -143.69 143.62 31.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.594 0.711 . . . . 0.0 110.78 176.162 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -98.38 81.06 2.7 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.578 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 6.2 t70 -117.58 -123.02 0.29 Allowed 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.24 -173.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.447 ' OG ' ' HA ' ' A' ' 50' ' ' LYS . 17.7 m -51.88 -72.45 0.05 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.248 0.547 . . . . 0.0 111.878 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.651 HG13 ' HB2' ' A' ' 49' ' ' MET . 22.3 pt -130.23 140.89 47.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.42 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.818 HG12 HG22 ' A' ' 48' ' ' THR . 57.4 t -124.66 108.66 20.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 110.837 -0.06 . . . . 0.0 110.837 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.749 ' HB ' ' HB3' ' A' ' 47' ' ' LEU . 55.6 t -87.7 122.92 39.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 O-C-N 124.331 1.019 . . . . 0.0 110.993 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.83 108.02 16.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.995 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.465 ' HB2' ' HB2' ' A' ' 135' ' ' ALA . 20.3 mmt -136.47 119.11 16.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 5.1 p-10 -129.03 138.67 52.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.043 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -115.18 95.24 41.75 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.7 -12.77 26.56 Favored 'Trans proline' 0 CA--C 1.512 -0.576 0 C-N-CA 123.222 2.615 . . . . 0.0 112.756 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.5 m -94.12 -53.99 3.75 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.153 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.481 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 52.9 t -129.46 15.06 6.06 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -167.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.86 ' HA3' HD21 ' A' ' 131' ' ' LEU . . . -154.76 2.98 0.22 Allowed Glycine 0 N--CA 1.462 0.427 0 C-N-CA 118.003 -2.046 . . . . 0.0 114.882 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.693 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 10.3 t70 54.99 -101.41 0.13 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.878 0.871 . . . . 0.0 111.077 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 18.7 ptp180 -155.77 150.63 26.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.769 0.713 . . . . 0.0 112.133 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.59 HG13 ' CD1' ' A' ' 61' ' ' PHE . 8.6 tt -133.97 125.06 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 45.6 mtp180 -118.82 104.04 10.19 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 111.107 -176.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.749 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 20.1 tp -88.22 95.68 10.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.26 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.818 HG22 HG12 ' A' ' 33' ' ' VAL . 61.7 p -88.8 110.16 20.79 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.651 ' HB2' HG13 ' A' ' 32' ' ' ILE . 15.0 mtt -107.77 -179.98 4.06 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.136 0.493 . . . . 0.0 111.356 -171.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.578 ' HG3' ' OD2' ' A' ' 30' ' ' ASP . 50.5 tttp -153.58 101.35 2.48 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 1.4 pt? -124.15 93.48 3.93 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -92.21 60.27 3.67 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.644 -170.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 146.51 -98.43 0.2 Allowed Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 174.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -132.27 20.17 4.41 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.948 0.404 . . . . 0.0 110.415 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -129.0 152.13 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.81 119.54 49.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -105.49 -29.29 10.29 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.931 0.872 . . . . 0.0 108.824 -167.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.647 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 1.4 t70 -144.11 153.8 42.52 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.424 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -164.26 118.72 1.45 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.845 ' HE2' ' HA3' ' A' ' 26' ' ' GLY . 38.8 mtpt -125.71 99.68 6.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.069 0.938 . . . . 0.0 111.527 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.59 ' CD1' HG13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -70.7 139.06 51.09 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.815 176.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 15.4 tt0 -143.79 126.29 15.88 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.979 0.895 . . . . 0.0 109.009 169.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.05 -175.02 45.73 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.835 -172.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.693 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -143.88 163.0 34.65 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 -179.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.38 -133.47 4.9 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 119.203 -1.475 . . . . 0.0 113.019 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 94.1 m -85.73 163.96 17.9 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.308 0.575 . . . . 0.0 112.305 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 t -75.17 -26.55 59.17 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.211 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.848 HG13 HG21 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -77.2 -33.51 20.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.256 177.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.481 ' HG ' HD13 ' A' ' 68' ' ' ILE . 4.4 m -69.12 -48.6 62.04 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.993 0.901 . . . . 0.0 108.934 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 52.2 ttp -56.14 -34.27 65.96 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.619 170.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.75 -39.16 67.07 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.479 0.487 . . . . 0.0 111.565 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.799 ' HB2' HD11 ' A' ' 116' ' ' LEU . 12.7 t -58.99 -47.77 83.98 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.518 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -62.76 -49.26 75.72 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.538 177.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.482 ' HB3' ' CG ' ' A' ' 18' ' ' HIS . 68.3 m -51.64 -61.7 2.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.882 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.626 ' HB2' HG13 ' A' ' 14' ' ' VAL . 9.1 tpt -74.92 -46.92 32.55 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.575 -169.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.92 ' HG2' HD22 ' A' ' 136' ' ' LEU . 6.9 tpt -80.37 -28.09 38.06 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 88.1 m -68.79 -17.91 64.11 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.555 -1.341 . . . . 0.0 108.823 168.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' A' ' 75' ' ' MET . 1.5 tt0 -80.59 -38.37 29.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.341 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.69 -45.82 9.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.998 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.486 HG12 ' HE2' ' A' ' 76' ' ' MET . 0.5 OUTLIER -73.6 -32.24 35.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 123.326 0.65 . . . . 0.0 110.703 -170.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.647 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 60.3 tttm -53.71 -15.47 1.24 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.452 0.644 . . . . 0.0 110.93 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 80' ' ' ILE . . . -114.65 32.37 5.89 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.596 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -129.46 -165.47 1.53 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -132.67 -172.1 2.83 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.701 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -74.98 -46.02 41.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.656 -175.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.76 -40.69 79.65 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.207 0.317 . . . . 0.0 111.393 -175.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.2 p -58.01 -36.5 72.77 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.457 0.646 . . . . 0.0 110.533 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.844 ' HB3' ' HB2' ' A' ' 141' ' ' ALA . . . -71.89 -49.15 40.46 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.022 0.529 . . . . 0.0 110.712 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 42.1 mt -55.01 -44.49 74.61 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.639 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.549 ' O ' HG12 ' A' ' 94' ' ' ILE . 38.3 p -68.61 -33.53 74.2 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.246 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.544 ' HA ' ' CG1' ' A' ' 94' ' ' ILE . 25.1 ttt -64.91 -16.65 63.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.383 0.611 . . . . 0.0 110.429 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.499 ' CB ' ' HG3' ' A' ' 143' ' ' GLU . 6.1 m -86.29 -40.25 15.69 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -66.3 -43.87 85.04 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.616 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.549 HG12 ' O ' ' A' ' 90' ' ' SER . 10.0 pt -71.45 -40.88 72.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.624 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 91' ' ' MET . 5.9 t80 -56.9 -29.77 63.32 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.32 174.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 t -80.8 -36.86 31.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -65.61 -42.03 92.04 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.139 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.57 ' HA ' ' H ' ' A' ' 103' ' ' GLU . 16.8 tpt -35.59 -50.45 0.61 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 123.827 0.705 . . . . 0.0 112.568 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 42.4 tpp -48.87 -19.56 0.39 Allowed 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -140.28 -29.84 0.69 Allowed 'General case' 0 C--O 1.242 0.673 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.23 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -99.79 -36.73 4.15 Favored Glycine 0 C--N 1.318 -0.472 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.647 -174.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 63.9 tttm 88.59 70.31 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.57 ' H ' ' HA ' ' A' ' 98' ' ' MET . 10.3 tp10 -153.8 133.88 13.25 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 113.335 -1.757 . . . . 0.0 107.226 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.48 -59.39 1.46 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.644 -168.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.699 ' HB3' HD12 ' A' ' 110' ' ' LEU . 14.7 t70 -144.58 97.2 2.99 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.463 ' H ' HD12 ' A' ' 94' ' ' ILE . 14.8 t70 -34.8 -31.45 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 174.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.9 m -95.94 2.78 53.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.77 -0.582 . . . . 0.0 111.301 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 108' ' ' ILE . 31.9 mm 69.53 24.97 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 122.667 1.222 . . . . 0.0 109.124 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -96.78 73.95 2.67 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.929 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.699 HD12 ' HB3' ' A' ' 105' ' ' ASP . 5.0 mp -98.01 10.84 39.38 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.995 -166.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -40.18 -38.22 1.26 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 115.645 1.018 . . . . 0.0 115.645 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.752 ' HB2' ' HB2' ' A' ' 76' ' ' MET . 18.4 t70 -80.88 -51.3 8.74 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.579 0.704 . . . . 0.0 110.42 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.646 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 53.4 mt -65.09 -24.14 34.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.823 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 117' ' ' GLN . 47.3 mt-10 -67.91 -58.38 4.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.57 77.13 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.974 0.797 . . . . 0.0 112.479 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.799 HD11 ' HB2' ' A' ' 72' ' ' SER . 8.9 mp -94.65 -5.84 44.74 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.646 ' HB3' ' O ' ' A' ' 113' ' ' ILE . 2.9 pt20 -61.65 -28.31 69.3 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.79 0.805 . . . . 0.0 111.762 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.86 -16.46 65.41 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.536 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.848 HG21 HG13 ' A' ' 68' ' ' ILE . 24.1 t -86.8 -57.62 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 124.047 0.939 . . . . 0.0 111.003 -172.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 3.3 p -45.0 -14.59 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -176.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -128.6 0.53 5.53 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 118.481 -1.287 . . . . 0.0 112.045 -165.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 6.1 m-85 -90.13 130.61 41.58 Favored Pre-proline 0 N--CA 1.441 -0.883 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.43 -29.0 29.5 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.935 2.424 . . . . 0.0 112.241 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.86 -2.88 52.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.446 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.515 ' HB3' HG11 ' A' ' 119' ' ' VAL . 89.8 mtt180 -125.39 11.71 8.08 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.1 tt -80.33 -36.78 16.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.08 0.943 . . . . 0.0 109.029 -171.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -85.64 -18.03 34.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.167 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 3.7 t -79.87 -19.28 48.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.593 ' HB3' HG12 ' A' ' 119' ' ' VAL . . . -85.85 -33.19 21.36 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.57 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.763 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 26.2 p -77.28 -32.31 55.43 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 119.323 -0.951 . . . . 0.0 108.926 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.86 HD21 ' HA3' ' A' ' 42' ' ' GLY . 19.2 tp -47.31 -59.41 3.21 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.663 169.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.8 m -79.09 -61.06 2.13 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.675 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.537 ' HB2' HD23 ' A' ' 116' ' ' LEU . 2.6 t90 -63.12 -51.37 66.81 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.458 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.763 ' HB2' ' O ' ' A' ' 130' ' ' THR . 27.4 mmmt -61.67 -42.43 98.91 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 121.855 -0.528 . . . . 0.0 110.986 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 36' ' ' MET . . . -57.02 -36.74 70.8 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.307 174.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.92 HD22 ' HG2' ' A' ' 76' ' ' MET . 4.6 tp -79.55 -40.74 28.79 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.826 0.822 . . . . 0.0 110.114 -175.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 139' ' ' GLY . 39.4 tt0 -79.12 -53.01 7.42 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.283 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -78.87 15.63 1.05 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.878 -169.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.562 ' O ' HD11 ' A' ' 32' ' ' ILE . . . -101.08 -26.61 7.77 Favored Glycine 0 N--CA 1.424 -2.148 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.921 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.29 -33.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 O-C-N 122.242 -0.563 . . . . 0.0 110.295 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.844 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . . . -102.19 119.16 38.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.39 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.61 ' H ' ' CD2' ' A' ' 89' ' ' LEU . 47.9 mtmt -146.55 113.09 5.96 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.731 0.301 . . . . 0.0 110.446 173.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.499 ' HG3' ' CB ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -57.11 69.89 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.221 0.534 . . . . 0.0 111.971 162.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 C--N 1.322 -0.624 0 CA-C-O 122.014 0.911 . . . . 0.0 110.12 176.862 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.3 t30 . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 122.467 1.127 . . . . 0.0 108.739 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.625 HD11 HD13 ' A' ' 10' ' ' LEU . 34.3 tp -118.38 -12.28 9.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.764 -175.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.541 ' HA ' ' HD2' ' A' ' 11' ' ' TYR . 2.2 m-20 -58.44 -58.62 7.7 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.108 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 p -56.45 -41.04 75.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.925 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.625 HD13 HD11 ' A' ' 7' ' ' LEU . 62.6 mt -55.42 -41.69 73.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.285 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.541 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 47.9 m-85 -57.16 -51.54 68.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.322 0.582 . . . . 0.0 109.92 173.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -56.65 -39.63 74.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.51 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.5 tp60 -74.09 -35.17 64.19 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.709 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.605 HG23 ' HE1' ' A' ' 75' ' ' MET . 75.6 t -70.02 -45.48 76.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.69 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 66.6 mt -67.52 -23.19 29.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.1 ttt -73.2 -53.71 10.26 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.898 -0.502 . . . . 0.0 110.294 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -69.59 -44.81 70.02 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.49 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -65.6 -20.69 66.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.157 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 82.8 t80 -62.94 -50.09 72.18 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 121.959 -0.463 . . . . 0.0 110.56 173.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -44.85 -29.75 0.86 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.897 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -122.4 82.23 46.4 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 120.885 0.374 . . . . 0.0 110.141 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.6 73.45 1.29 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.125 2.55 . . . . 0.0 113.064 -172.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.3 ttm105 -145.55 72.47 1.31 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.659 0.742 . . . . 0.0 110.168 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -105.53 64.29 0.7 Allowed 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.641 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.665 ' HZ3' ' HB3' ' A' ' 25' ' ' LYS . 5.5 ttpm? 179.52 163.45 0.95 Allowed 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 144.82 153.53 5.89 Favored Glycine 0 C--O 1.218 -0.867 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.998 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.836 ' HB ' ' HB2' ' A' ' 62' ' ' GLU . 2.6 p -168.46 117.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.715 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -141.33 149.0 40.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.056 0.455 . . . . 0.0 111.152 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -107.55 104.81 14.45 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.31 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -149.75 -110.36 0.07 Allowed 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.468 0.48 . . . . 0.0 110.383 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.649 ' HB3' HD22 ' A' ' 51' ' ' LEU . 22.3 m -54.06 -74.0 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 124.79 1.306 . . . . 0.0 112.05 -171.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.68 HG13 ' HB3' ' A' ' 49' ' ' MET . 10.6 pt -134.82 136.71 51.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.779 0.8 . . . . 0.0 109.111 174.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.739 HG12 HG21 ' A' ' 48' ' ' THR . 33.8 t -117.69 105.23 17.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.842 0.829 . . . . 0.0 108.791 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.767 HG23 ' HA2' ' A' ' 139' ' ' GLY . 85.6 t -98.41 124.49 51.56 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.845 -171.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.752 ' HB3' ' HE ' ' A' ' 46' ' ' ARG . 5.4 p-10 -136.88 145.9 44.9 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.506 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.3 mmt -154.19 135.66 14.23 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.768 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 43' ' ' ASP . 22.6 p-10 -122.13 142.05 50.79 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.04 174.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.627 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 56.4 t30 -125.57 106.04 27.02 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 174.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 1.3 Cg_endo -42.85 133.02 5.7 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 125.123 3.882 . . . . 0.0 114.458 -167.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.0 m 77.12 -36.56 0.25 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.139 175.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 127' ' ' LYS . 44.1 t -85.85 -78.61 0.27 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -171.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.606 ' HA3' HD12 ' A' ' 131' ' ' LEU . . . -102.6 11.48 56.47 Favored Glycine 0 CA--C 1.502 -0.761 0 C-N-CA 118.786 -1.673 . . . . 0.0 112.286 -166.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.563 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 18.3 t70 62.8 -90.9 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.423 0.719 . . . . 0.0 110.349 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -159.8 144.4 14.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 123.198 0.311 . . . . 0.0 110.466 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.42 133.92 59.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.752 ' HE ' ' HB3' ' A' ' 35' ' ' ASP . 28.8 ttm180 -134.41 109.4 8.74 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.583 HD13 ' HB3' ' A' ' 59' ' ' ALA . 11.8 tp -84.91 99.24 10.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.127 172.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.739 HG21 HG12 ' A' ' 33' ' ' VAL . 50.0 p -80.71 107.41 13.5 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 171.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.68 ' HB3' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -110.07 165.43 11.74 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -164.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HD2' ' HB3' ' A' ' 57' ' ' GLU . 8.5 tmtm? -156.33 97.21 1.75 Allowed 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.649 HD22 ' HB3' ' A' ' 31' ' ' SER . 2.6 pt? -118.85 93.82 4.23 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.62 59.26 1.76 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.373 1.082 . . . . 0.0 109.545 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 150.18 -99.44 0.19 Allowed Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.846 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.447 ' C ' HG12 ' A' ' 85' ' ' ILE . 2.0 t70 -134.91 24.25 3.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.442 0.639 . . . . 0.0 109.37 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.641 HD11 ' O ' ' A' ' 55' ' ' ILE . 2.2 pp -137.31 156.07 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 C-N-CA 124.435 1.094 . . . . 0.0 108.47 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 80' ' ' ILE . 3.3 p -96.77 119.46 44.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.139 0.971 . . . . 0.0 108.551 168.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.424 ' HB3' ' HD2' ' A' ' 50' ' ' LYS . 32.2 tt0 -98.03 -33.44 11.18 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.379 -171.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -146.22 147.55 31.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.483 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.583 ' HB3' HD13 ' A' ' 47' ' ' LEU . . . -155.82 123.09 5.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.498 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 46.8 mmtm -133.82 165.7 24.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.069 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.719 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 26.0 p90 -127.47 127.29 43.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.48 0.657 . . . . 0.0 111.612 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.836 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 8.8 tp10 -110.54 109.31 19.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.22 -178.62 48.59 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.518 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.563 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 15.1 mm-40 -142.29 168.5 19.58 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.3 -131.62 3.36 Favored Glycine 0 C--O 1.24 0.496 0 C-N-CA 119.588 -1.291 . . . . 0.0 112.93 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.8 m -78.34 178.88 7.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.6 m -93.18 -23.96 18.39 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.844 HD11 ' HB3' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -79.89 -38.74 19.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 113.831 -1.532 . . . . 0.0 110.614 175.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.4 p -65.41 -43.35 90.84 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.946 -0.471 . . . . 0.0 110.786 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.5 ptp -62.51 -29.17 70.35 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.852 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.57 -34.51 65.17 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.643 0.589 . . . . 0.0 111.642 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 m -62.25 -40.51 96.44 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.729 ' HA ' ' HG2' ' A' ' 76' ' ' MET . . . -64.95 -43.08 93.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.892 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.1 m -52.42 -49.0 65.4 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 122.324 0.249 . . . . 0.0 110.653 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.605 ' HE1' HG23 ' A' ' 14' ' ' VAL . 4.6 mmt -66.0 -47.5 74.29 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.988 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.729 ' HG2' ' HA ' ' A' ' 73' ' ' ALA . 19.7 ptt? -59.82 -41.41 91.23 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.962 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.4 p -60.18 -35.57 75.67 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.257 -0.902 . . . . 0.0 111.052 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.448 ' HG2' ' HA ' ' A' ' 75' ' ' MET . 20.4 pt20 -88.16 -41.37 13.04 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.926 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.66 -48.63 8.14 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 121.678 0.751 . . . . 0.0 111.425 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.584 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -71.47 -42.45 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.892 -174.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -61.7 -16.1 46.11 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.071 0.462 . . . . 0.0 111.273 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.12 43.61 1.65 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.322 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HG3' ' HB ' ' A' ' 87' ' ' THR . 2.9 tppt? -134.42 170.45 15.73 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -105.66 175.61 5.44 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.653 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.5 mm -78.07 -35.86 20.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.173 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.12 -48.03 79.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.638 0.733 . . . . 0.0 109.557 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.558 ' HB ' ' HG3' ' A' ' 83' ' ' LYS . 1.4 m -66.2 -40.32 90.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.711 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.655 ' HB3' HG22 ' A' ' 140' ' ' VAL . . . -63.94 -41.7 97.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 73.5 mt -66.64 -31.01 71.42 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.8 m -70.22 -44.33 68.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.154 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.74 ' HE3' HG13 ' A' ' 113' ' ' ILE . 13.1 tpt -60.11 -29.92 68.92 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.444 0.698 . . . . 0.0 110.4 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.508 ' OG ' ' HA ' ' A' ' 142' ' ' LYS . 71.7 p -87.92 -37.86 16.08 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.968 -175.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.654 ' HG3' ' HG2' ' A' ' 143' ' ' GLU . 61.2 tttm -67.5 -44.68 77.87 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.331 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' A' ' 105' ' ' ASP . 71.8 mt -63.79 -44.75 98.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.306 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 91' ' ' MET . 0.7 OUTLIER -53.34 -32.61 49.96 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.543 174.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.6 m -83.21 -40.34 19.77 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.8 0.333 . . . . 0.0 111.187 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -71.22 -37.57 72.04 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.799 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 27.1 ttt -45.28 -51.48 10.84 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.439 0.695 . . . . 0.0 112.308 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 46.5 ttp -61.03 -8.74 3.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -123.96 -31.82 3.34 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.908 -0.495 . . . . 0.0 110.841 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -89.51 -25.58 27.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.769 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 23.9 tptm 84.87 -31.35 0.06 Allowed 'General case' 0 N--CA 1.478 0.97 0 O-C-N 125.044 1.085 . . . . 0.0 109.119 175.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 98' ' ' MET . 0.4 OUTLIER -89.22 178.45 6.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.427 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -144.76 -108.84 0.11 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.112 0.482 . . . . 0.0 111.714 -173.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 107' ' ' SER . 20.2 t70 -109.16 107.9 18.35 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -175.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.08 3.89 0.38 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.616 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.554 ' O ' HG21 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -99.09 -18.95 17.46 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.554 HG21 ' O ' ' A' ' 107' ' ' SER . 6.6 tp 66.91 24.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.446 168.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.22 87.34 6.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 172.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.582 ' HA ' ' HE2' ' A' ' 91' ' ' MET . 1.1 mp -114.21 21.53 14.64 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.306 0.379 . . . . 0.0 111.546 -168.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -51.6 -54.52 24.26 Favored Glycine 0 C--O 1.242 0.656 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.247 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.416 ' OD1' ' HA ' ' A' ' 76' ' ' MET . 6.7 m-20 -58.04 -24.14 57.18 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.863 0.865 . . . . 0.0 111.998 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.74 HG13 ' HE3' ' A' ' 91' ' ' MET . 76.3 mt -100.69 -25.09 3.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -174.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 33.7 tt0 -75.36 -54.41 7.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.53 -1.213 . . . . 0.0 111.762 -163.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.503 ' O ' HD12 ' A' ' 7' ' ' LEU . . . -49.23 -24.76 1.9 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.81 0.694 . . . . 0.0 110.818 170.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.514 HD11 ' N ' ' A' ' 116' ' ' LEU . 4.6 mp -102.89 -3.18 26.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.472 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -54.48 -37.19 64.98 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.187 0.595 . . . . 0.0 110.686 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.82 -18.16 66.2 Favored Glycine 0 C--O 1.216 -0.986 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.557 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.825 HG13 ' HB1' ' A' ' 129' ' ' ALA . 48.4 t -84.11 -44.71 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 O-C-N 122.283 -0.539 . . . . 0.0 112.164 -174.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.5 p -45.93 -25.56 0.56 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.318 0.647 . . . . 0.0 110.247 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.589 ' NZ ' ' HB2' ' A' ' 121' ' ' LYS . 3.6 ttmp? -131.71 96.51 3.97 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.831 ' H ' ' HB3' ' A' ' 125' ' ' ARG . 0.1 OUTLIER -152.34 157.06 33.91 Favored Pre-proline 0 N--CA 1.448 -0.561 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -172.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 122' ' ' PHE . 10.8 Cg_endo -59.24 -22.85 66.95 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.705 1.603 . . . . 0.0 111.221 172.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.28 18.42 17.85 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.294 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.831 ' HB3' ' H ' ' A' ' 122' ' ' PHE . 25.6 ptt-85 -52.44 -44.5 65.52 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 124.105 0.878 . . . . 0.0 112.202 -165.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.421 ' N ' ' HG3' ' A' ' 125' ' ' ARG . 11.6 tt -85.24 -20.59 8.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -160.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.789 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 38.5 mmtm -75.97 -50.14 15.75 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.435 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.844 ' HB3' HD11 ' A' ' 68' ' ' ILE . 80.0 m -86.54 -29.11 22.92 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.256 -173.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.825 ' HB1' HG13 ' A' ' 119' ' ' VAL . . . -87.59 -29.8 20.98 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.033 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 63.8 m -84.5 -41.93 16.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.606 HD12 ' HA3' ' A' ' 42' ' ' GLY . 8.4 tt -51.82 -39.41 58.7 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.942 0.401 . . . . 0.0 110.612 173.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.9 m -84.05 -42.45 16.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.697 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.437 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 2.3 t90 -53.02 -50.48 64.15 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.114 0.566 . . . . 0.0 109.816 174.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 134' ' ' LYS . 68.2 mmtt -60.08 -42.59 94.9 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 124.68 1.238 . . . . 0.0 110.407 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.2 -41.96 63.12 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.455 0.472 . . . . 0.0 112.102 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 76' ' ' MET . 4.4 mm? -83.06 -38.45 22.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.534 0.683 . . . . 0.0 110.894 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.69 ' HG3' ' HB3' ' A' ' 142' ' ' LYS . 26.4 tt0 -68.69 -41.87 78.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.37 -177.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 9.3 mtpt -93.31 -0.75 56.58 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.063 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.767 ' HA2' HG23 ' A' ' 34' ' ' VAL . . . -79.99 -27.71 52.3 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.81 HG23 ' H ' ' A' ' 141' ' ' ALA . 16.9 m -129.89 -94.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 113.184 -1.508 . . . . 0.0 108.089 170.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.81 ' H ' HG23 ' A' ' 140' ' ' VAL . . . -166.86 153.48 8.61 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.563 0.745 . . . . 0.0 109.017 166.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.69 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 21.2 pttm -87.45 119.05 27.34 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.242 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.654 ' HG2' ' HG3' ' A' ' 93' ' ' LYS . 29.6 mt-10 68.02 -78.57 0.04 OUTLIER 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.259 0.624 . . . . 0.0 110.77 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 . . . . . 0 C--N 1.308 -1.198 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.334 179.643 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.446 ' HB3' ' HD2' ' A' ' 3' ' ' PHE . 24.2 mmt . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.754 0.311 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 m -88.06 61.17 6.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.044 0.449 . . . . 0.0 111.17 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.446 ' HD2' ' HB3' ' A' ' 1' ' ' MET . 98.3 m-85 -136.5 173.94 11.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.656 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.508 ' C ' ' H ' ' A' ' 6' ' ' ASN . 2.6 m-20 -77.58 -28.08 51.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.394 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.86 -22.88 0.16 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.903 0.752 . . . . 0.0 112.127 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.508 ' H ' ' C ' ' A' ' 4' ' ' ASN . 3.8 t-20 -60.26 82.28 0.01 OUTLIER 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.599 0.562 . . . . 0.0 111.54 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.68 HD13 ' O ' ' A' ' 115' ' ' ALA . 22.7 tp 177.32 -39.09 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 175.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.685 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.4 t70 -49.31 -63.03 1.22 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.505 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 p -59.58 -37.76 79.35 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.003 0.43 . . . . 0.0 112.043 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 mp -56.25 -50.58 70.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.898 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.75 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 5.8 p90 -85.59 -18.72 32.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.115 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 16' ' ' MET . 19.1 tpp180 -63.82 -51.99 62.21 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -63.89 -27.5 69.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.37 0.605 . . . . 0.0 109.453 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.75 ' HB ' ' HA ' ' A' ' 11' ' ' TYR . 2.1 t -70.56 -51.7 35.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.891 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 tt -72.19 -23.12 21.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.512 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -82.01 -42.68 18.99 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.261 0.351 . . . . 0.0 111.28 -178.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.532 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 20.9 t70 -69.11 -33.41 73.44 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.185 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.644 ' CE1' ' HB2' ' A' ' 74' ' ' SER . 86.2 t60 -74.4 -19.72 60.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.005 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -66.45 -40.63 89.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.532 ' HE3' ' HA ' ' A' ' 17' ' ' ASP . 70.9 mttt -49.98 -34.67 21.73 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.488 169.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.73 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 10.8 m120 -82.03 -179.6 1.54 Allowed Pre-proline 0 N--CA 1.465 0.298 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.73 ' HD2' ' HB3' ' A' ' 21' ' ' ASN . 11.1 Cg_endo -58.29 164.55 8.59 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.654 1.569 . . . . 0.0 111.215 164.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -85.83 -140.18 0.08 Allowed 'General case' 0 C--N 1.31 -1.137 0 O-C-N 122.038 -0.414 . . . . 0.0 111.072 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -116.91 52.46 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.981 0.419 . . . . 0.0 110.322 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.71 ' HD3' ' HG2' ' A' ' 62' ' ' GLU . 41.8 mmtm -144.03 83.68 1.75 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.587 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.28 137.14 5.23 Favored Glycine 0 C--O 1.228 -0.259 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.501 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 3.0 m -155.56 135.76 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.96 0.409 . . . . 0.0 110.171 -175.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.604 HD11 ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -144.09 170.28 16.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.363 0.602 . . . . 0.0 111.013 173.254 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -135.14 41.31 2.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.67 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.455 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 25.0 t70 -84.85 -9.73 57.85 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.88 0.371 . . . . 0.0 110.535 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.6 m -153.39 -85.45 0.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.301 0.572 . . . . 0.0 110.181 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.55 HD13 HD21 ' A' ' 51' ' ' LEU . 16.2 pt -127.66 141.77 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.783 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.938 HG13 HG23 ' A' ' 48' ' ' THR . 58.6 t -121.02 107.11 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.507 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.62 HG21 ' HA2' ' A' ' 139' ' ' GLY . 97.0 t -101.45 124.52 55.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 O-C-N 123.577 0.548 . . . . 0.0 110.413 -176.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -126.77 137.65 53.25 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.9 tpt -148.43 126.19 11.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -129.03 146.98 50.86 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.988 0.805 . . . . 0.0 111.368 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.954 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 20.2 t-20 -108.23 98.24 25.94 Favored Pre-proline 0 C--O 1.248 0.988 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.2 -23.73 70.78 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 123.623 2.882 . . . . 0.0 112.353 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.6 m -62.2 -31.87 72.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.085 0.865 . . . . 0.0 111.79 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 81.2 m -113.31 -51.58 2.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.47 -6.75 10.6 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 118.995 -1.574 . . . . 0.0 110.131 -156.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.954 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 24.4 m-20 -60.02 121.58 12.2 Favored 'General case' 0 C--O 1.213 -0.856 0 C-N-CA 123.742 0.817 . . . . 0.0 109.665 173.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -150.2 136.75 19.02 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 121.524 -0.735 . . . . 0.0 110.536 172.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 132' ' ' SER . 26.2 pt -138.75 145.02 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 81.0 mtm180 -125.86 105.21 8.78 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.509 0.671 . . . . 0.0 110.936 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.632 HD11 ' HE3' ' A' ' 49' ' ' MET . 1.3 tm? -89.7 98.49 11.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.918 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.938 HG23 HG13 ' A' ' 33' ' ' VAL . 71.7 p -100.48 120.16 39.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.632 ' HE3' HD11 ' A' ' 47' ' ' LEU . 35.7 mtt -111.2 -179.87 3.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.769 0.795 . . . . 0.0 112.591 -173.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HG3' ' OD2' ' A' ' 30' ' ' ASP . 60.7 tttm -149.53 93.68 2.09 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.55 HD21 HD13 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -124.23 101.98 7.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.62 -174.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -91.75 57.19 3.15 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.381 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.61 -99.55 0.22 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.445 ' C ' HD11 ' A' ' 85' ' ' ILE . 11.6 m-20 -131.2 25.9 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.675 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.472 HD11 ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -132.52 143.72 38.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.22 114.64 30.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -100.09 -24.9 14.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -169.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 11.6 t70 -153.21 155.5 36.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.693 171.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.58 ' H ' ' HE2' ' A' ' 81' ' ' LYS . . . -157.24 117.52 3.5 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -114.43 138.59 50.39 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 123.195 0.309 . . . . 0.0 110.219 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 5.4 p90 -129.5 137.88 51.06 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -169.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.71 ' HG2' ' HD3' ' A' ' 25' ' ' LYS . 3.6 tm-20 -120.04 135.04 55.08 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.86 138.57 7.0 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.202 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -150.93 142.44 23.51 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 43' ' ' ASP . . . 146.49 -134.75 5.46 Favored Glycine 0 CA--C 1.508 -0.386 0 C-N-CA 118.811 -1.661 . . . . 0.0 111.54 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 64.0 m -75.15 153.96 37.96 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 p -66.5 -27.12 67.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.892 0.377 . . . . 0.0 110.752 -170.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.687 HD13 HG22 ' A' ' 119' ' ' VAL . 2.7 pp -82.19 -32.1 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 121.568 0.699 . . . . 0.0 111.648 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.583 ' N ' HD11 ' A' ' 68' ' ' ILE . 6.7 m -73.17 -52.95 12.23 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.3 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.5 ptm -65.83 -17.82 64.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.979 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.527 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -86.67 -46.75 9.76 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.671 0.272 . . . . 0.0 111.633 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.2 p -69.88 -42.17 73.8 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.246 0.545 . . . . 0.0 110.304 -172.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.17 -56.05 26.27 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.204 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.644 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 60.4 p -63.88 -30.05 71.18 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.616 ' HG3' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -75.09 -53.0 9.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.028 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.566 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 11.9 tpt -70.04 -22.3 63.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.984 -177.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 8.5 p -72.93 -40.47 65.41 Favored 'General case' 0 C--O 1.212 -0.902 0 O-C-N 121.654 -0.654 . . . . 0.0 110.406 174.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -57.28 -31.14 65.3 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.41 172.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.86 -34.47 19.45 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.858 0.837 . . . . 0.0 110.25 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.5 OUTLIER -75.19 -32.25 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.685 -177.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.58 ' HE2' ' H ' ' A' ' 59' ' ' ALA . 46.2 tttm -49.88 -18.31 0.49 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.887 1.275 . . . . 0.0 111.838 175.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.1 46.99 1.05 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.427 ' HB2' HD11 ' A' ' 80' ' ' ILE . 42.8 mmtm -132.64 -175.69 3.85 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -118.09 -178.42 3.5 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 172.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.68 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -72.85 -44.16 58.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.143 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.87 -42.55 99.8 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.082 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 m -61.64 -45.47 93.93 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.565 0.698 . . . . 0.0 111.499 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.423 ' HB1' HD13 ' A' ' 80' ' ' ILE . . . -70.54 -32.46 69.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.529 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 83.1 mt -63.01 -35.73 81.2 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.166 0.984 . . . . 0.0 108.501 172.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.7 m -70.65 -33.91 71.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.489 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -63.65 -26.04 68.49 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.163 0.506 . . . . 0.0 110.926 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.499 ' HB3' ' HB1' ' A' ' 141' ' ' ALA . 0.9 OUTLIER -89.63 -34.35 16.33 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -178.177 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 143' ' ' GLU . 14.0 tmtt? -68.38 -37.22 80.2 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.545 HD11 ' HA ' ' A' ' 105' ' ' ASP . 21.8 mt -66.18 -46.47 87.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 123.558 0.743 . . . . 0.0 109.74 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.442 ' HD2' HG12 ' A' ' 113' ' ' ILE . 27.6 t80 -53.25 -30.18 36.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.697 0.76 . . . . 0.0 111.451 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.3 t -85.28 -39.03 18.18 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.626 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.95 -28.52 63.5 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.825 0.85 . . . . 0.0 111.672 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.633 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -57.8 -58.03 10.15 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.246 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.692 ' HE1' ' HA ' ' A' ' 99' ' ' MET . 3.4 mmt -64.7 -7.09 9.41 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -174.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -116.52 -35.94 4.11 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.375 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -94.69 -24.18 18.75 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.08 -173.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 23.7 ttmm 85.71 -21.87 0.2 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.046 0.927 . . . . 0.0 110.484 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 98' ' ' MET . 44.8 mt-10 -92.02 167.83 11.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.521 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 1.4 p90 -137.27 -110.75 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.02 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.817 ' HB3' HD12 ' A' ' 110' ' ' LEU . 13.9 t70 -93.93 110.54 22.21 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.498 0.666 . . . . 0.0 110.186 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -46.72 -11.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.527 -1.67 . . . . 0.0 113.027 172.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 105' ' ' ASP . 27.2 m -105.2 -15.37 15.08 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 121.678 -0.639 . . . . 0.0 110.495 177.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 108' ' ' ILE . 24.6 mm 70.77 19.15 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 124.049 0.843 . . . . 0.0 111.483 174.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -97.94 93.67 6.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.817 HD12 ' HB3' ' A' ' 105' ' ' ASP . 9.0 mp -124.07 31.82 5.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.249 -164.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -36.76 -43.75 0.85 Allowed Glycine 0 CA--C 1.534 1.219 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 6.9 p-10 -86.81 -44.73 11.51 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 117.657 0.728 . . . . 0.0 110.95 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.477 HD12 ' HG ' ' A' ' 110' ' ' LEU . 55.3 mt -62.74 -38.16 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.503 0.668 . . . . 0.0 110.58 -174.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.523 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 39.8 mt-10 -63.51 -53.69 48.07 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.028 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.68 ' O ' HD13 ' A' ' 7' ' ' LEU . . . -68.55 -37.73 80.2 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 124.527 1.142 . . . . 0.0 114.028 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.712 HD12 HG22 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -92.0 -11.3 36.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -173.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 114' ' ' GLU . 4.7 pp0? -60.32 -31.37 70.22 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.267 -0.895 . . . . 0.0 110.733 177.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.462 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -84.47 -18.1 62.87 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.461 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.712 HG22 HD12 ' A' ' 116' ' ' LEU . 72.9 t -86.69 -55.66 6.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.396 0.617 . . . . 0.0 110.368 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.766 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 23.5 t -41.22 -14.69 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.068 -1.878 . . . . 0.0 115.391 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 119' ' ' VAL . 55.0 mttm -131.56 7.6 4.51 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -163.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -103.01 136.39 19.24 Favored Pre-proline 0 CA--C 1.507 -0.71 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.83 -22.18 28.75 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.785 2.323 . . . . 0.0 111.621 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.53 -8.0 33.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.467 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.692 ' HB3' HG12 ' A' ' 119' ' ' VAL . 84.1 mtt180 -126.03 5.33 7.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 O-C-N 121.714 -0.616 . . . . 0.0 110.363 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 tt -84.53 -33.03 8.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.148 0.975 . . . . 0.0 108.954 -168.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.45 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 75.9 mmtt -72.72 -24.45 60.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.027 174.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.509 ' HA ' ' HB3' ' A' ' 131' ' ' LEU . 71.2 m -84.92 -17.76 36.77 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.582 0.706 . . . . 0.0 110.249 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.766 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -82.29 -21.54 36.11 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.557 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 65.5 m -83.63 -40.19 19.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.625 HD23 ' HB3' ' A' ' 43' ' ' ASP . 2.0 tp -50.51 -63.07 1.24 Allowed 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 113.459 -1.7 . . . . 0.0 111.185 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.554 ' HB2' HD22 ' A' ' 116' ' ' LEU . 20.5 m -76.44 -63.17 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -172.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.446 ' HB2' HD23 ' A' ' 116' ' ' LEU . 66.4 t90 -66.16 -49.84 66.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.145 -173.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.557 ' HB3' ' O ' ' A' ' 130' ' ' THR . 51.6 tttm -62.67 -35.69 80.48 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.134 -176.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.92 93.6 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.838 170.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.0 tp -66.46 -35.17 79.62 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.961 ' HA ' ' HB2' ' A' ' 141' ' ' ALA . 30.3 tt0 -69.04 -35.48 76.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.672 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -79.91 6.28 11.62 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 122.003 0.906 . . . . 0.0 110.023 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.62 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -103.71 -36.94 3.11 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.697 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.508 HG21 HG13 ' A' ' 85' ' ' ILE . 11.0 p -172.67 41.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.156 0.979 . . . . 0.0 109.698 -176.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.961 ' HB2' ' HA ' ' A' ' 137' ' ' GLU . . . -148.9 167.62 25.23 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.876 -172.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 143' ' ' GLU . 37.4 ttmt -171.02 -10.46 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.547 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 27.1 tt0 71.19 -67.29 0.26 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.887 0.742 . . . . 0.0 110.698 -175.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -105.49 141.72 36.48 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.524 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.37 -32.86 78.6 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.576 172.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.36 55.44 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 . . . . . 0 C--O 1.239 0.528 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.339 -172.518 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 111.56 0.208 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m 66.97 -76.61 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 177.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -78.1 97.86 5.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 122.031 -0.418 . . . . 0.0 111.036 -173.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.474 ' N ' HD21 ' A' ' 4' ' ' ASN . 0.1 OUTLIER -179.15 18.78 0.0 OUTLIER 'General case' 0 C--N 1.347 0.474 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 82.93 -176.2 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.9 0.88 . . . . 0.0 109.721 -175.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.432 ' CG ' ' H ' ' A' ' 7' ' ' LEU . 2.2 p30 -174.13 -88.5 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -175.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.432 ' H ' ' CG ' ' A' ' 6' ' ' ASN . 47.1 tp -143.99 -25.76 0.54 Allowed 'General case' 0 C--O 1.212 -0.899 0 C-N-CA 122.43 0.292 . . . . 0.0 111.687 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.415 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 14.6 t70 -49.17 -59.79 3.35 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.23 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -45.6 89.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.188 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.445 ' O ' HG21 ' A' ' 14' ' ' VAL . 74.7 mt -54.19 -51.67 63.64 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.481 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.415 ' CE1' ' HA ' ' A' ' 8' ' ' ASP . 2.2 p90 -85.14 -18.24 34.8 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.368 -175.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -60.52 -40.75 92.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.997 0.427 . . . . 0.0 110.128 169.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.616 ' HG3' ' HE3' ' A' ' 16' ' ' MET . 10.4 tt0 -73.1 -24.66 60.67 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.714 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 10' ' ' LEU . 90.0 t -73.17 -34.93 46.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.331 175.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.4 mt -73.9 -32.34 33.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.635 172.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.616 ' HE3' ' HG3' ' A' ' 13' ' ' GLN . 56.2 ttp -68.77 -46.27 69.2 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.899 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -38.2 89.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.702 -177.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.426 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -83.0 -14.24 54.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -69.09 -50.06 51.61 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.479 -1.388 . . . . 0.0 109.04 167.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -52.58 -37.39 57.92 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.391 0.676 . . . . 0.0 110.511 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.86 84.68 32.44 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.93 39.21 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.99 3.127 . . . . 0.0 114.408 -163.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -85.69 57.82 4.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.799 0.809 . . . . 0.0 110.868 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.426 ' OD1' ' HD2' ' A' ' 18' ' ' HIS . 4.6 m-20 -102.03 19.63 18.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.925 0.869 . . . . 0.0 109.496 172.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -136.99 143.96 43.05 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.002 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.793 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 157.96 139.74 2.77 Favored Glycine 0 C--O 1.21 -1.351 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.792 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.597 HG23 HG21 ' A' ' 48' ' ' THR . 4.0 p -167.18 120.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.465 0.65 . . . . 0.0 109.347 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.744 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -138.97 154.07 48.25 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.51 0.671 . . . . 0.0 110.533 175.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -102.2 79.64 1.88 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.841 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.472 ' OD1' ' HG3' ' A' ' 50' ' ' LYS . 6.5 t70 -115.8 -130.61 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.478 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 m -52.08 -71.71 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.976 0.798 . . . . 0.0 111.746 -172.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.731 HD13 HD22 ' A' ' 51' ' ' LEU . 10.4 pt -132.59 140.36 47.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.458 0.647 . . . . 0.0 110.978 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.683 HG13 HG23 ' A' ' 48' ' ' THR . 44.5 t -120.48 107.7 21.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.078 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 1.034 HG22 ' HA2' ' A' ' 139' ' ' GLY . 89.9 t -101.11 128.27 53.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.104 -172.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 1.5 p-10 -132.06 149.0 52.53 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.812 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.8 ' HE1' ' HA ' ' A' ' 36' ' ' MET . 3.5 mmt -143.08 122.77 13.33 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.341 1.026 . . . . 0.0 110.22 176.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.691 ' HB3' ' HB3' ' A' ' 44' ' ' ARG . 3.7 p-10 -118.44 134.2 55.26 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.131 0.894 . . . . 0.0 110.768 -176.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.43 ' N ' HD11 ' A' ' 131' ' ' LEU . 22.4 t30 -156.84 138.87 10.18 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -45.28 -35.61 11.56 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 124.447 3.431 . . . . 0.0 113.807 -178.367 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.587 HG21 ' O ' ' A' ' 124' ' ' ALA . 3.2 m -74.91 23.76 0.1 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 122.148 0.975 . . . . 0.0 111.427 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.629 ' SG ' HD13 ' A' ' 131' ' ' LEU . 72.3 m -136.22 -52.73 0.73 Allowed 'General case' 0 C--N 1.312 -1.06 0 O-C-N 121.463 -0.773 . . . . 0.0 110.335 167.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.29 -29.11 2.31 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.478 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 24.9 t0 -157.28 -88.45 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.82 0 CA-C-N 114.621 -0.79 . . . . 0.0 111.258 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.691 ' HB3' ' HB3' ' A' ' 37' ' ' ASN . 7.7 ptp85 179.63 -179.35 0.43 Allowed 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.036 0.446 . . . . 0.0 110.897 -169.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.644 HG23 ' HE1' ' A' ' 61' ' ' PHE . 19.5 pt -137.65 139.61 42.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.821 177.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.507 ' HD3' ' HD3' ' A' ' 44' ' ' ARG . 37.2 mmm-85 -114.03 100.69 8.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.494 0.664 . . . . 0.0 110.342 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.881 HD21 ' HG3' ' A' ' 49' ' ' MET . 0.8 OUTLIER -82.86 92.44 7.28 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.744 ' HB ' HD12 ' A' ' 28' ' ' LEU . 68.3 p -84.0 111.97 19.76 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.881 ' HG3' HD21 ' A' ' 47' ' ' LEU . 22.9 mtt -107.21 178.25 4.61 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.826 0.822 . . . . 0.0 111.298 -170.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.472 ' HG3' ' OD1' ' A' ' 30' ' ' ASP . 62.8 tttp -160.79 95.82 1.1 Allowed 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.731 HD22 HD13 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -119.56 84.52 2.22 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.852 -177.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.89 59.35 4.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.511 -164.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.92 -99.48 0.2 Allowed Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.804 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.415 ' C ' HG12 ' A' ' 85' ' ' ILE . 11.6 p-10 -133.37 24.47 4.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.466 0.65 . . . . 0.0 109.795 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.676 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.2 pp -139.66 152.91 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -99.83 121.17 50.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -104.15 -33.25 8.8 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.335 -169.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 6.9 t70 -140.17 143.02 35.9 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.417 -0.811 . . . . 0.0 108.86 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.572 ' HB2' HD22 ' A' ' 47' ' ' LEU . . . -167.74 101.74 0.48 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.793 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 47.7 mttp -115.32 167.53 10.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.058 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.644 ' HE1' HG23 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -124.41 131.28 53.5 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.627 0.727 . . . . 0.0 111.18 -174.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 10.3 tp10 -128.79 110.81 12.48 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.15 174.86 34.0 Favored Glycine 0 CA--C 1.493 -1.317 0 C-N-CA 119.325 -1.417 . . . . 0.0 113.486 -174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 1.3 tm-20 -147.74 132.25 17.7 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.95 -133.59 2.76 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.581 -171.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.2 p -110.03 172.81 6.64 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.662 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.7 t -74.16 -31.08 62.56 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.177 -165.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.711 HD11 ' SG ' ' A' ' 128' ' ' CYS . 2.7 pp -75.66 -24.57 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.148 0.499 . . . . 0.0 109.937 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.435 ' N ' HD13 ' A' ' 68' ' ' ILE . 13.1 m -78.86 -37.79 39.44 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 65.0 mtt -58.41 -33.0 69.17 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.779 0.799 . . . . 0.0 109.687 167.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.579 ' O ' ' HB3' ' A' ' 74' ' ' SER . . . -71.62 -38.1 70.83 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.999 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.794 ' HB2' HD13 ' A' ' 116' ' ' LEU . 41.7 t -59.98 -48.47 81.56 Favored 'General case' 0 C--O 1.219 -0.538 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.12 -41.33 78.81 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.815 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 71' ' ' ALA . 30.7 t -47.8 -67.59 0.26 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.242 173.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.466 ' SD ' ' HA3' ' A' ' 111' ' ' GLY . 25.5 mmt -65.15 -32.42 74.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.925 0.393 . . . . 0.0 110.518 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.752 ' SD ' ' HG ' ' A' ' 47' ' ' LEU . 31.9 ttm -56.66 -61.72 2.23 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.593 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 p -60.08 -27.62 67.14 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -90.02 -31.63 17.11 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.308 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.11 -41.22 15.92 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.299 0.571 . . . . 0.0 111.059 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.552 HG21 ' HE1' ' A' ' 49' ' ' MET . 14.7 mm -76.66 -39.71 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.443 -174.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.585 ' HZ1' ' HB3' ' A' ' 81' ' ' LYS . 3.0 mmmp? -52.56 -18.74 1.87 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.217 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.01 54.9 0.78 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.014 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.423 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 12.0 tppt? -133.3 169.45 16.89 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -114.28 -174.03 2.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 173.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.476 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 18.4 mm -85.49 -33.31 7.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.963 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -63.4 -46.42 86.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.198 0.523 . . . . 0.0 110.92 175.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 83' ' ' LYS . 0.9 OUTLIER -67.96 -37.61 81.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.352 178.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.885 ' HB2' HG21 ' A' ' 140' ' ' VAL . . . -64.18 -43.21 95.84 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.101 0.477 . . . . 0.0 111.37 175.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 70.9 mt -67.1 -35.54 80.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.318 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 p -73.03 -35.2 66.72 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.933 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.0 ttt -70.03 -22.58 63.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.875 0.845 . . . . 0.0 111.718 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.502 ' OG ' ' HA ' ' A' ' 142' ' ' LYS . 49.4 p -89.06 -36.59 15.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.859 ' HB2' ' HA ' ' A' ' 143' ' ' GLU . 87.1 tttt -66.8 -37.02 83.73 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 1.03 HD11 ' HA ' ' A' ' 105' ' ' ASP . 12.8 mt -67.74 -47.27 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.355 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.529 ' CE2' HG12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -55.95 -24.88 40.88 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 123.934 0.771 . . . . 0.0 110.04 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.4 m -81.71 -43.07 18.97 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.993 -0.442 . . . . 0.0 110.824 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 99' ' ' MET . 6.2 t70 -75.96 -29.19 58.2 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -173.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.8 ptm -54.31 -10.0 0.34 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.956 0.902 . . . . 0.0 112.307 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.49 ' H ' ' C ' ' A' ' 97' ' ' ASP . 95.6 mmm -100.1 -7.77 24.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.926 0.87 . . . . 0.0 109.241 -166.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -134.68 -22.74 1.65 Allowed 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.688 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.54 -23.49 6.87 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 119.207 -0.774 . . . . 0.0 112.302 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.3 tptm 81.48 -18.54 0.48 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.08 1.352 . . . . 0.0 109.692 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -77.91 149.15 34.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -137.03 -134.03 0.14 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -171.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 1.03 ' HA ' HD11 ' A' ' 94' ' ' ILE . 9.0 t70 -90.66 108.79 20.04 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.125 0.964 . . . . 0.0 109.33 -169.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -58.5 -2.86 0.23 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.284 173.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.538 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 1.5 m -89.79 -24.82 21.37 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 170.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.447 HG21 ' O ' ' A' ' 108' ' ' ILE . 22.7 mm 72.91 25.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-O 122.421 1.105 . . . . 0.0 110.703 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -94.89 70.03 3.36 Favored 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 121.618 -0.676 . . . . 0.0 109.952 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.798 ' HG ' HD13 ' A' ' 113' ' ' ILE . 6.1 mp -104.35 14.11 30.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.285 -169.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.466 ' HA3' ' SD ' ' A' ' 75' ' ' MET . . . -44.78 -39.26 6.07 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 119.857 -0.413 . . . . 0.0 113.849 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.09 -45.42 23.49 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-O 122.367 1.08 . . . . 0.0 109.906 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.798 HD13 ' HG ' ' A' ' 110' ' ' LEU . 36.8 mt -58.25 -28.95 36.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.902 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -76.27 -54.5 6.7 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.282 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.45 -41.45 69.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.3 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.794 HD13 ' HB2' ' A' ' 72' ' ' SER . 6.6 mp -96.04 -6.77 37.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 6.4 tt0 -45.53 -51.44 11.82 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.178 0.923 . . . . 0.0 110.853 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.48 -18.79 77.32 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.375 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.538 HG23 HD12 ' A' ' 68' ' ' ILE . 60.2 t -78.29 -60.25 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 O-C-N 122.056 -0.673 . . . . 0.0 111.606 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.518 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 14.5 p -50.93 -16.06 0.38 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.338 -1.301 . . . . 0.0 114.141 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.962 ' HA ' ' HE2' ' A' ' 121' ' ' LYS . 8.9 mmpt? -99.66 -16.73 18.09 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.492 -0.755 . . . . 0.0 110.822 -163.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -90.4 135.14 29.9 Favored Pre-proline 0 N--CA 1.443 -0.794 0 O-C-N 123.833 0.708 . . . . 0.0 109.819 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.0 -27.48 21.36 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.323 2.682 . . . . 0.0 111.78 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.587 ' O ' HG21 ' A' ' 40' ' ' THR . . . -84.34 -27.75 27.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.556 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 119' ' ' VAL . 30.5 mtm180 -113.9 17.76 17.75 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.775 -166.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.7 tt -84.9 -29.74 6.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.03 -17.78 45.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.778 -1.556 . . . . 0.0 107.999 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.711 ' SG ' HD11 ' A' ' 68' ' ' ILE . 54.1 t -84.34 -19.62 33.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.757 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.568 ' O ' ' HB3' ' A' ' 133' ' ' TRP . . . -85.78 -27.73 25.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.533 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.618 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 16.6 p -78.31 -35.84 47.26 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.629 HD13 ' SG ' ' A' ' 41' ' ' CYS . 10.0 tt -51.42 -54.17 29.43 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.225 172.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.508 ' HB2' HD22 ' A' ' 116' ' ' LEU . 35.9 m -81.88 -62.25 1.69 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.568 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 1.2 t90 -62.49 -50.43 71.44 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 120.943 0.401 . . . . 0.0 111.849 -175.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.618 ' HB3' ' O ' ' A' ' 130' ' ' THR . 37.7 ttpt -62.65 -29.34 70.56 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.608 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 131' ' ' LEU . . . -56.89 -31.02 64.45 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 169.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.5 mp -80.55 -35.17 34.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.4 ' OE1' ' HD2' ' A' ' 142' ' ' LYS . 7.5 mm-40 -61.65 -43.85 98.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.422 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -91.25 5.51 48.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.361 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 1.034 ' HA2' HG22 ' A' ' 34' ' ' VAL . . . -85.79 -39.99 7.87 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.885 HG21 ' HB2' ' A' ' 88' ' ' ALA . 20.1 m -127.06 -9.45 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 O-C-N 122.091 -0.653 . . . . 0.0 110.543 -177.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 140' ' ' VAL . . . 91.78 152.39 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.184 1.393 . . . . 0.0 108.425 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.502 ' HA ' ' OG ' ' A' ' 92' ' ' SER . 14.9 pttp -114.44 142.66 46.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -171.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.859 ' HA ' ' HB2' ' A' ' 93' ' ' LYS . 33.4 mt-10 65.81 -88.66 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.242 0.964 . . . . 0.0 111.861 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -107.94 107.5 18.24 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 123.587 0.554 . . . . 0.0 110.585 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.95 80.62 0.35 Allowed Glycine 0 CA--C 1.508 -0.35 0 O-C-N 123.906 0.754 . . . . 0.0 112.116 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.76 158.48 17.41 Favored Glycine 0 CA--C 1.506 -0.512 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.08 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 C--N 1.323 -0.569 0 O-C-N 122.286 -0.537 . . . . 0.0 110.287 179.408 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.869 0.366 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 m -66.82 -61.11 2.12 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.115 0.483 . . . . 0.0 110.279 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -137.39 -57.93 0.7 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.7 m120 64.93 152.71 0.05 Allowed 'General case' 0 N--CA 1.477 0.879 0 O-C-N 125.054 1.471 . . . . 0.0 112.134 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.84 93.14 6.49 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.272 0.558 . . . . 0.0 110.157 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.33 -82.14 0.5 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.532 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 115' ' ' ALA . 12.7 tp -137.54 0.28 2.25 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.983 0.897 . . . . 0.0 109.116 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.495 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -55.81 -63.53 1.14 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 125.348 1.459 . . . . 0.0 111.467 -178.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -62.7 -35.14 78.73 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.718 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.487 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 4.1 mm? -53.97 -39.52 66.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.103 174.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.858 ' HE1' HG22 ' A' ' 68' ' ' ILE . 22.7 m-85 -63.08 -57.71 9.71 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 121.52 0.676 . . . . 0.0 109.848 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.632 ' HA ' HG22 ' A' ' 15' ' ' ILE . 47.3 mtm180 -69.44 -18.92 63.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.03 -169.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -86.62 -35.86 19.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.685 1.231 . . . . 0.0 108.02 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.631 HG23 ' HB2' ' A' ' 115' ' ' ALA . 0.3 OUTLIER -80.1 -34.19 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.964 -175.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.632 HG22 ' HA ' ' A' ' 12' ' ' ARG . 10.5 tt -82.62 -19.1 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.683 175.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.604 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 17.2 tpt -61.73 -43.87 98.02 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.859 0.838 . . . . 0.0 110.388 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.02 -41.71 63.95 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.059 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -61.82 -28.23 69.33 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.774 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -66.84 -55.64 13.93 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.104 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -48.57 -38.35 20.38 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 124.039 0.837 . . . . 0.0 110.812 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -114.08 86.3 11.32 Favored Pre-proline 0 C--N 1.32 -0.676 0 O-C-N 123.426 0.454 . . . . 0.0 110.478 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.57 45.97 2.01 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.529 2.153 . . . . 0.0 114.038 -172.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.33 102.15 11.58 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.083 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -142.24 25.93 1.86 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.151 0.977 . . . . 0.0 108.366 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -132.09 124.46 29.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.224 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.767 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 155.28 146.94 4.56 Favored Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.713 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -165.39 93.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.873 0 O-C-N 124.619 0.835 . . . . 0.0 109.25 177.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.587 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -116.75 139.2 50.84 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 120.68 -1.263 . . . . 0.0 111.721 -175.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.495 ' HA ' HG23 ' A' ' 33' ' ' VAL . 58.1 t30 -81.24 81.34 7.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.627 172.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.507 ' HB2' HD11 ' A' ' 28' ' ' LEU . 10.3 t70 -101.48 -125.86 0.19 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.667 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.4 t -66.66 -64.92 0.75 Allowed 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.668 -0.645 . . . . 0.0 110.376 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.567 HG13 ' HB2' ' A' ' 49' ' ' MET . 34.4 pt -125.65 135.28 64.43 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.713 176.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.962 HG12 HG22 ' A' ' 48' ' ' THR . 84.9 t -116.16 138.11 47.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.917 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.735 HG23 ' HA2' ' A' ' 139' ' ' GLY . 98.1 t -127.95 124.65 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -120.41 136.91 54.58 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.35 0.119 . . . . 0.0 111.061 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.546 ' HG3' HD12 ' A' ' 131' ' ' LEU . 47.9 tpp -151.55 123.48 8.09 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 110.98 175.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -127.64 150.35 49.78 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.573 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -109.93 98.2 33.05 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.51 -11.62 32.79 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.596 2.864 . . . . 0.0 113.278 -171.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.4 m -75.85 -30.9 59.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.544 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.2 p -131.12 -12.67 3.59 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.43 3.78 58.49 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.317 -1.42 . . . . 0.0 113.538 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -70.15 115.5 9.42 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -127.83 141.08 51.67 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.907 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 31.6 pt -141.34 149.84 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.287 0.565 . . . . 0.0 110.172 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.728 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 50.5 mtt180 -140.51 107.64 5.48 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.957 -0.464 . . . . 0.0 111.525 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.705 HD23 ' HG3' ' A' ' 49' ' ' MET . 0.7 OUTLIER -93.66 89.67 6.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.962 HG22 HG12 ' A' ' 33' ' ' VAL . 67.4 p -88.02 128.5 35.4 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 173.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.705 ' HG3' HD23 ' A' ' 47' ' ' LEU . 30.5 mtt -113.67 -179.21 3.57 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.275 1.036 . . . . 0.0 112.92 -170.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.833 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 45.3 tttp -159.87 98.7 1.36 Allowed 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.539 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.3 pt? -126.48 93.12 3.71 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -172.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -99.17 59.92 1.17 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.731 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 148.77 -96.21 0.17 Allowed Glycine 0 C--N 1.316 -0.548 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.43 18.93 6.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -176.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 2.4 pp -140.54 167.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 p -116.2 116.81 53.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 168.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -106.58 -27.63 10.75 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.033 0.921 . . . . 0.0 109.95 -166.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.833 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 28.0 t70 -140.73 144.68 35.7 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.36 118.04 2.53 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.767 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 34.2 mmtp -107.25 130.41 54.75 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.728 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.7 p90 -129.01 147.28 50.86 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.35 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 42.2 tt0 -107.16 138.46 43.29 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.42 120.13 1.54 Allowed Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.637 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -163.15 106.63 1.04 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.15 -131.4 1.87 Allowed Glycine 0 C--O 1.236 0.24 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.904 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.7 m -77.21 173.67 11.6 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.8 m -89.87 17.31 6.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.795 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.858 HG22 ' HE1' ' A' ' 11' ' ' TYR . 2.7 pp -119.05 -45.13 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.393 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.502 ' N ' HD13 ' A' ' 68' ' ' ILE . 13.8 p -73.27 -46.18 51.34 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.798 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -27.25 64.43 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.172 177.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.0 -59.26 2.39 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.632 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.648 ' CB ' ' HB2' ' A' ' 116' ' ' LEU . 21.7 p -67.62 -45.84 74.22 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.437 -168.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.04 -53.81 50.33 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 120.901 0.381 . . . . 0.0 110.345 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.1 t -60.16 -35.33 75.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.414 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.402 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 17.9 tpt -67.78 -54.82 16.17 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.551 0.691 . . . . 0.0 110.349 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.443 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -62.98 -33.52 75.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.205 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.618 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 24.3 p -72.61 -39.43 67.3 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.348 0.594 . . . . 0.0 110.651 177.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' A' ' 75' ' ' MET . 28.1 tt0 -53.25 -38.05 62.65 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.586 171.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.98 -27.83 24.61 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.762 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.618 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -73.56 -36.83 48.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 O-C-N 124.359 1.037 . . . . 0.0 110.152 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -56.35 -17.51 8.07 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.848 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.95 42.59 1.79 Allowed Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.29 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.46 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 20.6 mmtm -134.53 -153.04 0.5 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.698 0.761 . . . . 0.0 111.875 -176.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.46 ' H ' ' HB3' ' A' ' 83' ' ' LYS . 4.4 m-20 -145.78 155.88 43.23 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 -167.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.627 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.6 mp -63.31 -49.75 81.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 O-C-N 123.342 0.401 . . . . 0.0 110.079 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.26 -38.73 82.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.863 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.508 ' O ' ' HG2' ' A' ' 91' ' ' MET . 4.8 m -68.35 -35.04 77.16 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 121.497 0.665 . . . . 0.0 110.428 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 141' ' ' ALA . . . -60.5 -41.88 95.21 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 173.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 32.8 mt -67.36 -31.83 72.35 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.287 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.426 ' OG ' ' HA ' ' A' ' 87' ' ' THR . 5.1 p -77.96 -29.63 49.93 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 121.66 -0.65 . . . . 0.0 111.76 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 87' ' ' THR . 22.1 mmt -75.66 -18.91 59.5 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.09 0.948 . . . . 0.0 110.846 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p -90.08 -31.47 17.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.377 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.85 -37.96 79.46 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.66 172.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.434 HD11 ' HB2' ' A' ' 105' ' ' ASP . 35.9 mt -62.23 -48.85 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 171.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.472 ' HD1' HG12 ' A' ' 113' ' ' ILE . 49.9 t80 -43.39 -35.91 1.73 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.471 0.653 . . . . 0.0 111.745 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.2 m -85.08 -35.51 21.78 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 121.686 -0.634 . . . . 0.0 111.454 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -84.3 -20.09 32.69 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.05 0.929 . . . . 0.0 112.3 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.446 ' CG ' ' HB3' ' A' ' 104' ' ' TYR . 2.1 tmt? -73.34 -13.07 61.04 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.233 -174.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.1 mmt -95.24 6.15 49.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.556 -160.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -103.97 16.85 25.35 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.5 30.25 74.85 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.509 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -102.7 -170.92 1.87 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.816 0.308 . . . . 0.0 110.211 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.59 156.86 33.87 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.456 ' HD2' ' H ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -124.64 -101.2 0.39 Allowed 'General case' 0 C--N 1.316 -0.883 0 O-C-N 123.717 0.636 . . . . 0.0 111.035 -178.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.625 ' HB3' HD11 ' A' ' 110' ' ' LEU . 15.4 t0 -116.14 107.26 14.67 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 123.742 0.651 . . . . 0.0 109.373 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.76 -2.01 1.6 Allowed 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.959 0.787 . . . . 0.0 111.531 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.59 ' O ' HG21 ' A' ' 108' ' ' ILE . 2.1 m -89.34 -15.8 32.54 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 172.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.59 HG21 ' O ' ' A' ' 107' ' ' SER . 4.3 tp 68.59 15.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.068 0.947 . . . . 0.0 113.512 165.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.442 ' C ' HD13 ' A' ' 110' ' ' LEU . 29.0 t0 -92.73 88.68 6.34 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.625 HD11 ' HB3' ' A' ' 105' ' ' ASP . 10.8 mp -127.0 43.75 3.05 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.037 -168.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -38.64 -44.87 1.89 Allowed Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.579 -0.737 . . . . 0.0 114.91 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.606 ' O ' ' HB3' ' A' ' 116' ' ' LEU . 16.1 p-10 -90.45 -41.53 11.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.52 1.152 . . . . 0.0 109.99 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.725 ' O ' ' HB2' ' A' ' 117' ' ' GLN . 50.7 mt -69.47 -27.49 34.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.591 -172.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -86.98 -69.59 0.67 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.396 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.631 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -63.52 -39.39 94.31 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -172.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.648 ' HB2' ' CB ' ' A' ' 72' ' ' SER . 48.4 tp -99.74 3.08 44.77 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.648 0.737 . . . . 0.0 111.17 -169.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.725 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 8.2 tt0 -63.48 -45.79 89.15 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.536 0.684 . . . . 0.0 110.445 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.95 -17.23 65.14 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 113.91 -1.495 . . . . 0.0 113.014 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.931 HG13 ' HG2' ' A' ' 125' ' ' ARG . 97.9 t -82.09 -40.78 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 121.765 0.793 . . . . 0.0 110.186 -169.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.511 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 16.4 t -42.98 -13.23 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.561 -1.654 . . . . 0.0 115.393 174.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.466 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 10.2 ptmt -142.93 -0.37 1.16 Allowed 'General case' 0 C--O 1.243 0.725 0 O-C-N 121.003 -1.061 . . . . 0.0 113.041 -162.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.63 ' HB2' ' HB3' ' A' ' 125' ' ' ARG . 30.0 m-85 -81.09 123.6 81.75 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 168.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -51.05 -28.79 25.76 Favored 'Trans proline' 0 C--O 1.218 -0.514 0 C-N-CA 123.347 2.698 . . . . 0.0 112.652 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.49 -0.11 32.81 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.216 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.931 ' HG2' HG13 ' A' ' 119' ' ' VAL . 33.0 ttm180 -126.08 6.02 7.19 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.393 -175.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.7 tt -80.73 -25.34 11.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.244 -171.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -76.8 -20.11 56.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.389 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.0 m -86.3 -19.33 30.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.228 174.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.562 ' HB2' HG11 ' A' ' 119' ' ' VAL . . . -72.62 -46.9 51.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.147 176.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.671 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 7.5 p -69.99 -37.58 75.76 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.546 HD12 ' HG3' ' A' ' 36' ' ' MET . 18.0 tp -46.38 -55.68 6.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.077 -0.389 . . . . 0.0 111.494 171.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.45 ' HB2' HD23 ' A' ' 116' ' ' LEU . 6.7 m -83.42 -55.87 4.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.812 0.339 . . . . 0.0 111.203 -171.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.411 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 6.4 t90 -63.47 -50.56 69.21 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.746 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.671 ' HB3' ' O ' ' A' ' 130' ' ' THR . 3.1 tppp? -60.65 -42.31 96.7 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.19 -41.13 78.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.937 0.399 . . . . 0.0 111.581 173.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.0 tp -73.97 -32.43 63.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.416 0.627 . . . . 0.0 110.173 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.681 ' HA ' ' O ' ' A' ' 141' ' ' ALA . 39.4 tt0 -69.55 -37.37 77.03 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.5 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.68 ' HB3' ' HZ2' ' A' ' 138' ' ' LYS . 9.6 mtpm? -87.64 10.63 17.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.695 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.735 ' HA2' HG23 ' A' ' 34' ' ' VAL . . . -94.82 -40.96 4.23 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.491 ' CG1' ' HE2' ' A' ' 49' ' ' MET . 14.8 p -178.13 -44.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.681 ' O ' ' HA ' ' A' ' 137' ' ' GLU . . . -82.97 100.61 10.54 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.409 ' HA ' ' HG3' ' A' ' 137' ' ' GLU . 13.4 ptmm? -142.91 28.29 1.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.102 0.477 . . . . 0.0 110.587 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 59.12 -167.28 0.16 Allowed 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.9 -171.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -93.81 -53.28 4.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.29 -89.76 0.12 Allowed Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.123 172.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.94 -133.8 13.52 Favored Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 C--N 1.317 -0.83 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.278 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 ttm . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 110.706 -0.109 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -79.88 119.38 22.67 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-O 121.304 0.573 . . . . 0.0 111.485 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -119.75 87.79 2.81 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -108.13 111.01 22.81 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.074 0.464 . . . . 0.0 110.063 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.83 -34.03 0.32 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.566 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -41.69 -33.44 0.48 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.275 1.03 . . . . 0.0 113.198 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.657 HD12 ' HB2' ' A' ' 10' ' ' LEU . 28.3 tp -105.5 -16.6 14.68 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.008 -0.433 . . . . 0.0 110.443 -168.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 30.4 t70 -56.53 -54.18 48.84 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.825 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.3 m -59.93 -42.25 93.58 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.536 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.657 ' HB2' HD12 ' A' ' 7' ' ' LEU . 70.0 mt -59.08 -36.41 75.04 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.835 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.544 ' O ' HG12 ' A' ' 15' ' ' ILE . 8.3 m-85 -63.92 -54.75 29.77 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.194 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.502 ' O ' ' HB2' ' A' ' 16' ' ' MET . 28.0 mtt85 -56.23 -37.33 69.58 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.86 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -75.49 -37.61 60.07 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.261 0.35 . . . . 0.0 110.868 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 t -76.93 -34.62 22.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.937 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 11' ' ' TYR . 29.0 pt -77.91 -18.44 13.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 121.813 -0.555 . . . . 0.0 109.804 174.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 45.7 ttm -69.04 -47.41 65.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -61.05 -46.41 90.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.733 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 58.9 t-80 -51.61 -45.86 63.37 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.251 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -66.72 -49.12 67.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.387 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -44.61 -41.38 6.54 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.238 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -131.73 81.05 64.6 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-O 121.407 0.622 . . . . 0.0 109.505 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -88.72 94.99 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.078 2.519 . . . . 0.0 112.875 -171.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -161.17 115.05 2.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.009 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.612 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 13.8 m120 -113.16 24.76 11.99 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.32 101.04 10.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.972 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.653 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -168.65 120.44 0.89 Allowed Glycine 0 CA--C 1.494 -1.237 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.755 HG22 ' HE ' ' A' ' 46' ' ' ARG . 2.4 p -167.88 105.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 O-C-N 121.185 -1.186 . . . . 0.0 110.982 -174.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.457 ' H ' ' CB ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -87.55 -155.36 0.29 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.396 0.617 . . . . 0.0 110.155 173.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.566 ' HA ' HG22 ' A' ' 33' ' ' VAL . 3.8 p-10 -166.42 13.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.357 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -99.42 -71.18 0.7 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.804 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.693 ' HB3' ' O ' ' A' ' 49' ' ' MET . 11.3 t -73.19 -143.98 0.02 OUTLIER 'General case' 0 C--O 1.238 0.486 0 O-C-N 123.157 0.286 . . . . 0.0 110.649 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.789 HG13 ' HB2' ' A' ' 49' ' ' MET . 27.9 pt -78.78 119.98 28.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.683 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.984 HG11 HG23 ' A' ' 48' ' ' THR . 79.9 t -119.2 135.02 60.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.257 -177.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.755 HG22 ' HA2' ' A' ' 139' ' ' GLY . 78.9 t -123.52 119.63 57.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -120.65 118.71 30.82 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.051 0.219 . . . . 0.0 110.766 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.774 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 3.4 mmt -144.51 121.17 11.15 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.15 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.498 ' HB3' ' HG3' ' A' ' 44' ' ' ARG . 3.1 p30 -120.09 158.65 26.43 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 172.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.624 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 25.9 t30 -114.46 100.07 52.38 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 121.384 0.611 . . . . 0.0 109.816 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.12 -19.34 40.87 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 123.157 2.571 . . . . 0.0 113.113 -173.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 60.1 m -62.91 -43.92 97.49 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.8 p -133.0 8.67 4.09 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.06 6.9 78.33 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.477 163.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.624 ' OD1' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -82.3 146.4 29.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.216 0.531 . . . . 0.0 110.153 176.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.498 ' HG3' ' HB3' ' A' ' 37' ' ' ASN . 52.3 ttt180 -139.71 148.32 42.16 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.622 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.7 tt -140.18 146.61 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 123.536 0.523 . . . . 0.0 110.12 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.755 ' HE ' HG22 ' A' ' 27' ' ' VAL . 75.4 mtp85 -141.17 100.38 3.79 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.241 0.543 . . . . 0.0 110.326 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.704 HD22 ' HG3' ' A' ' 49' ' ' MET . 0.3 OUTLIER -89.99 92.17 8.88 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.48 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.984 HG23 HG11 ' A' ' 33' ' ' VAL . 77.7 p -93.23 130.64 38.86 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.553 -0.717 . . . . 0.0 109.79 174.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.789 ' HB2' HG13 ' A' ' 32' ' ' ILE . 36.9 mtt -126.92 -177.7 4.13 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 121.819 -0.55 . . . . 0.0 110.815 -172.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.797 ' HZ1' ' HB2' ' A' ' 52' ' ' ASP . 10.5 tmtt? -160.61 110.93 1.78 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.5 pt? -128.57 94.3 3.84 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.942 0.877 . . . . 0.0 108.939 -170.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.797 ' HB2' ' HZ1' ' A' ' 50' ' ' LYS . 37.4 t70 -101.89 59.84 0.85 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.759 0.79 . . . . 0.0 109.951 -171.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.83 -94.82 0.16 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 170.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -133.77 24.71 4.0 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.408 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -139.48 160.13 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -173.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -95.68 97.12 6.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 123.485 1.612 . . . . 0.0 106.999 165.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 50' ' ' LYS . 37.8 tt0 -66.44 -41.88 88.46 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 112.509 -2.132 . . . . 0.0 110.189 -167.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -148.72 146.53 28.14 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.561 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.33 121.93 11.11 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.653 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 89.4 mttt -126.06 140.86 52.25 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.704 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.651 ' CZ ' ' HA ' ' A' ' 74' ' ' SER . 31.2 p90 -128.22 143.39 51.03 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.972 0.415 . . . . 0.0 110.575 -172.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.612 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 45.7 tt0 -117.05 114.02 23.16 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -121.38 128.66 7.42 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.265 -173.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -148.21 108.45 4.1 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 43' ' ' ASP . . . 170.84 -132.4 2.47 Favored Glycine 0 C--N 1.317 -0.523 0 C-N-CA 119.363 -1.398 . . . . 0.0 112.584 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 70' ' ' MET . 1.4 p -95.37 159.25 15.09 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 120.753 0.311 . . . . 0.0 110.261 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.9 t -78.75 24.9 0.28 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.467 -167.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.487 HD12 HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -118.19 -52.67 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 122.386 1.089 . . . . 0.0 109.652 179.022 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.613 ' HB3' HD21 ' A' ' 131' ' ' LEU . 1.2 m -77.23 -44.29 30.49 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 121.781 0.801 . . . . 0.0 111.098 -170.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 66' ' ' CYS . 26.9 ptm -72.16 -12.84 61.37 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.392 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.81 -45.98 11.08 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.071 -0.393 . . . . 0.0 111.379 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 p -62.62 -28.36 69.85 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 121.41 0.624 . . . . 0.0 109.849 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.61 -50.38 67.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.463 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.651 ' HA ' ' CZ ' ' A' ' 61' ' ' PHE . 24.3 m -59.64 -39.25 83.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -76.49 -58.61 3.18 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.829 -174.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.6 ' SD ' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -59.34 -34.0 71.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.817 -177.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 1.059 ' HA ' HG23 ' A' ' 80' ' ' ILE . 98.9 m -61.97 -43.18 99.37 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.088 0.858 . . . . 0.0 110.1 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 75' ' ' MET . 77.5 mt-30 -49.45 -37.01 24.34 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.773 0.797 . . . . 0.0 110.535 172.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.489 ' HB1' ' OD2' ' A' ' 109' ' ' ASP . . . -86.26 -31.84 21.44 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.682 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 1.059 HG23 ' HA ' ' A' ' 77' ' ' THR . 9.9 tp -83.24 -40.17 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.054 -173.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -54.34 -17.29 2.84 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.927 0.87 . . . . 0.0 111.346 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.26 40.88 2.12 Favored Glycine 0 C--N 1.31 -0.895 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -132.78 167.05 20.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -103.98 -177.06 3.26 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.678 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.4 mp -81.77 -45.37 20.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.21 -176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -58.36 -43.45 88.4 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.37 0.419 . . . . 0.0 111.099 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.522 ' HA ' ' OG ' ' A' ' 90' ' ' SER . 2.7 p -68.84 -37.65 79.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.389 0.614 . . . . 0.0 111.508 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.4 ' HB2' HG13 ' A' ' 140' ' ' VAL . . . -60.89 -40.52 93.37 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.863 175.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.835 HD21 ' HB3' ' A' ' 142' ' ' LYS . 34.0 mt -69.58 -37.5 76.97 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 110.819 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.522 ' OG ' ' HA ' ' A' ' 87' ' ' THR . 2.3 p -75.43 -35.24 61.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.072 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.533 ' HA ' HG23 ' A' ' 94' ' ' ILE . 11.2 tmm? -64.94 -20.85 66.68 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.778 0.799 . . . . 0.0 109.185 173.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.795 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 43.6 t -85.35 -42.96 14.1 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.297 -1.319 . . . . 0.0 107.577 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.637 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 54.3 tttp -67.42 -36.25 80.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.329 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.533 HG23 ' HA ' ' A' ' 91' ' ' MET . 9.1 tt -79.73 -39.77 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.087 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -46.19 -38.63 8.57 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.44 0.638 . . . . 0.0 111.247 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.5 m -86.66 -28.23 23.29 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.44 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -71.77 -21.57 61.71 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.052 0.541 . . . . 0.0 111.0 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -41.94 -47.27 4.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.673 0.789 . . . . 0.0 112.513 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.1 ttt -55.08 -18.24 5.14 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -129.3 -26.46 2.56 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.492 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.47 -40.17 4.26 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.512 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp 87.85 37.48 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.427 ' HB3' HD11 ' A' ' 94' ' ' ILE . 39.7 mt-10 -132.45 126.96 34.27 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.562 -2.108 . . . . 0.0 107.219 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.58 ' CD1' HD21 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -94.59 -89.73 0.23 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 107' ' ' SER . 5.3 t70 -115.02 112.64 22.96 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 156.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.491 ' H ' HD12 ' A' ' 94' ' ' ILE . 30.9 t70 -49.89 -21.81 1.29 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.775 173.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.462 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 1.3 m -80.11 -17.13 53.4 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.48 ' HA ' HD13 ' A' ' 110' ' ' LEU . 21.9 mm 72.23 24.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 122.507 1.146 . . . . 0.0 110.492 174.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.489 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 27.6 t70 -95.17 66.77 2.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.055 177.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.793 ' HG ' ' HB ' ' A' ' 113' ' ' ILE . 7.8 mp -95.94 40.32 1.12 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.127 -165.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.443 ' HA2' ' SD ' ' A' ' 75' ' ' MET . . . -38.31 -50.75 2.28 Favored Glycine 0 C--O 1.242 0.594 0 O-C-N 124.066 0.854 . . . . 0.0 114.145 177.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.63 ' HB2' HD21 ' A' ' 116' ' ' LEU . 8.5 p-10 -91.59 -43.38 9.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.8 -0.824 . . . . 0.0 110.238 176.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.793 ' HB ' ' HG ' ' A' ' 110' ' ' LEU . 16.4 mt -62.93 -33.3 59.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.575 -166.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.466 ' HG2' HD21 ' A' ' 10' ' ' LEU . 31.8 tt0 -61.98 -50.83 70.52 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.423 ' O ' HG21 ' A' ' 119' ' ' VAL . . . -69.68 -53.37 18.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.933 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 112' ' ' ASP . 3.9 mp -82.72 -2.7 54.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -164.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -62.79 -39.32 93.87 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.52 -17.19 64.62 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.864 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.85 HG13 ' HB3' ' A' ' 125' ' ' ARG . 91.8 t -86.17 -46.94 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -171.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.6 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 9.4 t -49.56 -10.16 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.63 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.824 ' HA ' ' HE3' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -134.0 -17.41 2.15 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.365 -160.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -88.63 130.06 46.63 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.56 -30.61 55.44 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 122.433 2.089 . . . . 0.0 112.276 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.25 1.75 56.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.255 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.85 ' HB3' HG13 ' A' ' 119' ' ' VAL . 27.9 mmt180 -134.92 8.01 3.49 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 118.61 0.641 . . . . 0.0 110.422 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.2 tt -84.34 -30.07 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -165.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.489 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 31.8 mmtp -74.99 -30.49 61.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.999 174.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.2 m -78.62 -17.64 55.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.023 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.6 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -78.38 -31.4 48.38 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.92 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.756 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 25.3 m -72.11 -44.47 63.15 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.613 HD21 ' HB3' ' A' ' 69' ' ' SER . 9.5 tt -50.2 -63.59 1.07 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.636 174.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.52 ' HB2' HD22 ' A' ' 116' ' ' LEU . 13.5 p -74.59 -63.49 1.23 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.985 -171.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.49 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 4.7 t90 -66.38 -56.34 11.54 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 122.58 0.352 . . . . 0.0 111.219 -175.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.756 ' HB3' ' O ' ' A' ' 130' ' ' THR . 24.1 tptm -56.6 -40.08 74.66 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 123.992 0.808 . . . . 0.0 110.184 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.1 -32.95 73.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.555 HD22 ' SD ' ' A' ' 76' ' ' MET . 15.7 tp -78.22 -33.8 49.65 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.018 0.914 . . . . 0.0 109.217 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.422 ' HA ' ' HB2' ' A' ' 141' ' ' ALA . 3.5 tp10 -68.82 -41.11 79.03 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 122.844 1.307 . . . . 0.0 109.395 175.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -85.37 13.71 6.29 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 113.965 -1.47 . . . . 0.0 109.907 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.755 ' HA2' HG22 ' A' ' 34' ' ' VAL . . . -95.87 -32.95 6.57 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.569 -177.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 88' ' ' ALA . 9.3 p -171.34 -28.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.795 ' HB1' ' HB2' ' A' ' 92' ' ' SER . . . -63.76 177.3 0.75 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 123.713 0.633 . . . . 0.0 110.438 173.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.835 ' HB3' HD21 ' A' ' 89' ' ' LEU . 86.0 tttt 177.76 -29.84 0.0 OUTLIER 'General case' 0 C--O 1.237 0.421 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -170.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.637 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 26.1 tt0 65.76 -76.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.816 0.341 . . . . 0.0 110.605 -172.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -172.42 123.38 0.47 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.929 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -156.63 -120.89 0.67 Allowed Glycine 0 C--O 1.242 0.613 0 C-N-CA 119.815 -1.183 . . . . 0.0 111.882 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.48 -126.44 4.44 Favored Glycine 0 C--O 1.244 0.769 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.925 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 44.8 t30 . . . . . 0 N--CA 1.47 0.551 0 CA-C-O 120.987 0.422 . . . . 0.0 110.983 179.519 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 C--O 1.245 0.852 0 CA-C-O 120.417 0.151 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -77.82 79.41 4.3 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -82.82 -32.71 27.47 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -75.97 73.31 2.86 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 6' ' ' ASN . . . -169.92 -60.04 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 124.206 1.003 . . . . 0.0 109.374 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 6.6 t30 72.73 21.41 3.45 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 122.071 0.939 . . . . 0.0 109.786 172.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.796 HD21 HG23 ' A' ' 68' ' ' ILE . 15.8 tp -102.11 -20.18 14.84 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.426 -171.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 18.6 t70 -52.76 -54.51 32.91 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.59 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -49.64 -40.49 39.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.545 175.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.509 HD12 ' HB3' ' A' ' 114' ' ' GLU . 2.7 mm? -65.74 -39.19 90.85 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.895 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.524 ' HE1' ' HB2' ' A' ' 67' ' ' SER . 41.3 m-85 -64.83 -47.92 76.25 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.428 176.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 8' ' ' ASP . 43.4 mtp180 -56.14 -47.06 78.92 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.056 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -72.01 -43.69 64.65 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 120.586 0.232 . . . . 0.0 111.58 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.9 t -81.21 -33.38 12.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.096 0.474 . . . . 0.0 111.809 -170.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 11' ' ' TYR . 1.7 mp -73.37 -24.54 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 O-C-N 121.932 -0.48 . . . . 0.0 110.195 173.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ttt -67.69 -51.0 54.77 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.593 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.24 -38.32 81.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.112 0.482 . . . . 0.0 110.369 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -54.49 -41.76 69.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.28 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -56.41 -59.09 5.47 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.924 0.393 . . . . 0.0 111.163 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -66.94 -18.83 65.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -137.49 82.12 28.73 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.394 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -90.93 73.61 0.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 123.476 2.784 . . . . 0.0 112.763 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -109.61 62.48 0.6 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.182 0.515 . . . . 0.0 111.008 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -136.64 37.2 2.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.608 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -145.53 43.51 1.28 Allowed 'General case' 0 C--N 1.315 -0.907 0 O-C-N 123.526 0.516 . . . . 0.0 109.631 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.25 167.31 29.02 Favored Glycine 0 C--O 1.222 -0.632 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.533 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.718 HG21 HG21 ' A' ' 48' ' ' THR . 3.1 p -165.87 130.68 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 117.212 0.506 . . . . 0.0 109.906 -174.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.733 HD11 ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -150.72 164.59 35.78 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.731 178.239 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -117.84 28.05 8.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.593 0.711 . . . . 0.0 110.739 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.27 2.48 9.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.898 -173.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.681 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 4.8 t -165.4 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.07 0.462 . . . . 0.0 110.543 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.46 HG13 ' SD ' ' A' ' 49' ' ' MET . 15.7 pt -127.37 146.66 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.962 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.938 HG11 HG23 ' A' ' 48' ' ' THR . 36.6 t -125.86 116.21 45.36 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.001 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.865 HG23 ' HA2' ' A' ' 139' ' ' GLY . 18.1 t -102.56 118.34 49.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.313 0.578 . . . . 0.0 110.478 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 9.2 t70 -119.28 127.95 53.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.023 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.609 ' SD ' ' HA ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -130.73 117.11 18.94 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.804 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 4.6 p30 -117.39 125.76 51.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.49 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -129.64 90.24 44.26 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -33.19 118.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.33 -0.403 1 C-N-CA 125.59 4.193 . . . . 0.0 114.773 -168.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.1 m 79.17 -35.68 0.16 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 171.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 32.5 t -94.98 -14.2 24.6 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 122.312 1.053 . . . . 0.0 109.217 -174.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.646 ' HA3' HD21 ' A' ' 131' ' ' LEU . . . 179.59 64.42 0.07 OUTLIER Glycine 0 N--CA 1.414 -2.781 0 N-CA-C 105.836 -2.906 . . . . 0.0 105.836 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 24.1 t70 -49.63 -47.26 49.89 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.33 1.052 . . . . 0.0 111.528 -159.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.804 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 12.8 ptm180 -164.66 151.88 11.37 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.914 169.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.48 HG22 ' HE1' ' A' ' 61' ' ' PHE . 43.8 pt -139.16 141.17 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.637 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 93.0 mtt180 -123.06 105.83 10.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.106 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.689 HD23 ' HE2' ' A' ' 49' ' ' MET . 1.3 tt -89.66 102.85 15.53 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.938 HG23 HG11 ' A' ' 33' ' ' VAL . 82.4 p -99.13 117.58 33.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.893 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.689 ' HE2' HD23 ' A' ' 47' ' ' LEU . 2.0 mpt? -105.82 178.65 4.5 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.243 0.544 . . . . 0.0 110.812 -172.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 31' ' ' SER . 14.5 tmtt? -152.29 97.93 2.35 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 10.0 mt -115.48 89.45 3.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.607 -171.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -113.02 94.31 4.84 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.445 1.117 . . . . 0.0 109.593 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.67 -104.24 0.45 Allowed Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.763 -173.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -151.74 22.34 0.69 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 111.813 -2.193 . . . . 0.0 108.439 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 2.0 pp -132.19 160.38 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.007 -170.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.442 ' HA ' HD23 ' A' ' 51' ' ' LEU . 3.0 p -97.92 109.06 22.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 166.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.582 ' HB2' HD13 ' A' ' 55' ' ' ILE . 2.5 tm-20 -97.68 -34.16 11.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -164.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.571 ' OD2' HD21 ' A' ' 28' ' ' LEU . 19.6 t70 -143.4 147.2 34.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.947 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 48' ' ' THR . . . -167.85 134.33 2.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.552 0.215 . . . . 0.0 110.524 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -136.85 175.56 9.5 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.637 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -127.57 133.83 49.75 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 123.972 0.795 . . . . 0.0 111.067 176.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -128.89 132.09 47.67 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.21 -177.96 48.58 Favored Glycine 0 C--N 1.31 -0.901 0 C-N-CA 118.695 -1.717 . . . . 0.0 113.804 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -139.82 125.47 19.33 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.96 -131.48 1.35 Allowed Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -171.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.4 p -131.48 174.5 10.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 118.187 0.994 . . . . 0.0 111.653 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.524 ' HB2' ' HE1' ' A' ' 11' ' ' TYR . 6.3 p -52.89 -49.3 66.14 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -168.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.796 HG23 HD21 ' A' ' 7' ' ' LEU . 2.5 pp -77.28 -24.62 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.704 -171.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.638 ' HG ' HD11 ' A' ' 68' ' ' ILE . 1.7 m -68.95 -45.69 70.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.381 0.61 . . . . 0.0 109.59 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.429 ' HG2' ' CZ ' ' A' ' 61' ' ' PHE . 55.2 mtt -67.08 -35.23 79.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.813 173.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 74' ' ' SER . . . -69.25 -44.36 72.12 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -172.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 50.5 m -62.89 -50.28 71.49 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.6 -40.54 72.19 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 114.59 -1.187 . . . . 0.0 111.414 174.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 71' ' ' ALA . 64.1 m -47.95 -55.94 8.78 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 175.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.765 ' HG3' ' HA3' ' A' ' 111' ' ' GLY . 1.3 tmt? -71.08 -37.4 72.45 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -172.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.658 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 6.6 mmt -77.0 -34.98 57.43 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.638 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 30.1 m -62.95 -21.12 65.86 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.946 -1.096 . . . . 0.0 109.393 169.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -85.81 -38.69 17.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.572 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.0 -44.41 11.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.626 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.658 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -76.61 -38.5 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 122.886 0.474 . . . . 0.0 111.084 -171.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.638 ' HB2' ' O ' ' A' ' 77' ' ' THR . 8.3 ttpp -49.77 -17.02 0.29 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.6 37.84 3.16 Favored Glycine 0 C--O 1.218 -0.86 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -133.32 -166.74 1.81 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.8 p-10 -123.78 -163.61 1.15 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.734 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -81.66 -44.74 20.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.267 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -66.09 -39.77 90.28 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.879 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.4 p -64.14 -38.76 92.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.701 0.286 . . . . 0.0 110.563 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.449 ' HB1' HG11 ' A' ' 140' ' ' VAL . . . -60.2 -46.49 89.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 122.011 0.91 . . . . 0.0 110.346 174.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 48.1 mt -63.3 -34.26 77.31 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.77 0.795 . . . . 0.0 109.797 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.401 ' O ' HG13 ' A' ' 94' ' ' ILE . 49.0 m -64.01 -25.63 68.21 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.731 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.493 ' HE3' ' HE3' ' A' ' 76' ' ' MET . 94.6 mmm -71.48 -38.64 71.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.3 0.571 . . . . 0.0 110.263 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.517 ' CB ' ' H ' ' A' ' 143' ' ' GLU . 15.1 t -64.41 -39.81 94.56 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.889 171.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.98 -45.33 86.93 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 121.954 0.883 . . . . 0.0 109.533 172.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 104' ' ' TYR . 44.9 mt -59.5 -51.31 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.563 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -57.6 -37.81 73.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.396 0.617 . . . . 0.0 112.233 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.2 p -72.62 -34.56 67.42 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.776 -0.578 . . . . 0.0 110.824 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.1 -42.71 72.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.497 0.665 . . . . 0.0 110.777 172.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.2 tmt? -56.1 -15.29 3.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.008 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 57.7 ttp -85.38 -22.21 28.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.857 0.837 . . . . 0.0 109.577 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -77.49 2.63 15.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.309 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.39 44.35 51.76 Favored Glycine 0 CA--C 1.503 -0.717 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.976 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.685 ' HG2' ' H ' ' A' ' 103' ' ' GLU . 78.2 tttt -123.3 -136.94 0.3 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.685 ' H ' ' HG2' ' A' ' 102' ' ' LYS . 51.0 mt-10 -75.25 -158.07 0.08 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.381 0.61 . . . . 0.0 110.207 172.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.518 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -146.73 -102.12 0.09 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.149 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' A' ' 107' ' ' SER . 8.0 t70 -108.7 105.94 15.76 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.29 20.65 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.505 0.722 . . . . 0.0 112.4 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 105' ' ' ASP . 1.7 m -109.59 -20.09 12.98 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 166.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.488 HG21 ' O ' ' A' ' 108' ' ' ILE . 22.3 mm 70.42 28.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.018 171.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -97.03 90.67 5.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.516 ' HB3' ' HG3' ' A' ' 114' ' ' GLU . 4.3 mp -127.23 17.34 7.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.978 -169.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.765 ' HA3' ' HG3' ' A' ' 75' ' ' MET . . . -46.58 -36.64 8.16 Favored Glycine 0 C--N 1.34 0.805 0 O-C-N 124.448 1.092 . . . . 0.0 114.192 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 16.7 p-10 -75.68 -58.48 3.25 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 122.582 -0.363 . . . . 0.0 111.271 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.725 ' HA ' ' HB2' ' A' ' 116' ' ' LEU . 53.1 mt -63.14 -24.94 37.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 C-N-CA 124.706 1.203 . . . . 0.0 111.299 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 16.8 mt-10 -62.74 -48.97 76.89 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.36 -47.07 71.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.708 171.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.725 ' HB2' ' HA ' ' A' ' 113' ' ' ILE . 8.1 mt -58.67 -34.32 71.12 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.026 0.441 . . . . 0.0 111.188 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 8.4 tt0 -42.97 -53.06 4.94 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.622 1.569 . . . . 0.0 112.386 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.38 -17.68 70.75 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.601 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.735 HG11 ' HB3' ' A' ' 125' ' ' ARG . 48.9 t -84.8 -46.24 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 117.224 0.512 . . . . 0.0 111.18 -173.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.692 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 24.5 m -42.49 -16.14 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -127.8 -3.25 5.91 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -162.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.702 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 6.6 m-85 -83.17 145.59 49.36 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -46.98 -39.15 24.79 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.424 2.75 . . . . 0.0 112.874 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.21 5.38 19.93 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.735 ' HB3' HG11 ' A' ' 119' ' ' VAL . 22.1 mtm180 -112.68 2.15 16.0 Favored 'General case' 0 C--O 1.202 -1.42 0 CA-C-O 122.303 1.049 . . . . 0.0 109.93 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -78.96 -37.65 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 113.989 -1.459 . . . . 0.0 108.912 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -74.79 -21.53 59.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.027 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.493 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 5.9 t -85.77 -16.91 37.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.582 -1.645 . . . . 0.0 109.248 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.692 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -85.65 -27.55 25.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 124.582 1.176 . . . . 0.0 108.988 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.72 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 3.0 m -70.67 -39.26 73.66 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 175.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.646 HD21 ' HA3' ' A' ' 42' ' ' GLY . 16.7 tp -49.62 -60.86 2.49 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.823 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.448 ' HB2' ' CD2' ' A' ' 116' ' ' LEU . 10.5 m -78.03 -60.67 2.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -171.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.502 ' HB2' HD22 ' A' ' 116' ' ' LEU . 67.0 t90 -66.42 -52.59 44.86 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.72 ' HB3' ' O ' ' A' ' 130' ' ' THR . 21.9 ttmt -58.94 -36.48 74.84 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.047 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.17 77.97 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.173 172.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.561 ' CD2' ' HG3' ' A' ' 76' ' ' MET . 13.5 tp -76.37 -35.87 58.45 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.74 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -71.18 -32.95 69.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.966 0.889 . . . . 0.0 109.073 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -81.44 4.99 19.04 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.403 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.865 ' HA2' HG23 ' A' ' 34' ' ' VAL . . . -91.86 -44.65 4.13 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.705 -0.679 . . . . 0.0 113.734 -171.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.449 HG11 ' HB1' ' A' ' 88' ' ' ALA . 12.4 p -166.95 -27.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 122.156 -0.614 . . . . 0.0 111.056 -174.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.713 ' HA ' HD23 ' A' ' 89' ' ' LEU . . . -78.94 160.73 27.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.484 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 141' ' ' ALA . 87.0 tttt 170.0 76.6 0.0 OUTLIER 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.372 0.669 . . . . 0.0 110.703 173.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.517 ' H ' ' CB ' ' A' ' 92' ' ' SER . 17.8 tp10 -81.62 -48.43 11.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 170.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -122.81 113.66 19.46 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.647 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -90.87 9.63 77.21 Favored Glycine 0 C--N 1.306 -1.115 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.806 -175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -158.7 -174.97 29.1 Favored Glycine 0 C--N 1.315 -0.615 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.071 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 120.983 0.42 . . . . 0.0 110.851 -177.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.454 0.169 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -150.58 -53.31 0.14 Allowed 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.575 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -116.91 159.15 22.87 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.064 0.546 . . . . 0.0 110.215 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.94 138.01 35.92 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.37 137.84 46.84 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 123.974 0.796 . . . . 0.0 110.425 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.525 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 26.6 p-10 -102.66 15.58 28.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 115' ' ' ALA . 22.0 tp -93.57 -19.71 20.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.827 -170.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -58.92 -56.99 15.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 124.042 0.838 . . . . 0.0 109.71 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.1 t -65.03 -37.66 88.33 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 6' ' ' ASN . 58.7 mt -53.1 -35.86 60.08 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.627 0.727 . . . . 0.0 111.039 173.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.423 ' O ' HG13 ' A' ' 15' ' ' ILE . 13.2 m-85 -70.92 -39.22 72.82 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -65.8 -35.21 80.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.659 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -65.84 -28.27 68.86 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 123.998 0.811 . . . . 0.0 109.988 174.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.984 HG12 ' HB1' ' A' ' 71' ' ' ALA . 66.6 t -84.0 -41.72 16.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.221 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 11' ' ' TYR . 76.0 mt -61.7 -29.51 46.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 CA-C-O 121.54 0.685 . . . . 0.0 110.15 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -62.08 -51.17 69.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.386 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 11.4 t70 -72.48 -40.35 67.0 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -54.26 -45.24 72.35 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.443 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -59.03 -52.14 67.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.341 0.256 . . . . 0.0 111.432 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 17' ' ' ASP . 32.7 ttpt -42.89 -34.15 0.91 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 173.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.514 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.0 OUTLIER -154.34 84.58 3.93 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-O 122.032 0.92 . . . . 0.0 111.952 177.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -86.1 65.91 5.22 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.319 2.679 . . . . 0.0 111.807 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 25' ' ' LYS . 62.8 mtt180 -73.27 -77.53 0.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.769 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 5.9 m120 67.24 -22.95 0.11 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 23' ' ' ARG . 30.6 mmtp -114.97 85.7 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.812 0.339 . . . . 0.0 111.24 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -139.75 146.17 17.57 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 121.087 -0.577 . . . . 0.0 112.284 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.504 HG22 HG21 ' A' ' 48' ' ' THR . 7.4 p -168.16 134.59 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 122.689 0.396 . . . . 0.0 110.193 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.655 HD11 ' HB ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -151.62 140.37 20.85 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.69 172.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.456 ' HA ' HG21 ' A' ' 33' ' ' VAL . 3.1 p-10 -100.51 39.33 1.38 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.367 -174.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.73 -104.06 0.03 OUTLIER 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.559 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.532 ' CB ' ' HG ' ' A' ' 51' ' ' LEU . 13.0 m -72.05 -76.18 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.317 0.579 . . . . 0.0 112.031 -174.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.888 HG13 ' HB2' ' A' ' 49' ' ' MET . 6.8 pt -119.58 131.05 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-O 121.411 0.624 . . . . 0.0 111.99 -176.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.875 HG13 HG23 ' A' ' 48' ' ' THR . 89.5 t -124.74 129.08 73.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 123.543 0.737 . . . . 0.0 109.762 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.771 HG21 ' HA2' ' A' ' 139' ' ' GLY . 7.1 t -134.25 127.84 51.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.329 0.585 . . . . 0.0 110.386 -173.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.571 ' OD2' ' HD2' ' A' ' 46' ' ' ARG . 2.0 m-20 -117.23 134.45 54.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.249 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.782 ' HA ' ' HE3' ' A' ' 36' ' ' MET . 0.7 OUTLIER -142.22 122.53 13.94 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -125.0 140.79 52.6 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.709 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 51.1 t30 -135.11 119.35 13.41 Favored Pre-proline 0 C--O 1.253 1.263 0 O-C-N 121.316 -0.865 . . . . 0.0 109.295 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.48 ' HD2' ' OD1' ' A' ' 38' ' ' ASN . 59.6 Cg_exo -25.5 105.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 1 C-N-CA 126.685 4.923 . . . . 0.0 116.417 -175.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.8 m 74.32 -34.52 0.28 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 165.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 127' ' ' LYS . 33.1 t -79.01 -49.23 13.03 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.604 -167.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.636 ' HA3' HD22 ' A' ' 131' ' ' LEU . . . -130.9 24.01 4.34 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.157 -1.021 . . . . 0.0 112.103 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.646 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 34.3 t70 40.77 -96.21 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.137 0 O-C-N 124.85 0.971 . . . . 0.0 111.936 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -136.44 146.38 46.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.356 0.598 . . . . 0.0 111.933 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 tt -131.98 125.18 54.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 170.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.571 ' HD2' ' OD2' ' A' ' 35' ' ' ASP . 24.4 mtm180 -130.36 109.22 10.57 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.189 -174.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.749 HD12 ' HE1' ' A' ' 49' ' ' MET . 0.7 OUTLIER -103.16 100.74 10.67 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 124.33 1.019 . . . . 0.0 108.934 -176.022 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.875 HG23 HG13 ' A' ' 33' ' ' VAL . 57.4 p -97.3 131.42 44.02 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 172.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.888 ' HB2' HG13 ' A' ' 32' ' ' ILE . 55.9 mtt -121.38 -178.56 3.82 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.584 0.707 . . . . 0.0 110.292 -176.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 45.2 tttm -157.63 111.66 2.59 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.541 HD23 HD12 ' A' ' 85' ' ' ILE . 6.3 mt -92.45 140.24 29.77 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.342 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.902 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . 2.4 m-20 -134.18 64.86 1.59 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 140.5 -133.25 5.85 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -164.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -121.11 31.79 6.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 168.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.48 HD11 ' HG2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -127.44 178.22 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.571 -172.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -107.61 112.93 42.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.902 ' HG3' ' HB2' ' A' ' 52' ' ' ASP . 4.3 mm-40 -101.8 -31.35 10.79 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 122.03 0.919 . . . . 0.0 109.414 -169.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 33.2 t0 -141.53 144.95 34.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.643 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.02 134.39 15.24 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.416 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 73.4 mmtt -124.96 129.82 51.12 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.514 ' HB3' HG23 ' A' ' 77' ' ' THR . 47.6 p90 -116.02 141.21 48.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.199 0.524 . . . . 0.0 111.203 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 26.4 tt0 -116.6 121.79 42.74 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.92 128.29 5.24 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.544 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.646 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 10.3 tp10 -150.8 128.02 11.25 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.65 -131.68 2.57 Favored Glycine 0 C--O 1.227 -0.284 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 -171.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.4 p -99.47 159.57 14.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.461 0.63 . . . . 0.0 109.787 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 p -59.22 -38.71 80.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.838 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.787 HD11 HG21 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -61.4 -48.37 89.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.7 m -68.93 -47.35 65.94 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 110.785 -173.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.2 ptp -61.61 -29.91 70.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.452 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.984 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -66.14 -53.17 41.08 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.29 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.47 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 16.2 m -56.42 -40.02 74.02 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 123.9 0.75 . . . . 0.0 109.651 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.7 -57.21 10.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.582 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.459 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 49.2 m -55.76 -48.62 74.96 Favored 'General case' 0 CA--C 1.493 -1.246 0 O-C-N 123.873 0.733 . . . . 0.0 112.266 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.8 tpt -70.65 -54.96 9.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 120.933 0.397 . . . . 0.0 110.551 -174.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.676 ' HG3' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -59.95 -44.76 94.19 Favored 'General case' 0 C--O 1.205 -1.252 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.556 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.66 ' HA ' HG23 ' A' ' 80' ' ' ILE . 32.0 m -63.03 -36.99 85.42 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.16 0.891 . . . . 0.0 109.784 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -52.41 -47.85 66.07 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.002 174.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.84 -23.97 25.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.453 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.66 HG23 ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -77.48 -30.75 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -174.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.544 ' HZ3' ' HB3' ' A' ' 81' ' ' LYS . 7.0 ttpm? -52.93 -18.64 2.06 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.483 170.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.78 44.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.638 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 8.3 mttp -132.61 -162.4 1.23 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.019 0.438 . . . . 0.0 110.508 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.9 m-20 -140.83 164.56 29.91 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mp -68.09 -51.25 50.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 119.239 0.927 . . . . 0.0 110.573 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.91 -36.45 79.3 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.776 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.4 m -66.77 -41.83 87.1 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.614 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.85 82.0 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.57 0.544 . . . . 0.0 111.325 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 83.2 mt -63.59 -39.15 93.65 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.863 0.84 . . . . 0.0 109.028 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.7 t -59.14 -41.9 89.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.411 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.52 ' HE3' ' HE2' ' A' ' 76' ' ' MET . 12.3 ttt -65.63 -38.35 89.14 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.069 0.461 . . . . 0.0 110.586 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.741 ' HB3' ' HD2' ' A' ' 142' ' ' LYS . 16.3 m -60.34 -48.49 81.52 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.045 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -59.85 -40.74 89.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.603 0.716 . . . . 0.0 109.471 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' A' ' 104' ' ' TYR . 29.8 mt -61.62 -47.83 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.966 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -56.65 -34.49 67.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.818 0.342 . . . . 0.0 110.57 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.3 m -71.58 -44.39 64.57 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.869 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.92 -52.02 53.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.779 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.1 tpt -38.95 -63.51 0.52 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.5 mmm -49.2 -17.13 0.2 Allowed 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -128.07 -4.1 5.67 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.892 0.315 . . . . 0.0 111.193 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -116.44 -32.25 1.67 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.947 -1.121 . . . . 0.0 113.871 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 88.41 -13.93 0.4 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.245 1.418 . . . . 0.0 110.075 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -98.59 134.85 40.95 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.667 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.492 ' HA ' HG22 ' A' ' 94' ' ' ILE . 3.2 p90 -124.75 -121.93 0.26 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.826 -176.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.471 ' O ' HD13 ' A' ' 108' ' ' ILE . 24.8 t70 -94.44 107.15 19.13 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 120.914 0.387 . . . . 0.0 110.342 -174.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -48.29 -19.06 0.26 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.205 -1.361 . . . . 0.0 113.049 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.7 t -92.8 -22.69 19.17 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.613 ' HA ' HD12 ' A' ' 110' ' ' LEU . 23.4 mm 67.56 39.14 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 122.164 0.983 . . . . 0.0 109.855 175.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -99.21 81.93 2.63 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.613 HD12 ' HA ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -144.57 51.34 1.27 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -174.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -39.65 -18.76 0.01 OUTLIER Glycine 0 CA--C 1.54 1.605 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.536 ' HB3' ' HG3' ' A' ' 76' ' ' MET . 14.0 p-10 -85.27 -43.4 13.78 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 117.692 0.746 . . . . 0.0 109.522 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.875 ' O ' ' HB2' ' A' ' 117' ' ' GLN . 5.0 tt -70.12 -16.81 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.47 -171.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -56.11 -64.78 0.75 Allowed 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.771 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -76.51 -44.77 33.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.918 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.651 HD11 HG21 ' A' ' 119' ' ' VAL . 14.2 tp -92.64 1.67 57.14 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -163.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.875 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 7.1 tt0 -58.44 -52.12 66.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.385 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.06 -13.6 72.91 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.933 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.787 HG21 HD11 ' A' ' 68' ' ' ILE . 93.3 t -78.83 -46.95 23.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 CA-C-N 117.093 0.446 . . . . 0.0 110.423 -162.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 125' ' ' ARG . 14.3 m -42.45 -15.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.59 1.556 . . . . 0.0 115.135 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 125' ' ' ARG . 63.9 pttt -131.3 13.81 5.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.528 -0.733 . . . . 0.0 112.47 -171.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.689 ' HD2' ' HA ' ' A' ' 119' ' ' VAL . 15.4 m-85 -76.43 170.03 18.08 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.199 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.421 ' HD2' ' HD1' ' A' ' 122' ' ' PHE . 30.5 Cg_endo -65.43 -18.95 61.16 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.207 1.938 . . . . 0.0 109.966 166.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.487 ' HB3' ' HD2' ' A' ' 127' ' ' LYS . . . -113.38 17.14 18.69 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.984 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.602 ' HG3' ' N ' ' A' ' 126' ' ' ILE . 18.6 ptp180 -44.05 -61.18 1.55 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.127 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.602 ' N ' ' HG3' ' A' ' 125' ' ' ARG . 39.9 pt -59.48 -22.97 24.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.184 -172.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.709 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 99.5 mttt -68.34 -63.25 1.1 Allowed 'General case' 0 C--N 1.313 -1.003 0 O-C-N 122.247 -0.283 . . . . 0.0 110.402 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.8 m -85.67 -35.2 21.05 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.451 0.644 . . . . 0.0 110.675 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.689 ' HB3' HG12 ' A' ' 119' ' ' VAL . . . -73.85 -51.28 16.8 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.618 -173.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.544 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 36.7 m -63.83 -45.87 87.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.183 -177.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.636 HD22 ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -56.63 -50.09 73.06 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.163 -0.961 . . . . 0.0 110.567 179.382 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.462 ' N ' ' HG ' ' A' ' 131' ' ' LEU . 7.1 m -76.7 -61.53 1.94 Allowed 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -174.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -61.51 -53.46 56.04 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 123.852 0.72 . . . . 0.0 111.139 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 130' ' ' THR . 88.0 tttt -55.33 -42.91 74.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 36' ' ' MET . . . -61.17 -50.29 73.74 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.549 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.676 HD23 ' HG3' ' A' ' 76' ' ' MET . 11.8 tp -65.2 -31.69 72.99 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.461 0.648 . . . . 0.0 110.338 -175.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.703 ' CG ' ' HD3' ' A' ' 142' ' ' LYS . 2.9 tp10 -83.52 -32.33 25.96 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.79 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -71.09 -47.15 59.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.771 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -41.36 -34.68 1.07 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.395 -0.82 . . . . 0.0 114.35 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.481 ' O ' HD23 ' A' ' 89' ' ' LEU . 27.2 m -108.12 -1.09 9.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.147 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 90.09 3.43 0.16 Allowed 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 168.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.741 ' HD2' ' HB3' ' A' ' 92' ' ' SER . 43.0 tptt 55.18 87.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 171.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 69.3 -52.69 0.6 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.956 0.903 . . . . 0.0 112.228 172.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -165.65 -71.47 0.03 OUTLIER 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.21 40.82 0.07 OUTLIER Glycine 0 C--N 1.319 -0.409 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.201 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.8 -122.82 0.72 Allowed Glycine 0 C--O 1.24 0.512 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.522 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.414 ' OD1' ' HE3' ' A' ' 142' ' ' LYS . 11.7 p30 . . . . . 0 N--CA 1.47 0.554 0 C-N-CA 123.95 0.9 . . . . 0.0 112.606 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 110.725 -0.102 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.5 m -126.51 128.22 46.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.978 0.418 . . . . 0.0 110.46 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.0 t80 66.4 91.58 0.08 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.823 0.82 . . . . 0.0 111.028 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -144.59 -1.39 0.9 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.617 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.25 95.88 2.22 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -103.99 -45.12 4.84 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.097 -174.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.486 HD22 HG23 ' A' ' 119' ' ' VAL . 21.5 tp -70.46 -42.75 71.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.022 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.799 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 17.8 t70 -54.5 -53.76 50.04 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.417 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 m -57.29 -54.39 47.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.337 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.617 ' O ' HG12 ' A' ' 14' ' ' VAL . 4.3 mp -47.33 -52.42 16.48 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.419 1.074 . . . . 0.0 111.862 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.799 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 0.6 OUTLIER -79.19 -19.42 50.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.488 -175.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -66.6 -35.67 80.74 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-O 121.412 0.625 . . . . 0.0 109.358 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -75.65 -35.23 60.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.081 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.755 HG21 ' HA ' ' A' ' 11' ' ' TYR . 3.2 m -72.48 -35.34 51.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.961 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.558 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 14.5 tt -77.41 -22.67 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.929 174.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 17.2 tpt -84.9 -38.78 18.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.323 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.763 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 20.3 t70 -77.9 -37.13 48.63 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.441 ' CD2' ' HB3' ' A' ' 24' ' ' ASN . 26.1 t60 -71.43 -16.46 62.38 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.068 171.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.558 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 46.4 t80 -73.57 -48.22 34.55 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.333 0.587 . . . . 0.0 110.014 171.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.763 ' HD3' ' HA ' ' A' ' 17' ' ' ASP . 41.4 mtpt -48.61 -45.79 38.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.846 171.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -114.81 78.41 5.22 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 18' ' ' HIS . 72.7 Cg_endo -77.62 51.11 3.44 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 122.999 2.466 . . . . 0.0 113.414 -165.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -83.72 50.41 1.8 Allowed 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 121.801 -0.562 . . . . 0.0 109.57 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.441 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . 20.0 p-10 -114.2 24.77 11.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.9 0.857 . . . . 0.0 109.044 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -133.15 139.44 47.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.835 -1.53 . . . . 0.0 108.868 173.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 142.67 141.89 3.94 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.103 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.635 HG11 ' HB2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -159.27 127.93 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.774 HD11 ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -136.11 147.68 47.9 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.491 0.663 . . . . 0.0 110.56 176.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -93.26 44.08 1.13 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.23 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 31' ' ' SER . 1.2 m-20 -85.67 -130.37 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.031 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.449 ' H ' ' HB3' ' A' ' 30' ' ' ASP . 14.9 m -52.12 -77.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.784 HG13 ' HB2' ' A' ' 49' ' ' MET . 12.8 pt -127.02 137.86 56.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.622 0.725 . . . . 0.0 110.394 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.596 HG12 HG22 ' A' ' 48' ' ' THR . 95.7 t -123.09 114.69 43.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.617 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.913 HG21 ' HA2' ' A' ' 139' ' ' GLY . 93.9 t -106.88 119.3 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.074 -176.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 2.0 p-10 -127.85 149.57 50.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.504 0.669 . . . . 0.0 110.141 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.462 ' O ' HG22 ' A' ' 45' ' ' ILE . 27.3 ttt -157.37 132.11 8.66 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.173 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 7.0 p30 -127.28 135.62 50.83 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -113.63 88.33 13.43 Favored Pre-proline 0 N--CA 1.439 -0.983 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 167.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -60.08 -6.26 4.8 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.386 2.058 . . . . 0.0 113.889 -169.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.7 p -98.6 -51.03 4.06 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.294 0.568 . . . . 0.0 111.784 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 51.6 t -135.23 17.99 3.42 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -169.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.22 -3.37 0.37 Allowed Glycine 0 N--CA 1.47 0.956 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.406 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.629 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 11.5 m-20 53.79 -110.7 0.56 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 118.394 -0.812 . . . . 0.0 111.117 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 31.3 ptt180 -158.67 148.83 19.69 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.652 1.115 . . . . 0.0 112.549 -176.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.572 HG13 ' CE1' ' A' ' 61' ' ' PHE . 5.0 tt -130.4 133.26 64.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.571 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -121.56 103.44 8.92 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.246 0.341 . . . . 0.0 111.695 173.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.672 HD23 ' HG3' ' A' ' 49' ' ' MET . 1.9 tt -92.6 106.63 18.58 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 172.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.774 ' HB ' HD11 ' A' ' 28' ' ' LEU . 44.9 p -99.27 123.5 43.6 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.784 ' HB2' HG13 ' A' ' 32' ' ' ILE . 52.2 mtt -113.26 178.7 4.19 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 123.741 0.651 . . . . 0.0 111.73 -175.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HA ' ' OG ' ' A' ' 31' ' ' SER . 86.9 tttt -160.24 100.56 1.37 Allowed 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.536 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -116.72 92.16 3.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.065 0.936 . . . . 0.0 111.501 -175.503 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -103.36 89.36 3.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.466 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.31 -100.88 0.32 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-O 122.985 1.325 . . . . 0.0 111.821 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -159.6 35.85 0.19 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 111.375 -2.412 . . . . 0.0 106.681 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.666 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.3 pp -140.13 143.58 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.187 -171.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.489 HG12 HG23 ' A' ' 80' ' ' ILE . 1.3 p -92.59 113.35 27.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -102.1 -32.01 10.34 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 113.978 -1.465 . . . . 0.0 107.941 -163.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -136.48 129.51 31.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.65 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.63 104.49 3.75 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.429 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 29.0 mmtp -120.75 151.95 38.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.922 -175.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CE1' HG13 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -130.53 135.75 48.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.635 ' HB2' HG11 ' A' ' 27' ' ' VAL . 1.1 tm-20 -142.09 114.56 8.39 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.76 -177.49 39.16 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.004 -172.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -139.85 157.71 45.28 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.629 ' HA2' ' HB2' ' A' ' 43' ' ' ASP . . . 157.26 -143.17 9.27 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 119.253 -1.451 . . . . 0.0 112.502 176.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.412 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 61.1 m -76.31 164.57 25.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.271 0.558 . . . . 0.0 110.828 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -63.41 -35.47 80.52 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.008 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.639 HG13 HG21 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -82.81 -29.02 8.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.05 -177.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.52 ' N ' HD11 ' A' ' 68' ' ' ILE . 8.3 m -66.92 -55.0 16.52 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.699 -0.625 . . . . 0.0 110.729 -174.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.445 ' HE2' HD12 ' A' ' 15' ' ' ILE . 24.7 ptt? -69.55 -16.25 63.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.656 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.492 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -85.84 -53.3 5.2 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.553 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.3 t -74.1 -51.21 16.39 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.746 0.654 . . . . 0.0 109.818 -171.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.36 -51.91 65.25 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.219 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.478 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . 30.3 t -66.16 -38.46 88.14 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.915 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.568 ' SD ' ' HB ' ' A' ' 14' ' ' VAL . 28.7 ttt -59.32 -46.83 87.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.352 0.596 . . . . 0.0 110.671 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.48 -23.28 56.78 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.175 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.593 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 99.6 m -67.97 -43.72 78.33 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-O 122.389 1.09 . . . . 0.0 110.008 172.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.8 tm0? -58.8 -27.03 64.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.835 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.74 -33.6 23.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.63 HG22 ' HE1' ' A' ' 49' ' ' MET . 2.3 mm -67.83 -36.24 75.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.616 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -56.8 -18.87 14.39 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.716 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.94 38.39 2.95 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.737 ' HE3' ' HB ' ' A' ' 87' ' ' THR . 27.3 tptt -131.45 164.33 25.97 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -172.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.596 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.4 p-10 -111.65 -175.2 2.64 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 169.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.752 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.1 mp -76.3 -39.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.267 -173.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -60.67 -48.59 81.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.002 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.737 ' HB ' ' HE3' ' A' ' 83' ' ' LYS . 18.6 p -71.7 -36.12 70.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.535 ' HB2' HG23 ' A' ' 140' ' ' VAL . . . -56.42 -40.5 74.84 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.429 0.633 . . . . 0.0 111.466 172.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 66.3 mt -62.62 -33.82 75.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.367 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -80.45 -25.2 39.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.631 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -65.0 -27.31 68.73 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 121.844 0.83 . . . . 0.0 109.362 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.4 m -88.59 -23.53 23.08 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.366 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 143' ' ' GLU . 83.5 tttt -79.01 -30.17 44.08 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.626 177.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.8 tt -82.21 -33.6 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -50.47 -33.34 20.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.166 163.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.7 m -81.65 -27.82 33.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.484 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 99' ' ' MET . 20.6 t70 -66.11 -35.79 81.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.707 ' HA ' ' CE1' ' A' ' 104' ' ' TYR . 59.7 ttp -48.15 -16.71 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.252 0.621 . . . . 0.0 112.609 169.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.451 ' H ' ' C ' ' A' ' 97' ' ' ASP . 73.7 mtm -117.96 -36.38 3.64 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.066 -0.396 . . . . 0.0 111.259 -173.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.33 -43.43 4.78 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.063 0.459 . . . . 0.0 110.457 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.419 ' HA3' ' OD1' ' A' ' 97' ' ' ASP . . . -81.5 -57.14 2.82 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.872 -174.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 61.28 81.4 0.19 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.538 0.685 . . . . 0.0 111.242 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -178.9 31.82 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.558 0.695 . . . . 0.0 110.335 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.707 ' CE1' ' HA ' ' A' ' 98' ' ' MET . 15.6 p90 -103.82 113.1 26.38 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.483 0.658 . . . . 0.0 110.045 -176.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -137.71 70.43 1.39 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.038 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.773 ' H ' HD21 ' A' ' 110' ' ' LEU . 32.1 t70 60.67 6.62 1.17 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.613 0.72 . . . . 0.0 111.202 168.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.2 m -111.9 3.74 17.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.703 -173.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.402 ' HB ' ' H ' ' A' ' 109' ' ' ASP . 1.9 mp -131.99 -77.69 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -144.79 166.72 24.43 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 167.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.773 HD21 ' H ' ' A' ' 106' ' ' ASP . 3.1 tp 173.11 -7.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -39.04 -46.39 2.38 Favored Glycine 0 C--N 1.355 1.589 0 C-N-CA 121.155 -0.545 . . . . 0.0 114.282 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.468 ' OD2' HG13 ' A' ' 113' ' ' ILE . 2.8 p-10 -70.69 -59.61 2.72 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.976 HG21 ' HB3' ' A' ' 117' ' ' GLN . 41.0 mt -50.9 -40.7 20.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.995 0.918 . . . . 0.0 112.57 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 10' ' ' LEU . 12.2 mm-40 -61.75 -12.22 15.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.462 0.649 . . . . 0.0 111.57 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.581 ' CB ' HG22 ' A' ' 14' ' ' VAL . . . -138.37 19.4 2.75 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.753 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.565 HD13 HG21 ' A' ' 119' ' ' VAL . 10.0 tp -161.88 -20.78 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -169.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.976 ' HB3' HG21 ' A' ' 113' ' ' ILE . 22.4 pt20 -60.09 -31.32 69.91 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.794 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.554 ' HA2' ' HE2' ' A' ' 121' ' ' LYS . . . -80.62 -16.96 74.34 Favored Glycine 0 CA--C 1.504 -0.597 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.656 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.825 HG13 ' HB3' ' A' ' 125' ' ' ARG . 79.7 t -81.6 -43.86 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 123.291 0.636 . . . . 0.0 110.36 -171.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.535 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 4.8 m -36.09 -16.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.554 ' HE2' ' HA2' ' A' ' 118' ' ' GLY . 0.3 OUTLIER -146.66 0.47 0.77 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 119.969 1.258 . . . . 0.0 113.626 -166.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.747 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 12.9 m-30 -75.18 136.22 72.71 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 172.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.05 -26.63 50.91 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.682 2.255 . . . . 0.0 111.971 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.38 -0.29 35.69 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.825 ' HB3' HG13 ' A' ' 119' ' ' VAL . 64.0 mtt180 -129.26 12.77 6.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.165 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -80.22 -32.24 13.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 122.796 1.284 . . . . 0.0 108.033 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -83.24 -20.91 33.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.606 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.481 ' HG ' ' HA ' ' A' ' 125' ' ' ARG . 57.4 m -82.57 -18.6 40.77 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.921 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.567 ' HB2' HG11 ' A' ' 119' ' ' VAL . . . -84.54 -36.43 22.16 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.972 -176.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.631 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 3.9 m -75.01 -40.45 60.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 69' ' ' SER . 8.2 tt -50.7 -51.14 52.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.105 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 t -80.24 -60.89 2.16 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.066 -174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -62.87 -53.27 56.78 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.854 0.359 . . . . 0.0 111.751 -175.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.631 ' HB3' ' O ' ' A' ' 130' ' ' THR . 19.9 tptm -59.39 -34.8 72.88 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.913 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 131' ' ' LEU . . . -53.89 -34.5 59.66 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.073 171.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.2 mt -84.24 -39.43 19.29 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.34 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -70.47 -39.74 74.06 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.64 0.733 . . . . 0.0 110.905 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.759 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -84.88 12.38 7.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.094 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.913 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -102.86 -29.72 5.74 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.196 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.675 HG12 ' HE2' ' A' ' 49' ' ' MET . 29.3 m -131.56 -23.49 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -174.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 140' ' ' VAL . . . 90.46 175.29 0.02 OUTLIER 'General case' 0 C--N 1.351 0.663 0 C-N-CA 125.093 1.357 . . . . 0.0 109.759 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -123.95 149.15 46.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.241 -0.912 . . . . 0.0 112.405 -169.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -92.48 104.83 17.11 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 162.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -87.96 -142.81 0.12 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.133 -166.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 163.48 35.42 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.24 157.65 15.09 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.061 -0.57 . . . . 0.0 111.788 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.1 t30 . . . . . 0 C--N 1.314 -0.972 0 CA-C-N 117.504 0.652 . . . . 0.0 111.486 -175.05 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.428 ' SD ' ' HB2' ' A' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.408 0.623 . . . . 0.0 109.613 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -75.64 -57.4 3.9 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.66 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.428 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 41.2 t80 72.69 -56.05 0.66 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.849 0.86 . . . . 0.0 110.95 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -75.83 116.09 16.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.88 72.5 6.63 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.704 -171.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -69.39 82.47 0.38 Allowed 'General case' 0 C--N 1.317 -0.82 0 O-C-N 123.876 0.735 . . . . 0.0 110.875 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.763 ' HA ' HD12 ' A' ' 10' ' ' LEU . 55.8 tp 169.47 -36.55 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 17.3 t70 -61.56 -57.03 13.72 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.32 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.545 ' HA ' ' HG2' ' A' ' 12' ' ' ARG . 29.1 p -51.02 -43.05 60.8 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.751 0.786 . . . . 0.0 111.729 173.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.763 HD12 ' HA ' ' A' ' 7' ' ' LEU . 88.2 mt -51.79 -48.01 63.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.81 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.498 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.8 m-85 -67.64 -35.55 79.1 Favored 'General case' 0 CA--C 1.5 -0.981 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.415 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.545 ' HG2' ' HA ' ' A' ' 9' ' ' THR . 21.6 mmm-85 -59.91 -30.76 69.26 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.739 -0.601 . . . . 0.0 110.075 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -82.32 -34.79 28.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.612 HG13 ' HB2' ' A' ' 75' ' ' MET . 94.9 t -76.96 -30.77 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.594 -176.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 11' ' ' TYR . 30.9 pt -83.84 -19.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.1 ttt -64.15 -44.65 91.48 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.838 0.828 . . . . 0.0 109.242 175.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.18 -33.9 63.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.481 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -62.11 -26.56 68.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.174 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -68.63 -54.35 16.93 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.566 -0.709 . . . . 0.0 110.557 168.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -48.68 -38.23 20.72 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.235 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -112.84 81.31 4.37 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.48 -16.39 23.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.422 3.415 . . . . 0.0 115.475 -159.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -148.48 164.74 33.27 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.286 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -151.03 81.02 1.32 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.114 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.635 ' HG3' ' HG3' ' A' ' 62' ' ' GLU . 58.7 tttm -141.82 93.79 2.6 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.363 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.78 152.63 24.75 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.754 HG23 HG22 ' A' ' 48' ' ' THR . 2.9 p -150.29 132.61 6.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.197 0.522 . . . . 0.0 110.141 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.757 HD11 ' HB ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -153.71 146.32 24.17 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 176.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -111.49 139.34 47.01 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.804 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t70 172.21 -79.74 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.603 0.761 . . . . 0.0 109.188 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.526 ' HB3' ' HG ' ' A' ' 51' ' ' LEU . 14.1 m -72.01 -86.49 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.519 -175.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.631 HG13 ' HB2' ' A' ' 49' ' ' MET . 4.3 pt -138.23 134.31 44.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.299 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.581 HG12 HG21 ' A' ' 48' ' ' THR . 61.4 t -125.62 121.93 61.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.728 0.775 . . . . 0.0 110.201 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 1.063 HG22 ' HA2' ' A' ' 139' ' ' GLY . 2.8 t -117.36 124.83 73.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.352 -176.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.498 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.5 p-10 -126.43 138.98 53.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.826 0.346 . . . . 0.0 110.395 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.915 ' HA ' ' HE3' ' A' ' 36' ' ' MET . 2.0 tpt -147.1 131.26 17.36 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -109.77 132.29 54.28 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.223 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -121.96 98.88 44.59 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 161.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -32.33 109.0 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 125.171 3.914 . . . . 0.0 115.147 -168.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 m 71.73 -20.49 0.24 Allowed 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.095 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 51.6 t -95.42 -33.19 12.57 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.37 1.081 . . . . 0.0 109.142 -175.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.463 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . -157.61 60.9 0.33 Allowed Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 104.714 -3.354 . . . . 0.0 104.714 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.68 -43.04 89.84 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.594 -1.303 . . . . 0.0 112.048 -156.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -148.44 132.41 17.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 118.246 -1.382 . . . . 0.0 109.926 168.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 36' ' ' MET . 8.7 tt -124.33 116.15 46.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 20.4 ttt180 -121.36 102.79 8.5 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.649 -0.657 . . . . 0.0 111.924 -172.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.927 HD23 ' HE3' ' A' ' 49' ' ' MET . 28.1 tp -87.82 102.58 14.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.342 173.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.757 ' HB ' HD11 ' A' ' 28' ' ' LEU . 31.6 p -98.4 112.35 24.39 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 171.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.927 ' HE3' HD23 ' A' ' 47' ' ' LEU . 24.9 mtt -100.87 178.88 4.56 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.117 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.892 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 56.3 tttp -157.28 93.4 1.31 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 2.2 pp -117.72 108.95 16.02 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 113.183 -1.826 . . . . 0.0 106.848 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -98.84 60.46 1.25 Allowed 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.931 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.28 -98.58 0.19 Allowed Glycine 0 N--CA 1.424 -2.152 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.195 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -128.78 22.47 5.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.75 HD11 ' O ' ' A' ' 55' ' ' ILE . 2.4 pp -135.77 144.8 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -98.28 122.77 50.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -115.94 -21.21 9.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.998 0.904 . . . . 0.0 109.099 -170.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.892 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 17.1 t70 -141.35 149.11 40.74 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.885 174.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -161.75 108.06 1.34 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.769 0.795 . . . . 0.0 109.124 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.428 ' HZ3' ' CD2' ' A' ' 28' ' ' LEU . 64.2 mttp -107.3 147.72 29.9 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.328 0.585 . . . . 0.0 109.57 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.9 t80 -121.38 129.01 52.79 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.998 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.635 ' HG3' ' HG3' ' A' ' 25' ' ' LYS . 27.8 tt0 -128.26 124.44 36.63 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.72 -177.72 48.28 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 119.132 -1.508 . . . . 0.0 112.72 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -141.71 128.95 21.02 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.463 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . -169.49 -132.1 1.4 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.5 -1.334 . . . . 0.0 110.81 -175.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 7.3 p -123.35 -163.98 1.17 Allowed 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 p -55.77 -26.5 46.22 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.762 HG13 ' HB3' ' A' ' 128' ' ' CYS . 7.3 mm -62.48 -66.62 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.649 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 p -55.43 -32.57 62.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.225 1.012 . . . . 0.0 109.909 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -61.7 -60.86 3.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.286 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 115' ' ' ALA . . . -71.68 -43.3 66.25 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -172.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.494 ' HB3' HD11 ' A' ' 116' ' ' LEU . 49.4 p -59.0 -39.61 82.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 110.632 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.768 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -75.01 -48.93 21.63 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.232 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 27.6 m -55.35 -61.04 2.6 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.802 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.612 ' HB2' HG13 ' A' ' 14' ' ' VAL . 12.6 tpt -83.1 -57.63 3.2 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.543 ' CG ' HD11 ' A' ' 136' ' ' LEU . 10.5 tpt -74.02 -27.9 61.18 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -171.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.768 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 85.6 m -73.32 -40.99 64.05 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 74' ' ' SER . 8.3 tt0 -59.54 -26.22 65.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.183 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.26 -33.58 22.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.67 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -67.6 -42.96 87.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.11 178.389 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 65.2 tttm -56.45 -16.28 5.57 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.686 0.794 . . . . 0.0 111.694 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.89 38.59 2.95 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.419 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -135.25 179.09 6.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.741 0.27 . . . . 0.0 111.597 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.631 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.0 m-20 -100.41 176.94 5.18 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.686 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 12.6 mm -84.41 -43.11 17.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.548 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -63.36 -38.27 90.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.02 0.438 . . . . 0.0 110.318 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -61.62 -41.3 97.27 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 121.72 0.772 . . . . 0.0 110.866 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.44 ' HB1' HG22 ' A' ' 140' ' ' VAL . . . -66.11 -34.98 79.28 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 121.927 -0.483 . . . . 0.0 110.605 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 70.7 mt -64.71 -39.72 94.12 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.453 1.121 . . . . 0.0 109.735 175.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.55 ' O ' HG12 ' A' ' 94' ' ' ILE . 26.9 t -67.09 -41.66 85.94 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.827 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.474 ' HE3' HD21 ' A' ' 110' ' ' LEU . 16.9 tpt -62.85 -22.42 66.66 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 122.287 1.041 . . . . 0.0 110.854 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.495 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 27.5 t -89.03 -35.95 16.07 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.499 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -66.58 -51.51 55.63 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.813 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 105' ' ' ASP . 22.1 pt -65.1 -39.83 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.838 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 91' ' ' MET . 39.2 t80 -53.51 -35.93 61.19 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.411 0.624 . . . . 0.0 111.143 174.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.6 m -86.31 -35.85 19.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.134 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.54 -35.96 75.92 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.096 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 1.3 tmt? -39.22 -49.75 1.9 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 124.127 0.892 . . . . 0.0 111.689 178.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.2 mtt -57.21 -10.63 1.32 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -124.46 -35.24 2.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.773 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.723 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -88.69 -32.07 11.92 Favored Glycine 0 C--O 1.239 0.448 0 C-N-CA 119.511 -1.328 . . . . 0.0 114.168 -173.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.723 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 22.4 tttm 97.64 -29.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.758 1.223 . . . . 0.0 109.699 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' MET . 0.7 OUTLIER -82.09 163.21 22.19 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.65 -106.34 0.24 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.7 ' HA ' HD12 ' A' ' 94' ' ' ILE . 31.7 t70 -95.34 101.73 13.48 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 172.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.27 8.87 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 105' ' ' ASP . 65.3 m -105.78 -16.95 14.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 169.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 108' ' ' ILE . 32.0 mm 65.37 27.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-O 121.816 0.817 . . . . 0.0 110.949 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -95.41 86.93 4.63 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 170.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.532 ' HB3' ' HB ' ' A' ' 113' ' ' ILE . 6.7 mt -123.75 43.94 2.84 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.393 -165.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -40.47 -33.21 0.53 Allowed Glycine 0 CA--C 1.538 1.51 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.674 168.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 3.8 p-10 -58.32 -72.78 0.09 Allowed 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 123.448 0.699 . . . . 0.0 109.989 171.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 110' ' ' LEU . 1.1 mp -46.2 -37.88 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.827 0.851 . . . . 0.0 110.313 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.608 ' O ' ' HB3' ' A' ' 10' ' ' LEU . 29.4 tt0 -61.57 -18.89 61.22 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.681 0.753 . . . . 0.0 111.704 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.556 ' C ' HD13 ' A' ' 116' ' ' LEU . . . -136.77 16.85 3.08 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.824 -0.548 . . . . 0.0 111.796 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.556 HD13 ' C ' ' A' ' 115' ' ' ALA . 5.7 mp -151.03 -24.39 0.21 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -167.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.42 ' HB2' HG21 ' A' ' 113' ' ' ILE . 7.7 tt0 -43.53 -52.32 6.26 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.41 0.443 . . . . 0.0 112.121 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.799 ' HA2' ' HE3' ' A' ' 121' ' ' LYS . . . -75.76 -17.36 80.13 Favored Glycine 0 CA--C 1.512 -0.155 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.489 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.778 HG13 ' HB3' ' A' ' 125' ' ' ARG . 65.8 t -74.92 -54.62 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 117.202 0.501 . . . . 0.0 111.397 -169.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.671 ' HB3' ' HZ2' ' A' ' 133' ' ' TRP . 16.9 m -44.77 -15.0 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 O-C-N 125.231 1.582 . . . . 0.0 114.621 -175.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.799 ' HE3' ' HA2' ' A' ' 118' ' ' GLY . 20.0 pttp -127.96 -4.7 5.68 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.71 -162.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.482 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 27.6 m-85 -86.7 133.98 38.57 Favored Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.109 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.64 -22.92 37.99 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 122.034 1.823 . . . . 0.0 111.55 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.68 -2.99 43.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.226 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.778 ' HB3' HG13 ' A' ' 119' ' ' VAL . 66.1 mtt85 -129.34 16.58 6.04 Favored 'General case' 0 C--O 1.213 -0.83 0 O-C-N 121.831 -0.543 . . . . 0.0 109.556 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.2 tt -87.36 -31.23 5.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.623 -171.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -78.38 -20.76 50.56 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.762 ' HB3' HG13 ' A' ' 68' ' ' ILE . 77.5 m -82.91 -18.5 39.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.286 176.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.653 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -84.99 -32.8 22.77 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.998 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.475 ' O ' ' HG3' ' A' ' 134' ' ' LYS . 16.9 p -74.9 -43.58 53.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.615 ' HA ' ' HG2' ' A' ' 36' ' ' MET . 4.6 pp -58.45 -34.88 71.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.456 ' HB3' HD22 ' A' ' 116' ' ' LEU . 49.1 m -69.95 -55.03 10.72 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.447 0.467 . . . . 0.0 111.853 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.671 ' HZ2' ' HB3' ' A' ' 120' ' ' SER . 25.6 m0 -55.56 -38.64 69.59 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.695 1.236 . . . . 0.0 111.194 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.627 ' HA ' ' HB3' ' A' ' 138' ' ' LYS . 50.0 mtpt -70.35 -42.41 71.89 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.605 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.544 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -58.4 -61.95 2.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.012 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.543 HD11 ' CG ' ' A' ' 76' ' ' MET . 72.6 mt -87.21 -43.59 12.1 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.054 -169.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.649 ' OE1' ' HA ' ' A' ' 133' ' ' TRP . 3.0 mp0 -84.8 -39.89 17.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -173.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.627 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 7.8 tmtm? -88.68 12.22 15.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.395 1.093 . . . . 0.0 109.051 176.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 1.063 ' HA2' HG22 ' A' ' 34' ' ' VAL . . . -88.13 -24.46 34.51 Favored Glycine 0 C--O 1.221 -0.658 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.114 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.458 ' O ' ' HB1' ' A' ' 141' ' ' ALA . 29.6 m -114.23 -0.98 9.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.899 -0.65 . . . . 0.0 110.438 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 140' ' ' VAL . . . 86.7 110.91 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.935 1.397 . . . . 0.0 108.403 -173.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -68.69 136.86 53.56 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.207 -169.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.787 ' HG3' ' H ' ' A' ' 144' ' ' GLU . 13.7 pt-20 41.01 -89.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 125.261 1.6 . . . . 0.0 113.58 176.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.787 ' H ' ' HG3' ' A' ' 143' ' ' GLU . 6.2 mm-40 -73.15 74.67 1.26 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 118.401 0.546 . . . . 0.0 109.836 172.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.33 103.75 0.16 Allowed Glycine 0 N--CA 1.436 -1.329 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.311 -175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.17 82.65 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.425 ' C ' HD21 ' A' ' 147' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.601 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.309 177.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 mtt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.23 0.538 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 m -57.35 116.77 3.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.448 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -127.71 14.66 6.99 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.943 0.401 . . . . 0.0 110.65 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -80.34 40.66 0.5 Allowed 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.401 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 179.59 19.98 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.397 -172.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.78 -50.42 73.54 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.011 -172.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' A' ' 10' ' ' LEU . 29.9 tp -126.57 -13.5 5.95 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.375 0.422 . . . . 0.0 110.154 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.69 -58.26 9.35 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.155 0.502 . . . . 0.0 111.427 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.3 m -55.14 -41.63 72.02 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.631 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.573 ' HB2' HD13 ' A' ' 7' ' ' LEU . 44.1 mt -55.56 -45.61 77.29 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.441 177.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.415 ' O ' HG22 ' A' ' 15' ' ' ILE . 15.7 m-85 -59.56 -46.37 89.11 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.367 0.604 . . . . 0.0 109.473 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -57.38 -45.27 84.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.599 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -67.31 -32.29 73.17 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.101 0.25 . . . . 0.0 110.682 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.626 HG13 ' HB2' ' A' ' 75' ' ' MET . 72.9 t -80.43 -47.99 20.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.833 -175.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 11' ' ' TYR . 18.2 tt -69.58 -25.53 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.2 ttt -78.29 -45.97 21.39 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.126 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.98 -42.77 76.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.489 0.662 . . . . 0.0 110.09 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.482 ' CG ' ' HB3' ' A' ' 74' ' ' SER . 85.9 t60 -66.95 -29.19 68.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.465 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -64.33 -45.48 87.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.941 -0.475 . . . . 0.0 110.615 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -47.52 -33.15 5.99 Favored 'General case' 0 C--O 1.247 0.937 0 O-C-N 124.197 0.936 . . . . 0.0 111.202 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -87.05 155.85 55.03 Favored Pre-proline 0 C--O 1.22 -0.492 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.146 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.24 -68.16 0.11 Allowed 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 123.606 2.871 . . . . 0.0 113.825 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.615 ' HG2' ' H ' ' A' ' 24' ' ' ASN . 25.0 ttm-85 176.61 -167.29 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.615 ' H ' ' HG2' ' A' ' 23' ' ' ARG . 18.6 p-10 -144.52 8.54 1.35 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.148 -0.345 . . . . 0.0 110.725 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 61' ' ' PHE . 60.6 tttp -99.91 115.32 29.37 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.633 0.73 . . . . 0.0 111.212 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.845 ' HA3' ' HE2' ' A' ' 60' ' ' LYS . . . -172.25 -177.83 42.03 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.457 HG21 HG23 ' A' ' 48' ' ' THR . 7.4 p -166.33 125.61 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 118.119 0.959 . . . . 0.0 110.655 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.745 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -143.69 143.62 31.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.594 0.711 . . . . 0.0 110.78 176.162 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -98.38 81.06 2.7 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.578 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 6.2 t70 -117.58 -123.02 0.29 Allowed 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.24 -173.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.447 ' OG ' ' HA ' ' A' ' 50' ' ' LYS . 17.7 m -51.88 -72.45 0.05 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.248 0.547 . . . . 0.0 111.878 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.651 HG13 ' HB2' ' A' ' 49' ' ' MET . 22.3 pt -130.23 140.89 47.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.42 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.818 HG12 HG22 ' A' ' 48' ' ' THR . 57.4 t -124.66 108.66 20.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 110.837 -0.06 . . . . 0.0 110.837 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.749 ' HB ' ' HB3' ' A' ' 47' ' ' LEU . 55.6 t -87.7 122.92 39.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 O-C-N 124.331 1.019 . . . . 0.0 110.993 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.83 108.02 16.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.995 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.465 ' HB2' ' HB2' ' A' ' 135' ' ' ALA . 20.3 mmt -136.47 119.11 16.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 5.1 p-10 -129.03 138.67 52.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.043 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -115.18 95.24 41.75 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.7 -12.77 26.56 Favored 'Trans proline' 0 CA--C 1.512 -0.576 0 C-N-CA 123.222 2.615 . . . . 0.0 112.756 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.5 m -94.12 -53.99 3.75 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.153 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.9 t -129.46 15.06 6.06 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -167.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.86 ' HA3' HD21 ' A' ' 131' ' ' LEU . . . -154.76 2.98 0.22 Allowed Glycine 0 N--CA 1.462 0.427 0 C-N-CA 118.003 -2.046 . . . . 0.0 114.882 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.693 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 10.3 t70 54.99 -101.41 0.13 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.878 0.871 . . . . 0.0 111.077 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 18.7 ptp180 -155.77 150.63 26.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.769 0.713 . . . . 0.0 112.133 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.59 HG13 ' CD1' ' A' ' 61' ' ' PHE . 8.6 tt -133.97 125.06 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 45.6 mtp180 -118.82 104.04 10.19 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 111.107 -176.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.749 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 20.1 tp -88.22 95.68 10.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.26 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.818 HG22 HG12 ' A' ' 33' ' ' VAL . 61.7 p -88.8 110.16 20.79 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.651 ' HB2' HG13 ' A' ' 32' ' ' ILE . 15.0 mtt -107.77 -179.98 4.06 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.136 0.493 . . . . 0.0 111.356 -171.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.578 ' HG3' ' OD2' ' A' ' 30' ' ' ASP . 50.5 tttp -153.58 101.35 2.48 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 1.4 pt? -124.15 93.48 3.93 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -92.21 60.27 3.67 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.644 -170.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 146.51 -98.43 0.2 Allowed Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 174.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -132.27 20.17 4.41 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.948 0.404 . . . . 0.0 110.415 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -129.0 152.13 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.81 119.54 49.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -105.49 -29.29 10.29 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.931 0.872 . . . . 0.0 108.824 -167.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.647 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 1.4 t70 -144.11 153.8 42.52 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.424 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -164.26 118.72 1.45 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.845 ' HE2' ' HA3' ' A' ' 26' ' ' GLY . 38.8 mtpt -125.71 99.68 6.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.069 0.938 . . . . 0.0 111.527 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.59 ' CD1' HG13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -70.7 139.06 51.09 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.815 176.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 15.4 tt0 -143.79 126.29 15.88 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.979 0.895 . . . . 0.0 109.009 169.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.05 -175.02 45.73 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.835 -172.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.693 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -143.88 163.0 34.65 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 -179.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.38 -133.47 4.9 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 119.203 -1.475 . . . . 0.0 113.019 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.1 m -85.73 163.96 17.9 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.308 0.575 . . . . 0.0 112.305 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 t -75.17 -26.55 59.17 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.211 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.848 HG13 HG21 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -77.2 -33.51 20.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.256 177.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.481 ' HG ' HD13 ' A' ' 68' ' ' ILE . 4.4 m -69.12 -48.6 62.04 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.993 0.901 . . . . 0.0 108.934 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 52.2 ttp -56.14 -34.27 65.96 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.619 170.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.75 -39.16 67.07 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.479 0.487 . . . . 0.0 111.565 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.799 ' HB2' HD11 ' A' ' 116' ' ' LEU . 12.7 t -58.99 -47.77 83.98 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.518 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -62.76 -49.26 75.72 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.538 177.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.482 ' HB3' ' CG ' ' A' ' 18' ' ' HIS . 68.3 m -51.64 -61.7 2.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.882 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.626 ' HB2' HG13 ' A' ' 14' ' ' VAL . 9.1 tpt -74.92 -46.92 32.55 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.575 -169.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.92 ' HG2' HD22 ' A' ' 136' ' ' LEU . 6.9 tpt -80.37 -28.09 38.06 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 88.1 m -68.79 -17.91 64.11 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.555 -1.341 . . . . 0.0 108.823 168.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' HB3' ' O ' ' A' ' 75' ' ' MET . 1.5 tt0 -80.59 -38.37 29.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.341 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.69 -45.82 9.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.998 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.486 HG12 ' HE2' ' A' ' 76' ' ' MET . 0.5 OUTLIER -73.6 -32.24 35.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 123.326 0.65 . . . . 0.0 110.703 -170.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.647 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 60.3 tttm -53.71 -15.47 1.24 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.452 0.644 . . . . 0.0 110.93 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 80' ' ' ILE . . . -114.65 32.37 5.89 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.596 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -129.46 -165.47 1.53 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -132.67 -172.1 2.83 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.701 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -74.98 -46.02 41.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.656 -175.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.76 -40.69 79.65 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.207 0.317 . . . . 0.0 111.393 -175.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.2 p -58.01 -36.5 72.77 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.457 0.646 . . . . 0.0 110.533 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.844 ' HB3' ' HB2' ' A' ' 141' ' ' ALA . . . -71.89 -49.15 40.46 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.022 0.529 . . . . 0.0 110.712 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 42.1 mt -55.01 -44.49 74.61 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.639 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.549 ' O ' HG12 ' A' ' 94' ' ' ILE . 38.3 p -68.61 -33.53 74.2 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.246 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.544 ' HA ' ' CG1' ' A' ' 94' ' ' ILE . 25.1 ttt -64.91 -16.65 63.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.383 0.611 . . . . 0.0 110.429 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.499 ' CB ' ' HG3' ' A' ' 143' ' ' GLU . 6.1 m -86.29 -40.25 15.69 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -66.3 -43.87 85.04 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.616 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.549 HG12 ' O ' ' A' ' 90' ' ' SER . 10.0 pt -71.45 -40.88 72.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.624 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 91' ' ' MET . 5.9 t80 -56.9 -29.77 63.32 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.32 174.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 t -80.8 -36.86 31.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -65.61 -42.03 92.04 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.139 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.57 ' HA ' ' H ' ' A' ' 103' ' ' GLU . 16.8 tpt -35.59 -50.45 0.61 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 123.827 0.705 . . . . 0.0 112.568 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 42.4 tpp -48.87 -19.56 0.39 Allowed 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -140.28 -29.84 0.69 Allowed 'General case' 0 C--O 1.242 0.673 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.23 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -99.79 -36.73 4.15 Favored Glycine 0 C--N 1.318 -0.472 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.647 -174.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 63.9 tttm 88.59 70.31 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.57 ' H ' ' HA ' ' A' ' 98' ' ' MET . 10.3 tp10 -153.8 133.88 13.25 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 113.335 -1.757 . . . . 0.0 107.226 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.48 -59.39 1.46 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.644 -168.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.699 ' HB3' HD12 ' A' ' 110' ' ' LEU . 14.7 t70 -144.58 97.2 2.99 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.463 ' H ' HD12 ' A' ' 94' ' ' ILE . 14.8 t70 -34.8 -31.45 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 174.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.9 m -95.94 2.78 53.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.77 -0.582 . . . . 0.0 111.301 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 108' ' ' ILE . 31.9 mm 69.53 24.97 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 122.667 1.222 . . . . 0.0 109.124 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -96.78 73.95 2.67 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.929 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.699 HD12 ' HB3' ' A' ' 105' ' ' ASP . 5.0 mp -98.01 10.84 39.38 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.995 -166.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -40.18 -38.22 1.26 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 115.645 1.018 . . . . 0.0 115.645 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.752 ' HB2' ' HB2' ' A' ' 76' ' ' MET . 18.4 t70 -80.88 -51.3 8.74 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.579 0.704 . . . . 0.0 110.42 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.646 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 53.4 mt -65.09 -24.14 34.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.823 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 117' ' ' GLN . 47.3 mt-10 -67.91 -58.38 4.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.57 77.13 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.974 0.797 . . . . 0.0 112.479 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.799 HD11 ' HB2' ' A' ' 72' ' ' SER . 8.9 mp -94.65 -5.84 44.74 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.646 ' HB3' ' O ' ' A' ' 113' ' ' ILE . 2.9 pt20 -61.65 -28.31 69.3 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.79 0.805 . . . . 0.0 111.762 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.86 -16.46 65.41 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.536 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.848 HG21 HG13 ' A' ' 68' ' ' ILE . 24.1 t -86.8 -57.62 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 124.047 0.939 . . . . 0.0 111.003 -172.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 3.3 p -45.0 -14.59 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -176.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -128.6 0.53 5.53 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 118.481 -1.287 . . . . 0.0 112.045 -165.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 6.1 m-85 -90.13 130.61 41.58 Favored Pre-proline 0 N--CA 1.441 -0.883 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.43 -29.0 29.5 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.935 2.424 . . . . 0.0 112.241 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.86 -2.88 52.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.446 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.515 ' HB3' HG11 ' A' ' 119' ' ' VAL . 89.8 mtt180 -125.39 11.71 8.08 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.1 tt -80.33 -36.78 16.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.08 0.943 . . . . 0.0 109.029 -171.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -85.64 -18.03 34.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.167 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 3.7 t -79.87 -19.28 48.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.593 ' HB3' HG12 ' A' ' 119' ' ' VAL . . . -85.85 -33.19 21.36 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.57 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.763 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 26.2 p -77.28 -32.31 55.43 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 119.323 -0.951 . . . . 0.0 108.926 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.86 HD21 ' HA3' ' A' ' 42' ' ' GLY . 19.2 tp -47.31 -59.41 3.21 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.663 169.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.8 m -79.09 -61.06 2.13 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.675 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.537 ' HB2' HD23 ' A' ' 116' ' ' LEU . 2.6 t90 -63.12 -51.37 66.81 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.458 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.763 ' HB2' ' O ' ' A' ' 130' ' ' THR . 27.4 mmmt -61.67 -42.43 98.91 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 121.855 -0.528 . . . . 0.0 110.986 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 36' ' ' MET . . . -57.02 -36.74 70.8 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.307 174.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.92 HD22 ' HG2' ' A' ' 76' ' ' MET . 4.6 tp -79.55 -40.74 28.79 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.826 0.822 . . . . 0.0 110.114 -175.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 139' ' ' GLY . 39.4 tt0 -79.12 -53.01 7.42 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.283 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -78.87 15.63 1.05 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.878 -169.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.562 ' O ' HD11 ' A' ' 32' ' ' ILE . . . -101.08 -26.61 7.77 Favored Glycine 0 N--CA 1.424 -2.148 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.921 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.29 -33.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 O-C-N 122.242 -0.563 . . . . 0.0 110.295 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.844 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . . . -102.19 119.16 38.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.39 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.61 ' H ' ' CD2' ' A' ' 89' ' ' LEU . 47.9 mtmt -146.55 113.09 5.96 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.731 0.301 . . . . 0.0 110.446 173.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.499 ' HG3' ' CB ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -57.11 69.89 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.221 0.534 . . . . 0.0 111.971 162.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -69.76 -22.36 63.36 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.014 0.911 . . . . 0.0 110.12 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.37 -23.29 0.57 Allowed Glycine 0 CA--C 1.502 -0.743 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.357 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 102.06 -69.53 0.37 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.336 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 . . . . . 0 C--N 1.319 -0.748 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.567 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.525 0.202 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -144.39 -52.1 0.31 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -127.81 88.81 2.83 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -76.46 -45.72 30.01 Favored 'General case' 0 C--O 1.241 0.656 0 O-C-N 123.973 0.796 . . . . 0.0 110.149 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.0 -73.91 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.273 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.3 t30 64.71 30.39 12.48 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 122.467 1.127 . . . . 0.0 108.739 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.625 HD11 HD13 ' A' ' 10' ' ' LEU . 34.3 tp -118.38 -12.28 9.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.764 -175.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.541 ' HA ' ' HD2' ' A' ' 11' ' ' TYR . 2.2 m-20 -58.44 -58.62 7.7 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.108 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 p -56.45 -41.04 75.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.925 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.625 HD13 HD11 ' A' ' 7' ' ' LEU . 62.6 mt -55.42 -41.69 73.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.285 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.541 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 47.9 m-85 -57.16 -51.54 68.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.322 0.582 . . . . 0.0 109.92 173.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -56.65 -39.63 74.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.51 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.5 tp60 -74.09 -35.17 64.19 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.709 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.605 HG23 ' HE1' ' A' ' 75' ' ' MET . 75.6 t -70.02 -45.48 76.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.69 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 66.6 mt -67.52 -23.19 29.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.1 ttt -73.2 -53.71 10.26 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.898 -0.502 . . . . 0.0 110.294 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -69.59 -44.81 70.02 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.49 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -65.6 -20.69 66.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.157 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 82.8 t80 -62.94 -50.09 72.18 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 121.959 -0.463 . . . . 0.0 110.56 173.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -44.85 -29.75 0.86 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.897 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -122.4 82.23 46.4 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 120.885 0.374 . . . . 0.0 110.141 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.6 73.45 1.29 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.125 2.55 . . . . 0.0 113.064 -172.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.3 ttm105 -145.55 72.47 1.31 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.659 0.742 . . . . 0.0 110.168 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -105.53 64.29 0.7 Allowed 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.641 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.665 ' HZ3' ' HB3' ' A' ' 25' ' ' LYS . 5.5 ttpm? 179.52 163.45 0.95 Allowed 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 144.82 153.53 5.89 Favored Glycine 0 C--O 1.218 -0.867 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.998 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.836 ' HB ' ' HB2' ' A' ' 62' ' ' GLU . 2.6 p -168.46 117.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.715 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -141.33 149.0 40.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.056 0.455 . . . . 0.0 111.152 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -107.55 104.81 14.45 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.31 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -149.75 -110.36 0.07 Allowed 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.468 0.48 . . . . 0.0 110.383 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.649 ' HB3' HD22 ' A' ' 51' ' ' LEU . 22.3 m -54.06 -74.0 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 124.79 1.306 . . . . 0.0 112.05 -171.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.68 HG13 ' HB3' ' A' ' 49' ' ' MET . 10.6 pt -134.82 136.71 51.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.779 0.8 . . . . 0.0 109.111 174.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.739 HG12 HG21 ' A' ' 48' ' ' THR . 33.8 t -117.69 105.23 17.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.842 0.829 . . . . 0.0 108.791 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.767 HG23 ' HA2' ' A' ' 139' ' ' GLY . 85.6 t -98.41 124.49 51.56 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.845 -171.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.752 ' HB3' ' HE ' ' A' ' 46' ' ' ARG . 5.4 p-10 -136.88 145.9 44.9 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.506 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.3 mmt -154.19 135.66 14.23 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.768 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 43' ' ' ASP . 22.6 p-10 -122.13 142.05 50.79 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.04 174.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.627 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 56.4 t30 -125.57 106.04 27.02 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 174.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 1.3 Cg_endo -42.85 133.02 5.7 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 125.123 3.882 . . . . 0.0 114.458 -167.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.0 m 77.12 -36.56 0.25 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.139 175.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.789 ' SG ' ' HB3' ' A' ' 127' ' ' LYS . 44.1 t -85.85 -78.61 0.27 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -171.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.606 ' HA3' HD12 ' A' ' 131' ' ' LEU . . . -102.6 11.48 56.47 Favored Glycine 0 CA--C 1.502 -0.761 0 C-N-CA 118.786 -1.673 . . . . 0.0 112.286 -166.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.563 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 18.3 t70 62.8 -90.9 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.423 0.719 . . . . 0.0 110.349 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -159.8 144.4 14.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 123.198 0.311 . . . . 0.0 110.466 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.42 133.92 59.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.752 ' HE ' ' HB3' ' A' ' 35' ' ' ASP . 28.8 ttm180 -134.41 109.4 8.74 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.583 HD13 ' HB3' ' A' ' 59' ' ' ALA . 11.8 tp -84.91 99.24 10.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.127 172.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.739 HG21 HG12 ' A' ' 33' ' ' VAL . 50.0 p -80.71 107.41 13.5 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 171.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.68 ' HB3' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -110.07 165.43 11.74 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -164.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HD2' ' HB3' ' A' ' 57' ' ' GLU . 8.5 tmtm? -156.33 97.21 1.75 Allowed 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.649 HD22 ' HB3' ' A' ' 31' ' ' SER . 2.6 pt? -118.85 93.82 4.23 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.62 59.26 1.76 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.373 1.082 . . . . 0.0 109.545 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 150.18 -99.44 0.19 Allowed Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.846 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.447 ' C ' HG12 ' A' ' 85' ' ' ILE . 2.0 t70 -134.91 24.25 3.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.442 0.639 . . . . 0.0 109.37 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.641 HD11 ' O ' ' A' ' 55' ' ' ILE . 2.2 pp -137.31 156.07 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 C-N-CA 124.435 1.094 . . . . 0.0 108.47 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 80' ' ' ILE . 3.3 p -96.77 119.46 44.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.139 0.971 . . . . 0.0 108.551 168.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.424 ' HB3' ' HD2' ' A' ' 50' ' ' LYS . 32.2 tt0 -98.03 -33.44 11.18 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.379 -171.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -146.22 147.55 31.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.483 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.583 ' HB3' HD13 ' A' ' 47' ' ' LEU . . . -155.82 123.09 5.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.498 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 46.8 mmtm -133.82 165.7 24.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.069 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.719 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 26.0 p90 -127.47 127.29 43.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.48 0.657 . . . . 0.0 111.612 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.836 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 8.8 tp10 -110.54 109.31 19.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.22 -178.62 48.59 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.518 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.563 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 15.1 mm-40 -142.29 168.5 19.58 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.3 -131.62 3.36 Favored Glycine 0 C--O 1.24 0.496 0 C-N-CA 119.588 -1.291 . . . . 0.0 112.93 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.8 m -78.34 178.88 7.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.6 m -93.18 -23.96 18.39 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.844 HD11 ' HB3' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -79.89 -38.74 19.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 113.831 -1.532 . . . . 0.0 110.614 175.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.4 p -65.41 -43.35 90.84 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.946 -0.471 . . . . 0.0 110.786 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.5 ptp -62.51 -29.17 70.35 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.852 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.57 -34.51 65.17 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.643 0.589 . . . . 0.0 111.642 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 m -62.25 -40.51 96.44 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.729 ' HA ' ' HG2' ' A' ' 76' ' ' MET . . . -64.95 -43.08 93.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.892 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.1 m -52.42 -49.0 65.4 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 122.324 0.249 . . . . 0.0 110.653 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.605 ' HE1' HG23 ' A' ' 14' ' ' VAL . 4.6 mmt -66.0 -47.5 74.29 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.988 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.729 ' HG2' ' HA ' ' A' ' 73' ' ' ALA . 19.7 ptt? -59.82 -41.41 91.23 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.962 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.4 p -60.18 -35.57 75.67 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.257 -0.902 . . . . 0.0 111.052 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.448 ' HG2' ' HA ' ' A' ' 75' ' ' MET . 20.4 pt20 -88.16 -41.37 13.04 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.926 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.66 -48.63 8.14 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 121.678 0.751 . . . . 0.0 111.425 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.584 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -71.47 -42.45 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.892 -174.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -61.7 -16.1 46.11 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.071 0.462 . . . . 0.0 111.273 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.12 43.61 1.65 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.322 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' HG3' ' HB ' ' A' ' 87' ' ' THR . 2.9 tppt? -134.42 170.45 15.73 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -105.66 175.61 5.44 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.653 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.5 mm -78.07 -35.86 20.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.173 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.12 -48.03 79.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.638 0.733 . . . . 0.0 109.557 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.558 ' HB ' ' HG3' ' A' ' 83' ' ' LYS . 1.4 m -66.2 -40.32 90.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.711 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.655 ' HB3' HG22 ' A' ' 140' ' ' VAL . . . -63.94 -41.7 97.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 73.5 mt -66.64 -31.01 71.42 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.8 m -70.22 -44.33 68.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.154 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.74 ' HE3' HG13 ' A' ' 113' ' ' ILE . 13.1 tpt -60.11 -29.92 68.92 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.444 0.698 . . . . 0.0 110.4 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.508 ' OG ' ' HA ' ' A' ' 142' ' ' LYS . 71.7 p -87.92 -37.86 16.08 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.968 -175.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.654 ' HG3' ' HG2' ' A' ' 143' ' ' GLU . 61.2 tttm -67.5 -44.68 77.87 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.331 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' A' ' 105' ' ' ASP . 71.8 mt -63.79 -44.75 98.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.306 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 91' ' ' MET . 0.7 OUTLIER -53.34 -32.61 49.96 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.543 174.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.6 m -83.21 -40.34 19.77 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.8 0.333 . . . . 0.0 111.187 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -71.22 -37.57 72.04 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.799 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 27.1 ttt -45.28 -51.48 10.84 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.439 0.695 . . . . 0.0 112.308 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 46.5 ttp -61.03 -8.74 3.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -123.96 -31.82 3.34 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.908 -0.495 . . . . 0.0 110.841 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -89.51 -25.58 27.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.769 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 23.9 tptm 84.87 -31.35 0.06 Allowed 'General case' 0 N--CA 1.478 0.97 0 O-C-N 125.044 1.085 . . . . 0.0 109.119 175.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 98' ' ' MET . 0.4 OUTLIER -89.22 178.45 6.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.427 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -144.76 -108.84 0.11 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.112 0.482 . . . . 0.0 111.714 -173.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 107' ' ' SER . 20.2 t70 -109.16 107.9 18.35 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -175.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.08 3.89 0.38 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.616 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.554 ' O ' HG21 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -99.09 -18.95 17.46 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.554 HG21 ' O ' ' A' ' 107' ' ' SER . 6.6 tp 66.91 24.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.446 168.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.22 87.34 6.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 172.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.582 ' HA ' ' HE2' ' A' ' 91' ' ' MET . 1.1 mp -114.21 21.53 14.64 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.306 0.379 . . . . 0.0 111.546 -168.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -51.6 -54.52 24.26 Favored Glycine 0 C--O 1.242 0.656 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.247 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.416 ' OD1' ' HA ' ' A' ' 76' ' ' MET . 6.7 m-20 -58.04 -24.14 57.18 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.863 0.865 . . . . 0.0 111.998 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.74 HG13 ' HE3' ' A' ' 91' ' ' MET . 76.3 mt -100.69 -25.09 3.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -174.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 33.7 tt0 -75.36 -54.41 7.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.53 -1.213 . . . . 0.0 111.762 -163.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.503 ' O ' HD12 ' A' ' 7' ' ' LEU . . . -49.23 -24.76 1.9 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.81 0.694 . . . . 0.0 110.818 170.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.514 HD11 ' N ' ' A' ' 116' ' ' LEU . 4.6 mp -102.89 -3.18 26.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.472 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -54.48 -37.19 64.98 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.187 0.595 . . . . 0.0 110.686 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.82 -18.16 66.2 Favored Glycine 0 C--O 1.216 -0.986 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.557 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.825 HG13 ' HB1' ' A' ' 129' ' ' ALA . 48.4 t -84.11 -44.71 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 O-C-N 122.283 -0.539 . . . . 0.0 112.164 -174.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.5 p -45.93 -25.56 0.56 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.318 0.647 . . . . 0.0 110.247 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.589 ' NZ ' ' HB2' ' A' ' 121' ' ' LYS . 3.6 ttmp? -131.71 96.51 3.97 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.831 ' H ' ' HB3' ' A' ' 125' ' ' ARG . 0.1 OUTLIER -152.34 157.06 33.91 Favored Pre-proline 0 N--CA 1.448 -0.561 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -172.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 122' ' ' PHE . 10.8 Cg_endo -59.24 -22.85 66.95 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.705 1.603 . . . . 0.0 111.221 172.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.28 18.42 17.85 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.294 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.831 ' HB3' ' H ' ' A' ' 122' ' ' PHE . 25.6 ptt-85 -52.44 -44.5 65.52 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 124.105 0.878 . . . . 0.0 112.202 -165.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.421 ' N ' ' HG3' ' A' ' 125' ' ' ARG . 11.6 tt -85.24 -20.59 8.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -160.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.789 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 38.5 mmtm -75.97 -50.14 15.75 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.435 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.844 ' HB3' HD11 ' A' ' 68' ' ' ILE . 80.0 m -86.54 -29.11 22.92 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.256 -173.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.825 ' HB1' HG13 ' A' ' 119' ' ' VAL . . . -87.59 -29.8 20.98 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.033 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 63.8 m -84.5 -41.93 16.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.606 HD12 ' HA3' ' A' ' 42' ' ' GLY . 8.4 tt -51.82 -39.41 58.7 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.942 0.401 . . . . 0.0 110.612 173.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.9 m -84.05 -42.45 16.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.697 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.437 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 2.3 t90 -53.02 -50.48 64.15 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.114 0.566 . . . . 0.0 109.816 174.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 134' ' ' LYS . 68.2 mmtt -60.08 -42.59 94.9 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 124.68 1.238 . . . . 0.0 110.407 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.2 -41.96 63.12 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.455 0.472 . . . . 0.0 112.102 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 76' ' ' MET . 4.4 mm? -83.06 -38.45 22.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.534 0.683 . . . . 0.0 110.894 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.69 ' HG3' ' HB3' ' A' ' 142' ' ' LYS . 26.4 tt0 -68.69 -41.87 78.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.37 -177.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 9.3 mtpt -93.31 -0.75 56.58 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.063 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.767 ' HA2' HG23 ' A' ' 34' ' ' VAL . . . -79.99 -27.71 52.3 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.81 HG23 ' H ' ' A' ' 141' ' ' ALA . 16.9 m -129.89 -94.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 113.184 -1.508 . . . . 0.0 108.089 170.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.81 ' H ' HG23 ' A' ' 140' ' ' VAL . . . -166.86 153.48 8.61 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.563 0.745 . . . . 0.0 109.017 166.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.69 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 21.2 pttm -87.45 119.05 27.34 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.242 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.654 ' HG2' ' HG3' ' A' ' 93' ' ' LYS . 29.6 mt-10 68.02 -78.57 0.04 OUTLIER 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.259 0.624 . . . . 0.0 110.77 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -124.76 -52.11 1.69 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.334 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.0 -41.19 0.97 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.909 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.03 49.5 0.37 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.592 -0.814 . . . . 0.0 111.887 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 . . . . . 0 C--O 1.24 0.605 0 CA-C-O 120.846 0.355 . . . . 0.0 110.686 179.34 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 55.2 t30 . . . . . 0 C--O 1.236 0.391 0 CA-C-O 121.125 0.488 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.694 HD11 ' O ' ' A' ' 115' ' ' ALA . 22.7 tp 177.32 -39.09 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 175.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.693 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.4 t70 -49.31 -63.03 1.22 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.505 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 p -59.58 -37.76 79.35 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.003 0.43 . . . . 0.0 112.043 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 mp -56.25 -50.58 70.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.898 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.778 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 5.8 p90 -85.59 -18.72 32.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.115 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 16' ' ' MET . 19.1 tpp180 -63.82 -51.99 62.21 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -63.89 -27.5 69.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.37 0.605 . . . . 0.0 109.453 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.778 ' HB ' ' HA ' ' A' ' 11' ' ' TYR . 2.1 t -70.56 -51.7 35.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.891 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 tt -72.19 -23.12 21.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -82.01 -42.68 18.99 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.261 0.351 . . . . 0.0 111.28 -178.178 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.529 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 20.9 t70 -69.11 -33.41 73.44 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.185 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.637 ' CE1' ' HB2' ' A' ' 74' ' ' SER . 86.2 t60 -74.4 -19.72 60.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.005 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -66.45 -40.63 89.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.529 ' HE3' ' HA ' ' A' ' 17' ' ' ASP . 70.9 mttt -49.98 -34.67 21.73 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.488 169.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.688 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 10.8 m120 -82.03 -179.6 1.54 Allowed Pre-proline 0 N--CA 1.465 0.298 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.688 ' HD2' ' HB3' ' A' ' 21' ' ' ASN . 11.1 Cg_endo -58.29 164.55 8.59 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.654 1.569 . . . . 0.0 111.215 164.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -85.83 -140.18 0.08 Allowed 'General case' 0 C--N 1.31 -1.137 0 O-C-N 122.038 -0.414 . . . . 0.0 111.072 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -116.91 52.46 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.981 0.419 . . . . 0.0 110.322 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.729 ' HD3' ' HG2' ' A' ' 62' ' ' GLU . 41.8 mmtm -144.03 83.68 1.75 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.587 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.28 137.14 5.23 Favored Glycine 0 C--O 1.228 -0.259 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.497 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 3.0 m -155.56 135.76 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.96 0.409 . . . . 0.0 110.171 -175.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.606 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -144.09 170.28 16.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.363 0.602 . . . . 0.0 111.013 173.254 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -135.14 41.31 2.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.67 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.471 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 25.0 t70 -84.85 -9.73 57.85 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.88 0.371 . . . . 0.0 110.535 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.6 m -153.39 -85.45 0.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.301 0.572 . . . . 0.0 110.181 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.522 HD11 HD21 ' A' ' 51' ' ' LEU . 16.2 pt -127.66 141.77 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.783 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.929 HG13 HG22 ' A' ' 48' ' ' THR . 58.6 t -121.02 107.11 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.507 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.655 HG21 ' HA2' ' A' ' 139' ' ' GLY . 97.0 t -101.45 124.52 55.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 O-C-N 123.577 0.548 . . . . 0.0 110.413 -176.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -126.77 137.65 53.25 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.9 tpt -148.43 126.19 11.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 17.0 p30 -129.03 146.98 50.86 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.988 0.805 . . . . 0.0 111.368 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.974 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 20.2 t-20 -108.23 98.24 25.94 Favored Pre-proline 0 C--O 1.248 0.988 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.2 -23.73 70.78 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 123.623 2.882 . . . . 0.0 112.353 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.6 m -62.2 -31.87 72.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.085 0.865 . . . . 0.0 111.79 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 81.2 m -113.31 -51.58 2.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.47 -6.75 10.6 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 118.995 -1.574 . . . . 0.0 110.131 -156.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.974 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 24.4 m-20 -60.02 121.58 12.2 Favored 'General case' 0 C--O 1.213 -0.856 0 C-N-CA 123.742 0.817 . . . . 0.0 109.665 173.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 30.3 ttp180 -150.2 136.75 19.02 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 121.524 -0.735 . . . . 0.0 110.536 172.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 132' ' ' SER . 26.2 pt -138.75 145.02 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 81.0 mtm180 -125.86 105.21 8.78 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.509 0.671 . . . . 0.0 110.936 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.409 HD12 ' HA3' ' A' ' 139' ' ' GLY . 1.3 tm? -89.7 98.49 11.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.918 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.929 HG22 HG13 ' A' ' 33' ' ' VAL . 71.7 p -100.48 120.16 39.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 35.7 mtt -111.2 -179.87 3.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.769 0.795 . . . . 0.0 112.591 -173.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 60.7 tttm -149.53 93.68 2.09 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.522 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -124.23 101.98 7.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.62 -174.776 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -91.75 57.19 3.15 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.381 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.61 -99.55 0.22 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.441 ' C ' HD13 ' A' ' 85' ' ' ILE . 11.6 m-20 -131.2 25.9 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.675 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.493 HD13 ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -132.52 143.72 38.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.22 114.64 30.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -100.09 -24.9 14.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -169.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 11.6 t70 -153.21 155.5 36.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.693 171.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.637 ' H ' ' HE2' ' A' ' 81' ' ' LYS . . . -157.24 117.52 3.5 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -114.43 138.59 50.39 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 123.195 0.309 . . . . 0.0 110.219 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 5.4 p90 -129.5 137.88 51.06 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -169.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.729 ' HG2' ' HD3' ' A' ' 25' ' ' LYS . 3.6 tm-20 -120.04 135.04 55.08 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.86 138.57 7.0 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.202 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -150.93 142.44 23.51 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 43' ' ' ASP . . . 146.49 -134.75 5.46 Favored Glycine 0 CA--C 1.508 -0.386 0 C-N-CA 118.811 -1.661 . . . . 0.0 111.54 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 64.0 m -75.15 153.96 37.96 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 p -66.5 -27.12 67.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.892 0.377 . . . . 0.0 110.752 -170.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.695 HD13 HG21 ' A' ' 119' ' ' VAL . 2.7 pp -82.19 -32.1 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 121.568 0.699 . . . . 0.0 111.648 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.596 ' N ' HD12 ' A' ' 68' ' ' ILE . 6.7 m -73.17 -52.95 12.23 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.3 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.5 ptm -65.83 -17.82 64.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.979 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.57 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -86.67 -46.75 9.76 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.671 0.272 . . . . 0.0 111.633 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.2 p -69.88 -42.17 73.8 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.246 0.545 . . . . 0.0 110.304 -172.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.17 -56.05 26.27 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.204 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.637 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 60.4 p -63.88 -30.05 71.18 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.599 ' HG3' HG22 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -75.09 -53.0 9.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.028 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.582 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 11.9 tpt -70.04 -22.3 63.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.984 -177.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 8.5 p -72.93 -40.47 65.41 Favored 'General case' 0 C--O 1.212 -0.902 0 O-C-N 121.654 -0.654 . . . . 0.0 110.406 174.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -57.28 -31.14 65.3 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.41 172.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.86 -34.47 19.45 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.858 0.837 . . . . 0.0 110.25 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.582 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.5 OUTLIER -75.19 -32.25 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.685 -177.259 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.637 ' HE2' ' H ' ' A' ' 59' ' ' ALA . 46.2 tttm -49.88 -18.31 0.49 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.887 1.275 . . . . 0.0 111.838 175.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.1 46.99 1.05 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.431 ' HB2' HD13 ' A' ' 80' ' ' ILE . 42.8 mmtm -132.64 -175.69 3.85 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -118.09 -178.42 3.5 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 172.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.701 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -72.85 -44.16 58.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.143 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.87 -42.55 99.8 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.082 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 m -61.64 -45.47 93.93 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.565 0.698 . . . . 0.0 111.499 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -70.54 -32.46 69.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.529 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 83.1 mt -63.01 -35.73 81.2 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.166 0.984 . . . . 0.0 108.501 172.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.7 m -70.65 -33.91 71.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.489 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -63.65 -26.04 68.49 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.163 0.506 . . . . 0.0 110.926 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.519 ' HB3' ' HB1' ' A' ' 141' ' ' ALA . 0.9 OUTLIER -89.63 -34.35 16.33 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -178.177 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 143' ' ' GLU . 14.0 tmtt? -68.38 -37.22 80.2 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 105' ' ' ASP . 21.8 mt -66.18 -46.47 87.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 123.558 0.743 . . . . 0.0 109.74 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.434 ' HD2' HG12 ' A' ' 113' ' ' ILE . 27.6 t80 -53.25 -30.18 36.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.697 0.76 . . . . 0.0 111.451 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.3 t -85.28 -39.03 18.18 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.626 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.95 -28.52 63.5 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.825 0.85 . . . . 0.0 111.672 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.64 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -57.8 -58.03 10.15 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.246 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.5 ' HA ' ' HE3' ' A' ' 99' ' ' MET . 3.4 mmt -64.7 -7.09 9.41 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -174.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -116.52 -35.94 4.11 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.375 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -94.69 -24.18 18.75 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.08 -173.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 23.7 ttmm 85.71 -21.87 0.2 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.046 0.927 . . . . 0.0 110.484 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 98' ' ' MET . 44.8 mt-10 -92.02 167.83 11.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.545 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 1.4 p90 -137.27 -110.75 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.02 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.848 ' HB3' HD11 ' A' ' 110' ' ' LEU . 13.9 t70 -93.93 110.54 22.21 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.498 0.666 . . . . 0.0 110.186 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -46.72 -11.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.527 -1.67 . . . . 0.0 113.027 172.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.2 m -105.2 -15.37 15.08 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 121.678 -0.639 . . . . 0.0 110.495 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.499 ' O ' HG22 ' A' ' 108' ' ' ILE . 24.6 mm 70.77 19.15 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 124.049 0.843 . . . . 0.0 111.483 174.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -97.94 93.67 6.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.848 HD11 ' HB3' ' A' ' 105' ' ' ASP . 9.0 mp -124.07 31.82 5.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.249 -164.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -36.76 -43.75 0.85 Allowed Glycine 0 CA--C 1.534 1.219 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 6.9 p-10 -86.81 -44.73 11.51 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 117.657 0.728 . . . . 0.0 110.95 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.537 HD12 ' HG ' ' A' ' 110' ' ' LEU . 55.3 mt -62.74 -38.16 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.503 0.668 . . . . 0.0 110.58 -174.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.553 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 39.8 mt-10 -63.51 -53.69 48.07 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.028 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.694 ' O ' HD11 ' A' ' 7' ' ' LEU . . . -68.55 -37.73 80.2 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 124.527 1.142 . . . . 0.0 114.028 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.734 HD12 HG21 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -92.0 -11.3 36.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -173.102 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 114' ' ' GLU . 4.7 pp0? -60.32 -31.37 70.22 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.267 -0.895 . . . . 0.0 110.733 177.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.487 ' HA3' HD13 ' A' ' 7' ' ' LEU . . . -84.47 -18.1 62.87 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.461 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 125' ' ' ARG . 72.9 t -86.69 -55.66 6.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.396 0.617 . . . . 0.0 110.368 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.766 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 23.5 t -41.22 -14.69 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.068 -1.878 . . . . 0.0 115.391 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -131.56 7.6 4.51 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -163.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -103.01 136.39 19.24 Favored Pre-proline 0 CA--C 1.507 -0.71 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.83 -22.18 28.75 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.785 2.323 . . . . 0.0 111.621 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.53 -8.0 33.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.467 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.766 ' HB3' HG13 ' A' ' 119' ' ' VAL . 84.1 mtt180 -126.03 5.33 7.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 O-C-N 121.714 -0.616 . . . . 0.0 110.363 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 tt -84.53 -33.03 8.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.148 0.975 . . . . 0.0 108.954 -168.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.474 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 75.9 mmtt -72.72 -24.45 60.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.027 174.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 131' ' ' LEU . 71.2 m -84.92 -17.76 36.77 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.582 0.706 . . . . 0.0 110.249 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.766 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -82.29 -21.54 36.11 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 65.5 m -83.63 -40.19 19.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.627 HD22 ' HB3' ' A' ' 43' ' ' ASP . 2.0 tp -50.51 -63.07 1.24 Allowed 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 113.459 -1.7 . . . . 0.0 111.185 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.609 ' HB2' HD21 ' A' ' 116' ' ' LEU . 20.5 m -76.44 -63.17 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -172.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.462 ' HB2' HD23 ' A' ' 116' ' ' LEU . 66.4 t90 -66.16 -49.84 66.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.145 -173.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 130' ' ' THR . 51.6 tttm -62.67 -35.69 80.48 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.134 -176.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.92 93.6 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.838 170.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.0 tp -66.46 -35.17 79.62 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 1.029 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 30.3 tt0 -69.04 -35.48 76.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.672 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -79.91 6.28 11.62 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 122.003 0.906 . . . . 0.0 110.023 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.655 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -103.71 -36.94 3.11 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.697 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.521 HG23 HG13 ' A' ' 85' ' ' ILE . 11.0 p -172.67 41.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.156 0.979 . . . . 0.0 109.698 -176.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 1.029 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . . . -148.9 167.62 25.23 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.876 -172.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 143' ' ' GLU . 37.4 ttmt -171.02 -10.46 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.547 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 27.1 tt0 71.19 -67.29 0.26 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.887 0.742 . . . . 0.0 110.698 -175.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--N 1.315 -0.925 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.524 -178.78 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 p30 . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.1 tp -143.99 -25.76 0.54 Allowed 'General case' 0 C--O 1.212 -0.899 0 C-N-CA 122.43 0.292 . . . . 0.0 111.687 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.444 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 14.6 t70 -49.17 -59.79 3.35 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.23 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -45.6 89.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.188 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 14' ' ' VAL . 74.7 mt -54.19 -51.67 63.64 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.481 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.444 ' CE1' ' HA ' ' A' ' 8' ' ' ASP . 2.2 p90 -85.14 -18.24 34.8 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.368 -175.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -60.52 -40.75 92.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.997 0.427 . . . . 0.0 110.128 169.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.514 ' HG3' ' HE1' ' A' ' 16' ' ' MET . 60.8 tt0 -73.1 -24.66 60.67 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.714 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 10' ' ' LEU . 90.0 t -73.17 -34.93 46.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.331 175.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.4 mt -73.9 -32.34 33.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.635 172.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.514 ' HE1' ' HG3' ' A' ' 13' ' ' GLN . 56.2 ttp -68.77 -46.27 69.2 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.899 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -38.2 89.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.702 -177.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.423 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -83.0 -14.24 54.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.185 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -69.09 -50.06 51.61 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.479 -1.388 . . . . 0.0 109.04 167.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -52.58 -37.39 57.92 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.391 0.676 . . . . 0.0 110.511 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -119.86 84.68 32.44 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.93 39.21 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.99 3.127 . . . . 0.0 114.408 -163.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -85.69 57.82 4.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.799 0.809 . . . . 0.0 110.868 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 18' ' ' HIS . 4.6 m-20 -102.03 19.63 18.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.925 0.869 . . . . 0.0 109.496 172.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -136.99 143.96 43.05 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.002 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.79 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 157.96 139.74 2.77 Favored Glycine 0 C--O 1.21 -1.351 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.792 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.598 HG23 HG21 ' A' ' 48' ' ' THR . 4.0 p -167.18 120.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.465 0.65 . . . . 0.0 109.347 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.744 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -138.97 154.07 48.25 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.51 0.671 . . . . 0.0 110.533 175.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -102.2 79.64 1.88 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.841 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.47 ' OD1' ' HG3' ' A' ' 50' ' ' LYS . 6.5 t70 -115.8 -130.61 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.478 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 m -52.08 -71.71 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.976 0.798 . . . . 0.0 111.746 -172.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.743 HD11 HD21 ' A' ' 51' ' ' LEU . 10.4 pt -132.59 140.36 47.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.458 0.647 . . . . 0.0 110.978 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.679 HG13 HG22 ' A' ' 48' ' ' THR . 44.5 t -120.48 107.7 21.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.078 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.061 HG21 ' HA2' ' A' ' 139' ' ' GLY . 89.9 t -101.11 128.27 53.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.104 -172.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 1.5 p-10 -132.06 149.0 52.53 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.812 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.537 ' HA ' ' CE ' ' A' ' 36' ' ' MET . 3.5 mmt -143.08 122.77 13.33 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.341 1.026 . . . . 0.0 110.22 176.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.698 ' HB3' ' HB3' ' A' ' 44' ' ' ARG . 3.7 p-10 -118.44 134.2 55.26 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.131 0.894 . . . . 0.0 110.768 -176.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.44 ' N ' HD12 ' A' ' 131' ' ' LEU . 22.4 t30 -156.84 138.87 10.18 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -45.28 -35.61 11.56 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 124.447 3.431 . . . . 0.0 113.807 -178.367 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.576 HG21 ' O ' ' A' ' 124' ' ' ALA . 3.2 m -74.91 23.76 0.1 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 122.148 0.975 . . . . 0.0 111.427 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.637 ' SG ' HD13 ' A' ' 131' ' ' LEU . 72.3 m -136.22 -52.73 0.73 Allowed 'General case' 0 C--N 1.312 -1.06 0 O-C-N 121.463 -0.773 . . . . 0.0 110.335 167.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.29 -29.11 2.31 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 24.9 t0 -157.28 -88.45 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.82 0 CA-C-N 114.621 -0.79 . . . . 0.0 111.258 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.698 ' HB3' ' HB3' ' A' ' 37' ' ' ASN . 7.7 ptp85 179.63 -179.35 0.43 Allowed 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.036 0.446 . . . . 0.0 110.897 -169.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.661 HG22 ' HE1' ' A' ' 61' ' ' PHE . 19.5 pt -137.65 139.61 42.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.821 177.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.528 ' HD3' ' HD3' ' A' ' 44' ' ' ARG . 37.2 mmm-85 -114.03 100.69 8.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.494 0.664 . . . . 0.0 110.342 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.927 HD22 ' HG3' ' A' ' 49' ' ' MET . 0.8 OUTLIER -82.86 92.44 7.28 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.744 ' HB ' HD12 ' A' ' 28' ' ' LEU . 68.3 p -84.0 111.97 19.76 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.927 ' HG3' HD22 ' A' ' 47' ' ' LEU . 22.9 mtt -107.21 178.25 4.61 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.826 0.822 . . . . 0.0 111.298 -170.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 62.8 tttp -160.79 95.82 1.1 Allowed 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.743 HD21 HD11 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -119.56 84.52 2.22 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.852 -177.66 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.89 59.35 4.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.511 -164.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.92 -99.48 0.2 Allowed Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.804 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.428 ' C ' HG12 ' A' ' 85' ' ' ILE . 11.6 p-10 -133.37 24.47 4.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.466 0.65 . . . . 0.0 109.795 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.698 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.2 pp -139.66 152.91 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -99.83 121.17 50.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -104.15 -33.25 8.8 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.335 -169.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 6.9 t70 -140.17 143.02 35.9 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.417 -0.811 . . . . 0.0 108.86 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.58 ' HB1' HD21 ' A' ' 47' ' ' LEU . . . -167.74 101.74 0.48 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.79 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 47.7 mttp -115.32 167.53 10.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.058 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.661 ' HE1' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -124.41 131.28 53.5 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.627 0.727 . . . . 0.0 111.18 -174.241 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 10.3 tp10 -128.79 110.81 12.48 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.15 174.86 34.0 Favored Glycine 0 CA--C 1.493 -1.317 0 C-N-CA 119.325 -1.417 . . . . 0.0 113.486 -174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 1.3 tm-20 -147.74 132.25 17.7 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.95 -133.59 2.76 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.581 -171.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.2 p -110.03 172.81 6.64 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.662 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.7 t -74.16 -31.08 62.56 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.177 -165.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.738 HD11 ' SG ' ' A' ' 128' ' ' CYS . 2.7 pp -75.66 -24.57 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.148 0.499 . . . . 0.0 109.937 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 68' ' ' ILE . 13.1 m -78.86 -37.79 39.44 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 65.0 mtt -58.41 -33.0 69.17 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.779 0.799 . . . . 0.0 109.687 167.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.599 ' O ' ' HB3' ' A' ' 74' ' ' SER . . . -71.62 -38.1 70.83 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.999 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.804 ' HB2' HD11 ' A' ' 116' ' ' LEU . 41.7 t -59.98 -48.47 81.56 Favored 'General case' 0 C--O 1.219 -0.538 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.12 -41.33 78.81 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.815 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.599 ' HB3' ' O ' ' A' ' 71' ' ' ALA . 30.7 t -47.8 -67.59 0.26 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.242 173.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.485 ' SD ' ' HA3' ' A' ' 111' ' ' GLY . 25.5 mmt -65.15 -32.42 74.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.925 0.393 . . . . 0.0 110.518 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.75 ' SD ' ' HG ' ' A' ' 47' ' ' LEU . 31.9 ttm -56.66 -61.72 2.23 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.593 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 p -60.08 -27.62 67.14 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -90.02 -31.63 17.11 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.308 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.11 -41.22 15.92 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.299 0.571 . . . . 0.0 111.059 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 80' ' ' ILE . 14.7 mm -76.66 -39.71 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.443 -174.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.535 ' HD3' ' H ' ' A' ' 59' ' ' ALA . 3.0 mmmp? -52.56 -18.74 1.87 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.217 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.01 54.9 0.78 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.014 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.449 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 12.0 tppt? -133.3 169.45 16.89 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -114.28 -174.03 2.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 173.465 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.489 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 18.4 mm -85.49 -33.31 7.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.963 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -63.4 -46.42 86.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.198 0.523 . . . . 0.0 110.92 175.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 83' ' ' LYS . 0.9 OUTLIER -67.96 -37.61 81.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.352 178.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.917 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -64.18 -43.21 95.84 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.101 0.477 . . . . 0.0 111.37 175.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 70.9 mt -67.1 -35.54 80.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.318 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 p -73.03 -35.2 66.72 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.933 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.0 ttt -70.03 -22.58 63.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.875 0.845 . . . . 0.0 111.718 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.509 ' OG ' ' HA ' ' A' ' 142' ' ' LYS . 49.4 p -89.06 -36.59 15.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.874 ' HB2' ' HA ' ' A' ' 143' ' ' GLU . 87.1 tttt -66.8 -37.02 83.73 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 1.053 HD13 ' HA ' ' A' ' 105' ' ' ASP . 12.8 mt -67.74 -47.27 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.355 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.549 ' CE2' HG12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -55.95 -24.88 40.88 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 123.934 0.771 . . . . 0.0 110.04 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.4 m -81.71 -43.07 18.97 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.993 -0.442 . . . . 0.0 110.824 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -75.96 -29.19 58.2 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -173.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.8 ptm -54.31 -10.0 0.34 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.956 0.902 . . . . 0.0 112.307 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 95.6 mmm -100.1 -7.77 24.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.926 0.87 . . . . 0.0 109.241 -166.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -134.68 -22.74 1.65 Allowed 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.688 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -107.54 -23.49 6.87 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 119.207 -0.774 . . . . 0.0 112.302 -177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 22.3 tptm 81.48 -18.54 0.48 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.08 1.352 . . . . 0.0 109.692 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -77.91 149.15 34.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.41 ' HB2' ' H ' ' A' ' 105' ' ' ASP . 3.5 p90 -137.03 -134.03 0.14 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -171.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 1.053 ' HA ' HD13 ' A' ' 94' ' ' ILE . 9.0 t70 -90.66 108.79 20.04 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.125 0.964 . . . . 0.0 109.33 -169.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -58.5 -2.86 0.23 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.284 173.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.532 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 1.5 m -89.79 -24.82 21.37 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 170.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 108' ' ' ILE . 22.7 mm 72.91 25.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-O 122.421 1.105 . . . . 0.0 110.703 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -94.89 70.03 3.36 Favored 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 121.618 -0.676 . . . . 0.0 109.952 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.839 ' HG ' HD12 ' A' ' 113' ' ' ILE . 6.1 mp -104.35 14.11 30.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.285 -169.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.485 ' HA3' ' SD ' ' A' ' 75' ' ' MET . . . -44.78 -39.26 6.07 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 119.857 -0.413 . . . . 0.0 113.849 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.09 -45.42 23.49 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-O 122.367 1.08 . . . . 0.0 109.906 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.839 HD12 ' HG ' ' A' ' 110' ' ' LEU . 36.8 mt -58.25 -28.95 36.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.902 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 8.2 mm-40 -76.27 -54.5 6.7 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.282 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.45 -41.45 69.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.3 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.804 HD11 ' HB2' ' A' ' 72' ' ' SER . 6.6 mp -96.04 -6.77 37.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.566 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 44.8 tt0 -45.53 -51.44 11.82 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.178 0.923 . . . . 0.0 110.853 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.48 -18.79 77.32 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.375 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 68' ' ' ILE . 60.2 t -78.29 -60.25 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 O-C-N 122.056 -0.673 . . . . 0.0 111.606 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 129' ' ' ALA . 14.5 p -50.93 -16.06 0.38 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.338 -1.301 . . . . 0.0 114.141 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.987 ' HE2' ' HA ' ' A' ' 121' ' ' LYS . 8.9 mmpt? -99.66 -16.73 18.09 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.492 -0.755 . . . . 0.0 110.822 -163.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -90.4 135.14 29.9 Favored Pre-proline 0 N--CA 1.443 -0.794 0 O-C-N 123.833 0.708 . . . . 0.0 109.819 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.0 -27.48 21.36 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.323 2.682 . . . . 0.0 111.78 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.576 ' O ' HG21 ' A' ' 40' ' ' THR . . . -84.34 -27.75 27.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.556 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.527 ' HB3' HG13 ' A' ' 119' ' ' VAL . 30.5 mtm180 -113.9 17.76 17.75 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.775 -166.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.7 tt -84.9 -29.74 6.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.03 -17.78 45.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.778 -1.556 . . . . 0.0 107.999 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.738 ' SG ' HD11 ' A' ' 68' ' ' ILE . 54.1 t -84.34 -19.62 33.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.757 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.577 ' O ' ' HB3' ' A' ' 133' ' ' TRP . . . -85.78 -27.73 25.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.533 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 16.6 p -78.31 -35.84 47.26 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.637 HD13 ' SG ' ' A' ' 41' ' ' CYS . 10.0 tt -51.42 -54.17 29.43 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.225 172.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.512 ' HB2' HD21 ' A' ' 116' ' ' LEU . 35.9 m -81.88 -62.25 1.69 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.577 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 1.2 t90 -62.49 -50.43 71.44 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 120.943 0.401 . . . . 0.0 111.849 -175.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.64 ' HB3' ' O ' ' A' ' 130' ' ' THR . 37.7 ttpt -62.65 -29.34 70.56 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.608 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 132' ' ' SER . . . -56.89 -31.02 64.45 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 169.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.5 mp -80.55 -35.17 34.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.421 ' OE1' ' HD2' ' A' ' 142' ' ' LYS . 7.5 mm-40 -61.65 -43.85 98.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.422 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -91.25 5.51 48.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.361 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 1.061 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -85.79 -39.99 7.87 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.917 HG21 ' HB1' ' A' ' 88' ' ' ALA . 20.1 m -127.06 -9.45 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 O-C-N 122.091 -0.653 . . . . 0.0 110.543 -177.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 91.78 152.39 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.184 1.393 . . . . 0.0 108.425 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.509 ' HA ' ' OG ' ' A' ' 92' ' ' SER . 14.9 pttp -114.44 142.66 46.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -171.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.874 ' HA ' ' HB2' ' A' ' 93' ' ' LYS . 33.4 mt-10 65.81 -88.66 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.242 0.964 . . . . 0.0 111.861 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 C--N 1.311 -1.068 0 O-C-N 123.587 0.554 . . . . 0.0 110.585 -178.227 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.516 -0.358 0 CA-C-O 121.104 0.478 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.506 HD11 ' O ' ' A' ' 115' ' ' ALA . 12.7 tp -137.54 0.28 2.25 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.983 0.897 . . . . 0.0 109.116 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.51 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -55.81 -63.53 1.14 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 125.348 1.459 . . . . 0.0 111.467 -178.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -62.7 -35.14 78.73 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.718 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.517 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 4.1 mm? -53.97 -39.52 66.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.103 174.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.879 ' HE1' HG22 ' A' ' 68' ' ' ILE . 22.7 m-85 -63.08 -57.71 9.71 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 121.52 0.676 . . . . 0.0 109.848 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.654 ' HA ' HG22 ' A' ' 15' ' ' ILE . 47.3 mtm180 -69.44 -18.92 63.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.03 -169.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.419 ' HA ' ' OE1' ' A' ' 13' ' ' GLN . 16.3 mm-40 -86.62 -35.86 19.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.685 1.231 . . . . 0.0 108.02 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.621 HG21 ' HB2' ' A' ' 115' ' ' ALA . 0.3 OUTLIER -80.1 -34.19 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.964 -175.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.654 HG22 ' HA ' ' A' ' 12' ' ' ARG . 10.5 tt -82.62 -19.1 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.683 175.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.613 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 17.2 tpt -61.73 -43.87 98.02 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.859 0.838 . . . . 0.0 110.388 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.02 -41.71 63.95 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.059 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -61.82 -28.23 69.33 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.774 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -66.84 -55.64 13.93 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.104 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -48.57 -38.35 20.38 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 124.039 0.837 . . . . 0.0 110.812 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -114.08 86.3 11.32 Favored Pre-proline 0 C--N 1.32 -0.676 0 O-C-N 123.426 0.454 . . . . 0.0 110.478 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.57 45.97 2.01 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.529 2.153 . . . . 0.0 114.038 -172.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.33 102.15 11.58 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.083 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -142.24 25.93 1.86 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.151 0.977 . . . . 0.0 108.366 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -132.09 124.46 29.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.224 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.764 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 155.28 146.94 4.56 Favored Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.713 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -165.39 93.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.873 0 O-C-N 124.619 0.835 . . . . 0.0 109.25 177.234 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.579 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -116.75 139.2 50.84 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 120.68 -1.263 . . . . 0.0 111.721 -175.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.512 ' HA ' HG21 ' A' ' 33' ' ' VAL . 58.1 t30 -81.24 81.34 7.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.627 172.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.555 ' HB2' HD13 ' A' ' 28' ' ' LEU . 10.3 t70 -101.48 -125.86 0.19 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.667 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.4 t -66.66 -64.92 0.75 Allowed 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.668 -0.645 . . . . 0.0 110.376 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.615 HG13 ' HB2' ' A' ' 49' ' ' MET . 34.4 pt -125.65 135.28 64.43 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.713 176.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.948 HG13 HG22 ' A' ' 48' ' ' THR . 84.9 t -116.16 138.11 47.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.917 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.764 HG21 ' HA2' ' A' ' 139' ' ' GLY . 98.1 t -127.95 124.65 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -120.41 136.91 54.58 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.35 0.119 . . . . 0.0 111.061 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.577 ' HG3' HD12 ' A' ' 131' ' ' LEU . 47.9 tpp -151.55 123.48 8.09 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 110.98 175.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 7.6 p30 -127.64 150.35 49.78 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.573 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -109.93 98.2 33.05 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.51 -11.62 32.79 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.596 2.864 . . . . 0.0 113.278 -171.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.4 m -75.85 -30.9 59.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.544 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.476 ' SG ' ' OD2' ' A' ' 43' ' ' ASP . 6.2 p -131.12 -12.67 3.59 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.43 3.78 58.49 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.317 -1.42 . . . . 0.0 113.538 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.476 ' OD2' ' SG ' ' A' ' 41' ' ' CYS . 21.7 m-20 -70.15 115.5 9.42 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 18.8 ptp180 -127.83 141.08 51.67 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 31.6 pt -141.34 149.84 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.287 0.565 . . . . 0.0 110.172 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.732 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 50.5 mtt180 -140.51 107.64 5.48 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.957 -0.464 . . . . 0.0 111.525 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.709 HD22 ' HG3' ' A' ' 49' ' ' MET . 0.7 OUTLIER -93.66 89.67 6.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.948 HG22 HG13 ' A' ' 33' ' ' VAL . 67.4 p -88.02 128.5 35.4 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 173.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.709 ' HG3' HD22 ' A' ' 47' ' ' LEU . 30.5 mtt -113.67 -179.21 3.57 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.275 1.036 . . . . 0.0 112.92 -170.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.838 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 45.3 tttp -159.87 98.7 1.36 Allowed 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.3 pt? -126.48 93.12 3.71 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -172.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -99.17 59.92 1.17 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.731 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 148.77 -96.21 0.17 Allowed Glycine 0 C--N 1.316 -0.548 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.43 18.93 6.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -176.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 2.4 pp -140.54 167.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 p -116.2 116.81 53.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 168.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' HB2' HD13 ' A' ' 55' ' ' ILE . 23.5 tt0 -106.58 -27.63 10.75 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.033 0.921 . . . . 0.0 109.95 -166.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.838 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 28.0 t70 -140.73 144.68 35.7 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 48' ' ' THR . . . -160.36 118.04 2.53 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.764 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 34.2 mmtp -107.25 130.41 54.75 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.732 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.7 p90 -129.01 147.28 50.86 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.35 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 42.2 tt0 -107.16 138.46 43.29 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.42 120.13 1.54 Allowed Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.637 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 44' ' ' ARG . 7.9 pt-20 -163.15 106.63 1.04 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.15 -131.4 1.87 Allowed Glycine 0 C--O 1.236 0.24 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.904 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.7 m -77.21 173.67 11.6 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.8 m -89.87 17.31 6.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.795 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.879 HG22 ' HE1' ' A' ' 11' ' ' TYR . 2.7 pp -119.05 -45.13 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.393 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.514 ' N ' HD12 ' A' ' 68' ' ' ILE . 13.8 p -73.27 -46.18 51.34 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.798 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -27.25 64.43 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.172 177.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.0 -59.26 2.39 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.632 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.667 ' CB ' ' HB2' ' A' ' 116' ' ' LEU . 21.7 p -67.62 -45.84 74.22 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.437 -168.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.04 -53.81 50.33 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 120.901 0.381 . . . . 0.0 110.345 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.1 t -60.16 -35.33 75.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.414 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.416 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 17.9 tpt -67.78 -54.82 16.17 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.551 0.691 . . . . 0.0 110.349 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.431 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -62.98 -33.52 75.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.205 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.616 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 24.3 p -72.61 -39.43 67.3 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.348 0.594 . . . . 0.0 110.651 177.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.416 ' HB3' ' O ' ' A' ' 75' ' ' MET . 28.1 tt0 -53.25 -38.05 62.65 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.586 171.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.98 -27.83 24.61 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.762 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -73.56 -36.83 48.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 O-C-N 124.359 1.037 . . . . 0.0 110.152 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 55.5 tttm -56.35 -17.51 8.07 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.848 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.95 42.59 1.79 Allowed Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.29 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -134.53 -153.04 0.5 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.698 0.761 . . . . 0.0 111.875 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -145.78 155.88 43.23 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 -167.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.637 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.6 mp -63.31 -49.75 81.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 O-C-N 123.342 0.401 . . . . 0.0 110.079 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.26 -38.73 82.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.863 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.522 ' O ' ' HG2' ' A' ' 91' ' ' MET . 4.8 m -68.35 -35.04 77.16 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 121.497 0.665 . . . . 0.0 110.428 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' A' ' 141' ' ' ALA . . . -60.5 -41.88 95.21 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 173.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 32.8 mt -67.36 -31.83 72.35 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.287 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.441 ' O ' HG13 ' A' ' 94' ' ' ILE . 5.1 p -77.96 -29.63 49.93 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 121.66 -0.65 . . . . 0.0 111.76 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' A' ' 87' ' ' THR . 22.1 mmt -75.66 -18.91 59.5 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.09 0.948 . . . . 0.0 110.846 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p -90.08 -31.47 17.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.377 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.85 -37.96 79.46 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.66 172.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.447 HD12 ' SD ' ' A' ' 91' ' ' MET . 35.9 mt -62.23 -48.85 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 171.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.485 ' HD1' HG12 ' A' ' 113' ' ' ILE . 49.9 t80 -43.39 -35.91 1.73 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.471 0.653 . . . . 0.0 111.745 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.2 m -85.08 -35.51 21.78 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 121.686 -0.634 . . . . 0.0 111.454 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -84.3 -20.09 32.69 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.05 0.929 . . . . 0.0 112.3 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.46 ' CG ' ' HB3' ' A' ' 104' ' ' TYR . 2.1 tmt? -73.34 -13.07 61.04 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.233 -174.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.1 mmt -95.24 6.15 49.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.556 -160.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -103.97 16.85 25.35 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.5 30.25 74.85 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.509 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 102' ' ' LYS . 7.3 mmpt? -102.7 -170.92 1.87 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.816 0.308 . . . . 0.0 110.211 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.59 156.86 33.87 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.503 ' HD2' ' H ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -124.64 -101.2 0.39 Allowed 'General case' 0 C--N 1.316 -0.883 0 O-C-N 123.717 0.636 . . . . 0.0 111.035 -178.574 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.636 ' HB3' HD11 ' A' ' 110' ' ' LEU . 15.4 t0 -116.14 107.26 14.67 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 123.742 0.651 . . . . 0.0 109.373 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.76 -2.01 1.6 Allowed 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.959 0.787 . . . . 0.0 111.531 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.587 ' O ' HG22 ' A' ' 108' ' ' ILE . 2.1 m -89.34 -15.8 32.54 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 172.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.587 HG22 ' O ' ' A' ' 107' ' ' SER . 4.3 tp 68.59 15.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.068 0.947 . . . . 0.0 113.512 165.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -92.73 88.68 6.34 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.636 HD11 ' HB3' ' A' ' 105' ' ' ASP . 10.8 mp -127.0 43.75 3.05 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.037 -168.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -38.64 -44.87 1.89 Allowed Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.579 -0.737 . . . . 0.0 114.91 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.609 ' O ' ' HB3' ' A' ' 116' ' ' LEU . 16.1 p-10 -90.45 -41.53 11.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.52 1.152 . . . . 0.0 109.99 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.74 ' O ' ' HB2' ' A' ' 117' ' ' GLN . 50.7 mt -69.47 -27.49 34.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.591 -172.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -86.98 -69.59 0.67 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.396 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.621 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -63.52 -39.39 94.31 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -172.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.667 ' HB2' ' CB ' ' A' ' 72' ' ' SER . 48.4 tp -99.74 3.08 44.77 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.648 0.737 . . . . 0.0 111.17 -169.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.74 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 8.2 tt0 -63.48 -45.79 89.15 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.536 0.684 . . . . 0.0 110.445 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.95 -17.23 65.14 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 113.91 -1.495 . . . . 0.0 113.014 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.932 HG13 ' HG2' ' A' ' 125' ' ' ARG . 97.9 t -82.09 -40.78 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 121.765 0.793 . . . . 0.0 110.186 -169.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.533 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 16.4 t -42.98 -13.23 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.561 -1.654 . . . . 0.0 115.393 174.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.458 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 10.2 ptmt -142.93 -0.37 1.16 Allowed 'General case' 0 C--O 1.243 0.725 0 O-C-N 121.003 -1.061 . . . . 0.0 113.041 -162.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.671 ' HB2' ' HB3' ' A' ' 125' ' ' ARG . 30.0 m-85 -81.09 123.6 81.75 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 168.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -51.05 -28.79 25.76 Favored 'Trans proline' 0 C--O 1.218 -0.514 0 C-N-CA 123.347 2.698 . . . . 0.0 112.652 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.49 -0.11 32.81 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.216 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.932 ' HG2' HG13 ' A' ' 119' ' ' VAL . 33.0 ttm180 -126.08 6.02 7.19 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.393 -175.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.7 tt -80.73 -25.34 11.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.244 -171.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -76.8 -20.11 56.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.389 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.414 ' HB3' HD11 ' A' ' 68' ' ' ILE . 61.0 m -86.3 -19.33 30.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.228 174.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.582 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -72.62 -46.9 51.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.147 176.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.694 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 7.5 p -69.99 -37.58 75.76 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.577 HD12 ' HG3' ' A' ' 36' ' ' MET . 18.0 tp -46.38 -55.68 6.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.077 -0.389 . . . . 0.0 111.494 171.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.463 ' HB2' HD21 ' A' ' 116' ' ' LEU . 6.7 m -83.42 -55.87 4.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.812 0.339 . . . . 0.0 111.203 -171.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 6.4 t90 -63.47 -50.56 69.21 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.746 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.694 ' HB3' ' O ' ' A' ' 130' ' ' THR . 3.1 tppp? -60.65 -42.31 96.7 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.19 -41.13 78.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.937 0.399 . . . . 0.0 111.581 173.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.401 HD21 ' CG ' ' A' ' 76' ' ' MET . 17.0 tp -73.97 -32.43 63.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.416 0.627 . . . . 0.0 110.173 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' A' ' 141' ' ' ALA . 39.4 tt0 -69.55 -37.37 77.03 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.5 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.476 ' HB3' ' NZ ' ' A' ' 138' ' ' LYS . 9.6 mtpm? -87.64 10.63 17.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.695 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.764 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -94.82 -40.96 4.23 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.8 p -178.13 -44.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.694 ' O ' ' HA ' ' A' ' 137' ' ' GLU . . . -82.97 100.61 10.54 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.435 ' HA ' ' HG3' ' A' ' 137' ' ' GLU . 13.4 ptmm? -142.91 28.29 1.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.102 0.477 . . . . 0.0 110.587 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 59.12 -167.28 0.16 Allowed 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.9 -171.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.493 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.545 ' N ' HD21 ' A' ' 6' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 10' ' ' LEU . 28.3 tp -105.5 -16.6 14.68 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.008 -0.433 . . . . 0.0 110.443 -168.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 30.4 t70 -56.53 -54.18 48.84 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.825 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.3 m -59.93 -42.25 93.58 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.536 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.669 ' HB2' HD12 ' A' ' 7' ' ' LEU . 70.0 mt -59.08 -36.41 75.04 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.835 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.555 ' O ' HG12 ' A' ' 15' ' ' ILE . 8.3 m-85 -63.92 -54.75 29.77 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.194 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 16' ' ' MET . 28.0 mtt85 -56.23 -37.33 69.58 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.86 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -75.49 -37.61 60.07 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.261 0.35 . . . . 0.0 110.868 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 t -76.93 -34.62 22.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.937 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 11' ' ' TYR . 29.0 pt -77.91 -18.44 13.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 121.813 -0.555 . . . . 0.0 109.804 174.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 45.7 ttm -69.04 -47.41 65.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -61.05 -46.41 90.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.733 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 58.9 t-80 -51.61 -45.86 63.37 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.251 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -66.72 -49.12 67.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.387 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -44.61 -41.38 6.54 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.238 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -131.73 81.05 64.6 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-O 121.407 0.622 . . . . 0.0 109.505 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -88.72 94.99 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.078 2.519 . . . . 0.0 112.875 -171.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -161.17 115.05 2.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.009 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.628 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 13.8 m120 -113.16 24.76 11.99 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.32 101.04 10.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.972 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.688 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -168.65 120.44 0.89 Allowed Glycine 0 CA--C 1.494 -1.237 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.738 HG21 ' HE ' ' A' ' 46' ' ' ARG . 2.4 p -167.88 105.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 O-C-N 121.185 -1.186 . . . . 0.0 110.982 -174.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.524 ' H ' ' CB ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -87.55 -155.36 0.29 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.396 0.617 . . . . 0.0 110.155 173.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.59 ' HA ' HG21 ' A' ' 33' ' ' VAL . 3.8 p-10 -166.42 13.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.357 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -99.42 -71.18 0.7 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.804 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.709 ' HB3' ' O ' ' A' ' 49' ' ' MET . 11.3 t -73.19 -143.98 0.02 OUTLIER 'General case' 0 C--O 1.238 0.486 0 O-C-N 123.157 0.286 . . . . 0.0 110.649 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.817 HG13 ' HB2' ' A' ' 49' ' ' MET . 27.9 pt -78.78 119.98 28.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.683 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.001 HG13 HG22 ' A' ' 48' ' ' THR . 79.9 t -119.2 135.02 60.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.257 -177.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.765 HG21 ' HA2' ' A' ' 139' ' ' GLY . 78.9 t -123.52 119.63 57.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -120.65 118.71 30.82 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.051 0.219 . . . . 0.0 110.766 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.515 ' HE2' ' HA ' ' A' ' 36' ' ' MET . 3.4 mmt -144.51 121.17 11.15 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.15 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 3.1 p30 -120.09 158.65 26.43 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 172.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.624 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 25.9 t30 -114.46 100.07 52.38 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 121.384 0.611 . . . . 0.0 109.816 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.12 -19.34 40.87 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 123.157 2.571 . . . . 0.0 113.113 -173.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 60.1 m -62.91 -43.92 97.49 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.8 p -133.0 8.67 4.09 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.06 6.9 78.33 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.477 163.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.624 ' OD1' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -82.3 146.4 29.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.216 0.531 . . . . 0.0 110.153 176.655 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 52.3 ttt180 -139.71 148.32 42.16 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.622 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.7 tt -140.18 146.61 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 123.536 0.523 . . . . 0.0 110.12 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.738 ' HE ' HG21 ' A' ' 27' ' ' VAL . 75.4 mtp85 -141.17 100.38 3.79 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.241 0.543 . . . . 0.0 110.326 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.717 HD22 ' HG3' ' A' ' 49' ' ' MET . 0.3 OUTLIER -89.99 92.17 8.88 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.48 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 1.001 HG22 HG13 ' A' ' 33' ' ' VAL . 77.7 p -93.23 130.64 38.86 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.553 -0.717 . . . . 0.0 109.79 174.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.817 ' HB2' HG13 ' A' ' 32' ' ' ILE . 36.9 mtt -126.92 -177.7 4.13 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 121.819 -0.55 . . . . 0.0 110.815 -172.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' A' ' 52' ' ' ASP . 10.5 tmtt? -160.61 110.93 1.78 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.564 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.5 pt? -128.57 94.3 3.84 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.942 0.877 . . . . 0.0 108.939 -170.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.503 ' HB2' ' HZ3' ' A' ' 50' ' ' LYS . 37.4 t70 -101.89 59.84 0.85 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.759 0.79 . . . . 0.0 109.951 -171.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.83 -94.82 0.16 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 170.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -133.77 24.71 4.0 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -139.48 160.13 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -173.382 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -95.68 97.12 6.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 123.485 1.612 . . . . 0.0 106.999 165.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 50' ' ' LYS . 37.8 tt0 -66.44 -41.88 88.46 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 112.509 -2.132 . . . . 0.0 110.189 -167.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -148.72 146.53 28.14 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.561 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.33 121.93 11.11 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.688 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 89.4 mttt -126.06 140.86 52.25 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.704 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.642 ' CZ ' ' HA ' ' A' ' 74' ' ' SER . 31.2 p90 -128.22 143.39 51.03 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.972 0.415 . . . . 0.0 110.575 -172.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 45.7 tt0 -117.05 114.02 23.16 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.482 ' H ' ' HB3' ' A' ' 24' ' ' ASN . . . -121.38 128.66 7.42 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.265 -173.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -148.21 108.45 4.1 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 43' ' ' ASP . . . 170.84 -132.4 2.47 Favored Glycine 0 C--N 1.317 -0.523 0 C-N-CA 119.363 -1.398 . . . . 0.0 112.584 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 70' ' ' MET . 1.4 p -95.37 159.25 15.09 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 120.753 0.311 . . . . 0.0 110.261 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.9 t -78.75 24.9 0.28 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.467 -167.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -118.19 -52.67 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 122.386 1.089 . . . . 0.0 109.652 179.022 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.631 ' HB3' HD22 ' A' ' 131' ' ' LEU . 1.2 m -77.23 -44.29 30.49 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 121.781 0.801 . . . . 0.0 111.098 -170.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 66' ' ' CYS . 26.9 ptm -72.16 -12.84 61.37 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.392 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.81 -45.98 11.08 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.071 -0.393 . . . . 0.0 111.379 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 p -62.62 -28.36 69.85 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 121.41 0.624 . . . . 0.0 109.849 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.61 -50.38 67.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.463 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.642 ' HA ' ' CZ ' ' A' ' 61' ' ' PHE . 24.3 m -59.64 -39.25 83.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.477 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -76.49 -58.61 3.18 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.829 -174.268 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.609 ' SD ' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -59.34 -34.0 71.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.817 -177.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 1.055 ' HA ' HG22 ' A' ' 80' ' ' ILE . 98.9 m -61.97 -43.18 99.37 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.088 0.858 . . . . 0.0 110.1 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' MET . 77.5 mt-30 -49.45 -37.01 24.34 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.773 0.797 . . . . 0.0 110.535 172.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.509 ' HB1' ' OD2' ' A' ' 109' ' ' ASP . . . -86.26 -31.84 21.44 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.682 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.055 HG22 ' HA ' ' A' ' 77' ' ' THR . 9.9 tp -83.24 -40.17 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.054 -173.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -54.34 -17.29 2.84 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.927 0.87 . . . . 0.0 111.346 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.26 40.88 2.12 Favored Glycine 0 C--N 1.31 -0.895 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -132.78 167.05 20.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -103.98 -177.06 3.26 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.681 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.4 mp -81.77 -45.37 20.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.21 -176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -58.36 -43.45 88.4 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.37 0.419 . . . . 0.0 111.099 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.536 ' HA ' ' OG ' ' A' ' 90' ' ' SER . 2.7 p -68.84 -37.65 79.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.389 0.614 . . . . 0.0 111.508 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.411 ' HB1' HG13 ' A' ' 140' ' ' VAL . . . -60.89 -40.52 93.37 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.863 175.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.841 HD22 ' HB3' ' A' ' 142' ' ' LYS . 34.0 mt -69.58 -37.5 76.97 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 110.819 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 87' ' ' THR . 2.3 p -75.43 -35.24 61.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.072 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.512 ' HA ' HG22 ' A' ' 94' ' ' ILE . 11.2 tmm? -64.94 -20.85 66.68 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.778 0.799 . . . . 0.0 109.185 173.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.796 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 43.6 t -85.35 -42.96 14.1 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.297 -1.319 . . . . 0.0 107.577 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.643 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 54.3 tttp -67.42 -36.25 80.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.329 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 90' ' ' SER . 9.1 tt -79.73 -39.77 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.087 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -46.19 -38.63 8.57 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.44 0.638 . . . . 0.0 111.247 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.5 m -86.66 -28.23 23.29 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.44 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -71.77 -21.57 61.71 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.052 0.541 . . . . 0.0 111.0 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -41.94 -47.27 4.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.673 0.789 . . . . 0.0 112.513 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.1 ttt -55.08 -18.24 5.14 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -129.3 -26.46 2.56 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.492 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.47 -40.17 4.26 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.512 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp 87.85 37.48 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.449 ' HB3' HD11 ' A' ' 94' ' ' ILE . 39.7 mt-10 -132.45 126.96 34.27 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.562 -2.108 . . . . 0.0 107.219 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.575 ' CD1' HD21 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -94.59 -89.73 0.23 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.462 ' HB3' HD12 ' A' ' 110' ' ' LEU . 5.3 t70 -115.02 112.64 22.96 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 156.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.466 ' H ' HD13 ' A' ' 94' ' ' ILE . 30.9 t70 -49.89 -21.81 1.29 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.775 173.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.459 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 1.3 m -80.11 -17.13 53.4 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.487 ' HA ' HD13 ' A' ' 110' ' ' LEU . 21.9 mm 72.23 24.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 122.507 1.146 . . . . 0.0 110.492 174.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.509 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 27.6 t70 -95.17 66.77 2.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.055 177.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.807 ' HG ' ' HB ' ' A' ' 113' ' ' ILE . 7.8 mp -95.94 40.32 1.12 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.127 -165.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.444 ' HA2' ' SD ' ' A' ' 75' ' ' MET . . . -38.31 -50.75 2.28 Favored Glycine 0 C--O 1.242 0.594 0 O-C-N 124.066 0.854 . . . . 0.0 114.145 177.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.634 ' HB2' HD22 ' A' ' 116' ' ' LEU . 8.5 p-10 -91.59 -43.38 9.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.8 -0.824 . . . . 0.0 110.238 176.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.807 ' HB ' ' HG ' ' A' ' 110' ' ' LEU . 16.4 mt -62.93 -33.3 59.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.575 -166.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.496 ' HG2' HD22 ' A' ' 10' ' ' LEU . 31.8 tt0 -61.98 -50.83 70.52 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 119' ' ' VAL . . . -69.68 -53.37 18.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.933 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.634 HD22 ' HB2' ' A' ' 112' ' ' ASP . 3.9 mp -82.72 -2.7 54.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -164.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -62.79 -39.32 93.87 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.52 -17.19 64.62 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.864 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.872 HG13 ' HB3' ' A' ' 125' ' ' ARG . 91.8 t -86.17 -46.94 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -171.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.598 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 9.4 t -49.56 -10.16 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.63 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.839 ' HE3' ' HA ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -134.0 -17.41 2.15 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.365 -160.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -88.63 130.06 46.63 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.56 -30.61 55.44 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 122.433 2.089 . . . . 0.0 112.276 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.25 1.75 56.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.255 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.872 ' HB3' HG13 ' A' ' 119' ' ' VAL . 27.9 mmt180 -134.92 8.01 3.49 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 118.61 0.641 . . . . 0.0 110.422 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.2 tt -84.34 -30.07 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -165.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.51 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 31.8 mmtp -74.99 -30.49 61.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.999 174.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.2 m -78.62 -17.64 55.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.023 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.598 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -78.38 -31.4 48.38 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.92 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.764 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 25.3 m -72.11 -44.47 63.15 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 69' ' ' SER . 9.5 tt -50.2 -63.59 1.07 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.636 174.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.544 ' HB2' HD21 ' A' ' 116' ' ' LEU . 13.5 p -74.59 -63.49 1.23 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.985 -171.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.5 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 4.7 t90 -66.38 -56.34 11.54 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 122.58 0.352 . . . . 0.0 111.219 -175.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.764 ' HB3' ' O ' ' A' ' 130' ' ' THR . 24.1 tptm -56.6 -40.08 74.66 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 123.992 0.808 . . . . 0.0 110.184 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.1 -32.95 73.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.567 HD21 ' SD ' ' A' ' 76' ' ' MET . 15.7 tp -78.22 -33.8 49.65 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.018 0.914 . . . . 0.0 109.217 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 3.5 tp10 -68.82 -41.11 79.03 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 122.844 1.307 . . . . 0.0 109.395 175.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -85.37 13.71 6.29 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 113.965 -1.47 . . . . 0.0 109.907 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.765 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -95.87 -32.95 6.57 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.569 -177.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.411 HG13 ' HB1' ' A' ' 88' ' ' ALA . 9.3 p -171.34 -28.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.796 ' HB1' ' HB2' ' A' ' 92' ' ' SER . . . -63.76 177.3 0.75 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 123.713 0.633 . . . . 0.0 110.438 173.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.841 ' HB3' HD22 ' A' ' 89' ' ' LEU . 86.0 tttt 177.76 -29.84 0.0 OUTLIER 'General case' 0 C--O 1.237 0.421 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -170.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.643 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 26.1 tt0 65.76 -76.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.816 0.341 . . . . 0.0 110.605 -172.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--N 1.318 -0.791 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.929 -172.888 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 C--O 1.241 0.631 0 CA-C-O 122.071 0.939 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.823 HD21 HG21 ' A' ' 68' ' ' ILE . 15.8 tp -102.11 -20.18 14.84 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.426 -171.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 18.6 t70 -52.76 -54.51 32.91 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.59 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -49.64 -40.49 39.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.545 175.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.5 HD11 ' HB3' ' A' ' 114' ' ' GLU . 2.7 mm? -65.74 -39.19 90.85 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.895 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.501 ' HE1' ' HB2' ' A' ' 67' ' ' SER . 41.3 m-85 -64.83 -47.92 76.25 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.428 176.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 8' ' ' ASP . 43.4 mtp180 -56.14 -47.06 78.92 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.056 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -72.01 -43.69 64.65 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 120.586 0.232 . . . . 0.0 111.58 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.9 t -81.21 -33.38 12.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.096 0.474 . . . . 0.0 111.809 -170.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 11' ' ' TYR . 1.7 mp -73.37 -24.54 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 O-C-N 121.932 -0.48 . . . . 0.0 110.195 173.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ttt -67.69 -51.0 54.77 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.593 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.24 -38.32 81.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.112 0.482 . . . . 0.0 110.369 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -54.49 -41.76 69.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.28 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -56.41 -59.09 5.47 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.924 0.393 . . . . 0.0 111.163 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -66.94 -18.83 65.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -137.49 82.12 28.73 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.394 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -90.93 73.61 0.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 123.476 2.784 . . . . 0.0 112.763 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -109.61 62.48 0.6 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.182 0.515 . . . . 0.0 111.008 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.411 ' OD1' ' HA ' ' A' ' 74' ' ' SER . 10.0 m120 -136.64 37.2 2.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.608 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 31.9 ttmt -145.53 43.51 1.28 Allowed 'General case' 0 C--N 1.315 -0.907 0 O-C-N 123.526 0.516 . . . . 0.0 109.631 -175.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.25 167.31 29.02 Favored Glycine 0 C--O 1.222 -0.632 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.533 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.708 HG23 HG21 ' A' ' 48' ' ' THR . 3.1 p -165.87 130.68 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 117.212 0.506 . . . . 0.0 109.906 -174.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.734 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -150.72 164.59 35.78 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.731 178.239 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -117.84 28.05 8.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.593 0.711 . . . . 0.0 110.739 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.27 2.48 9.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.898 -173.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.724 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 4.8 t -165.4 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.07 0.462 . . . . 0.0 110.543 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.457 ' H ' ' HB3' ' A' ' 31' ' ' SER . 15.7 pt -127.37 146.66 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.962 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.96 HG13 HG22 ' A' ' 48' ' ' THR . 36.6 t -125.86 116.21 45.36 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.001 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.877 HG21 ' HA2' ' A' ' 139' ' ' GLY . 18.1 t -102.56 118.34 49.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.313 0.578 . . . . 0.0 110.478 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 9.2 t70 -119.28 127.95 53.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.023 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.603 ' SD ' ' HA ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -130.73 117.11 18.94 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.778 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 4.6 p30 -117.39 125.76 51.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.49 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -129.64 90.24 44.26 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -33.19 118.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.33 -0.403 1 C-N-CA 125.59 4.193 . . . . 0.0 114.773 -168.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.1 m 79.17 -35.68 0.16 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 171.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 32.5 t -94.98 -14.2 24.6 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 122.312 1.053 . . . . 0.0 109.217 -174.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.701 ' HA3' HD22 ' A' ' 131' ' ' LEU . . . 179.59 64.42 0.07 OUTLIER Glycine 0 N--CA 1.414 -2.781 0 N-CA-C 105.836 -2.906 . . . . 0.0 105.836 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 24.1 t70 -49.63 -47.26 49.89 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.33 1.052 . . . . 0.0 111.528 -159.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.778 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 12.8 ptm180 -164.66 151.88 11.37 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.914 169.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 43.8 pt -139.16 141.17 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.663 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 93.0 mtt180 -123.06 105.83 10.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.106 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.71 ' HB3' ' HE3' ' A' ' 49' ' ' MET . 1.3 tt -89.66 102.85 15.53 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.96 HG22 HG13 ' A' ' 33' ' ' VAL . 82.4 p -99.13 117.58 33.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.893 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.71 ' HE3' ' HB3' ' A' ' 47' ' ' LEU . 2.0 mpt? -105.82 178.65 4.5 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.243 0.544 . . . . 0.0 110.812 -172.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.724 ' HA ' ' HB2' ' A' ' 31' ' ' SER . 14.5 tmtt? -152.29 97.93 2.35 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 10.0 mt -115.48 89.45 3.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.607 -171.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -113.02 94.31 4.84 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.445 1.117 . . . . 0.0 109.593 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.67 -104.24 0.45 Allowed Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.763 -173.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -151.74 22.34 0.69 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 111.813 -2.193 . . . . 0.0 108.439 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 2.0 pp -132.19 160.38 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.007 -170.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.476 ' HA ' HD23 ' A' ' 51' ' ' LEU . 3.0 p -97.92 109.06 22.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 166.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.589 ' HB2' HD13 ' A' ' 55' ' ' ILE . 2.5 tm-20 -97.68 -34.16 11.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -164.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.559 ' OD2' HD21 ' A' ' 28' ' ' LEU . 19.6 t70 -143.4 147.2 34.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.947 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 48' ' ' THR . . . -167.85 134.33 2.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.552 0.215 . . . . 0.0 110.524 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -136.85 175.56 9.5 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.663 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -127.57 133.83 49.75 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 123.972 0.795 . . . . 0.0 111.067 176.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -128.89 132.09 47.67 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.21 -177.96 48.58 Favored Glycine 0 C--N 1.31 -0.901 0 C-N-CA 118.695 -1.717 . . . . 0.0 113.804 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -139.82 125.47 19.33 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.96 -131.48 1.35 Allowed Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -171.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.4 p -131.48 174.5 10.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 118.187 0.994 . . . . 0.0 111.653 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.501 ' HB2' ' HE1' ' A' ' 11' ' ' TYR . 6.3 p -52.89 -49.3 66.14 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -168.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.823 HG21 HD21 ' A' ' 7' ' ' LEU . 2.5 pp -77.28 -24.62 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.704 -171.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.559 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.7 m -68.95 -45.69 70.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.381 0.61 . . . . 0.0 109.59 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.435 ' HG2' ' CZ ' ' A' ' 61' ' ' PHE . 55.2 mtt -67.08 -35.23 79.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.813 173.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 74' ' ' SER . . . -69.25 -44.36 72.12 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -172.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 50.5 m -62.89 -50.28 71.49 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.6 -40.54 72.19 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 114.59 -1.187 . . . . 0.0 111.414 174.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 71' ' ' ALA . 64.1 m -47.95 -55.94 8.78 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 175.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.764 ' HG3' ' HA3' ' A' ' 111' ' ' GLY . 1.3 tmt? -71.08 -37.4 72.45 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -172.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.681 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 6.6 mmt -77.0 -34.98 57.43 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.656 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 30.1 m -62.95 -21.12 65.86 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.946 -1.096 . . . . 0.0 109.393 169.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -85.81 -38.69 17.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.572 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.0 -44.41 11.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.626 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -76.61 -38.5 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 122.886 0.474 . . . . 0.0 111.084 -171.284 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' A' ' 77' ' ' THR . 8.3 ttpp -49.77 -17.02 0.29 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.6 37.84 3.16 Favored Glycine 0 C--O 1.218 -0.86 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -133.32 -166.74 1.81 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.8 p-10 -123.78 -163.61 1.15 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.752 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -81.66 -44.74 20.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.267 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -66.09 -39.77 90.28 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.879 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.4 p -64.14 -38.76 92.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.701 0.286 . . . . 0.0 110.563 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.46 ' HB1' HG13 ' A' ' 140' ' ' VAL . . . -60.2 -46.49 89.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 122.011 0.91 . . . . 0.0 110.346 174.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 48.1 mt -63.3 -34.26 77.31 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.77 0.795 . . . . 0.0 109.797 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.0 m -64.01 -25.63 68.21 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.731 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 94.6 mmm -71.48 -38.64 71.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.3 0.571 . . . . 0.0 110.263 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.55 ' CB ' ' H ' ' A' ' 143' ' ' GLU . 15.1 t -64.41 -39.81 94.56 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.889 171.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.98 -45.33 86.93 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 121.954 0.883 . . . . 0.0 109.533 172.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 104' ' ' TYR . 44.9 mt -59.5 -51.31 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.563 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -57.6 -37.81 73.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.396 0.617 . . . . 0.0 112.233 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.2 p -72.62 -34.56 67.42 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.776 -0.578 . . . . 0.0 110.824 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.1 -42.71 72.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.497 0.665 . . . . 0.0 110.777 172.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.2 tmt? -56.1 -15.29 3.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.008 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 57.7 ttp -85.38 -22.21 28.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.857 0.837 . . . . 0.0 109.577 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -77.49 2.63 15.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.309 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.39 44.35 51.76 Favored Glycine 0 CA--C 1.503 -0.717 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.976 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.639 ' HG2' ' H ' ' A' ' 103' ' ' GLU . 78.2 tttt -123.3 -136.94 0.3 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.639 ' H ' ' HG2' ' A' ' 102' ' ' LYS . 51.0 mt-10 -75.25 -158.07 0.08 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.381 0.61 . . . . 0.0 110.207 172.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.51 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -146.73 -102.12 0.09 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.149 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.51 ' H ' ' HD1' ' A' ' 104' ' ' TYR . 8.0 t70 -108.7 105.94 15.76 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.29 20.65 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.505 0.722 . . . . 0.0 112.4 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.488 ' H ' ' C ' ' A' ' 105' ' ' ASP . 1.7 m -109.59 -20.09 12.98 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 166.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 108' ' ' ILE . 22.3 mm 70.42 28.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.018 171.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -97.03 90.67 5.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.543 ' HB3' ' HG3' ' A' ' 114' ' ' GLU . 4.3 mp -127.23 17.34 7.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.978 -169.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.764 ' HA3' ' HG3' ' A' ' 75' ' ' MET . . . -46.58 -36.64 8.16 Favored Glycine 0 C--N 1.34 0.805 0 O-C-N 124.448 1.092 . . . . 0.0 114.192 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 16.7 p-10 -75.68 -58.48 3.25 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 122.582 -0.363 . . . . 0.0 111.271 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.732 ' HA ' ' HB2' ' A' ' 116' ' ' LEU . 53.1 mt -63.14 -24.94 37.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 C-N-CA 124.706 1.203 . . . . 0.0 111.299 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 16.8 mt-10 -62.74 -48.97 76.89 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.36 -47.07 71.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.708 171.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.732 ' HB2' ' HA ' ' A' ' 113' ' ' ILE . 8.1 mt -58.67 -34.32 71.12 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.026 0.441 . . . . 0.0 111.188 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 52.6 tt0 -42.97 -53.06 4.94 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.622 1.569 . . . . 0.0 112.386 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.38 -17.68 70.75 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.601 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.719 HG13 ' HB3' ' A' ' 125' ' ' ARG . 48.9 t -84.8 -46.24 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 117.224 0.512 . . . . 0.0 111.18 -173.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.673 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 24.5 m -42.49 -16.14 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -127.8 -3.25 5.91 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -162.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.735 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 6.6 m-85 -83.17 145.59 49.36 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -46.98 -39.15 24.79 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.424 2.75 . . . . 0.0 112.874 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.21 5.38 19.93 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.735 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 22.1 mtm180 -112.68 2.15 16.0 Favored 'General case' 0 C--O 1.202 -1.42 0 CA-C-O 122.303 1.049 . . . . 0.0 109.93 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -78.96 -37.65 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 113.989 -1.459 . . . . 0.0 108.912 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -74.79 -21.53 59.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.027 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 5.9 t -85.77 -16.91 37.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.582 -1.645 . . . . 0.0 109.248 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.673 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -85.65 -27.55 25.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 124.582 1.176 . . . . 0.0 108.988 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.735 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 3.0 m -70.67 -39.26 73.66 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 175.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.701 HD22 ' HA3' ' A' ' 42' ' ' GLY . 16.7 tp -49.62 -60.86 2.49 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.823 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.475 ' HB2' ' CD2' ' A' ' 116' ' ' LEU . 10.5 m -78.03 -60.67 2.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -171.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.532 ' HB2' HD22 ' A' ' 116' ' ' LEU . 67.0 t90 -66.42 -52.59 44.86 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.735 ' HB3' ' O ' ' A' ' 130' ' ' THR . 21.9 ttmt -58.94 -36.48 74.84 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.047 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.17 77.97 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.173 172.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.55 ' CD2' ' HG3' ' A' ' 76' ' ' MET . 13.5 tp -76.37 -35.87 58.45 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.74 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -71.18 -32.95 69.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.966 0.889 . . . . 0.0 109.073 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -81.44 4.99 19.04 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.403 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.877 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -91.86 -44.65 4.13 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.705 -0.679 . . . . 0.0 113.734 -171.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.46 HG13 ' HB1' ' A' ' 88' ' ' ALA . 12.4 p -166.95 -27.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 122.156 -0.614 . . . . 0.0 111.056 -174.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.72 ' HA ' HD23 ' A' ' 89' ' ' LEU . . . -78.94 160.73 27.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.484 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 141' ' ' ALA . 87.0 tttt 170.0 76.6 0.0 OUTLIER 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.372 0.669 . . . . 0.0 110.703 173.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.55 ' H ' ' CB ' ' A' ' 92' ' ' SER . 17.8 tp10 -81.62 -48.43 11.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 170.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 . . . . . 0 N--CA 1.441 -0.916 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.647 175.113 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.547 ' N ' HD21 ' A' ' 6' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.56 HD11 ' O ' ' A' ' 115' ' ' ALA . 22.0 tp -93.57 -19.71 20.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.827 -170.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -58.92 -56.99 15.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 124.042 0.838 . . . . 0.0 109.71 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.1 t -65.03 -37.66 88.33 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 6' ' ' ASN . 58.7 mt -53.1 -35.86 60.08 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.627 0.727 . . . . 0.0 111.039 173.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.428 ' O ' HG13 ' A' ' 15' ' ' ILE . 13.2 m-85 -70.92 -39.22 72.82 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -65.8 -35.21 80.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.659 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -65.84 -28.27 68.86 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 123.998 0.811 . . . . 0.0 109.988 174.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.982 HG11 ' HB1' ' A' ' 71' ' ' ALA . 66.6 t -84.0 -41.72 16.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.221 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 11' ' ' TYR . 76.0 mt -61.7 -29.51 46.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 CA-C-O 121.54 0.685 . . . . 0.0 110.15 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -62.08 -51.17 69.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.386 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 11.4 t70 -72.48 -40.35 67.0 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 10.0 t-80 -54.26 -45.24 72.35 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.443 -177.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -59.03 -52.14 67.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.341 0.256 . . . . 0.0 111.432 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 17' ' ' ASP . 32.7 ttpt -42.89 -34.15 0.91 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 173.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.516 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -154.34 84.58 3.93 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-O 122.032 0.92 . . . . 0.0 111.952 177.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -86.1 65.91 5.22 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.319 2.679 . . . . 0.0 111.807 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 25' ' ' LYS . 62.8 mtt180 -73.27 -77.53 0.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.769 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 5.9 m120 67.24 -22.95 0.11 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 23' ' ' ARG . 30.6 mmtp -114.97 85.7 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.812 0.339 . . . . 0.0 111.24 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -139.75 146.17 17.57 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 121.087 -0.577 . . . . 0.0 112.284 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.49 HG23 HG21 ' A' ' 48' ' ' THR . 7.4 p -168.16 134.59 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 122.689 0.396 . . . . 0.0 110.193 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.682 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -151.62 140.37 20.85 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.69 172.325 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.46 ' HA ' HG21 ' A' ' 33' ' ' VAL . 3.1 p-10 -100.51 39.33 1.38 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.367 -174.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.73 -104.06 0.03 OUTLIER 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.559 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.549 ' CB ' ' HG ' ' A' ' 51' ' ' LEU . 13.0 m -72.05 -76.18 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.317 0.579 . . . . 0.0 112.031 -174.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.906 HG13 ' HB2' ' A' ' 49' ' ' MET . 6.8 pt -119.58 131.05 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-O 121.411 0.624 . . . . 0.0 111.99 -176.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.895 HG13 HG22 ' A' ' 48' ' ' THR . 89.5 t -124.74 129.08 73.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 123.543 0.737 . . . . 0.0 109.762 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.837 HG21 ' HA2' ' A' ' 139' ' ' GLY . 7.1 t -134.25 127.84 51.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.329 0.585 . . . . 0.0 110.386 -173.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.587 ' OD2' ' HD2' ' A' ' 46' ' ' ARG . 2.0 m-20 -117.23 134.45 54.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.249 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.571 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -142.22 122.53 13.94 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.251 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -125.0 140.79 52.6 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.728 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 51.1 t30 -135.11 119.35 13.41 Favored Pre-proline 0 C--O 1.253 1.263 0 O-C-N 121.316 -0.865 . . . . 0.0 109.295 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.469 ' HD2' ' OD1' ' A' ' 38' ' ' ASN . 59.6 Cg_exo -25.5 105.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 1 C-N-CA 126.685 4.923 . . . . 0.0 116.417 -175.11 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.8 m 74.32 -34.52 0.28 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 165.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 127' ' ' LYS . 33.1 t -79.01 -49.23 13.03 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.604 -167.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.654 ' HA3' HD22 ' A' ' 131' ' ' LEU . . . -130.9 24.01 4.34 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.157 -1.021 . . . . 0.0 112.103 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.647 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 34.3 t70 40.77 -96.21 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.137 0 O-C-N 124.85 0.971 . . . . 0.0 111.936 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -136.44 146.38 46.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.356 0.598 . . . . 0.0 111.933 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 tt -131.98 125.18 54.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 170.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.587 ' HD2' ' OD2' ' A' ' 35' ' ' ASP . 24.4 mtm180 -130.36 109.22 10.57 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.189 -174.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.737 HD11 ' HE3' ' A' ' 49' ' ' MET . 0.7 OUTLIER -103.16 100.74 10.67 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 124.33 1.019 . . . . 0.0 108.934 -176.022 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.895 HG22 HG13 ' A' ' 33' ' ' VAL . 57.4 p -97.3 131.42 44.02 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 172.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.906 ' HB2' HG13 ' A' ' 32' ' ' ILE . 55.9 mtt -121.38 -178.56 3.82 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.584 0.707 . . . . 0.0 110.292 -176.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 45.2 tttm -157.63 111.66 2.59 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.549 ' HG ' ' CB ' ' A' ' 31' ' ' SER . 6.3 mt -92.45 140.24 29.77 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.342 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.919 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . 2.4 m-20 -134.18 64.86 1.59 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 140.5 -133.25 5.85 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -164.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -121.11 31.79 6.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 168.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.498 HD11 ' HG2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -127.44 178.22 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.571 -172.27 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -107.61 112.93 42.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.919 ' HG3' ' HB2' ' A' ' 52' ' ' ASP . 4.3 mm-40 -101.8 -31.35 10.79 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 122.03 0.919 . . . . 0.0 109.414 -169.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 33.2 t0 -141.53 144.95 34.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.643 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -152.02 134.39 15.24 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 73.4 mmtt -124.96 129.82 51.12 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.513 ' HB3' HG21 ' A' ' 77' ' ' THR . 47.6 p90 -116.02 141.21 48.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.199 0.524 . . . . 0.0 111.203 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 26.4 tt0 -116.6 121.79 42.74 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.92 128.29 5.24 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.544 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.647 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 10.3 tp10 -150.8 128.02 11.25 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.65 -131.68 2.57 Favored Glycine 0 C--O 1.227 -0.284 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 -171.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.4 p -99.47 159.57 14.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.461 0.63 . . . . 0.0 109.787 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 p -59.22 -38.71 80.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.838 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.785 HD11 HG21 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -61.4 -48.37 89.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.7 m -68.93 -47.35 65.94 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 110.785 -173.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.2 ptp -61.61 -29.91 70.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.452 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.982 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -66.14 -53.17 41.08 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.29 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.2 m -56.42 -40.02 74.02 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 123.9 0.75 . . . . 0.0 109.651 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.7 -57.21 10.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.582 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.441 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 49.2 m -55.76 -48.62 74.96 Favored 'General case' 0 CA--C 1.493 -1.246 0 O-C-N 123.873 0.733 . . . . 0.0 112.266 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.8 tpt -70.65 -54.96 9.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 120.933 0.397 . . . . 0.0 110.551 -174.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.675 ' HG3' HD21 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -59.95 -44.76 94.19 Favored 'General case' 0 C--O 1.205 -1.252 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.556 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.689 ' HA ' HG22 ' A' ' 80' ' ' ILE . 32.0 m -63.03 -36.99 85.42 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.16 0.891 . . . . 0.0 109.784 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -52.41 -47.85 66.07 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.002 174.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.84 -23.97 25.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.453 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.689 HG22 ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -77.48 -30.75 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -174.107 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 81' ' ' LYS . 7.0 ttpm? -52.93 -18.64 2.06 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.483 170.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.78 44.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.638 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 8.3 mttp -132.61 -162.4 1.23 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.019 0.438 . . . . 0.0 110.508 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.9 m-20 -140.83 164.56 29.91 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.577 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mp -68.09 -51.25 50.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 119.239 0.927 . . . . 0.0 110.573 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.91 -36.45 79.3 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.776 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.4 m -66.77 -41.83 87.1 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.614 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.85 82.0 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.57 0.544 . . . . 0.0 111.325 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 83.2 mt -63.59 -39.15 93.65 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.863 0.84 . . . . 0.0 109.028 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.7 t -59.14 -41.9 89.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.411 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.424 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 12.3 ttt -65.63 -38.35 89.14 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.069 0.461 . . . . 0.0 110.586 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.769 ' HB3' ' HD2' ' A' ' 142' ' ' LYS . 16.3 m -60.34 -48.49 81.52 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.045 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.432 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 35.5 ttpt -59.85 -40.74 89.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.603 0.716 . . . . 0.0 109.471 175.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.513 HG23 ' HA ' ' A' ' 104' ' ' TYR . 29.8 mt -61.62 -47.83 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.966 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -56.65 -34.49 67.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.818 0.342 . . . . 0.0 110.57 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.3 m -71.58 -44.39 64.57 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.869 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.92 -52.02 53.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.779 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.1 tpt -38.95 -63.51 0.52 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.5 mmm -49.2 -17.13 0.2 Allowed 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -128.07 -4.1 5.67 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.892 0.315 . . . . 0.0 111.193 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -116.44 -32.25 1.67 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.947 -1.121 . . . . 0.0 113.871 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 88.41 -13.93 0.4 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.245 1.418 . . . . 0.0 110.075 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -98.59 134.85 40.95 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.667 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.513 ' HA ' HG23 ' A' ' 94' ' ' ILE . 3.2 p90 -124.75 -121.93 0.26 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.826 -176.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.504 ' O ' HD13 ' A' ' 108' ' ' ILE . 24.8 t70 -94.44 107.15 19.13 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 120.914 0.387 . . . . 0.0 110.342 -174.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -48.29 -19.06 0.26 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.205 -1.361 . . . . 0.0 113.049 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.7 t -92.8 -22.69 19.17 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.662 ' HA ' HD11 ' A' ' 110' ' ' LEU . 23.4 mm 67.56 39.14 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 122.164 0.983 . . . . 0.0 109.855 175.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -99.21 81.93 2.63 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.662 HD11 ' HA ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -144.57 51.34 1.27 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -174.081 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -39.65 -18.76 0.01 OUTLIER Glycine 0 CA--C 1.54 1.605 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.529 ' HB3' ' HG3' ' A' ' 76' ' ' MET . 14.0 p-10 -85.27 -43.4 13.78 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 117.692 0.746 . . . . 0.0 109.522 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.881 ' O ' ' HB2' ' A' ' 117' ' ' GLN . 5.0 tt -70.12 -16.81 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.47 -171.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.4 ' O ' HD13 ' A' ' 10' ' ' LEU . 3.5 mm-40 -56.11 -64.78 0.75 Allowed 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.765 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -76.51 -44.77 33.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.918 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.648 HD12 HG21 ' A' ' 119' ' ' VAL . 14.2 tp -92.64 1.67 57.14 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -163.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.881 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 41.9 tt0 -58.44 -52.12 66.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.385 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.06 -13.6 72.91 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.933 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.785 HG21 HD11 ' A' ' 68' ' ' ILE . 93.3 t -78.83 -46.95 23.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 CA-C-N 117.093 0.446 . . . . 0.0 110.423 -162.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.44 ' O ' ' HD3' ' A' ' 125' ' ' ARG . 14.3 m -42.45 -15.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.59 1.556 . . . . 0.0 115.135 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 125' ' ' ARG . 63.9 pttt -131.3 13.81 5.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.528 -0.733 . . . . 0.0 112.47 -171.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.69 ' HD2' ' HA ' ' A' ' 119' ' ' VAL . 15.4 m-85 -76.43 170.03 18.08 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.199 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.453 ' HD2' ' HD1' ' A' ' 122' ' ' PHE . 30.5 Cg_endo -65.43 -18.95 61.16 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.207 1.938 . . . . 0.0 109.966 166.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.505 ' HB1' ' HD2' ' A' ' 127' ' ' LYS . . . -113.38 17.14 18.69 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.984 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.616 ' HG3' ' N ' ' A' ' 126' ' ' ILE . 18.6 ptp180 -44.05 -61.18 1.55 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.127 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.616 ' N ' ' HG3' ' A' ' 125' ' ' ARG . 39.9 pt -59.48 -22.97 24.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.184 -172.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.728 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 99.5 mttt -68.34 -63.25 1.1 Allowed 'General case' 0 C--N 1.313 -1.003 0 O-C-N 122.247 -0.283 . . . . 0.0 110.402 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.8 m -85.67 -35.2 21.05 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.451 0.644 . . . . 0.0 110.675 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.689 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -73.85 -51.28 16.8 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.618 -173.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.567 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 36.7 m -63.83 -45.87 87.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.183 -177.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.654 HD22 ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -56.63 -50.09 73.06 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.163 -0.961 . . . . 0.0 110.567 179.382 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.478 ' N ' ' HG ' ' A' ' 131' ' ' LEU . 7.1 m -76.7 -61.53 1.94 Allowed 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -174.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -61.51 -53.46 56.04 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 123.852 0.72 . . . . 0.0 111.139 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 130' ' ' THR . 88.0 tttt -55.33 -42.91 74.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' A' ' 36' ' ' MET . . . -61.17 -50.29 73.74 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.549 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.675 HD21 ' HG3' ' A' ' 76' ' ' MET . 11.8 tp -65.2 -31.69 72.99 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.461 0.648 . . . . 0.0 110.338 -175.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.708 ' CG ' ' HD3' ' A' ' 142' ' ' LYS . 2.9 tp10 -83.52 -32.33 25.96 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.79 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 23.9 tptp -71.09 -47.15 59.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.837 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -41.36 -34.68 1.07 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.395 -0.82 . . . . 0.0 114.35 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.465 ' O ' HD21 ' A' ' 89' ' ' LEU . 27.2 m -108.12 -1.09 9.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.147 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 90.09 3.43 0.16 Allowed 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 168.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.769 ' HD2' ' HB3' ' A' ' 92' ' ' SER . 43.0 tptt 55.18 87.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 171.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 69.3 -52.69 0.6 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.956 0.903 . . . . 0.0 112.228 172.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 C--O 1.24 0.602 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.297 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--O 1.214 -0.79 0 CA-C-O 121.079 0.466 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.509 HD21 HG22 ' A' ' 119' ' ' VAL . 21.5 tp -70.46 -42.75 71.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.022 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.81 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 17.8 t70 -54.5 -53.76 50.04 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.417 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 m -57.29 -54.39 47.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.337 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.616 ' O ' HG13 ' A' ' 14' ' ' VAL . 4.3 mp -47.33 -52.42 16.48 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.419 1.074 . . . . 0.0 111.862 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.81 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 0.6 OUTLIER -79.19 -19.42 50.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.488 -175.506 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -66.6 -35.67 80.74 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-O 121.412 0.625 . . . . 0.0 109.358 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -75.65 -35.23 60.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.081 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.788 HG22 ' HA ' ' A' ' 11' ' ' TYR . 3.2 m -72.48 -35.34 51.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.961 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.576 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 14.5 tt -77.41 -22.67 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.929 174.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 17.2 tpt -84.9 -38.78 18.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.323 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.775 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 20.3 t70 -77.9 -37.13 48.63 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.458 ' CD2' ' HB3' ' A' ' 24' ' ' ASN . 26.1 t60 -71.43 -16.46 62.38 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.068 171.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.576 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 46.4 t80 -73.57 -48.22 34.55 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.333 0.587 . . . . 0.0 110.014 171.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.775 ' HD3' ' HA ' ' A' ' 17' ' ' ASP . 41.4 mtpt -48.61 -45.79 38.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.846 171.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -114.81 78.41 5.22 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 18' ' ' HIS . 72.7 Cg_endo -77.62 51.11 3.44 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 122.999 2.466 . . . . 0.0 113.414 -165.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -83.72 50.41 1.8 Allowed 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 121.801 -0.562 . . . . 0.0 109.57 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.458 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . 20.0 p-10 -114.2 24.77 11.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.9 0.857 . . . . 0.0 109.044 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -133.15 139.44 47.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.835 -1.53 . . . . 0.0 108.868 173.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 142.67 141.89 3.94 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.103 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.661 HG13 ' HB2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -159.27 127.93 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.349 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.757 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -136.11 147.68 47.9 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.491 0.663 . . . . 0.0 110.56 176.435 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -93.26 44.08 1.13 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.23 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.458 ' HB3' ' H ' ' A' ' 31' ' ' SER . 1.2 m-20 -85.67 -130.37 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.031 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.458 ' H ' ' HB3' ' A' ' 30' ' ' ASP . 14.9 m -52.12 -77.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.814 HG13 ' HB2' ' A' ' 49' ' ' MET . 12.8 pt -127.02 137.86 56.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.622 0.725 . . . . 0.0 110.394 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.639 HG13 HG22 ' A' ' 48' ' ' THR . 95.7 t -123.09 114.69 43.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.617 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.963 HG21 ' HA2' ' A' ' 139' ' ' GLY . 93.9 t -106.88 119.3 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.074 -176.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 2.0 p-10 -127.85 149.57 50.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.504 0.669 . . . . 0.0 110.141 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 45' ' ' ILE . 27.3 ttt -157.37 132.11 8.66 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.173 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 7.0 p30 -127.28 135.62 50.83 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -113.63 88.33 13.43 Favored Pre-proline 0 N--CA 1.439 -0.983 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 167.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -60.08 -6.26 4.8 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.386 2.058 . . . . 0.0 113.889 -169.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.7 p -98.6 -51.03 4.06 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.294 0.568 . . . . 0.0 111.784 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 51.6 t -135.23 17.99 3.42 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -169.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.22 -3.37 0.37 Allowed Glycine 0 N--CA 1.47 0.956 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.406 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.631 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 11.5 m-20 53.79 -110.7 0.56 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 118.394 -0.812 . . . . 0.0 111.117 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 31.3 ptt180 -158.67 148.83 19.69 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.652 1.115 . . . . 0.0 112.549 -176.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.568 HG13 ' CE1' ' A' ' 61' ' ' PHE . 5.0 tt -130.4 133.26 64.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.571 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -121.56 103.44 8.92 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.246 0.341 . . . . 0.0 111.695 173.187 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.682 HD22 ' HG3' ' A' ' 49' ' ' MET . 1.9 tt -92.6 106.63 18.58 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 172.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.757 ' HB ' HD12 ' A' ' 28' ' ' LEU . 44.9 p -99.27 123.5 43.6 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.814 ' HB2' HG13 ' A' ' 32' ' ' ILE . 52.2 mtt -113.26 178.7 4.19 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 123.741 0.651 . . . . 0.0 111.73 -175.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.435 ' HA ' ' OG ' ' A' ' 31' ' ' SER . 86.9 tttt -160.24 100.56 1.37 Allowed 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -116.72 92.16 3.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.065 0.936 . . . . 0.0 111.501 -175.503 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -103.36 89.36 3.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.466 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.31 -100.88 0.32 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-O 122.985 1.325 . . . . 0.0 111.821 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -159.6 35.85 0.19 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 111.375 -2.412 . . . . 0.0 106.681 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.676 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.3 pp -140.13 143.58 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.187 -171.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.49 HG11 HG23 ' A' ' 80' ' ' ILE . 1.3 p -92.59 113.35 27.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -102.1 -32.01 10.34 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 113.978 -1.465 . . . . 0.0 107.941 -163.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -136.48 129.51 31.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.65 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.63 104.49 3.75 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.434 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 29.0 mmtp -120.75 151.95 38.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.922 -175.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.568 ' CE1' HG13 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -130.53 135.75 48.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.661 ' HB2' HG13 ' A' ' 27' ' ' VAL . 1.1 tm-20 -142.09 114.56 8.39 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.76 -177.49 39.16 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.004 -172.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -139.85 157.71 45.28 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.631 ' HA2' ' HB2' ' A' ' 43' ' ' ASP . . . 157.26 -143.17 9.27 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 119.253 -1.451 . . . . 0.0 112.502 176.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 61.1 m -76.31 164.57 25.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.271 0.558 . . . . 0.0 110.828 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -63.41 -35.47 80.52 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.008 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.644 HG13 HG21 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -82.81 -29.02 8.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.05 -177.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.526 ' N ' HD13 ' A' ' 68' ' ' ILE . 8.3 m -66.92 -55.0 16.52 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.699 -0.625 . . . . 0.0 110.729 -174.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -69.55 -16.25 63.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.656 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.542 ' HB1' HG23 ' A' ' 14' ' ' VAL . . . -85.84 -53.3 5.2 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.553 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.417 ' OG ' ' HB2' ' A' ' 116' ' ' LEU . 37.3 t -74.1 -51.21 16.39 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.746 0.654 . . . . 0.0 109.818 -171.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.36 -51.91 65.25 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.219 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . 30.3 t -66.16 -38.46 88.14 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.915 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.563 ' SD ' ' HB ' ' A' ' 14' ' ' VAL . 28.7 ttt -59.32 -46.83 87.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.352 0.596 . . . . 0.0 110.671 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.409 ' HB3' ' CD1' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -75.48 -23.28 56.78 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.175 178.497 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.596 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 99.6 m -67.97 -43.72 78.33 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-O 122.389 1.09 . . . . 0.0 110.008 172.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.8 tm0? -58.8 -27.03 64.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.835 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.74 -33.6 23.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.596 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 2.3 mm -67.83 -36.24 75.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.616 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -56.8 -18.87 14.39 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.716 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.94 38.39 2.95 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.749 ' HE3' ' HB ' ' A' ' 87' ' ' THR . 27.3 tptt -131.45 164.33 25.97 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -172.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.635 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.4 p-10 -111.65 -175.2 2.64 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 169.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.768 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.1 mp -76.3 -39.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.267 -173.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -60.67 -48.59 81.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.002 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.749 ' HB ' ' HE3' ' A' ' 83' ' ' LYS . 18.6 p -71.7 -36.12 70.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.557 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -56.42 -40.5 74.84 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.429 0.633 . . . . 0.0 111.466 172.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 66.3 mt -62.62 -33.82 75.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.367 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -80.45 -25.2 39.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.631 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -65.0 -27.31 68.73 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 121.844 0.83 . . . . 0.0 109.362 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.4 m -88.59 -23.53 23.08 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.366 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 143' ' ' GLU . 83.5 tttt -79.01 -30.17 44.08 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.626 177.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.8 tt -82.21 -33.6 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -50.47 -33.34 20.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.166 163.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.7 m -81.65 -27.82 33.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.484 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.422 ' OD1' ' HA3' ' A' ' 101' ' ' GLY . 20.6 t70 -66.11 -35.79 81.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.707 ' HA ' ' CE1' ' A' ' 104' ' ' TYR . 59.7 ttp -48.15 -16.71 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.252 0.621 . . . . 0.0 112.609 169.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 73.7 mtm -117.96 -36.38 3.64 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.066 -0.396 . . . . 0.0 111.259 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -106.33 -43.43 4.78 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.063 0.459 . . . . 0.0 110.457 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.422 ' HA3' ' OD1' ' A' ' 97' ' ' ASP . . . -81.5 -57.14 2.82 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.872 -174.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 61.28 81.4 0.19 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.538 0.685 . . . . 0.0 111.242 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -178.9 31.82 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.558 0.695 . . . . 0.0 110.335 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.736 ' HD2' HD11 ' A' ' 110' ' ' LEU . 15.6 p90 -103.82 113.1 26.38 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.483 0.658 . . . . 0.0 110.045 -176.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -137.71 70.43 1.39 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.038 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.86 ' H ' HD22 ' A' ' 110' ' ' LEU . 32.1 t70 60.67 6.62 1.17 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.613 0.72 . . . . 0.0 111.202 168.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.2 m -111.9 3.74 17.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.703 -173.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.422 ' HB ' ' H ' ' A' ' 109' ' ' ASP . 1.9 mp -131.99 -77.69 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.422 ' H ' ' HB ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -144.79 166.72 24.43 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 167.404 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.86 HD22 ' H ' ' A' ' 106' ' ' ASP . 3.1 tp 173.11 -7.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -39.04 -46.39 2.38 Favored Glycine 0 C--N 1.355 1.589 0 C-N-CA 121.155 -0.545 . . . . 0.0 114.282 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.477 ' OD2' HG13 ' A' ' 113' ' ' ILE . 2.8 p-10 -70.69 -59.61 2.72 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.994 HG23 ' HB3' ' A' ' 117' ' ' GLN . 41.0 mt -50.9 -40.7 20.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.995 0.918 . . . . 0.0 112.57 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 10' ' ' LEU . 12.2 mm-40 -61.75 -12.22 15.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.462 0.649 . . . . 0.0 111.57 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.589 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -138.37 19.4 2.75 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.753 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.585 HD12 HG21 ' A' ' 119' ' ' VAL . 10.0 tp -161.88 -20.78 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -169.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.994 ' HB3' HG23 ' A' ' 113' ' ' ILE . 22.4 pt20 -60.09 -31.32 69.91 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.794 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.578 ' HA2' ' HE2' ' A' ' 121' ' ' LYS . . . -80.62 -16.96 74.34 Favored Glycine 0 CA--C 1.504 -0.597 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.656 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.851 HG13 ' HB3' ' A' ' 125' ' ' ARG . 79.7 t -81.6 -43.86 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 123.291 0.636 . . . . 0.0 110.36 -171.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.563 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 4.8 m -36.09 -16.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.578 ' HE2' ' HA2' ' A' ' 118' ' ' GLY . 0.3 OUTLIER -146.66 0.47 0.77 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 119.969 1.258 . . . . 0.0 113.626 -166.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.771 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 12.9 m-30 -75.18 136.22 72.71 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 172.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 122' ' ' PHE . 52.4 Cg_exo -55.05 -26.63 50.91 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.682 2.255 . . . . 0.0 111.971 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.38 -0.29 35.69 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.851 ' HB3' HG13 ' A' ' 119' ' ' VAL . 64.0 mtt180 -129.26 12.77 6.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.165 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -80.22 -32.24 13.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 122.796 1.284 . . . . 0.0 108.033 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -83.24 -20.91 33.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.606 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 57.4 m -82.57 -18.6 40.77 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.921 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.596 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -84.54 -36.43 22.16 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.972 -176.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.643 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 3.9 m -75.01 -40.45 60.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.428 HD22 ' HB3' ' A' ' 69' ' ' SER . 8.2 tt -50.7 -51.14 52.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.105 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 t -80.24 -60.89 2.16 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.066 -174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -62.87 -53.27 56.78 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.854 0.359 . . . . 0.0 111.751 -175.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.643 ' HB3' ' O ' ' A' ' 130' ' ' THR . 19.9 tptm -59.39 -34.8 72.88 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.913 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.89 -34.5 59.66 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.073 171.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.409 ' CD1' ' HB3' ' A' ' 76' ' ' MET . 82.2 mt -84.24 -39.43 19.29 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.34 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -70.47 -39.74 74.06 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.64 0.733 . . . . 0.0 110.905 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.759 ' HE3' ' HA ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -84.88 12.38 7.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.094 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.963 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -102.86 -29.72 5.74 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.196 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.557 HG21 ' HB1' ' A' ' 88' ' ' ALA . 29.3 m -131.56 -23.49 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -174.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 90.46 175.29 0.02 OUTLIER 'General case' 0 C--N 1.351 0.663 0 C-N-CA 125.093 1.357 . . . . 0.0 109.759 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -123.95 149.15 46.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.241 -0.912 . . . . 0.0 112.405 -169.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -92.48 104.83 17.11 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 162.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 144' ' ' GLU . 10.3 pt-20 . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.133 -166.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.1 m120 . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 120.956 0.408 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.783 ' HA ' HD12 ' A' ' 10' ' ' LEU . 55.8 tp 169.47 -36.55 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 17.3 t70 -61.56 -57.03 13.72 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.32 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.603 ' HA ' ' HG2' ' A' ' 12' ' ' ARG . 29.1 p -51.02 -43.05 60.8 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.751 0.786 . . . . 0.0 111.729 173.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.783 HD12 ' HA ' ' A' ' 7' ' ' LEU . 88.2 mt -51.79 -48.01 63.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.81 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.5 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.8 m-85 -67.64 -35.55 79.1 Favored 'General case' 0 CA--C 1.5 -0.981 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.415 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.603 ' HG2' ' HA ' ' A' ' 9' ' ' THR . 21.6 mmm-85 -59.91 -30.76 69.26 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.739 -0.601 . . . . 0.0 110.075 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -82.32 -34.79 28.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 75' ' ' MET . 94.9 t -76.96 -30.77 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.594 -176.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 11' ' ' TYR . 30.9 pt -83.84 -19.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 26.1 ttt -64.15 -44.65 91.48 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.838 0.828 . . . . 0.0 109.242 175.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.18 -33.9 63.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.481 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -62.11 -26.56 68.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.174 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -68.63 -54.35 16.93 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.566 -0.709 . . . . 0.0 110.557 168.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -48.68 -38.23 20.72 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.235 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -112.84 81.31 4.37 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.48 -16.39 23.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.422 3.415 . . . . 0.0 115.475 -159.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -148.48 164.74 33.27 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.286 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -151.03 81.02 1.32 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.114 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.638 ' HG3' ' HG3' ' A' ' 62' ' ' GLU . 58.7 tttm -141.82 93.79 2.6 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.363 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.78 152.63 24.75 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.787 HG23 HG21 ' A' ' 48' ' ' THR . 2.9 p -150.29 132.61 6.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.197 0.522 . . . . 0.0 110.141 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.771 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -153.71 146.32 24.17 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 176.283 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -111.49 139.34 47.01 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.804 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t70 172.21 -79.74 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.603 0.761 . . . . 0.0 109.188 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.528 ' HB3' ' HG ' ' A' ' 51' ' ' LEU . 14.1 m -72.01 -86.49 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.519 -175.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.671 HG13 ' HB2' ' A' ' 49' ' ' MET . 4.3 pt -138.23 134.31 44.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.299 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.579 HG13 HG22 ' A' ' 48' ' ' THR . 61.4 t -125.62 121.93 61.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.728 0.775 . . . . 0.0 110.201 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.025 HG21 ' HA2' ' A' ' 139' ' ' GLY . 2.8 t -117.36 124.83 73.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.352 -176.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.5 p-10 -126.43 138.98 53.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.826 0.346 . . . . 0.0 110.395 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.657 ' HG2' ' HA ' ' A' ' 131' ' ' LEU . 2.0 tpt -147.1 131.26 17.36 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.532 ' H ' ' HE2' ' A' ' 36' ' ' MET . 8.5 p30 -109.77 132.29 54.28 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.223 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -121.96 98.88 44.59 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 161.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -32.33 109.0 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 125.171 3.914 . . . . 0.0 115.147 -168.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 m 71.73 -20.49 0.24 Allowed 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.095 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 51.6 t -95.42 -33.19 12.57 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.37 1.081 . . . . 0.0 109.142 -175.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.506 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . -157.61 60.9 0.33 Allowed Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 104.714 -3.354 . . . . 0.0 104.714 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.68 -43.04 89.84 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.594 -1.303 . . . . 0.0 112.048 -156.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -148.44 132.41 17.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 118.246 -1.382 . . . . 0.0 109.926 168.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.586 HG13 ' CE1' ' A' ' 61' ' ' PHE . 8.7 tt -124.33 116.15 46.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 20.4 ttt180 -121.36 102.79 8.5 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.649 -0.657 . . . . 0.0 111.924 -172.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.574 HD21 ' CE ' ' A' ' 49' ' ' MET . 28.1 tp -87.82 102.58 14.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.342 173.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.787 HG21 HG23 ' A' ' 27' ' ' VAL . 31.6 p -98.4 112.35 24.39 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 171.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.671 ' HB2' HG13 ' A' ' 32' ' ' ILE . 24.9 mtt -100.87 178.88 4.56 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.117 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.914 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 56.3 tttp -157.28 93.4 1.31 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.609 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 2.2 pp -117.72 108.95 16.02 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 113.183 -1.826 . . . . 0.0 106.848 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -98.84 60.46 1.25 Allowed 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.931 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.28 -98.58 0.19 Allowed Glycine 0 N--CA 1.424 -2.152 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.195 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -128.78 22.47 5.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.757 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.4 pp -135.77 144.8 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -98.28 122.77 50.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -115.94 -21.21 9.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.998 0.904 . . . . 0.0 109.099 -170.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.914 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 17.1 t70 -141.35 149.11 40.74 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.885 174.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -161.75 108.06 1.34 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.769 0.795 . . . . 0.0 109.124 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -107.3 147.72 29.9 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.328 0.585 . . . . 0.0 109.57 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.601 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.9 t80 -121.38 129.01 52.79 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.998 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.638 ' HG3' ' HG3' ' A' ' 25' ' ' LYS . 27.8 tt0 -128.26 124.44 36.63 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.72 -177.72 48.28 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 119.132 -1.508 . . . . 0.0 112.72 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -141.71 128.95 21.02 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.506 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . -169.49 -132.1 1.4 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.5 -1.334 . . . . 0.0 110.81 -175.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 7.3 p -123.35 -163.98 1.17 Allowed 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 p -55.77 -26.5 46.22 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.798 HG13 ' HB3' ' A' ' 128' ' ' CYS . 7.3 mm -62.48 -66.62 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.649 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 p -55.43 -32.57 62.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.225 1.012 . . . . 0.0 109.909 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -61.7 -60.86 3.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.286 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.626 ' HB1' ' HB1' ' A' ' 115' ' ' ALA . . . -71.68 -43.3 66.25 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -172.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.513 ' HB3' HD11 ' A' ' 116' ' ' LEU . 49.4 p -59.0 -39.61 82.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 110.632 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.765 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -75.01 -48.93 21.63 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.232 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 27.6 m -55.35 -61.04 2.6 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.802 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.621 ' HB2' HG13 ' A' ' 14' ' ' VAL . 12.6 tpt -83.1 -57.63 3.2 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.525 ' CG ' HD13 ' A' ' 136' ' ' LEU . 10.5 tpt -74.02 -27.9 61.18 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -171.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.765 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 85.6 m -73.32 -40.99 64.05 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 74' ' ' SER . 8.3 tt0 -59.54 -26.22 65.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.183 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.26 -33.58 22.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.65 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -67.6 -42.96 87.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.11 178.389 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 65.2 tttm -56.45 -16.28 5.57 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.686 0.794 . . . . 0.0 111.694 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.89 38.59 2.95 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.419 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -135.25 179.09 6.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.741 0.27 . . . . 0.0 111.597 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.649 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.0 m-20 -100.41 176.94 5.18 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.699 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 12.6 mm -84.41 -43.11 17.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.548 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -63.36 -38.27 90.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.02 0.438 . . . . 0.0 110.318 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -61.62 -41.3 97.27 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 121.72 0.772 . . . . 0.0 110.866 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -66.11 -34.98 79.28 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 121.927 -0.483 . . . . 0.0 110.605 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 70.7 mt -64.71 -39.72 94.12 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.453 1.121 . . . . 0.0 109.735 175.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.551 ' O ' HG12 ' A' ' 94' ' ' ILE . 26.9 t -67.09 -41.66 85.94 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.827 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.475 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 16.9 tpt -62.85 -22.42 66.66 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 122.287 1.041 . . . . 0.0 110.854 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.542 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 27.5 t -89.03 -35.95 16.07 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.499 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -66.58 -51.51 55.63 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.813 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 105' ' ' ASP . 22.1 pt -65.1 -39.83 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.838 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 91' ' ' MET . 39.2 t80 -53.51 -35.93 61.19 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.411 0.624 . . . . 0.0 111.143 174.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.6 m -86.31 -35.85 19.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.134 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.54 -35.96 75.92 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.096 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 1.3 tmt? -39.22 -49.75 1.9 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 124.127 0.892 . . . . 0.0 111.689 178.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.2 mtt -57.21 -10.63 1.32 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -124.46 -35.24 2.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.773 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.734 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -88.69 -32.07 11.92 Favored Glycine 0 C--O 1.239 0.448 0 C-N-CA 119.511 -1.328 . . . . 0.0 114.168 -173.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.734 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 22.4 tttm 97.64 -29.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.758 1.223 . . . . 0.0 109.699 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 98' ' ' MET . 0.7 OUTLIER -82.09 163.21 22.19 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.103 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.65 -106.34 0.24 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.72 ' HA ' HD12 ' A' ' 94' ' ' ILE . 31.7 t70 -95.34 101.73 13.48 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 172.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.27 8.87 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.449 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 65.3 m -105.78 -16.95 14.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 169.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 108' ' ' ILE . 32.0 mm 65.37 27.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-O 121.816 0.817 . . . . 0.0 110.949 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -95.41 86.93 4.63 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 170.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 113' ' ' ILE . 6.7 mt -123.75 43.94 2.84 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.393 -165.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -40.47 -33.21 0.53 Allowed Glycine 0 CA--C 1.538 1.51 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.674 168.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.54 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 3.8 p-10 -58.32 -72.78 0.09 Allowed 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 123.448 0.699 . . . . 0.0 109.989 171.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' A' ' 110' ' ' LEU . 1.1 mp -46.2 -37.88 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.827 0.851 . . . . 0.0 110.313 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.629 ' O ' ' HB3' ' A' ' 10' ' ' LEU . 29.4 tt0 -61.57 -18.89 61.22 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.681 0.753 . . . . 0.0 111.704 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.626 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -136.77 16.85 3.08 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.824 -0.548 . . . . 0.0 111.796 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 115' ' ' ALA . 5.7 mp -151.03 -24.39 0.21 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -167.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.435 ' HB2' HG23 ' A' ' 113' ' ' ILE . 54.4 tt0 -43.53 -52.32 6.26 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.41 0.443 . . . . 0.0 112.121 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.815 ' HA2' ' HE3' ' A' ' 121' ' ' LYS . . . -75.76 -17.36 80.13 Favored Glycine 0 CA--C 1.512 -0.155 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.489 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.799 HG13 ' HB3' ' A' ' 125' ' ' ARG . 65.8 t -74.92 -54.62 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 117.202 0.501 . . . . 0.0 111.397 -169.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.666 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 16.9 m -44.77 -15.0 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 O-C-N 125.231 1.582 . . . . 0.0 114.621 -175.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.815 ' HE3' ' HA2' ' A' ' 118' ' ' GLY . 20.0 pttp -127.96 -4.7 5.68 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.71 -162.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.518 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 27.6 m-85 -86.7 133.98 38.57 Favored Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.109 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.64 -22.92 37.99 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 122.034 1.823 . . . . 0.0 111.55 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.68 -2.99 43.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.226 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.799 ' HB3' HG13 ' A' ' 119' ' ' VAL . 66.1 mtt85 -129.34 16.58 6.04 Favored 'General case' 0 C--O 1.213 -0.83 0 O-C-N 121.831 -0.543 . . . . 0.0 109.556 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.2 tt -87.36 -31.23 5.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.623 -171.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -78.38 -20.76 50.56 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.798 ' HB3' HG13 ' A' ' 68' ' ' ILE . 77.5 m -82.91 -18.5 39.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.286 176.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -84.99 -32.8 22.77 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.998 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 134' ' ' LYS . 16.9 p -74.9 -43.58 53.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.657 ' HA ' ' HG2' ' A' ' 36' ' ' MET . 4.6 pp -58.45 -34.88 71.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.481 ' HB3' HD21 ' A' ' 116' ' ' LEU . 49.1 m -69.95 -55.03 10.72 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.447 0.467 . . . . 0.0 111.853 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.662 ' HA ' ' OE1' ' A' ' 137' ' ' GLU . 25.6 m0 -55.56 -38.64 69.59 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.695 1.236 . . . . 0.0 111.194 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' A' ' 138' ' ' LYS . 50.0 mtpt -70.35 -42.41 71.89 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.605 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.578 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -58.4 -61.95 2.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.012 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.525 HD13 ' CG ' ' A' ' 76' ' ' MET . 72.6 mt -87.21 -43.59 12.1 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.054 -169.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.662 ' OE1' ' HA ' ' A' ' 133' ' ' TRP . 3.0 mp0 -84.8 -39.89 17.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -173.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.661 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 7.8 tmtm? -88.68 12.22 15.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.395 1.093 . . . . 0.0 109.051 176.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 1.025 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -88.13 -24.46 34.51 Favored Glycine 0 C--O 1.221 -0.658 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.114 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.523 HG21 ' HB1' ' A' ' 88' ' ' ALA . 29.6 m -114.23 -0.98 9.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.899 -0.65 . . . . 0.0 110.438 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 86.7 110.91 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.935 1.397 . . . . 0.0 108.403 -173.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -68.69 136.86 53.56 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.207 -169.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.779 ' HG3' ' H ' ' A' ' 144' ' ' GLU . 13.7 pt-20 41.01 -89.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 125.261 1.6 . . . . 0.0 113.58 176.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.779 ' H ' ' HG3' ' A' ' 143' ' ' GLU . 6.2 mm-40 . . . . . 0 N--CA 1.45 -0.453 0 CA-C-N 118.401 0.546 . . . . 0.0 109.836 172.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 55.8 t30 . . . . . 0 C--O 1.24 0.588 0 CA-C-O 120.113 0.006 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.612 HD12 ' HB2' ' A' ' 10' ' ' LEU . 29.9 tp -126.57 -13.5 5.95 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.375 0.422 . . . . 0.0 110.154 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.69 -58.26 9.35 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.155 0.502 . . . . 0.0 111.427 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.3 m -55.14 -41.63 72.02 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.631 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.612 ' HB2' HD12 ' A' ' 7' ' ' LEU . 44.1 mt -55.56 -45.61 77.29 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.441 177.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.434 ' O ' HG22 ' A' ' 15' ' ' ILE . 15.7 m-85 -59.56 -46.37 89.11 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.367 0.604 . . . . 0.0 109.473 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -57.38 -45.27 84.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.599 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -67.31 -32.29 73.17 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.101 0.25 . . . . 0.0 110.682 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.654 HG13 ' HB2' ' A' ' 75' ' ' MET . 72.9 t -80.43 -47.99 20.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.833 -175.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 11' ' ' TYR . 18.2 tt -69.58 -25.53 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.2 ttt -78.29 -45.97 21.39 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.126 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.98 -42.77 76.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.489 0.662 . . . . 0.0 110.09 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.479 ' CG ' ' HB3' ' A' ' 74' ' ' SER . 85.9 t60 -66.95 -29.19 68.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.465 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -64.33 -45.48 87.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.941 -0.475 . . . . 0.0 110.615 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -47.52 -33.15 5.99 Favored 'General case' 0 C--O 1.247 0.937 0 O-C-N 124.197 0.936 . . . . 0.0 111.202 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -87.05 155.85 55.03 Favored Pre-proline 0 C--O 1.22 -0.492 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.146 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.24 -68.16 0.11 Allowed 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 123.606 2.871 . . . . 0.0 113.825 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.621 ' HG2' ' H ' ' A' ' 24' ' ' ASN . 25.0 ttm-85 176.61 -167.29 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.621 ' H ' ' HG2' ' A' ' 23' ' ' ARG . 18.6 p-10 -144.52 8.54 1.35 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.148 -0.345 . . . . 0.0 110.725 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 61' ' ' PHE . 60.6 tttp -99.91 115.32 29.37 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.633 0.73 . . . . 0.0 111.212 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.829 ' HA3' ' HE2' ' A' ' 60' ' ' LYS . . . -172.25 -177.83 42.03 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.48 HG23 HG21 ' A' ' 48' ' ' THR . 7.4 p -166.33 125.61 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 118.119 0.959 . . . . 0.0 110.655 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.748 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -143.69 143.62 31.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.594 0.711 . . . . 0.0 110.78 176.162 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -98.38 81.06 2.7 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.583 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 6.2 t70 -117.58 -123.02 0.29 Allowed 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.24 -173.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.448 ' OG ' ' HA ' ' A' ' 50' ' ' LYS . 17.7 m -51.88 -72.45 0.05 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.248 0.547 . . . . 0.0 111.878 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.691 HG13 ' HB2' ' A' ' 49' ' ' MET . 22.3 pt -130.23 140.89 47.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.42 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.827 HG13 HG22 ' A' ' 48' ' ' THR . 57.4 t -124.66 108.66 20.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 110.837 -0.06 . . . . 0.0 110.837 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.754 ' HB ' ' HB3' ' A' ' 47' ' ' LEU . 55.6 t -87.7 122.92 39.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 O-C-N 124.331 1.019 . . . . 0.0 110.993 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.83 108.02 16.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.995 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.47 ' HB2' ' HB2' ' A' ' 135' ' ' ALA . 20.3 mmt -136.47 119.11 16.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 6.2 p30 -129.03 138.67 52.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.043 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -115.18 95.24 41.75 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.7 -12.77 26.56 Favored 'Trans proline' 0 CA--C 1.512 -0.576 0 C-N-CA 123.222 2.615 . . . . 0.0 112.756 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.5 m -94.12 -53.99 3.75 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.153 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.481 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 52.9 t -129.46 15.06 6.06 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -167.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.867 ' HA3' HD22 ' A' ' 131' ' ' LEU . . . -154.76 2.98 0.22 Allowed Glycine 0 N--CA 1.462 0.427 0 C-N-CA 118.003 -2.046 . . . . 0.0 114.882 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.708 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 10.3 t70 54.99 -101.41 0.13 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.878 0.871 . . . . 0.0 111.077 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 18.7 ptp180 -155.77 150.63 26.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.769 0.713 . . . . 0.0 112.133 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.597 HG13 ' CD1' ' A' ' 61' ' ' PHE . 8.6 tt -133.97 125.06 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 45.6 mtp180 -118.82 104.04 10.19 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 111.107 -176.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.754 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 20.1 tp -88.22 95.68 10.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.26 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.827 HG22 HG13 ' A' ' 33' ' ' VAL . 61.7 p -88.8 110.16 20.79 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.691 ' HB2' HG13 ' A' ' 32' ' ' ILE . 15.0 mtt -107.77 -179.98 4.06 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.136 0.493 . . . . 0.0 111.356 -171.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.583 ' HG3' ' OD2' ' A' ' 30' ' ' ASP . 50.5 tttp -153.58 101.35 2.48 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.606 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 1.4 pt? -124.15 93.48 3.93 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -92.21 60.27 3.67 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.644 -170.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 146.51 -98.43 0.2 Allowed Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 174.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -132.27 20.17 4.41 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.948 0.404 . . . . 0.0 110.415 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -129.0 152.13 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.81 119.54 49.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -105.49 -29.29 10.29 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.931 0.872 . . . . 0.0 108.824 -167.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.662 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 1.4 t70 -144.11 153.8 42.52 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.424 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.594 ' HB2' ' HG2' ' A' ' 49' ' ' MET . . . -164.26 118.72 1.45 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.829 ' HE2' ' HA3' ' A' ' 26' ' ' GLY . 38.8 mtpt -125.71 99.68 6.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.069 0.938 . . . . 0.0 111.527 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.597 ' CD1' HG13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -70.7 139.06 51.09 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.815 176.396 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 15.4 tt0 -143.79 126.29 15.88 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.979 0.895 . . . . 0.0 109.009 169.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.05 -175.02 45.73 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.835 -172.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.708 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -143.88 163.0 34.65 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 -179.381 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.38 -133.47 4.9 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 119.203 -1.475 . . . . 0.0 113.019 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 94.1 m -85.73 163.96 17.9 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.308 0.575 . . . . 0.0 112.305 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 t -75.17 -26.55 59.17 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.211 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.887 HG13 HG21 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -77.2 -33.51 20.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.256 177.464 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.4 m -69.12 -48.6 62.04 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.993 0.901 . . . . 0.0 108.934 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 52.2 ttp -56.14 -34.27 65.96 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.619 170.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.75 -39.16 67.07 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.479 0.487 . . . . 0.0 111.565 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.833 ' HB2' HD11 ' A' ' 116' ' ' LEU . 12.7 t -58.99 -47.77 83.98 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -62.76 -49.26 75.72 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.538 177.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.479 ' HB3' ' CG ' ' A' ' 18' ' ' HIS . 68.3 m -51.64 -61.7 2.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.882 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.654 ' HB2' HG13 ' A' ' 14' ' ' VAL . 9.1 tpt -74.92 -46.92 32.55 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.575 -169.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.94 ' HG2' HD21 ' A' ' 136' ' ' LEU . 6.9 tpt -80.37 -28.09 38.06 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 88.1 m -68.79 -17.91 64.11 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.555 -1.341 . . . . 0.0 108.823 168.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 75' ' ' MET . 1.5 tt0 -80.59 -38.37 29.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.341 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.69 -45.82 9.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.998 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.5 OUTLIER -73.6 -32.24 35.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 123.326 0.65 . . . . 0.0 110.703 -170.087 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.662 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 60.3 tttm -53.71 -15.47 1.24 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.452 0.644 . . . . 0.0 110.93 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.65 32.37 5.89 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.596 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -129.46 -165.47 1.53 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -132.67 -172.1 2.83 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.728 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -74.98 -46.02 41.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.656 -175.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.76 -40.69 79.65 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.207 0.317 . . . . 0.0 111.393 -175.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.2 p -58.01 -36.5 72.77 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.457 0.646 . . . . 0.0 110.533 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.901 ' HB1' ' HB2' ' A' ' 141' ' ' ALA . . . -71.89 -49.15 40.46 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.022 0.529 . . . . 0.0 110.712 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 42.1 mt -55.01 -44.49 74.61 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.639 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.553 ' O ' HG12 ' A' ' 94' ' ' ILE . 38.3 p -68.61 -33.53 74.2 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.246 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.541 ' HA ' ' CG1' ' A' ' 94' ' ' ILE . 25.1 ttt -64.91 -16.65 63.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.383 0.611 . . . . 0.0 110.429 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.511 ' CB ' ' HG3' ' A' ' 143' ' ' GLU . 6.1 m -86.29 -40.25 15.69 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -66.3 -43.87 85.04 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.616 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 90' ' ' SER . 10.0 pt -71.45 -40.88 72.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.624 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 91' ' ' MET . 5.9 t80 -56.9 -29.77 63.32 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.32 174.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 t -80.8 -36.86 31.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -65.61 -42.03 92.04 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.139 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.616 ' HA ' ' H ' ' A' ' 103' ' ' GLU . 16.8 tpt -35.59 -50.45 0.61 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 123.827 0.705 . . . . 0.0 112.568 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 42.4 tpp -48.87 -19.56 0.39 Allowed 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -140.28 -29.84 0.69 Allowed 'General case' 0 C--O 1.242 0.673 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.23 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -99.79 -36.73 4.15 Favored Glycine 0 C--N 1.318 -0.472 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.647 -174.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 63.9 tttm 88.59 70.31 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.616 ' H ' ' HA ' ' A' ' 98' ' ' MET . 10.3 tp10 -153.8 133.88 13.25 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 113.335 -1.757 . . . . 0.0 107.226 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.538 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -124.48 -59.39 1.46 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.644 -168.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.768 ' HB3' HD12 ' A' ' 110' ' ' LEU . 14.7 t70 -144.58 97.2 2.99 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.456 ' H ' HD12 ' A' ' 94' ' ' ILE . 14.8 t70 -34.8 -31.45 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 174.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.9 m -95.94 2.78 53.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.77 -0.582 . . . . 0.0 111.301 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 108' ' ' ILE . 31.9 mm 69.53 24.97 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 122.667 1.222 . . . . 0.0 109.124 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -96.78 73.95 2.67 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.929 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.768 HD12 ' HB3' ' A' ' 105' ' ' ASP . 5.0 mp -98.01 10.84 39.38 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.995 -166.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -40.18 -38.22 1.26 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 115.645 1.018 . . . . 0.0 115.645 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.74 ' HB2' ' HB2' ' A' ' 76' ' ' MET . 18.4 t70 -80.88 -51.3 8.74 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.579 0.704 . . . . 0.0 110.42 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.646 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 53.4 mt -65.09 -24.14 34.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.823 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.536 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 47.3 mt-10 -67.91 -58.38 4.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.57 77.13 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.974 0.797 . . . . 0.0 112.479 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.833 HD11 ' HB2' ' A' ' 72' ' ' SER . 8.9 mp -94.65 -5.84 44.74 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.646 ' HB3' ' O ' ' A' ' 113' ' ' ILE . 13.0 pt20 -61.65 -28.31 69.3 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.79 0.805 . . . . 0.0 111.762 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.86 -16.46 65.41 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.536 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.887 HG21 HG13 ' A' ' 68' ' ' ILE . 24.1 t -86.8 -57.62 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 124.047 0.939 . . . . 0.0 111.003 -172.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 3.3 p -45.0 -14.59 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -176.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -128.6 0.53 5.53 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 118.481 -1.287 . . . . 0.0 112.045 -165.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.5 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 6.1 m-85 -90.13 130.61 41.58 Favored Pre-proline 0 N--CA 1.441 -0.883 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.43 -29.0 29.5 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.935 2.424 . . . . 0.0 112.241 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.86 -2.88 52.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.446 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 89.8 mtt180 -125.39 11.71 8.08 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.1 tt -80.33 -36.78 16.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.08 0.943 . . . . 0.0 109.029 -171.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -85.64 -18.03 34.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.167 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 3.7 t -79.87 -19.28 48.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.565 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -85.85 -33.19 21.36 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.57 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.763 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 26.2 p -77.28 -32.31 55.43 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 119.323 -0.951 . . . . 0.0 108.926 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.867 HD22 ' HA3' ' A' ' 42' ' ' GLY . 19.2 tp -47.31 -59.41 3.21 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.663 169.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.8 m -79.09 -61.06 2.13 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.675 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.555 ' HB2' HD23 ' A' ' 116' ' ' LEU . 2.6 t90 -63.12 -51.37 66.81 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.458 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.763 ' HB2' ' O ' ' A' ' 130' ' ' THR . 27.4 mmmt -61.67 -42.43 98.91 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 121.855 -0.528 . . . . 0.0 110.986 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 36' ' ' MET . . . -57.02 -36.74 70.8 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.307 174.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.94 HD21 ' HG2' ' A' ' 76' ' ' MET . 4.6 tp -79.55 -40.74 28.79 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.826 0.822 . . . . 0.0 110.114 -175.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 139' ' ' GLY . 39.4 tt0 -79.12 -53.01 7.42 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.283 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 134' ' ' LYS . 72.3 tttt -78.87 15.63 1.05 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.878 -169.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.551 ' O ' HD12 ' A' ' 32' ' ' ILE . . . -101.08 -26.61 7.77 Favored Glycine 0 N--CA 1.424 -2.148 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.921 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.29 -33.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 O-C-N 122.242 -0.563 . . . . 0.0 110.295 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.901 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . . . -102.19 119.16 38.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.39 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.634 ' H ' ' CD2' ' A' ' 89' ' ' LEU . 47.9 mtmt -146.55 113.09 5.96 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.731 0.301 . . . . 0.0 110.446 173.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.511 ' HG3' ' CB ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -57.11 69.89 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.221 0.534 . . . . 0.0 111.971 162.686 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 C--N 1.322 -0.624 0 CA-C-O 122.014 0.911 . . . . 0.0 110.12 176.862 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.3 t30 . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 122.467 1.127 . . . . 0.0 108.739 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.598 HD12 HD12 ' A' ' 10' ' ' LEU . 34.3 tp -118.38 -12.28 9.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.764 -175.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.54 ' HA ' ' HD2' ' A' ' 11' ' ' TYR . 2.2 m-20 -58.44 -58.62 7.7 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.108 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 p -56.45 -41.04 75.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.925 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.598 HD12 HD12 ' A' ' 7' ' ' LEU . 62.6 mt -55.42 -41.69 73.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.285 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.54 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 47.9 m-85 -57.16 -51.54 68.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.322 0.582 . . . . 0.0 109.92 173.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -56.65 -39.63 74.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.51 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.5 tp60 -74.09 -35.17 64.19 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.709 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 115' ' ' ALA . 75.6 t -70.02 -45.48 76.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.69 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 66.6 mt -67.52 -23.19 29.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.1 ttt -73.2 -53.71 10.26 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.898 -0.502 . . . . 0.0 110.294 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -69.59 -44.81 70.02 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.49 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -65.6 -20.69 66.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.157 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 82.8 t80 -62.94 -50.09 72.18 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 121.959 -0.463 . . . . 0.0 110.56 173.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -44.85 -29.75 0.86 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.897 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -122.4 82.23 46.4 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 120.885 0.374 . . . . 0.0 110.141 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.6 73.45 1.29 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.125 2.55 . . . . 0.0 113.064 -172.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.3 ttm105 -145.55 72.47 1.31 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.659 0.742 . . . . 0.0 110.168 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -105.53 64.29 0.7 Allowed 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.641 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 179.52 163.45 0.95 Allowed 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 144.82 153.53 5.89 Favored Glycine 0 C--O 1.218 -0.867 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.998 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.847 ' HB ' ' HB2' ' A' ' 62' ' ' GLU . 2.6 p -168.46 117.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.724 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -141.33 149.0 40.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.056 0.455 . . . . 0.0 111.152 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -107.55 104.81 14.45 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.31 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -149.75 -110.36 0.07 Allowed 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.468 0.48 . . . . 0.0 110.383 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.684 ' HB3' HD23 ' A' ' 51' ' ' LEU . 22.3 m -54.06 -74.0 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 124.79 1.306 . . . . 0.0 112.05 -171.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.712 HG13 ' HB3' ' A' ' 49' ' ' MET . 10.6 pt -134.82 136.71 51.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.779 0.8 . . . . 0.0 109.111 174.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.741 HG13 HG22 ' A' ' 48' ' ' THR . 33.8 t -117.69 105.23 17.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.842 0.829 . . . . 0.0 108.791 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.764 HG21 ' HA2' ' A' ' 139' ' ' GLY . 85.6 t -98.41 124.49 51.56 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.845 -171.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.789 ' HB3' ' HE ' ' A' ' 46' ' ' ARG . 5.4 p-10 -136.88 145.9 44.9 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.506 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.3 mmt -154.19 135.66 14.23 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.768 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.521 ' HB2' ' O ' ' A' ' 43' ' ' ASP . 22.6 p-10 -122.13 142.05 50.79 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.04 174.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.657 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 56.4 t30 -125.57 106.04 27.02 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 174.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 1.3 Cg_endo -42.85 133.02 5.7 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 125.123 3.882 . . . . 0.0 114.458 -167.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.0 m 77.12 -36.56 0.25 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.139 175.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.799 ' SG ' ' HB3' ' A' ' 127' ' ' LYS . 44.1 t -85.85 -78.61 0.27 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -171.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.613 ' HA3' HD13 ' A' ' 131' ' ' LEU . . . -102.6 11.48 56.47 Favored Glycine 0 CA--C 1.502 -0.761 0 C-N-CA 118.786 -1.673 . . . . 0.0 112.286 -166.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.58 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 18.3 t70 62.8 -90.9 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.423 0.719 . . . . 0.0 110.349 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -159.8 144.4 14.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 123.198 0.311 . . . . 0.0 110.466 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.42 133.92 59.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.789 ' HE ' ' HB3' ' A' ' 35' ' ' ASP . 28.8 ttm180 -134.41 109.4 8.74 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.594 HD11 ' HB1' ' A' ' 59' ' ' ALA . 11.8 tp -84.91 99.24 10.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.127 172.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.741 HG22 HG13 ' A' ' 33' ' ' VAL . 50.0 p -80.71 107.41 13.5 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 171.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.712 ' HB3' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -110.07 165.43 11.74 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -164.373 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 57' ' ' GLU . 8.5 tmtm? -156.33 97.21 1.75 Allowed 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.684 HD23 ' HB3' ' A' ' 31' ' ' SER . 2.6 pt? -118.85 93.82 4.23 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.62 59.26 1.76 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.373 1.082 . . . . 0.0 109.545 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 150.18 -99.44 0.19 Allowed Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.846 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.473 ' C ' HG12 ' A' ' 85' ' ' ILE . 2.0 t70 -134.91 24.25 3.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.442 0.639 . . . . 0.0 109.37 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.645 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.2 pp -137.31 156.07 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 C-N-CA 124.435 1.094 . . . . 0.0 108.47 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.496 HG11 ' O ' ' A' ' 80' ' ' ILE . 3.3 p -96.77 119.46 44.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.139 0.971 . . . . 0.0 108.551 168.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 50' ' ' LYS . 32.2 tt0 -98.03 -33.44 11.18 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.379 -171.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -146.22 147.55 31.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.483 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.594 ' HB1' HD11 ' A' ' 47' ' ' LEU . . . -155.82 123.09 5.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.488 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 46.8 mmtm -133.82 165.7 24.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.069 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.718 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 26.0 p90 -127.47 127.29 43.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.48 0.657 . . . . 0.0 111.612 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.847 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 8.8 tp10 -110.54 109.31 19.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.22 -178.62 48.59 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.518 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.58 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 15.1 mm-40 -142.29 168.5 19.58 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.3 -131.62 3.36 Favored Glycine 0 C--O 1.24 0.496 0 C-N-CA 119.588 -1.291 . . . . 0.0 112.93 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.8 m -78.34 178.88 7.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.6 m -93.18 -23.96 18.39 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -79.89 -38.74 19.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 113.831 -1.532 . . . . 0.0 110.614 175.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.4 p -65.41 -43.35 90.84 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.946 -0.471 . . . . 0.0 110.786 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.5 ptp -62.51 -29.17 70.35 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.852 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.57 -34.51 65.17 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.643 0.589 . . . . 0.0 111.642 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 m -62.25 -40.51 96.44 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.761 ' HA ' ' HG2' ' A' ' 76' ' ' MET . . . -64.95 -43.08 93.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.892 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.1 m -52.42 -49.0 65.4 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 122.324 0.249 . . . . 0.0 110.653 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.474 ' HA ' ' HG2' ' A' ' 78' ' ' GLN . 4.6 mmt -66.0 -47.5 74.29 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.988 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.761 ' HG2' ' HA ' ' A' ' 73' ' ' ALA . 19.7 ptt? -59.82 -41.41 91.23 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.962 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.4 p -60.18 -35.57 75.67 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.257 -0.902 . . . . 0.0 111.052 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.474 ' HG2' ' HA ' ' A' ' 75' ' ' MET . 20.4 pt20 -88.16 -41.37 13.04 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.926 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.66 -48.63 8.14 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 121.678 0.751 . . . . 0.0 111.425 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.598 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -71.47 -42.45 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.892 -174.604 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -61.7 -16.1 46.11 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.071 0.462 . . . . 0.0 111.273 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.12 43.61 1.65 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.322 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.589 ' HG3' ' HB ' ' A' ' 87' ' ' THR . 2.9 tppt? -134.42 170.45 15.73 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -105.66 175.61 5.44 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.668 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.5 mm -78.07 -35.86 20.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.173 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.12 -48.03 79.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.638 0.733 . . . . 0.0 109.557 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.589 ' HB ' ' HG3' ' A' ' 83' ' ' LYS . 1.4 m -66.2 -40.32 90.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.711 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.708 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -63.94 -41.7 97.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 73.5 mt -66.64 -31.01 71.42 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.8 m -70.22 -44.33 68.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.154 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.584 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 13.1 tpt -60.11 -29.92 68.92 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.444 0.698 . . . . 0.0 110.4 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.51 ' OG ' ' HA ' ' A' ' 142' ' ' LYS . 71.7 p -87.92 -37.86 16.08 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.968 -175.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.627 ' HG3' ' HG2' ' A' ' 143' ' ' GLU . 61.2 tttm -67.5 -44.68 77.87 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.331 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 105' ' ' ASP . 71.8 mt -63.79 -44.75 98.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.306 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 91' ' ' MET . 0.7 OUTLIER -53.34 -32.61 49.96 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.543 174.676 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.6 m -83.21 -40.34 19.77 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.8 0.333 . . . . 0.0 111.187 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -71.22 -37.57 72.04 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.799 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.1 ttt -45.28 -51.48 10.84 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.439 0.695 . . . . 0.0 112.308 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 46.5 ttp -61.03 -8.74 3.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -123.96 -31.82 3.34 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.908 -0.495 . . . . 0.0 110.841 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -89.51 -25.58 27.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.769 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 23.9 tptm 84.87 -31.35 0.06 Allowed 'General case' 0 N--CA 1.478 0.97 0 O-C-N 125.044 1.085 . . . . 0.0 109.119 175.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.22 178.45 6.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.411 ' CG ' HD21 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -144.76 -108.84 0.11 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.112 0.482 . . . . 0.0 111.714 -173.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.436 ' HB2' HD13 ' A' ' 94' ' ' ILE . 20.2 t70 -109.16 107.9 18.35 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -175.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.08 3.89 0.38 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.616 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.562 ' O ' HG22 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -99.09 -18.95 17.46 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 107' ' ' SER . 6.6 tp 66.91 24.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.446 168.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.22 87.34 6.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 172.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 114' ' ' GLU . 1.1 mp -114.21 21.53 14.64 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.306 0.379 . . . . 0.0 111.546 -168.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -51.6 -54.52 24.26 Favored Glycine 0 C--O 1.242 0.656 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.247 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.584 ' HB2' ' HE2' ' A' ' 91' ' ' MET . 6.7 m-20 -58.04 -24.14 57.18 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.863 0.865 . . . . 0.0 111.998 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 76.3 mt -100.69 -25.09 3.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -174.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 33.7 tt0 -75.36 -54.41 7.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.53 -1.213 . . . . 0.0 111.762 -163.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.517 ' O ' HD11 ' A' ' 7' ' ' LEU . . . -49.23 -24.76 1.9 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.81 0.694 . . . . 0.0 110.818 170.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.6 mp -102.89 -3.18 26.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.472 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.429 ' HB2' ' HA ' ' A' ' 114' ' ' GLU . 45.4 tt0 -54.48 -37.19 64.98 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.187 0.595 . . . . 0.0 110.686 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.82 -18.16 66.2 Favored Glycine 0 C--O 1.216 -0.986 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.557 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.803 HG12 ' HB2' ' A' ' 129' ' ' ALA . 48.4 t -84.11 -44.71 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 O-C-N 122.283 -0.539 . . . . 0.0 112.164 -174.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.5 p -45.93 -25.56 0.56 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.318 0.647 . . . . 0.0 110.247 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.586 ' HB2' ' NZ ' ' A' ' 121' ' ' LYS . 3.6 ttmp? -131.71 96.51 3.97 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.996 ' H ' ' HB3' ' A' ' 125' ' ' ARG . 0.1 OUTLIER -152.34 157.06 33.91 Favored Pre-proline 0 N--CA 1.448 -0.561 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -172.558 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.454 ' HD2' ' CG ' ' A' ' 122' ' ' PHE . 10.8 Cg_endo -59.24 -22.85 66.95 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.705 1.603 . . . . 0.0 111.221 172.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.28 18.42 17.85 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.294 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.996 ' HB3' ' H ' ' A' ' 122' ' ' PHE . 25.6 ptt-85 -52.44 -44.5 65.52 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 124.105 0.878 . . . . 0.0 112.202 -165.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.431 ' N ' ' HG3' ' A' ' 125' ' ' ARG . 11.6 tt -85.24 -20.59 8.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -160.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.799 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 38.5 mmtm -75.97 -50.14 15.75 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.435 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.873 ' HB3' HD12 ' A' ' 68' ' ' ILE . 80.0 m -86.54 -29.11 22.92 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.256 -173.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.803 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -87.59 -29.8 20.98 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.033 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 63.8 m -84.5 -41.93 16.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.613 HD13 ' HA3' ' A' ' 42' ' ' GLY . 8.4 tt -51.82 -39.41 58.7 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.942 0.401 . . . . 0.0 110.612 173.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.9 m -84.05 -42.45 16.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.697 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.459 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 2.3 t90 -53.02 -50.48 64.15 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.114 0.566 . . . . 0.0 109.816 174.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 68.2 mmtt -60.08 -42.59 94.9 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 124.68 1.238 . . . . 0.0 110.407 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.2 -41.96 63.12 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.455 0.472 . . . . 0.0 112.102 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 76' ' ' MET . 4.4 mm? -83.06 -38.45 22.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.534 0.683 . . . . 0.0 110.894 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.718 ' HG3' ' HB3' ' A' ' 142' ' ' LYS . 26.4 tt0 -68.69 -41.87 78.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.37 -177.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.508 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 9.3 mtpt -93.31 -0.75 56.58 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.063 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.764 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -79.99 -27.71 52.3 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.903 HG23 ' H ' ' A' ' 141' ' ' ALA . 16.9 m -129.89 -94.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 113.184 -1.508 . . . . 0.0 108.089 170.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.903 ' H ' HG23 ' A' ' 140' ' ' VAL . . . -166.86 153.48 8.61 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.563 0.745 . . . . 0.0 109.017 166.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.718 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 21.2 pttm -87.45 119.05 27.34 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.242 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.627 ' HG2' ' HG3' ' A' ' 93' ' ' LYS . 29.6 mt-10 68.02 -78.57 0.04 OUTLIER 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.259 0.624 . . . . 0.0 110.77 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 . . . . . 0 C--N 1.308 -1.198 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.334 179.643 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.475 ' HB3' ' HD2' ' A' ' 3' ' ' PHE . 24.2 mmt . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.754 0.311 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 m -88.06 61.17 6.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.044 0.449 . . . . 0.0 111.17 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.475 ' HD2' ' HB3' ' A' ' 1' ' ' MET . 98.3 m-85 -136.5 173.94 11.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.656 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 6' ' ' ASN . 2.6 m-20 -77.58 -28.08 51.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.394 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.86 -22.88 0.16 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.903 0.752 . . . . 0.0 112.127 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 4' ' ' ASN . 55.2 t30 -60.26 82.28 0.01 OUTLIER 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.599 0.562 . . . . 0.0 111.54 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.694 HD11 ' O ' ' A' ' 115' ' ' ALA . 22.7 tp 177.32 -39.09 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 175.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.693 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.4 t70 -49.31 -63.03 1.22 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.505 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 p -59.58 -37.76 79.35 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.003 0.43 . . . . 0.0 112.043 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 mp -56.25 -50.58 70.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.898 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.778 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 5.8 p90 -85.59 -18.72 32.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.115 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 16' ' ' MET . 19.1 tpp180 -63.82 -51.99 62.21 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -63.89 -27.5 69.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.37 0.605 . . . . 0.0 109.453 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.778 ' HB ' ' HA ' ' A' ' 11' ' ' TYR . 2.1 t -70.56 -51.7 35.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.891 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 tt -72.19 -23.12 21.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -82.01 -42.68 18.99 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.261 0.351 . . . . 0.0 111.28 -178.178 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.529 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 20.9 t70 -69.11 -33.41 73.44 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.185 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.637 ' CE1' ' HB2' ' A' ' 74' ' ' SER . 86.2 t60 -74.4 -19.72 60.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.005 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -66.45 -40.63 89.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.529 ' HE3' ' HA ' ' A' ' 17' ' ' ASP . 70.9 mttt -49.98 -34.67 21.73 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.488 169.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.688 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 10.8 m120 -82.03 -179.6 1.54 Allowed Pre-proline 0 N--CA 1.465 0.298 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.688 ' HD2' ' HB3' ' A' ' 21' ' ' ASN . 11.1 Cg_endo -58.29 164.55 8.59 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.654 1.569 . . . . 0.0 111.215 164.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -85.83 -140.18 0.08 Allowed 'General case' 0 C--N 1.31 -1.137 0 O-C-N 122.038 -0.414 . . . . 0.0 111.072 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -116.91 52.46 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.981 0.419 . . . . 0.0 110.322 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.729 ' HD3' ' HG2' ' A' ' 62' ' ' GLU . 41.8 mmtm -144.03 83.68 1.75 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.587 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.28 137.14 5.23 Favored Glycine 0 C--O 1.228 -0.259 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.497 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 3.0 m -155.56 135.76 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.96 0.409 . . . . 0.0 110.171 -175.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.606 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -144.09 170.28 16.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.363 0.602 . . . . 0.0 111.013 173.254 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -135.14 41.31 2.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.67 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.471 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 25.0 t70 -84.85 -9.73 57.85 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.88 0.371 . . . . 0.0 110.535 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.6 m -153.39 -85.45 0.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.301 0.572 . . . . 0.0 110.181 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.522 HD11 HD21 ' A' ' 51' ' ' LEU . 16.2 pt -127.66 141.77 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.783 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.929 HG13 HG22 ' A' ' 48' ' ' THR . 58.6 t -121.02 107.11 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.507 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.655 HG21 ' HA2' ' A' ' 139' ' ' GLY . 97.0 t -101.45 124.52 55.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 O-C-N 123.577 0.548 . . . . 0.0 110.413 -176.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -126.77 137.65 53.25 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.9 tpt -148.43 126.19 11.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 17.0 p30 -129.03 146.98 50.86 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.988 0.805 . . . . 0.0 111.368 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.974 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 20.2 t-20 -108.23 98.24 25.94 Favored Pre-proline 0 C--O 1.248 0.988 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.2 -23.73 70.78 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 123.623 2.882 . . . . 0.0 112.353 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.6 m -62.2 -31.87 72.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.085 0.865 . . . . 0.0 111.79 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 81.2 m -113.31 -51.58 2.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.47 -6.75 10.6 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 118.995 -1.574 . . . . 0.0 110.131 -156.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.974 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 24.4 m-20 -60.02 121.58 12.2 Favored 'General case' 0 C--O 1.213 -0.856 0 C-N-CA 123.742 0.817 . . . . 0.0 109.665 173.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 30.3 ttp180 -150.2 136.75 19.02 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 121.524 -0.735 . . . . 0.0 110.536 172.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 132' ' ' SER . 26.2 pt -138.75 145.02 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 81.0 mtm180 -125.86 105.21 8.78 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.509 0.671 . . . . 0.0 110.936 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.409 HD12 ' HA3' ' A' ' 139' ' ' GLY . 1.3 tm? -89.7 98.49 11.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.918 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.929 HG22 HG13 ' A' ' 33' ' ' VAL . 71.7 p -100.48 120.16 39.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 35.7 mtt -111.2 -179.87 3.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.769 0.795 . . . . 0.0 112.591 -173.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 60.7 tttm -149.53 93.68 2.09 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.522 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -124.23 101.98 7.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.62 -174.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -91.75 57.19 3.15 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.381 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.61 -99.55 0.22 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.441 ' C ' HD13 ' A' ' 85' ' ' ILE . 11.6 m-20 -131.2 25.9 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.675 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.493 HD13 ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -132.52 143.72 38.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.22 114.64 30.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -100.09 -24.9 14.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -169.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 11.6 t70 -153.21 155.5 36.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.693 171.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.637 ' H ' ' HE2' ' A' ' 81' ' ' LYS . . . -157.24 117.52 3.5 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -114.43 138.59 50.39 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 123.195 0.309 . . . . 0.0 110.219 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 5.4 p90 -129.5 137.88 51.06 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -169.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.729 ' HG2' ' HD3' ' A' ' 25' ' ' LYS . 3.6 tm-20 -120.04 135.04 55.08 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.86 138.57 7.0 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.202 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -150.93 142.44 23.51 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 43' ' ' ASP . . . 146.49 -134.75 5.46 Favored Glycine 0 CA--C 1.508 -0.386 0 C-N-CA 118.811 -1.661 . . . . 0.0 111.54 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 64.0 m -75.15 153.96 37.96 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 p -66.5 -27.12 67.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.892 0.377 . . . . 0.0 110.752 -170.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.695 HD13 HG21 ' A' ' 119' ' ' VAL . 2.7 pp -82.19 -32.1 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 121.568 0.699 . . . . 0.0 111.648 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.596 ' N ' HD12 ' A' ' 68' ' ' ILE . 6.7 m -73.17 -52.95 12.23 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.3 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.5 ptm -65.83 -17.82 64.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.979 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.57 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -86.67 -46.75 9.76 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.671 0.272 . . . . 0.0 111.633 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.2 p -69.88 -42.17 73.8 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.246 0.545 . . . . 0.0 110.304 -172.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.17 -56.05 26.27 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.204 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.637 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 60.4 p -63.88 -30.05 71.18 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.599 ' HG3' HG22 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -75.09 -53.0 9.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.028 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.582 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 11.9 tpt -70.04 -22.3 63.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.984 -177.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 8.5 p -72.93 -40.47 65.41 Favored 'General case' 0 C--O 1.212 -0.902 0 O-C-N 121.654 -0.654 . . . . 0.0 110.406 174.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -57.28 -31.14 65.3 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.41 172.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.86 -34.47 19.45 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.858 0.837 . . . . 0.0 110.25 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.582 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.5 OUTLIER -75.19 -32.25 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.685 -177.259 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.637 ' HE2' ' H ' ' A' ' 59' ' ' ALA . 46.2 tttm -49.88 -18.31 0.49 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.887 1.275 . . . . 0.0 111.838 175.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.1 46.99 1.05 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.431 ' HB2' HD13 ' A' ' 80' ' ' ILE . 42.8 mmtm -132.64 -175.69 3.85 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -118.09 -178.42 3.5 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 172.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.701 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -72.85 -44.16 58.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.143 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.87 -42.55 99.8 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.082 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 m -61.64 -45.47 93.93 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.565 0.698 . . . . 0.0 111.499 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -70.54 -32.46 69.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.529 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 83.1 mt -63.01 -35.73 81.2 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.166 0.984 . . . . 0.0 108.501 172.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.7 m -70.65 -33.91 71.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.489 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -63.65 -26.04 68.49 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.163 0.506 . . . . 0.0 110.926 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.519 ' HB3' ' HB1' ' A' ' 141' ' ' ALA . 0.9 OUTLIER -89.63 -34.35 16.33 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -178.177 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 143' ' ' GLU . 14.0 tmtt? -68.38 -37.22 80.2 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 105' ' ' ASP . 21.8 mt -66.18 -46.47 87.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 123.558 0.743 . . . . 0.0 109.74 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.434 ' HD2' HG12 ' A' ' 113' ' ' ILE . 27.6 t80 -53.25 -30.18 36.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.697 0.76 . . . . 0.0 111.451 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.3 t -85.28 -39.03 18.18 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.626 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.95 -28.52 63.5 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.825 0.85 . . . . 0.0 111.672 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.64 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -57.8 -58.03 10.15 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.246 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.5 ' HA ' ' HE3' ' A' ' 99' ' ' MET . 3.4 mmt -64.7 -7.09 9.41 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -174.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -116.52 -35.94 4.11 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.375 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -94.69 -24.18 18.75 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.08 -173.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 23.7 ttmm 85.71 -21.87 0.2 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.046 0.927 . . . . 0.0 110.484 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 98' ' ' MET . 44.8 mt-10 -92.02 167.83 11.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.545 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 1.4 p90 -137.27 -110.75 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.02 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.848 ' HB3' HD11 ' A' ' 110' ' ' LEU . 13.9 t70 -93.93 110.54 22.21 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.498 0.666 . . . . 0.0 110.186 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -46.72 -11.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.527 -1.67 . . . . 0.0 113.027 172.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.2 m -105.2 -15.37 15.08 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 121.678 -0.639 . . . . 0.0 110.495 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.499 ' O ' HG22 ' A' ' 108' ' ' ILE . 24.6 mm 70.77 19.15 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 124.049 0.843 . . . . 0.0 111.483 174.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -97.94 93.67 6.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.848 HD11 ' HB3' ' A' ' 105' ' ' ASP . 9.0 mp -124.07 31.82 5.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.249 -164.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -36.76 -43.75 0.85 Allowed Glycine 0 CA--C 1.534 1.219 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 6.9 p-10 -86.81 -44.73 11.51 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 117.657 0.728 . . . . 0.0 110.95 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.537 HD12 ' HG ' ' A' ' 110' ' ' LEU . 55.3 mt -62.74 -38.16 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.503 0.668 . . . . 0.0 110.58 -174.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.553 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 39.8 mt-10 -63.51 -53.69 48.07 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.028 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.694 ' O ' HD11 ' A' ' 7' ' ' LEU . . . -68.55 -37.73 80.2 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 124.527 1.142 . . . . 0.0 114.028 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.734 HD12 HG21 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -92.0 -11.3 36.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -173.102 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 114' ' ' GLU . 4.7 pp0? -60.32 -31.37 70.22 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.267 -0.895 . . . . 0.0 110.733 177.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.487 ' HA3' HD13 ' A' ' 7' ' ' LEU . . . -84.47 -18.1 62.87 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.461 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 125' ' ' ARG . 72.9 t -86.69 -55.66 6.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.396 0.617 . . . . 0.0 110.368 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.766 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 23.5 t -41.22 -14.69 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.068 -1.878 . . . . 0.0 115.391 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -131.56 7.6 4.51 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -163.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -103.01 136.39 19.24 Favored Pre-proline 0 CA--C 1.507 -0.71 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.83 -22.18 28.75 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.785 2.323 . . . . 0.0 111.621 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.53 -8.0 33.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.467 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.766 ' HB3' HG13 ' A' ' 119' ' ' VAL . 84.1 mtt180 -126.03 5.33 7.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 O-C-N 121.714 -0.616 . . . . 0.0 110.363 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 tt -84.53 -33.03 8.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.148 0.975 . . . . 0.0 108.954 -168.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.474 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 75.9 mmtt -72.72 -24.45 60.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.027 174.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 131' ' ' LEU . 71.2 m -84.92 -17.76 36.77 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.582 0.706 . . . . 0.0 110.249 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.766 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -82.29 -21.54 36.11 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 65.5 m -83.63 -40.19 19.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.627 HD22 ' HB3' ' A' ' 43' ' ' ASP . 2.0 tp -50.51 -63.07 1.24 Allowed 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 113.459 -1.7 . . . . 0.0 111.185 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.609 ' HB2' HD21 ' A' ' 116' ' ' LEU . 20.5 m -76.44 -63.17 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -172.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.462 ' HB2' HD23 ' A' ' 116' ' ' LEU . 66.4 t90 -66.16 -49.84 66.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.145 -173.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 130' ' ' THR . 51.6 tttm -62.67 -35.69 80.48 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.134 -176.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.92 93.6 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.838 170.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.0 tp -66.46 -35.17 79.62 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 1.029 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 30.3 tt0 -69.04 -35.48 76.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.672 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -79.91 6.28 11.62 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 122.003 0.906 . . . . 0.0 110.023 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.655 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -103.71 -36.94 3.11 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.697 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.521 HG23 HG13 ' A' ' 85' ' ' ILE . 11.0 p -172.67 41.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.156 0.979 . . . . 0.0 109.698 -176.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 1.029 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . . . -148.9 167.62 25.23 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.876 -172.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 143' ' ' GLU . 37.4 ttmt -171.02 -10.46 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.547 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 27.1 tt0 71.19 -67.29 0.26 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.887 0.742 . . . . 0.0 110.698 -175.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -105.49 141.72 36.48 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.524 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.37 -32.86 78.6 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.576 172.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.36 55.44 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 . . . . . 0 C--O 1.239 0.528 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.339 -172.518 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 111.56 0.208 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m 66.97 -76.61 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 177.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -78.1 97.86 5.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 122.031 -0.418 . . . . 0.0 111.036 -173.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.483 HD22 ' N ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -179.15 18.78 0.0 OUTLIER 'General case' 0 C--N 1.347 0.474 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.015 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 4' ' ' ASN . . . 82.93 -176.2 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.9 0.88 . . . . 0.0 109.721 -175.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -174.13 -88.5 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -175.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.1 tp -143.99 -25.76 0.54 Allowed 'General case' 0 C--O 1.212 -0.899 0 C-N-CA 122.43 0.292 . . . . 0.0 111.687 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.444 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 14.6 t70 -49.17 -59.79 3.35 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.23 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -45.6 89.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.188 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 14' ' ' VAL . 74.7 mt -54.19 -51.67 63.64 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.481 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.444 ' CE1' ' HA ' ' A' ' 8' ' ' ASP . 2.2 p90 -85.14 -18.24 34.8 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.368 -175.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -60.52 -40.75 92.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.997 0.427 . . . . 0.0 110.128 169.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.514 ' HG3' ' HE1' ' A' ' 16' ' ' MET . 60.8 tt0 -73.1 -24.66 60.67 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.714 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 10' ' ' LEU . 90.0 t -73.17 -34.93 46.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.331 175.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.4 mt -73.9 -32.34 33.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.635 172.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.514 ' HE1' ' HG3' ' A' ' 13' ' ' GLN . 56.2 ttp -68.77 -46.27 69.2 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.899 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -38.2 89.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.702 -177.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.423 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -83.0 -14.24 54.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.185 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -69.09 -50.06 51.61 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.479 -1.388 . . . . 0.0 109.04 167.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -52.58 -37.39 57.92 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.391 0.676 . . . . 0.0 110.511 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -119.86 84.68 32.44 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.93 39.21 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.99 3.127 . . . . 0.0 114.408 -163.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -85.69 57.82 4.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.799 0.809 . . . . 0.0 110.868 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 18' ' ' HIS . 4.6 m-20 -102.03 19.63 18.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.925 0.869 . . . . 0.0 109.496 172.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -136.99 143.96 43.05 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.002 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.79 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 157.96 139.74 2.77 Favored Glycine 0 C--O 1.21 -1.351 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.792 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.598 HG23 HG21 ' A' ' 48' ' ' THR . 4.0 p -167.18 120.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.465 0.65 . . . . 0.0 109.347 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.744 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -138.97 154.07 48.25 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.51 0.671 . . . . 0.0 110.533 175.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -102.2 79.64 1.88 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.841 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.47 ' OD1' ' HG3' ' A' ' 50' ' ' LYS . 6.5 t70 -115.8 -130.61 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.478 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 m -52.08 -71.71 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.976 0.798 . . . . 0.0 111.746 -172.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.743 HD11 HD21 ' A' ' 51' ' ' LEU . 10.4 pt -132.59 140.36 47.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.458 0.647 . . . . 0.0 110.978 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.679 HG13 HG22 ' A' ' 48' ' ' THR . 44.5 t -120.48 107.7 21.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.078 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.061 HG21 ' HA2' ' A' ' 139' ' ' GLY . 89.9 t -101.11 128.27 53.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.104 -172.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 1.5 p-10 -132.06 149.0 52.53 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.812 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.537 ' HA ' ' CE ' ' A' ' 36' ' ' MET . 3.5 mmt -143.08 122.77 13.33 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.341 1.026 . . . . 0.0 110.22 176.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.698 ' HB3' ' HB3' ' A' ' 44' ' ' ARG . 3.7 p-10 -118.44 134.2 55.26 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.131 0.894 . . . . 0.0 110.768 -176.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.44 ' N ' HD12 ' A' ' 131' ' ' LEU . 22.4 t30 -156.84 138.87 10.18 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -45.28 -35.61 11.56 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 124.447 3.431 . . . . 0.0 113.807 -178.367 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.576 HG21 ' O ' ' A' ' 124' ' ' ALA . 3.2 m -74.91 23.76 0.1 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 122.148 0.975 . . . . 0.0 111.427 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.637 ' SG ' HD13 ' A' ' 131' ' ' LEU . 72.3 m -136.22 -52.73 0.73 Allowed 'General case' 0 C--N 1.312 -1.06 0 O-C-N 121.463 -0.773 . . . . 0.0 110.335 167.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.29 -29.11 2.31 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 24.9 t0 -157.28 -88.45 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.82 0 CA-C-N 114.621 -0.79 . . . . 0.0 111.258 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.698 ' HB3' ' HB3' ' A' ' 37' ' ' ASN . 7.7 ptp85 179.63 -179.35 0.43 Allowed 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.036 0.446 . . . . 0.0 110.897 -169.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.661 HG22 ' HE1' ' A' ' 61' ' ' PHE . 19.5 pt -137.65 139.61 42.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.821 177.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.528 ' HD3' ' HD3' ' A' ' 44' ' ' ARG . 37.2 mmm-85 -114.03 100.69 8.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.494 0.664 . . . . 0.0 110.342 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.927 HD22 ' HG3' ' A' ' 49' ' ' MET . 0.8 OUTLIER -82.86 92.44 7.28 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.744 ' HB ' HD12 ' A' ' 28' ' ' LEU . 68.3 p -84.0 111.97 19.76 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.927 ' HG3' HD22 ' A' ' 47' ' ' LEU . 22.9 mtt -107.21 178.25 4.61 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.826 0.822 . . . . 0.0 111.298 -170.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 62.8 tttp -160.79 95.82 1.1 Allowed 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.743 HD21 HD11 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -119.56 84.52 2.22 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.852 -177.66 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.89 59.35 4.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.511 -164.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.92 -99.48 0.2 Allowed Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.804 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.428 ' C ' HG12 ' A' ' 85' ' ' ILE . 11.6 p-10 -133.37 24.47 4.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.466 0.65 . . . . 0.0 109.795 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.698 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.2 pp -139.66 152.91 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -99.83 121.17 50.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -104.15 -33.25 8.8 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.335 -169.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 6.9 t70 -140.17 143.02 35.9 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.417 -0.811 . . . . 0.0 108.86 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.58 ' HB1' HD21 ' A' ' 47' ' ' LEU . . . -167.74 101.74 0.48 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.79 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 47.7 mttp -115.32 167.53 10.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.058 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.661 ' HE1' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -124.41 131.28 53.5 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.627 0.727 . . . . 0.0 111.18 -174.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 10.3 tp10 -128.79 110.81 12.48 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.15 174.86 34.0 Favored Glycine 0 CA--C 1.493 -1.317 0 C-N-CA 119.325 -1.417 . . . . 0.0 113.486 -174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 1.3 tm-20 -147.74 132.25 17.7 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.95 -133.59 2.76 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.581 -171.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.2 p -110.03 172.81 6.64 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.662 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.7 t -74.16 -31.08 62.56 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.177 -165.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.738 HD11 ' SG ' ' A' ' 128' ' ' CYS . 2.7 pp -75.66 -24.57 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.148 0.499 . . . . 0.0 109.937 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 68' ' ' ILE . 13.1 m -78.86 -37.79 39.44 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 65.0 mtt -58.41 -33.0 69.17 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.779 0.799 . . . . 0.0 109.687 167.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.599 ' O ' ' HB3' ' A' ' 74' ' ' SER . . . -71.62 -38.1 70.83 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.999 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.804 ' HB2' HD11 ' A' ' 116' ' ' LEU . 41.7 t -59.98 -48.47 81.56 Favored 'General case' 0 C--O 1.219 -0.538 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.12 -41.33 78.81 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.815 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.599 ' HB3' ' O ' ' A' ' 71' ' ' ALA . 30.7 t -47.8 -67.59 0.26 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.242 173.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.485 ' SD ' ' HA3' ' A' ' 111' ' ' GLY . 25.5 mmt -65.15 -32.42 74.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.925 0.393 . . . . 0.0 110.518 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.75 ' SD ' ' HG ' ' A' ' 47' ' ' LEU . 31.9 ttm -56.66 -61.72 2.23 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.593 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 p -60.08 -27.62 67.14 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -90.02 -31.63 17.11 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.308 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.11 -41.22 15.92 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.299 0.571 . . . . 0.0 111.059 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 80' ' ' ILE . 14.7 mm -76.66 -39.71 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.443 -174.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.535 ' HD3' ' H ' ' A' ' 59' ' ' ALA . 3.0 mmmp? -52.56 -18.74 1.87 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.217 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.01 54.9 0.78 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.014 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.449 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 12.0 tppt? -133.3 169.45 16.89 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -114.28 -174.03 2.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 173.465 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.489 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 18.4 mm -85.49 -33.31 7.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.963 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -63.4 -46.42 86.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.198 0.523 . . . . 0.0 110.92 175.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 83' ' ' LYS . 0.9 OUTLIER -67.96 -37.61 81.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.352 178.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.917 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -64.18 -43.21 95.84 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.101 0.477 . . . . 0.0 111.37 175.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 70.9 mt -67.1 -35.54 80.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.318 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 p -73.03 -35.2 66.72 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.933 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.0 ttt -70.03 -22.58 63.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.875 0.845 . . . . 0.0 111.718 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.509 ' OG ' ' HA ' ' A' ' 142' ' ' LYS . 49.4 p -89.06 -36.59 15.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.874 ' HB2' ' HA ' ' A' ' 143' ' ' GLU . 87.1 tttt -66.8 -37.02 83.73 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 1.053 HD13 ' HA ' ' A' ' 105' ' ' ASP . 12.8 mt -67.74 -47.27 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.355 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.549 ' CE2' HG12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -55.95 -24.88 40.88 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 123.934 0.771 . . . . 0.0 110.04 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.4 m -81.71 -43.07 18.97 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.993 -0.442 . . . . 0.0 110.824 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -75.96 -29.19 58.2 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -173.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.8 ptm -54.31 -10.0 0.34 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.956 0.902 . . . . 0.0 112.307 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 95.6 mmm -100.1 -7.77 24.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.926 0.87 . . . . 0.0 109.241 -166.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -134.68 -22.74 1.65 Allowed 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.688 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -107.54 -23.49 6.87 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 119.207 -0.774 . . . . 0.0 112.302 -177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 22.3 tptm 81.48 -18.54 0.48 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.08 1.352 . . . . 0.0 109.692 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -77.91 149.15 34.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.41 ' HB2' ' H ' ' A' ' 105' ' ' ASP . 3.5 p90 -137.03 -134.03 0.14 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -171.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 1.053 ' HA ' HD13 ' A' ' 94' ' ' ILE . 9.0 t70 -90.66 108.79 20.04 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.125 0.964 . . . . 0.0 109.33 -169.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -58.5 -2.86 0.23 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.284 173.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.532 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 1.5 m -89.79 -24.82 21.37 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 170.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 108' ' ' ILE . 22.7 mm 72.91 25.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-O 122.421 1.105 . . . . 0.0 110.703 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -94.89 70.03 3.36 Favored 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 121.618 -0.676 . . . . 0.0 109.952 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.839 ' HG ' HD12 ' A' ' 113' ' ' ILE . 6.1 mp -104.35 14.11 30.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.285 -169.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.485 ' HA3' ' SD ' ' A' ' 75' ' ' MET . . . -44.78 -39.26 6.07 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 119.857 -0.413 . . . . 0.0 113.849 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.09 -45.42 23.49 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-O 122.367 1.08 . . . . 0.0 109.906 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.839 HD12 ' HG ' ' A' ' 110' ' ' LEU . 36.8 mt -58.25 -28.95 36.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.902 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 8.2 mm-40 -76.27 -54.5 6.7 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.282 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.45 -41.45 69.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.3 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.804 HD11 ' HB2' ' A' ' 72' ' ' SER . 6.6 mp -96.04 -6.77 37.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.566 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 44.8 tt0 -45.53 -51.44 11.82 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.178 0.923 . . . . 0.0 110.853 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.48 -18.79 77.32 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.375 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 68' ' ' ILE . 60.2 t -78.29 -60.25 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 O-C-N 122.056 -0.673 . . . . 0.0 111.606 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 129' ' ' ALA . 14.5 p -50.93 -16.06 0.38 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.338 -1.301 . . . . 0.0 114.141 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.987 ' HE2' ' HA ' ' A' ' 121' ' ' LYS . 8.9 mmpt? -99.66 -16.73 18.09 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.492 -0.755 . . . . 0.0 110.822 -163.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -90.4 135.14 29.9 Favored Pre-proline 0 N--CA 1.443 -0.794 0 O-C-N 123.833 0.708 . . . . 0.0 109.819 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.0 -27.48 21.36 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.323 2.682 . . . . 0.0 111.78 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.576 ' O ' HG21 ' A' ' 40' ' ' THR . . . -84.34 -27.75 27.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.556 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.527 ' HB3' HG13 ' A' ' 119' ' ' VAL . 30.5 mtm180 -113.9 17.76 17.75 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.775 -166.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.7 tt -84.9 -29.74 6.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.03 -17.78 45.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.778 -1.556 . . . . 0.0 107.999 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.738 ' SG ' HD11 ' A' ' 68' ' ' ILE . 54.1 t -84.34 -19.62 33.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.757 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.577 ' O ' ' HB3' ' A' ' 133' ' ' TRP . . . -85.78 -27.73 25.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.533 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 16.6 p -78.31 -35.84 47.26 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.637 HD13 ' SG ' ' A' ' 41' ' ' CYS . 10.0 tt -51.42 -54.17 29.43 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.225 172.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.512 ' HB2' HD21 ' A' ' 116' ' ' LEU . 35.9 m -81.88 -62.25 1.69 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.577 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 1.2 t90 -62.49 -50.43 71.44 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 120.943 0.401 . . . . 0.0 111.849 -175.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.64 ' HB3' ' O ' ' A' ' 130' ' ' THR . 37.7 ttpt -62.65 -29.34 70.56 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.608 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 132' ' ' SER . . . -56.89 -31.02 64.45 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 169.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.5 mp -80.55 -35.17 34.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.421 ' OE1' ' HD2' ' A' ' 142' ' ' LYS . 7.5 mm-40 -61.65 -43.85 98.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.422 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -91.25 5.51 48.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.361 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 1.061 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -85.79 -39.99 7.87 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.917 HG21 ' HB1' ' A' ' 88' ' ' ALA . 20.1 m -127.06 -9.45 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 O-C-N 122.091 -0.653 . . . . 0.0 110.543 -177.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 91.78 152.39 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.184 1.393 . . . . 0.0 108.425 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.509 ' HA ' ' OG ' ' A' ' 92' ' ' SER . 14.9 pttp -114.44 142.66 46.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -171.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.874 ' HA ' ' HB2' ' A' ' 93' ' ' LYS . 33.4 mt-10 65.81 -88.66 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.242 0.964 . . . . 0.0 111.861 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -107.94 107.5 18.24 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 123.587 0.554 . . . . 0.0 110.585 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.95 80.62 0.35 Allowed Glycine 0 CA--C 1.508 -0.35 0 O-C-N 123.906 0.754 . . . . 0.0 112.116 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.76 158.48 17.41 Favored Glycine 0 CA--C 1.506 -0.512 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.08 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 C--N 1.323 -0.569 0 O-C-N 122.286 -0.537 . . . . 0.0 110.287 179.408 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.869 0.366 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 m -66.82 -61.11 2.12 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.115 0.483 . . . . 0.0 110.279 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -137.39 -57.93 0.7 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.7 m120 64.93 152.71 0.05 Allowed 'General case' 0 N--CA 1.477 0.879 0 O-C-N 125.054 1.471 . . . . 0.0 112.134 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.84 93.14 6.49 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.272 0.558 . . . . 0.0 110.157 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -103.33 -82.14 0.5 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.532 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.506 HD11 ' O ' ' A' ' 115' ' ' ALA . 12.7 tp -137.54 0.28 2.25 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.983 0.897 . . . . 0.0 109.116 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.51 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -55.81 -63.53 1.14 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 125.348 1.459 . . . . 0.0 111.467 -178.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -62.7 -35.14 78.73 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.718 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.517 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 4.1 mm? -53.97 -39.52 66.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.103 174.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.879 ' HE1' HG22 ' A' ' 68' ' ' ILE . 22.7 m-85 -63.08 -57.71 9.71 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 121.52 0.676 . . . . 0.0 109.848 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.654 ' HA ' HG22 ' A' ' 15' ' ' ILE . 47.3 mtm180 -69.44 -18.92 63.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.03 -169.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.419 ' HA ' ' OE1' ' A' ' 13' ' ' GLN . 16.3 mm-40 -86.62 -35.86 19.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.685 1.231 . . . . 0.0 108.02 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.621 HG21 ' HB2' ' A' ' 115' ' ' ALA . 0.3 OUTLIER -80.1 -34.19 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.964 -175.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.654 HG22 ' HA ' ' A' ' 12' ' ' ARG . 10.5 tt -82.62 -19.1 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.683 175.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.613 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 17.2 tpt -61.73 -43.87 98.02 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.859 0.838 . . . . 0.0 110.388 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.02 -41.71 63.95 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.059 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -61.82 -28.23 69.33 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.774 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -66.84 -55.64 13.93 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.104 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -48.57 -38.35 20.38 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 124.039 0.837 . . . . 0.0 110.812 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -114.08 86.3 11.32 Favored Pre-proline 0 C--N 1.32 -0.676 0 O-C-N 123.426 0.454 . . . . 0.0 110.478 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.57 45.97 2.01 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.529 2.153 . . . . 0.0 114.038 -172.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.33 102.15 11.58 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.083 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -142.24 25.93 1.86 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.151 0.977 . . . . 0.0 108.366 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -132.09 124.46 29.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.224 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.764 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 155.28 146.94 4.56 Favored Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.713 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -165.39 93.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.873 0 O-C-N 124.619 0.835 . . . . 0.0 109.25 177.234 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.579 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -116.75 139.2 50.84 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 120.68 -1.263 . . . . 0.0 111.721 -175.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.512 ' HA ' HG21 ' A' ' 33' ' ' VAL . 58.1 t30 -81.24 81.34 7.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.627 172.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.555 ' HB2' HD13 ' A' ' 28' ' ' LEU . 10.3 t70 -101.48 -125.86 0.19 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.667 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.4 t -66.66 -64.92 0.75 Allowed 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.668 -0.645 . . . . 0.0 110.376 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.615 HG13 ' HB2' ' A' ' 49' ' ' MET . 34.4 pt -125.65 135.28 64.43 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.713 176.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.948 HG13 HG22 ' A' ' 48' ' ' THR . 84.9 t -116.16 138.11 47.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.917 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.764 HG21 ' HA2' ' A' ' 139' ' ' GLY . 98.1 t -127.95 124.65 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -120.41 136.91 54.58 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.35 0.119 . . . . 0.0 111.061 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.577 ' HG3' HD12 ' A' ' 131' ' ' LEU . 47.9 tpp -151.55 123.48 8.09 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 110.98 175.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 7.6 p30 -127.64 150.35 49.78 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.573 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -109.93 98.2 33.05 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.51 -11.62 32.79 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.596 2.864 . . . . 0.0 113.278 -171.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.4 m -75.85 -30.9 59.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.544 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.2 p -131.12 -12.67 3.59 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.43 3.78 58.49 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.317 -1.42 . . . . 0.0 113.538 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -70.15 115.5 9.42 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 18.8 ptp180 -127.83 141.08 51.67 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 31.6 pt -141.34 149.84 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.287 0.565 . . . . 0.0 110.172 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.732 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 50.5 mtt180 -140.51 107.64 5.48 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.957 -0.464 . . . . 0.0 111.525 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.709 HD22 ' HG3' ' A' ' 49' ' ' MET . 0.7 OUTLIER -93.66 89.67 6.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.948 HG22 HG13 ' A' ' 33' ' ' VAL . 67.4 p -88.02 128.5 35.4 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 173.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.709 ' HG3' HD22 ' A' ' 47' ' ' LEU . 30.5 mtt -113.67 -179.21 3.57 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.275 1.036 . . . . 0.0 112.92 -170.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.838 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 45.3 tttp -159.87 98.7 1.36 Allowed 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 51' ' ' LEU . 2.3 pt? -126.48 93.12 3.71 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -172.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -99.17 59.92 1.17 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.731 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 148.77 -96.21 0.17 Allowed Glycine 0 C--N 1.316 -0.548 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.43 18.93 6.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -176.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 2.4 pp -140.54 167.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 p -116.2 116.81 53.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 168.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' HB2' HD13 ' A' ' 55' ' ' ILE . 23.5 tt0 -106.58 -27.63 10.75 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.033 0.921 . . . . 0.0 109.95 -166.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.838 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 28.0 t70 -140.73 144.68 35.7 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 48' ' ' THR . . . -160.36 118.04 2.53 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.764 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 34.2 mmtp -107.25 130.41 54.75 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.732 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.7 p90 -129.01 147.28 50.86 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.35 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 42.2 tt0 -107.16 138.46 43.29 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.42 120.13 1.54 Allowed Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.637 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 44' ' ' ARG . 7.9 pt-20 -163.15 106.63 1.04 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.15 -131.4 1.87 Allowed Glycine 0 C--O 1.236 0.24 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.904 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.7 m -77.21 173.67 11.6 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.8 m -89.87 17.31 6.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.795 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.879 HG22 ' HE1' ' A' ' 11' ' ' TYR . 2.7 pp -119.05 -45.13 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.393 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.514 ' N ' HD12 ' A' ' 68' ' ' ILE . 13.8 p -73.27 -46.18 51.34 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.798 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -27.25 64.43 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.172 177.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.0 -59.26 2.39 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.632 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.667 ' CB ' ' HB2' ' A' ' 116' ' ' LEU . 21.7 p -67.62 -45.84 74.22 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.437 -168.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.04 -53.81 50.33 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 120.901 0.381 . . . . 0.0 110.345 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.1 t -60.16 -35.33 75.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.414 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.416 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 17.9 tpt -67.78 -54.82 16.17 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.551 0.691 . . . . 0.0 110.349 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.431 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -62.98 -33.52 75.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.205 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.616 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 24.3 p -72.61 -39.43 67.3 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.348 0.594 . . . . 0.0 110.651 177.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.416 ' HB3' ' O ' ' A' ' 75' ' ' MET . 28.1 tt0 -53.25 -38.05 62.65 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.586 171.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.98 -27.83 24.61 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.762 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -73.56 -36.83 48.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 O-C-N 124.359 1.037 . . . . 0.0 110.152 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 55.5 tttm -56.35 -17.51 8.07 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.848 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.95 42.59 1.79 Allowed Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.29 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -134.53 -153.04 0.5 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.698 0.761 . . . . 0.0 111.875 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -145.78 155.88 43.23 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 -167.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.637 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.6 mp -63.31 -49.75 81.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 O-C-N 123.342 0.401 . . . . 0.0 110.079 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.26 -38.73 82.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.863 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.522 ' O ' ' HG2' ' A' ' 91' ' ' MET . 4.8 m -68.35 -35.04 77.16 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 121.497 0.665 . . . . 0.0 110.428 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' A' ' 141' ' ' ALA . . . -60.5 -41.88 95.21 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 173.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 32.8 mt -67.36 -31.83 72.35 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.287 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.441 ' O ' HG13 ' A' ' 94' ' ' ILE . 5.1 p -77.96 -29.63 49.93 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 121.66 -0.65 . . . . 0.0 111.76 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' A' ' 87' ' ' THR . 22.1 mmt -75.66 -18.91 59.5 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.09 0.948 . . . . 0.0 110.846 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p -90.08 -31.47 17.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.377 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.85 -37.96 79.46 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.66 172.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.447 HD12 ' SD ' ' A' ' 91' ' ' MET . 35.9 mt -62.23 -48.85 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 171.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.485 ' HD1' HG12 ' A' ' 113' ' ' ILE . 49.9 t80 -43.39 -35.91 1.73 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.471 0.653 . . . . 0.0 111.745 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.2 m -85.08 -35.51 21.78 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 121.686 -0.634 . . . . 0.0 111.454 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -84.3 -20.09 32.69 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.05 0.929 . . . . 0.0 112.3 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.46 ' CG ' ' HB3' ' A' ' 104' ' ' TYR . 2.1 tmt? -73.34 -13.07 61.04 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.233 -174.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.1 mmt -95.24 6.15 49.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.556 -160.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -103.97 16.85 25.35 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.5 30.25 74.85 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.509 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 102' ' ' LYS . 7.3 mmpt? -102.7 -170.92 1.87 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.816 0.308 . . . . 0.0 110.211 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.59 156.86 33.87 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.503 ' HD2' ' H ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -124.64 -101.2 0.39 Allowed 'General case' 0 C--N 1.316 -0.883 0 O-C-N 123.717 0.636 . . . . 0.0 111.035 -178.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.636 ' HB3' HD11 ' A' ' 110' ' ' LEU . 15.4 t0 -116.14 107.26 14.67 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 123.742 0.651 . . . . 0.0 109.373 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.76 -2.01 1.6 Allowed 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.959 0.787 . . . . 0.0 111.531 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.587 ' O ' HG22 ' A' ' 108' ' ' ILE . 2.1 m -89.34 -15.8 32.54 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 172.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.587 HG22 ' O ' ' A' ' 107' ' ' SER . 4.3 tp 68.59 15.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.068 0.947 . . . . 0.0 113.512 165.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -92.73 88.68 6.34 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.636 HD11 ' HB3' ' A' ' 105' ' ' ASP . 10.8 mp -127.0 43.75 3.05 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.037 -168.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -38.64 -44.87 1.89 Allowed Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.579 -0.737 . . . . 0.0 114.91 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.609 ' O ' ' HB3' ' A' ' 116' ' ' LEU . 16.1 p-10 -90.45 -41.53 11.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.52 1.152 . . . . 0.0 109.99 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.74 ' O ' ' HB2' ' A' ' 117' ' ' GLN . 50.7 mt -69.47 -27.49 34.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.591 -172.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -86.98 -69.59 0.67 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.396 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.621 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -63.52 -39.39 94.31 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -172.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.667 ' HB2' ' CB ' ' A' ' 72' ' ' SER . 48.4 tp -99.74 3.08 44.77 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.648 0.737 . . . . 0.0 111.17 -169.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.74 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 8.2 tt0 -63.48 -45.79 89.15 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.536 0.684 . . . . 0.0 110.445 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.95 -17.23 65.14 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 113.91 -1.495 . . . . 0.0 113.014 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.932 HG13 ' HG2' ' A' ' 125' ' ' ARG . 97.9 t -82.09 -40.78 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 121.765 0.793 . . . . 0.0 110.186 -169.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.533 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 16.4 t -42.98 -13.23 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.561 -1.654 . . . . 0.0 115.393 174.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.458 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 10.2 ptmt -142.93 -0.37 1.16 Allowed 'General case' 0 C--O 1.243 0.725 0 O-C-N 121.003 -1.061 . . . . 0.0 113.041 -162.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.671 ' HB2' ' HB3' ' A' ' 125' ' ' ARG . 30.0 m-85 -81.09 123.6 81.75 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 168.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -51.05 -28.79 25.76 Favored 'Trans proline' 0 C--O 1.218 -0.514 0 C-N-CA 123.347 2.698 . . . . 0.0 112.652 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.49 -0.11 32.81 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.216 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.932 ' HG2' HG13 ' A' ' 119' ' ' VAL . 33.0 ttm180 -126.08 6.02 7.19 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.393 -175.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.7 tt -80.73 -25.34 11.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.244 -171.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -76.8 -20.11 56.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.389 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.414 ' HB3' HD11 ' A' ' 68' ' ' ILE . 61.0 m -86.3 -19.33 30.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.228 174.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.582 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -72.62 -46.9 51.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.147 176.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.694 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 7.5 p -69.99 -37.58 75.76 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.577 HD12 ' HG3' ' A' ' 36' ' ' MET . 18.0 tp -46.38 -55.68 6.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.077 -0.389 . . . . 0.0 111.494 171.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.463 ' HB2' HD21 ' A' ' 116' ' ' LEU . 6.7 m -83.42 -55.87 4.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.812 0.339 . . . . 0.0 111.203 -171.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 6.4 t90 -63.47 -50.56 69.21 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.746 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.694 ' HB3' ' O ' ' A' ' 130' ' ' THR . 3.1 tppp? -60.65 -42.31 96.7 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.19 -41.13 78.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.937 0.399 . . . . 0.0 111.581 173.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.401 HD21 ' CG ' ' A' ' 76' ' ' MET . 17.0 tp -73.97 -32.43 63.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.416 0.627 . . . . 0.0 110.173 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' A' ' 141' ' ' ALA . 39.4 tt0 -69.55 -37.37 77.03 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.5 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.476 ' HB3' ' NZ ' ' A' ' 138' ' ' LYS . 9.6 mtpm? -87.64 10.63 17.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.695 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.764 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -94.82 -40.96 4.23 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.8 p -178.13 -44.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.694 ' O ' ' HA ' ' A' ' 137' ' ' GLU . . . -82.97 100.61 10.54 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.435 ' HA ' ' HG3' ' A' ' 137' ' ' GLU . 13.4 ptmm? -142.91 28.29 1.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.102 0.477 . . . . 0.0 110.587 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 59.12 -167.28 0.16 Allowed 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.9 -171.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -93.81 -53.28 4.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.29 -89.76 0.12 Allowed Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.123 172.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.94 -133.8 13.52 Favored Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 C--N 1.317 -0.83 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.278 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 ttm . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 110.706 -0.109 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -79.88 119.38 22.67 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-O 121.304 0.573 . . . . 0.0 111.485 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -119.75 87.79 2.81 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -108.13 111.01 22.81 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.074 0.464 . . . . 0.0 110.063 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.83 -34.03 0.32 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.566 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -41.69 -33.44 0.48 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.275 1.03 . . . . 0.0 113.198 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 10' ' ' LEU . 28.3 tp -105.5 -16.6 14.68 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.008 -0.433 . . . . 0.0 110.443 -168.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 30.4 t70 -56.53 -54.18 48.84 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.825 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.3 m -59.93 -42.25 93.58 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.536 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.669 ' HB2' HD12 ' A' ' 7' ' ' LEU . 70.0 mt -59.08 -36.41 75.04 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.835 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.555 ' O ' HG12 ' A' ' 15' ' ' ILE . 8.3 m-85 -63.92 -54.75 29.77 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.194 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 16' ' ' MET . 28.0 mtt85 -56.23 -37.33 69.58 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.86 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -75.49 -37.61 60.07 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.261 0.35 . . . . 0.0 110.868 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 t -76.93 -34.62 22.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.937 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 11' ' ' TYR . 29.0 pt -77.91 -18.44 13.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 121.813 -0.555 . . . . 0.0 109.804 174.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 45.7 ttm -69.04 -47.41 65.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -61.05 -46.41 90.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.733 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 58.9 t-80 -51.61 -45.86 63.37 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.251 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -66.72 -49.12 67.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.387 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -44.61 -41.38 6.54 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.238 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -131.73 81.05 64.6 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-O 121.407 0.622 . . . . 0.0 109.505 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -88.72 94.99 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.078 2.519 . . . . 0.0 112.875 -171.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -161.17 115.05 2.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.009 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.628 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 13.8 m120 -113.16 24.76 11.99 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.32 101.04 10.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.972 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.688 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -168.65 120.44 0.89 Allowed Glycine 0 CA--C 1.494 -1.237 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.738 HG21 ' HE ' ' A' ' 46' ' ' ARG . 2.4 p -167.88 105.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 O-C-N 121.185 -1.186 . . . . 0.0 110.982 -174.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.524 ' H ' ' CB ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -87.55 -155.36 0.29 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.396 0.617 . . . . 0.0 110.155 173.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.59 ' HA ' HG21 ' A' ' 33' ' ' VAL . 3.8 p-10 -166.42 13.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.357 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -99.42 -71.18 0.7 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.804 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.709 ' HB3' ' O ' ' A' ' 49' ' ' MET . 11.3 t -73.19 -143.98 0.02 OUTLIER 'General case' 0 C--O 1.238 0.486 0 O-C-N 123.157 0.286 . . . . 0.0 110.649 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.817 HG13 ' HB2' ' A' ' 49' ' ' MET . 27.9 pt -78.78 119.98 28.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.683 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.001 HG13 HG22 ' A' ' 48' ' ' THR . 79.9 t -119.2 135.02 60.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.257 -177.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.765 HG21 ' HA2' ' A' ' 139' ' ' GLY . 78.9 t -123.52 119.63 57.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -120.65 118.71 30.82 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.051 0.219 . . . . 0.0 110.766 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.515 ' HE2' ' HA ' ' A' ' 36' ' ' MET . 3.4 mmt -144.51 121.17 11.15 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.15 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 3.1 p30 -120.09 158.65 26.43 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 172.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.624 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 25.9 t30 -114.46 100.07 52.38 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 121.384 0.611 . . . . 0.0 109.816 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.12 -19.34 40.87 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 123.157 2.571 . . . . 0.0 113.113 -173.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 60.1 m -62.91 -43.92 97.49 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.8 p -133.0 8.67 4.09 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.06 6.9 78.33 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.477 163.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.624 ' OD1' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -82.3 146.4 29.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.216 0.531 . . . . 0.0 110.153 176.655 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 52.3 ttt180 -139.71 148.32 42.16 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.622 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.7 tt -140.18 146.61 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 123.536 0.523 . . . . 0.0 110.12 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.738 ' HE ' HG21 ' A' ' 27' ' ' VAL . 75.4 mtp85 -141.17 100.38 3.79 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.241 0.543 . . . . 0.0 110.326 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.717 HD22 ' HG3' ' A' ' 49' ' ' MET . 0.3 OUTLIER -89.99 92.17 8.88 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.48 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 1.001 HG22 HG13 ' A' ' 33' ' ' VAL . 77.7 p -93.23 130.64 38.86 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.553 -0.717 . . . . 0.0 109.79 174.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.817 ' HB2' HG13 ' A' ' 32' ' ' ILE . 36.9 mtt -126.92 -177.7 4.13 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 121.819 -0.55 . . . . 0.0 110.815 -172.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' A' ' 52' ' ' ASP . 10.5 tmtt? -160.61 110.93 1.78 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.564 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.5 pt? -128.57 94.3 3.84 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.942 0.877 . . . . 0.0 108.939 -170.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.503 ' HB2' ' HZ3' ' A' ' 50' ' ' LYS . 37.4 t70 -101.89 59.84 0.85 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.759 0.79 . . . . 0.0 109.951 -171.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.83 -94.82 0.16 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 170.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -133.77 24.71 4.0 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -139.48 160.13 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -173.382 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -95.68 97.12 6.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 123.485 1.612 . . . . 0.0 106.999 165.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 50' ' ' LYS . 37.8 tt0 -66.44 -41.88 88.46 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 112.509 -2.132 . . . . 0.0 110.189 -167.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -148.72 146.53 28.14 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.561 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.33 121.93 11.11 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.688 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 89.4 mttt -126.06 140.86 52.25 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.704 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.642 ' CZ ' ' HA ' ' A' ' 74' ' ' SER . 31.2 p90 -128.22 143.39 51.03 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.972 0.415 . . . . 0.0 110.575 -172.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 45.7 tt0 -117.05 114.02 23.16 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.482 ' H ' ' HB3' ' A' ' 24' ' ' ASN . . . -121.38 128.66 7.42 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.265 -173.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -148.21 108.45 4.1 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 43' ' ' ASP . . . 170.84 -132.4 2.47 Favored Glycine 0 C--N 1.317 -0.523 0 C-N-CA 119.363 -1.398 . . . . 0.0 112.584 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 70' ' ' MET . 1.4 p -95.37 159.25 15.09 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 120.753 0.311 . . . . 0.0 110.261 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.9 t -78.75 24.9 0.28 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.467 -167.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -118.19 -52.67 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 122.386 1.089 . . . . 0.0 109.652 179.022 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.631 ' HB3' HD22 ' A' ' 131' ' ' LEU . 1.2 m -77.23 -44.29 30.49 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 121.781 0.801 . . . . 0.0 111.098 -170.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 66' ' ' CYS . 26.9 ptm -72.16 -12.84 61.37 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.392 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.81 -45.98 11.08 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.071 -0.393 . . . . 0.0 111.379 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 p -62.62 -28.36 69.85 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 121.41 0.624 . . . . 0.0 109.849 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.61 -50.38 67.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.463 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.642 ' HA ' ' CZ ' ' A' ' 61' ' ' PHE . 24.3 m -59.64 -39.25 83.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.477 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -76.49 -58.61 3.18 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.829 -174.268 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.609 ' SD ' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -59.34 -34.0 71.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.817 -177.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 1.055 ' HA ' HG22 ' A' ' 80' ' ' ILE . 98.9 m -61.97 -43.18 99.37 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.088 0.858 . . . . 0.0 110.1 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' MET . 77.5 mt-30 -49.45 -37.01 24.34 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.773 0.797 . . . . 0.0 110.535 172.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.509 ' HB1' ' OD2' ' A' ' 109' ' ' ASP . . . -86.26 -31.84 21.44 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.682 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.055 HG22 ' HA ' ' A' ' 77' ' ' THR . 9.9 tp -83.24 -40.17 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.054 -173.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -54.34 -17.29 2.84 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.927 0.87 . . . . 0.0 111.346 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.26 40.88 2.12 Favored Glycine 0 C--N 1.31 -0.895 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -132.78 167.05 20.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -103.98 -177.06 3.26 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.681 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.4 mp -81.77 -45.37 20.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.21 -176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -58.36 -43.45 88.4 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.37 0.419 . . . . 0.0 111.099 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.536 ' HA ' ' OG ' ' A' ' 90' ' ' SER . 2.7 p -68.84 -37.65 79.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.389 0.614 . . . . 0.0 111.508 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.411 ' HB1' HG13 ' A' ' 140' ' ' VAL . . . -60.89 -40.52 93.37 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.863 175.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.841 HD22 ' HB3' ' A' ' 142' ' ' LYS . 34.0 mt -69.58 -37.5 76.97 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 110.819 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 87' ' ' THR . 2.3 p -75.43 -35.24 61.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.072 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.512 ' HA ' HG22 ' A' ' 94' ' ' ILE . 11.2 tmm? -64.94 -20.85 66.68 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.778 0.799 . . . . 0.0 109.185 173.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.796 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 43.6 t -85.35 -42.96 14.1 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.297 -1.319 . . . . 0.0 107.577 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.643 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 54.3 tttp -67.42 -36.25 80.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.329 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 90' ' ' SER . 9.1 tt -79.73 -39.77 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.087 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -46.19 -38.63 8.57 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.44 0.638 . . . . 0.0 111.247 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.5 m -86.66 -28.23 23.29 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.44 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -71.77 -21.57 61.71 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.052 0.541 . . . . 0.0 111.0 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -41.94 -47.27 4.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.673 0.789 . . . . 0.0 112.513 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.1 ttt -55.08 -18.24 5.14 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -129.3 -26.46 2.56 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.492 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.47 -40.17 4.26 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.512 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp 87.85 37.48 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.449 ' HB3' HD11 ' A' ' 94' ' ' ILE . 39.7 mt-10 -132.45 126.96 34.27 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.562 -2.108 . . . . 0.0 107.219 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.575 ' CD1' HD21 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -94.59 -89.73 0.23 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.462 ' HB3' HD12 ' A' ' 110' ' ' LEU . 5.3 t70 -115.02 112.64 22.96 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 156.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.466 ' H ' HD13 ' A' ' 94' ' ' ILE . 30.9 t70 -49.89 -21.81 1.29 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.775 173.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.459 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 1.3 m -80.11 -17.13 53.4 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.487 ' HA ' HD13 ' A' ' 110' ' ' LEU . 21.9 mm 72.23 24.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 122.507 1.146 . . . . 0.0 110.492 174.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.509 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 27.6 t70 -95.17 66.77 2.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.055 177.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.807 ' HG ' ' HB ' ' A' ' 113' ' ' ILE . 7.8 mp -95.94 40.32 1.12 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.127 -165.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.444 ' HA2' ' SD ' ' A' ' 75' ' ' MET . . . -38.31 -50.75 2.28 Favored Glycine 0 C--O 1.242 0.594 0 O-C-N 124.066 0.854 . . . . 0.0 114.145 177.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.634 ' HB2' HD22 ' A' ' 116' ' ' LEU . 8.5 p-10 -91.59 -43.38 9.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.8 -0.824 . . . . 0.0 110.238 176.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.807 ' HB ' ' HG ' ' A' ' 110' ' ' LEU . 16.4 mt -62.93 -33.3 59.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.575 -166.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.496 ' HG2' HD22 ' A' ' 10' ' ' LEU . 31.8 tt0 -61.98 -50.83 70.52 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 119' ' ' VAL . . . -69.68 -53.37 18.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.933 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.634 HD22 ' HB2' ' A' ' 112' ' ' ASP . 3.9 mp -82.72 -2.7 54.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -164.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -62.79 -39.32 93.87 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.52 -17.19 64.62 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.864 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.872 HG13 ' HB3' ' A' ' 125' ' ' ARG . 91.8 t -86.17 -46.94 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -171.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.598 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 9.4 t -49.56 -10.16 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.63 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.839 ' HE3' ' HA ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -134.0 -17.41 2.15 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.365 -160.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -88.63 130.06 46.63 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.56 -30.61 55.44 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 122.433 2.089 . . . . 0.0 112.276 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.25 1.75 56.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.255 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.872 ' HB3' HG13 ' A' ' 119' ' ' VAL . 27.9 mmt180 -134.92 8.01 3.49 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 118.61 0.641 . . . . 0.0 110.422 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.2 tt -84.34 -30.07 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -165.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.51 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 31.8 mmtp -74.99 -30.49 61.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.999 174.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.2 m -78.62 -17.64 55.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.023 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.598 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -78.38 -31.4 48.38 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.92 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.764 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 25.3 m -72.11 -44.47 63.15 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 69' ' ' SER . 9.5 tt -50.2 -63.59 1.07 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.636 174.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.544 ' HB2' HD21 ' A' ' 116' ' ' LEU . 13.5 p -74.59 -63.49 1.23 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.985 -171.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.5 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 4.7 t90 -66.38 -56.34 11.54 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 122.58 0.352 . . . . 0.0 111.219 -175.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.764 ' HB3' ' O ' ' A' ' 130' ' ' THR . 24.1 tptm -56.6 -40.08 74.66 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 123.992 0.808 . . . . 0.0 110.184 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.1 -32.95 73.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.567 HD21 ' SD ' ' A' ' 76' ' ' MET . 15.7 tp -78.22 -33.8 49.65 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.018 0.914 . . . . 0.0 109.217 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 3.5 tp10 -68.82 -41.11 79.03 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 122.844 1.307 . . . . 0.0 109.395 175.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -85.37 13.71 6.29 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 113.965 -1.47 . . . . 0.0 109.907 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.765 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -95.87 -32.95 6.57 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.569 -177.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.411 HG13 ' HB1' ' A' ' 88' ' ' ALA . 9.3 p -171.34 -28.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.796 ' HB1' ' HB2' ' A' ' 92' ' ' SER . . . -63.76 177.3 0.75 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 123.713 0.633 . . . . 0.0 110.438 173.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.841 ' HB3' HD22 ' A' ' 89' ' ' LEU . 86.0 tttt 177.76 -29.84 0.0 OUTLIER 'General case' 0 C--O 1.237 0.421 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -170.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.643 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 26.1 tt0 65.76 -76.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.816 0.341 . . . . 0.0 110.605 -172.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -172.42 123.38 0.47 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.929 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -156.63 -120.89 0.67 Allowed Glycine 0 C--O 1.242 0.613 0 C-N-CA 119.815 -1.183 . . . . 0.0 111.882 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.48 -126.44 4.44 Favored Glycine 0 C--O 1.244 0.769 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.925 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 44.8 t30 . . . . . 0 N--CA 1.47 0.551 0 CA-C-O 120.987 0.422 . . . . 0.0 110.983 179.519 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 C--O 1.245 0.852 0 CA-C-O 120.417 0.151 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -77.82 79.41 4.3 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -82.82 -32.71 27.47 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -75.97 73.31 2.86 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 6' ' ' ASN . . . -169.92 -60.04 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 124.206 1.003 . . . . 0.0 109.374 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 6.6 t30 72.73 21.41 3.45 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 122.071 0.939 . . . . 0.0 109.786 172.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.823 HD21 HG21 ' A' ' 68' ' ' ILE . 15.8 tp -102.11 -20.18 14.84 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.426 -171.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 18.6 t70 -52.76 -54.51 32.91 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.59 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -49.64 -40.49 39.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.545 175.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.5 HD11 ' HB3' ' A' ' 114' ' ' GLU . 2.7 mm? -65.74 -39.19 90.85 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.895 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.501 ' HE1' ' HB2' ' A' ' 67' ' ' SER . 41.3 m-85 -64.83 -47.92 76.25 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.428 176.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 8' ' ' ASP . 43.4 mtp180 -56.14 -47.06 78.92 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.056 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -72.01 -43.69 64.65 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 120.586 0.232 . . . . 0.0 111.58 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.9 t -81.21 -33.38 12.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.096 0.474 . . . . 0.0 111.809 -170.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 11' ' ' TYR . 1.7 mp -73.37 -24.54 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 O-C-N 121.932 -0.48 . . . . 0.0 110.195 173.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ttt -67.69 -51.0 54.77 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.593 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.24 -38.32 81.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.112 0.482 . . . . 0.0 110.369 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -54.49 -41.76 69.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.28 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -56.41 -59.09 5.47 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.924 0.393 . . . . 0.0 111.163 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -66.94 -18.83 65.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -137.49 82.12 28.73 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.394 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -90.93 73.61 0.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 123.476 2.784 . . . . 0.0 112.763 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -109.61 62.48 0.6 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.182 0.515 . . . . 0.0 111.008 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.411 ' OD1' ' HA ' ' A' ' 74' ' ' SER . 10.0 m120 -136.64 37.2 2.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.608 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 31.9 ttmt -145.53 43.51 1.28 Allowed 'General case' 0 C--N 1.315 -0.907 0 O-C-N 123.526 0.516 . . . . 0.0 109.631 -175.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.25 167.31 29.02 Favored Glycine 0 C--O 1.222 -0.632 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.533 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.708 HG23 HG21 ' A' ' 48' ' ' THR . 3.1 p -165.87 130.68 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 117.212 0.506 . . . . 0.0 109.906 -174.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.734 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -150.72 164.59 35.78 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.731 178.239 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -117.84 28.05 8.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.593 0.711 . . . . 0.0 110.739 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.27 2.48 9.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.898 -173.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.724 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 4.8 t -165.4 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.07 0.462 . . . . 0.0 110.543 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.457 ' H ' ' HB3' ' A' ' 31' ' ' SER . 15.7 pt -127.37 146.66 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.962 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.96 HG13 HG22 ' A' ' 48' ' ' THR . 36.6 t -125.86 116.21 45.36 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.001 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.877 HG21 ' HA2' ' A' ' 139' ' ' GLY . 18.1 t -102.56 118.34 49.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.313 0.578 . . . . 0.0 110.478 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 9.2 t70 -119.28 127.95 53.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.023 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.603 ' SD ' ' HA ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -130.73 117.11 18.94 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.778 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 4.6 p30 -117.39 125.76 51.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.49 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -129.64 90.24 44.26 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -33.19 118.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.33 -0.403 1 C-N-CA 125.59 4.193 . . . . 0.0 114.773 -168.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.1 m 79.17 -35.68 0.16 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 171.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 32.5 t -94.98 -14.2 24.6 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 122.312 1.053 . . . . 0.0 109.217 -174.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.701 ' HA3' HD22 ' A' ' 131' ' ' LEU . . . 179.59 64.42 0.07 OUTLIER Glycine 0 N--CA 1.414 -2.781 0 N-CA-C 105.836 -2.906 . . . . 0.0 105.836 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 24.1 t70 -49.63 -47.26 49.89 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.33 1.052 . . . . 0.0 111.528 -159.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.778 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 12.8 ptm180 -164.66 151.88 11.37 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.914 169.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 43.8 pt -139.16 141.17 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.663 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 93.0 mtt180 -123.06 105.83 10.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.106 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.71 ' HB3' ' HE3' ' A' ' 49' ' ' MET . 1.3 tt -89.66 102.85 15.53 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.96 HG22 HG13 ' A' ' 33' ' ' VAL . 82.4 p -99.13 117.58 33.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.893 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.71 ' HE3' ' HB3' ' A' ' 47' ' ' LEU . 2.0 mpt? -105.82 178.65 4.5 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.243 0.544 . . . . 0.0 110.812 -172.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.724 ' HA ' ' HB2' ' A' ' 31' ' ' SER . 14.5 tmtt? -152.29 97.93 2.35 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 10.0 mt -115.48 89.45 3.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.607 -171.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -113.02 94.31 4.84 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.445 1.117 . . . . 0.0 109.593 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.67 -104.24 0.45 Allowed Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.763 -173.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -151.74 22.34 0.69 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 111.813 -2.193 . . . . 0.0 108.439 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 2.0 pp -132.19 160.38 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.007 -170.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.476 ' HA ' HD23 ' A' ' 51' ' ' LEU . 3.0 p -97.92 109.06 22.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 166.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.589 ' HB2' HD13 ' A' ' 55' ' ' ILE . 2.5 tm-20 -97.68 -34.16 11.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -164.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.559 ' OD2' HD21 ' A' ' 28' ' ' LEU . 19.6 t70 -143.4 147.2 34.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.947 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 48' ' ' THR . . . -167.85 134.33 2.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.552 0.215 . . . . 0.0 110.524 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -136.85 175.56 9.5 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.663 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -127.57 133.83 49.75 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 123.972 0.795 . . . . 0.0 111.067 176.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -128.89 132.09 47.67 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.21 -177.96 48.58 Favored Glycine 0 C--N 1.31 -0.901 0 C-N-CA 118.695 -1.717 . . . . 0.0 113.804 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -139.82 125.47 19.33 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.96 -131.48 1.35 Allowed Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -171.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.4 p -131.48 174.5 10.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 118.187 0.994 . . . . 0.0 111.653 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.501 ' HB2' ' HE1' ' A' ' 11' ' ' TYR . 6.3 p -52.89 -49.3 66.14 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -168.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.823 HG21 HD21 ' A' ' 7' ' ' LEU . 2.5 pp -77.28 -24.62 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.704 -171.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.559 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.7 m -68.95 -45.69 70.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.381 0.61 . . . . 0.0 109.59 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.435 ' HG2' ' CZ ' ' A' ' 61' ' ' PHE . 55.2 mtt -67.08 -35.23 79.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.813 173.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 74' ' ' SER . . . -69.25 -44.36 72.12 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -172.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 50.5 m -62.89 -50.28 71.49 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.6 -40.54 72.19 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 114.59 -1.187 . . . . 0.0 111.414 174.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 71' ' ' ALA . 64.1 m -47.95 -55.94 8.78 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 175.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.764 ' HG3' ' HA3' ' A' ' 111' ' ' GLY . 1.3 tmt? -71.08 -37.4 72.45 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -172.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.681 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 6.6 mmt -77.0 -34.98 57.43 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.656 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 30.1 m -62.95 -21.12 65.86 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.946 -1.096 . . . . 0.0 109.393 169.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -85.81 -38.69 17.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.572 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.0 -44.41 11.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.626 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -76.61 -38.5 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 122.886 0.474 . . . . 0.0 111.084 -171.284 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' A' ' 77' ' ' THR . 8.3 ttpp -49.77 -17.02 0.29 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.6 37.84 3.16 Favored Glycine 0 C--O 1.218 -0.86 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -133.32 -166.74 1.81 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.8 p-10 -123.78 -163.61 1.15 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.752 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -81.66 -44.74 20.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.267 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -66.09 -39.77 90.28 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.879 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.4 p -64.14 -38.76 92.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.701 0.286 . . . . 0.0 110.563 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.46 ' HB1' HG13 ' A' ' 140' ' ' VAL . . . -60.2 -46.49 89.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 122.011 0.91 . . . . 0.0 110.346 174.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 48.1 mt -63.3 -34.26 77.31 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.77 0.795 . . . . 0.0 109.797 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.0 m -64.01 -25.63 68.21 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.731 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 94.6 mmm -71.48 -38.64 71.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.3 0.571 . . . . 0.0 110.263 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.55 ' CB ' ' H ' ' A' ' 143' ' ' GLU . 15.1 t -64.41 -39.81 94.56 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.889 171.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.98 -45.33 86.93 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 121.954 0.883 . . . . 0.0 109.533 172.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 104' ' ' TYR . 44.9 mt -59.5 -51.31 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.563 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -57.6 -37.81 73.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.396 0.617 . . . . 0.0 112.233 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.2 p -72.62 -34.56 67.42 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.776 -0.578 . . . . 0.0 110.824 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.1 -42.71 72.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.497 0.665 . . . . 0.0 110.777 172.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.2 tmt? -56.1 -15.29 3.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.008 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 57.7 ttp -85.38 -22.21 28.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.857 0.837 . . . . 0.0 109.577 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -77.49 2.63 15.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.309 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.39 44.35 51.76 Favored Glycine 0 CA--C 1.503 -0.717 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.976 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.639 ' HG2' ' H ' ' A' ' 103' ' ' GLU . 78.2 tttt -123.3 -136.94 0.3 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.639 ' H ' ' HG2' ' A' ' 102' ' ' LYS . 51.0 mt-10 -75.25 -158.07 0.08 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.381 0.61 . . . . 0.0 110.207 172.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.51 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -146.73 -102.12 0.09 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.149 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.51 ' H ' ' HD1' ' A' ' 104' ' ' TYR . 8.0 t70 -108.7 105.94 15.76 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.29 20.65 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.505 0.722 . . . . 0.0 112.4 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.488 ' H ' ' C ' ' A' ' 105' ' ' ASP . 1.7 m -109.59 -20.09 12.98 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 166.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 108' ' ' ILE . 22.3 mm 70.42 28.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.018 171.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -97.03 90.67 5.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.543 ' HB3' ' HG3' ' A' ' 114' ' ' GLU . 4.3 mp -127.23 17.34 7.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.978 -169.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.764 ' HA3' ' HG3' ' A' ' 75' ' ' MET . . . -46.58 -36.64 8.16 Favored Glycine 0 C--N 1.34 0.805 0 O-C-N 124.448 1.092 . . . . 0.0 114.192 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 16.7 p-10 -75.68 -58.48 3.25 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 122.582 -0.363 . . . . 0.0 111.271 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.732 ' HA ' ' HB2' ' A' ' 116' ' ' LEU . 53.1 mt -63.14 -24.94 37.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 C-N-CA 124.706 1.203 . . . . 0.0 111.299 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 16.8 mt-10 -62.74 -48.97 76.89 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.36 -47.07 71.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.708 171.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.732 ' HB2' ' HA ' ' A' ' 113' ' ' ILE . 8.1 mt -58.67 -34.32 71.12 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.026 0.441 . . . . 0.0 111.188 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 52.6 tt0 -42.97 -53.06 4.94 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.622 1.569 . . . . 0.0 112.386 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.38 -17.68 70.75 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.601 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.719 HG13 ' HB3' ' A' ' 125' ' ' ARG . 48.9 t -84.8 -46.24 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 117.224 0.512 . . . . 0.0 111.18 -173.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.673 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 24.5 m -42.49 -16.14 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -127.8 -3.25 5.91 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -162.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.735 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 6.6 m-85 -83.17 145.59 49.36 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -46.98 -39.15 24.79 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.424 2.75 . . . . 0.0 112.874 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.21 5.38 19.93 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.735 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 22.1 mtm180 -112.68 2.15 16.0 Favored 'General case' 0 C--O 1.202 -1.42 0 CA-C-O 122.303 1.049 . . . . 0.0 109.93 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -78.96 -37.65 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 113.989 -1.459 . . . . 0.0 108.912 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -74.79 -21.53 59.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.027 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 5.9 t -85.77 -16.91 37.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.582 -1.645 . . . . 0.0 109.248 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.673 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -85.65 -27.55 25.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 124.582 1.176 . . . . 0.0 108.988 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.735 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 3.0 m -70.67 -39.26 73.66 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 175.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.701 HD22 ' HA3' ' A' ' 42' ' ' GLY . 16.7 tp -49.62 -60.86 2.49 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.823 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.475 ' HB2' ' CD2' ' A' ' 116' ' ' LEU . 10.5 m -78.03 -60.67 2.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -171.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.532 ' HB2' HD22 ' A' ' 116' ' ' LEU . 67.0 t90 -66.42 -52.59 44.86 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.735 ' HB3' ' O ' ' A' ' 130' ' ' THR . 21.9 ttmt -58.94 -36.48 74.84 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.047 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.17 77.97 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.173 172.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.55 ' CD2' ' HG3' ' A' ' 76' ' ' MET . 13.5 tp -76.37 -35.87 58.45 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.74 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -71.18 -32.95 69.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.966 0.889 . . . . 0.0 109.073 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -81.44 4.99 19.04 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.403 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.877 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -91.86 -44.65 4.13 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.705 -0.679 . . . . 0.0 113.734 -171.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.46 HG13 ' HB1' ' A' ' 88' ' ' ALA . 12.4 p -166.95 -27.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 122.156 -0.614 . . . . 0.0 111.056 -174.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.72 ' HA ' HD23 ' A' ' 89' ' ' LEU . . . -78.94 160.73 27.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.484 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 141' ' ' ALA . 87.0 tttt 170.0 76.6 0.0 OUTLIER 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.372 0.669 . . . . 0.0 110.703 173.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.55 ' H ' ' CB ' ' A' ' 92' ' ' SER . 17.8 tp10 -81.62 -48.43 11.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 170.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -122.81 113.66 19.46 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.647 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -90.87 9.63 77.21 Favored Glycine 0 C--N 1.306 -1.115 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.806 -175.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -158.7 -174.97 29.1 Favored Glycine 0 C--N 1.315 -0.615 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.071 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 120.983 0.42 . . . . 0.0 110.851 -177.977 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.454 0.169 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -150.58 -53.31 0.14 Allowed 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.575 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -116.91 159.15 22.87 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.064 0.546 . . . . 0.0 110.215 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.94 138.01 35.92 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.37 137.84 46.84 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 123.974 0.796 . . . . 0.0 110.425 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.54 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 26.6 p-10 -102.66 15.58 28.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.56 HD11 ' O ' ' A' ' 115' ' ' ALA . 22.0 tp -93.57 -19.71 20.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.827 -170.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -58.92 -56.99 15.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 124.042 0.838 . . . . 0.0 109.71 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.1 t -65.03 -37.66 88.33 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 6' ' ' ASN . 58.7 mt -53.1 -35.86 60.08 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.627 0.727 . . . . 0.0 111.039 173.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.428 ' O ' HG13 ' A' ' 15' ' ' ILE . 13.2 m-85 -70.92 -39.22 72.82 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -65.8 -35.21 80.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.659 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -65.84 -28.27 68.86 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 123.998 0.811 . . . . 0.0 109.988 174.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.982 HG11 ' HB1' ' A' ' 71' ' ' ALA . 66.6 t -84.0 -41.72 16.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.221 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 11' ' ' TYR . 76.0 mt -61.7 -29.51 46.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 CA-C-O 121.54 0.685 . . . . 0.0 110.15 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -62.08 -51.17 69.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.386 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 11.4 t70 -72.48 -40.35 67.0 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 10.0 t-80 -54.26 -45.24 72.35 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.443 -177.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -59.03 -52.14 67.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.341 0.256 . . . . 0.0 111.432 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 17' ' ' ASP . 32.7 ttpt -42.89 -34.15 0.91 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 173.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.516 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -154.34 84.58 3.93 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-O 122.032 0.92 . . . . 0.0 111.952 177.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -86.1 65.91 5.22 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.319 2.679 . . . . 0.0 111.807 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 25' ' ' LYS . 62.8 mtt180 -73.27 -77.53 0.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.769 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 5.9 m120 67.24 -22.95 0.11 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 23' ' ' ARG . 30.6 mmtp -114.97 85.7 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.812 0.339 . . . . 0.0 111.24 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -139.75 146.17 17.57 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 121.087 -0.577 . . . . 0.0 112.284 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.49 HG23 HG21 ' A' ' 48' ' ' THR . 7.4 p -168.16 134.59 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 122.689 0.396 . . . . 0.0 110.193 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.682 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -151.62 140.37 20.85 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.69 172.325 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.46 ' HA ' HG21 ' A' ' 33' ' ' VAL . 3.1 p-10 -100.51 39.33 1.38 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.367 -174.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.73 -104.06 0.03 OUTLIER 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.559 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.549 ' CB ' ' HG ' ' A' ' 51' ' ' LEU . 13.0 m -72.05 -76.18 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.317 0.579 . . . . 0.0 112.031 -174.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.906 HG13 ' HB2' ' A' ' 49' ' ' MET . 6.8 pt -119.58 131.05 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-O 121.411 0.624 . . . . 0.0 111.99 -176.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.895 HG13 HG22 ' A' ' 48' ' ' THR . 89.5 t -124.74 129.08 73.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 123.543 0.737 . . . . 0.0 109.762 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.837 HG21 ' HA2' ' A' ' 139' ' ' GLY . 7.1 t -134.25 127.84 51.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.329 0.585 . . . . 0.0 110.386 -173.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.587 ' OD2' ' HD2' ' A' ' 46' ' ' ARG . 2.0 m-20 -117.23 134.45 54.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.249 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.571 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -142.22 122.53 13.94 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.251 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -125.0 140.79 52.6 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.728 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 51.1 t30 -135.11 119.35 13.41 Favored Pre-proline 0 C--O 1.253 1.263 0 O-C-N 121.316 -0.865 . . . . 0.0 109.295 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.469 ' HD2' ' OD1' ' A' ' 38' ' ' ASN . 59.6 Cg_exo -25.5 105.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 1 C-N-CA 126.685 4.923 . . . . 0.0 116.417 -175.11 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.8 m 74.32 -34.52 0.28 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 165.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 127' ' ' LYS . 33.1 t -79.01 -49.23 13.03 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.604 -167.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.654 ' HA3' HD22 ' A' ' 131' ' ' LEU . . . -130.9 24.01 4.34 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.157 -1.021 . . . . 0.0 112.103 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.647 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 34.3 t70 40.77 -96.21 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.137 0 O-C-N 124.85 0.971 . . . . 0.0 111.936 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -136.44 146.38 46.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.356 0.598 . . . . 0.0 111.933 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 tt -131.98 125.18 54.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 170.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.587 ' HD2' ' OD2' ' A' ' 35' ' ' ASP . 24.4 mtm180 -130.36 109.22 10.57 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.189 -174.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.737 HD11 ' HE3' ' A' ' 49' ' ' MET . 0.7 OUTLIER -103.16 100.74 10.67 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 124.33 1.019 . . . . 0.0 108.934 -176.022 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.895 HG22 HG13 ' A' ' 33' ' ' VAL . 57.4 p -97.3 131.42 44.02 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 172.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.906 ' HB2' HG13 ' A' ' 32' ' ' ILE . 55.9 mtt -121.38 -178.56 3.82 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.584 0.707 . . . . 0.0 110.292 -176.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 45.2 tttm -157.63 111.66 2.59 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.549 ' HG ' ' CB ' ' A' ' 31' ' ' SER . 6.3 mt -92.45 140.24 29.77 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.342 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.919 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . 2.4 m-20 -134.18 64.86 1.59 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 140.5 -133.25 5.85 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -164.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -121.11 31.79 6.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 168.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.498 HD11 ' HG2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -127.44 178.22 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.571 -172.27 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -107.61 112.93 42.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.919 ' HG3' ' HB2' ' A' ' 52' ' ' ASP . 4.3 mm-40 -101.8 -31.35 10.79 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 122.03 0.919 . . . . 0.0 109.414 -169.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 33.2 t0 -141.53 144.95 34.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.643 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -152.02 134.39 15.24 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 73.4 mmtt -124.96 129.82 51.12 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.513 ' HB3' HG21 ' A' ' 77' ' ' THR . 47.6 p90 -116.02 141.21 48.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.199 0.524 . . . . 0.0 111.203 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 26.4 tt0 -116.6 121.79 42.74 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.92 128.29 5.24 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.544 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.647 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 10.3 tp10 -150.8 128.02 11.25 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.65 -131.68 2.57 Favored Glycine 0 C--O 1.227 -0.284 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 -171.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.4 p -99.47 159.57 14.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.461 0.63 . . . . 0.0 109.787 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 p -59.22 -38.71 80.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.838 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.785 HD11 HG21 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -61.4 -48.37 89.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.7 m -68.93 -47.35 65.94 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 110.785 -173.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.2 ptp -61.61 -29.91 70.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.452 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.982 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -66.14 -53.17 41.08 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.29 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.2 m -56.42 -40.02 74.02 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 123.9 0.75 . . . . 0.0 109.651 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.7 -57.21 10.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.582 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.441 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 49.2 m -55.76 -48.62 74.96 Favored 'General case' 0 CA--C 1.493 -1.246 0 O-C-N 123.873 0.733 . . . . 0.0 112.266 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.8 tpt -70.65 -54.96 9.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 120.933 0.397 . . . . 0.0 110.551 -174.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.675 ' HG3' HD21 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -59.95 -44.76 94.19 Favored 'General case' 0 C--O 1.205 -1.252 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.556 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.689 ' HA ' HG22 ' A' ' 80' ' ' ILE . 32.0 m -63.03 -36.99 85.42 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.16 0.891 . . . . 0.0 109.784 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -52.41 -47.85 66.07 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.002 174.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.84 -23.97 25.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.453 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.689 HG22 ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -77.48 -30.75 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -174.107 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 81' ' ' LYS . 7.0 ttpm? -52.93 -18.64 2.06 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.483 170.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.78 44.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.638 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 8.3 mttp -132.61 -162.4 1.23 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.019 0.438 . . . . 0.0 110.508 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.9 m-20 -140.83 164.56 29.91 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.577 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mp -68.09 -51.25 50.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 119.239 0.927 . . . . 0.0 110.573 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.91 -36.45 79.3 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.776 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.4 m -66.77 -41.83 87.1 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.614 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.85 82.0 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.57 0.544 . . . . 0.0 111.325 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 83.2 mt -63.59 -39.15 93.65 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.863 0.84 . . . . 0.0 109.028 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.7 t -59.14 -41.9 89.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.411 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.424 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 12.3 ttt -65.63 -38.35 89.14 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.069 0.461 . . . . 0.0 110.586 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.769 ' HB3' ' HD2' ' A' ' 142' ' ' LYS . 16.3 m -60.34 -48.49 81.52 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.045 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 35.5 ttpt -59.85 -40.74 89.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.603 0.716 . . . . 0.0 109.471 175.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.513 HG23 ' HA ' ' A' ' 104' ' ' TYR . 29.8 mt -61.62 -47.83 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.966 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -56.65 -34.49 67.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.818 0.342 . . . . 0.0 110.57 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.3 m -71.58 -44.39 64.57 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.869 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.92 -52.02 53.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.779 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.1 tpt -38.95 -63.51 0.52 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.5 mmm -49.2 -17.13 0.2 Allowed 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -128.07 -4.1 5.67 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.892 0.315 . . . . 0.0 111.193 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -116.44 -32.25 1.67 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.947 -1.121 . . . . 0.0 113.871 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 88.41 -13.93 0.4 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.245 1.418 . . . . 0.0 110.075 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -98.59 134.85 40.95 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.667 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.513 ' HA ' HG23 ' A' ' 94' ' ' ILE . 3.2 p90 -124.75 -121.93 0.26 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.826 -176.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.504 ' O ' HD13 ' A' ' 108' ' ' ILE . 24.8 t70 -94.44 107.15 19.13 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 120.914 0.387 . . . . 0.0 110.342 -174.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -48.29 -19.06 0.26 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.205 -1.361 . . . . 0.0 113.049 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.7 t -92.8 -22.69 19.17 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.662 ' HA ' HD11 ' A' ' 110' ' ' LEU . 23.4 mm 67.56 39.14 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 122.164 0.983 . . . . 0.0 109.855 175.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -99.21 81.93 2.63 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.662 HD11 ' HA ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -144.57 51.34 1.27 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -174.081 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -39.65 -18.76 0.01 OUTLIER Glycine 0 CA--C 1.54 1.605 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.529 ' HB3' ' HG3' ' A' ' 76' ' ' MET . 14.0 p-10 -85.27 -43.4 13.78 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 117.692 0.746 . . . . 0.0 109.522 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.881 ' O ' ' HB2' ' A' ' 117' ' ' GLN . 5.0 tt -70.12 -16.81 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.47 -171.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.4 ' O ' HD13 ' A' ' 10' ' ' LEU . 3.5 mm-40 -56.11 -64.78 0.75 Allowed 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.765 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -76.51 -44.77 33.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.918 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.648 HD12 HG21 ' A' ' 119' ' ' VAL . 14.2 tp -92.64 1.67 57.14 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -163.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.881 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 41.9 tt0 -58.44 -52.12 66.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.385 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.06 -13.6 72.91 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.933 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.785 HG21 HD11 ' A' ' 68' ' ' ILE . 93.3 t -78.83 -46.95 23.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 CA-C-N 117.093 0.446 . . . . 0.0 110.423 -162.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.44 ' O ' ' HD3' ' A' ' 125' ' ' ARG . 14.3 m -42.45 -15.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.59 1.556 . . . . 0.0 115.135 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 125' ' ' ARG . 63.9 pttt -131.3 13.81 5.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.528 -0.733 . . . . 0.0 112.47 -171.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.69 ' HD2' ' HA ' ' A' ' 119' ' ' VAL . 15.4 m-85 -76.43 170.03 18.08 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.199 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.453 ' HD2' ' HD1' ' A' ' 122' ' ' PHE . 30.5 Cg_endo -65.43 -18.95 61.16 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.207 1.938 . . . . 0.0 109.966 166.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.505 ' HB1' ' HD2' ' A' ' 127' ' ' LYS . . . -113.38 17.14 18.69 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.984 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.616 ' HG3' ' N ' ' A' ' 126' ' ' ILE . 18.6 ptp180 -44.05 -61.18 1.55 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.127 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.616 ' N ' ' HG3' ' A' ' 125' ' ' ARG . 39.9 pt -59.48 -22.97 24.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.184 -172.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.728 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 99.5 mttt -68.34 -63.25 1.1 Allowed 'General case' 0 C--N 1.313 -1.003 0 O-C-N 122.247 -0.283 . . . . 0.0 110.402 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.8 m -85.67 -35.2 21.05 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.451 0.644 . . . . 0.0 110.675 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.689 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -73.85 -51.28 16.8 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.618 -173.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.567 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 36.7 m -63.83 -45.87 87.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.183 -177.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.654 HD22 ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -56.63 -50.09 73.06 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.163 -0.961 . . . . 0.0 110.567 179.382 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.478 ' N ' ' HG ' ' A' ' 131' ' ' LEU . 7.1 m -76.7 -61.53 1.94 Allowed 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -174.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -61.51 -53.46 56.04 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 123.852 0.72 . . . . 0.0 111.139 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 130' ' ' THR . 88.0 tttt -55.33 -42.91 74.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' A' ' 36' ' ' MET . . . -61.17 -50.29 73.74 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.549 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.675 HD21 ' HG3' ' A' ' 76' ' ' MET . 11.8 tp -65.2 -31.69 72.99 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.461 0.648 . . . . 0.0 110.338 -175.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.708 ' CG ' ' HD3' ' A' ' 142' ' ' LYS . 2.9 tp10 -83.52 -32.33 25.96 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.79 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 23.9 tptp -71.09 -47.15 59.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.837 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -41.36 -34.68 1.07 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.395 -0.82 . . . . 0.0 114.35 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.465 ' O ' HD21 ' A' ' 89' ' ' LEU . 27.2 m -108.12 -1.09 9.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.147 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 90.09 3.43 0.16 Allowed 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 168.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.769 ' HD2' ' HB3' ' A' ' 92' ' ' SER . 43.0 tptt 55.18 87.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 171.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 69.3 -52.69 0.6 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.956 0.903 . . . . 0.0 112.228 172.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -165.65 -71.47 0.03 OUTLIER 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.21 40.82 0.07 OUTLIER Glycine 0 C--N 1.319 -0.409 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.201 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.8 -122.82 0.72 Allowed Glycine 0 C--O 1.24 0.512 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.522 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.438 ' OD1' ' HE3' ' A' ' 142' ' ' LYS . 11.7 p30 . . . . . 0 N--CA 1.47 0.554 0 C-N-CA 123.95 0.9 . . . . 0.0 112.606 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 110.725 -0.102 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.5 m -126.51 128.22 46.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.978 0.418 . . . . 0.0 110.46 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.0 t80 66.4 91.58 0.08 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.823 0.82 . . . . 0.0 111.028 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -144.59 -1.39 0.9 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.617 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.25 95.88 2.22 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -103.99 -45.12 4.84 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.097 -174.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.509 HD21 HG22 ' A' ' 119' ' ' VAL . 21.5 tp -70.46 -42.75 71.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.022 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.81 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 17.8 t70 -54.5 -53.76 50.04 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.417 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 m -57.29 -54.39 47.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.337 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.616 ' O ' HG13 ' A' ' 14' ' ' VAL . 4.3 mp -47.33 -52.42 16.48 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.419 1.074 . . . . 0.0 111.862 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.81 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 0.6 OUTLIER -79.19 -19.42 50.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.488 -175.506 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -66.6 -35.67 80.74 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-O 121.412 0.625 . . . . 0.0 109.358 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -75.65 -35.23 60.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.081 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.788 HG22 ' HA ' ' A' ' 11' ' ' TYR . 3.2 m -72.48 -35.34 51.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.961 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.576 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 14.5 tt -77.41 -22.67 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.929 174.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 17.2 tpt -84.9 -38.78 18.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.323 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.775 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 20.3 t70 -77.9 -37.13 48.63 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.458 ' CD2' ' HB3' ' A' ' 24' ' ' ASN . 26.1 t60 -71.43 -16.46 62.38 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.068 171.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.576 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 46.4 t80 -73.57 -48.22 34.55 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.333 0.587 . . . . 0.0 110.014 171.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.775 ' HD3' ' HA ' ' A' ' 17' ' ' ASP . 41.4 mtpt -48.61 -45.79 38.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.846 171.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -114.81 78.41 5.22 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 18' ' ' HIS . 72.7 Cg_endo -77.62 51.11 3.44 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 122.999 2.466 . . . . 0.0 113.414 -165.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -83.72 50.41 1.8 Allowed 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 121.801 -0.562 . . . . 0.0 109.57 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.458 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . 20.0 p-10 -114.2 24.77 11.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.9 0.857 . . . . 0.0 109.044 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -133.15 139.44 47.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.835 -1.53 . . . . 0.0 108.868 173.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 142.67 141.89 3.94 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.103 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.661 HG13 ' HB2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -159.27 127.93 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.349 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.757 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -136.11 147.68 47.9 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.491 0.663 . . . . 0.0 110.56 176.435 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -93.26 44.08 1.13 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.23 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.458 ' HB3' ' H ' ' A' ' 31' ' ' SER . 1.2 m-20 -85.67 -130.37 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.031 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.458 ' H ' ' HB3' ' A' ' 30' ' ' ASP . 14.9 m -52.12 -77.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.814 HG13 ' HB2' ' A' ' 49' ' ' MET . 12.8 pt -127.02 137.86 56.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.622 0.725 . . . . 0.0 110.394 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.639 HG13 HG22 ' A' ' 48' ' ' THR . 95.7 t -123.09 114.69 43.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.617 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.963 HG21 ' HA2' ' A' ' 139' ' ' GLY . 93.9 t -106.88 119.3 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.074 -176.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 2.0 p-10 -127.85 149.57 50.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.504 0.669 . . . . 0.0 110.141 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 45' ' ' ILE . 27.3 ttt -157.37 132.11 8.66 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.173 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 7.0 p30 -127.28 135.62 50.83 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -113.63 88.33 13.43 Favored Pre-proline 0 N--CA 1.439 -0.983 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 167.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -60.08 -6.26 4.8 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.386 2.058 . . . . 0.0 113.889 -169.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.7 p -98.6 -51.03 4.06 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.294 0.568 . . . . 0.0 111.784 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 51.6 t -135.23 17.99 3.42 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -169.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.22 -3.37 0.37 Allowed Glycine 0 N--CA 1.47 0.956 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.406 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.631 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 11.5 m-20 53.79 -110.7 0.56 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 118.394 -0.812 . . . . 0.0 111.117 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 31.3 ptt180 -158.67 148.83 19.69 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.652 1.115 . . . . 0.0 112.549 -176.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.568 HG13 ' CE1' ' A' ' 61' ' ' PHE . 5.0 tt -130.4 133.26 64.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.571 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -121.56 103.44 8.92 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.246 0.341 . . . . 0.0 111.695 173.187 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.682 HD22 ' HG3' ' A' ' 49' ' ' MET . 1.9 tt -92.6 106.63 18.58 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 172.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.757 ' HB ' HD12 ' A' ' 28' ' ' LEU . 44.9 p -99.27 123.5 43.6 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.814 ' HB2' HG13 ' A' ' 32' ' ' ILE . 52.2 mtt -113.26 178.7 4.19 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 123.741 0.651 . . . . 0.0 111.73 -175.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.435 ' HA ' ' OG ' ' A' ' 31' ' ' SER . 86.9 tttt -160.24 100.56 1.37 Allowed 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -116.72 92.16 3.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.065 0.936 . . . . 0.0 111.501 -175.503 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -103.36 89.36 3.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.466 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.31 -100.88 0.32 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-O 122.985 1.325 . . . . 0.0 111.821 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -159.6 35.85 0.19 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 111.375 -2.412 . . . . 0.0 106.681 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.676 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.3 pp -140.13 143.58 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.187 -171.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.49 HG11 HG23 ' A' ' 80' ' ' ILE . 1.3 p -92.59 113.35 27.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -102.1 -32.01 10.34 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 113.978 -1.465 . . . . 0.0 107.941 -163.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -136.48 129.51 31.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.65 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.63 104.49 3.75 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.434 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 29.0 mmtp -120.75 151.95 38.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.922 -175.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.568 ' CE1' HG13 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -130.53 135.75 48.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.661 ' HB2' HG13 ' A' ' 27' ' ' VAL . 1.1 tm-20 -142.09 114.56 8.39 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.76 -177.49 39.16 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.004 -172.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -139.85 157.71 45.28 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.631 ' HA2' ' HB2' ' A' ' 43' ' ' ASP . . . 157.26 -143.17 9.27 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 119.253 -1.451 . . . . 0.0 112.502 176.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.412 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 61.1 m -76.31 164.57 25.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.271 0.558 . . . . 0.0 110.828 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -63.41 -35.47 80.52 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.008 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.644 HG13 HG21 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -82.81 -29.02 8.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.05 -177.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.526 ' N ' HD13 ' A' ' 68' ' ' ILE . 8.3 m -66.92 -55.0 16.52 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.699 -0.625 . . . . 0.0 110.729 -174.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -69.55 -16.25 63.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.656 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.542 ' HB1' HG23 ' A' ' 14' ' ' VAL . . . -85.84 -53.3 5.2 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.553 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.417 ' OG ' ' HB2' ' A' ' 116' ' ' LEU . 37.3 t -74.1 -51.21 16.39 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.746 0.654 . . . . 0.0 109.818 -171.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.36 -51.91 65.25 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.219 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . 30.3 t -66.16 -38.46 88.14 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.915 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.563 ' SD ' ' HB ' ' A' ' 14' ' ' VAL . 28.7 ttt -59.32 -46.83 87.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.352 0.596 . . . . 0.0 110.671 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.409 ' HB3' ' CD1' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -75.48 -23.28 56.78 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.175 178.497 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.596 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 99.6 m -67.97 -43.72 78.33 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-O 122.389 1.09 . . . . 0.0 110.008 172.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.8 tm0? -58.8 -27.03 64.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.835 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.74 -33.6 23.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.596 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 2.3 mm -67.83 -36.24 75.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.616 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -56.8 -18.87 14.39 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.716 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.94 38.39 2.95 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.749 ' HE3' ' HB ' ' A' ' 87' ' ' THR . 27.3 tptt -131.45 164.33 25.97 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -172.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.635 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.4 p-10 -111.65 -175.2 2.64 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 169.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.768 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.1 mp -76.3 -39.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.267 -173.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -60.67 -48.59 81.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.002 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.749 ' HB ' ' HE3' ' A' ' 83' ' ' LYS . 18.6 p -71.7 -36.12 70.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.557 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -56.42 -40.5 74.84 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.429 0.633 . . . . 0.0 111.466 172.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 66.3 mt -62.62 -33.82 75.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.367 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -80.45 -25.2 39.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.631 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -65.0 -27.31 68.73 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 121.844 0.83 . . . . 0.0 109.362 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.4 m -88.59 -23.53 23.08 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.366 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 143' ' ' GLU . 83.5 tttt -79.01 -30.17 44.08 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.626 177.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.8 tt -82.21 -33.6 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -50.47 -33.34 20.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.166 163.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.7 m -81.65 -27.82 33.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.484 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.422 ' OD1' ' HA3' ' A' ' 101' ' ' GLY . 20.6 t70 -66.11 -35.79 81.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.707 ' HA ' ' CE1' ' A' ' 104' ' ' TYR . 59.7 ttp -48.15 -16.71 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.252 0.621 . . . . 0.0 112.609 169.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 73.7 mtm -117.96 -36.38 3.64 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.066 -0.396 . . . . 0.0 111.259 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -106.33 -43.43 4.78 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.063 0.459 . . . . 0.0 110.457 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.422 ' HA3' ' OD1' ' A' ' 97' ' ' ASP . . . -81.5 -57.14 2.82 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.872 -174.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 61.28 81.4 0.19 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.538 0.685 . . . . 0.0 111.242 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -178.9 31.82 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.558 0.695 . . . . 0.0 110.335 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.736 ' HD2' HD11 ' A' ' 110' ' ' LEU . 15.6 p90 -103.82 113.1 26.38 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.483 0.658 . . . . 0.0 110.045 -176.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -137.71 70.43 1.39 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.038 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.86 ' H ' HD22 ' A' ' 110' ' ' LEU . 32.1 t70 60.67 6.62 1.17 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.613 0.72 . . . . 0.0 111.202 168.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.2 m -111.9 3.74 17.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.703 -173.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.422 ' HB ' ' H ' ' A' ' 109' ' ' ASP . 1.9 mp -131.99 -77.69 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.422 ' H ' ' HB ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -144.79 166.72 24.43 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 167.404 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.86 HD22 ' H ' ' A' ' 106' ' ' ASP . 3.1 tp 173.11 -7.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -39.04 -46.39 2.38 Favored Glycine 0 C--N 1.355 1.589 0 C-N-CA 121.155 -0.545 . . . . 0.0 114.282 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.477 ' OD2' HG13 ' A' ' 113' ' ' ILE . 2.8 p-10 -70.69 -59.61 2.72 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.994 HG23 ' HB3' ' A' ' 117' ' ' GLN . 41.0 mt -50.9 -40.7 20.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.995 0.918 . . . . 0.0 112.57 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 10' ' ' LEU . 12.2 mm-40 -61.75 -12.22 15.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.462 0.649 . . . . 0.0 111.57 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.589 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -138.37 19.4 2.75 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.753 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.585 HD12 HG21 ' A' ' 119' ' ' VAL . 10.0 tp -161.88 -20.78 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -169.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.994 ' HB3' HG23 ' A' ' 113' ' ' ILE . 22.4 pt20 -60.09 -31.32 69.91 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.794 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.578 ' HA2' ' HE2' ' A' ' 121' ' ' LYS . . . -80.62 -16.96 74.34 Favored Glycine 0 CA--C 1.504 -0.597 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.656 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.851 HG13 ' HB3' ' A' ' 125' ' ' ARG . 79.7 t -81.6 -43.86 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 123.291 0.636 . . . . 0.0 110.36 -171.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.563 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 4.8 m -36.09 -16.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.578 ' HE2' ' HA2' ' A' ' 118' ' ' GLY . 0.3 OUTLIER -146.66 0.47 0.77 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 119.969 1.258 . . . . 0.0 113.626 -166.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.771 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 12.9 m-30 -75.18 136.22 72.71 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 172.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 122' ' ' PHE . 52.4 Cg_exo -55.05 -26.63 50.91 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.682 2.255 . . . . 0.0 111.971 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.38 -0.29 35.69 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.851 ' HB3' HG13 ' A' ' 119' ' ' VAL . 64.0 mtt180 -129.26 12.77 6.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.165 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -80.22 -32.24 13.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 122.796 1.284 . . . . 0.0 108.033 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -83.24 -20.91 33.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.606 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 57.4 m -82.57 -18.6 40.77 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.921 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.596 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -84.54 -36.43 22.16 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.972 -176.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.643 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 3.9 m -75.01 -40.45 60.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.428 HD22 ' HB3' ' A' ' 69' ' ' SER . 8.2 tt -50.7 -51.14 52.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.105 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 t -80.24 -60.89 2.16 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.066 -174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -62.87 -53.27 56.78 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.854 0.359 . . . . 0.0 111.751 -175.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.643 ' HB3' ' O ' ' A' ' 130' ' ' THR . 19.9 tptm -59.39 -34.8 72.88 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.913 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.89 -34.5 59.66 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.073 171.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.409 ' CD1' ' HB3' ' A' ' 76' ' ' MET . 82.2 mt -84.24 -39.43 19.29 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.34 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -70.47 -39.74 74.06 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.64 0.733 . . . . 0.0 110.905 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.759 ' HE3' ' HA ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -84.88 12.38 7.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.094 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.963 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -102.86 -29.72 5.74 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.196 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.557 HG21 ' HB1' ' A' ' 88' ' ' ALA . 29.3 m -131.56 -23.49 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -174.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 90.46 175.29 0.02 OUTLIER 'General case' 0 C--N 1.351 0.663 0 C-N-CA 125.093 1.357 . . . . 0.0 109.759 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -123.95 149.15 46.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.241 -0.912 . . . . 0.0 112.405 -169.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -92.48 104.83 17.11 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 162.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 144' ' ' GLU . 10.3 pt-20 -87.96 -142.81 0.12 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.133 -166.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 163.48 35.42 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.24 157.65 15.09 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.061 -0.57 . . . . 0.0 111.788 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.1 t30 . . . . . 0 C--N 1.314 -0.972 0 CA-C-N 117.504 0.652 . . . . 0.0 111.486 -175.05 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.436 ' SD ' ' HB2' ' A' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.408 0.623 . . . . 0.0 109.613 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -75.64 -57.4 3.9 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.66 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.436 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 41.2 t80 72.69 -56.05 0.66 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.849 0.86 . . . . 0.0 110.95 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -75.83 116.09 16.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.88 72.5 6.63 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.704 -171.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -69.39 82.47 0.38 Allowed 'General case' 0 C--N 1.317 -0.82 0 O-C-N 123.876 0.735 . . . . 0.0 110.875 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.783 ' HA ' HD12 ' A' ' 10' ' ' LEU . 55.8 tp 169.47 -36.55 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 17.3 t70 -61.56 -57.03 13.72 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.32 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.603 ' HA ' ' HG2' ' A' ' 12' ' ' ARG . 29.1 p -51.02 -43.05 60.8 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.751 0.786 . . . . 0.0 111.729 173.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.783 HD12 ' HA ' ' A' ' 7' ' ' LEU . 88.2 mt -51.79 -48.01 63.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.81 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.5 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.8 m-85 -67.64 -35.55 79.1 Favored 'General case' 0 CA--C 1.5 -0.981 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.415 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.603 ' HG2' ' HA ' ' A' ' 9' ' ' THR . 21.6 mmm-85 -59.91 -30.76 69.26 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.739 -0.601 . . . . 0.0 110.075 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -82.32 -34.79 28.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 75' ' ' MET . 94.9 t -76.96 -30.77 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.594 -176.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 11' ' ' TYR . 30.9 pt -83.84 -19.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 26.1 ttt -64.15 -44.65 91.48 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.838 0.828 . . . . 0.0 109.242 175.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.18 -33.9 63.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.481 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -62.11 -26.56 68.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.174 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -68.63 -54.35 16.93 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.566 -0.709 . . . . 0.0 110.557 168.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -48.68 -38.23 20.72 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.235 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -112.84 81.31 4.37 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.48 -16.39 23.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.422 3.415 . . . . 0.0 115.475 -159.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -148.48 164.74 33.27 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.286 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -151.03 81.02 1.32 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.114 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.638 ' HG3' ' HG3' ' A' ' 62' ' ' GLU . 58.7 tttm -141.82 93.79 2.6 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.363 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.78 152.63 24.75 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.787 HG23 HG21 ' A' ' 48' ' ' THR . 2.9 p -150.29 132.61 6.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.197 0.522 . . . . 0.0 110.141 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.771 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -153.71 146.32 24.17 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 176.283 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -111.49 139.34 47.01 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.804 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t70 172.21 -79.74 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.603 0.761 . . . . 0.0 109.188 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.528 ' HB3' ' HG ' ' A' ' 51' ' ' LEU . 14.1 m -72.01 -86.49 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.519 -175.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.671 HG13 ' HB2' ' A' ' 49' ' ' MET . 4.3 pt -138.23 134.31 44.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.299 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.579 HG13 HG22 ' A' ' 48' ' ' THR . 61.4 t -125.62 121.93 61.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.728 0.775 . . . . 0.0 110.201 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.025 HG21 ' HA2' ' A' ' 139' ' ' GLY . 2.8 t -117.36 124.83 73.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.352 -176.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.5 p-10 -126.43 138.98 53.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.826 0.346 . . . . 0.0 110.395 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.657 ' HG2' ' HA ' ' A' ' 131' ' ' LEU . 2.0 tpt -147.1 131.26 17.36 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.532 ' H ' ' HE2' ' A' ' 36' ' ' MET . 8.5 p30 -109.77 132.29 54.28 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.223 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -121.96 98.88 44.59 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 161.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -32.33 109.0 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 125.171 3.914 . . . . 0.0 115.147 -168.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 m 71.73 -20.49 0.24 Allowed 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.095 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 51.6 t -95.42 -33.19 12.57 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.37 1.081 . . . . 0.0 109.142 -175.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.506 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . -157.61 60.9 0.33 Allowed Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 104.714 -3.354 . . . . 0.0 104.714 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.68 -43.04 89.84 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.594 -1.303 . . . . 0.0 112.048 -156.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -148.44 132.41 17.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 118.246 -1.382 . . . . 0.0 109.926 168.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.586 HG13 ' CE1' ' A' ' 61' ' ' PHE . 8.7 tt -124.33 116.15 46.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 20.4 ttt180 -121.36 102.79 8.5 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.649 -0.657 . . . . 0.0 111.924 -172.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.574 HD21 ' CE ' ' A' ' 49' ' ' MET . 28.1 tp -87.82 102.58 14.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.342 173.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.787 HG21 HG23 ' A' ' 27' ' ' VAL . 31.6 p -98.4 112.35 24.39 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 171.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.671 ' HB2' HG13 ' A' ' 32' ' ' ILE . 24.9 mtt -100.87 178.88 4.56 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.117 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.914 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 56.3 tttp -157.28 93.4 1.31 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.609 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 2.2 pp -117.72 108.95 16.02 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 113.183 -1.826 . . . . 0.0 106.848 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -98.84 60.46 1.25 Allowed 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.931 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.28 -98.58 0.19 Allowed Glycine 0 N--CA 1.424 -2.152 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.195 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -128.78 22.47 5.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.757 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.4 pp -135.77 144.8 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -98.28 122.77 50.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -115.94 -21.21 9.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.998 0.904 . . . . 0.0 109.099 -170.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.914 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 17.1 t70 -141.35 149.11 40.74 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.885 174.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -161.75 108.06 1.34 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.769 0.795 . . . . 0.0 109.124 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -107.3 147.72 29.9 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.328 0.585 . . . . 0.0 109.57 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.601 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.9 t80 -121.38 129.01 52.79 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.998 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.638 ' HG3' ' HG3' ' A' ' 25' ' ' LYS . 27.8 tt0 -128.26 124.44 36.63 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.72 -177.72 48.28 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 119.132 -1.508 . . . . 0.0 112.72 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -141.71 128.95 21.02 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.506 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . -169.49 -132.1 1.4 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.5 -1.334 . . . . 0.0 110.81 -175.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 7.3 p -123.35 -163.98 1.17 Allowed 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 p -55.77 -26.5 46.22 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.798 HG13 ' HB3' ' A' ' 128' ' ' CYS . 7.3 mm -62.48 -66.62 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.649 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 p -55.43 -32.57 62.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.225 1.012 . . . . 0.0 109.909 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -61.7 -60.86 3.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.286 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.626 ' HB1' ' HB1' ' A' ' 115' ' ' ALA . . . -71.68 -43.3 66.25 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -172.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.513 ' HB3' HD11 ' A' ' 116' ' ' LEU . 49.4 p -59.0 -39.61 82.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 110.632 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.765 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -75.01 -48.93 21.63 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.232 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 27.6 m -55.35 -61.04 2.6 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.802 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.621 ' HB2' HG13 ' A' ' 14' ' ' VAL . 12.6 tpt -83.1 -57.63 3.2 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.525 ' CG ' HD13 ' A' ' 136' ' ' LEU . 10.5 tpt -74.02 -27.9 61.18 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -171.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.765 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 85.6 m -73.32 -40.99 64.05 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 74' ' ' SER . 8.3 tt0 -59.54 -26.22 65.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.183 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.26 -33.58 22.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.65 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -67.6 -42.96 87.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.11 178.389 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 65.2 tttm -56.45 -16.28 5.57 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.686 0.794 . . . . 0.0 111.694 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.89 38.59 2.95 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.419 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -135.25 179.09 6.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.741 0.27 . . . . 0.0 111.597 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.649 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.0 m-20 -100.41 176.94 5.18 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.699 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 12.6 mm -84.41 -43.11 17.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.548 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -63.36 -38.27 90.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.02 0.438 . . . . 0.0 110.318 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -61.62 -41.3 97.27 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 121.72 0.772 . . . . 0.0 110.866 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -66.11 -34.98 79.28 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 121.927 -0.483 . . . . 0.0 110.605 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 70.7 mt -64.71 -39.72 94.12 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.453 1.121 . . . . 0.0 109.735 175.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.551 ' O ' HG12 ' A' ' 94' ' ' ILE . 26.9 t -67.09 -41.66 85.94 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.827 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.475 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 16.9 tpt -62.85 -22.42 66.66 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 122.287 1.041 . . . . 0.0 110.854 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.542 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 27.5 t -89.03 -35.95 16.07 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.499 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -66.58 -51.51 55.63 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.813 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 105' ' ' ASP . 22.1 pt -65.1 -39.83 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.838 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 91' ' ' MET . 39.2 t80 -53.51 -35.93 61.19 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.411 0.624 . . . . 0.0 111.143 174.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.6 m -86.31 -35.85 19.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.134 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.54 -35.96 75.92 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.096 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 1.3 tmt? -39.22 -49.75 1.9 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 124.127 0.892 . . . . 0.0 111.689 178.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.2 mtt -57.21 -10.63 1.32 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -124.46 -35.24 2.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.773 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.734 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -88.69 -32.07 11.92 Favored Glycine 0 C--O 1.239 0.448 0 C-N-CA 119.511 -1.328 . . . . 0.0 114.168 -173.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.734 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 22.4 tttm 97.64 -29.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.758 1.223 . . . . 0.0 109.699 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 98' ' ' MET . 0.7 OUTLIER -82.09 163.21 22.19 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.103 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.65 -106.34 0.24 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.72 ' HA ' HD12 ' A' ' 94' ' ' ILE . 31.7 t70 -95.34 101.73 13.48 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 172.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.27 8.87 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.449 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 65.3 m -105.78 -16.95 14.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 169.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 108' ' ' ILE . 32.0 mm 65.37 27.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-O 121.816 0.817 . . . . 0.0 110.949 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -95.41 86.93 4.63 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 170.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 113' ' ' ILE . 6.7 mt -123.75 43.94 2.84 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.393 -165.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -40.47 -33.21 0.53 Allowed Glycine 0 CA--C 1.538 1.51 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.674 168.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.54 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 3.8 p-10 -58.32 -72.78 0.09 Allowed 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 123.448 0.699 . . . . 0.0 109.989 171.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' A' ' 110' ' ' LEU . 1.1 mp -46.2 -37.88 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.827 0.851 . . . . 0.0 110.313 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.629 ' O ' ' HB3' ' A' ' 10' ' ' LEU . 29.4 tt0 -61.57 -18.89 61.22 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.681 0.753 . . . . 0.0 111.704 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.626 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -136.77 16.85 3.08 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.824 -0.548 . . . . 0.0 111.796 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 115' ' ' ALA . 5.7 mp -151.03 -24.39 0.21 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -167.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.435 ' HB2' HG23 ' A' ' 113' ' ' ILE . 54.4 tt0 -43.53 -52.32 6.26 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.41 0.443 . . . . 0.0 112.121 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.815 ' HA2' ' HE3' ' A' ' 121' ' ' LYS . . . -75.76 -17.36 80.13 Favored Glycine 0 CA--C 1.512 -0.155 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.489 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.799 HG13 ' HB3' ' A' ' 125' ' ' ARG . 65.8 t -74.92 -54.62 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 117.202 0.501 . . . . 0.0 111.397 -169.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.666 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 16.9 m -44.77 -15.0 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 O-C-N 125.231 1.582 . . . . 0.0 114.621 -175.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.815 ' HE3' ' HA2' ' A' ' 118' ' ' GLY . 20.0 pttp -127.96 -4.7 5.68 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.71 -162.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.518 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 27.6 m-85 -86.7 133.98 38.57 Favored Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.109 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.64 -22.92 37.99 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 122.034 1.823 . . . . 0.0 111.55 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.68 -2.99 43.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.226 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.799 ' HB3' HG13 ' A' ' 119' ' ' VAL . 66.1 mtt85 -129.34 16.58 6.04 Favored 'General case' 0 C--O 1.213 -0.83 0 O-C-N 121.831 -0.543 . . . . 0.0 109.556 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.2 tt -87.36 -31.23 5.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.623 -171.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -78.38 -20.76 50.56 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.798 ' HB3' HG13 ' A' ' 68' ' ' ILE . 77.5 m -82.91 -18.5 39.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.286 176.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -84.99 -32.8 22.77 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.998 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 134' ' ' LYS . 16.9 p -74.9 -43.58 53.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.657 ' HA ' ' HG2' ' A' ' 36' ' ' MET . 4.6 pp -58.45 -34.88 71.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.481 ' HB3' HD21 ' A' ' 116' ' ' LEU . 49.1 m -69.95 -55.03 10.72 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.447 0.467 . . . . 0.0 111.853 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.662 ' HA ' ' OE1' ' A' ' 137' ' ' GLU . 25.6 m0 -55.56 -38.64 69.59 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.695 1.236 . . . . 0.0 111.194 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' A' ' 138' ' ' LYS . 50.0 mtpt -70.35 -42.41 71.89 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.605 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.578 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -58.4 -61.95 2.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.012 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.525 HD13 ' CG ' ' A' ' 76' ' ' MET . 72.6 mt -87.21 -43.59 12.1 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.054 -169.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.662 ' OE1' ' HA ' ' A' ' 133' ' ' TRP . 3.0 mp0 -84.8 -39.89 17.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -173.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.661 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 7.8 tmtm? -88.68 12.22 15.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.395 1.093 . . . . 0.0 109.051 176.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 1.025 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -88.13 -24.46 34.51 Favored Glycine 0 C--O 1.221 -0.658 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.114 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.523 HG21 ' HB1' ' A' ' 88' ' ' ALA . 29.6 m -114.23 -0.98 9.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.899 -0.65 . . . . 0.0 110.438 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 86.7 110.91 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.935 1.397 . . . . 0.0 108.403 -173.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -68.69 136.86 53.56 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.207 -169.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.779 ' HG3' ' H ' ' A' ' 144' ' ' GLU . 13.7 pt-20 41.01 -89.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 125.261 1.6 . . . . 0.0 113.58 176.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.779 ' H ' ' HG3' ' A' ' 143' ' ' GLU . 6.2 mm-40 -73.15 74.67 1.26 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 118.401 0.546 . . . . 0.0 109.836 172.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.33 103.75 0.16 Allowed Glycine 0 N--CA 1.436 -1.329 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.311 -175.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.17 82.65 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.445 ' C ' HD22 ' A' ' 147' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.601 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.309 177.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 mtt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.23 0.538 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 m -57.35 116.77 3.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.448 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -127.71 14.66 6.99 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.943 0.401 . . . . 0.0 110.65 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -80.34 40.66 0.5 Allowed 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.401 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 179.59 19.98 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.397 -172.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -60.78 -50.42 73.54 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.011 -172.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.612 HD12 ' HB2' ' A' ' 10' ' ' LEU . 29.9 tp -126.57 -13.5 5.95 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.375 0.422 . . . . 0.0 110.154 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.69 -58.26 9.35 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.155 0.502 . . . . 0.0 111.427 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.3 m -55.14 -41.63 72.02 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.631 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.612 ' HB2' HD12 ' A' ' 7' ' ' LEU . 44.1 mt -55.56 -45.61 77.29 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.441 177.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.434 ' O ' HG22 ' A' ' 15' ' ' ILE . 15.7 m-85 -59.56 -46.37 89.11 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.367 0.604 . . . . 0.0 109.473 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -57.38 -45.27 84.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.599 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -67.31 -32.29 73.17 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.101 0.25 . . . . 0.0 110.682 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.654 HG13 ' HB2' ' A' ' 75' ' ' MET . 72.9 t -80.43 -47.99 20.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.833 -175.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 11' ' ' TYR . 18.2 tt -69.58 -25.53 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.2 ttt -78.29 -45.97 21.39 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.126 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.98 -42.77 76.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.489 0.662 . . . . 0.0 110.09 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.479 ' CG ' ' HB3' ' A' ' 74' ' ' SER . 85.9 t60 -66.95 -29.19 68.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.465 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -64.33 -45.48 87.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.941 -0.475 . . . . 0.0 110.615 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -47.52 -33.15 5.99 Favored 'General case' 0 C--O 1.247 0.937 0 O-C-N 124.197 0.936 . . . . 0.0 111.202 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -87.05 155.85 55.03 Favored Pre-proline 0 C--O 1.22 -0.492 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.146 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.24 -68.16 0.11 Allowed 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 123.606 2.871 . . . . 0.0 113.825 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.621 ' HG2' ' H ' ' A' ' 24' ' ' ASN . 25.0 ttm-85 176.61 -167.29 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.621 ' H ' ' HG2' ' A' ' 23' ' ' ARG . 18.6 p-10 -144.52 8.54 1.35 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.148 -0.345 . . . . 0.0 110.725 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 61' ' ' PHE . 60.6 tttp -99.91 115.32 29.37 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.633 0.73 . . . . 0.0 111.212 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.829 ' HA3' ' HE2' ' A' ' 60' ' ' LYS . . . -172.25 -177.83 42.03 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.48 HG23 HG21 ' A' ' 48' ' ' THR . 7.4 p -166.33 125.61 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 118.119 0.959 . . . . 0.0 110.655 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.748 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -143.69 143.62 31.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.594 0.711 . . . . 0.0 110.78 176.162 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -98.38 81.06 2.7 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.583 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 6.2 t70 -117.58 -123.02 0.29 Allowed 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.24 -173.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.448 ' OG ' ' HA ' ' A' ' 50' ' ' LYS . 17.7 m -51.88 -72.45 0.05 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.248 0.547 . . . . 0.0 111.878 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.691 HG13 ' HB2' ' A' ' 49' ' ' MET . 22.3 pt -130.23 140.89 47.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.42 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.827 HG13 HG22 ' A' ' 48' ' ' THR . 57.4 t -124.66 108.66 20.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 110.837 -0.06 . . . . 0.0 110.837 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.754 ' HB ' ' HB3' ' A' ' 47' ' ' LEU . 55.6 t -87.7 122.92 39.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 O-C-N 124.331 1.019 . . . . 0.0 110.993 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.83 108.02 16.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.995 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.47 ' HB2' ' HB2' ' A' ' 135' ' ' ALA . 20.3 mmt -136.47 119.11 16.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 6.2 p30 -129.03 138.67 52.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.043 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -115.18 95.24 41.75 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.7 -12.77 26.56 Favored 'Trans proline' 0 CA--C 1.512 -0.576 0 C-N-CA 123.222 2.615 . . . . 0.0 112.756 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.5 m -94.12 -53.99 3.75 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.153 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.9 t -129.46 15.06 6.06 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -167.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.867 ' HA3' HD22 ' A' ' 131' ' ' LEU . . . -154.76 2.98 0.22 Allowed Glycine 0 N--CA 1.462 0.427 0 C-N-CA 118.003 -2.046 . . . . 0.0 114.882 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.708 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 10.3 t70 54.99 -101.41 0.13 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.878 0.871 . . . . 0.0 111.077 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 18.7 ptp180 -155.77 150.63 26.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.769 0.713 . . . . 0.0 112.133 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.597 HG13 ' CD1' ' A' ' 61' ' ' PHE . 8.6 tt -133.97 125.06 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 45.6 mtp180 -118.82 104.04 10.19 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 111.107 -176.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.754 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 20.1 tp -88.22 95.68 10.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.26 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.827 HG22 HG13 ' A' ' 33' ' ' VAL . 61.7 p -88.8 110.16 20.79 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.691 ' HB2' HG13 ' A' ' 32' ' ' ILE . 15.0 mtt -107.77 -179.98 4.06 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.136 0.493 . . . . 0.0 111.356 -171.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.583 ' HG3' ' OD2' ' A' ' 30' ' ' ASP . 50.5 tttp -153.58 101.35 2.48 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.606 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 1.4 pt? -124.15 93.48 3.93 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -92.21 60.27 3.67 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.644 -170.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 146.51 -98.43 0.2 Allowed Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 174.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -132.27 20.17 4.41 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.948 0.404 . . . . 0.0 110.415 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -129.0 152.13 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.81 119.54 49.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -105.49 -29.29 10.29 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.931 0.872 . . . . 0.0 108.824 -167.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.662 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 1.4 t70 -144.11 153.8 42.52 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.424 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.594 ' HB2' ' HG2' ' A' ' 49' ' ' MET . . . -164.26 118.72 1.45 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.829 ' HE2' ' HA3' ' A' ' 26' ' ' GLY . 38.8 mtpt -125.71 99.68 6.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.069 0.938 . . . . 0.0 111.527 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.597 ' CD1' HG13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -70.7 139.06 51.09 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.815 176.396 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 15.4 tt0 -143.79 126.29 15.88 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.979 0.895 . . . . 0.0 109.009 169.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.05 -175.02 45.73 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.835 -172.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.708 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -143.88 163.0 34.65 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 -179.381 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.38 -133.47 4.9 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 119.203 -1.475 . . . . 0.0 113.019 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.1 m -85.73 163.96 17.9 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.308 0.575 . . . . 0.0 112.305 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 t -75.17 -26.55 59.17 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.211 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.887 HG13 HG21 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -77.2 -33.51 20.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.256 177.464 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.4 m -69.12 -48.6 62.04 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.993 0.901 . . . . 0.0 108.934 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 52.2 ttp -56.14 -34.27 65.96 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.619 170.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.75 -39.16 67.07 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.479 0.487 . . . . 0.0 111.565 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.833 ' HB2' HD11 ' A' ' 116' ' ' LEU . 12.7 t -58.99 -47.77 83.98 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -62.76 -49.26 75.72 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.538 177.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.479 ' HB3' ' CG ' ' A' ' 18' ' ' HIS . 68.3 m -51.64 -61.7 2.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.882 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.654 ' HB2' HG13 ' A' ' 14' ' ' VAL . 9.1 tpt -74.92 -46.92 32.55 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.575 -169.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.94 ' HG2' HD21 ' A' ' 136' ' ' LEU . 6.9 tpt -80.37 -28.09 38.06 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 88.1 m -68.79 -17.91 64.11 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.555 -1.341 . . . . 0.0 108.823 168.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 75' ' ' MET . 1.5 tt0 -80.59 -38.37 29.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.341 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.69 -45.82 9.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.998 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.5 OUTLIER -73.6 -32.24 35.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 123.326 0.65 . . . . 0.0 110.703 -170.087 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.662 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 60.3 tttm -53.71 -15.47 1.24 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.452 0.644 . . . . 0.0 110.93 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.65 32.37 5.89 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.596 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -129.46 -165.47 1.53 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -132.67 -172.1 2.83 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.728 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -74.98 -46.02 41.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.656 -175.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.76 -40.69 79.65 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.207 0.317 . . . . 0.0 111.393 -175.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.2 p -58.01 -36.5 72.77 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.457 0.646 . . . . 0.0 110.533 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.901 ' HB1' ' HB2' ' A' ' 141' ' ' ALA . . . -71.89 -49.15 40.46 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.022 0.529 . . . . 0.0 110.712 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 42.1 mt -55.01 -44.49 74.61 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.639 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.553 ' O ' HG12 ' A' ' 94' ' ' ILE . 38.3 p -68.61 -33.53 74.2 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.246 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.541 ' HA ' ' CG1' ' A' ' 94' ' ' ILE . 25.1 ttt -64.91 -16.65 63.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.383 0.611 . . . . 0.0 110.429 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.511 ' CB ' ' HG3' ' A' ' 143' ' ' GLU . 6.1 m -86.29 -40.25 15.69 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -66.3 -43.87 85.04 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.616 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 90' ' ' SER . 10.0 pt -71.45 -40.88 72.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.624 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 91' ' ' MET . 5.9 t80 -56.9 -29.77 63.32 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.32 174.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 t -80.8 -36.86 31.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -65.61 -42.03 92.04 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.139 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.616 ' HA ' ' H ' ' A' ' 103' ' ' GLU . 16.8 tpt -35.59 -50.45 0.61 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 123.827 0.705 . . . . 0.0 112.568 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 42.4 tpp -48.87 -19.56 0.39 Allowed 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -140.28 -29.84 0.69 Allowed 'General case' 0 C--O 1.242 0.673 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.23 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -99.79 -36.73 4.15 Favored Glycine 0 C--N 1.318 -0.472 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.647 -174.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 63.9 tttm 88.59 70.31 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.616 ' H ' ' HA ' ' A' ' 98' ' ' MET . 10.3 tp10 -153.8 133.88 13.25 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 113.335 -1.757 . . . . 0.0 107.226 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.538 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -124.48 -59.39 1.46 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.644 -168.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.768 ' HB3' HD12 ' A' ' 110' ' ' LEU . 14.7 t70 -144.58 97.2 2.99 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.456 ' H ' HD12 ' A' ' 94' ' ' ILE . 14.8 t70 -34.8 -31.45 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 174.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.9 m -95.94 2.78 53.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.77 -0.582 . . . . 0.0 111.301 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 108' ' ' ILE . 31.9 mm 69.53 24.97 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 122.667 1.222 . . . . 0.0 109.124 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -96.78 73.95 2.67 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.929 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.768 HD12 ' HB3' ' A' ' 105' ' ' ASP . 5.0 mp -98.01 10.84 39.38 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.995 -166.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -40.18 -38.22 1.26 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 115.645 1.018 . . . . 0.0 115.645 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.74 ' HB2' ' HB2' ' A' ' 76' ' ' MET . 18.4 t70 -80.88 -51.3 8.74 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.579 0.704 . . . . 0.0 110.42 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.646 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 53.4 mt -65.09 -24.14 34.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.823 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.536 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 47.3 mt-10 -67.91 -58.38 4.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.57 77.13 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.974 0.797 . . . . 0.0 112.479 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.833 HD11 ' HB2' ' A' ' 72' ' ' SER . 8.9 mp -94.65 -5.84 44.74 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.646 ' HB3' ' O ' ' A' ' 113' ' ' ILE . 13.0 pt20 -61.65 -28.31 69.3 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.79 0.805 . . . . 0.0 111.762 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.86 -16.46 65.41 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.536 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.887 HG21 HG13 ' A' ' 68' ' ' ILE . 24.1 t -86.8 -57.62 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 124.047 0.939 . . . . 0.0 111.003 -172.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 3.3 p -45.0 -14.59 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -176.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -128.6 0.53 5.53 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 118.481 -1.287 . . . . 0.0 112.045 -165.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.5 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 6.1 m-85 -90.13 130.61 41.58 Favored Pre-proline 0 N--CA 1.441 -0.883 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.43 -29.0 29.5 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.935 2.424 . . . . 0.0 112.241 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.86 -2.88 52.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.446 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 89.8 mtt180 -125.39 11.71 8.08 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.1 tt -80.33 -36.78 16.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.08 0.943 . . . . 0.0 109.029 -171.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -85.64 -18.03 34.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.167 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 3.7 t -79.87 -19.28 48.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.565 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -85.85 -33.19 21.36 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.57 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.763 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 26.2 p -77.28 -32.31 55.43 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 119.323 -0.951 . . . . 0.0 108.926 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.867 HD22 ' HA3' ' A' ' 42' ' ' GLY . 19.2 tp -47.31 -59.41 3.21 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.663 169.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.8 m -79.09 -61.06 2.13 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.675 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.555 ' HB2' HD23 ' A' ' 116' ' ' LEU . 2.6 t90 -63.12 -51.37 66.81 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.458 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.763 ' HB2' ' O ' ' A' ' 130' ' ' THR . 27.4 mmmt -61.67 -42.43 98.91 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 121.855 -0.528 . . . . 0.0 110.986 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 36' ' ' MET . . . -57.02 -36.74 70.8 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.307 174.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.94 HD21 ' HG2' ' A' ' 76' ' ' MET . 4.6 tp -79.55 -40.74 28.79 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.826 0.822 . . . . 0.0 110.114 -175.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 139' ' ' GLY . 39.4 tt0 -79.12 -53.01 7.42 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.283 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 134' ' ' LYS . 72.3 tttt -78.87 15.63 1.05 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.878 -169.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.551 ' O ' HD12 ' A' ' 32' ' ' ILE . . . -101.08 -26.61 7.77 Favored Glycine 0 N--CA 1.424 -2.148 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.921 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.29 -33.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 O-C-N 122.242 -0.563 . . . . 0.0 110.295 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.901 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . . . -102.19 119.16 38.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.39 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.634 ' H ' ' CD2' ' A' ' 89' ' ' LEU . 47.9 mtmt -146.55 113.09 5.96 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.731 0.301 . . . . 0.0 110.446 173.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.511 ' HG3' ' CB ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -57.11 69.89 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.221 0.534 . . . . 0.0 111.971 162.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -69.76 -22.36 63.36 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.014 0.911 . . . . 0.0 110.12 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.37 -23.29 0.57 Allowed Glycine 0 CA--C 1.502 -0.743 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.357 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 102.06 -69.53 0.37 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.336 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 . . . . . 0 C--N 1.319 -0.748 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.567 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.525 0.202 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -144.39 -52.1 0.31 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -127.81 88.81 2.83 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -76.46 -45.72 30.01 Favored 'General case' 0 C--O 1.241 0.656 0 O-C-N 123.973 0.796 . . . . 0.0 110.149 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.0 -73.91 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.273 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.3 t30 64.71 30.39 12.48 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 122.467 1.127 . . . . 0.0 108.739 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.598 HD12 HD12 ' A' ' 10' ' ' LEU . 34.3 tp -118.38 -12.28 9.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.764 -175.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.54 ' HA ' ' HD2' ' A' ' 11' ' ' TYR . 2.2 m-20 -58.44 -58.62 7.7 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.108 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 p -56.45 -41.04 75.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.925 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.598 HD12 HD12 ' A' ' 7' ' ' LEU . 62.6 mt -55.42 -41.69 73.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.285 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.54 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 47.9 m-85 -57.16 -51.54 68.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.322 0.582 . . . . 0.0 109.92 173.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -56.65 -39.63 74.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.51 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.5 tp60 -74.09 -35.17 64.19 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.709 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 115' ' ' ALA . 75.6 t -70.02 -45.48 76.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.69 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 66.6 mt -67.52 -23.19 29.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.1 ttt -73.2 -53.71 10.26 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.898 -0.502 . . . . 0.0 110.294 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -69.59 -44.81 70.02 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.49 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -65.6 -20.69 66.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.157 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 82.8 t80 -62.94 -50.09 72.18 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 121.959 -0.463 . . . . 0.0 110.56 173.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -44.85 -29.75 0.86 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.897 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -122.4 82.23 46.4 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 120.885 0.374 . . . . 0.0 110.141 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.6 73.45 1.29 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.125 2.55 . . . . 0.0 113.064 -172.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.3 ttm105 -145.55 72.47 1.31 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.659 0.742 . . . . 0.0 110.168 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -105.53 64.29 0.7 Allowed 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.641 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 179.52 163.45 0.95 Allowed 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 144.82 153.53 5.89 Favored Glycine 0 C--O 1.218 -0.867 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.998 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.847 ' HB ' ' HB2' ' A' ' 62' ' ' GLU . 2.6 p -168.46 117.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.724 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -141.33 149.0 40.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.056 0.455 . . . . 0.0 111.152 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -107.55 104.81 14.45 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.31 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -149.75 -110.36 0.07 Allowed 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.468 0.48 . . . . 0.0 110.383 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.684 ' HB3' HD23 ' A' ' 51' ' ' LEU . 22.3 m -54.06 -74.0 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 124.79 1.306 . . . . 0.0 112.05 -171.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.712 HG13 ' HB3' ' A' ' 49' ' ' MET . 10.6 pt -134.82 136.71 51.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.779 0.8 . . . . 0.0 109.111 174.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.741 HG13 HG22 ' A' ' 48' ' ' THR . 33.8 t -117.69 105.23 17.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.842 0.829 . . . . 0.0 108.791 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.764 HG21 ' HA2' ' A' ' 139' ' ' GLY . 85.6 t -98.41 124.49 51.56 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.845 -171.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.789 ' HB3' ' HE ' ' A' ' 46' ' ' ARG . 5.4 p-10 -136.88 145.9 44.9 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.506 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.3 mmt -154.19 135.66 14.23 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.768 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.521 ' HB2' ' O ' ' A' ' 43' ' ' ASP . 22.6 p-10 -122.13 142.05 50.79 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.04 174.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.657 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 56.4 t30 -125.57 106.04 27.02 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 174.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 1.3 Cg_endo -42.85 133.02 5.7 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 125.123 3.882 . . . . 0.0 114.458 -167.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.0 m 77.12 -36.56 0.25 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.139 175.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.799 ' SG ' ' HB3' ' A' ' 127' ' ' LYS . 44.1 t -85.85 -78.61 0.27 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -171.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.613 ' HA3' HD13 ' A' ' 131' ' ' LEU . . . -102.6 11.48 56.47 Favored Glycine 0 CA--C 1.502 -0.761 0 C-N-CA 118.786 -1.673 . . . . 0.0 112.286 -166.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.58 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 18.3 t70 62.8 -90.9 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.423 0.719 . . . . 0.0 110.349 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -159.8 144.4 14.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 123.198 0.311 . . . . 0.0 110.466 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.42 133.92 59.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.789 ' HE ' ' HB3' ' A' ' 35' ' ' ASP . 28.8 ttm180 -134.41 109.4 8.74 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.594 HD11 ' HB1' ' A' ' 59' ' ' ALA . 11.8 tp -84.91 99.24 10.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.127 172.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.741 HG22 HG13 ' A' ' 33' ' ' VAL . 50.0 p -80.71 107.41 13.5 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 171.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.712 ' HB3' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -110.07 165.43 11.74 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -164.373 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 57' ' ' GLU . 8.5 tmtm? -156.33 97.21 1.75 Allowed 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.684 HD23 ' HB3' ' A' ' 31' ' ' SER . 2.6 pt? -118.85 93.82 4.23 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.62 59.26 1.76 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.373 1.082 . . . . 0.0 109.545 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 150.18 -99.44 0.19 Allowed Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.846 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.473 ' C ' HG12 ' A' ' 85' ' ' ILE . 2.0 t70 -134.91 24.25 3.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.442 0.639 . . . . 0.0 109.37 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.645 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.2 pp -137.31 156.07 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 C-N-CA 124.435 1.094 . . . . 0.0 108.47 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.496 HG11 ' O ' ' A' ' 80' ' ' ILE . 3.3 p -96.77 119.46 44.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.139 0.971 . . . . 0.0 108.551 168.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 50' ' ' LYS . 32.2 tt0 -98.03 -33.44 11.18 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.379 -171.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -146.22 147.55 31.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.483 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.594 ' HB1' HD11 ' A' ' 47' ' ' LEU . . . -155.82 123.09 5.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.488 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 46.8 mmtm -133.82 165.7 24.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.069 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.718 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 26.0 p90 -127.47 127.29 43.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.48 0.657 . . . . 0.0 111.612 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.847 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 8.8 tp10 -110.54 109.31 19.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.22 -178.62 48.59 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.518 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.58 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 15.1 mm-40 -142.29 168.5 19.58 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.3 -131.62 3.36 Favored Glycine 0 C--O 1.24 0.496 0 C-N-CA 119.588 -1.291 . . . . 0.0 112.93 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.8 m -78.34 178.88 7.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.6 m -93.18 -23.96 18.39 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -79.89 -38.74 19.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 113.831 -1.532 . . . . 0.0 110.614 175.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.4 p -65.41 -43.35 90.84 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.946 -0.471 . . . . 0.0 110.786 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.5 ptp -62.51 -29.17 70.35 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.852 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.57 -34.51 65.17 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.643 0.589 . . . . 0.0 111.642 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 m -62.25 -40.51 96.44 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.761 ' HA ' ' HG2' ' A' ' 76' ' ' MET . . . -64.95 -43.08 93.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.892 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.1 m -52.42 -49.0 65.4 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 122.324 0.249 . . . . 0.0 110.653 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.474 ' HA ' ' HG2' ' A' ' 78' ' ' GLN . 4.6 mmt -66.0 -47.5 74.29 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.988 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.761 ' HG2' ' HA ' ' A' ' 73' ' ' ALA . 19.7 ptt? -59.82 -41.41 91.23 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.962 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.4 p -60.18 -35.57 75.67 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.257 -0.902 . . . . 0.0 111.052 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.474 ' HG2' ' HA ' ' A' ' 75' ' ' MET . 20.4 pt20 -88.16 -41.37 13.04 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.926 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.66 -48.63 8.14 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 121.678 0.751 . . . . 0.0 111.425 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.598 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -71.47 -42.45 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.892 -174.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -61.7 -16.1 46.11 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.071 0.462 . . . . 0.0 111.273 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.12 43.61 1.65 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.322 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.589 ' HG3' ' HB ' ' A' ' 87' ' ' THR . 2.9 tppt? -134.42 170.45 15.73 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -105.66 175.61 5.44 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.668 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.5 mm -78.07 -35.86 20.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.173 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.12 -48.03 79.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.638 0.733 . . . . 0.0 109.557 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.589 ' HB ' ' HG3' ' A' ' 83' ' ' LYS . 1.4 m -66.2 -40.32 90.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.711 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.708 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -63.94 -41.7 97.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 73.5 mt -66.64 -31.01 71.42 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.8 m -70.22 -44.33 68.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.154 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.584 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 13.1 tpt -60.11 -29.92 68.92 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.444 0.698 . . . . 0.0 110.4 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.51 ' OG ' ' HA ' ' A' ' 142' ' ' LYS . 71.7 p -87.92 -37.86 16.08 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.968 -175.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.627 ' HG3' ' HG2' ' A' ' 143' ' ' GLU . 61.2 tttm -67.5 -44.68 77.87 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.331 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 105' ' ' ASP . 71.8 mt -63.79 -44.75 98.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.306 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 91' ' ' MET . 0.7 OUTLIER -53.34 -32.61 49.96 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.543 174.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.6 m -83.21 -40.34 19.77 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.8 0.333 . . . . 0.0 111.187 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -71.22 -37.57 72.04 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.799 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.1 ttt -45.28 -51.48 10.84 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.439 0.695 . . . . 0.0 112.308 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 46.5 ttp -61.03 -8.74 3.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -123.96 -31.82 3.34 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.908 -0.495 . . . . 0.0 110.841 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -89.51 -25.58 27.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.769 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 23.9 tptm 84.87 -31.35 0.06 Allowed 'General case' 0 N--CA 1.478 0.97 0 O-C-N 125.044 1.085 . . . . 0.0 109.119 175.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.22 178.45 6.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.411 ' CG ' HD21 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -144.76 -108.84 0.11 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.112 0.482 . . . . 0.0 111.714 -173.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.436 ' HB2' HD13 ' A' ' 94' ' ' ILE . 20.2 t70 -109.16 107.9 18.35 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -175.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.08 3.89 0.38 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.616 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.562 ' O ' HG22 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -99.09 -18.95 17.46 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 107' ' ' SER . 6.6 tp 66.91 24.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.446 168.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.22 87.34 6.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 172.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 114' ' ' GLU . 1.1 mp -114.21 21.53 14.64 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.306 0.379 . . . . 0.0 111.546 -168.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -51.6 -54.52 24.26 Favored Glycine 0 C--O 1.242 0.656 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.247 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.584 ' HB2' ' HE2' ' A' ' 91' ' ' MET . 6.7 m-20 -58.04 -24.14 57.18 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.863 0.865 . . . . 0.0 111.998 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 76.3 mt -100.69 -25.09 3.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -174.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 33.7 tt0 -75.36 -54.41 7.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.53 -1.213 . . . . 0.0 111.762 -163.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.517 ' O ' HD11 ' A' ' 7' ' ' LEU . . . -49.23 -24.76 1.9 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.81 0.694 . . . . 0.0 110.818 170.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.6 mp -102.89 -3.18 26.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.472 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.429 ' HB2' ' HA ' ' A' ' 114' ' ' GLU . 45.4 tt0 -54.48 -37.19 64.98 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.187 0.595 . . . . 0.0 110.686 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.82 -18.16 66.2 Favored Glycine 0 C--O 1.216 -0.986 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.557 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.803 HG12 ' HB2' ' A' ' 129' ' ' ALA . 48.4 t -84.11 -44.71 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 O-C-N 122.283 -0.539 . . . . 0.0 112.164 -174.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.5 p -45.93 -25.56 0.56 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.318 0.647 . . . . 0.0 110.247 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.586 ' HB2' ' NZ ' ' A' ' 121' ' ' LYS . 3.6 ttmp? -131.71 96.51 3.97 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.996 ' H ' ' HB3' ' A' ' 125' ' ' ARG . 0.1 OUTLIER -152.34 157.06 33.91 Favored Pre-proline 0 N--CA 1.448 -0.561 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -172.558 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.454 ' HD2' ' CG ' ' A' ' 122' ' ' PHE . 10.8 Cg_endo -59.24 -22.85 66.95 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.705 1.603 . . . . 0.0 111.221 172.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.28 18.42 17.85 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.294 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.996 ' HB3' ' H ' ' A' ' 122' ' ' PHE . 25.6 ptt-85 -52.44 -44.5 65.52 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 124.105 0.878 . . . . 0.0 112.202 -165.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.431 ' N ' ' HG3' ' A' ' 125' ' ' ARG . 11.6 tt -85.24 -20.59 8.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -160.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.799 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 38.5 mmtm -75.97 -50.14 15.75 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.435 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.873 ' HB3' HD12 ' A' ' 68' ' ' ILE . 80.0 m -86.54 -29.11 22.92 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.256 -173.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.803 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -87.59 -29.8 20.98 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.033 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 63.8 m -84.5 -41.93 16.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.613 HD13 ' HA3' ' A' ' 42' ' ' GLY . 8.4 tt -51.82 -39.41 58.7 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.942 0.401 . . . . 0.0 110.612 173.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.9 m -84.05 -42.45 16.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.697 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.459 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 2.3 t90 -53.02 -50.48 64.15 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.114 0.566 . . . . 0.0 109.816 174.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 68.2 mmtt -60.08 -42.59 94.9 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 124.68 1.238 . . . . 0.0 110.407 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.2 -41.96 63.12 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.455 0.472 . . . . 0.0 112.102 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 76' ' ' MET . 4.4 mm? -83.06 -38.45 22.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.534 0.683 . . . . 0.0 110.894 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.718 ' HG3' ' HB3' ' A' ' 142' ' ' LYS . 26.4 tt0 -68.69 -41.87 78.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.37 -177.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.508 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 9.3 mtpt -93.31 -0.75 56.58 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.063 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.764 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -79.99 -27.71 52.3 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.903 HG23 ' H ' ' A' ' 141' ' ' ALA . 16.9 m -129.89 -94.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 113.184 -1.508 . . . . 0.0 108.089 170.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.903 ' H ' HG23 ' A' ' 140' ' ' VAL . . . -166.86 153.48 8.61 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.563 0.745 . . . . 0.0 109.017 166.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.718 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 21.2 pttm -87.45 119.05 27.34 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.242 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.627 ' HG2' ' HG3' ' A' ' 93' ' ' LYS . 29.6 mt-10 68.02 -78.57 0.04 OUTLIER 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.259 0.624 . . . . 0.0 110.77 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -124.76 -52.11 1.69 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.334 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.0 -41.19 0.97 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.909 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.03 49.5 0.37 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.592 -0.814 . . . . 0.0 111.887 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 48.6 t30 . . . . . 0 C--O 1.24 0.605 0 CA-C-O 120.846 0.355 . . . . 0.0 110.686 179.34 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 . . . . . 0 C--O 1.236 0.391 0 CA-C-O 121.125 0.488 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.694 HD11 ' O ' ' A' ' 115' ' ' ALA . 22.7 tp 177.32 -39.09 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 175.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.693 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.4 t70 -49.31 -63.03 1.22 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.505 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 p -59.58 -37.76 79.35 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.003 0.43 . . . . 0.0 112.043 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 mp -56.25 -50.58 70.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.898 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.778 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 5.8 p90 -85.59 -18.72 32.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.115 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 16' ' ' MET . 19.1 tpp180 -63.82 -51.99 62.21 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -63.89 -27.5 69.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.37 0.605 . . . . 0.0 109.453 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.778 ' HB ' ' HA ' ' A' ' 11' ' ' TYR . 2.1 t -70.56 -51.7 35.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.891 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 tt -72.19 -23.12 21.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -82.01 -42.68 18.99 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.261 0.351 . . . . 0.0 111.28 -178.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.529 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 20.9 t70 -69.11 -33.41 73.44 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.185 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.637 ' CE1' ' HB2' ' A' ' 74' ' ' SER . 86.2 t60 -74.4 -19.72 60.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.005 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -66.45 -40.63 89.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.529 ' HE3' ' HA ' ' A' ' 17' ' ' ASP . 70.9 mttt -49.98 -34.67 21.73 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.488 169.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.688 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 10.8 m120 -82.03 -179.6 1.54 Allowed Pre-proline 0 N--CA 1.465 0.298 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.688 ' HD2' ' HB3' ' A' ' 21' ' ' ASN . 11.1 Cg_endo -58.29 164.55 8.59 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.654 1.569 . . . . 0.0 111.215 164.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -85.83 -140.18 0.08 Allowed 'General case' 0 C--N 1.31 -1.137 0 O-C-N 122.038 -0.414 . . . . 0.0 111.072 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -116.91 52.46 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.981 0.419 . . . . 0.0 110.322 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.729 ' HD3' ' HG2' ' A' ' 62' ' ' GLU . 41.8 mmtm -144.03 83.68 1.75 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.587 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.28 137.14 5.23 Favored Glycine 0 C--O 1.228 -0.259 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.497 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 3.0 m -155.56 135.76 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.96 0.409 . . . . 0.0 110.171 -175.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.606 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -144.09 170.28 16.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.363 0.602 . . . . 0.0 111.013 173.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -135.14 41.31 2.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.67 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.471 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 25.0 t70 -84.85 -9.73 57.85 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.88 0.371 . . . . 0.0 110.535 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.6 m -153.39 -85.45 0.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.301 0.572 . . . . 0.0 110.181 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.522 HD11 HD21 ' A' ' 51' ' ' LEU . 16.2 pt -127.66 141.77 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.783 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.929 HG13 HG22 ' A' ' 48' ' ' THR . 58.6 t -121.02 107.11 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.507 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.655 HG21 ' HA2' ' A' ' 139' ' ' GLY . 97.0 t -101.45 124.52 55.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 O-C-N 123.577 0.548 . . . . 0.0 110.413 -176.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -126.77 137.65 53.25 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.9 tpt -148.43 126.19 11.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 17.0 p30 -129.03 146.98 50.86 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.988 0.805 . . . . 0.0 111.368 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.974 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 20.2 t-20 -108.23 98.24 25.94 Favored Pre-proline 0 C--O 1.248 0.988 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.2 -23.73 70.78 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 123.623 2.882 . . . . 0.0 112.353 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.6 m -62.2 -31.87 72.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.085 0.865 . . . . 0.0 111.79 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 81.2 m -113.31 -51.58 2.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.47 -6.75 10.6 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 118.995 -1.574 . . . . 0.0 110.131 -156.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.974 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 24.4 m-20 -60.02 121.58 12.2 Favored 'General case' 0 C--O 1.213 -0.856 0 C-N-CA 123.742 0.817 . . . . 0.0 109.665 173.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 30.3 ttp180 -150.2 136.75 19.02 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 121.524 -0.735 . . . . 0.0 110.536 172.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 132' ' ' SER . 26.2 pt -138.75 145.02 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 81.0 mtm180 -125.86 105.21 8.78 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.509 0.671 . . . . 0.0 110.936 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.409 HD12 ' HA3' ' A' ' 139' ' ' GLY . 1.3 tm? -89.7 98.49 11.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.918 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.929 HG22 HG13 ' A' ' 33' ' ' VAL . 71.7 p -100.48 120.16 39.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 35.7 mtt -111.2 -179.87 3.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.769 0.795 . . . . 0.0 112.591 -173.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 60.7 tttm -149.53 93.68 2.09 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.522 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -124.23 101.98 7.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.62 -174.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -91.75 57.19 3.15 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.381 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.61 -99.55 0.22 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.441 ' C ' HD13 ' A' ' 85' ' ' ILE . 11.6 m-20 -131.2 25.9 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.675 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.493 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -132.52 143.72 38.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.22 114.64 30.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -100.09 -24.9 14.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -169.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 11.6 t70 -153.21 155.5 36.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.693 171.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.637 ' H ' ' HE2' ' A' ' 81' ' ' LYS . . . -157.24 117.52 3.5 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -114.43 138.59 50.39 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 123.195 0.309 . . . . 0.0 110.219 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 5.4 p90 -129.5 137.88 51.06 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -169.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.729 ' HG2' ' HD3' ' A' ' 25' ' ' LYS . 3.6 tm-20 -120.04 135.04 55.08 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.86 138.57 7.0 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.202 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -150.93 142.44 23.51 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 43' ' ' ASP . . . 146.49 -134.75 5.46 Favored Glycine 0 CA--C 1.508 -0.386 0 C-N-CA 118.811 -1.661 . . . . 0.0 111.54 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 64.0 m -75.15 153.96 37.96 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 p -66.5 -27.12 67.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.892 0.377 . . . . 0.0 110.752 -170.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.695 HD13 HG21 ' A' ' 119' ' ' VAL . 2.7 pp -82.19 -32.1 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 121.568 0.699 . . . . 0.0 111.648 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.596 ' N ' HD12 ' A' ' 68' ' ' ILE . 6.7 m -73.17 -52.95 12.23 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.3 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.5 ptm -65.83 -17.82 64.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.979 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.57 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -86.67 -46.75 9.76 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.671 0.272 . . . . 0.0 111.633 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.2 p -69.88 -42.17 73.8 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.246 0.545 . . . . 0.0 110.304 -172.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.17 -56.05 26.27 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.204 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.637 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 60.4 p -63.88 -30.05 71.18 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.599 ' HG3' HG22 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -75.09 -53.0 9.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.028 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.582 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 11.9 tpt -70.04 -22.3 63.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.984 -177.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 8.5 p -72.93 -40.47 65.41 Favored 'General case' 0 C--O 1.212 -0.902 0 O-C-N 121.654 -0.654 . . . . 0.0 110.406 174.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -57.28 -31.14 65.3 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.41 172.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.86 -34.47 19.45 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.858 0.837 . . . . 0.0 110.25 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.582 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.5 OUTLIER -75.19 -32.25 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.685 -177.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.637 ' HE2' ' H ' ' A' ' 59' ' ' ALA . 46.2 tttm -49.88 -18.31 0.49 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.887 1.275 . . . . 0.0 111.838 175.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.1 46.99 1.05 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.431 ' HB2' HD13 ' A' ' 80' ' ' ILE . 42.8 mmtm -132.64 -175.69 3.85 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -118.09 -178.42 3.5 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 172.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.701 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -72.85 -44.16 58.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.143 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.87 -42.55 99.8 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.082 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 m -61.64 -45.47 93.93 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.565 0.698 . . . . 0.0 111.499 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -70.54 -32.46 69.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.529 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 83.1 mt -63.01 -35.73 81.2 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.166 0.984 . . . . 0.0 108.501 172.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.7 m -70.65 -33.91 71.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.489 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -63.65 -26.04 68.49 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.163 0.506 . . . . 0.0 110.926 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.519 ' HB3' ' HB1' ' A' ' 141' ' ' ALA . 0.9 OUTLIER -89.63 -34.35 16.33 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -178.177 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 143' ' ' GLU . 14.0 tmtt? -68.38 -37.22 80.2 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 105' ' ' ASP . 21.8 mt -66.18 -46.47 87.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 123.558 0.743 . . . . 0.0 109.74 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.434 ' HD2' HG12 ' A' ' 113' ' ' ILE . 27.6 t80 -53.25 -30.18 36.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.697 0.76 . . . . 0.0 111.451 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.3 t -85.28 -39.03 18.18 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.626 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.95 -28.52 63.5 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.825 0.85 . . . . 0.0 111.672 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.64 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -57.8 -58.03 10.15 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.246 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.5 ' HE3' ' HA ' ' A' ' 99' ' ' MET . 3.4 mmt -64.7 -7.09 9.41 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -174.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -116.52 -35.94 4.11 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.375 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -94.69 -24.18 18.75 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.08 -173.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 23.7 ttmm 85.71 -21.87 0.2 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.046 0.927 . . . . 0.0 110.484 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 98' ' ' MET . 44.8 mt-10 -92.02 167.83 11.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.545 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 1.4 p90 -137.27 -110.75 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.02 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.848 ' HB3' HD11 ' A' ' 110' ' ' LEU . 13.9 t70 -93.93 110.54 22.21 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.498 0.666 . . . . 0.0 110.186 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -46.72 -11.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.527 -1.67 . . . . 0.0 113.027 172.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.2 m -105.2 -15.37 15.08 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 121.678 -0.639 . . . . 0.0 110.495 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 108' ' ' ILE . 24.6 mm 70.77 19.15 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 124.049 0.843 . . . . 0.0 111.483 174.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -97.94 93.67 6.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.848 HD11 ' HB3' ' A' ' 105' ' ' ASP . 9.0 mp -124.07 31.82 5.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.249 -164.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -36.76 -43.75 0.85 Allowed Glycine 0 CA--C 1.534 1.219 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 6.9 p-10 -86.81 -44.73 11.51 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 117.657 0.728 . . . . 0.0 110.95 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.537 HD12 ' HG ' ' A' ' 110' ' ' LEU . 55.3 mt -62.74 -38.16 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.503 0.668 . . . . 0.0 110.58 -174.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.553 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 39.8 mt-10 -63.51 -53.69 48.07 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.028 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.694 ' O ' HD11 ' A' ' 7' ' ' LEU . . . -68.55 -37.73 80.2 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 124.527 1.142 . . . . 0.0 114.028 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.734 HD12 HG21 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -92.0 -11.3 36.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -173.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 114' ' ' GLU . 4.7 pp0? -60.32 -31.37 70.22 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.267 -0.895 . . . . 0.0 110.733 177.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.487 ' HA3' HD13 ' A' ' 7' ' ' LEU . . . -84.47 -18.1 62.87 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.461 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 125' ' ' ARG . 72.9 t -86.69 -55.66 6.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.396 0.617 . . . . 0.0 110.368 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.766 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 23.5 t -41.22 -14.69 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.068 -1.878 . . . . 0.0 115.391 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -131.56 7.6 4.51 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -163.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -103.01 136.39 19.24 Favored Pre-proline 0 CA--C 1.507 -0.71 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.83 -22.18 28.75 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.785 2.323 . . . . 0.0 111.621 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.53 -8.0 33.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.467 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.766 ' HB3' HG13 ' A' ' 119' ' ' VAL . 84.1 mtt180 -126.03 5.33 7.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 O-C-N 121.714 -0.616 . . . . 0.0 110.363 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 tt -84.53 -33.03 8.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.148 0.975 . . . . 0.0 108.954 -168.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.474 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 75.9 mmtt -72.72 -24.45 60.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.027 174.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 131' ' ' LEU . 71.2 m -84.92 -17.76 36.77 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.582 0.706 . . . . 0.0 110.249 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.766 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -82.29 -21.54 36.11 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 65.5 m -83.63 -40.19 19.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.627 HD22 ' HB3' ' A' ' 43' ' ' ASP . 2.0 tp -50.51 -63.07 1.24 Allowed 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 113.459 -1.7 . . . . 0.0 111.185 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.609 ' HB2' HD21 ' A' ' 116' ' ' LEU . 20.5 m -76.44 -63.17 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -172.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.462 ' HB2' HD23 ' A' ' 116' ' ' LEU . 66.4 t90 -66.16 -49.84 66.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.145 -173.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 130' ' ' THR . 51.6 tttm -62.67 -35.69 80.48 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.134 -176.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.92 93.6 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.838 170.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.0 tp -66.46 -35.17 79.62 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 1.029 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 30.3 tt0 -69.04 -35.48 76.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.672 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -79.91 6.28 11.62 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 122.003 0.906 . . . . 0.0 110.023 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.655 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -103.71 -36.94 3.11 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.697 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.521 HG23 HG13 ' A' ' 85' ' ' ILE . 11.0 p -172.67 41.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.156 0.979 . . . . 0.0 109.698 -176.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 1.029 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . . . -148.9 167.62 25.23 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.876 -172.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 143' ' ' GLU . 37.4 ttmt -171.02 -10.46 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.547 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 27.1 tt0 71.19 -67.29 0.26 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.887 0.742 . . . . 0.0 110.698 -175.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--N 1.315 -0.925 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.524 -178.78 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 p30 . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.1 tp -143.99 -25.76 0.54 Allowed 'General case' 0 C--O 1.212 -0.899 0 C-N-CA 122.43 0.292 . . . . 0.0 111.687 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.444 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 14.6 t70 -49.17 -59.79 3.35 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.23 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -45.6 89.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.188 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 14' ' ' VAL . 74.7 mt -54.19 -51.67 63.64 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.481 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.444 ' CE1' ' HA ' ' A' ' 8' ' ' ASP . 2.2 p90 -85.14 -18.24 34.8 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.368 -175.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -60.52 -40.75 92.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.997 0.427 . . . . 0.0 110.128 169.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.514 ' HG3' ' HE1' ' A' ' 16' ' ' MET . 10.4 tt0 -73.1 -24.66 60.67 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.714 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 10' ' ' LEU . 90.0 t -73.17 -34.93 46.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.331 175.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.4 mt -73.9 -32.34 33.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.635 172.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.514 ' HE1' ' HG3' ' A' ' 13' ' ' GLN . 56.2 ttp -68.77 -46.27 69.2 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.899 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -38.2 89.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.702 -177.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.423 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -83.0 -14.24 54.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -69.09 -50.06 51.61 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.479 -1.388 . . . . 0.0 109.04 167.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -52.58 -37.39 57.92 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.391 0.676 . . . . 0.0 110.511 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.86 84.68 32.44 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.93 39.21 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.99 3.127 . . . . 0.0 114.408 -163.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -85.69 57.82 4.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.799 0.809 . . . . 0.0 110.868 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 18' ' ' HIS . 4.6 m-20 -102.03 19.63 18.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.925 0.869 . . . . 0.0 109.496 172.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -136.99 143.96 43.05 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.002 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.79 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 157.96 139.74 2.77 Favored Glycine 0 C--O 1.21 -1.351 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.792 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.598 HG23 HG21 ' A' ' 48' ' ' THR . 4.0 p -167.18 120.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.465 0.65 . . . . 0.0 109.347 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.744 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -138.97 154.07 48.25 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.51 0.671 . . . . 0.0 110.533 175.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -102.2 79.64 1.88 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.841 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.47 ' OD1' ' HG3' ' A' ' 50' ' ' LYS . 6.5 t70 -115.8 -130.61 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.478 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 m -52.08 -71.71 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.976 0.798 . . . . 0.0 111.746 -172.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.743 HD11 HD21 ' A' ' 51' ' ' LEU . 10.4 pt -132.59 140.36 47.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.458 0.647 . . . . 0.0 110.978 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.679 HG13 HG22 ' A' ' 48' ' ' THR . 44.5 t -120.48 107.7 21.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.078 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.061 HG21 ' HA2' ' A' ' 139' ' ' GLY . 89.9 t -101.11 128.27 53.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.104 -172.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 1.5 p-10 -132.06 149.0 52.53 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.812 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.537 ' HA ' ' CE ' ' A' ' 36' ' ' MET . 3.5 mmt -143.08 122.77 13.33 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.341 1.026 . . . . 0.0 110.22 176.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.698 ' HB3' ' HB3' ' A' ' 44' ' ' ARG . 3.7 p-10 -118.44 134.2 55.26 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.131 0.894 . . . . 0.0 110.768 -176.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.44 ' N ' HD12 ' A' ' 131' ' ' LEU . 22.4 t30 -156.84 138.87 10.18 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -45.28 -35.61 11.56 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 124.447 3.431 . . . . 0.0 113.807 -178.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.576 HG21 ' O ' ' A' ' 124' ' ' ALA . 3.2 m -74.91 23.76 0.1 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 122.148 0.975 . . . . 0.0 111.427 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.637 ' SG ' HD13 ' A' ' 131' ' ' LEU . 72.3 m -136.22 -52.73 0.73 Allowed 'General case' 0 C--N 1.312 -1.06 0 O-C-N 121.463 -0.773 . . . . 0.0 110.335 167.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.29 -29.11 2.31 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 24.9 t0 -157.28 -88.45 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.82 0 CA-C-N 114.621 -0.79 . . . . 0.0 111.258 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.698 ' HB3' ' HB3' ' A' ' 37' ' ' ASN . 7.7 ptp85 179.63 -179.35 0.43 Allowed 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.036 0.446 . . . . 0.0 110.897 -169.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.661 HG22 ' HE1' ' A' ' 61' ' ' PHE . 19.5 pt -137.65 139.61 42.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.821 177.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.528 ' HD3' ' HD3' ' A' ' 44' ' ' ARG . 37.2 mmm-85 -114.03 100.69 8.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.494 0.664 . . . . 0.0 110.342 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.927 HD22 ' HG3' ' A' ' 49' ' ' MET . 0.8 OUTLIER -82.86 92.44 7.28 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.744 ' HB ' HD12 ' A' ' 28' ' ' LEU . 68.3 p -84.0 111.97 19.76 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.927 ' HG3' HD22 ' A' ' 47' ' ' LEU . 22.9 mtt -107.21 178.25 4.61 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.826 0.822 . . . . 0.0 111.298 -170.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 62.8 tttp -160.79 95.82 1.1 Allowed 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.743 HD21 HD11 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -119.56 84.52 2.22 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.852 -177.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.89 59.35 4.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.511 -164.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.92 -99.48 0.2 Allowed Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.804 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.428 ' C ' HG12 ' A' ' 85' ' ' ILE . 11.6 p-10 -133.37 24.47 4.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.466 0.65 . . . . 0.0 109.795 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.698 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.2 pp -139.66 152.91 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -99.83 121.17 50.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -104.15 -33.25 8.8 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.335 -169.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 6.9 t70 -140.17 143.02 35.9 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.417 -0.811 . . . . 0.0 108.86 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.58 ' HB1' HD21 ' A' ' 47' ' ' LEU . . . -167.74 101.74 0.48 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.79 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 47.7 mttp -115.32 167.53 10.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.058 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.661 ' HE1' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -124.41 131.28 53.5 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.627 0.727 . . . . 0.0 111.18 -174.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 10.3 tp10 -128.79 110.81 12.48 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.15 174.86 34.0 Favored Glycine 0 CA--C 1.493 -1.317 0 C-N-CA 119.325 -1.417 . . . . 0.0 113.486 -174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 1.3 tm-20 -147.74 132.25 17.7 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.95 -133.59 2.76 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.581 -171.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.2 p -110.03 172.81 6.64 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.662 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.7 t -74.16 -31.08 62.56 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.177 -165.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.738 HD11 ' SG ' ' A' ' 128' ' ' CYS . 2.7 pp -75.66 -24.57 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.148 0.499 . . . . 0.0 109.937 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 68' ' ' ILE . 13.1 m -78.86 -37.79 39.44 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 65.0 mtt -58.41 -33.0 69.17 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.779 0.799 . . . . 0.0 109.687 167.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.599 ' O ' ' HB3' ' A' ' 74' ' ' SER . . . -71.62 -38.1 70.83 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.999 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.804 ' HB2' HD11 ' A' ' 116' ' ' LEU . 41.7 t -59.98 -48.47 81.56 Favored 'General case' 0 C--O 1.219 -0.538 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.12 -41.33 78.81 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.815 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.599 ' HB3' ' O ' ' A' ' 71' ' ' ALA . 30.7 t -47.8 -67.59 0.26 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.242 173.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.485 ' SD ' ' HA3' ' A' ' 111' ' ' GLY . 25.5 mmt -65.15 -32.42 74.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.925 0.393 . . . . 0.0 110.518 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.75 ' SD ' ' HG ' ' A' ' 47' ' ' LEU . 31.9 ttm -56.66 -61.72 2.23 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.593 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 p -60.08 -27.62 67.14 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -90.02 -31.63 17.11 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.308 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.11 -41.22 15.92 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.299 0.571 . . . . 0.0 111.059 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 80' ' ' ILE . 14.7 mm -76.66 -39.71 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.443 -174.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.535 ' HD3' ' H ' ' A' ' 59' ' ' ALA . 3.0 mmmp? -52.56 -18.74 1.87 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.217 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.01 54.9 0.78 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.014 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.449 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 12.0 tppt? -133.3 169.45 16.89 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -114.28 -174.03 2.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 173.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.489 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 18.4 mm -85.49 -33.31 7.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.963 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -63.4 -46.42 86.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.198 0.523 . . . . 0.0 110.92 175.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 83' ' ' LYS . 0.9 OUTLIER -67.96 -37.61 81.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.352 178.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.917 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -64.18 -43.21 95.84 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.101 0.477 . . . . 0.0 111.37 175.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 70.9 mt -67.1 -35.54 80.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.318 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 p -73.03 -35.2 66.72 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.933 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.0 ttt -70.03 -22.58 63.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.875 0.845 . . . . 0.0 111.718 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.509 ' OG ' ' HA ' ' A' ' 142' ' ' LYS . 49.4 p -89.06 -36.59 15.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.874 ' HB2' ' HA ' ' A' ' 143' ' ' GLU . 87.1 tttt -66.8 -37.02 83.73 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 1.053 HD13 ' HA ' ' A' ' 105' ' ' ASP . 12.8 mt -67.74 -47.27 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.355 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.549 ' CE2' HG12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -55.95 -24.88 40.88 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 123.934 0.771 . . . . 0.0 110.04 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.4 m -81.71 -43.07 18.97 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.993 -0.442 . . . . 0.0 110.824 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -75.96 -29.19 58.2 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -173.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.8 ptm -54.31 -10.0 0.34 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.956 0.902 . . . . 0.0 112.307 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 95.6 mmm -100.1 -7.77 24.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.926 0.87 . . . . 0.0 109.241 -166.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -134.68 -22.74 1.65 Allowed 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.688 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -107.54 -23.49 6.87 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 119.207 -0.774 . . . . 0.0 112.302 -177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 22.3 tptm 81.48 -18.54 0.48 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.08 1.352 . . . . 0.0 109.692 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -77.91 149.15 34.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.41 ' HB2' ' H ' ' A' ' 105' ' ' ASP . 3.5 p90 -137.03 -134.03 0.14 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -171.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 1.053 ' HA ' HD13 ' A' ' 94' ' ' ILE . 9.0 t70 -90.66 108.79 20.04 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.125 0.964 . . . . 0.0 109.33 -169.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -58.5 -2.86 0.23 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.284 173.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.532 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 1.5 m -89.79 -24.82 21.37 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 170.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 108' ' ' ILE . 22.7 mm 72.91 25.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-O 122.421 1.105 . . . . 0.0 110.703 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -94.89 70.03 3.36 Favored 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 121.618 -0.676 . . . . 0.0 109.952 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.839 ' HG ' HD12 ' A' ' 113' ' ' ILE . 6.1 mp -104.35 14.11 30.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.285 -169.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.485 ' HA3' ' SD ' ' A' ' 75' ' ' MET . . . -44.78 -39.26 6.07 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 119.857 -0.413 . . . . 0.0 113.849 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.09 -45.42 23.49 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-O 122.367 1.08 . . . . 0.0 109.906 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.839 HD12 ' HG ' ' A' ' 110' ' ' LEU . 36.8 mt -58.25 -28.95 36.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.902 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 8.2 mm-40 -76.27 -54.5 6.7 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.282 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.45 -41.45 69.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.3 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.804 HD11 ' HB2' ' A' ' 72' ' ' SER . 6.6 mp -96.04 -6.77 37.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.566 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 6.4 tt0 -45.53 -51.44 11.82 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.178 0.923 . . . . 0.0 110.853 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.48 -18.79 77.32 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.375 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 68' ' ' ILE . 60.2 t -78.29 -60.25 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 O-C-N 122.056 -0.673 . . . . 0.0 111.606 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 129' ' ' ALA . 14.5 p -50.93 -16.06 0.38 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.338 -1.301 . . . . 0.0 114.141 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.987 ' HA ' ' HE2' ' A' ' 121' ' ' LYS . 8.9 mmpt? -99.66 -16.73 18.09 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.492 -0.755 . . . . 0.0 110.822 -163.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -90.4 135.14 29.9 Favored Pre-proline 0 N--CA 1.443 -0.794 0 O-C-N 123.833 0.708 . . . . 0.0 109.819 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.0 -27.48 21.36 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.323 2.682 . . . . 0.0 111.78 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.576 ' O ' HG21 ' A' ' 40' ' ' THR . . . -84.34 -27.75 27.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.556 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.527 ' HB3' HG13 ' A' ' 119' ' ' VAL . 30.5 mtm180 -113.9 17.76 17.75 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.775 -166.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.7 tt -84.9 -29.74 6.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.03 -17.78 45.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.778 -1.556 . . . . 0.0 107.999 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.738 ' SG ' HD11 ' A' ' 68' ' ' ILE . 54.1 t -84.34 -19.62 33.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.757 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.577 ' O ' ' HB3' ' A' ' 133' ' ' TRP . . . -85.78 -27.73 25.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.533 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 16.6 p -78.31 -35.84 47.26 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.637 HD13 ' SG ' ' A' ' 41' ' ' CYS . 10.0 tt -51.42 -54.17 29.43 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.225 172.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.512 ' HB2' HD21 ' A' ' 116' ' ' LEU . 35.9 m -81.88 -62.25 1.69 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.577 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 1.2 t90 -62.49 -50.43 71.44 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 120.943 0.401 . . . . 0.0 111.849 -175.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.64 ' HB3' ' O ' ' A' ' 130' ' ' THR . 37.7 ttpt -62.65 -29.34 70.56 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.608 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 132' ' ' SER . . . -56.89 -31.02 64.45 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 169.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.5 mp -80.55 -35.17 34.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.421 ' OE1' ' HD2' ' A' ' 142' ' ' LYS . 7.5 mm-40 -61.65 -43.85 98.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.422 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -91.25 5.51 48.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.361 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 1.061 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -85.79 -39.99 7.87 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.917 HG21 ' HB1' ' A' ' 88' ' ' ALA . 20.1 m -127.06 -9.45 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 O-C-N 122.091 -0.653 . . . . 0.0 110.543 -177.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 91.78 152.39 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.184 1.393 . . . . 0.0 108.425 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.509 ' HA ' ' OG ' ' A' ' 92' ' ' SER . 14.9 pttp -114.44 142.66 46.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -171.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.874 ' HA ' ' HB2' ' A' ' 93' ' ' LYS . 33.4 mt-10 65.81 -88.66 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.242 0.964 . . . . 0.0 111.861 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 C--N 1.311 -1.068 0 O-C-N 123.587 0.554 . . . . 0.0 110.585 -178.227 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.516 -0.358 0 CA-C-O 121.104 0.478 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.506 HD11 ' O ' ' A' ' 115' ' ' ALA . 12.7 tp -137.54 0.28 2.25 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.983 0.897 . . . . 0.0 109.116 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.51 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -55.81 -63.53 1.14 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 125.348 1.459 . . . . 0.0 111.467 -178.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -62.7 -35.14 78.73 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.718 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.517 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 4.1 mm? -53.97 -39.52 66.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.103 174.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.879 ' HE1' HG22 ' A' ' 68' ' ' ILE . 22.7 m-85 -63.08 -57.71 9.71 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 121.52 0.676 . . . . 0.0 109.848 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.654 ' HA ' HG22 ' A' ' 15' ' ' ILE . 47.3 mtm180 -69.44 -18.92 63.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.03 -169.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.419 ' HA ' ' OE1' ' A' ' 13' ' ' GLN . 16.3 mm-40 -86.62 -35.86 19.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.685 1.231 . . . . 0.0 108.02 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.621 HG21 ' HB2' ' A' ' 115' ' ' ALA . 0.3 OUTLIER -80.1 -34.19 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.964 -175.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.654 HG22 ' HA ' ' A' ' 12' ' ' ARG . 10.5 tt -82.62 -19.1 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.683 175.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.613 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 17.2 tpt -61.73 -43.87 98.02 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.859 0.838 . . . . 0.0 110.388 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.02 -41.71 63.95 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.059 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -61.82 -28.23 69.33 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.774 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -66.84 -55.64 13.93 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.104 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -48.57 -38.35 20.38 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 124.039 0.837 . . . . 0.0 110.812 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -114.08 86.3 11.32 Favored Pre-proline 0 C--N 1.32 -0.676 0 O-C-N 123.426 0.454 . . . . 0.0 110.478 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.57 45.97 2.01 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.529 2.153 . . . . 0.0 114.038 -172.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.33 102.15 11.58 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.083 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -142.24 25.93 1.86 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.151 0.977 . . . . 0.0 108.366 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -132.09 124.46 29.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.224 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.764 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 155.28 146.94 4.56 Favored Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.713 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -165.39 93.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.873 0 O-C-N 124.619 0.835 . . . . 0.0 109.25 177.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.579 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -116.75 139.2 50.84 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 120.68 -1.263 . . . . 0.0 111.721 -175.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.512 ' HA ' HG21 ' A' ' 33' ' ' VAL . 58.1 t30 -81.24 81.34 7.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.627 172.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.555 ' HB2' HD13 ' A' ' 28' ' ' LEU . 10.3 t70 -101.48 -125.86 0.19 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.667 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.4 t -66.66 -64.92 0.75 Allowed 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.668 -0.645 . . . . 0.0 110.376 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.615 HG13 ' HB2' ' A' ' 49' ' ' MET . 34.4 pt -125.65 135.28 64.43 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.713 176.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.948 HG13 HG22 ' A' ' 48' ' ' THR . 84.9 t -116.16 138.11 47.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.917 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.764 HG21 ' HA2' ' A' ' 139' ' ' GLY . 98.1 t -127.95 124.65 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -120.41 136.91 54.58 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.35 0.119 . . . . 0.0 111.061 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.577 ' HG3' HD12 ' A' ' 131' ' ' LEU . 47.9 tpp -151.55 123.48 8.09 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 110.98 175.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 7.6 p30 -127.64 150.35 49.78 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.573 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -109.93 98.2 33.05 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.51 -11.62 32.79 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.596 2.864 . . . . 0.0 113.278 -171.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.4 m -75.85 -30.9 59.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.544 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.476 ' SG ' ' OD2' ' A' ' 43' ' ' ASP . 6.2 p -131.12 -12.67 3.59 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.43 3.78 58.49 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.317 -1.42 . . . . 0.0 113.538 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.476 ' OD2' ' SG ' ' A' ' 41' ' ' CYS . 21.7 m-20 -70.15 115.5 9.42 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 18.8 ptp180 -127.83 141.08 51.67 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 31.6 pt -141.34 149.84 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.287 0.565 . . . . 0.0 110.172 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.732 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 50.5 mtt180 -140.51 107.64 5.48 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.957 -0.464 . . . . 0.0 111.525 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.709 HD22 ' HG3' ' A' ' 49' ' ' MET . 0.7 OUTLIER -93.66 89.67 6.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.948 HG22 HG13 ' A' ' 33' ' ' VAL . 67.4 p -88.02 128.5 35.4 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 173.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.709 ' HG3' HD22 ' A' ' 47' ' ' LEU . 30.5 mtt -113.67 -179.21 3.57 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.275 1.036 . . . . 0.0 112.92 -170.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.838 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 45.3 tttp -159.87 98.7 1.36 Allowed 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.619 ' H ' HD23 ' A' ' 51' ' ' LEU . 2.3 pt? -126.48 93.12 3.71 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -172.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -99.17 59.92 1.17 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.731 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 148.77 -96.21 0.17 Allowed Glycine 0 C--N 1.316 -0.548 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.43 18.93 6.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -176.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 2.4 pp -140.54 167.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 p -116.2 116.81 53.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 168.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' HB2' HD13 ' A' ' 55' ' ' ILE . 23.5 tt0 -106.58 -27.63 10.75 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.033 0.921 . . . . 0.0 109.95 -166.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.838 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 28.0 t70 -140.73 144.68 35.7 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 48' ' ' THR . . . -160.36 118.04 2.53 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.764 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 34.2 mmtp -107.25 130.41 54.75 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.732 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.7 p90 -129.01 147.28 50.86 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.35 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 42.2 tt0 -107.16 138.46 43.29 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.42 120.13 1.54 Allowed Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.637 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 44' ' ' ARG . 7.9 pt-20 -163.15 106.63 1.04 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.15 -131.4 1.87 Allowed Glycine 0 C--O 1.236 0.24 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.904 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.7 m -77.21 173.67 11.6 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.8 m -89.87 17.31 6.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.795 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.879 HG22 ' HE1' ' A' ' 11' ' ' TYR . 2.7 pp -119.05 -45.13 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.393 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.514 ' N ' HD12 ' A' ' 68' ' ' ILE . 13.8 p -73.27 -46.18 51.34 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.798 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -27.25 64.43 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.172 177.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.0 -59.26 2.39 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.632 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.667 ' CB ' ' HB2' ' A' ' 116' ' ' LEU . 21.7 p -67.62 -45.84 74.22 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.437 -168.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.04 -53.81 50.33 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 120.901 0.381 . . . . 0.0 110.345 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.1 t -60.16 -35.33 75.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.414 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.416 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 17.9 tpt -67.78 -54.82 16.17 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.551 0.691 . . . . 0.0 110.349 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.431 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -62.98 -33.52 75.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.205 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.616 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 24.3 p -72.61 -39.43 67.3 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.348 0.594 . . . . 0.0 110.651 177.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.416 ' HB3' ' O ' ' A' ' 75' ' ' MET . 28.1 tt0 -53.25 -38.05 62.65 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.586 171.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.98 -27.83 24.61 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.762 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -73.56 -36.83 48.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 O-C-N 124.359 1.037 . . . . 0.0 110.152 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 55.5 tttm -56.35 -17.51 8.07 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.848 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.95 42.59 1.79 Allowed Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.29 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -134.53 -153.04 0.5 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.698 0.761 . . . . 0.0 111.875 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -145.78 155.88 43.23 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 -167.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.637 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.6 mp -63.31 -49.75 81.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 O-C-N 123.342 0.401 . . . . 0.0 110.079 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.26 -38.73 82.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.863 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.522 ' O ' ' HG2' ' A' ' 91' ' ' MET . 4.8 m -68.35 -35.04 77.16 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 121.497 0.665 . . . . 0.0 110.428 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' A' ' 141' ' ' ALA . . . -60.5 -41.88 95.21 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 173.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 32.8 mt -67.36 -31.83 72.35 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.287 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.441 ' O ' HG13 ' A' ' 94' ' ' ILE . 5.1 p -77.96 -29.63 49.93 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 121.66 -0.65 . . . . 0.0 111.76 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' A' ' 87' ' ' THR . 22.1 mmt -75.66 -18.91 59.5 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.09 0.948 . . . . 0.0 110.846 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p -90.08 -31.47 17.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.377 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.85 -37.96 79.46 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.66 172.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.447 HD12 ' SD ' ' A' ' 91' ' ' MET . 35.9 mt -62.23 -48.85 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 171.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.485 ' HD1' HG12 ' A' ' 113' ' ' ILE . 49.9 t80 -43.39 -35.91 1.73 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.471 0.653 . . . . 0.0 111.745 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.2 m -85.08 -35.51 21.78 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 121.686 -0.634 . . . . 0.0 111.454 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -84.3 -20.09 32.69 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.05 0.929 . . . . 0.0 112.3 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.46 ' CG ' ' HB3' ' A' ' 104' ' ' TYR . 2.1 tmt? -73.34 -13.07 61.04 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.233 -174.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.1 mmt -95.24 6.15 49.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.556 -160.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -103.97 16.85 25.35 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.5 30.25 74.85 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.509 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 102' ' ' LYS . 7.3 mmpt? -102.7 -170.92 1.87 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.816 0.308 . . . . 0.0 110.211 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.59 156.86 33.87 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.503 ' HD2' ' H ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -124.64 -101.2 0.39 Allowed 'General case' 0 C--N 1.316 -0.883 0 O-C-N 123.717 0.636 . . . . 0.0 111.035 -178.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.636 ' HB3' HD11 ' A' ' 110' ' ' LEU . 15.4 t0 -116.14 107.26 14.67 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 123.742 0.651 . . . . 0.0 109.373 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.76 -2.01 1.6 Allowed 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.959 0.787 . . . . 0.0 111.531 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.587 ' O ' HG22 ' A' ' 108' ' ' ILE . 2.1 m -89.34 -15.8 32.54 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 172.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.587 HG22 ' O ' ' A' ' 107' ' ' SER . 4.3 tp 68.59 15.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.068 0.947 . . . . 0.0 113.512 165.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -92.73 88.68 6.34 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.636 HD11 ' HB3' ' A' ' 105' ' ' ASP . 10.8 mp -127.0 43.75 3.05 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.037 -168.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -38.64 -44.87 1.89 Allowed Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.579 -0.737 . . . . 0.0 114.91 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.609 ' O ' ' HB3' ' A' ' 116' ' ' LEU . 16.1 p-10 -90.45 -41.53 11.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.52 1.152 . . . . 0.0 109.99 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.74 ' O ' ' HB2' ' A' ' 117' ' ' GLN . 50.7 mt -69.47 -27.49 34.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.591 -172.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -86.98 -69.59 0.67 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.396 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.621 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -63.52 -39.39 94.31 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -172.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.667 ' HB2' ' CB ' ' A' ' 72' ' ' SER . 48.4 tp -99.74 3.08 44.77 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.648 0.737 . . . . 0.0 111.17 -169.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.74 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 8.2 tt0 -63.48 -45.79 89.15 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.536 0.684 . . . . 0.0 110.445 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.95 -17.23 65.14 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 113.91 -1.495 . . . . 0.0 113.014 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.932 HG13 ' HG2' ' A' ' 125' ' ' ARG . 97.9 t -82.09 -40.78 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 121.765 0.793 . . . . 0.0 110.186 -169.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.533 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 16.4 t -42.98 -13.23 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.561 -1.654 . . . . 0.0 115.393 174.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.458 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 10.2 ptmt -142.93 -0.37 1.16 Allowed 'General case' 0 C--O 1.243 0.725 0 O-C-N 121.003 -1.061 . . . . 0.0 113.041 -162.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.671 ' HB2' ' HB3' ' A' ' 125' ' ' ARG . 30.0 m-85 -81.09 123.6 81.75 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 168.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -51.05 -28.79 25.76 Favored 'Trans proline' 0 C--O 1.218 -0.514 0 C-N-CA 123.347 2.698 . . . . 0.0 112.652 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.49 -0.11 32.81 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.216 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.932 ' HG2' HG13 ' A' ' 119' ' ' VAL . 33.0 ttm180 -126.08 6.02 7.19 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.393 -175.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.7 tt -80.73 -25.34 11.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.244 -171.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -76.8 -20.11 56.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.389 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.414 ' HB3' HD11 ' A' ' 68' ' ' ILE . 61.0 m -86.3 -19.33 30.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.228 174.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.582 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -72.62 -46.9 51.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.147 176.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.694 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 7.5 p -69.99 -37.58 75.76 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.577 HD12 ' HG3' ' A' ' 36' ' ' MET . 18.0 tp -46.38 -55.68 6.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.077 -0.389 . . . . 0.0 111.494 171.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.463 ' HB2' HD21 ' A' ' 116' ' ' LEU . 6.7 m -83.42 -55.87 4.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.812 0.339 . . . . 0.0 111.203 -171.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 6.4 t90 -63.47 -50.56 69.21 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.746 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.694 ' HB3' ' O ' ' A' ' 130' ' ' THR . 3.1 tppp? -60.65 -42.31 96.7 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.19 -41.13 78.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.937 0.399 . . . . 0.0 111.581 173.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.401 HD21 ' CG ' ' A' ' 76' ' ' MET . 17.0 tp -73.97 -32.43 63.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.416 0.627 . . . . 0.0 110.173 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' A' ' 141' ' ' ALA . 39.4 tt0 -69.55 -37.37 77.03 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.5 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.476 ' NZ ' ' HB3' ' A' ' 138' ' ' LYS . 9.6 mtpm? -87.64 10.63 17.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.695 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.764 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -94.82 -40.96 4.23 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.8 p -178.13 -44.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.694 ' O ' ' HA ' ' A' ' 137' ' ' GLU . . . -82.97 100.61 10.54 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.435 ' HA ' ' HG3' ' A' ' 137' ' ' GLU . 13.4 ptmm? -142.91 28.29 1.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.102 0.477 . . . . 0.0 110.587 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 59.12 -167.28 0.16 Allowed 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.9 -171.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.493 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 10' ' ' LEU . 28.3 tp -105.5 -16.6 14.68 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.008 -0.433 . . . . 0.0 110.443 -168.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 30.4 t70 -56.53 -54.18 48.84 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.825 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.3 m -59.93 -42.25 93.58 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.536 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.669 ' HB2' HD12 ' A' ' 7' ' ' LEU . 70.0 mt -59.08 -36.41 75.04 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.835 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.555 ' O ' HG12 ' A' ' 15' ' ' ILE . 8.3 m-85 -63.92 -54.75 29.77 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.194 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 16' ' ' MET . 28.0 mtt85 -56.23 -37.33 69.58 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.86 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -75.49 -37.61 60.07 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.261 0.35 . . . . 0.0 110.868 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 t -76.93 -34.62 22.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.937 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 11' ' ' TYR . 29.0 pt -77.91 -18.44 13.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 121.813 -0.555 . . . . 0.0 109.804 174.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 45.7 ttm -69.04 -47.41 65.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -61.05 -46.41 90.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.733 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 58.9 t-80 -51.61 -45.86 63.37 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.251 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -66.72 -49.12 67.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.387 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -44.61 -41.38 6.54 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.238 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -131.73 81.05 64.6 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-O 121.407 0.622 . . . . 0.0 109.505 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -88.72 94.99 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.078 2.519 . . . . 0.0 112.875 -171.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -161.17 115.05 2.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.009 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.628 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 13.8 m120 -113.16 24.76 11.99 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.32 101.04 10.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.972 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.688 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -168.65 120.44 0.89 Allowed Glycine 0 CA--C 1.494 -1.237 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.738 HG21 ' HE ' ' A' ' 46' ' ' ARG . 2.4 p -167.88 105.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 O-C-N 121.185 -1.186 . . . . 0.0 110.982 -174.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.524 ' H ' ' CB ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -87.55 -155.36 0.29 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.396 0.617 . . . . 0.0 110.155 173.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.59 ' HA ' HG21 ' A' ' 33' ' ' VAL . 3.8 p-10 -166.42 13.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.357 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -99.42 -71.18 0.7 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.804 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.709 ' HB3' ' O ' ' A' ' 49' ' ' MET . 11.3 t -73.19 -143.98 0.02 OUTLIER 'General case' 0 C--O 1.238 0.486 0 O-C-N 123.157 0.286 . . . . 0.0 110.649 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.817 HG13 ' HB2' ' A' ' 49' ' ' MET . 27.9 pt -78.78 119.98 28.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.683 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.001 HG13 HG22 ' A' ' 48' ' ' THR . 79.9 t -119.2 135.02 60.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.257 -177.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.765 HG21 ' HA2' ' A' ' 139' ' ' GLY . 78.9 t -123.52 119.63 57.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -120.65 118.71 30.82 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.051 0.219 . . . . 0.0 110.766 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.515 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 3.4 mmt -144.51 121.17 11.15 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.15 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 3.1 p30 -120.09 158.65 26.43 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 172.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.624 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 25.9 t30 -114.46 100.07 52.38 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 121.384 0.611 . . . . 0.0 109.816 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.12 -19.34 40.87 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 123.157 2.571 . . . . 0.0 113.113 -173.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 60.1 m -62.91 -43.92 97.49 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.8 p -133.0 8.67 4.09 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.06 6.9 78.33 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.477 163.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.624 ' OD1' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -82.3 146.4 29.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.216 0.531 . . . . 0.0 110.153 176.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 52.3 ttt180 -139.71 148.32 42.16 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.622 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.7 tt -140.18 146.61 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 123.536 0.523 . . . . 0.0 110.12 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.738 ' HE ' HG21 ' A' ' 27' ' ' VAL . 75.4 mtp85 -141.17 100.38 3.79 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.241 0.543 . . . . 0.0 110.326 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.717 HD22 ' HG3' ' A' ' 49' ' ' MET . 0.3 OUTLIER -89.99 92.17 8.88 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.48 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 1.001 HG22 HG13 ' A' ' 33' ' ' VAL . 77.7 p -93.23 130.64 38.86 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.553 -0.717 . . . . 0.0 109.79 174.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.817 ' HB2' HG13 ' A' ' 32' ' ' ILE . 36.9 mtt -126.92 -177.7 4.13 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 121.819 -0.55 . . . . 0.0 110.815 -172.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' A' ' 52' ' ' ASP . 10.5 tmtt? -160.61 110.93 1.78 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.564 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.5 pt? -128.57 94.3 3.84 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.942 0.877 . . . . 0.0 108.939 -170.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.503 ' HB2' ' HZ3' ' A' ' 50' ' ' LYS . 37.4 t70 -101.89 59.84 0.85 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.759 0.79 . . . . 0.0 109.951 -171.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.83 -94.82 0.16 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 170.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -133.77 24.71 4.0 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.437 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -139.48 160.13 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -173.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -95.68 97.12 6.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 123.485 1.612 . . . . 0.0 106.999 165.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 50' ' ' LYS . 37.8 tt0 -66.44 -41.88 88.46 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 112.509 -2.132 . . . . 0.0 110.189 -167.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -148.72 146.53 28.14 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.561 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.33 121.93 11.11 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.688 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 89.4 mttt -126.06 140.86 52.25 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.704 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.642 ' CZ ' ' HA ' ' A' ' 74' ' ' SER . 31.2 p90 -128.22 143.39 51.03 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.972 0.415 . . . . 0.0 110.575 -172.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 45.7 tt0 -117.05 114.02 23.16 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.482 ' H ' ' HB3' ' A' ' 24' ' ' ASN . . . -121.38 128.66 7.42 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.265 -173.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -148.21 108.45 4.1 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 43' ' ' ASP . . . 170.84 -132.4 2.47 Favored Glycine 0 C--N 1.317 -0.523 0 C-N-CA 119.363 -1.398 . . . . 0.0 112.584 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 70' ' ' MET . 1.4 p -95.37 159.25 15.09 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 120.753 0.311 . . . . 0.0 110.261 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.9 t -78.75 24.9 0.28 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.467 -167.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -118.19 -52.67 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 122.386 1.089 . . . . 0.0 109.652 179.022 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.631 ' HB3' HD22 ' A' ' 131' ' ' LEU . 1.2 m -77.23 -44.29 30.49 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 121.781 0.801 . . . . 0.0 111.098 -170.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 66' ' ' CYS . 26.9 ptm -72.16 -12.84 61.37 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.392 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.81 -45.98 11.08 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.071 -0.393 . . . . 0.0 111.379 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 p -62.62 -28.36 69.85 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 121.41 0.624 . . . . 0.0 109.849 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.61 -50.38 67.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.463 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.642 ' HA ' ' CZ ' ' A' ' 61' ' ' PHE . 24.3 m -59.64 -39.25 83.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.477 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -76.49 -58.61 3.18 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.829 -174.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.609 ' SD ' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -59.34 -34.0 71.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.817 -177.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 1.055 ' HA ' HG22 ' A' ' 80' ' ' ILE . 98.9 m -61.97 -43.18 99.37 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.088 0.858 . . . . 0.0 110.1 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' MET . 77.5 mt-30 -49.45 -37.01 24.34 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.773 0.797 . . . . 0.0 110.535 172.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.509 ' HB1' ' OD2' ' A' ' 109' ' ' ASP . . . -86.26 -31.84 21.44 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.682 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.055 HG22 ' HA ' ' A' ' 77' ' ' THR . 9.9 tp -83.24 -40.17 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.054 -173.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -54.34 -17.29 2.84 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.927 0.87 . . . . 0.0 111.346 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.26 40.88 2.12 Favored Glycine 0 C--N 1.31 -0.895 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -132.78 167.05 20.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -103.98 -177.06 3.26 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.681 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.4 mp -81.77 -45.37 20.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.21 -176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -58.36 -43.45 88.4 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.37 0.419 . . . . 0.0 111.099 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.536 ' HA ' ' OG ' ' A' ' 90' ' ' SER . 2.7 p -68.84 -37.65 79.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.389 0.614 . . . . 0.0 111.508 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.411 ' HB1' HG13 ' A' ' 140' ' ' VAL . . . -60.89 -40.52 93.37 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.863 175.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.841 HD22 ' HB3' ' A' ' 142' ' ' LYS . 34.0 mt -69.58 -37.5 76.97 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 110.819 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 87' ' ' THR . 2.3 p -75.43 -35.24 61.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.072 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.512 ' HA ' HG22 ' A' ' 94' ' ' ILE . 11.2 tmm? -64.94 -20.85 66.68 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.778 0.799 . . . . 0.0 109.185 173.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.796 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 43.6 t -85.35 -42.96 14.1 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.297 -1.319 . . . . 0.0 107.577 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.643 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 54.3 tttp -67.42 -36.25 80.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.329 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 90' ' ' SER . 9.1 tt -79.73 -39.77 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.087 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -46.19 -38.63 8.57 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.44 0.638 . . . . 0.0 111.247 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.5 m -86.66 -28.23 23.29 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.44 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -71.77 -21.57 61.71 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.052 0.541 . . . . 0.0 111.0 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -41.94 -47.27 4.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.673 0.789 . . . . 0.0 112.513 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.1 ttt -55.08 -18.24 5.14 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -129.3 -26.46 2.56 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.492 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.47 -40.17 4.26 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.512 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp 87.85 37.48 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.449 ' HB3' HD11 ' A' ' 94' ' ' ILE . 39.7 mt-10 -132.45 126.96 34.27 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.562 -2.108 . . . . 0.0 107.219 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.575 ' CD1' HD21 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -94.59 -89.73 0.23 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.462 ' HB3' HD12 ' A' ' 110' ' ' LEU . 5.3 t70 -115.02 112.64 22.96 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 156.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.466 ' H ' HD13 ' A' ' 94' ' ' ILE . 30.9 t70 -49.89 -21.81 1.29 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.775 173.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.459 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 1.3 m -80.11 -17.13 53.4 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.487 ' HA ' HD13 ' A' ' 110' ' ' LEU . 21.9 mm 72.23 24.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 122.507 1.146 . . . . 0.0 110.492 174.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.509 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 27.6 t70 -95.17 66.77 2.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.055 177.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.807 ' HG ' ' HB ' ' A' ' 113' ' ' ILE . 7.8 mp -95.94 40.32 1.12 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.127 -165.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.444 ' HA2' ' SD ' ' A' ' 75' ' ' MET . . . -38.31 -50.75 2.28 Favored Glycine 0 C--O 1.242 0.594 0 O-C-N 124.066 0.854 . . . . 0.0 114.145 177.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.634 ' HB2' HD22 ' A' ' 116' ' ' LEU . 8.5 p-10 -91.59 -43.38 9.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.8 -0.824 . . . . 0.0 110.238 176.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.807 ' HB ' ' HG ' ' A' ' 110' ' ' LEU . 16.4 mt -62.93 -33.3 59.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.575 -166.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.496 ' HG2' HD22 ' A' ' 10' ' ' LEU . 31.8 tt0 -61.98 -50.83 70.52 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 119' ' ' VAL . . . -69.68 -53.37 18.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.933 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.634 HD22 ' HB2' ' A' ' 112' ' ' ASP . 3.9 mp -82.72 -2.7 54.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -164.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -62.79 -39.32 93.87 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.52 -17.19 64.62 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.864 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.872 HG13 ' HB3' ' A' ' 125' ' ' ARG . 91.8 t -86.17 -46.94 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -171.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.598 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 9.4 t -49.56 -10.16 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.63 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.839 ' HA ' ' HE3' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -134.0 -17.41 2.15 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.365 -160.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -88.63 130.06 46.63 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.56 -30.61 55.44 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 122.433 2.089 . . . . 0.0 112.276 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.25 1.75 56.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.255 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.872 ' HB3' HG13 ' A' ' 119' ' ' VAL . 27.9 mmt180 -134.92 8.01 3.49 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 118.61 0.641 . . . . 0.0 110.422 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.2 tt -84.34 -30.07 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -165.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.51 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 31.8 mmtp -74.99 -30.49 61.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.999 174.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.2 m -78.62 -17.64 55.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.023 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.598 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -78.38 -31.4 48.38 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.92 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.764 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 25.3 m -72.11 -44.47 63.15 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 69' ' ' SER . 9.5 tt -50.2 -63.59 1.07 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.636 174.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.544 ' HB2' HD21 ' A' ' 116' ' ' LEU . 13.5 p -74.59 -63.49 1.23 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.985 -171.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.5 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 4.7 t90 -66.38 -56.34 11.54 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 122.58 0.352 . . . . 0.0 111.219 -175.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.764 ' HB3' ' O ' ' A' ' 130' ' ' THR . 24.1 tptm -56.6 -40.08 74.66 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 123.992 0.808 . . . . 0.0 110.184 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.1 -32.95 73.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.567 HD21 ' SD ' ' A' ' 76' ' ' MET . 15.7 tp -78.22 -33.8 49.65 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.018 0.914 . . . . 0.0 109.217 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 3.5 tp10 -68.82 -41.11 79.03 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 122.844 1.307 . . . . 0.0 109.395 175.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -85.37 13.71 6.29 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 113.965 -1.47 . . . . 0.0 109.907 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.765 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -95.87 -32.95 6.57 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.569 -177.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.411 HG13 ' HB1' ' A' ' 88' ' ' ALA . 9.3 p -171.34 -28.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.796 ' HB1' ' HB2' ' A' ' 92' ' ' SER . . . -63.76 177.3 0.75 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 123.713 0.633 . . . . 0.0 110.438 173.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.841 ' HB3' HD22 ' A' ' 89' ' ' LEU . 86.0 tttt 177.76 -29.84 0.0 OUTLIER 'General case' 0 C--O 1.237 0.421 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -170.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.643 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 26.1 tt0 65.76 -76.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.816 0.341 . . . . 0.0 110.605 -172.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--N 1.318 -0.791 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.929 -172.888 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 C--O 1.241 0.631 0 CA-C-O 122.071 0.939 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.823 HD21 HG21 ' A' ' 68' ' ' ILE . 15.8 tp -102.11 -20.18 14.84 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.426 -171.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 18.6 t70 -52.76 -54.51 32.91 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.59 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -49.64 -40.49 39.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.545 175.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.5 HD11 ' HB3' ' A' ' 114' ' ' GLU . 2.7 mm? -65.74 -39.19 90.85 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.895 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.501 ' HE1' ' HB2' ' A' ' 67' ' ' SER . 41.3 m-85 -64.83 -47.92 76.25 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.428 176.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 8' ' ' ASP . 43.4 mtp180 -56.14 -47.06 78.92 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.056 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -72.01 -43.69 64.65 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 120.586 0.232 . . . . 0.0 111.58 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.9 t -81.21 -33.38 12.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.096 0.474 . . . . 0.0 111.809 -170.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 11' ' ' TYR . 1.7 mp -73.37 -24.54 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 O-C-N 121.932 -0.48 . . . . 0.0 110.195 173.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ttt -67.69 -51.0 54.77 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.593 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.24 -38.32 81.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.112 0.482 . . . . 0.0 110.369 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -54.49 -41.76 69.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.28 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -56.41 -59.09 5.47 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.924 0.393 . . . . 0.0 111.163 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -66.94 -18.83 65.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -137.49 82.12 28.73 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.394 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -90.93 73.61 0.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 123.476 2.784 . . . . 0.0 112.763 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -109.61 62.48 0.6 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.182 0.515 . . . . 0.0 111.008 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.411 ' OD1' ' HA ' ' A' ' 74' ' ' SER . 10.0 m120 -136.64 37.2 2.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.608 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 31.9 ttmt -145.53 43.51 1.28 Allowed 'General case' 0 C--N 1.315 -0.907 0 O-C-N 123.526 0.516 . . . . 0.0 109.631 -175.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.25 167.31 29.02 Favored Glycine 0 C--O 1.222 -0.632 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.533 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.708 HG23 HG21 ' A' ' 48' ' ' THR . 3.1 p -165.87 130.68 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 117.212 0.506 . . . . 0.0 109.906 -174.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.734 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -150.72 164.59 35.78 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.731 178.239 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -117.84 28.05 8.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.593 0.711 . . . . 0.0 110.739 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.27 2.48 9.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.898 -173.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.724 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 4.8 t -165.4 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.07 0.462 . . . . 0.0 110.543 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.457 ' H ' ' HB3' ' A' ' 31' ' ' SER . 15.7 pt -127.37 146.66 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.962 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.96 HG13 HG22 ' A' ' 48' ' ' THR . 36.6 t -125.86 116.21 45.36 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.001 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.877 HG21 ' HA2' ' A' ' 139' ' ' GLY . 18.1 t -102.56 118.34 49.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.313 0.578 . . . . 0.0 110.478 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 9.2 t70 -119.28 127.95 53.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.023 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.603 ' SD ' ' HA ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -130.73 117.11 18.94 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.778 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 4.6 p30 -117.39 125.76 51.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.49 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -129.64 90.24 44.26 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -33.19 118.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.33 -0.403 1 C-N-CA 125.59 4.193 . . . . 0.0 114.773 -168.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.1 m 79.17 -35.68 0.16 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 171.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 32.5 t -94.98 -14.2 24.6 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 122.312 1.053 . . . . 0.0 109.217 -174.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.701 ' HA3' HD22 ' A' ' 131' ' ' LEU . . . 179.59 64.42 0.07 OUTLIER Glycine 0 N--CA 1.414 -2.781 0 N-CA-C 105.836 -2.906 . . . . 0.0 105.836 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 24.1 t70 -49.63 -47.26 49.89 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.33 1.052 . . . . 0.0 111.528 -159.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.778 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 12.8 ptm180 -164.66 151.88 11.37 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.914 169.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 43.8 pt -139.16 141.17 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.663 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 93.0 mtt180 -123.06 105.83 10.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.106 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.71 ' HB3' ' HE3' ' A' ' 49' ' ' MET . 1.3 tt -89.66 102.85 15.53 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.96 HG22 HG13 ' A' ' 33' ' ' VAL . 82.4 p -99.13 117.58 33.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.893 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.71 ' HE3' ' HB3' ' A' ' 47' ' ' LEU . 2.0 mpt? -105.82 178.65 4.5 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.243 0.544 . . . . 0.0 110.812 -172.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.724 ' HA ' ' HB2' ' A' ' 31' ' ' SER . 14.5 tmtt? -152.29 97.93 2.35 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 10.0 mt -115.48 89.45 3.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.607 -171.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -113.02 94.31 4.84 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.445 1.117 . . . . 0.0 109.593 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.67 -104.24 0.45 Allowed Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.763 -173.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -151.74 22.34 0.69 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 111.813 -2.193 . . . . 0.0 108.439 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 2.0 pp -132.19 160.38 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.007 -170.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.476 ' HA ' HD23 ' A' ' 51' ' ' LEU . 3.0 p -97.92 109.06 22.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 166.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.589 ' HB2' HD13 ' A' ' 55' ' ' ILE . 2.5 tm-20 -97.68 -34.16 11.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -164.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.559 ' OD2' HD21 ' A' ' 28' ' ' LEU . 19.6 t70 -143.4 147.2 34.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.947 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 48' ' ' THR . . . -167.85 134.33 2.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.552 0.215 . . . . 0.0 110.524 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -136.85 175.56 9.5 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.663 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -127.57 133.83 49.75 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 123.972 0.795 . . . . 0.0 111.067 176.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -128.89 132.09 47.67 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.21 -177.96 48.58 Favored Glycine 0 C--N 1.31 -0.901 0 C-N-CA 118.695 -1.717 . . . . 0.0 113.804 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -139.82 125.47 19.33 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.96 -131.48 1.35 Allowed Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -171.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.4 p -131.48 174.5 10.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 118.187 0.994 . . . . 0.0 111.653 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.501 ' HB2' ' HE1' ' A' ' 11' ' ' TYR . 6.3 p -52.89 -49.3 66.14 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -168.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.823 HG21 HD21 ' A' ' 7' ' ' LEU . 2.5 pp -77.28 -24.62 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.704 -171.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.559 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.7 m -68.95 -45.69 70.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.381 0.61 . . . . 0.0 109.59 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.435 ' HG2' ' CZ ' ' A' ' 61' ' ' PHE . 55.2 mtt -67.08 -35.23 79.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.813 173.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 74' ' ' SER . . . -69.25 -44.36 72.12 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -172.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 50.5 m -62.89 -50.28 71.49 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.6 -40.54 72.19 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 114.59 -1.187 . . . . 0.0 111.414 174.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 71' ' ' ALA . 64.1 m -47.95 -55.94 8.78 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 175.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.764 ' HG3' ' HA3' ' A' ' 111' ' ' GLY . 1.3 tmt? -71.08 -37.4 72.45 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -172.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.681 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 6.6 mmt -77.0 -34.98 57.43 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.656 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 30.1 m -62.95 -21.12 65.86 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.946 -1.096 . . . . 0.0 109.393 169.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -85.81 -38.69 17.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.572 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.0 -44.41 11.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.626 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -76.61 -38.5 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 122.886 0.474 . . . . 0.0 111.084 -171.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' A' ' 77' ' ' THR . 8.3 ttpp -49.77 -17.02 0.29 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.6 37.84 3.16 Favored Glycine 0 C--O 1.218 -0.86 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -133.32 -166.74 1.81 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.8 p-10 -123.78 -163.61 1.15 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.752 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -81.66 -44.74 20.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.267 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -66.09 -39.77 90.28 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.879 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.4 p -64.14 -38.76 92.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.701 0.286 . . . . 0.0 110.563 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.46 ' HB1' HG13 ' A' ' 140' ' ' VAL . . . -60.2 -46.49 89.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 122.011 0.91 . . . . 0.0 110.346 174.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 48.1 mt -63.3 -34.26 77.31 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.77 0.795 . . . . 0.0 109.797 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.0 m -64.01 -25.63 68.21 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.731 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 94.6 mmm -71.48 -38.64 71.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.3 0.571 . . . . 0.0 110.263 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.55 ' CB ' ' H ' ' A' ' 143' ' ' GLU . 15.1 t -64.41 -39.81 94.56 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.889 171.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.98 -45.33 86.93 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 121.954 0.883 . . . . 0.0 109.533 172.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 104' ' ' TYR . 44.9 mt -59.5 -51.31 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.563 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -57.6 -37.81 73.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.396 0.617 . . . . 0.0 112.233 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.2 p -72.62 -34.56 67.42 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.776 -0.578 . . . . 0.0 110.824 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.1 -42.71 72.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.497 0.665 . . . . 0.0 110.777 172.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.2 tmt? -56.1 -15.29 3.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.008 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 57.7 ttp -85.38 -22.21 28.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.857 0.837 . . . . 0.0 109.577 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -77.49 2.63 15.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.309 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.39 44.35 51.76 Favored Glycine 0 CA--C 1.503 -0.717 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.976 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.639 ' HG2' ' H ' ' A' ' 103' ' ' GLU . 78.2 tttt -123.3 -136.94 0.3 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.639 ' H ' ' HG2' ' A' ' 102' ' ' LYS . 51.0 mt-10 -75.25 -158.07 0.08 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.381 0.61 . . . . 0.0 110.207 172.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.51 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -146.73 -102.12 0.09 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.51 ' H ' ' HD1' ' A' ' 104' ' ' TYR . 8.0 t70 -108.7 105.94 15.76 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.29 20.65 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.505 0.722 . . . . 0.0 112.4 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.488 ' H ' ' C ' ' A' ' 105' ' ' ASP . 1.7 m -109.59 -20.09 12.98 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 166.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 108' ' ' ILE . 22.3 mm 70.42 28.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.018 171.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -97.03 90.67 5.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.543 ' HB3' ' HG3' ' A' ' 114' ' ' GLU . 4.3 mp -127.23 17.34 7.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.978 -169.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.764 ' HA3' ' HG3' ' A' ' 75' ' ' MET . . . -46.58 -36.64 8.16 Favored Glycine 0 C--N 1.34 0.805 0 O-C-N 124.448 1.092 . . . . 0.0 114.192 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 16.7 p-10 -75.68 -58.48 3.25 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 122.582 -0.363 . . . . 0.0 111.271 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.732 ' HA ' ' HB2' ' A' ' 116' ' ' LEU . 53.1 mt -63.14 -24.94 37.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 C-N-CA 124.706 1.203 . . . . 0.0 111.299 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 16.8 mt-10 -62.74 -48.97 76.89 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.36 -47.07 71.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.708 171.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.732 ' HB2' ' HA ' ' A' ' 113' ' ' ILE . 8.1 mt -58.67 -34.32 71.12 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.026 0.441 . . . . 0.0 111.188 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 8.4 tt0 -42.97 -53.06 4.94 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.622 1.569 . . . . 0.0 112.386 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.38 -17.68 70.75 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.601 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.719 HG13 ' HB3' ' A' ' 125' ' ' ARG . 48.9 t -84.8 -46.24 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 117.224 0.512 . . . . 0.0 111.18 -173.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.673 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 24.5 m -42.49 -16.14 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -127.8 -3.25 5.91 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -162.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.735 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 6.6 m-85 -83.17 145.59 49.36 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -46.98 -39.15 24.79 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.424 2.75 . . . . 0.0 112.874 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.21 5.38 19.93 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.735 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 22.1 mtm180 -112.68 2.15 16.0 Favored 'General case' 0 C--O 1.202 -1.42 0 CA-C-O 122.303 1.049 . . . . 0.0 109.93 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -78.96 -37.65 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 113.989 -1.459 . . . . 0.0 108.912 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -74.79 -21.53 59.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.027 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 5.9 t -85.77 -16.91 37.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.582 -1.645 . . . . 0.0 109.248 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.673 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -85.65 -27.55 25.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 124.582 1.176 . . . . 0.0 108.988 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.735 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 3.0 m -70.67 -39.26 73.66 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 175.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.701 HD22 ' HA3' ' A' ' 42' ' ' GLY . 16.7 tp -49.62 -60.86 2.49 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.823 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.475 ' HB2' ' CD2' ' A' ' 116' ' ' LEU . 10.5 m -78.03 -60.67 2.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -171.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.532 ' HB2' HD22 ' A' ' 116' ' ' LEU . 67.0 t90 -66.42 -52.59 44.86 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.735 ' HB3' ' O ' ' A' ' 130' ' ' THR . 21.9 ttmt -58.94 -36.48 74.84 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.047 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.17 77.97 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.173 172.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.55 ' CD2' ' HG3' ' A' ' 76' ' ' MET . 13.5 tp -76.37 -35.87 58.45 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.74 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -71.18 -32.95 69.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.966 0.889 . . . . 0.0 109.073 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -81.44 4.99 19.04 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.403 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.877 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -91.86 -44.65 4.13 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.705 -0.679 . . . . 0.0 113.734 -171.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.46 HG13 ' HB1' ' A' ' 88' ' ' ALA . 12.4 p -166.95 -27.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 122.156 -0.614 . . . . 0.0 111.056 -174.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.72 ' HA ' HD23 ' A' ' 89' ' ' LEU . . . -78.94 160.73 27.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.484 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 141' ' ' ALA . 87.0 tttt 170.0 76.6 0.0 OUTLIER 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.372 0.669 . . . . 0.0 110.703 173.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.55 ' H ' ' CB ' ' A' ' 92' ' ' SER . 17.8 tp10 -81.62 -48.43 11.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 170.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 . . . . . 0 N--CA 1.441 -0.916 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.647 175.113 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.54 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 26.6 p-10 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.56 HD11 ' O ' ' A' ' 115' ' ' ALA . 22.0 tp -93.57 -19.71 20.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.827 -170.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -58.92 -56.99 15.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 124.042 0.838 . . . . 0.0 109.71 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.1 t -65.03 -37.66 88.33 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 6' ' ' ASN . 58.7 mt -53.1 -35.86 60.08 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.627 0.727 . . . . 0.0 111.039 173.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.428 ' O ' HG13 ' A' ' 15' ' ' ILE . 13.2 m-85 -70.92 -39.22 72.82 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -65.8 -35.21 80.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.659 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -65.84 -28.27 68.86 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 123.998 0.811 . . . . 0.0 109.988 174.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.982 HG11 ' HB1' ' A' ' 71' ' ' ALA . 66.6 t -84.0 -41.72 16.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.221 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 11' ' ' TYR . 76.0 mt -61.7 -29.51 46.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 CA-C-O 121.54 0.685 . . . . 0.0 110.15 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -62.08 -51.17 69.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.386 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 11.4 t70 -72.48 -40.35 67.0 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 10.0 t-80 -54.26 -45.24 72.35 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.443 -177.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -59.03 -52.14 67.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.341 0.256 . . . . 0.0 111.432 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 17' ' ' ASP . 32.7 ttpt -42.89 -34.15 0.91 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 173.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.516 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -154.34 84.58 3.93 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-O 122.032 0.92 . . . . 0.0 111.952 177.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -86.1 65.91 5.22 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.319 2.679 . . . . 0.0 111.807 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 25' ' ' LYS . 62.8 mtt180 -73.27 -77.53 0.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.769 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 5.9 m120 67.24 -22.95 0.11 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 23' ' ' ARG . 30.6 mmtp -114.97 85.7 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.812 0.339 . . . . 0.0 111.24 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -139.75 146.17 17.57 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 121.087 -0.577 . . . . 0.0 112.284 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.49 HG23 HG21 ' A' ' 48' ' ' THR . 7.4 p -168.16 134.59 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 122.689 0.396 . . . . 0.0 110.193 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.682 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -151.62 140.37 20.85 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.69 172.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.46 ' HA ' HG21 ' A' ' 33' ' ' VAL . 3.1 p-10 -100.51 39.33 1.38 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.367 -174.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.73 -104.06 0.03 OUTLIER 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.559 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.549 ' CB ' ' HG ' ' A' ' 51' ' ' LEU . 13.0 m -72.05 -76.18 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.317 0.579 . . . . 0.0 112.031 -174.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.906 HG13 ' HB2' ' A' ' 49' ' ' MET . 6.8 pt -119.58 131.05 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-O 121.411 0.624 . . . . 0.0 111.99 -176.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.895 HG13 HG22 ' A' ' 48' ' ' THR . 89.5 t -124.74 129.08 73.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 123.543 0.737 . . . . 0.0 109.762 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.837 HG21 ' HA2' ' A' ' 139' ' ' GLY . 7.1 t -134.25 127.84 51.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.329 0.585 . . . . 0.0 110.386 -173.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.587 ' OD2' ' HD2' ' A' ' 46' ' ' ARG . 2.0 m-20 -117.23 134.45 54.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.249 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.571 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -142.22 122.53 13.94 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -125.0 140.79 52.6 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.728 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 51.1 t30 -135.11 119.35 13.41 Favored Pre-proline 0 C--O 1.253 1.263 0 O-C-N 121.316 -0.865 . . . . 0.0 109.295 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.469 ' HD2' ' OD1' ' A' ' 38' ' ' ASN . 59.6 Cg_exo -25.5 105.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 1 C-N-CA 126.685 4.923 . . . . 0.0 116.417 -175.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.8 m 74.32 -34.52 0.28 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 165.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 127' ' ' LYS . 33.1 t -79.01 -49.23 13.03 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.604 -167.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.654 ' HA3' HD22 ' A' ' 131' ' ' LEU . . . -130.9 24.01 4.34 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.157 -1.021 . . . . 0.0 112.103 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.647 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 34.3 t70 40.77 -96.21 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.137 0 O-C-N 124.85 0.971 . . . . 0.0 111.936 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -136.44 146.38 46.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.356 0.598 . . . . 0.0 111.933 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 tt -131.98 125.18 54.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 170.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.587 ' HD2' ' OD2' ' A' ' 35' ' ' ASP . 24.4 mtm180 -130.36 109.22 10.57 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.189 -174.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.737 HD11 ' HE3' ' A' ' 49' ' ' MET . 0.7 OUTLIER -103.16 100.74 10.67 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 124.33 1.019 . . . . 0.0 108.934 -176.022 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.895 HG22 HG13 ' A' ' 33' ' ' VAL . 57.4 p -97.3 131.42 44.02 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 172.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.906 ' HB2' HG13 ' A' ' 32' ' ' ILE . 55.9 mtt -121.38 -178.56 3.82 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.584 0.707 . . . . 0.0 110.292 -176.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 45.2 tttm -157.63 111.66 2.59 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.549 ' HG ' ' CB ' ' A' ' 31' ' ' SER . 6.3 mt -92.45 140.24 29.77 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.342 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.919 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . 2.4 m-20 -134.18 64.86 1.59 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 140.5 -133.25 5.85 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -164.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -121.11 31.79 6.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 168.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.498 HD11 ' HG2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -127.44 178.22 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.571 -172.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -107.61 112.93 42.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.919 ' HG3' ' HB2' ' A' ' 52' ' ' ASP . 4.3 mm-40 -101.8 -31.35 10.79 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 122.03 0.919 . . . . 0.0 109.414 -169.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 33.2 t0 -141.53 144.95 34.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.643 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -152.02 134.39 15.24 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 73.4 mmtt -124.96 129.82 51.12 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.513 ' HB3' HG21 ' A' ' 77' ' ' THR . 47.6 p90 -116.02 141.21 48.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.199 0.524 . . . . 0.0 111.203 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 26.4 tt0 -116.6 121.79 42.74 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.92 128.29 5.24 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.544 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.647 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 10.3 tp10 -150.8 128.02 11.25 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.65 -131.68 2.57 Favored Glycine 0 C--O 1.227 -0.284 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 -171.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.4 p -99.47 159.57 14.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.461 0.63 . . . . 0.0 109.787 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 p -59.22 -38.71 80.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.838 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.785 HD11 HG21 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -61.4 -48.37 89.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.7 m -68.93 -47.35 65.94 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 110.785 -173.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.2 ptp -61.61 -29.91 70.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.452 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.982 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -66.14 -53.17 41.08 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.29 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.2 m -56.42 -40.02 74.02 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 123.9 0.75 . . . . 0.0 109.651 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.7 -57.21 10.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.582 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.441 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 49.2 m -55.76 -48.62 74.96 Favored 'General case' 0 CA--C 1.493 -1.246 0 O-C-N 123.873 0.733 . . . . 0.0 112.266 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.8 tpt -70.65 -54.96 9.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 120.933 0.397 . . . . 0.0 110.551 -174.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.675 ' HG3' HD21 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -59.95 -44.76 94.19 Favored 'General case' 0 C--O 1.205 -1.252 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.556 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.689 ' HA ' HG22 ' A' ' 80' ' ' ILE . 32.0 m -63.03 -36.99 85.42 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.16 0.891 . . . . 0.0 109.784 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -52.41 -47.85 66.07 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.002 174.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.84 -23.97 25.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.453 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.689 HG22 ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -77.48 -30.75 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -174.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 81' ' ' LYS . 7.0 ttpm? -52.93 -18.64 2.06 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.483 170.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.78 44.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.638 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 8.3 mttp -132.61 -162.4 1.23 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.019 0.438 . . . . 0.0 110.508 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.9 m-20 -140.83 164.56 29.91 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.577 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mp -68.09 -51.25 50.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 119.239 0.927 . . . . 0.0 110.573 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.91 -36.45 79.3 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.776 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.4 m -66.77 -41.83 87.1 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.614 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.85 82.0 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.57 0.544 . . . . 0.0 111.325 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 83.2 mt -63.59 -39.15 93.65 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.863 0.84 . . . . 0.0 109.028 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.7 t -59.14 -41.9 89.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.411 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.424 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 12.3 ttt -65.63 -38.35 89.14 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.069 0.461 . . . . 0.0 110.586 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.769 ' HB3' ' HD2' ' A' ' 142' ' ' LYS . 16.3 m -60.34 -48.49 81.52 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.045 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.432 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 35.5 ttpt -59.85 -40.74 89.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.603 0.716 . . . . 0.0 109.471 175.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.513 HG23 ' HA ' ' A' ' 104' ' ' TYR . 29.8 mt -61.62 -47.83 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.966 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -56.65 -34.49 67.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.818 0.342 . . . . 0.0 110.57 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.3 m -71.58 -44.39 64.57 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.869 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.92 -52.02 53.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.779 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.1 tpt -38.95 -63.51 0.52 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.5 mmm -49.2 -17.13 0.2 Allowed 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -128.07 -4.1 5.67 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.892 0.315 . . . . 0.0 111.193 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -116.44 -32.25 1.67 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.947 -1.121 . . . . 0.0 113.871 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 88.41 -13.93 0.4 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.245 1.418 . . . . 0.0 110.075 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -98.59 134.85 40.95 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.667 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.513 ' HA ' HG23 ' A' ' 94' ' ' ILE . 3.2 p90 -124.75 -121.93 0.26 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.826 -176.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.504 ' O ' HD13 ' A' ' 108' ' ' ILE . 24.8 t70 -94.44 107.15 19.13 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 120.914 0.387 . . . . 0.0 110.342 -174.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -48.29 -19.06 0.26 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.205 -1.361 . . . . 0.0 113.049 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.7 t -92.8 -22.69 19.17 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.662 ' HA ' HD11 ' A' ' 110' ' ' LEU . 23.4 mm 67.56 39.14 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 122.164 0.983 . . . . 0.0 109.855 175.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -99.21 81.93 2.63 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.662 HD11 ' HA ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -144.57 51.34 1.27 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -174.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -39.65 -18.76 0.01 OUTLIER Glycine 0 CA--C 1.54 1.605 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.529 ' HB3' ' HG3' ' A' ' 76' ' ' MET . 14.0 p-10 -85.27 -43.4 13.78 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 117.692 0.746 . . . . 0.0 109.522 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.881 ' O ' ' HB2' ' A' ' 117' ' ' GLN . 5.0 tt -70.12 -16.81 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.47 -171.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.4 ' O ' HD13 ' A' ' 10' ' ' LEU . 3.5 mm-40 -56.11 -64.78 0.75 Allowed 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.765 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -76.51 -44.77 33.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.918 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.648 HD12 HG21 ' A' ' 119' ' ' VAL . 14.2 tp -92.64 1.67 57.14 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -163.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.881 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 7.1 tt0 -58.44 -52.12 66.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.385 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.06 -13.6 72.91 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.933 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.785 HG21 HD11 ' A' ' 68' ' ' ILE . 93.3 t -78.83 -46.95 23.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 CA-C-N 117.093 0.446 . . . . 0.0 110.423 -162.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.44 ' O ' ' HD3' ' A' ' 125' ' ' ARG . 14.3 m -42.45 -15.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.59 1.556 . . . . 0.0 115.135 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 125' ' ' ARG . 63.9 pttt -131.3 13.81 5.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.528 -0.733 . . . . 0.0 112.47 -171.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.69 ' HD2' ' HA ' ' A' ' 119' ' ' VAL . 15.4 m-85 -76.43 170.03 18.08 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.199 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.453 ' HD2' ' HD1' ' A' ' 122' ' ' PHE . 30.5 Cg_endo -65.43 -18.95 61.16 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.207 1.938 . . . . 0.0 109.966 166.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.505 ' HB1' ' HD2' ' A' ' 127' ' ' LYS . . . -113.38 17.14 18.69 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.984 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.616 ' HG3' ' N ' ' A' ' 126' ' ' ILE . 18.6 ptp180 -44.05 -61.18 1.55 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.127 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.616 ' N ' ' HG3' ' A' ' 125' ' ' ARG . 39.9 pt -59.48 -22.97 24.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.184 -172.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.728 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 99.5 mttt -68.34 -63.25 1.1 Allowed 'General case' 0 C--N 1.313 -1.003 0 O-C-N 122.247 -0.283 . . . . 0.0 110.402 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.8 m -85.67 -35.2 21.05 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.451 0.644 . . . . 0.0 110.675 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.689 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -73.85 -51.28 16.8 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.618 -173.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.567 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 36.7 m -63.83 -45.87 87.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.183 -177.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.654 HD22 ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -56.63 -50.09 73.06 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.163 -0.961 . . . . 0.0 110.567 179.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.478 ' N ' ' HG ' ' A' ' 131' ' ' LEU . 7.1 m -76.7 -61.53 1.94 Allowed 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -174.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -61.51 -53.46 56.04 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 123.852 0.72 . . . . 0.0 111.139 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 130' ' ' THR . 88.0 tttt -55.33 -42.91 74.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' A' ' 36' ' ' MET . . . -61.17 -50.29 73.74 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.549 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.675 HD21 ' HG3' ' A' ' 76' ' ' MET . 11.8 tp -65.2 -31.69 72.99 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.461 0.648 . . . . 0.0 110.338 -175.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.708 ' CG ' ' HD3' ' A' ' 142' ' ' LYS . 2.9 tp10 -83.52 -32.33 25.96 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.79 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 23.9 tptp -71.09 -47.15 59.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.837 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -41.36 -34.68 1.07 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.395 -0.82 . . . . 0.0 114.35 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.465 ' O ' HD21 ' A' ' 89' ' ' LEU . 27.2 m -108.12 -1.09 9.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.147 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 90.09 3.43 0.16 Allowed 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 168.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.769 ' HD2' ' HB3' ' A' ' 92' ' ' SER . 43.0 tptt 55.18 87.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 171.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 69.3 -52.69 0.6 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.956 0.903 . . . . 0.0 112.228 172.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 C--O 1.24 0.602 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.297 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--O 1.214 -0.79 0 CA-C-O 121.079 0.466 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.509 HD21 HG22 ' A' ' 119' ' ' VAL . 21.5 tp -70.46 -42.75 71.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.022 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.81 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 17.8 t70 -54.5 -53.76 50.04 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.417 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 m -57.29 -54.39 47.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.337 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.616 ' O ' HG13 ' A' ' 14' ' ' VAL . 4.3 mp -47.33 -52.42 16.48 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.419 1.074 . . . . 0.0 111.862 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.81 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 0.6 OUTLIER -79.19 -19.42 50.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.488 -175.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -66.6 -35.67 80.74 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-O 121.412 0.625 . . . . 0.0 109.358 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -75.65 -35.23 60.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.081 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.788 HG22 ' HA ' ' A' ' 11' ' ' TYR . 3.2 m -72.48 -35.34 51.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.961 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.576 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 14.5 tt -77.41 -22.67 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.929 174.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 17.2 tpt -84.9 -38.78 18.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.323 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.775 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 20.3 t70 -77.9 -37.13 48.63 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.458 ' CD2' ' HB3' ' A' ' 24' ' ' ASN . 26.1 t60 -71.43 -16.46 62.38 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.068 171.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.576 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 46.4 t80 -73.57 -48.22 34.55 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.333 0.587 . . . . 0.0 110.014 171.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.775 ' HD3' ' HA ' ' A' ' 17' ' ' ASP . 41.4 mtpt -48.61 -45.79 38.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.846 171.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -114.81 78.41 5.22 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 18' ' ' HIS . 72.7 Cg_endo -77.62 51.11 3.44 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 122.999 2.466 . . . . 0.0 113.414 -165.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -83.72 50.41 1.8 Allowed 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 121.801 -0.562 . . . . 0.0 109.57 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.458 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . 20.0 p-10 -114.2 24.77 11.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.9 0.857 . . . . 0.0 109.044 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -133.15 139.44 47.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.835 -1.53 . . . . 0.0 108.868 173.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 142.67 141.89 3.94 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.103 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.661 HG13 ' HB2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -159.27 127.93 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.757 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -136.11 147.68 47.9 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.491 0.663 . . . . 0.0 110.56 176.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -93.26 44.08 1.13 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.23 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.458 ' HB3' ' H ' ' A' ' 31' ' ' SER . 1.2 m-20 -85.67 -130.37 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.031 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.458 ' H ' ' HB3' ' A' ' 30' ' ' ASP . 14.9 m -52.12 -77.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.814 HG13 ' HB2' ' A' ' 49' ' ' MET . 12.8 pt -127.02 137.86 56.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.622 0.725 . . . . 0.0 110.394 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.639 HG13 HG22 ' A' ' 48' ' ' THR . 95.7 t -123.09 114.69 43.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.617 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.963 HG21 ' HA2' ' A' ' 139' ' ' GLY . 93.9 t -106.88 119.3 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.074 -176.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 2.0 p-10 -127.85 149.57 50.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.504 0.669 . . . . 0.0 110.141 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 45' ' ' ILE . 27.3 ttt -157.37 132.11 8.66 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.173 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 7.0 p30 -127.28 135.62 50.83 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -113.63 88.33 13.43 Favored Pre-proline 0 N--CA 1.439 -0.983 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 167.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -60.08 -6.26 4.8 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.386 2.058 . . . . 0.0 113.889 -169.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.7 p -98.6 -51.03 4.06 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.294 0.568 . . . . 0.0 111.784 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 51.6 t -135.23 17.99 3.42 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -169.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.22 -3.37 0.37 Allowed Glycine 0 N--CA 1.47 0.956 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.406 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.631 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 11.5 m-20 53.79 -110.7 0.56 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 118.394 -0.812 . . . . 0.0 111.117 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 31.3 ptt180 -158.67 148.83 19.69 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.652 1.115 . . . . 0.0 112.549 -176.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.568 HG13 ' CE1' ' A' ' 61' ' ' PHE . 5.0 tt -130.4 133.26 64.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.571 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -121.56 103.44 8.92 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.246 0.341 . . . . 0.0 111.695 173.187 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.682 HD22 ' HG3' ' A' ' 49' ' ' MET . 1.9 tt -92.6 106.63 18.58 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 172.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.757 ' HB ' HD12 ' A' ' 28' ' ' LEU . 44.9 p -99.27 123.5 43.6 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.814 ' HB2' HG13 ' A' ' 32' ' ' ILE . 52.2 mtt -113.26 178.7 4.19 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 123.741 0.651 . . . . 0.0 111.73 -175.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.435 ' HA ' ' OG ' ' A' ' 31' ' ' SER . 86.9 tttt -160.24 100.56 1.37 Allowed 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -116.72 92.16 3.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.065 0.936 . . . . 0.0 111.501 -175.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -103.36 89.36 3.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.466 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.31 -100.88 0.32 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-O 122.985 1.325 . . . . 0.0 111.821 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -159.6 35.85 0.19 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 111.375 -2.412 . . . . 0.0 106.681 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.676 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.3 pp -140.13 143.58 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.187 -171.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.49 HG11 HG23 ' A' ' 80' ' ' ILE . 1.3 p -92.59 113.35 27.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -102.1 -32.01 10.34 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 113.978 -1.465 . . . . 0.0 107.941 -163.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -136.48 129.51 31.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.65 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.63 104.49 3.75 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.434 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 29.0 mmtp -120.75 151.95 38.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.922 -175.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.568 ' CE1' HG13 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -130.53 135.75 48.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.661 ' HB2' HG13 ' A' ' 27' ' ' VAL . 1.1 tm-20 -142.09 114.56 8.39 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.76 -177.49 39.16 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.004 -172.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -139.85 157.71 45.28 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.631 ' HA2' ' HB2' ' A' ' 43' ' ' ASP . . . 157.26 -143.17 9.27 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 119.253 -1.451 . . . . 0.0 112.502 176.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 61.1 m -76.31 164.57 25.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.271 0.558 . . . . 0.0 110.828 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -63.41 -35.47 80.52 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.008 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.644 HG13 HG21 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -82.81 -29.02 8.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.05 -177.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.526 ' N ' HD13 ' A' ' 68' ' ' ILE . 8.3 m -66.92 -55.0 16.52 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.699 -0.625 . . . . 0.0 110.729 -174.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -69.55 -16.25 63.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.656 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.542 ' HB1' HG23 ' A' ' 14' ' ' VAL . . . -85.84 -53.3 5.2 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.553 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.417 ' OG ' ' HB2' ' A' ' 116' ' ' LEU . 37.3 t -74.1 -51.21 16.39 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.746 0.654 . . . . 0.0 109.818 -171.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.36 -51.91 65.25 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.219 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . 30.3 t -66.16 -38.46 88.14 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.915 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.563 ' SD ' ' HB ' ' A' ' 14' ' ' VAL . 28.7 ttt -59.32 -46.83 87.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.352 0.596 . . . . 0.0 110.671 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.409 ' HB3' ' CD1' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -75.48 -23.28 56.78 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.175 178.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.596 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 99.6 m -67.97 -43.72 78.33 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-O 122.389 1.09 . . . . 0.0 110.008 172.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.8 tm0? -58.8 -27.03 64.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.835 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.74 -33.6 23.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.596 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 2.3 mm -67.83 -36.24 75.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.616 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -56.8 -18.87 14.39 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.716 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.94 38.39 2.95 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.749 ' HE3' ' HB ' ' A' ' 87' ' ' THR . 27.3 tptt -131.45 164.33 25.97 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -172.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.635 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.4 p-10 -111.65 -175.2 2.64 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 169.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.768 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.1 mp -76.3 -39.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.267 -173.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -60.67 -48.59 81.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.002 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.749 ' HB ' ' HE3' ' A' ' 83' ' ' LYS . 18.6 p -71.7 -36.12 70.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.557 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -56.42 -40.5 74.84 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.429 0.633 . . . . 0.0 111.466 172.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 66.3 mt -62.62 -33.82 75.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.367 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -80.45 -25.2 39.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.631 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -65.0 -27.31 68.73 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 121.844 0.83 . . . . 0.0 109.362 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.4 m -88.59 -23.53 23.08 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.366 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 143' ' ' GLU . 83.5 tttt -79.01 -30.17 44.08 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.626 177.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.8 tt -82.21 -33.6 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -50.47 -33.34 20.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.166 163.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.7 m -81.65 -27.82 33.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.484 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.422 ' OD1' ' HA3' ' A' ' 101' ' ' GLY . 20.6 t70 -66.11 -35.79 81.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.707 ' HA ' ' CE1' ' A' ' 104' ' ' TYR . 59.7 ttp -48.15 -16.71 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.252 0.621 . . . . 0.0 112.609 169.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 73.7 mtm -117.96 -36.38 3.64 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.066 -0.396 . . . . 0.0 111.259 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.33 -43.43 4.78 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.063 0.459 . . . . 0.0 110.457 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.422 ' HA3' ' OD1' ' A' ' 97' ' ' ASP . . . -81.5 -57.14 2.82 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.872 -174.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 61.28 81.4 0.19 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.538 0.685 . . . . 0.0 111.242 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -178.9 31.82 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.558 0.695 . . . . 0.0 110.335 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.736 ' HD2' HD11 ' A' ' 110' ' ' LEU . 15.6 p90 -103.82 113.1 26.38 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.483 0.658 . . . . 0.0 110.045 -176.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -137.71 70.43 1.39 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.038 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.86 ' H ' HD22 ' A' ' 110' ' ' LEU . 32.1 t70 60.67 6.62 1.17 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.613 0.72 . . . . 0.0 111.202 168.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.2 m -111.9 3.74 17.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.703 -173.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.422 ' HB ' ' H ' ' A' ' 109' ' ' ASP . 1.9 mp -131.99 -77.69 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.422 ' H ' ' HB ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -144.79 166.72 24.43 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 167.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.86 HD22 ' H ' ' A' ' 106' ' ' ASP . 3.1 tp 173.11 -7.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -39.04 -46.39 2.38 Favored Glycine 0 C--N 1.355 1.589 0 C-N-CA 121.155 -0.545 . . . . 0.0 114.282 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.477 ' OD2' HG13 ' A' ' 113' ' ' ILE . 2.8 p-10 -70.69 -59.61 2.72 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.994 HG23 ' HB3' ' A' ' 117' ' ' GLN . 41.0 mt -50.9 -40.7 20.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.995 0.918 . . . . 0.0 112.57 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 10' ' ' LEU . 12.2 mm-40 -61.75 -12.22 15.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.462 0.649 . . . . 0.0 111.57 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.589 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -138.37 19.4 2.75 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.753 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.585 HD12 HG21 ' A' ' 119' ' ' VAL . 10.0 tp -161.88 -20.78 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -169.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.994 ' HB3' HG23 ' A' ' 113' ' ' ILE . 22.4 pt20 -60.09 -31.32 69.91 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.794 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.578 ' HA2' ' HE2' ' A' ' 121' ' ' LYS . . . -80.62 -16.96 74.34 Favored Glycine 0 CA--C 1.504 -0.597 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.656 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.851 HG13 ' HB3' ' A' ' 125' ' ' ARG . 79.7 t -81.6 -43.86 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 123.291 0.636 . . . . 0.0 110.36 -171.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.563 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 4.8 m -36.09 -16.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.578 ' HE2' ' HA2' ' A' ' 118' ' ' GLY . 0.3 OUTLIER -146.66 0.47 0.77 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 119.969 1.258 . . . . 0.0 113.626 -166.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.771 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 12.9 m-30 -75.18 136.22 72.71 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 172.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 122' ' ' PHE . 52.4 Cg_exo -55.05 -26.63 50.91 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.682 2.255 . . . . 0.0 111.971 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.38 -0.29 35.69 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.851 ' HB3' HG13 ' A' ' 119' ' ' VAL . 64.0 mtt180 -129.26 12.77 6.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.165 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -80.22 -32.24 13.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 122.796 1.284 . . . . 0.0 108.033 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -83.24 -20.91 33.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.606 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 57.4 m -82.57 -18.6 40.77 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.921 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.596 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -84.54 -36.43 22.16 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.972 -176.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.643 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 3.9 m -75.01 -40.45 60.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.428 HD22 ' HB3' ' A' ' 69' ' ' SER . 8.2 tt -50.7 -51.14 52.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.105 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 t -80.24 -60.89 2.16 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.066 -174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -62.87 -53.27 56.78 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.854 0.359 . . . . 0.0 111.751 -175.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.643 ' HB3' ' O ' ' A' ' 130' ' ' THR . 19.9 tptm -59.39 -34.8 72.88 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.913 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.89 -34.5 59.66 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.073 171.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.409 ' CD1' ' HB3' ' A' ' 76' ' ' MET . 82.2 mt -84.24 -39.43 19.29 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.34 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -70.47 -39.74 74.06 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.64 0.733 . . . . 0.0 110.905 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.759 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -84.88 12.38 7.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.094 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.963 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -102.86 -29.72 5.74 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.196 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.557 HG21 ' HB1' ' A' ' 88' ' ' ALA . 29.3 m -131.56 -23.49 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -174.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 90.46 175.29 0.02 OUTLIER 'General case' 0 C--N 1.351 0.663 0 C-N-CA 125.093 1.357 . . . . 0.0 109.759 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -123.95 149.15 46.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.241 -0.912 . . . . 0.0 112.405 -169.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -92.48 104.83 17.11 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 162.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 144' ' ' GLU . 10.3 pt-20 . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.133 -166.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.1 m120 . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 120.956 0.408 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.783 ' HA ' HD12 ' A' ' 10' ' ' LEU . 55.8 tp 169.47 -36.55 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 17.3 t70 -61.56 -57.03 13.72 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.32 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.603 ' HA ' ' HG2' ' A' ' 12' ' ' ARG . 29.1 p -51.02 -43.05 60.8 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.751 0.786 . . . . 0.0 111.729 173.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.783 HD12 ' HA ' ' A' ' 7' ' ' LEU . 88.2 mt -51.79 -48.01 63.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.81 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.5 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.8 m-85 -67.64 -35.55 79.1 Favored 'General case' 0 CA--C 1.5 -0.981 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.415 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.603 ' HG2' ' HA ' ' A' ' 9' ' ' THR . 21.6 mmm-85 -59.91 -30.76 69.26 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.739 -0.601 . . . . 0.0 110.075 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -82.32 -34.79 28.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 75' ' ' MET . 94.9 t -76.96 -30.77 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.594 -176.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 11' ' ' TYR . 30.9 pt -83.84 -19.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 26.1 ttt -64.15 -44.65 91.48 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.838 0.828 . . . . 0.0 109.242 175.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.18 -33.9 63.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.481 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -62.11 -26.56 68.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.174 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -68.63 -54.35 16.93 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.566 -0.709 . . . . 0.0 110.557 168.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -48.68 -38.23 20.72 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.235 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -112.84 81.31 4.37 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.48 -16.39 23.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.422 3.415 . . . . 0.0 115.475 -159.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -148.48 164.74 33.27 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.286 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -151.03 81.02 1.32 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.114 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.638 ' HG3' ' HG3' ' A' ' 62' ' ' GLU . 58.7 tttm -141.82 93.79 2.6 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.363 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.78 152.63 24.75 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.787 HG23 HG21 ' A' ' 48' ' ' THR . 2.9 p -150.29 132.61 6.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.197 0.522 . . . . 0.0 110.141 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.771 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -153.71 146.32 24.17 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 176.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -111.49 139.34 47.01 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.804 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t70 172.21 -79.74 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.603 0.761 . . . . 0.0 109.188 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.528 ' HB3' ' HG ' ' A' ' 51' ' ' LEU . 14.1 m -72.01 -86.49 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.519 -175.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.671 HG13 ' HB2' ' A' ' 49' ' ' MET . 4.3 pt -138.23 134.31 44.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.299 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.579 HG13 HG22 ' A' ' 48' ' ' THR . 61.4 t -125.62 121.93 61.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.728 0.775 . . . . 0.0 110.201 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.025 HG21 ' HA2' ' A' ' 139' ' ' GLY . 2.8 t -117.36 124.83 73.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.352 -176.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.5 p-10 -126.43 138.98 53.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.826 0.346 . . . . 0.0 110.395 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.657 ' HG2' ' HA ' ' A' ' 131' ' ' LEU . 2.0 tpt -147.1 131.26 17.36 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.532 ' H ' ' HE2' ' A' ' 36' ' ' MET . 8.5 p30 -109.77 132.29 54.28 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.223 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -121.96 98.88 44.59 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 161.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -32.33 109.0 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 125.171 3.914 . . . . 0.0 115.147 -168.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 m 71.73 -20.49 0.24 Allowed 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.095 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 51.6 t -95.42 -33.19 12.57 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.37 1.081 . . . . 0.0 109.142 -175.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.506 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . -157.61 60.9 0.33 Allowed Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 104.714 -3.354 . . . . 0.0 104.714 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.68 -43.04 89.84 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.594 -1.303 . . . . 0.0 112.048 -156.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -148.44 132.41 17.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 118.246 -1.382 . . . . 0.0 109.926 168.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.586 HG13 ' CE1' ' A' ' 61' ' ' PHE . 8.7 tt -124.33 116.15 46.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 20.4 ttt180 -121.36 102.79 8.5 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.649 -0.657 . . . . 0.0 111.924 -172.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.574 HD21 ' CE ' ' A' ' 49' ' ' MET . 28.1 tp -87.82 102.58 14.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.342 173.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.787 HG21 HG23 ' A' ' 27' ' ' VAL . 31.6 p -98.4 112.35 24.39 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 171.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.671 ' HB2' HG13 ' A' ' 32' ' ' ILE . 24.9 mtt -100.87 178.88 4.56 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.117 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.914 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 56.3 tttp -157.28 93.4 1.31 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.609 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 2.2 pp -117.72 108.95 16.02 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 113.183 -1.826 . . . . 0.0 106.848 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -98.84 60.46 1.25 Allowed 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.931 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.28 -98.58 0.19 Allowed Glycine 0 N--CA 1.424 -2.152 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.195 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -128.78 22.47 5.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.757 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.4 pp -135.77 144.8 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -98.28 122.77 50.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -115.94 -21.21 9.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.998 0.904 . . . . 0.0 109.099 -170.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.914 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 17.1 t70 -141.35 149.11 40.74 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.885 174.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -161.75 108.06 1.34 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.769 0.795 . . . . 0.0 109.124 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -107.3 147.72 29.9 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.328 0.585 . . . . 0.0 109.57 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.601 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.9 t80 -121.38 129.01 52.79 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.998 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.638 ' HG3' ' HG3' ' A' ' 25' ' ' LYS . 27.8 tt0 -128.26 124.44 36.63 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.72 -177.72 48.28 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 119.132 -1.508 . . . . 0.0 112.72 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -141.71 128.95 21.02 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.506 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . -169.49 -132.1 1.4 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.5 -1.334 . . . . 0.0 110.81 -175.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 7.3 p -123.35 -163.98 1.17 Allowed 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 p -55.77 -26.5 46.22 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.798 HG13 ' HB3' ' A' ' 128' ' ' CYS . 7.3 mm -62.48 -66.62 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.649 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 p -55.43 -32.57 62.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.225 1.012 . . . . 0.0 109.909 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -61.7 -60.86 3.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.286 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.626 ' HB1' ' HB1' ' A' ' 115' ' ' ALA . . . -71.68 -43.3 66.25 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -172.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.513 ' HB3' HD11 ' A' ' 116' ' ' LEU . 49.4 p -59.0 -39.61 82.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 110.632 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.765 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -75.01 -48.93 21.63 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.232 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 27.6 m -55.35 -61.04 2.6 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.802 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.621 ' HB2' HG13 ' A' ' 14' ' ' VAL . 12.6 tpt -83.1 -57.63 3.2 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.525 ' CG ' HD13 ' A' ' 136' ' ' LEU . 10.5 tpt -74.02 -27.9 61.18 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -171.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.765 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 85.6 m -73.32 -40.99 64.05 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 74' ' ' SER . 8.3 tt0 -59.54 -26.22 65.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.183 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.26 -33.58 22.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.65 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -67.6 -42.96 87.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.11 178.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 65.2 tttm -56.45 -16.28 5.57 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.686 0.794 . . . . 0.0 111.694 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.89 38.59 2.95 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.419 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -135.25 179.09 6.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.741 0.27 . . . . 0.0 111.597 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.649 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.0 m-20 -100.41 176.94 5.18 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.699 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 12.6 mm -84.41 -43.11 17.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.548 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -63.36 -38.27 90.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.02 0.438 . . . . 0.0 110.318 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -61.62 -41.3 97.27 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 121.72 0.772 . . . . 0.0 110.866 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -66.11 -34.98 79.28 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 121.927 -0.483 . . . . 0.0 110.605 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 70.7 mt -64.71 -39.72 94.12 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.453 1.121 . . . . 0.0 109.735 175.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.551 ' O ' HG12 ' A' ' 94' ' ' ILE . 26.9 t -67.09 -41.66 85.94 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.827 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.475 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 16.9 tpt -62.85 -22.42 66.66 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 122.287 1.041 . . . . 0.0 110.854 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.542 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 27.5 t -89.03 -35.95 16.07 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.499 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -66.58 -51.51 55.63 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.813 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 105' ' ' ASP . 22.1 pt -65.1 -39.83 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.838 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 91' ' ' MET . 39.2 t80 -53.51 -35.93 61.19 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.411 0.624 . . . . 0.0 111.143 174.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.6 m -86.31 -35.85 19.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.134 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.54 -35.96 75.92 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.096 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 1.3 tmt? -39.22 -49.75 1.9 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 124.127 0.892 . . . . 0.0 111.689 178.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.2 mtt -57.21 -10.63 1.32 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -124.46 -35.24 2.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.773 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.734 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -88.69 -32.07 11.92 Favored Glycine 0 C--O 1.239 0.448 0 C-N-CA 119.511 -1.328 . . . . 0.0 114.168 -173.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.734 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 22.4 tttm 97.64 -29.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.758 1.223 . . . . 0.0 109.699 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 98' ' ' MET . 0.7 OUTLIER -82.09 163.21 22.19 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.65 -106.34 0.24 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.72 ' HA ' HD12 ' A' ' 94' ' ' ILE . 31.7 t70 -95.34 101.73 13.48 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 172.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.27 8.87 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.449 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 65.3 m -105.78 -16.95 14.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 169.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 108' ' ' ILE . 32.0 mm 65.37 27.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-O 121.816 0.817 . . . . 0.0 110.949 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -95.41 86.93 4.63 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 170.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 113' ' ' ILE . 6.7 mt -123.75 43.94 2.84 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.393 -165.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -40.47 -33.21 0.53 Allowed Glycine 0 CA--C 1.538 1.51 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.674 168.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.54 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 3.8 p-10 -58.32 -72.78 0.09 Allowed 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 123.448 0.699 . . . . 0.0 109.989 171.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' A' ' 110' ' ' LEU . 1.1 mp -46.2 -37.88 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.827 0.851 . . . . 0.0 110.313 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.629 ' O ' ' HB3' ' A' ' 10' ' ' LEU . 29.4 tt0 -61.57 -18.89 61.22 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.681 0.753 . . . . 0.0 111.704 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.626 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -136.77 16.85 3.08 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.824 -0.548 . . . . 0.0 111.796 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 115' ' ' ALA . 5.7 mp -151.03 -24.39 0.21 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -167.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.435 ' HB2' HG23 ' A' ' 113' ' ' ILE . 7.7 tt0 -43.53 -52.32 6.26 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.41 0.443 . . . . 0.0 112.121 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.815 ' HA2' ' HE3' ' A' ' 121' ' ' LYS . . . -75.76 -17.36 80.13 Favored Glycine 0 CA--C 1.512 -0.155 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.489 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.799 HG13 ' HB3' ' A' ' 125' ' ' ARG . 65.8 t -74.92 -54.62 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 117.202 0.501 . . . . 0.0 111.397 -169.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.666 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 16.9 m -44.77 -15.0 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 O-C-N 125.231 1.582 . . . . 0.0 114.621 -175.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.815 ' HE3' ' HA2' ' A' ' 118' ' ' GLY . 20.0 pttp -127.96 -4.7 5.68 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.71 -162.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.518 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 27.6 m-85 -86.7 133.98 38.57 Favored Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.109 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.64 -22.92 37.99 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 122.034 1.823 . . . . 0.0 111.55 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.68 -2.99 43.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.226 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.799 ' HB3' HG13 ' A' ' 119' ' ' VAL . 66.1 mtt85 -129.34 16.58 6.04 Favored 'General case' 0 C--O 1.213 -0.83 0 O-C-N 121.831 -0.543 . . . . 0.0 109.556 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.2 tt -87.36 -31.23 5.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.623 -171.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -78.38 -20.76 50.56 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.798 ' HB3' HG13 ' A' ' 68' ' ' ILE . 77.5 m -82.91 -18.5 39.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.286 176.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -84.99 -32.8 22.77 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.998 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 134' ' ' LYS . 16.9 p -74.9 -43.58 53.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.657 ' HA ' ' HG2' ' A' ' 36' ' ' MET . 4.6 pp -58.45 -34.88 71.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.481 ' HB3' HD21 ' A' ' 116' ' ' LEU . 49.1 m -69.95 -55.03 10.72 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.447 0.467 . . . . 0.0 111.853 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.662 ' HA ' ' OE1' ' A' ' 137' ' ' GLU . 25.6 m0 -55.56 -38.64 69.59 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.695 1.236 . . . . 0.0 111.194 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' A' ' 138' ' ' LYS . 50.0 mtpt -70.35 -42.41 71.89 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.605 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.578 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -58.4 -61.95 2.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.012 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.525 HD13 ' CG ' ' A' ' 76' ' ' MET . 72.6 mt -87.21 -43.59 12.1 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.054 -169.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.662 ' OE1' ' HA ' ' A' ' 133' ' ' TRP . 3.0 mp0 -84.8 -39.89 17.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -173.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.661 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 7.8 tmtm? -88.68 12.22 15.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.395 1.093 . . . . 0.0 109.051 176.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 1.025 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -88.13 -24.46 34.51 Favored Glycine 0 C--O 1.221 -0.658 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.114 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.523 HG21 ' HB1' ' A' ' 88' ' ' ALA . 29.6 m -114.23 -0.98 9.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.899 -0.65 . . . . 0.0 110.438 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 86.7 110.91 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.935 1.397 . . . . 0.0 108.403 -173.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -68.69 136.86 53.56 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.207 -169.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.779 ' HG3' ' H ' ' A' ' 144' ' ' GLU . 13.7 pt-20 41.01 -89.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 125.261 1.6 . . . . 0.0 113.58 176.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.779 ' H ' ' HG3' ' A' ' 143' ' ' GLU . 6.2 mm-40 . . . . . 0 N--CA 1.45 -0.453 0 CA-C-N 118.401 0.546 . . . . 0.0 109.836 172.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 C--O 1.24 0.588 0 CA-C-O 120.113 0.006 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.612 HD12 ' HB2' ' A' ' 10' ' ' LEU . 29.9 tp -126.57 -13.5 5.95 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.375 0.422 . . . . 0.0 110.154 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.69 -58.26 9.35 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.155 0.502 . . . . 0.0 111.427 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.3 m -55.14 -41.63 72.02 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.631 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.612 ' HB2' HD12 ' A' ' 7' ' ' LEU . 44.1 mt -55.56 -45.61 77.29 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.441 177.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.434 ' O ' HG22 ' A' ' 15' ' ' ILE . 15.7 m-85 -59.56 -46.37 89.11 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.367 0.604 . . . . 0.0 109.473 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -57.38 -45.27 84.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.599 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -67.31 -32.29 73.17 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.101 0.25 . . . . 0.0 110.682 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.654 HG13 ' HB2' ' A' ' 75' ' ' MET . 72.9 t -80.43 -47.99 20.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.833 -175.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 11' ' ' TYR . 18.2 tt -69.58 -25.53 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.2 ttt -78.29 -45.97 21.39 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.126 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.98 -42.77 76.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.489 0.662 . . . . 0.0 110.09 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.479 ' CG ' ' HB3' ' A' ' 74' ' ' SER . 85.9 t60 -66.95 -29.19 68.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.465 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -64.33 -45.48 87.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.941 -0.475 . . . . 0.0 110.615 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -47.52 -33.15 5.99 Favored 'General case' 0 C--O 1.247 0.937 0 O-C-N 124.197 0.936 . . . . 0.0 111.202 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -87.05 155.85 55.03 Favored Pre-proline 0 C--O 1.22 -0.492 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.146 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.24 -68.16 0.11 Allowed 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 123.606 2.871 . . . . 0.0 113.825 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.621 ' HG2' ' H ' ' A' ' 24' ' ' ASN . 25.0 ttm-85 176.61 -167.29 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.621 ' H ' ' HG2' ' A' ' 23' ' ' ARG . 18.6 p-10 -144.52 8.54 1.35 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.148 -0.345 . . . . 0.0 110.725 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 61' ' ' PHE . 60.6 tttp -99.91 115.32 29.37 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.633 0.73 . . . . 0.0 111.212 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.829 ' HA3' ' HE2' ' A' ' 60' ' ' LYS . . . -172.25 -177.83 42.03 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.48 HG23 HG21 ' A' ' 48' ' ' THR . 7.4 p -166.33 125.61 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 118.119 0.959 . . . . 0.0 110.655 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.748 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -143.69 143.62 31.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.594 0.711 . . . . 0.0 110.78 176.162 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -98.38 81.06 2.7 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.583 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 6.2 t70 -117.58 -123.02 0.29 Allowed 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.24 -173.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.448 ' OG ' ' HA ' ' A' ' 50' ' ' LYS . 17.7 m -51.88 -72.45 0.05 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.248 0.547 . . . . 0.0 111.878 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.691 HG13 ' HB2' ' A' ' 49' ' ' MET . 22.3 pt -130.23 140.89 47.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.42 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.827 HG13 HG22 ' A' ' 48' ' ' THR . 57.4 t -124.66 108.66 20.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 110.837 -0.06 . . . . 0.0 110.837 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.754 ' HB ' ' HB3' ' A' ' 47' ' ' LEU . 55.6 t -87.7 122.92 39.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 O-C-N 124.331 1.019 . . . . 0.0 110.993 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.83 108.02 16.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.995 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.47 ' HB2' ' HB2' ' A' ' 135' ' ' ALA . 20.3 mmt -136.47 119.11 16.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 5.1 p-10 -129.03 138.67 52.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.043 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -115.18 95.24 41.75 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.7 -12.77 26.56 Favored 'Trans proline' 0 CA--C 1.512 -0.576 0 C-N-CA 123.222 2.615 . . . . 0.0 112.756 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.5 m -94.12 -53.99 3.75 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.153 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.481 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 52.9 t -129.46 15.06 6.06 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -167.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.867 ' HA3' HD22 ' A' ' 131' ' ' LEU . . . -154.76 2.98 0.22 Allowed Glycine 0 N--CA 1.462 0.427 0 C-N-CA 118.003 -2.046 . . . . 0.0 114.882 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.708 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 10.3 t70 54.99 -101.41 0.13 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.878 0.871 . . . . 0.0 111.077 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 18.7 ptp180 -155.77 150.63 26.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.769 0.713 . . . . 0.0 112.133 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.597 HG13 ' CD1' ' A' ' 61' ' ' PHE . 8.6 tt -133.97 125.06 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 45.6 mtp180 -118.82 104.04 10.19 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 111.107 -176.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.754 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 20.1 tp -88.22 95.68 10.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.26 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.827 HG22 HG13 ' A' ' 33' ' ' VAL . 61.7 p -88.8 110.16 20.79 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.691 ' HB2' HG13 ' A' ' 32' ' ' ILE . 15.0 mtt -107.77 -179.98 4.06 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.136 0.493 . . . . 0.0 111.356 -171.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.583 ' HG3' ' OD2' ' A' ' 30' ' ' ASP . 50.5 tttp -153.58 101.35 2.48 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.606 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 1.4 pt? -124.15 93.48 3.93 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -92.21 60.27 3.67 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.644 -170.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 146.51 -98.43 0.2 Allowed Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 174.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -132.27 20.17 4.41 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.948 0.404 . . . . 0.0 110.415 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -129.0 152.13 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.81 119.54 49.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -105.49 -29.29 10.29 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.931 0.872 . . . . 0.0 108.824 -167.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.662 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 1.4 t70 -144.11 153.8 42.52 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.424 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.594 ' HB2' ' HG2' ' A' ' 49' ' ' MET . . . -164.26 118.72 1.45 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.829 ' HE2' ' HA3' ' A' ' 26' ' ' GLY . 38.8 mtpt -125.71 99.68 6.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.069 0.938 . . . . 0.0 111.527 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.597 ' CD1' HG13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -70.7 139.06 51.09 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.815 176.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 15.4 tt0 -143.79 126.29 15.88 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.979 0.895 . . . . 0.0 109.009 169.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.05 -175.02 45.73 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.835 -172.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.708 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -143.88 163.0 34.65 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 -179.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.38 -133.47 4.9 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 119.203 -1.475 . . . . 0.0 113.019 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 94.1 m -85.73 163.96 17.9 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.308 0.575 . . . . 0.0 112.305 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 t -75.17 -26.55 59.17 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.211 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.887 HG13 HG21 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -77.2 -33.51 20.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.256 177.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.4 m -69.12 -48.6 62.04 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.993 0.901 . . . . 0.0 108.934 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 52.2 ttp -56.14 -34.27 65.96 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.619 170.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.75 -39.16 67.07 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.479 0.487 . . . . 0.0 111.565 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.833 ' HB2' HD11 ' A' ' 116' ' ' LEU . 12.7 t -58.99 -47.77 83.98 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -62.76 -49.26 75.72 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.538 177.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.479 ' HB3' ' CG ' ' A' ' 18' ' ' HIS . 68.3 m -51.64 -61.7 2.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.882 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.654 ' HB2' HG13 ' A' ' 14' ' ' VAL . 9.1 tpt -74.92 -46.92 32.55 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.575 -169.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.94 ' HG2' HD21 ' A' ' 136' ' ' LEU . 6.9 tpt -80.37 -28.09 38.06 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 88.1 m -68.79 -17.91 64.11 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.555 -1.341 . . . . 0.0 108.823 168.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 75' ' ' MET . 1.5 tt0 -80.59 -38.37 29.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.341 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.69 -45.82 9.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.998 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.5 OUTLIER -73.6 -32.24 35.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 123.326 0.65 . . . . 0.0 110.703 -170.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.662 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 60.3 tttm -53.71 -15.47 1.24 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.452 0.644 . . . . 0.0 110.93 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.65 32.37 5.89 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.596 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -129.46 -165.47 1.53 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -132.67 -172.1 2.83 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.728 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -74.98 -46.02 41.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.656 -175.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.76 -40.69 79.65 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.207 0.317 . . . . 0.0 111.393 -175.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.2 p -58.01 -36.5 72.77 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.457 0.646 . . . . 0.0 110.533 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.901 ' HB1' ' HB2' ' A' ' 141' ' ' ALA . . . -71.89 -49.15 40.46 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.022 0.529 . . . . 0.0 110.712 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 42.1 mt -55.01 -44.49 74.61 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.639 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.553 ' O ' HG12 ' A' ' 94' ' ' ILE . 38.3 p -68.61 -33.53 74.2 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.246 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.541 ' HA ' ' CG1' ' A' ' 94' ' ' ILE . 25.1 ttt -64.91 -16.65 63.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.383 0.611 . . . . 0.0 110.429 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.511 ' CB ' ' HG3' ' A' ' 143' ' ' GLU . 6.1 m -86.29 -40.25 15.69 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -66.3 -43.87 85.04 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.616 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 90' ' ' SER . 10.0 pt -71.45 -40.88 72.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.624 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 91' ' ' MET . 5.9 t80 -56.9 -29.77 63.32 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.32 174.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 t -80.8 -36.86 31.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -65.61 -42.03 92.04 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.139 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.616 ' HA ' ' H ' ' A' ' 103' ' ' GLU . 16.8 tpt -35.59 -50.45 0.61 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 123.827 0.705 . . . . 0.0 112.568 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 42.4 tpp -48.87 -19.56 0.39 Allowed 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -140.28 -29.84 0.69 Allowed 'General case' 0 C--O 1.242 0.673 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.23 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -99.79 -36.73 4.15 Favored Glycine 0 C--N 1.318 -0.472 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.647 -174.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 63.9 tttm 88.59 70.31 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.616 ' H ' ' HA ' ' A' ' 98' ' ' MET . 10.3 tp10 -153.8 133.88 13.25 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 113.335 -1.757 . . . . 0.0 107.226 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.538 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -124.48 -59.39 1.46 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.644 -168.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.768 ' HB3' HD12 ' A' ' 110' ' ' LEU . 14.7 t70 -144.58 97.2 2.99 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.456 ' H ' HD12 ' A' ' 94' ' ' ILE . 14.8 t70 -34.8 -31.45 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 174.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.9 m -95.94 2.78 53.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.77 -0.582 . . . . 0.0 111.301 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 108' ' ' ILE . 31.9 mm 69.53 24.97 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 122.667 1.222 . . . . 0.0 109.124 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -96.78 73.95 2.67 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.929 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.768 HD12 ' HB3' ' A' ' 105' ' ' ASP . 5.0 mp -98.01 10.84 39.38 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.995 -166.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -40.18 -38.22 1.26 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 115.645 1.018 . . . . 0.0 115.645 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.74 ' HB2' ' HB2' ' A' ' 76' ' ' MET . 18.4 t70 -80.88 -51.3 8.74 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.579 0.704 . . . . 0.0 110.42 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.646 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 53.4 mt -65.09 -24.14 34.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.823 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.536 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 47.3 mt-10 -67.91 -58.38 4.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.57 77.13 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.974 0.797 . . . . 0.0 112.479 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.833 HD11 ' HB2' ' A' ' 72' ' ' SER . 8.9 mp -94.65 -5.84 44.74 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.646 ' HB3' ' O ' ' A' ' 113' ' ' ILE . 2.9 pt20 -61.65 -28.31 69.3 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.79 0.805 . . . . 0.0 111.762 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.86 -16.46 65.41 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.536 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.887 HG21 HG13 ' A' ' 68' ' ' ILE . 24.1 t -86.8 -57.62 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 124.047 0.939 . . . . 0.0 111.003 -172.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 3.3 p -45.0 -14.59 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -176.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -128.6 0.53 5.53 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 118.481 -1.287 . . . . 0.0 112.045 -165.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.5 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 6.1 m-85 -90.13 130.61 41.58 Favored Pre-proline 0 N--CA 1.441 -0.883 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.43 -29.0 29.5 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.935 2.424 . . . . 0.0 112.241 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.86 -2.88 52.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.446 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 89.8 mtt180 -125.39 11.71 8.08 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.1 tt -80.33 -36.78 16.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.08 0.943 . . . . 0.0 109.029 -171.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -85.64 -18.03 34.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.167 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 3.7 t -79.87 -19.28 48.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.565 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -85.85 -33.19 21.36 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.57 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.763 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 26.2 p -77.28 -32.31 55.43 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 119.323 -0.951 . . . . 0.0 108.926 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.867 HD22 ' HA3' ' A' ' 42' ' ' GLY . 19.2 tp -47.31 -59.41 3.21 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.663 169.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.8 m -79.09 -61.06 2.13 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.675 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.555 ' HB2' HD23 ' A' ' 116' ' ' LEU . 2.6 t90 -63.12 -51.37 66.81 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.458 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.763 ' HB2' ' O ' ' A' ' 130' ' ' THR . 27.4 mmmt -61.67 -42.43 98.91 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 121.855 -0.528 . . . . 0.0 110.986 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 36' ' ' MET . . . -57.02 -36.74 70.8 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.307 174.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.94 HD21 ' HG2' ' A' ' 76' ' ' MET . 4.6 tp -79.55 -40.74 28.79 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.826 0.822 . . . . 0.0 110.114 -175.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 139' ' ' GLY . 39.4 tt0 -79.12 -53.01 7.42 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.283 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 134' ' ' LYS . 72.3 tttt -78.87 15.63 1.05 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.878 -169.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.551 ' O ' HD12 ' A' ' 32' ' ' ILE . . . -101.08 -26.61 7.77 Favored Glycine 0 N--CA 1.424 -2.148 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.921 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.29 -33.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 O-C-N 122.242 -0.563 . . . . 0.0 110.295 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.901 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . . . -102.19 119.16 38.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.39 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.634 ' H ' ' CD2' ' A' ' 89' ' ' LEU . 47.9 mtmt -146.55 113.09 5.96 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.731 0.301 . . . . 0.0 110.446 173.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.511 ' HG3' ' CB ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -57.11 69.89 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.221 0.534 . . . . 0.0 111.971 162.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 C--N 1.322 -0.624 0 CA-C-O 122.014 0.911 . . . . 0.0 110.12 176.862 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.3 t30 . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 122.467 1.127 . . . . 0.0 108.739 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.598 HD12 HD12 ' A' ' 10' ' ' LEU . 34.3 tp -118.38 -12.28 9.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.764 -175.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.54 ' HA ' ' HD2' ' A' ' 11' ' ' TYR . 2.2 m-20 -58.44 -58.62 7.7 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.108 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 p -56.45 -41.04 75.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.925 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.598 HD12 HD12 ' A' ' 7' ' ' LEU . 62.6 mt -55.42 -41.69 73.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.285 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.54 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 47.9 m-85 -57.16 -51.54 68.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.322 0.582 . . . . 0.0 109.92 173.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -56.65 -39.63 74.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.51 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.5 tp60 -74.09 -35.17 64.19 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.709 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 115' ' ' ALA . 75.6 t -70.02 -45.48 76.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.69 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 66.6 mt -67.52 -23.19 29.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.1 ttt -73.2 -53.71 10.26 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.898 -0.502 . . . . 0.0 110.294 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -69.59 -44.81 70.02 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.49 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -65.6 -20.69 66.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.157 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 82.8 t80 -62.94 -50.09 72.18 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 121.959 -0.463 . . . . 0.0 110.56 173.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -44.85 -29.75 0.86 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.897 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -122.4 82.23 46.4 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 120.885 0.374 . . . . 0.0 110.141 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.6 73.45 1.29 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.125 2.55 . . . . 0.0 113.064 -172.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.3 ttm105 -145.55 72.47 1.31 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.659 0.742 . . . . 0.0 110.168 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -105.53 64.29 0.7 Allowed 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.641 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 179.52 163.45 0.95 Allowed 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 144.82 153.53 5.89 Favored Glycine 0 C--O 1.218 -0.867 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.998 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.847 ' HB ' ' HB2' ' A' ' 62' ' ' GLU . 2.6 p -168.46 117.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.724 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -141.33 149.0 40.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.056 0.455 . . . . 0.0 111.152 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -107.55 104.81 14.45 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.31 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -149.75 -110.36 0.07 Allowed 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.468 0.48 . . . . 0.0 110.383 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.684 ' HB3' HD23 ' A' ' 51' ' ' LEU . 22.3 m -54.06 -74.0 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 124.79 1.306 . . . . 0.0 112.05 -171.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.712 HG13 ' HB3' ' A' ' 49' ' ' MET . 10.6 pt -134.82 136.71 51.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.779 0.8 . . . . 0.0 109.111 174.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.741 HG13 HG22 ' A' ' 48' ' ' THR . 33.8 t -117.69 105.23 17.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.842 0.829 . . . . 0.0 108.791 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.764 HG21 ' HA2' ' A' ' 139' ' ' GLY . 85.6 t -98.41 124.49 51.56 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.845 -171.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.789 ' HB3' ' HE ' ' A' ' 46' ' ' ARG . 5.4 p-10 -136.88 145.9 44.9 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.506 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.3 mmt -154.19 135.66 14.23 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.768 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.521 ' HB2' ' O ' ' A' ' 43' ' ' ASP . 22.6 p-10 -122.13 142.05 50.79 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.04 174.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.657 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 56.4 t30 -125.57 106.04 27.02 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 174.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 1.3 Cg_endo -42.85 133.02 5.7 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 125.123 3.882 . . . . 0.0 114.458 -167.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.0 m 77.12 -36.56 0.25 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.139 175.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.799 ' SG ' ' HB3' ' A' ' 127' ' ' LYS . 44.1 t -85.85 -78.61 0.27 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -171.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.613 ' HA3' HD13 ' A' ' 131' ' ' LEU . . . -102.6 11.48 56.47 Favored Glycine 0 CA--C 1.502 -0.761 0 C-N-CA 118.786 -1.673 . . . . 0.0 112.286 -166.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.58 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 18.3 t70 62.8 -90.9 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.423 0.719 . . . . 0.0 110.349 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -159.8 144.4 14.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 123.198 0.311 . . . . 0.0 110.466 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.42 133.92 59.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.789 ' HE ' ' HB3' ' A' ' 35' ' ' ASP . 28.8 ttm180 -134.41 109.4 8.74 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.594 HD11 ' HB1' ' A' ' 59' ' ' ALA . 11.8 tp -84.91 99.24 10.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.127 172.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.741 HG22 HG13 ' A' ' 33' ' ' VAL . 50.0 p -80.71 107.41 13.5 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 171.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.712 ' HB3' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -110.07 165.43 11.74 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -164.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 57' ' ' GLU . 8.5 tmtm? -156.33 97.21 1.75 Allowed 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.684 HD23 ' HB3' ' A' ' 31' ' ' SER . 2.6 pt? -118.85 93.82 4.23 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.62 59.26 1.76 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.373 1.082 . . . . 0.0 109.545 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 150.18 -99.44 0.19 Allowed Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.846 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.473 ' C ' HG12 ' A' ' 85' ' ' ILE . 2.0 t70 -134.91 24.25 3.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.442 0.639 . . . . 0.0 109.37 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.645 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.2 pp -137.31 156.07 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 C-N-CA 124.435 1.094 . . . . 0.0 108.47 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.496 HG11 ' O ' ' A' ' 80' ' ' ILE . 3.3 p -96.77 119.46 44.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.139 0.971 . . . . 0.0 108.551 168.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 50' ' ' LYS . 32.2 tt0 -98.03 -33.44 11.18 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.379 -171.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -146.22 147.55 31.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.483 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.594 ' HB1' HD11 ' A' ' 47' ' ' LEU . . . -155.82 123.09 5.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.488 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 46.8 mmtm -133.82 165.7 24.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.069 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.718 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 26.0 p90 -127.47 127.29 43.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.48 0.657 . . . . 0.0 111.612 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.847 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 8.8 tp10 -110.54 109.31 19.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.22 -178.62 48.59 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.518 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.58 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 15.1 mm-40 -142.29 168.5 19.58 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.3 -131.62 3.36 Favored Glycine 0 C--O 1.24 0.496 0 C-N-CA 119.588 -1.291 . . . . 0.0 112.93 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.8 m -78.34 178.88 7.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.6 m -93.18 -23.96 18.39 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -79.89 -38.74 19.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 113.831 -1.532 . . . . 0.0 110.614 175.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.4 p -65.41 -43.35 90.84 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.946 -0.471 . . . . 0.0 110.786 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.5 ptp -62.51 -29.17 70.35 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.852 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.57 -34.51 65.17 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.643 0.589 . . . . 0.0 111.642 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 m -62.25 -40.51 96.44 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.761 ' HA ' ' HG2' ' A' ' 76' ' ' MET . . . -64.95 -43.08 93.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.892 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.1 m -52.42 -49.0 65.4 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 122.324 0.249 . . . . 0.0 110.653 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.474 ' HA ' ' HG2' ' A' ' 78' ' ' GLN . 4.6 mmt -66.0 -47.5 74.29 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.988 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.761 ' HG2' ' HA ' ' A' ' 73' ' ' ALA . 19.7 ptt? -59.82 -41.41 91.23 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.962 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.4 p -60.18 -35.57 75.67 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.257 -0.902 . . . . 0.0 111.052 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.474 ' HG2' ' HA ' ' A' ' 75' ' ' MET . 20.4 pt20 -88.16 -41.37 13.04 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.926 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.66 -48.63 8.14 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 121.678 0.751 . . . . 0.0 111.425 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.598 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -71.47 -42.45 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.892 -174.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -61.7 -16.1 46.11 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.071 0.462 . . . . 0.0 111.273 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.12 43.61 1.65 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.322 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.589 ' HG3' ' HB ' ' A' ' 87' ' ' THR . 2.9 tppt? -134.42 170.45 15.73 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -105.66 175.61 5.44 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.668 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.5 mm -78.07 -35.86 20.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.173 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.12 -48.03 79.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.638 0.733 . . . . 0.0 109.557 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.589 ' HB ' ' HG3' ' A' ' 83' ' ' LYS . 1.4 m -66.2 -40.32 90.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.711 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.708 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -63.94 -41.7 97.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 73.5 mt -66.64 -31.01 71.42 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.8 m -70.22 -44.33 68.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.154 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.584 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 13.1 tpt -60.11 -29.92 68.92 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.444 0.698 . . . . 0.0 110.4 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.51 ' OG ' ' HA ' ' A' ' 142' ' ' LYS . 71.7 p -87.92 -37.86 16.08 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.968 -175.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.627 ' HG3' ' HG2' ' A' ' 143' ' ' GLU . 61.2 tttm -67.5 -44.68 77.87 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.331 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 105' ' ' ASP . 71.8 mt -63.79 -44.75 98.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.306 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 91' ' ' MET . 0.7 OUTLIER -53.34 -32.61 49.96 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.543 174.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.6 m -83.21 -40.34 19.77 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.8 0.333 . . . . 0.0 111.187 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -71.22 -37.57 72.04 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.799 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.1 ttt -45.28 -51.48 10.84 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.439 0.695 . . . . 0.0 112.308 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 46.5 ttp -61.03 -8.74 3.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -123.96 -31.82 3.34 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.908 -0.495 . . . . 0.0 110.841 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -89.51 -25.58 27.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.769 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 23.9 tptm 84.87 -31.35 0.06 Allowed 'General case' 0 N--CA 1.478 0.97 0 O-C-N 125.044 1.085 . . . . 0.0 109.119 175.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.22 178.45 6.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.411 ' CG ' HD21 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -144.76 -108.84 0.11 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.112 0.482 . . . . 0.0 111.714 -173.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.436 ' HB2' HD13 ' A' ' 94' ' ' ILE . 20.2 t70 -109.16 107.9 18.35 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -175.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.08 3.89 0.38 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.616 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.562 ' O ' HG22 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -99.09 -18.95 17.46 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 107' ' ' SER . 6.6 tp 66.91 24.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.446 168.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.22 87.34 6.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 172.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 114' ' ' GLU . 1.1 mp -114.21 21.53 14.64 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.306 0.379 . . . . 0.0 111.546 -168.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -51.6 -54.52 24.26 Favored Glycine 0 C--O 1.242 0.656 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.247 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.584 ' HB2' ' HE2' ' A' ' 91' ' ' MET . 6.7 m-20 -58.04 -24.14 57.18 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.863 0.865 . . . . 0.0 111.998 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 76.3 mt -100.69 -25.09 3.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -174.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 33.7 tt0 -75.36 -54.41 7.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.53 -1.213 . . . . 0.0 111.762 -163.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.517 ' O ' HD11 ' A' ' 7' ' ' LEU . . . -49.23 -24.76 1.9 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.81 0.694 . . . . 0.0 110.818 170.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.6 mp -102.89 -3.18 26.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.472 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.429 ' HB2' ' HA ' ' A' ' 114' ' ' GLU . 7.8 tt0 -54.48 -37.19 64.98 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.187 0.595 . . . . 0.0 110.686 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.82 -18.16 66.2 Favored Glycine 0 C--O 1.216 -0.986 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.557 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.803 HG12 ' HB2' ' A' ' 129' ' ' ALA . 48.4 t -84.11 -44.71 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 O-C-N 122.283 -0.539 . . . . 0.0 112.164 -174.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.5 p -45.93 -25.56 0.56 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.318 0.647 . . . . 0.0 110.247 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.586 ' NZ ' ' HB2' ' A' ' 121' ' ' LYS . 3.6 ttmp? -131.71 96.51 3.97 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.996 ' H ' ' HB3' ' A' ' 125' ' ' ARG . 0.1 OUTLIER -152.34 157.06 33.91 Favored Pre-proline 0 N--CA 1.448 -0.561 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -172.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.454 ' HD2' ' CG ' ' A' ' 122' ' ' PHE . 10.8 Cg_endo -59.24 -22.85 66.95 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.705 1.603 . . . . 0.0 111.221 172.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.28 18.42 17.85 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.294 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.996 ' HB3' ' H ' ' A' ' 122' ' ' PHE . 25.6 ptt-85 -52.44 -44.5 65.52 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 124.105 0.878 . . . . 0.0 112.202 -165.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.431 ' N ' ' HG3' ' A' ' 125' ' ' ARG . 11.6 tt -85.24 -20.59 8.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -160.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.799 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 38.5 mmtm -75.97 -50.14 15.75 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.435 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.873 ' HB3' HD12 ' A' ' 68' ' ' ILE . 80.0 m -86.54 -29.11 22.92 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.256 -173.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.803 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -87.59 -29.8 20.98 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.033 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 63.8 m -84.5 -41.93 16.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.613 HD13 ' HA3' ' A' ' 42' ' ' GLY . 8.4 tt -51.82 -39.41 58.7 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.942 0.401 . . . . 0.0 110.612 173.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.9 m -84.05 -42.45 16.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.697 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.459 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 2.3 t90 -53.02 -50.48 64.15 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.114 0.566 . . . . 0.0 109.816 174.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 68.2 mmtt -60.08 -42.59 94.9 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 124.68 1.238 . . . . 0.0 110.407 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.2 -41.96 63.12 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.455 0.472 . . . . 0.0 112.102 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 76' ' ' MET . 4.4 mm? -83.06 -38.45 22.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.534 0.683 . . . . 0.0 110.894 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.718 ' HG3' ' HB3' ' A' ' 142' ' ' LYS . 26.4 tt0 -68.69 -41.87 78.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.37 -177.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.508 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 9.3 mtpt -93.31 -0.75 56.58 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.063 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.764 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -79.99 -27.71 52.3 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.903 HG23 ' H ' ' A' ' 141' ' ' ALA . 16.9 m -129.89 -94.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 113.184 -1.508 . . . . 0.0 108.089 170.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.903 ' H ' HG23 ' A' ' 140' ' ' VAL . . . -166.86 153.48 8.61 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.563 0.745 . . . . 0.0 109.017 166.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.718 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 21.2 pttm -87.45 119.05 27.34 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.242 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.627 ' HG2' ' HG3' ' A' ' 93' ' ' LYS . 29.6 mt-10 68.02 -78.57 0.04 OUTLIER 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.259 0.624 . . . . 0.0 110.77 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 . . . . . 0 C--N 1.308 -1.198 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.334 179.643 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.475 ' HB3' ' HD2' ' A' ' 3' ' ' PHE . 24.2 mmt . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.754 0.311 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 m -88.06 61.17 6.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.044 0.449 . . . . 0.0 111.17 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.475 ' HD2' ' HB3' ' A' ' 1' ' ' MET . 98.3 m-85 -136.5 173.94 11.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.656 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 6' ' ' ASN . 2.6 m-20 -77.58 -28.08 51.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.394 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.86 -22.88 0.16 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.903 0.752 . . . . 0.0 112.127 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 4' ' ' ASN . 3.8 t-20 -60.26 82.28 0.01 OUTLIER 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.599 0.562 . . . . 0.0 111.54 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.694 HD11 ' O ' ' A' ' 115' ' ' ALA . 22.7 tp 177.32 -39.09 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 175.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.693 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.4 t70 -49.31 -63.03 1.22 Allowed 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.505 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 p -59.58 -37.76 79.35 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.003 0.43 . . . . 0.0 112.043 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 mp -56.25 -50.58 70.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.898 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.778 ' HA ' ' HB ' ' A' ' 14' ' ' VAL . 5.8 p90 -85.59 -18.72 32.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.115 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 16' ' ' MET . 19.1 tpp180 -63.82 -51.99 62.21 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -63.89 -27.5 69.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.37 0.605 . . . . 0.0 109.453 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.778 ' HB ' ' HA ' ' A' ' 11' ' ' TYR . 2.1 t -70.56 -51.7 35.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.891 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.4 tt -72.19 -23.12 21.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -82.01 -42.68 18.99 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.261 0.351 . . . . 0.0 111.28 -178.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.529 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 20.9 t70 -69.11 -33.41 73.44 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.185 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.637 ' CE1' ' HB2' ' A' ' 74' ' ' SER . 86.2 t60 -74.4 -19.72 60.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.005 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -66.45 -40.63 89.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.529 ' HE3' ' HA ' ' A' ' 17' ' ' ASP . 70.9 mttt -49.98 -34.67 21.73 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.488 169.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.688 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 10.8 m120 -82.03 -179.6 1.54 Allowed Pre-proline 0 N--CA 1.465 0.298 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.688 ' HD2' ' HB3' ' A' ' 21' ' ' ASN . 11.1 Cg_endo -58.29 164.55 8.59 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.654 1.569 . . . . 0.0 111.215 164.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -85.83 -140.18 0.08 Allowed 'General case' 0 C--N 1.31 -1.137 0 O-C-N 122.038 -0.414 . . . . 0.0 111.072 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -116.91 52.46 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.981 0.419 . . . . 0.0 110.322 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.729 ' HD3' ' HG2' ' A' ' 62' ' ' GLU . 41.8 mmtm -144.03 83.68 1.75 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.587 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.28 137.14 5.23 Favored Glycine 0 C--O 1.228 -0.259 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.497 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 3.0 m -155.56 135.76 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.96 0.409 . . . . 0.0 110.171 -175.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.606 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -144.09 170.28 16.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.363 0.602 . . . . 0.0 111.013 173.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -135.14 41.31 2.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.67 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.471 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 25.0 t70 -84.85 -9.73 57.85 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.88 0.371 . . . . 0.0 110.535 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.6 m -153.39 -85.45 0.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.301 0.572 . . . . 0.0 110.181 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.522 HD11 HD21 ' A' ' 51' ' ' LEU . 16.2 pt -127.66 141.77 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.783 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.929 HG13 HG22 ' A' ' 48' ' ' THR . 58.6 t -121.02 107.11 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.507 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.655 HG21 ' HA2' ' A' ' 139' ' ' GLY . 97.0 t -101.45 124.52 55.25 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 O-C-N 123.577 0.548 . . . . 0.0 110.413 -176.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -126.77 137.65 53.25 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.9 tpt -148.43 126.19 11.86 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 17.0 p30 -129.03 146.98 50.86 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.988 0.805 . . . . 0.0 111.368 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.974 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 20.2 t-20 -108.23 98.24 25.94 Favored Pre-proline 0 C--O 1.248 0.988 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.2 -23.73 70.78 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 123.623 2.882 . . . . 0.0 112.353 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.6 m -62.2 -31.87 72.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 124.085 0.865 . . . . 0.0 111.79 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 81.2 m -113.31 -51.58 2.81 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.47 -6.75 10.6 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 118.995 -1.574 . . . . 0.0 110.131 -156.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.974 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 24.4 m-20 -60.02 121.58 12.2 Favored 'General case' 0 C--O 1.213 -0.856 0 C-N-CA 123.742 0.817 . . . . 0.0 109.665 173.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 30.3 ttp180 -150.2 136.75 19.02 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 121.524 -0.735 . . . . 0.0 110.536 172.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 132' ' ' SER . 26.2 pt -138.75 145.02 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 81.0 mtm180 -125.86 105.21 8.78 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.509 0.671 . . . . 0.0 110.936 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.409 HD12 ' HA3' ' A' ' 139' ' ' GLY . 1.3 tm? -89.7 98.49 11.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.918 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.929 HG22 HG13 ' A' ' 33' ' ' VAL . 71.7 p -100.48 120.16 39.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 35.7 mtt -111.2 -179.87 3.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.769 0.795 . . . . 0.0 112.591 -173.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 60.7 tttm -149.53 93.68 2.09 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.522 HD21 HD11 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -124.23 101.98 7.47 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.62 -174.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -91.75 57.19 3.15 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.381 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.61 -99.55 0.22 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 174.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.441 ' C ' HD13 ' A' ' 85' ' ' ILE . 11.6 m-20 -131.2 25.9 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.675 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.493 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -132.52 143.72 38.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.22 114.64 30.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 169.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -100.09 -24.9 14.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -169.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 11.6 t70 -153.21 155.5 36.75 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.988 -1.46 . . . . 0.0 109.693 171.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.637 ' H ' ' HE2' ' A' ' 81' ' ' LYS . . . -157.24 117.52 3.5 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -114.43 138.59 50.39 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 123.195 0.309 . . . . 0.0 110.219 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 5.4 p90 -129.5 137.88 51.06 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -169.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.729 ' HG2' ' HD3' ' A' ' 25' ' ' LYS . 3.6 tm-20 -120.04 135.04 55.08 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.86 138.57 7.0 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.202 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -150.93 142.44 23.51 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 43' ' ' ASP . . . 146.49 -134.75 5.46 Favored Glycine 0 CA--C 1.508 -0.386 0 C-N-CA 118.811 -1.661 . . . . 0.0 111.54 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 64.0 m -75.15 153.96 37.96 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 p -66.5 -27.12 67.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.892 0.377 . . . . 0.0 110.752 -170.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.695 HD13 HG21 ' A' ' 119' ' ' VAL . 2.7 pp -82.19 -32.1 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 121.568 0.699 . . . . 0.0 111.648 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.596 ' N ' HD12 ' A' ' 68' ' ' ILE . 6.7 m -73.17 -52.95 12.23 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.3 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 21.5 ptm -65.83 -17.82 64.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.979 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.57 ' HB1' HG12 ' A' ' 14' ' ' VAL . . . -86.67 -46.75 9.76 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.671 0.272 . . . . 0.0 111.633 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.2 p -69.88 -42.17 73.8 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.246 0.545 . . . . 0.0 110.304 -172.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.17 -56.05 26.27 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.204 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.637 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 60.4 p -63.88 -30.05 71.18 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.599 ' HG3' HG22 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -75.09 -53.0 9.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.028 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.582 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 11.9 tpt -70.04 -22.3 63.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.984 -177.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 8.5 p -72.93 -40.47 65.41 Favored 'General case' 0 C--O 1.212 -0.902 0 O-C-N 121.654 -0.654 . . . . 0.0 110.406 174.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -57.28 -31.14 65.3 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.41 172.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.86 -34.47 19.45 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.858 0.837 . . . . 0.0 110.25 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.582 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.5 OUTLIER -75.19 -32.25 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.685 -177.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.637 ' HE2' ' H ' ' A' ' 59' ' ' ALA . 46.2 tttm -49.88 -18.31 0.49 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.887 1.275 . . . . 0.0 111.838 175.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.1 46.99 1.05 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.431 ' HB2' HD13 ' A' ' 80' ' ' ILE . 42.8 mmtm -132.64 -175.69 3.85 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -118.09 -178.42 3.5 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 172.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.701 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -72.85 -44.16 58.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.143 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.87 -42.55 99.8 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.082 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 m -61.64 -45.47 93.93 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.565 0.698 . . . . 0.0 111.499 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' A' ' 80' ' ' ILE . . . -70.54 -32.46 69.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.529 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 83.1 mt -63.01 -35.73 81.2 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.166 0.984 . . . . 0.0 108.501 172.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 41.7 m -70.65 -33.91 71.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.489 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -63.65 -26.04 68.49 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.163 0.506 . . . . 0.0 110.926 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.519 ' HB3' ' HB1' ' A' ' 141' ' ' ALA . 0.9 OUTLIER -89.63 -34.35 16.33 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -178.177 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 143' ' ' GLU . 14.0 tmtt? -68.38 -37.22 80.2 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 105' ' ' ASP . 21.8 mt -66.18 -46.47 87.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 123.558 0.743 . . . . 0.0 109.74 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.434 ' HD2' HG12 ' A' ' 113' ' ' ILE . 27.6 t80 -53.25 -30.18 36.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.697 0.76 . . . . 0.0 111.451 175.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.3 t -85.28 -39.03 18.18 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.626 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.95 -28.52 63.5 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.825 0.85 . . . . 0.0 111.672 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.64 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -57.8 -58.03 10.15 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.246 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.5 ' HE3' ' HA ' ' A' ' 99' ' ' MET . 3.4 mmt -64.7 -7.09 9.41 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -174.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -116.52 -35.94 4.11 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.375 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -94.69 -24.18 18.75 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.08 -173.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 23.7 ttmm 85.71 -21.87 0.2 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.046 0.927 . . . . 0.0 110.484 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 98' ' ' MET . 44.8 mt-10 -92.02 167.83 11.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.545 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 1.4 p90 -137.27 -110.75 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.02 -174.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.848 ' HB3' HD11 ' A' ' 110' ' ' LEU . 13.9 t70 -93.93 110.54 22.21 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.498 0.666 . . . . 0.0 110.186 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -46.72 -11.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.527 -1.67 . . . . 0.0 113.027 172.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.2 m -105.2 -15.37 15.08 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 121.678 -0.639 . . . . 0.0 110.495 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 108' ' ' ILE . 24.6 mm 70.77 19.15 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 124.049 0.843 . . . . 0.0 111.483 174.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -97.94 93.67 6.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.848 HD11 ' HB3' ' A' ' 105' ' ' ASP . 9.0 mp -124.07 31.82 5.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.249 -164.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -36.76 -43.75 0.85 Allowed Glycine 0 CA--C 1.534 1.219 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 6.9 p-10 -86.81 -44.73 11.51 Favored 'General case' 0 C--O 1.208 -1.088 0 CA-C-N 117.657 0.728 . . . . 0.0 110.95 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.537 HD12 ' HG ' ' A' ' 110' ' ' LEU . 55.3 mt -62.74 -38.16 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.503 0.668 . . . . 0.0 110.58 -174.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.553 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 39.8 mt-10 -63.51 -53.69 48.07 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.028 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.694 ' O ' HD11 ' A' ' 7' ' ' LEU . . . -68.55 -37.73 80.2 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 124.527 1.142 . . . . 0.0 114.028 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.734 HD12 HG21 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -92.0 -11.3 36.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -173.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 114' ' ' GLU . 4.7 pp0? -60.32 -31.37 70.22 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 121.267 -0.895 . . . . 0.0 110.733 177.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.487 ' HA3' HD13 ' A' ' 7' ' ' LEU . . . -84.47 -18.1 62.87 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.461 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 125' ' ' ARG . 72.9 t -86.69 -55.66 6.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.396 0.617 . . . . 0.0 110.368 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.766 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 23.5 t -41.22 -14.69 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.068 -1.878 . . . . 0.0 115.391 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -131.56 7.6 4.51 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -163.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -103.01 136.39 19.24 Favored Pre-proline 0 CA--C 1.507 -0.71 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.83 -22.18 28.75 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.785 2.323 . . . . 0.0 111.621 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.53 -8.0 33.1 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.467 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.766 ' HB3' HG13 ' A' ' 119' ' ' VAL . 84.1 mtt180 -126.03 5.33 7.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 O-C-N 121.714 -0.616 . . . . 0.0 110.363 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 tt -84.53 -33.03 8.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 122.148 0.975 . . . . 0.0 108.954 -168.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.474 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 75.9 mmtt -72.72 -24.45 60.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.027 174.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 131' ' ' LEU . 71.2 m -84.92 -17.76 36.77 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.582 0.706 . . . . 0.0 110.249 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.766 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -82.29 -21.54 36.11 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 65.5 m -83.63 -40.19 19.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.627 HD22 ' HB3' ' A' ' 43' ' ' ASP . 2.0 tp -50.51 -63.07 1.24 Allowed 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 113.459 -1.7 . . . . 0.0 111.185 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.609 ' HB2' HD21 ' A' ' 116' ' ' LEU . 20.5 m -76.44 -63.17 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -172.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.462 ' HB2' HD23 ' A' ' 116' ' ' LEU . 66.4 t90 -66.16 -49.84 66.01 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.145 -173.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 130' ' ' THR . 51.6 tttm -62.67 -35.69 80.48 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.134 -176.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.92 93.6 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.838 170.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.0 tp -66.46 -35.17 79.62 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 1.029 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 30.3 tt0 -69.04 -35.48 76.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.672 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -79.91 6.28 11.62 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-O 122.003 0.906 . . . . 0.0 110.023 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.655 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -103.71 -36.94 3.11 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.697 -176.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.521 HG23 HG13 ' A' ' 85' ' ' ILE . 11.0 p -172.67 41.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 122.156 0.979 . . . . 0.0 109.698 -176.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 1.029 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . . . -148.9 167.62 25.23 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.876 -172.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 143' ' ' GLU . 37.4 ttmt -171.02 -10.46 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.547 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 27.1 tt0 71.19 -67.29 0.26 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.887 0.742 . . . . 0.0 110.698 -175.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -105.49 141.72 36.48 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.524 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.37 -32.86 78.6 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.576 172.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.36 55.44 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 . . . . . 0 C--O 1.239 0.528 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.339 -172.518 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 111.56 0.208 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m 66.97 -76.61 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 177.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -78.1 97.86 5.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 122.031 -0.418 . . . . 0.0 111.036 -173.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.483 HD22 ' N ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -179.15 18.78 0.0 OUTLIER 'General case' 0 C--N 1.347 0.474 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 4' ' ' ASN . . . 82.93 -176.2 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.9 0.88 . . . . 0.0 109.721 -175.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -174.13 -88.5 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -175.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.1 tp -143.99 -25.76 0.54 Allowed 'General case' 0 C--O 1.212 -0.899 0 C-N-CA 122.43 0.292 . . . . 0.0 111.687 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.444 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 14.6 t70 -49.17 -59.79 3.35 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.23 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -45.6 89.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.188 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 14' ' ' VAL . 74.7 mt -54.19 -51.67 63.64 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.481 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.444 ' CE1' ' HA ' ' A' ' 8' ' ' ASP . 2.2 p90 -85.14 -18.24 34.8 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.368 -175.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -60.52 -40.75 92.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.997 0.427 . . . . 0.0 110.128 169.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.514 ' HG3' ' HE1' ' A' ' 16' ' ' MET . 10.4 tt0 -73.1 -24.66 60.67 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.714 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 10' ' ' LEU . 90.0 t -73.17 -34.93 46.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.331 175.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.4 mt -73.9 -32.34 33.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.635 172.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.514 ' HE1' ' HG3' ' A' ' 13' ' ' GLN . 56.2 ttp -68.77 -46.27 69.2 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.899 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -38.2 89.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.702 -177.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.423 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -83.0 -14.24 54.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -69.09 -50.06 51.61 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.479 -1.388 . . . . 0.0 109.04 167.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -52.58 -37.39 57.92 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.391 0.676 . . . . 0.0 110.511 172.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.86 84.68 32.44 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 176.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.93 39.21 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.99 3.127 . . . . 0.0 114.408 -163.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -85.69 57.82 4.69 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.799 0.809 . . . . 0.0 110.868 177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 18' ' ' HIS . 4.6 m-20 -102.03 19.63 18.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.925 0.869 . . . . 0.0 109.496 172.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -136.99 143.96 43.05 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 113.644 -1.616 . . . . 0.0 109.002 176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.79 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 157.96 139.74 2.77 Favored Glycine 0 C--O 1.21 -1.351 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.792 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.598 HG23 HG21 ' A' ' 48' ' ' THR . 4.0 p -167.18 120.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.465 0.65 . . . . 0.0 109.347 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.744 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -138.97 154.07 48.25 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.51 0.671 . . . . 0.0 110.533 175.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -102.2 79.64 1.88 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.841 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.47 ' OD1' ' HG3' ' A' ' 50' ' ' LYS . 6.5 t70 -115.8 -130.61 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.478 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 m -52.08 -71.71 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.976 0.798 . . . . 0.0 111.746 -172.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.743 HD11 HD21 ' A' ' 51' ' ' LEU . 10.4 pt -132.59 140.36 47.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.458 0.647 . . . . 0.0 110.978 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.679 HG13 HG22 ' A' ' 48' ' ' THR . 44.5 t -120.48 107.7 21.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.078 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.061 HG21 ' HA2' ' A' ' 139' ' ' GLY . 89.9 t -101.11 128.27 53.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.104 -172.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 1.5 p-10 -132.06 149.0 52.53 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.812 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.537 ' HA ' ' CE ' ' A' ' 36' ' ' MET . 3.5 mmt -143.08 122.77 13.33 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.341 1.026 . . . . 0.0 110.22 176.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.698 ' HB3' ' HB3' ' A' ' 44' ' ' ARG . 3.7 p-10 -118.44 134.2 55.26 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.131 0.894 . . . . 0.0 110.768 -176.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.44 ' N ' HD12 ' A' ' 131' ' ' LEU . 22.4 t30 -156.84 138.87 10.18 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -45.28 -35.61 11.56 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 124.447 3.431 . . . . 0.0 113.807 -178.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.576 HG21 ' O ' ' A' ' 124' ' ' ALA . 3.2 m -74.91 23.76 0.1 Allowed 'General case' 0 C--O 1.246 0.914 0 CA-C-O 122.148 0.975 . . . . 0.0 111.427 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.637 ' SG ' HD13 ' A' ' 131' ' ' LEU . 72.3 m -136.22 -52.73 0.73 Allowed 'General case' 0 C--N 1.312 -1.06 0 O-C-N 121.463 -0.773 . . . . 0.0 110.335 167.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.29 -29.11 2.31 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 24.9 t0 -157.28 -88.45 0.04 OUTLIER 'General case' 0 C--O 1.213 -0.82 0 CA-C-N 114.621 -0.79 . . . . 0.0 111.258 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.698 ' HB3' ' HB3' ' A' ' 37' ' ' ASN . 7.7 ptp85 179.63 -179.35 0.43 Allowed 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.036 0.446 . . . . 0.0 110.897 -169.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.661 HG22 ' HE1' ' A' ' 61' ' ' PHE . 19.5 pt -137.65 139.61 42.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.821 177.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.528 ' HD3' ' HD3' ' A' ' 44' ' ' ARG . 37.2 mmm-85 -114.03 100.69 8.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.494 0.664 . . . . 0.0 110.342 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.927 HD22 ' HG3' ' A' ' 49' ' ' MET . 0.8 OUTLIER -82.86 92.44 7.28 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.744 ' HB ' HD12 ' A' ' 28' ' ' LEU . 68.3 p -84.0 111.97 19.76 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.927 ' HG3' HD22 ' A' ' 47' ' ' LEU . 22.9 mtt -107.21 178.25 4.61 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.826 0.822 . . . . 0.0 111.298 -170.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 62.8 tttp -160.79 95.82 1.1 Allowed 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.743 HD21 HD11 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -119.56 84.52 2.22 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.852 -177.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.89 59.35 4.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.511 -164.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.92 -99.48 0.2 Allowed Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.804 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.428 ' C ' HG12 ' A' ' 85' ' ' ILE . 11.6 p-10 -133.37 24.47 4.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.466 0.65 . . . . 0.0 109.795 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.698 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.2 pp -139.66 152.91 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -99.83 121.17 50.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 169.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -104.15 -33.25 8.8 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.335 -169.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 6.9 t70 -140.17 143.02 35.9 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.417 -0.811 . . . . 0.0 108.86 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.58 ' HB1' HD21 ' A' ' 47' ' ' LEU . . . -167.74 101.74 0.48 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.79 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 47.7 mttp -115.32 167.53 10.78 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.058 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.661 ' HE1' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -124.41 131.28 53.5 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.627 0.727 . . . . 0.0 111.18 -174.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 10.3 tp10 -128.79 110.81 12.48 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.15 174.86 34.0 Favored Glycine 0 CA--C 1.493 -1.317 0 C-N-CA 119.325 -1.417 . . . . 0.0 113.486 -174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 1.3 tm-20 -147.74 132.25 17.7 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.95 -133.59 2.76 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.581 -171.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 21.2 p -110.03 172.81 6.64 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.662 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.7 t -74.16 -31.08 62.56 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.177 -165.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.738 HD11 ' SG ' ' A' ' 128' ' ' CYS . 2.7 pp -75.66 -24.57 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.148 0.499 . . . . 0.0 109.937 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 68' ' ' ILE . 13.1 m -78.86 -37.79 39.44 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 65.0 mtt -58.41 -33.0 69.17 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.779 0.799 . . . . 0.0 109.687 167.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.599 ' O ' ' HB3' ' A' ' 74' ' ' SER . . . -71.62 -38.1 70.83 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.999 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.804 ' HB2' HD11 ' A' ' 116' ' ' LEU . 41.7 t -59.98 -48.47 81.56 Favored 'General case' 0 C--O 1.219 -0.538 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.12 -41.33 78.81 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.815 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.599 ' HB3' ' O ' ' A' ' 71' ' ' ALA . 30.7 t -47.8 -67.59 0.26 Allowed 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.242 173.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.485 ' SD ' ' HA3' ' A' ' 111' ' ' GLY . 25.5 mmt -65.15 -32.42 74.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.925 0.393 . . . . 0.0 110.518 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.75 ' SD ' ' HG ' ' A' ' 47' ' ' LEU . 31.9 ttm -56.66 -61.72 2.23 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.593 175.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.2 p -60.08 -27.62 67.14 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -90.02 -31.63 17.11 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.308 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.11 -41.22 15.92 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.299 0.571 . . . . 0.0 111.059 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 80' ' ' ILE . 14.7 mm -76.66 -39.71 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.443 -174.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.535 ' HD3' ' H ' ' A' ' 59' ' ' ALA . 3.0 mmmp? -52.56 -18.74 1.87 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 120.471 -0.492 . . . . 0.0 112.217 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.01 54.9 0.78 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.014 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.449 ' HD2' ' HB ' ' A' ' 87' ' ' THR . 12.0 tppt? -133.3 169.45 16.89 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -114.28 -174.03 2.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 173.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.489 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 18.4 mm -85.49 -33.31 7.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.963 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -63.4 -46.42 86.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.198 0.523 . . . . 0.0 110.92 175.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 83' ' ' LYS . 0.9 OUTLIER -67.96 -37.61 81.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.352 178.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.917 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -64.18 -43.21 95.84 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.101 0.477 . . . . 0.0 111.37 175.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 70.9 mt -67.1 -35.54 80.01 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.318 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 p -73.03 -35.2 66.72 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.933 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.0 ttt -70.03 -22.58 63.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.875 0.845 . . . . 0.0 111.718 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.509 ' OG ' ' HA ' ' A' ' 142' ' ' LYS . 49.4 p -89.06 -36.59 15.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.874 ' HB2' ' HA ' ' A' ' 143' ' ' GLU . 87.1 tttt -66.8 -37.02 83.73 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 1.053 HD13 ' HA ' ' A' ' 105' ' ' ASP . 12.8 mt -67.74 -47.27 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.355 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.549 ' CE2' HG12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -55.95 -24.88 40.88 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 123.934 0.771 . . . . 0.0 110.04 177.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 25.4 m -81.71 -43.07 18.97 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.993 -0.442 . . . . 0.0 110.824 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -75.96 -29.19 58.2 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -173.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.8 ptm -54.31 -10.0 0.34 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.956 0.902 . . . . 0.0 112.307 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 95.6 mmm -100.1 -7.77 24.51 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.926 0.87 . . . . 0.0 109.241 -166.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -134.68 -22.74 1.65 Allowed 'General case' 0 C--O 1.245 0.852 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.688 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -107.54 -23.49 6.87 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 119.207 -0.774 . . . . 0.0 112.302 -177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 22.3 tptm 81.48 -18.54 0.48 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.08 1.352 . . . . 0.0 109.692 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -77.91 149.15 34.28 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.41 ' HB2' ' H ' ' A' ' 105' ' ' ASP . 3.5 p90 -137.03 -134.03 0.14 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -171.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 1.053 ' HA ' HD13 ' A' ' 94' ' ' ILE . 9.0 t70 -90.66 108.79 20.04 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.125 0.964 . . . . 0.0 109.33 -169.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -58.5 -2.86 0.23 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.384 -1.28 . . . . 0.0 113.284 173.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.532 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 1.5 m -89.79 -24.82 21.37 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 170.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 108' ' ' ILE . 22.7 mm 72.91 25.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-O 122.421 1.105 . . . . 0.0 110.703 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -94.89 70.03 3.36 Favored 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 121.618 -0.676 . . . . 0.0 109.952 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.839 ' HG ' HD12 ' A' ' 113' ' ' ILE . 6.1 mp -104.35 14.11 30.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.285 -169.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.485 ' HA3' ' SD ' ' A' ' 75' ' ' MET . . . -44.78 -39.26 6.07 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 119.857 -0.413 . . . . 0.0 113.849 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.09 -45.42 23.49 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-O 122.367 1.08 . . . . 0.0 109.906 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.839 HD12 ' HG ' ' A' ' 110' ' ' LEU . 36.8 mt -58.25 -28.95 36.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.902 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 8.2 mm-40 -76.27 -54.5 6.7 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.282 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.45 -41.45 69.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.3 176.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.804 HD11 ' HB2' ' A' ' 72' ' ' SER . 6.6 mp -96.04 -6.77 37.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.566 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 6.4 tt0 -45.53 -51.44 11.82 Favored 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.178 0.923 . . . . 0.0 110.853 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.48 -18.79 77.32 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.375 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 68' ' ' ILE . 60.2 t -78.29 -60.25 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 O-C-N 122.056 -0.673 . . . . 0.0 111.606 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 129' ' ' ALA . 14.5 p -50.93 -16.06 0.38 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.338 -1.301 . . . . 0.0 114.141 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.987 ' HA ' ' HE2' ' A' ' 121' ' ' LYS . 8.9 mmpt? -99.66 -16.73 18.09 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.492 -0.755 . . . . 0.0 110.822 -163.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -90.4 135.14 29.9 Favored Pre-proline 0 N--CA 1.443 -0.794 0 O-C-N 123.833 0.708 . . . . 0.0 109.819 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.0 -27.48 21.36 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.323 2.682 . . . . 0.0 111.78 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.576 ' O ' HG21 ' A' ' 40' ' ' THR . . . -84.34 -27.75 27.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.556 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.527 ' HB3' HG13 ' A' ' 119' ' ' VAL . 30.5 mtm180 -113.9 17.76 17.75 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.775 -166.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.7 tt -84.9 -29.74 6.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.03 -17.78 45.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.778 -1.556 . . . . 0.0 107.999 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.738 ' SG ' HD11 ' A' ' 68' ' ' ILE . 54.1 t -84.34 -19.62 33.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.757 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.577 ' O ' ' HB3' ' A' ' 133' ' ' TRP . . . -85.78 -27.73 25.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.533 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.64 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 16.6 p -78.31 -35.84 47.26 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.637 HD13 ' SG ' ' A' ' 41' ' ' CYS . 10.0 tt -51.42 -54.17 29.43 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.225 172.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.512 ' HB2' HD21 ' A' ' 116' ' ' LEU . 35.9 m -81.88 -62.25 1.69 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -174.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.577 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 1.2 t90 -62.49 -50.43 71.44 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 120.943 0.401 . . . . 0.0 111.849 -175.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.64 ' HB3' ' O ' ' A' ' 130' ' ' THR . 37.7 ttpt -62.65 -29.34 70.56 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.608 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 132' ' ' SER . . . -56.89 -31.02 64.45 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 169.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.5 mp -80.55 -35.17 34.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.421 ' OE1' ' HD2' ' A' ' 142' ' ' LYS . 7.5 mm-40 -61.65 -43.85 98.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.422 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -91.25 5.51 48.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.361 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 1.061 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -85.79 -39.99 7.87 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -177.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.917 HG21 ' HB1' ' A' ' 88' ' ' ALA . 20.1 m -127.06 -9.45 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 O-C-N 122.091 -0.653 . . . . 0.0 110.543 -177.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 91.78 152.39 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.184 1.393 . . . . 0.0 108.425 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.509 ' HA ' ' OG ' ' A' ' 92' ' ' SER . 14.9 pttp -114.44 142.66 46.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -171.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.874 ' HA ' ' HB2' ' A' ' 93' ' ' LYS . 33.4 mt-10 65.81 -88.66 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.242 0.964 . . . . 0.0 111.861 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -107.94 107.5 18.24 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 123.587 0.554 . . . . 0.0 110.585 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -69.95 80.62 0.35 Allowed Glycine 0 CA--C 1.508 -0.35 0 O-C-N 123.906 0.754 . . . . 0.0 112.116 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.76 158.48 17.41 Favored Glycine 0 CA--C 1.506 -0.512 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.08 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 C--N 1.323 -0.569 0 O-C-N 122.286 -0.537 . . . . 0.0 110.287 179.408 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.869 0.366 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 m -66.82 -61.11 2.12 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.115 0.483 . . . . 0.0 110.279 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -137.39 -57.93 0.7 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.7 m120 64.93 152.71 0.05 Allowed 'General case' 0 N--CA 1.477 0.879 0 O-C-N 125.054 1.471 . . . . 0.0 112.134 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.84 93.14 6.49 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.272 0.558 . . . . 0.0 110.157 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.33 -82.14 0.5 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.532 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.506 HD11 ' O ' ' A' ' 115' ' ' ALA . 12.7 tp -137.54 0.28 2.25 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.983 0.897 . . . . 0.0 109.116 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.51 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -55.81 -63.53 1.14 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 125.348 1.459 . . . . 0.0 111.467 -178.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -62.7 -35.14 78.73 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.718 178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.517 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 4.1 mm? -53.97 -39.52 66.07 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.103 174.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.879 ' HE1' HG22 ' A' ' 68' ' ' ILE . 22.7 m-85 -63.08 -57.71 9.71 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 121.52 0.676 . . . . 0.0 109.848 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.654 ' HA ' HG22 ' A' ' 15' ' ' ILE . 47.3 mtm180 -69.44 -18.92 63.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.03 -169.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.419 ' HA ' ' OE1' ' A' ' 13' ' ' GLN . 16.3 mm-40 -86.62 -35.86 19.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.685 1.231 . . . . 0.0 108.02 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.621 HG21 ' HB2' ' A' ' 115' ' ' ALA . 0.3 OUTLIER -80.1 -34.19 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.964 -175.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.654 HG22 ' HA ' ' A' ' 12' ' ' ARG . 10.5 tt -82.62 -19.1 10.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.683 175.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.613 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 17.2 tpt -61.73 -43.87 98.02 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.859 0.838 . . . . 0.0 110.388 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.02 -41.71 63.95 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.059 177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -61.82 -28.23 69.33 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.774 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -66.84 -55.64 13.93 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.104 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -48.57 -38.35 20.38 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 124.039 0.837 . . . . 0.0 110.812 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -114.08 86.3 11.32 Favored Pre-proline 0 C--N 1.32 -0.676 0 O-C-N 123.426 0.454 . . . . 0.0 110.478 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.57 45.97 2.01 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.529 2.153 . . . . 0.0 114.038 -172.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.33 102.15 11.58 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.083 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -142.24 25.93 1.86 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.151 0.977 . . . . 0.0 108.366 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -132.09 124.46 29.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.224 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.764 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 155.28 146.94 4.56 Favored Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.713 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -165.39 93.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.873 0 O-C-N 124.619 0.835 . . . . 0.0 109.25 177.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.579 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -116.75 139.2 50.84 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 120.68 -1.263 . . . . 0.0 111.721 -175.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.512 ' HA ' HG21 ' A' ' 33' ' ' VAL . 58.1 t30 -81.24 81.34 7.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.627 172.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.555 ' HB2' HD13 ' A' ' 28' ' ' LEU . 10.3 t70 -101.48 -125.86 0.19 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.667 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.4 t -66.66 -64.92 0.75 Allowed 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.668 -0.645 . . . . 0.0 110.376 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.615 HG13 ' HB2' ' A' ' 49' ' ' MET . 34.4 pt -125.65 135.28 64.43 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.713 176.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.948 HG13 HG22 ' A' ' 48' ' ' THR . 84.9 t -116.16 138.11 47.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.917 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.764 HG21 ' HA2' ' A' ' 139' ' ' GLY . 98.1 t -127.95 124.65 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -120.41 136.91 54.58 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.35 0.119 . . . . 0.0 111.061 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.577 ' HG3' HD12 ' A' ' 131' ' ' LEU . 47.9 tpp -151.55 123.48 8.09 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 120.826 0.346 . . . . 0.0 110.98 175.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 7.6 p30 -127.64 150.35 49.78 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.573 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -109.93 98.2 33.05 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.51 -11.62 32.79 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.596 2.864 . . . . 0.0 113.278 -171.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.4 m -75.85 -30.9 59.08 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.544 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.2 p -131.12 -12.67 3.59 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.43 3.78 58.49 Favored Glycine 0 C--N 1.343 0.957 0 C-N-CA 119.317 -1.42 . . . . 0.0 113.538 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -70.15 115.5 9.42 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 18.8 ptp180 -127.83 141.08 51.67 Favored 'General case' 0 C--O 1.248 1.018 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 62' ' ' GLU . 31.6 pt -141.34 149.84 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.287 0.565 . . . . 0.0 110.172 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.732 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 50.5 mtt180 -140.51 107.64 5.48 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.957 -0.464 . . . . 0.0 111.525 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.709 HD22 ' HG3' ' A' ' 49' ' ' MET . 0.7 OUTLIER -93.66 89.67 6.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.948 HG22 HG13 ' A' ' 33' ' ' VAL . 67.4 p -88.02 128.5 35.4 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 173.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.709 ' HG3' HD22 ' A' ' 47' ' ' LEU . 30.5 mtt -113.67 -179.21 3.57 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.275 1.036 . . . . 0.0 112.92 -170.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.838 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 45.3 tttp -159.87 98.7 1.36 Allowed 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.619 ' H ' HD23 ' A' ' 51' ' ' LEU . 2.3 pt? -126.48 93.12 3.71 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -172.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -99.17 59.92 1.17 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.374 -0.93 . . . . 0.0 109.731 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 148.77 -96.21 0.17 Allowed Glycine 0 C--N 1.316 -0.548 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.43 18.93 6.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -176.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 2.4 pp -140.54 167.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 p -116.2 116.81 53.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 168.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' HB2' HD13 ' A' ' 55' ' ' ILE . 23.5 tt0 -106.58 -27.63 10.75 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.033 0.921 . . . . 0.0 109.95 -166.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.838 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 28.0 t70 -140.73 144.68 35.7 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 48' ' ' THR . . . -160.36 118.04 2.53 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.764 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 34.2 mmtp -107.25 130.41 54.75 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.732 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.7 p90 -129.01 147.28 50.86 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.35 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 42.2 tt0 -107.16 138.46 43.29 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.42 120.13 1.54 Allowed Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.637 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 44' ' ' ARG . 7.9 pt-20 -163.15 106.63 1.04 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.15 -131.4 1.87 Allowed Glycine 0 C--O 1.236 0.24 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.904 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.7 m -77.21 173.67 11.6 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.8 m -89.87 17.31 6.84 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.795 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.879 HG22 ' HE1' ' A' ' 11' ' ' TYR . 2.7 pp -119.05 -45.13 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.393 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.514 ' N ' HD12 ' A' ' 68' ' ' ILE . 13.8 p -73.27 -46.18 51.34 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.798 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -27.25 64.43 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.172 177.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.0 -59.26 2.39 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.632 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.667 ' CB ' ' HB2' ' A' ' 116' ' ' LEU . 21.7 p -67.62 -45.84 74.22 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.437 -168.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.04 -53.81 50.33 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 120.901 0.381 . . . . 0.0 110.345 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.1 t -60.16 -35.33 75.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.414 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.416 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 17.9 tpt -67.78 -54.82 16.17 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.551 0.691 . . . . 0.0 110.349 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.431 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -62.98 -33.52 75.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.205 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.616 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 24.3 p -72.61 -39.43 67.3 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.348 0.594 . . . . 0.0 110.651 177.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.416 ' HB3' ' O ' ' A' ' 75' ' ' MET . 28.1 tt0 -53.25 -38.05 62.65 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.586 171.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.98 -27.83 24.61 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.762 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -73.56 -36.83 48.69 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.771 0 O-C-N 124.359 1.037 . . . . 0.0 110.152 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 55.5 tttm -56.35 -17.51 8.07 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.848 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.95 42.59 1.79 Allowed Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.29 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm -134.53 -153.04 0.5 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.698 0.761 . . . . 0.0 111.875 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -145.78 155.88 43.23 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 -167.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.637 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.6 mp -63.31 -49.75 81.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 O-C-N 123.342 0.401 . . . . 0.0 110.079 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.26 -38.73 82.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.863 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.522 ' O ' ' HG2' ' A' ' 91' ' ' MET . 4.8 m -68.35 -35.04 77.16 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 121.497 0.665 . . . . 0.0 110.428 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' A' ' 141' ' ' ALA . . . -60.5 -41.88 95.21 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 173.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 32.8 mt -67.36 -31.83 72.35 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.287 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.441 ' O ' HG13 ' A' ' 94' ' ' ILE . 5.1 p -77.96 -29.63 49.93 Favored 'General case' 0 C--N 1.317 -0.835 0 O-C-N 121.66 -0.65 . . . . 0.0 111.76 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' A' ' 87' ' ' THR . 22.1 mmt -75.66 -18.91 59.5 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.09 0.948 . . . . 0.0 110.846 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p -90.08 -31.47 17.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.142 -1.39 . . . . 0.0 107.377 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.85 -37.96 79.46 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.66 172.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.447 HD12 ' SD ' ' A' ' 91' ' ' MET . 35.9 mt -62.23 -48.85 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 171.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.485 ' HD1' HG12 ' A' ' 113' ' ' ILE . 49.9 t80 -43.39 -35.91 1.73 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.471 0.653 . . . . 0.0 111.745 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.2 m -85.08 -35.51 21.78 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 121.686 -0.634 . . . . 0.0 111.454 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -84.3 -20.09 32.69 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.05 0.929 . . . . 0.0 112.3 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.46 ' CG ' ' HB3' ' A' ' 104' ' ' TYR . 2.1 tmt? -73.34 -13.07 61.04 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.233 -174.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.1 mmt -95.24 6.15 49.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.556 -160.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -103.97 16.85 25.35 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.5 30.25 74.85 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.509 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 102' ' ' LYS . 7.3 mmpt? -102.7 -170.92 1.87 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.816 0.308 . . . . 0.0 110.211 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.59 156.86 33.87 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.503 ' HD2' ' H ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -124.64 -101.2 0.39 Allowed 'General case' 0 C--N 1.316 -0.883 0 O-C-N 123.717 0.636 . . . . 0.0 111.035 -178.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.636 ' HB3' HD11 ' A' ' 110' ' ' LEU . 15.4 t0 -116.14 107.26 14.67 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 123.742 0.651 . . . . 0.0 109.373 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.76 -2.01 1.6 Allowed 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.959 0.787 . . . . 0.0 111.531 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.587 ' O ' HG22 ' A' ' 108' ' ' ILE . 2.1 m -89.34 -15.8 32.54 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 172.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.587 HG22 ' O ' ' A' ' 107' ' ' SER . 4.3 tp 68.59 15.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.068 0.947 . . . . 0.0 113.512 165.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -92.73 88.68 6.34 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.636 HD11 ' HB3' ' A' ' 105' ' ' ASP . 10.8 mp -127.0 43.75 3.05 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.037 -168.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -38.64 -44.87 1.89 Allowed Glycine 0 CA--C 1.539 1.543 0 CA-C-N 115.579 -0.737 . . . . 0.0 114.91 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.609 ' O ' ' HB3' ' A' ' 116' ' ' LEU . 16.1 p-10 -90.45 -41.53 11.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.52 1.152 . . . . 0.0 109.99 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.74 ' O ' ' HB2' ' A' ' 117' ' ' GLN . 50.7 mt -69.47 -27.49 34.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.591 -172.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -86.98 -69.59 0.67 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.396 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.621 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -63.52 -39.39 94.31 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -172.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.667 ' HB2' ' CB ' ' A' ' 72' ' ' SER . 48.4 tp -99.74 3.08 44.77 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.648 0.737 . . . . 0.0 111.17 -169.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.74 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 8.2 tt0 -63.48 -45.79 89.15 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.536 0.684 . . . . 0.0 110.445 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.95 -17.23 65.14 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 113.91 -1.495 . . . . 0.0 113.014 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.932 HG13 ' HG2' ' A' ' 125' ' ' ARG . 97.9 t -82.09 -40.78 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 121.765 0.793 . . . . 0.0 110.186 -169.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.533 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 16.4 t -42.98 -13.23 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 113.561 -1.654 . . . . 0.0 115.393 174.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.458 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 10.2 ptmt -142.93 -0.37 1.16 Allowed 'General case' 0 C--O 1.243 0.725 0 O-C-N 121.003 -1.061 . . . . 0.0 113.041 -162.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.671 ' HB2' ' HB3' ' A' ' 125' ' ' ARG . 30.0 m-85 -81.09 123.6 81.75 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 168.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -51.05 -28.79 25.76 Favored 'Trans proline' 0 C--O 1.218 -0.514 0 C-N-CA 123.347 2.698 . . . . 0.0 112.652 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.49 -0.11 32.81 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.216 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.932 ' HG2' HG13 ' A' ' 119' ' ' VAL . 33.0 ttm180 -126.08 6.02 7.19 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.393 -175.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.7 tt -80.73 -25.34 11.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.244 -171.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -76.8 -20.11 56.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.389 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.414 ' HB3' HD11 ' A' ' 68' ' ' ILE . 61.0 m -86.3 -19.33 30.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.228 174.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.582 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -72.62 -46.9 51.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.147 176.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.694 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 7.5 p -69.99 -37.58 75.76 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.577 HD12 ' HG3' ' A' ' 36' ' ' MET . 18.0 tp -46.38 -55.68 6.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.077 -0.389 . . . . 0.0 111.494 171.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.463 ' HB2' HD21 ' A' ' 116' ' ' LEU . 6.7 m -83.42 -55.87 4.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.812 0.339 . . . . 0.0 111.203 -171.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 6.4 t90 -63.47 -50.56 69.21 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.746 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.694 ' HB3' ' O ' ' A' ' 130' ' ' THR . 3.1 tppp? -60.65 -42.31 96.7 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.19 -41.13 78.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.937 0.399 . . . . 0.0 111.581 173.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.401 HD21 ' CG ' ' A' ' 76' ' ' MET . 17.0 tp -73.97 -32.43 63.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.416 0.627 . . . . 0.0 110.173 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' A' ' 141' ' ' ALA . 39.4 tt0 -69.55 -37.37 77.03 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.5 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.476 ' NZ ' ' HB3' ' A' ' 138' ' ' LYS . 9.6 mtpm? -87.64 10.63 17.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.695 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.764 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -94.82 -40.96 4.23 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.8 p -178.13 -44.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.694 ' O ' ' HA ' ' A' ' 137' ' ' GLU . . . -82.97 100.61 10.54 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.435 ' HA ' ' HG3' ' A' ' 137' ' ' GLU . 13.4 ptmm? -142.91 28.29 1.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.102 0.477 . . . . 0.0 110.587 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 59.12 -167.28 0.16 Allowed 'General case' 0 C--N 1.353 0.759 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.9 -171.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -93.81 -53.28 4.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.29 -89.76 0.12 Allowed Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.123 172.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.94 -133.8 13.52 Favored Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 C--N 1.317 -0.83 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.278 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 ttm . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 110.706 -0.109 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -79.88 119.38 22.67 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-O 121.304 0.573 . . . . 0.0 111.485 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -119.75 87.79 2.81 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -108.13 111.01 22.81 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.074 0.464 . . . . 0.0 110.063 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.83 -34.03 0.32 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.566 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -41.69 -33.44 0.48 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.275 1.03 . . . . 0.0 113.198 175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' A' ' 10' ' ' LEU . 28.3 tp -105.5 -16.6 14.68 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.008 -0.433 . . . . 0.0 110.443 -168.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 30.4 t70 -56.53 -54.18 48.84 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.825 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.3 m -59.93 -42.25 93.58 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.536 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.669 ' HB2' HD12 ' A' ' 7' ' ' LEU . 70.0 mt -59.08 -36.41 75.04 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.835 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.555 ' O ' HG12 ' A' ' 15' ' ' ILE . 8.3 m-85 -63.92 -54.75 29.77 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.194 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 16' ' ' MET . 28.0 mtt85 -56.23 -37.33 69.58 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.86 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -75.49 -37.61 60.07 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.261 0.35 . . . . 0.0 110.868 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 t -76.93 -34.62 22.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.937 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 11' ' ' TYR . 29.0 pt -77.91 -18.44 13.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 121.813 -0.555 . . . . 0.0 109.804 174.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 45.7 ttm -69.04 -47.41 65.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -61.05 -46.41 90.82 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.733 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 15' ' ' ILE . 58.9 t-80 -51.61 -45.86 63.37 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.251 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -66.72 -49.12 67.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.387 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -44.61 -41.38 6.54 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.238 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -131.73 81.05 64.6 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-O 121.407 0.622 . . . . 0.0 109.505 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -88.72 94.99 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.078 2.519 . . . . 0.0 112.875 -171.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -161.17 115.05 2.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.009 174.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.628 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 13.8 m120 -113.16 24.76 11.99 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.32 101.04 10.44 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.972 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.688 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -168.65 120.44 0.89 Allowed Glycine 0 CA--C 1.494 -1.237 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 175.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.738 HG21 ' HE ' ' A' ' 46' ' ' ARG . 2.4 p -167.88 105.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 O-C-N 121.185 -1.186 . . . . 0.0 110.982 -174.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.524 ' H ' ' CB ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -87.55 -155.36 0.29 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.396 0.617 . . . . 0.0 110.155 173.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.59 ' HA ' HG21 ' A' ' 33' ' ' VAL . 3.8 p-10 -166.42 13.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.357 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -99.42 -71.18 0.7 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.804 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.709 ' HB3' ' O ' ' A' ' 49' ' ' MET . 11.3 t -73.19 -143.98 0.02 OUTLIER 'General case' 0 C--O 1.238 0.486 0 O-C-N 123.157 0.286 . . . . 0.0 110.649 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.817 HG13 ' HB2' ' A' ' 49' ' ' MET . 27.9 pt -78.78 119.98 28.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.683 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.001 HG13 HG22 ' A' ' 48' ' ' THR . 79.9 t -119.2 135.02 60.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.257 -177.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.765 HG21 ' HA2' ' A' ' 139' ' ' GLY . 78.9 t -123.52 119.63 57.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -176.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -120.65 118.71 30.82 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.051 0.219 . . . . 0.0 110.766 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.515 ' HA ' ' HE2' ' A' ' 36' ' ' MET . 3.4 mmt -144.51 121.17 11.15 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.15 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 3.1 p30 -120.09 158.65 26.43 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 172.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.624 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 25.9 t30 -114.46 100.07 52.38 Favored Pre-proline 0 N--CA 1.44 -0.934 0 CA-C-O 121.384 0.611 . . . . 0.0 109.816 -178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -58.12 -19.34 40.87 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 123.157 2.571 . . . . 0.0 113.113 -173.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 60.1 m -62.91 -43.92 97.49 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.8 p -133.0 8.67 4.09 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.06 6.9 78.33 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.477 163.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.624 ' OD1' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -82.3 146.4 29.45 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.216 0.531 . . . . 0.0 110.153 176.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 52.3 ttt180 -139.71 148.32 42.16 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.622 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.7 tt -140.18 146.61 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 O-C-N 123.536 0.523 . . . . 0.0 110.12 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.738 ' HE ' HG21 ' A' ' 27' ' ' VAL . 75.4 mtp85 -141.17 100.38 3.79 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.241 0.543 . . . . 0.0 110.326 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.717 HD22 ' HG3' ' A' ' 49' ' ' MET . 0.3 OUTLIER -89.99 92.17 8.88 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.48 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 1.001 HG22 HG13 ' A' ' 33' ' ' VAL . 77.7 p -93.23 130.64 38.86 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.553 -0.717 . . . . 0.0 109.79 174.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.817 ' HB2' HG13 ' A' ' 32' ' ' ILE . 36.9 mtt -126.92 -177.7 4.13 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 121.819 -0.55 . . . . 0.0 110.815 -172.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' A' ' 52' ' ' ASP . 10.5 tmtt? -160.61 110.93 1.78 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.564 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 2.5 pt? -128.57 94.3 3.84 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.942 0.877 . . . . 0.0 108.939 -170.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.503 ' HB2' ' HZ3' ' A' ' 50' ' ' LYS . 37.4 t70 -101.89 59.84 0.85 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.759 0.79 . . . . 0.0 109.951 -171.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.83 -94.82 0.16 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 170.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -133.77 24.71 4.0 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.437 ' O ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -139.48 160.13 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -173.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -95.68 97.12 6.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 123.485 1.612 . . . . 0.0 106.999 165.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 50' ' ' LYS . 37.8 tt0 -66.44 -41.88 88.46 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 112.509 -2.132 . . . . 0.0 110.189 -167.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -148.72 146.53 28.14 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.561 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.33 121.93 11.11 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.688 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 89.4 mttt -126.06 140.86 52.25 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.704 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.642 ' CZ ' ' HA ' ' A' ' 74' ' ' SER . 31.2 p90 -128.22 143.39 51.03 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 120.972 0.415 . . . . 0.0 110.575 -172.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 45.7 tt0 -117.05 114.02 23.16 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.482 ' H ' ' HB3' ' A' ' 24' ' ' ASN . . . -121.38 128.66 7.42 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.265 -173.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -148.21 108.45 4.1 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 43' ' ' ASP . . . 170.84 -132.4 2.47 Favored Glycine 0 C--N 1.317 -0.523 0 C-N-CA 119.363 -1.398 . . . . 0.0 112.584 -174.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 70' ' ' MET . 1.4 p -95.37 159.25 15.09 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 120.753 0.311 . . . . 0.0 110.261 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.9 t -78.75 24.9 0.28 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.467 -167.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -118.19 -52.67 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-O 122.386 1.089 . . . . 0.0 109.652 179.022 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.631 ' HB3' HD22 ' A' ' 131' ' ' LEU . 1.2 m -77.23 -44.29 30.49 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-O 121.781 0.801 . . . . 0.0 111.098 -170.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 66' ' ' CYS . 26.9 ptm -72.16 -12.84 61.37 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.392 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.81 -45.98 11.08 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.071 -0.393 . . . . 0.0 111.379 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 p -62.62 -28.36 69.85 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 121.41 0.624 . . . . 0.0 109.849 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.61 -50.38 67.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.463 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.642 ' HA ' ' CZ ' ' A' ' 61' ' ' PHE . 24.3 m -59.64 -39.25 83.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.477 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -76.49 -58.61 3.18 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.829 -174.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.609 ' SD ' ' HB ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -59.34 -34.0 71.83 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.817 -177.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 1.055 ' HA ' HG22 ' A' ' 80' ' ' ILE . 98.9 m -61.97 -43.18 99.37 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.088 0.858 . . . . 0.0 110.1 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' MET . 77.5 mt-30 -49.45 -37.01 24.34 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.773 0.797 . . . . 0.0 110.535 172.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.509 ' HB1' ' OD2' ' A' ' 109' ' ' ASP . . . -86.26 -31.84 21.44 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.682 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.055 HG22 ' HA ' ' A' ' 77' ' ' THR . 9.9 tp -83.24 -40.17 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.054 -173.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -54.34 -17.29 2.84 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.927 0.87 . . . . 0.0 111.346 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.26 40.88 2.12 Favored Glycine 0 C--N 1.31 -0.895 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -132.78 167.05 20.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -103.98 -177.06 3.26 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.681 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.4 mp -81.77 -45.37 20.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.21 -176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -58.36 -43.45 88.4 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.37 0.419 . . . . 0.0 111.099 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.536 ' HA ' ' OG ' ' A' ' 90' ' ' SER . 2.7 p -68.84 -37.65 79.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.389 0.614 . . . . 0.0 111.508 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.411 ' HB1' HG13 ' A' ' 140' ' ' VAL . . . -60.89 -40.52 93.37 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.863 175.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.841 HD22 ' HB3' ' A' ' 142' ' ' LYS . 34.0 mt -69.58 -37.5 76.97 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 110.819 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 87' ' ' THR . 2.3 p -75.43 -35.24 61.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.072 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.512 ' HA ' HG22 ' A' ' 94' ' ' ILE . 11.2 tmm? -64.94 -20.85 66.68 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 121.778 0.799 . . . . 0.0 109.185 173.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.796 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 43.6 t -85.35 -42.96 14.1 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 114.297 -1.319 . . . . 0.0 107.577 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.643 ' HA ' ' HG3' ' A' ' 143' ' ' GLU . 54.3 tttp -67.42 -36.25 80.87 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.329 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 90' ' ' SER . 9.1 tt -79.73 -39.77 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.087 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -46.19 -38.63 8.57 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.44 0.638 . . . . 0.0 111.247 170.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.5 m -86.66 -28.23 23.29 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.44 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -71.77 -21.57 61.71 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.052 0.541 . . . . 0.0 111.0 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -41.94 -47.27 4.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.673 0.789 . . . . 0.0 112.513 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.1 ttt -55.08 -18.24 5.14 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -129.3 -26.46 2.56 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.492 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.47 -40.17 4.26 Favored Glycine 0 N--CA 1.433 -1.566 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.512 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp 87.85 37.48 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.449 ' HB3' HD11 ' A' ' 94' ' ' ILE . 39.7 mt-10 -132.45 126.96 34.27 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 112.562 -2.108 . . . . 0.0 107.219 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.575 ' CD1' HD21 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -94.59 -89.73 0.23 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.462 ' HB3' HD12 ' A' ' 110' ' ' LEU . 5.3 t70 -115.02 112.64 22.96 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 156.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.466 ' H ' HD13 ' A' ' 94' ' ' ILE . 30.9 t70 -49.89 -21.81 1.29 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.775 173.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.459 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 1.3 m -80.11 -17.13 53.4 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.487 ' HA ' HD13 ' A' ' 110' ' ' LEU . 21.9 mm 72.23 24.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 122.507 1.146 . . . . 0.0 110.492 174.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.509 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 27.6 t70 -95.17 66.77 2.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.055 177.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.807 ' HG ' ' HB ' ' A' ' 113' ' ' ILE . 7.8 mp -95.94 40.32 1.12 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.127 -165.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.444 ' HA2' ' SD ' ' A' ' 75' ' ' MET . . . -38.31 -50.75 2.28 Favored Glycine 0 C--O 1.242 0.594 0 O-C-N 124.066 0.854 . . . . 0.0 114.145 177.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.634 ' HB2' HD22 ' A' ' 116' ' ' LEU . 8.5 p-10 -91.59 -43.38 9.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.8 -0.824 . . . . 0.0 110.238 176.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.807 ' HB ' ' HG ' ' A' ' 110' ' ' LEU . 16.4 mt -62.93 -33.3 59.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.575 -166.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.496 ' HG2' HD22 ' A' ' 10' ' ' LEU . 31.8 tt0 -61.98 -50.83 70.52 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 119' ' ' VAL . . . -69.68 -53.37 18.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.933 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.634 HD22 ' HB2' ' A' ' 112' ' ' ASP . 3.9 mp -82.72 -2.7 54.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -164.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -62.79 -39.32 93.87 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.52 -17.19 64.62 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.864 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.872 HG13 ' HB3' ' A' ' 125' ' ' ARG . 91.8 t -86.17 -46.94 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -171.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.598 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 9.4 t -49.56 -10.16 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.492 -1.231 . . . . 0.0 113.63 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.839 ' HA ' ' HE3' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -134.0 -17.41 2.15 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.365 -160.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -88.63 130.06 46.63 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.56 -30.61 55.44 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 122.433 2.089 . . . . 0.0 112.276 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.25 1.75 56.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.255 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.872 ' HB3' HG13 ' A' ' 119' ' ' VAL . 27.9 mmt180 -134.92 8.01 3.49 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 118.61 0.641 . . . . 0.0 110.422 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.2 tt -84.34 -30.07 7.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -165.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.51 ' HB3' ' ND2' ' A' ' 38' ' ' ASN . 31.8 mmtp -74.99 -30.49 61.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.999 174.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 90.2 m -78.62 -17.64 55.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.023 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.598 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -78.38 -31.4 48.38 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.92 -179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.764 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 25.3 m -72.11 -44.47 63.15 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 69' ' ' SER . 9.5 tt -50.2 -63.59 1.07 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.636 174.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.544 ' HB2' HD21 ' A' ' 116' ' ' LEU . 13.5 p -74.59 -63.49 1.23 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.985 -171.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.5 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 4.7 t90 -66.38 -56.34 11.54 Favored 'General case' 0 C--O 1.21 -1.014 0 C-N-CA 122.58 0.352 . . . . 0.0 111.219 -175.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.764 ' HB3' ' O ' ' A' ' 130' ' ' THR . 24.1 tptm -56.6 -40.08 74.66 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 123.992 0.808 . . . . 0.0 110.184 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.1 -32.95 73.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.567 HD21 ' SD ' ' A' ' 76' ' ' MET . 15.7 tp -78.22 -33.8 49.65 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.018 0.914 . . . . 0.0 109.217 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 141' ' ' ALA . 3.5 tp10 -68.82 -41.11 79.03 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 122.844 1.307 . . . . 0.0 109.395 175.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -85.37 13.71 6.29 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 113.965 -1.47 . . . . 0.0 109.907 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.765 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -95.87 -32.95 6.57 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.569 -177.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.411 HG13 ' HB1' ' A' ' 88' ' ' ALA . 9.3 p -171.34 -28.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.796 ' HB1' ' HB2' ' A' ' 92' ' ' SER . . . -63.76 177.3 0.75 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 123.713 0.633 . . . . 0.0 110.438 173.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.841 ' HB3' HD22 ' A' ' 89' ' ' LEU . 86.0 tttt 177.76 -29.84 0.0 OUTLIER 'General case' 0 C--O 1.237 0.421 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -170.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.643 ' HG3' ' HA ' ' A' ' 93' ' ' LYS . 26.1 tt0 65.76 -76.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.816 0.341 . . . . 0.0 110.605 -172.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -172.42 123.38 0.47 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.929 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -156.63 -120.89 0.67 Allowed Glycine 0 C--O 1.242 0.613 0 C-N-CA 119.815 -1.183 . . . . 0.0 111.882 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.48 -126.44 4.44 Favored Glycine 0 C--O 1.244 0.769 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.925 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 44.8 t30 . . . . . 0 N--CA 1.47 0.551 0 CA-C-O 120.987 0.422 . . . . 0.0 110.983 179.519 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 C--O 1.245 0.852 0 CA-C-O 120.417 0.151 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -77.82 79.41 4.3 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -82.82 -32.71 27.47 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -75.97 73.31 2.86 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 6' ' ' ASN . . . -169.92 -60.04 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 124.206 1.003 . . . . 0.0 109.374 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 6.6 t30 72.73 21.41 3.45 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 122.071 0.939 . . . . 0.0 109.786 172.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.823 HD21 HG21 ' A' ' 68' ' ' ILE . 15.8 tp -102.11 -20.18 14.84 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.426 -171.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 18.6 t70 -52.76 -54.51 32.91 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.59 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -49.64 -40.49 39.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.545 175.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.5 HD11 ' HB3' ' A' ' 114' ' ' GLU . 2.7 mm? -65.74 -39.19 90.85 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.895 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.501 ' HE1' ' HB2' ' A' ' 67' ' ' SER . 41.3 m-85 -64.83 -47.92 76.25 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.428 176.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 8' ' ' ASP . 43.4 mtp180 -56.14 -47.06 78.92 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.056 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -72.01 -43.69 64.65 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 120.586 0.232 . . . . 0.0 111.58 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.9 t -81.21 -33.38 12.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.096 0.474 . . . . 0.0 111.809 -170.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 11' ' ' TYR . 1.7 mp -73.37 -24.54 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 O-C-N 121.932 -0.48 . . . . 0.0 110.195 173.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 25.8 ttt -67.69 -51.0 54.77 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.593 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.24 -38.32 81.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.112 0.482 . . . . 0.0 110.369 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -54.49 -41.76 69.96 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.28 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -56.41 -59.09 5.47 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.924 0.393 . . . . 0.0 111.163 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -66.94 -18.83 65.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -137.49 82.12 28.73 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-O 120.91 0.386 . . . . 0.0 110.394 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -90.93 73.61 0.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 123.476 2.784 . . . . 0.0 112.763 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -109.61 62.48 0.6 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.182 0.515 . . . . 0.0 111.008 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.411 ' OD1' ' HA ' ' A' ' 74' ' ' SER . 10.0 m120 -136.64 37.2 2.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.608 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 31.9 ttmt -145.53 43.51 1.28 Allowed 'General case' 0 C--N 1.315 -0.907 0 O-C-N 123.526 0.516 . . . . 0.0 109.631 -175.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.25 167.31 29.02 Favored Glycine 0 C--O 1.222 -0.632 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.533 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.708 HG23 HG21 ' A' ' 48' ' ' THR . 3.1 p -165.87 130.68 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 117.212 0.506 . . . . 0.0 109.906 -174.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.734 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -150.72 164.59 35.78 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.731 178.239 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -117.84 28.05 8.65 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.593 0.711 . . . . 0.0 110.739 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.27 2.48 9.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.898 -173.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.724 ' HB2' ' HA ' ' A' ' 50' ' ' LYS . 4.8 t -165.4 -87.61 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.07 0.462 . . . . 0.0 110.543 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.457 ' H ' ' HB3' ' A' ' 31' ' ' SER . 15.7 pt -127.37 146.66 32.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.962 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.96 HG13 HG22 ' A' ' 48' ' ' THR . 36.6 t -125.86 116.21 45.36 Favored 'Isoleucine or valine' 0 C--O 1.247 0.946 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.001 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.877 HG21 ' HA2' ' A' ' 139' ' ' GLY . 18.1 t -102.56 118.34 49.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.313 0.578 . . . . 0.0 110.478 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 9.2 t70 -119.28 127.95 53.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.023 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.603 ' SD ' ' HA ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -130.73 117.11 18.94 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.778 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 4.6 p30 -117.39 125.76 51.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.49 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -129.64 90.24 44.26 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -33.19 118.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.33 -0.403 1 C-N-CA 125.59 4.193 . . . . 0.0 114.773 -168.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.1 m 79.17 -35.68 0.16 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 171.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 32.5 t -94.98 -14.2 24.6 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 122.312 1.053 . . . . 0.0 109.217 -174.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.701 ' HA3' HD22 ' A' ' 131' ' ' LEU . . . 179.59 64.42 0.07 OUTLIER Glycine 0 N--CA 1.414 -2.781 0 N-CA-C 105.836 -2.906 . . . . 0.0 105.836 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 24.1 t70 -49.63 -47.26 49.89 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.33 1.052 . . . . 0.0 111.528 -159.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.778 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 12.8 ptm180 -164.66 151.88 11.37 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.914 169.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 43.8 pt -139.16 141.17 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 176.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.663 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 93.0 mtt180 -123.06 105.83 10.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.106 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.71 ' HB3' ' HE3' ' A' ' 49' ' ' MET . 1.3 tt -89.66 102.85 15.53 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 168.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.96 HG22 HG13 ' A' ' 33' ' ' VAL . 82.4 p -99.13 117.58 33.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.893 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.71 ' HE3' ' HB3' ' A' ' 47' ' ' LEU . 2.0 mpt? -105.82 178.65 4.5 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.243 0.544 . . . . 0.0 110.812 -172.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.724 ' HA ' ' HB2' ' A' ' 31' ' ' SER . 14.5 tmtt? -152.29 97.93 2.35 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 10.0 mt -115.48 89.45 3.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.607 -171.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -113.02 94.31 4.84 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.445 1.117 . . . . 0.0 109.593 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.67 -104.24 0.45 Allowed Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.763 -173.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -151.74 22.34 0.69 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 111.813 -2.193 . . . . 0.0 108.439 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 2.0 pp -132.19 160.38 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.007 -170.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.476 ' HA ' HD23 ' A' ' 51' ' ' LEU . 3.0 p -97.92 109.06 22.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 166.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.589 ' HB2' HD13 ' A' ' 55' ' ' ILE . 2.5 tm-20 -97.68 -34.16 11.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -164.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.559 ' OD2' HD21 ' A' ' 28' ' ' LEU . 19.6 t70 -143.4 147.2 34.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.947 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 48' ' ' THR . . . -167.85 134.33 2.09 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.552 0.215 . . . . 0.0 110.524 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -136.85 175.56 9.5 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.663 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -127.57 133.83 49.75 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 123.972 0.795 . . . . 0.0 111.067 176.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -128.89 132.09 47.67 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.21 -177.96 48.58 Favored Glycine 0 C--N 1.31 -0.901 0 C-N-CA 118.695 -1.717 . . . . 0.0 113.804 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -139.82 125.47 19.33 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.96 -131.48 1.35 Allowed Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -171.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.4 p -131.48 174.5 10.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 118.187 0.994 . . . . 0.0 111.653 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.501 ' HB2' ' HE1' ' A' ' 11' ' ' TYR . 6.3 p -52.89 -49.3 66.14 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -168.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.823 HG21 HD21 ' A' ' 7' ' ' LEU . 2.5 pp -77.28 -24.62 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.704 -171.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.559 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.7 m -68.95 -45.69 70.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.381 0.61 . . . . 0.0 109.59 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.435 ' HG2' ' CZ ' ' A' ' 61' ' ' PHE . 55.2 mtt -67.08 -35.23 79.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.813 173.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 74' ' ' SER . . . -69.25 -44.36 72.12 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -172.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 50.5 m -62.89 -50.28 71.49 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.6 -40.54 72.19 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 114.59 -1.187 . . . . 0.0 111.414 174.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 71' ' ' ALA . 64.1 m -47.95 -55.94 8.78 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 175.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.764 ' HG3' ' HA3' ' A' ' 111' ' ' GLY . 1.3 tmt? -71.08 -37.4 72.45 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -172.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.681 ' O ' ' HB ' ' A' ' 80' ' ' ILE . 6.6 mmt -77.0 -34.98 57.43 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.656 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 30.1 m -62.95 -21.12 65.86 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.946 -1.096 . . . . 0.0 109.393 169.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -85.81 -38.69 17.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.572 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.0 -44.41 11.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.626 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -76.61 -38.5 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 122.886 0.474 . . . . 0.0 111.084 -171.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' A' ' 77' ' ' THR . 8.3 ttpp -49.77 -17.02 0.29 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.6 37.84 3.16 Favored Glycine 0 C--O 1.218 -0.86 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -133.32 -166.74 1.81 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.8 p-10 -123.78 -163.61 1.15 Allowed 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.752 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -81.66 -44.74 20.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.267 -176.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -66.09 -39.77 90.28 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.879 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.4 p -64.14 -38.76 92.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.701 0.286 . . . . 0.0 110.563 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.46 ' HB1' HG13 ' A' ' 140' ' ' VAL . . . -60.2 -46.49 89.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 122.011 0.91 . . . . 0.0 110.346 174.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 48.1 mt -63.3 -34.26 77.31 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.77 0.795 . . . . 0.0 109.797 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.0 m -64.01 -25.63 68.21 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.731 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 94.6 mmm -71.48 -38.64 71.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.3 0.571 . . . . 0.0 110.263 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.55 ' CB ' ' H ' ' A' ' 143' ' ' GLU . 15.1 t -64.41 -39.81 94.56 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.889 171.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.98 -45.33 86.93 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 121.954 0.883 . . . . 0.0 109.533 172.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 104' ' ' TYR . 44.9 mt -59.5 -51.31 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.563 175.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -57.6 -37.81 73.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.396 0.617 . . . . 0.0 112.233 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.2 p -72.62 -34.56 67.42 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.776 -0.578 . . . . 0.0 110.824 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.1 -42.71 72.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.497 0.665 . . . . 0.0 110.777 172.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.2 tmt? -56.1 -15.29 3.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.008 172.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 57.7 ttp -85.38 -22.21 28.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.857 0.837 . . . . 0.0 109.577 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -77.49 2.63 15.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.309 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.39 44.35 51.76 Favored Glycine 0 CA--C 1.503 -0.717 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.976 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.639 ' HG2' ' H ' ' A' ' 103' ' ' GLU . 78.2 tttt -123.3 -136.94 0.3 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.639 ' H ' ' HG2' ' A' ' 102' ' ' LYS . 51.0 mt-10 -75.25 -158.07 0.08 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.381 0.61 . . . . 0.0 110.207 172.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.51 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -146.73 -102.12 0.09 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.51 ' H ' ' HD1' ' A' ' 104' ' ' TYR . 8.0 t70 -108.7 105.94 15.76 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.29 20.65 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.505 0.722 . . . . 0.0 112.4 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.488 ' H ' ' C ' ' A' ' 105' ' ' ASP . 1.7 m -109.59 -20.09 12.98 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 166.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 108' ' ' ILE . 22.3 mm 70.42 28.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.018 171.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -97.03 90.67 5.26 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 172.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.543 ' HB3' ' HG3' ' A' ' 114' ' ' GLU . 4.3 mp -127.23 17.34 7.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.978 -169.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.764 ' HA3' ' HG3' ' A' ' 75' ' ' MET . . . -46.58 -36.64 8.16 Favored Glycine 0 C--N 1.34 0.805 0 O-C-N 124.448 1.092 . . . . 0.0 114.192 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 16.7 p-10 -75.68 -58.48 3.25 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 122.582 -0.363 . . . . 0.0 111.271 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.732 ' HA ' ' HB2' ' A' ' 116' ' ' LEU . 53.1 mt -63.14 -24.94 37.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 C-N-CA 124.706 1.203 . . . . 0.0 111.299 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 16.8 mt-10 -62.74 -48.97 76.89 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.36 -47.07 71.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.708 171.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.732 ' HB2' ' HA ' ' A' ' 113' ' ' ILE . 8.1 mt -58.67 -34.32 71.12 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.026 0.441 . . . . 0.0 111.188 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 8.4 tt0 -42.97 -53.06 4.94 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.622 1.569 . . . . 0.0 112.386 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.38 -17.68 70.75 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.601 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.719 HG13 ' HB3' ' A' ' 125' ' ' ARG . 48.9 t -84.8 -46.24 17.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 117.224 0.512 . . . . 0.0 111.18 -173.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.673 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 24.5 m -42.49 -16.14 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -127.8 -3.25 5.91 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -162.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.735 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 6.6 m-85 -83.17 145.59 49.36 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -46.98 -39.15 24.79 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.424 2.75 . . . . 0.0 112.874 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.21 5.38 19.93 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.735 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 22.1 mtm180 -112.68 2.15 16.0 Favored 'General case' 0 C--O 1.202 -1.42 0 CA-C-O 122.303 1.049 . . . . 0.0 109.93 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -78.96 -37.65 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 113.989 -1.459 . . . . 0.0 108.912 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -74.79 -21.53 59.26 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.027 173.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 131' ' ' LEU . 5.9 t -85.77 -16.91 37.34 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.582 -1.645 . . . . 0.0 109.248 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.673 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -85.65 -27.55 25.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 124.582 1.176 . . . . 0.0 108.988 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.735 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 3.0 m -70.67 -39.26 73.66 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 175.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.701 HD22 ' HA3' ' A' ' 42' ' ' GLY . 16.7 tp -49.62 -60.86 2.49 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.319 -1.764 . . . . 0.0 111.823 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.475 ' HB2' ' CD2' ' A' ' 116' ' ' LEU . 10.5 m -78.03 -60.67 2.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -171.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.532 ' HB2' HD22 ' A' ' 116' ' ' LEU . 67.0 t90 -66.42 -52.59 44.86 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.735 ' HB3' ' O ' ' A' ' 130' ' ' THR . 21.9 ttmt -58.94 -36.48 74.84 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.047 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.17 77.97 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.173 172.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.55 ' CD2' ' HG3' ' A' ' 76' ' ' MET . 13.5 tp -76.37 -35.87 58.45 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.74 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -71.18 -32.95 69.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.966 0.889 . . . . 0.0 109.073 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -81.44 4.99 19.04 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.403 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.877 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -91.86 -44.65 4.13 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.705 -0.679 . . . . 0.0 113.734 -171.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.46 HG13 ' HB1' ' A' ' 88' ' ' ALA . 12.4 p -166.95 -27.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 122.156 -0.614 . . . . 0.0 111.056 -174.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.72 ' HA ' HD23 ' A' ' 89' ' ' LEU . . . -78.94 160.73 27.11 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.484 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 141' ' ' ALA . 87.0 tttt 170.0 76.6 0.0 OUTLIER 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.372 0.669 . . . . 0.0 110.703 173.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.55 ' H ' ' CB ' ' A' ' 92' ' ' SER . 17.8 tp10 -81.62 -48.43 11.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 170.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -122.81 113.66 19.46 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.647 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -90.87 9.63 77.21 Favored Glycine 0 C--N 1.306 -1.115 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.806 -175.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -158.7 -174.97 29.1 Favored Glycine 0 C--N 1.315 -0.615 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.071 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 120.983 0.42 . . . . 0.0 110.851 -177.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.454 0.169 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 p -150.58 -53.31 0.14 Allowed 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.575 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -116.91 159.15 22.87 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.064 0.546 . . . . 0.0 110.215 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -97.94 138.01 35.92 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.37 137.84 46.84 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 123.974 0.796 . . . . 0.0 110.425 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.54 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 26.6 p-10 -102.66 15.58 28.9 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.56 HD11 ' O ' ' A' ' 115' ' ' ALA . 22.0 tp -93.57 -19.71 20.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.827 -170.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -58.92 -56.99 15.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 124.042 0.838 . . . . 0.0 109.71 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.1 t -65.03 -37.66 88.33 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 6' ' ' ASN . 58.7 mt -53.1 -35.86 60.08 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.627 0.727 . . . . 0.0 111.039 173.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.428 ' O ' HG13 ' A' ' 15' ' ' ILE . 13.2 m-85 -70.92 -39.22 72.82 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -65.8 -35.21 80.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.659 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -65.84 -28.27 68.86 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 123.998 0.811 . . . . 0.0 109.988 174.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.982 HG11 ' HB1' ' A' ' 71' ' ' ALA . 66.6 t -84.0 -41.72 16.65 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.221 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 11' ' ' TYR . 76.0 mt -61.7 -29.51 46.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 CA-C-O 121.54 0.685 . . . . 0.0 110.15 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -62.08 -51.17 69.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.386 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 11.4 t70 -72.48 -40.35 67.0 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 10.0 t-80 -54.26 -45.24 72.35 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.443 -177.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -59.03 -52.14 67.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.341 0.256 . . . . 0.0 111.432 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 17' ' ' ASP . 32.7 ttpt -42.89 -34.15 0.91 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 173.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.516 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -154.34 84.58 3.93 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-O 122.032 0.92 . . . . 0.0 111.952 177.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -86.1 65.91 5.22 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.319 2.679 . . . . 0.0 111.807 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 25' ' ' LYS . 62.8 mtt180 -73.27 -77.53 0.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.769 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 5.9 m120 67.24 -22.95 0.11 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 23' ' ' ARG . 30.6 mmtp -114.97 85.7 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.812 0.339 . . . . 0.0 111.24 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . -139.75 146.17 17.57 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 121.087 -0.577 . . . . 0.0 112.284 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.49 HG23 HG21 ' A' ' 48' ' ' THR . 7.4 p -168.16 134.59 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 122.689 0.396 . . . . 0.0 110.193 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.682 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -151.62 140.37 20.85 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.69 172.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.46 ' HA ' HG21 ' A' ' 33' ' ' VAL . 3.1 p-10 -100.51 39.33 1.38 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.367 -174.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.73 -104.06 0.03 OUTLIER 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.559 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.549 ' CB ' ' HG ' ' A' ' 51' ' ' LEU . 13.0 m -72.05 -76.18 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.317 0.579 . . . . 0.0 112.031 -174.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.906 HG13 ' HB2' ' A' ' 49' ' ' MET . 6.8 pt -119.58 131.05 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-O 121.411 0.624 . . . . 0.0 111.99 -176.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.895 HG13 HG22 ' A' ' 48' ' ' THR . 89.5 t -124.74 129.08 73.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 123.543 0.737 . . . . 0.0 109.762 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.837 HG21 ' HA2' ' A' ' 139' ' ' GLY . 7.1 t -134.25 127.84 51.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.329 0.585 . . . . 0.0 110.386 -173.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.587 ' OD2' ' HD2' ' A' ' 46' ' ' ARG . 2.0 m-20 -117.23 134.45 54.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.249 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.571 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -142.22 122.53 13.94 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -125.0 140.79 52.6 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.728 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 51.1 t30 -135.11 119.35 13.41 Favored Pre-proline 0 C--O 1.253 1.263 0 O-C-N 121.316 -0.865 . . . . 0.0 109.295 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.469 ' HD2' ' OD1' ' A' ' 38' ' ' ASN . 59.6 Cg_exo -25.5 105.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 1 C-N-CA 126.685 4.923 . . . . 0.0 116.417 -175.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.8 m 74.32 -34.52 0.28 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 165.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 127' ' ' LYS . 33.1 t -79.01 -49.23 13.03 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.604 -167.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.654 ' HA3' HD22 ' A' ' 131' ' ' LEU . . . -130.9 24.01 4.34 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.157 -1.021 . . . . 0.0 112.103 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.647 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 34.3 t70 40.77 -96.21 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.137 0 O-C-N 124.85 0.971 . . . . 0.0 111.936 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -136.44 146.38 46.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.356 0.598 . . . . 0.0 111.933 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 tt -131.98 125.18 54.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 170.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.587 ' HD2' ' OD2' ' A' ' 35' ' ' ASP . 24.4 mtm180 -130.36 109.22 10.57 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.189 -174.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.737 HD11 ' HE3' ' A' ' 49' ' ' MET . 0.7 OUTLIER -103.16 100.74 10.67 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 124.33 1.019 . . . . 0.0 108.934 -176.022 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.895 HG22 HG13 ' A' ' 33' ' ' VAL . 57.4 p -97.3 131.42 44.02 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 172.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.906 ' HB2' HG13 ' A' ' 32' ' ' ILE . 55.9 mtt -121.38 -178.56 3.82 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.584 0.707 . . . . 0.0 110.292 -176.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 45.2 tttm -157.63 111.66 2.59 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.549 ' HG ' ' CB ' ' A' ' 31' ' ' SER . 6.3 mt -92.45 140.24 29.77 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.342 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.919 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . 2.4 m-20 -134.18 64.86 1.59 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 140.5 -133.25 5.85 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -164.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -121.11 31.79 6.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 168.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.498 HD11 ' HG2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -127.44 178.22 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.571 -172.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 p -107.61 112.93 42.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.919 ' HG3' ' HB2' ' A' ' 52' ' ' ASP . 4.3 mm-40 -101.8 -31.35 10.79 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 122.03 0.919 . . . . 0.0 109.414 -169.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 33.2 t0 -141.53 144.95 34.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.643 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -152.02 134.39 15.24 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.422 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 73.4 mmtt -124.96 129.82 51.12 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.513 ' HB3' HG21 ' A' ' 77' ' ' THR . 47.6 p90 -116.02 141.21 48.42 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 121.199 0.524 . . . . 0.0 111.203 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 24' ' ' ASN . 26.4 tt0 -116.6 121.79 42.74 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.92 128.29 5.24 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.544 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.647 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 10.3 tp10 -150.8 128.02 11.25 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.65 -131.68 2.57 Favored Glycine 0 C--O 1.227 -0.284 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 -171.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.4 p -99.47 159.57 14.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.461 0.63 . . . . 0.0 109.787 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 p -59.22 -38.71 80.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.838 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.785 HD11 HG21 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -61.4 -48.37 89.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.7 m -68.93 -47.35 65.94 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 110.785 -173.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.2 ptp -61.61 -29.91 70.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.452 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.982 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -66.14 -53.17 41.08 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.29 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.2 m -56.42 -40.02 74.02 Favored 'General case' 0 C--N 1.344 0.345 0 O-C-N 123.9 0.75 . . . . 0.0 109.651 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.7 -57.21 10.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.582 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.441 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 49.2 m -55.76 -48.62 74.96 Favored 'General case' 0 CA--C 1.493 -1.246 0 O-C-N 123.873 0.733 . . . . 0.0 112.266 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.8 tpt -70.65 -54.96 9.92 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 120.933 0.397 . . . . 0.0 110.551 -174.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.675 ' HG3' HD21 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -59.95 -44.76 94.19 Favored 'General case' 0 C--O 1.205 -1.252 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.556 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.689 ' HA ' HG22 ' A' ' 80' ' ' ILE . 32.0 m -63.03 -36.99 85.42 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.16 0.891 . . . . 0.0 109.784 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -52.41 -47.85 66.07 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.002 174.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.84 -23.97 25.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.453 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.689 HG22 ' HA ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -77.48 -30.75 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -174.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 81' ' ' LYS . 7.0 ttpm? -52.93 -18.64 2.06 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.483 170.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.78 44.47 1.48 Allowed Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.638 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 80' ' ' ILE . 8.3 mttp -132.61 -162.4 1.23 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.019 0.438 . . . . 0.0 110.508 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.9 m-20 -140.83 164.56 29.91 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.577 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mp -68.09 -51.25 50.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 119.239 0.927 . . . . 0.0 110.573 -176.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.91 -36.45 79.3 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.776 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.4 m -66.77 -41.83 87.1 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.614 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.98 -37.85 82.0 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 123.57 0.544 . . . . 0.0 111.325 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 83.2 mt -63.59 -39.15 93.65 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.863 0.84 . . . . 0.0 109.028 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.7 t -59.14 -41.9 89.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.411 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.424 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 12.3 ttt -65.63 -38.35 89.14 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.069 0.461 . . . . 0.0 110.586 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.769 ' HB3' ' HD2' ' A' ' 142' ' ' LYS . 16.3 m -60.34 -48.49 81.52 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.045 175.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 35.5 ttpt -59.85 -40.74 89.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.603 0.716 . . . . 0.0 109.471 175.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.513 HG23 ' HA ' ' A' ' 104' ' ' TYR . 29.8 mt -61.62 -47.83 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.966 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -56.65 -34.49 67.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.818 0.342 . . . . 0.0 110.57 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 34.3 m -71.58 -44.39 64.57 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.869 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.92 -52.02 53.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.779 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.1 tpt -38.95 -63.51 0.52 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.5 mmm -49.2 -17.13 0.2 Allowed 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -128.07 -4.1 5.67 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.892 0.315 . . . . 0.0 111.193 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -116.44 -32.25 1.67 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.947 -1.121 . . . . 0.0 113.871 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 88.41 -13.93 0.4 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.245 1.418 . . . . 0.0 110.075 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -98.59 134.85 40.95 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.667 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.513 ' HA ' HG23 ' A' ' 94' ' ' ILE . 3.2 p90 -124.75 -121.93 0.26 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.826 -176.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.504 ' O ' HD13 ' A' ' 108' ' ' ILE . 24.8 t70 -94.44 107.15 19.13 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 120.914 0.387 . . . . 0.0 110.342 -174.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -48.29 -19.06 0.26 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.205 -1.361 . . . . 0.0 113.049 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.7 t -92.8 -22.69 19.17 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.662 ' HA ' HD11 ' A' ' 110' ' ' LEU . 23.4 mm 67.56 39.14 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 122.164 0.983 . . . . 0.0 109.855 175.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -99.21 81.93 2.63 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.662 HD11 ' HA ' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -144.57 51.34 1.27 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -174.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -39.65 -18.76 0.01 OUTLIER Glycine 0 CA--C 1.54 1.605 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.529 ' HB3' ' HG3' ' A' ' 76' ' ' MET . 14.0 p-10 -85.27 -43.4 13.78 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 117.692 0.746 . . . . 0.0 109.522 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.881 ' O ' ' HB2' ' A' ' 117' ' ' GLN . 5.0 tt -70.12 -16.81 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.47 -171.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.4 ' O ' HD13 ' A' ' 10' ' ' LEU . 3.5 mm-40 -56.11 -64.78 0.75 Allowed 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.765 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -76.51 -44.77 33.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.918 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.648 HD12 HG21 ' A' ' 119' ' ' VAL . 14.2 tp -92.64 1.67 57.14 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -163.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.881 ' HB2' ' O ' ' A' ' 113' ' ' ILE . 7.1 tt0 -58.44 -52.12 66.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.385 -174.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.06 -13.6 72.91 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.933 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.785 HG21 HD11 ' A' ' 68' ' ' ILE . 93.3 t -78.83 -46.95 23.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 CA-C-N 117.093 0.446 . . . . 0.0 110.423 -162.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.44 ' O ' ' HD3' ' A' ' 125' ' ' ARG . 14.3 m -42.45 -15.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.59 1.556 . . . . 0.0 115.135 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 125' ' ' ARG . 63.9 pttt -131.3 13.81 5.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.528 -0.733 . . . . 0.0 112.47 -171.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.69 ' HD2' ' HA ' ' A' ' 119' ' ' VAL . 15.4 m-85 -76.43 170.03 18.08 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.199 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.453 ' HD2' ' HD1' ' A' ' 122' ' ' PHE . 30.5 Cg_endo -65.43 -18.95 61.16 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.207 1.938 . . . . 0.0 109.966 166.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.505 ' HB1' ' HD2' ' A' ' 127' ' ' LYS . . . -113.38 17.14 18.69 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.984 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.616 ' HG3' ' N ' ' A' ' 126' ' ' ILE . 18.6 ptp180 -44.05 -61.18 1.55 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.127 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.616 ' N ' ' HG3' ' A' ' 125' ' ' ARG . 39.9 pt -59.48 -22.97 24.25 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.184 -172.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.728 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 99.5 mttt -68.34 -63.25 1.1 Allowed 'General case' 0 C--N 1.313 -1.003 0 O-C-N 122.247 -0.283 . . . . 0.0 110.402 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.8 m -85.67 -35.2 21.05 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.451 0.644 . . . . 0.0 110.675 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.689 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -73.85 -51.28 16.8 Favored 'General case' 0 CA--C 1.493 -1.238 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.618 -173.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.567 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 36.7 m -63.83 -45.87 87.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.183 -177.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.654 HD22 ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -56.63 -50.09 73.06 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.163 -0.961 . . . . 0.0 110.567 179.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.478 ' N ' ' HG ' ' A' ' 131' ' ' LEU . 7.1 m -76.7 -61.53 1.94 Allowed 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -174.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -61.51 -53.46 56.04 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 123.852 0.72 . . . . 0.0 111.139 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 130' ' ' THR . 88.0 tttt -55.33 -42.91 74.41 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' A' ' 36' ' ' MET . . . -61.17 -50.29 73.74 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.549 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.675 HD21 ' HG3' ' A' ' 76' ' ' MET . 11.8 tp -65.2 -31.69 72.99 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.461 0.648 . . . . 0.0 110.338 -175.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.708 ' CG ' ' HD3' ' A' ' 142' ' ' LYS . 2.9 tp10 -83.52 -32.33 25.96 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.79 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 134' ' ' LYS . 23.9 tptp -71.09 -47.15 59.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.837 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -41.36 -34.68 1.07 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.395 -0.82 . . . . 0.0 114.35 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.465 ' O ' HD21 ' A' ' 89' ' ' LEU . 27.2 m -108.12 -1.09 9.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.851 -0.74 . . . . 0.0 112.147 -177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 90.09 3.43 0.16 Allowed 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 168.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.769 ' HD2' ' HB3' ' A' ' 92' ' ' SER . 43.0 tptt 55.18 87.86 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 171.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 69.3 -52.69 0.6 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.956 0.903 . . . . 0.0 112.228 172.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -165.65 -71.47 0.03 OUTLIER 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.21 40.82 0.07 OUTLIER Glycine 0 C--N 1.319 -0.409 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.201 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.8 -122.82 0.72 Allowed Glycine 0 C--O 1.24 0.512 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.522 -177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.438 ' OD1' ' HE3' ' A' ' 142' ' ' LYS . 11.7 p30 . . . . . 0 N--CA 1.47 0.554 0 C-N-CA 123.95 0.9 . . . . 0.0 112.606 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 110.725 -0.102 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.5 m -126.51 128.22 46.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.978 0.418 . . . . 0.0 110.46 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.0 t80 66.4 91.58 0.08 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.823 0.82 . . . . 0.0 111.028 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -144.59 -1.39 0.9 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.617 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.25 95.88 2.22 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -103.99 -45.12 4.84 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.097 -174.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.509 HD21 HG22 ' A' ' 119' ' ' VAL . 21.5 tp -70.46 -42.75 71.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.022 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.81 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 17.8 t70 -54.5 -53.76 50.04 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.417 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 m -57.29 -54.39 47.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.337 175.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.616 ' O ' HG13 ' A' ' 14' ' ' VAL . 4.3 mp -47.33 -52.42 16.48 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.419 1.074 . . . . 0.0 111.862 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.81 ' CE2' ' HA ' ' A' ' 8' ' ' ASP . 0.6 OUTLIER -79.19 -19.42 50.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.488 -175.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -66.6 -35.67 80.74 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-O 121.412 0.625 . . . . 0.0 109.358 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -75.65 -35.23 60.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.081 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.788 HG22 ' HA ' ' A' ' 11' ' ' TYR . 3.2 m -72.48 -35.34 51.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.961 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.576 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 14.5 tt -77.41 -22.67 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.929 174.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 17.2 tpt -84.9 -38.78 18.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.323 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.775 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 20.3 t70 -77.9 -37.13 48.63 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.458 ' CD2' ' HB3' ' A' ' 24' ' ' ASN . 26.1 t60 -71.43 -16.46 62.38 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.068 171.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.576 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 46.4 t80 -73.57 -48.22 34.55 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.333 0.587 . . . . 0.0 110.014 171.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.775 ' HD3' ' HA ' ' A' ' 17' ' ' ASP . 41.4 mtpt -48.61 -45.79 38.76 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.846 171.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -114.81 78.41 5.22 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 18' ' ' HIS . 72.7 Cg_endo -77.62 51.11 3.44 Favored 'Trans proline' 0 N--CA 1.475 0.392 0 C-N-CA 122.999 2.466 . . . . 0.0 113.414 -165.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -83.72 50.41 1.8 Allowed 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 121.801 -0.562 . . . . 0.0 109.57 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.458 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . 20.0 p-10 -114.2 24.77 11.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.9 0.857 . . . . 0.0 109.044 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -133.15 139.44 47.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.835 -1.53 . . . . 0.0 108.868 173.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 142.67 141.89 3.94 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.103 -178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.661 HG13 ' HB2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -159.27 127.93 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.757 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -136.11 147.68 47.9 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.491 0.663 . . . . 0.0 110.56 176.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -93.26 44.08 1.13 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.23 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.458 ' HB3' ' H ' ' A' ' 31' ' ' SER . 1.2 m-20 -85.67 -130.37 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.031 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.458 ' H ' ' HB3' ' A' ' 30' ' ' ASP . 14.9 m -52.12 -77.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.814 HG13 ' HB2' ' A' ' 49' ' ' MET . 12.8 pt -127.02 137.86 56.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.622 0.725 . . . . 0.0 110.394 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.639 HG13 HG22 ' A' ' 48' ' ' THR . 95.7 t -123.09 114.69 43.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.617 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.963 HG21 ' HA2' ' A' ' 139' ' ' GLY . 93.9 t -106.88 119.3 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.074 -176.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 2.0 p-10 -127.85 149.57 50.23 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.504 0.669 . . . . 0.0 110.141 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.464 ' O ' HG22 ' A' ' 45' ' ' ILE . 27.3 ttt -157.37 132.11 8.66 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.173 178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 7.0 p30 -127.28 135.62 50.83 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -113.63 88.33 13.43 Favored Pre-proline 0 N--CA 1.439 -0.983 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 167.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -60.08 -6.26 4.8 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.386 2.058 . . . . 0.0 113.889 -169.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.7 p -98.6 -51.03 4.06 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.294 0.568 . . . . 0.0 111.784 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 51.6 t -135.23 17.99 3.42 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -169.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.22 -3.37 0.37 Allowed Glycine 0 N--CA 1.47 0.956 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.406 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.631 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 11.5 m-20 53.79 -110.7 0.56 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 118.394 -0.812 . . . . 0.0 111.117 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 31.3 ptt180 -158.67 148.83 19.69 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.652 1.115 . . . . 0.0 112.549 -176.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.568 HG13 ' CE1' ' A' ' 61' ' ' PHE . 5.0 tt -130.4 133.26 64.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.571 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -121.56 103.44 8.92 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.246 0.341 . . . . 0.0 111.695 173.187 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.682 HD22 ' HG3' ' A' ' 49' ' ' MET . 1.9 tt -92.6 106.63 18.58 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 172.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.757 ' HB ' HD12 ' A' ' 28' ' ' LEU . 44.9 p -99.27 123.5 43.6 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.814 ' HB2' HG13 ' A' ' 32' ' ' ILE . 52.2 mtt -113.26 178.7 4.19 Favored 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 123.741 0.651 . . . . 0.0 111.73 -175.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.435 ' HA ' ' OG ' ' A' ' 31' ' ' SER . 86.9 tttt -160.24 100.56 1.37 Allowed 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -116.72 92.16 3.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.065 0.936 . . . . 0.0 111.501 -175.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -103.36 89.36 3.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.466 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.31 -100.88 0.32 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-O 122.985 1.325 . . . . 0.0 111.821 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -159.6 35.85 0.19 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 111.375 -2.412 . . . . 0.0 106.681 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.676 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.3 pp -140.13 143.58 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 113.767 -1.56 . . . . 0.0 108.187 -171.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.49 HG11 HG23 ' A' ' 80' ' ' ILE . 1.3 p -92.59 113.35 27.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -102.1 -32.01 10.34 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 113.978 -1.465 . . . . 0.0 107.941 -163.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -136.48 129.51 31.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.65 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.63 104.49 3.75 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.434 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 29.0 mmtp -120.75 151.95 38.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.922 -175.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.568 ' CE1' HG13 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -130.53 135.75 48.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.661 ' HB2' HG13 ' A' ' 27' ' ' VAL . 1.1 tm-20 -142.09 114.56 8.39 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.76 -177.49 39.16 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.004 -172.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -139.85 157.71 45.28 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.631 ' HA2' ' HB2' ' A' ' 43' ' ' ASP . . . 157.26 -143.17 9.27 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 119.253 -1.451 . . . . 0.0 112.502 176.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.412 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 61.1 m -76.31 164.57 25.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.271 0.558 . . . . 0.0 110.828 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.9 p -63.41 -35.47 80.52 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.008 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.644 HG13 HG21 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -82.81 -29.02 8.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.05 -177.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.526 ' N ' HD13 ' A' ' 68' ' ' ILE . 8.3 m -66.92 -55.0 16.52 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.699 -0.625 . . . . 0.0 110.729 -174.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -69.55 -16.25 63.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.656 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.542 ' HB1' HG23 ' A' ' 14' ' ' VAL . . . -85.84 -53.3 5.2 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.553 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.417 ' OG ' ' HB2' ' A' ' 116' ' ' LEU . 37.3 t -74.1 -51.21 16.39 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.746 0.654 . . . . 0.0 109.818 -171.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.36 -51.91 65.25 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.219 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . 30.3 t -66.16 -38.46 88.14 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.915 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.563 ' SD ' ' HB ' ' A' ' 14' ' ' VAL . 28.7 ttt -59.32 -46.83 87.51 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.352 0.596 . . . . 0.0 110.671 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.409 ' HB3' ' CD1' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -75.48 -23.28 56.78 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.175 178.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.596 ' HA ' ' HB ' ' A' ' 80' ' ' ILE . 99.6 m -67.97 -43.72 78.33 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-O 122.389 1.09 . . . . 0.0 110.008 172.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.8 tm0? -58.8 -27.03 64.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.835 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.74 -33.6 23.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.596 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 2.3 mm -67.83 -36.24 75.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.616 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -56.8 -18.87 14.39 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.716 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.94 38.39 2.95 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.749 ' HE3' ' HB ' ' A' ' 87' ' ' THR . 27.3 tptt -131.45 164.33 25.97 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -172.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.635 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 6.4 p-10 -111.65 -175.2 2.64 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 169.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.768 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.1 mp -76.3 -39.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.267 -173.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -60.67 -48.59 81.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.002 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.749 ' HB ' ' HE3' ' A' ' 83' ' ' LYS . 18.6 p -71.7 -36.12 70.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.557 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -56.42 -40.5 74.84 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.429 0.633 . . . . 0.0 111.466 172.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 66.3 mt -62.62 -33.82 75.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.367 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -80.45 -25.2 39.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.631 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -65.0 -27.31 68.73 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 121.844 0.83 . . . . 0.0 109.362 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.4 m -88.59 -23.53 23.08 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.366 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 143' ' ' GLU . 83.5 tttt -79.01 -30.17 44.08 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.626 177.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.8 tt -82.21 -33.6 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -50.47 -33.34 20.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.166 163.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.7 m -81.65 -27.82 33.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.484 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.422 ' OD1' ' HA3' ' A' ' 101' ' ' GLY . 20.6 t70 -66.11 -35.79 81.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.707 ' HA ' ' CE1' ' A' ' 104' ' ' TYR . 59.7 ttp -48.15 -16.71 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.252 0.621 . . . . 0.0 112.609 169.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 73.7 mtm -117.96 -36.38 3.64 Favored 'General case' 0 C--N 1.319 -0.736 0 O-C-N 122.066 -0.396 . . . . 0.0 111.259 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.33 -43.43 4.78 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.063 0.459 . . . . 0.0 110.457 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.422 ' HA3' ' OD1' ' A' ' 97' ' ' ASP . . . -81.5 -57.14 2.82 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.872 -174.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 61.28 81.4 0.19 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.538 0.685 . . . . 0.0 111.242 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -178.9 31.82 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.558 0.695 . . . . 0.0 110.335 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.736 ' HD2' HD11 ' A' ' 110' ' ' LEU . 15.6 p90 -103.82 113.1 26.38 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 121.483 0.658 . . . . 0.0 110.045 -176.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -137.71 70.43 1.39 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.038 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.86 ' H ' HD22 ' A' ' 110' ' ' LEU . 32.1 t70 60.67 6.62 1.17 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.613 0.72 . . . . 0.0 111.202 168.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.2 m -111.9 3.74 17.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.703 -173.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.422 ' HB ' ' H ' ' A' ' 109' ' ' ASP . 1.9 mp -131.99 -77.69 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.422 ' H ' ' HB ' ' A' ' 108' ' ' ILE . 0.6 OUTLIER -144.79 166.72 24.43 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 167.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.86 HD22 ' H ' ' A' ' 106' ' ' ASP . 3.1 tp 173.11 -7.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -39.04 -46.39 2.38 Favored Glycine 0 C--N 1.355 1.589 0 C-N-CA 121.155 -0.545 . . . . 0.0 114.282 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.477 ' OD2' HG13 ' A' ' 113' ' ' ILE . 2.8 p-10 -70.69 -59.61 2.72 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.994 HG23 ' HB3' ' A' ' 117' ' ' GLN . 41.0 mt -50.9 -40.7 20.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.995 0.918 . . . . 0.0 112.57 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 10' ' ' LEU . 12.2 mm-40 -61.75 -12.22 15.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.462 0.649 . . . . 0.0 111.57 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.589 ' CB ' HG21 ' A' ' 14' ' ' VAL . . . -138.37 19.4 2.75 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.753 -175.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.585 HD12 HG21 ' A' ' 119' ' ' VAL . 10.0 tp -161.88 -20.78 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -169.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.994 ' HB3' HG23 ' A' ' 113' ' ' ILE . 22.4 pt20 -60.09 -31.32 69.91 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.794 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.578 ' HA2' ' HE2' ' A' ' 121' ' ' LYS . . . -80.62 -16.96 74.34 Favored Glycine 0 CA--C 1.504 -0.597 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.656 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.851 HG13 ' HB3' ' A' ' 125' ' ' ARG . 79.7 t -81.6 -43.86 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 123.291 0.636 . . . . 0.0 110.36 -171.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.563 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 4.8 m -36.09 -16.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.578 ' HE2' ' HA2' ' A' ' 118' ' ' GLY . 0.3 OUTLIER -146.66 0.47 0.77 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 119.969 1.258 . . . . 0.0 113.626 -166.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.771 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 12.9 m-30 -75.18 136.22 72.71 Favored Pre-proline 0 N--CA 1.446 -0.664 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 172.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 122' ' ' PHE . 52.4 Cg_exo -55.05 -26.63 50.91 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.682 2.255 . . . . 0.0 111.971 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.38 -0.29 35.69 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.851 ' HB3' HG13 ' A' ' 119' ' ' VAL . 64.0 mtt180 -129.26 12.77 6.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.165 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -80.22 -32.24 13.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 122.796 1.284 . . . . 0.0 108.033 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -83.24 -20.91 33.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.606 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 57.4 m -82.57 -18.6 40.77 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.921 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.596 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -84.54 -36.43 22.16 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.972 -176.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.643 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 3.9 m -75.01 -40.45 60.6 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.428 HD22 ' HB3' ' A' ' 69' ' ' SER . 8.2 tt -50.7 -51.14 52.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.105 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.9 t -80.24 -60.89 2.16 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.066 -174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -62.87 -53.27 56.78 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.854 0.359 . . . . 0.0 111.751 -175.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.643 ' HB3' ' O ' ' A' ' 130' ' ' THR . 19.9 tptm -59.39 -34.8 72.88 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.913 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.89 -34.5 59.66 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.073 171.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.409 ' CD1' ' HB3' ' A' ' 76' ' ' MET . 82.2 mt -84.24 -39.43 19.29 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.34 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -70.47 -39.74 74.06 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.64 0.733 . . . . 0.0 110.905 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.759 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -84.88 12.38 7.55 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.094 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.963 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -102.86 -29.72 5.74 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.196 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.557 HG21 ' HB1' ' A' ' 88' ' ' ALA . 29.3 m -131.56 -23.49 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -174.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 90.46 175.29 0.02 OUTLIER 'General case' 0 C--N 1.351 0.663 0 C-N-CA 125.093 1.357 . . . . 0.0 109.759 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -123.95 149.15 46.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.241 -0.912 . . . . 0.0 112.405 -169.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -92.48 104.83 17.11 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 162.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 144' ' ' GLU . 10.3 pt-20 -87.96 -142.81 0.12 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.133 -166.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 163.48 35.42 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.24 157.65 15.09 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.061 -0.57 . . . . 0.0 111.788 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 37.1 t30 . . . . . 0 C--N 1.314 -0.972 0 CA-C-N 117.504 0.652 . . . . 0.0 111.486 -175.05 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.436 ' SD ' ' HB2' ' A' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.408 0.623 . . . . 0.0 109.613 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -75.64 -57.4 3.9 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.66 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.436 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 41.2 t80 72.69 -56.05 0.66 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.849 0.86 . . . . 0.0 110.95 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -75.83 116.09 16.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.88 72.5 6.63 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.704 -171.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -69.39 82.47 0.38 Allowed 'General case' 0 C--N 1.317 -0.82 0 O-C-N 123.876 0.735 . . . . 0.0 110.875 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.783 ' HA ' HD12 ' A' ' 10' ' ' LEU . 55.8 tp 169.47 -36.55 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 176.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 17.3 t70 -61.56 -57.03 13.72 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.32 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.603 ' HA ' ' HG2' ' A' ' 12' ' ' ARG . 29.1 p -51.02 -43.05 60.8 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.751 0.786 . . . . 0.0 111.729 173.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.783 HD12 ' HA ' ' A' ' 7' ' ' LEU . 88.2 mt -51.79 -48.01 63.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.81 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.5 ' O ' HG12 ' A' ' 15' ' ' ILE . 22.8 m-85 -67.64 -35.55 79.1 Favored 'General case' 0 CA--C 1.5 -0.981 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.415 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.603 ' HG2' ' HA ' ' A' ' 9' ' ' THR . 21.6 mmm-85 -59.91 -30.76 69.26 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.739 -0.601 . . . . 0.0 110.075 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -82.32 -34.79 28.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.621 HG13 ' HB2' ' A' ' 75' ' ' MET . 94.9 t -76.96 -30.77 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.594 -176.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 11' ' ' TYR . 30.9 pt -83.84 -19.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 172.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 12' ' ' ARG . 26.1 ttt -64.15 -44.65 91.48 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.838 0.828 . . . . 0.0 109.242 175.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.18 -33.9 63.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.481 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -62.11 -26.56 68.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.174 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -68.63 -54.35 16.93 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.566 -0.709 . . . . 0.0 110.557 168.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -48.68 -38.23 20.72 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.235 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -112.84 81.31 4.37 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.48 -16.39 23.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.422 3.415 . . . . 0.0 115.475 -159.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -148.48 164.74 33.27 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.484 -0.487 . . . . 0.0 111.286 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -151.03 81.02 1.32 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.114 176.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.638 ' HG3' ' HG3' ' A' ' 62' ' ' GLU . 58.7 tttm -141.82 93.79 2.6 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.363 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.78 152.63 24.75 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.787 HG23 HG21 ' A' ' 48' ' ' THR . 2.9 p -150.29 132.61 6.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.197 0.522 . . . . 0.0 110.141 -176.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.771 HD12 ' HB ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -153.71 146.32 24.17 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 176.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -111.49 139.34 47.01 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.804 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t70 172.21 -79.74 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.603 0.761 . . . . 0.0 109.188 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.528 ' HB3' ' HG ' ' A' ' 51' ' ' LEU . 14.1 m -72.01 -86.49 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.519 -175.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.671 HG13 ' HB2' ' A' ' 49' ' ' MET . 4.3 pt -138.23 134.31 44.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.299 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.579 HG13 HG22 ' A' ' 48' ' ' THR . 61.4 t -125.62 121.93 61.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.728 0.775 . . . . 0.0 110.201 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.025 HG21 ' HA2' ' A' ' 139' ' ' GLY . 2.8 t -117.36 124.83 73.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.352 -176.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 45' ' ' ILE . 4.5 p-10 -126.43 138.98 53.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.826 0.346 . . . . 0.0 110.395 178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.657 ' HG2' ' HA ' ' A' ' 131' ' ' LEU . 2.0 tpt -147.1 131.26 17.36 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.532 ' H ' ' HE2' ' A' ' 36' ' ' MET . 8.5 p30 -109.77 132.29 54.28 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.223 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -121.96 98.88 44.59 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 161.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -32.33 109.0 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 125.171 3.914 . . . . 0.0 115.147 -168.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 m 71.73 -20.49 0.24 Allowed 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.095 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 66' ' ' CYS . 51.6 t -95.42 -33.19 12.57 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 122.37 1.081 . . . . 0.0 109.142 -175.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.506 ' HA2' ' HA3' ' A' ' 65' ' ' GLY . . . -157.61 60.9 0.33 Allowed Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 104.714 -3.354 . . . . 0.0 104.714 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.68 -43.04 89.84 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.594 -1.303 . . . . 0.0 112.048 -156.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -148.44 132.41 17.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 118.246 -1.382 . . . . 0.0 109.926 168.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.586 HG13 ' CE1' ' A' ' 61' ' ' PHE . 8.7 tt -124.33 116.15 46.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 20.4 ttt180 -121.36 102.79 8.5 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 121.649 -0.657 . . . . 0.0 111.924 -172.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.574 HD21 ' CE ' ' A' ' 49' ' ' MET . 28.1 tp -87.82 102.58 14.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.342 173.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.787 HG21 HG23 ' A' ' 27' ' ' VAL . 31.6 p -98.4 112.35 24.39 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 171.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.671 ' HB2' HG13 ' A' ' 32' ' ' ILE . 24.9 mtt -100.87 178.88 4.56 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.117 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.914 ' HB3' ' HB3' ' A' ' 58' ' ' ASP . 56.3 tttp -157.28 93.4 1.31 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.609 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 2.2 pp -117.72 108.95 16.02 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 113.183 -1.826 . . . . 0.0 106.848 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -98.84 60.46 1.25 Allowed 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.931 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.28 -98.58 0.19 Allowed Glycine 0 N--CA 1.424 -2.152 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.195 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -128.78 22.47 5.84 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.757 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.4 pp -135.77 144.8 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -98.28 122.77 50.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -115.94 -21.21 9.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.998 0.904 . . . . 0.0 109.099 -170.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.914 ' HB3' ' HB3' ' A' ' 50' ' ' LYS . 17.1 t70 -141.35 149.11 40.74 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.885 174.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 49' ' ' MET . . . -161.75 108.06 1.34 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.769 0.795 . . . . 0.0 109.124 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -107.3 147.72 29.9 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.328 0.585 . . . . 0.0 109.57 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.601 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 1.9 t80 -121.38 129.01 52.79 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.998 178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.638 ' HG3' ' HG3' ' A' ' 25' ' ' LYS . 27.8 tt0 -128.26 124.44 36.63 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 179.72 -177.72 48.28 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 119.132 -1.508 . . . . 0.0 112.72 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -141.71 128.95 21.02 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.506 ' HA3' ' HA2' ' A' ' 42' ' ' GLY . . . -169.49 -132.1 1.4 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.5 -1.334 . . . . 0.0 110.81 -175.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 7.3 p -123.35 -163.98 1.17 Allowed 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.3 p -55.77 -26.5 46.22 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.798 HG13 ' HB3' ' A' ' 128' ' ' CYS . 7.3 mm -62.48 -66.62 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.649 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 p -55.43 -32.57 62.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.225 1.012 . . . . 0.0 109.909 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -61.7 -60.86 3.03 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 113.838 -1.528 . . . . 0.0 110.286 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.626 ' HB1' ' HB1' ' A' ' 115' ' ' ALA . . . -71.68 -43.3 66.25 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -172.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.513 ' HB3' HD11 ' A' ' 116' ' ' LEU . 49.4 p -59.0 -39.61 82.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 110.632 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.765 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -75.01 -48.93 21.63 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.232 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 27.6 m -55.35 -61.04 2.6 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.802 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.621 ' HB2' HG13 ' A' ' 14' ' ' VAL . 12.6 tpt -83.1 -57.63 3.2 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.525 ' CG ' HD13 ' A' ' 136' ' ' LEU . 10.5 tpt -74.02 -27.9 61.18 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -171.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.765 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 85.6 m -73.32 -40.99 64.05 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 74' ' ' SER . 8.3 tt0 -59.54 -26.22 65.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.183 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.26 -33.58 22.13 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.65 ' HB ' ' HA ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -67.6 -42.96 87.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.11 178.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 65.2 tttm -56.45 -16.28 5.57 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.686 0.794 . . . . 0.0 111.694 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.89 38.59 2.95 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.419 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -135.25 179.09 6.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.741 0.27 . . . . 0.0 111.597 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.649 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 2.0 m-20 -100.41 176.94 5.18 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.699 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 12.6 mm -84.41 -43.11 17.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.548 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -63.36 -38.27 90.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.02 0.438 . . . . 0.0 110.318 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -61.62 -41.3 97.27 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 121.72 0.772 . . . . 0.0 110.866 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -66.11 -34.98 79.28 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 121.927 -0.483 . . . . 0.0 110.605 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 70.7 mt -64.71 -39.72 94.12 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.453 1.121 . . . . 0.0 109.735 175.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.551 ' O ' HG12 ' A' ' 94' ' ' ILE . 26.9 t -67.09 -41.66 85.94 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.827 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.475 ' O ' ' HB2' ' A' ' 95' ' ' PHE . 16.9 tpt -62.85 -22.42 66.66 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 122.287 1.041 . . . . 0.0 110.854 178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.542 ' HB3' ' H ' ' A' ' 143' ' ' GLU . 27.5 t -89.03 -35.95 16.07 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.499 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -66.58 -51.51 55.63 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.813 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 105' ' ' ASP . 22.1 pt -65.1 -39.83 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.838 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 91' ' ' MET . 39.2 t80 -53.51 -35.93 61.19 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.411 0.624 . . . . 0.0 111.143 174.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.6 m -86.31 -35.85 19.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.134 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.54 -35.96 75.92 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.096 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 1.3 tmt? -39.22 -49.75 1.9 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 124.127 0.892 . . . . 0.0 111.689 178.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.2 mtt -57.21 -10.63 1.32 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -124.46 -35.24 2.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.773 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.734 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -88.69 -32.07 11.92 Favored Glycine 0 C--O 1.239 0.448 0 C-N-CA 119.511 -1.328 . . . . 0.0 114.168 -173.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.734 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 22.4 tttm 97.64 -29.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.758 1.223 . . . . 0.0 109.699 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 98' ' ' MET . 0.7 OUTLIER -82.09 163.21 22.19 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.65 -106.34 0.24 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.72 ' HA ' HD12 ' A' ' 94' ' ' ILE . 31.7 t70 -95.34 101.73 13.48 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 172.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.27 8.87 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.449 ' HB2' ' OD2' ' A' ' 105' ' ' ASP . 65.3 m -105.78 -16.95 14.53 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 169.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 108' ' ' ILE . 32.0 mm 65.37 27.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 CA-C-O 121.816 0.817 . . . . 0.0 110.949 175.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -95.41 86.93 4.63 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 170.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 113' ' ' ILE . 6.7 mt -123.75 43.94 2.84 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.393 -165.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -40.47 -33.21 0.53 Allowed Glycine 0 CA--C 1.538 1.51 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.674 168.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.54 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 3.8 p-10 -58.32 -72.78 0.09 Allowed 'General case' 0 C--O 1.212 -0.904 0 C-N-CA 123.448 0.699 . . . . 0.0 109.989 171.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' A' ' 110' ' ' LEU . 1.1 mp -46.2 -37.88 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.827 0.851 . . . . 0.0 110.313 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.629 ' O ' ' HB3' ' A' ' 10' ' ' LEU . 29.4 tt0 -61.57 -18.89 61.22 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.681 0.753 . . . . 0.0 111.704 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.626 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -136.77 16.85 3.08 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.824 -0.548 . . . . 0.0 111.796 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 115' ' ' ALA . 5.7 mp -151.03 -24.39 0.21 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -167.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.435 ' HB2' HG23 ' A' ' 113' ' ' ILE . 7.7 tt0 -43.53 -52.32 6.26 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.41 0.443 . . . . 0.0 112.121 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.815 ' HA2' ' HE3' ' A' ' 121' ' ' LYS . . . -75.76 -17.36 80.13 Favored Glycine 0 CA--C 1.512 -0.155 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.489 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.799 HG13 ' HB3' ' A' ' 125' ' ' ARG . 65.8 t -74.92 -54.62 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 117.202 0.501 . . . . 0.0 111.397 -169.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.666 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 16.9 m -44.77 -15.0 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 O-C-N 125.231 1.582 . . . . 0.0 114.621 -175.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.815 ' HE3' ' HA2' ' A' ' 118' ' ' GLY . 20.0 pttp -127.96 -4.7 5.68 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.71 -162.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.518 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 27.6 m-85 -86.7 133.98 38.57 Favored Pre-proline 0 N--CA 1.448 -0.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.109 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.64 -22.92 37.99 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 122.034 1.823 . . . . 0.0 111.55 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.68 -2.99 43.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.226 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.799 ' HB3' HG13 ' A' ' 119' ' ' VAL . 66.1 mtt85 -129.34 16.58 6.04 Favored 'General case' 0 C--O 1.213 -0.83 0 O-C-N 121.831 -0.543 . . . . 0.0 109.556 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.2 tt -87.36 -31.23 5.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.623 -171.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -78.38 -20.76 50.56 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.798 ' HB3' HG13 ' A' ' 68' ' ' ILE . 77.5 m -82.91 -18.5 39.93 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.286 176.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 120' ' ' SER . . . -84.99 -32.8 22.77 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.998 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 134' ' ' LYS . 16.9 p -74.9 -43.58 53.53 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.15 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.657 ' HA ' ' HG2' ' A' ' 36' ' ' MET . 4.6 pp -58.45 -34.88 71.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.481 ' HB3' HD21 ' A' ' 116' ' ' LEU . 49.1 m -69.95 -55.03 10.72 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.447 0.467 . . . . 0.0 111.853 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.662 ' HA ' ' OE1' ' A' ' 137' ' ' GLU . 25.6 m0 -55.56 -38.64 69.59 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.695 1.236 . . . . 0.0 111.194 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.661 ' HA ' ' HB3' ' A' ' 138' ' ' LYS . 50.0 mtpt -70.35 -42.41 71.89 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.605 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.578 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -58.4 -61.95 2.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.012 176.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.525 HD13 ' CG ' ' A' ' 76' ' ' MET . 72.6 mt -87.21 -43.59 12.1 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.285 -0.566 . . . . 0.0 112.054 -169.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.662 ' OE1' ' HA ' ' A' ' 133' ' ' TRP . 3.0 mp0 -84.8 -39.89 17.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -173.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.661 ' HB3' ' HA ' ' A' ' 134' ' ' LYS . 7.8 tmtm? -88.68 12.22 15.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.395 1.093 . . . . 0.0 109.051 176.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 1.025 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -88.13 -24.46 34.51 Favored Glycine 0 C--O 1.221 -0.658 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.114 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.523 HG21 ' HB1' ' A' ' 88' ' ' ALA . 29.6 m -114.23 -0.98 9.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.899 -0.65 . . . . 0.0 110.438 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 140' ' ' VAL . . . 86.7 110.91 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.935 1.397 . . . . 0.0 108.403 -173.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -68.69 136.86 53.56 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.207 -169.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.779 ' HG3' ' H ' ' A' ' 144' ' ' GLU . 13.7 pt-20 41.01 -89.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 125.261 1.6 . . . . 0.0 113.58 176.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.779 ' H ' ' HG3' ' A' ' 143' ' ' GLU . 6.2 mm-40 -73.15 74.67 1.26 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 118.401 0.546 . . . . 0.0 109.836 172.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -53.33 103.75 0.16 Allowed Glycine 0 N--CA 1.436 -1.329 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.311 -175.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.17 82.65 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.445 HD22 ' C ' ' A' ' 147' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.601 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.309 177.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 mtt . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.23 0.538 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 m -57.35 116.77 3.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.448 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -127.71 14.66 6.99 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.943 0.401 . . . . 0.0 110.65 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -80.34 40.66 0.5 Allowed 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.401 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 179.59 19.98 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.397 -172.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -60.78 -50.42 73.54 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.011 -172.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.612 HD12 ' HB2' ' A' ' 10' ' ' LEU . 29.9 tp -126.57 -13.5 5.95 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.375 0.422 . . . . 0.0 110.154 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.69 -58.26 9.35 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.155 0.502 . . . . 0.0 111.427 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.3 m -55.14 -41.63 72.02 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.631 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.612 ' HB2' HD12 ' A' ' 7' ' ' LEU . 44.1 mt -55.56 -45.61 77.29 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.441 177.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.434 ' O ' HG22 ' A' ' 15' ' ' ILE . 15.7 m-85 -59.56 -46.37 89.11 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.367 0.604 . . . . 0.0 109.473 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -57.38 -45.27 84.66 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.599 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -67.31 -32.29 73.17 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.101 0.25 . . . . 0.0 110.682 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.654 HG13 ' HB2' ' A' ' 75' ' ' MET . 72.9 t -80.43 -47.99 20.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.833 -175.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 11' ' ' TYR . 18.2 tt -69.58 -25.53 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.2 ttt -78.29 -45.97 21.39 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.126 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.98 -42.77 76.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.489 0.662 . . . . 0.0 110.09 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.479 ' CG ' ' HB3' ' A' ' 74' ' ' SER . 85.9 t60 -66.95 -29.19 68.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.465 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -64.33 -45.48 87.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.941 -0.475 . . . . 0.0 110.615 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -47.52 -33.15 5.99 Favored 'General case' 0 C--O 1.247 0.937 0 O-C-N 124.197 0.936 . . . . 0.0 111.202 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -87.05 155.85 55.03 Favored Pre-proline 0 C--O 1.22 -0.492 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.146 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.24 -68.16 0.11 Allowed 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 123.606 2.871 . . . . 0.0 113.825 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.621 ' HG2' ' H ' ' A' ' 24' ' ' ASN . 25.0 ttm-85 176.61 -167.29 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.621 ' H ' ' HG2' ' A' ' 23' ' ' ARG . 18.6 p-10 -144.52 8.54 1.35 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.148 -0.345 . . . . 0.0 110.725 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 61' ' ' PHE . 60.6 tttp -99.91 115.32 29.37 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.633 0.73 . . . . 0.0 111.212 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.829 ' HA3' ' HE2' ' A' ' 60' ' ' LYS . . . -172.25 -177.83 42.03 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.48 HG23 HG21 ' A' ' 48' ' ' THR . 7.4 p -166.33 125.61 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 118.119 0.959 . . . . 0.0 110.655 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.748 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.5 OUTLIER -143.69 143.62 31.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.594 0.711 . . . . 0.0 110.78 176.162 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -98.38 81.06 2.7 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.583 ' OD2' ' HG3' ' A' ' 50' ' ' LYS . 6.2 t70 -117.58 -123.02 0.29 Allowed 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.24 -173.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.448 ' OG ' ' HA ' ' A' ' 50' ' ' LYS . 17.7 m -51.88 -72.45 0.05 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.248 0.547 . . . . 0.0 111.878 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.691 HG13 ' HB2' ' A' ' 49' ' ' MET . 22.3 pt -130.23 140.89 47.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.42 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.827 HG13 HG22 ' A' ' 48' ' ' THR . 57.4 t -124.66 108.66 20.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 110.837 -0.06 . . . . 0.0 110.837 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.754 ' HB ' ' HB3' ' A' ' 47' ' ' LEU . 55.6 t -87.7 122.92 39.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 O-C-N 124.331 1.019 . . . . 0.0 110.993 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.83 108.02 16.2 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.995 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.47 ' HB2' ' HB2' ' A' ' 135' ' ' ALA . 20.3 mmt -136.47 119.11 16.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' ARG . 5.1 p-10 -129.03 138.67 52.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.043 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -115.18 95.24 41.75 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.7 -12.77 26.56 Favored 'Trans proline' 0 CA--C 1.512 -0.576 0 C-N-CA 123.222 2.615 . . . . 0.0 112.756 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.5 m -94.12 -53.99 3.75 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.153 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.9 t -129.46 15.06 6.06 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -167.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.867 ' HA3' HD22 ' A' ' 131' ' ' LEU . . . -154.76 2.98 0.22 Allowed Glycine 0 N--CA 1.462 0.427 0 C-N-CA 118.003 -2.046 . . . . 0.0 114.882 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.708 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 10.3 t70 54.99 -101.41 0.13 Allowed 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.878 0.871 . . . . 0.0 111.077 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' ASN . 18.7 ptp180 -155.77 150.63 26.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.769 0.713 . . . . 0.0 112.133 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.597 HG13 ' CD1' ' A' ' 61' ' ' PHE . 8.6 tt -133.97 125.06 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 45.6 mtp180 -118.82 104.04 10.19 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 111.107 -176.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.754 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 20.1 tp -88.22 95.68 10.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.26 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.827 HG22 HG13 ' A' ' 33' ' ' VAL . 61.7 p -88.8 110.16 20.79 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.691 ' HB2' HG13 ' A' ' 32' ' ' ILE . 15.0 mtt -107.77 -179.98 4.06 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.136 0.493 . . . . 0.0 111.356 -171.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.583 ' HG3' ' OD2' ' A' ' 30' ' ' ASP . 50.5 tttp -153.58 101.35 2.48 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.606 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 1.4 pt? -124.15 93.48 3.93 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -175.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -92.21 60.27 3.67 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.644 -170.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 146.51 -98.43 0.2 Allowed Glycine 0 N--CA 1.421 -2.32 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 174.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -132.27 20.17 4.41 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.948 0.404 . . . . 0.0 110.415 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -129.0 152.13 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.81 119.54 49.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -105.49 -29.29 10.29 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.931 0.872 . . . . 0.0 108.824 -167.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.662 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 1.4 t70 -144.11 153.8 42.52 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.424 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.594 ' HB2' ' HG2' ' A' ' 49' ' ' MET . . . -164.26 118.72 1.45 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.829 ' HE2' ' HA3' ' A' ' 26' ' ' GLY . 38.8 mtpt -125.71 99.68 6.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.069 0.938 . . . . 0.0 111.527 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.597 ' CD1' HG13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -70.7 139.06 51.09 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.815 176.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 15.4 tt0 -143.79 126.29 15.88 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.979 0.895 . . . . 0.0 109.009 169.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.05 -175.02 45.73 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.835 -172.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.708 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -143.88 163.0 34.65 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 -179.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.38 -133.47 4.9 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 119.203 -1.475 . . . . 0.0 113.019 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.1 m -85.73 163.96 17.9 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.308 0.575 . . . . 0.0 112.305 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.6 t -75.17 -26.55 59.17 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.211 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.887 HG13 HG21 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -77.2 -33.51 20.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.256 177.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.4 m -69.12 -48.6 62.04 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.993 0.901 . . . . 0.0 108.934 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 52.2 ttp -56.14 -34.27 65.96 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.619 170.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.75 -39.16 67.07 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.479 0.487 . . . . 0.0 111.565 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.833 ' HB2' HD11 ' A' ' 116' ' ' LEU . 12.7 t -58.99 -47.77 83.98 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 77' ' ' THR . . . -62.76 -49.26 75.72 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.538 177.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.479 ' HB3' ' CG ' ' A' ' 18' ' ' HIS . 68.3 m -51.64 -61.7 2.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.882 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.654 ' HB2' HG13 ' A' ' 14' ' ' VAL . 9.1 tpt -74.92 -46.92 32.55 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.575 -169.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.94 ' HG2' HD21 ' A' ' 136' ' ' LEU . 6.9 tpt -80.37 -28.09 38.06 Favored 'General case' 0 C--O 1.206 -1.186 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 88.1 m -68.79 -17.91 64.11 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.555 -1.341 . . . . 0.0 108.823 168.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.443 ' HB3' ' O ' ' A' ' 75' ' ' MET . 1.5 tt0 -80.59 -38.37 29.52 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.341 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -88.69 -45.82 9.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.998 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.5 OUTLIER -73.6 -32.24 35.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 123.326 0.65 . . . . 0.0 110.703 -170.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.662 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 60.3 tttm -53.71 -15.47 1.24 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.452 0.644 . . . . 0.0 110.93 173.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.65 32.37 5.89 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.596 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -129.46 -165.47 1.53 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -132.67 -172.1 2.83 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.728 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mp -74.98 -46.02 41.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.656 -175.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.76 -40.69 79.65 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 123.207 0.317 . . . . 0.0 111.393 -175.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.2 p -58.01 -36.5 72.77 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.457 0.646 . . . . 0.0 110.533 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.901 ' HB1' ' HB2' ' A' ' 141' ' ' ALA . . . -71.89 -49.15 40.46 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.022 0.529 . . . . 0.0 110.712 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 42.1 mt -55.01 -44.49 74.61 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.639 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.553 ' O ' HG12 ' A' ' 94' ' ' ILE . 38.3 p -68.61 -33.53 74.2 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.246 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.541 ' HA ' ' CG1' ' A' ' 94' ' ' ILE . 25.1 ttt -64.91 -16.65 63.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.383 0.611 . . . . 0.0 110.429 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.511 ' CB ' ' HG3' ' A' ' 143' ' ' GLU . 6.1 m -86.29 -40.25 15.69 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -66.3 -43.87 85.04 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.616 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 90' ' ' SER . 10.0 pt -71.45 -40.88 72.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.624 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 91' ' ' MET . 5.9 t80 -56.9 -29.77 63.32 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.32 174.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 t -80.8 -36.86 31.13 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -65.61 -42.03 92.04 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.139 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.616 ' HA ' ' H ' ' A' ' 103' ' ' GLU . 16.8 tpt -35.59 -50.45 0.61 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 123.827 0.705 . . . . 0.0 112.568 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 42.4 tpp -48.87 -19.56 0.39 Allowed 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -140.28 -29.84 0.69 Allowed 'General case' 0 C--O 1.242 0.673 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.23 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -99.79 -36.73 4.15 Favored Glycine 0 C--N 1.318 -0.472 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.647 -174.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 63.9 tttm 88.59 70.31 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.616 ' H ' ' HA ' ' A' ' 98' ' ' MET . 10.3 tp10 -153.8 133.88 13.25 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 113.335 -1.757 . . . . 0.0 107.226 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.538 ' HD1' ' H ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -124.48 -59.39 1.46 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.644 -168.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.768 ' HB3' HD12 ' A' ' 110' ' ' LEU . 14.7 t70 -144.58 97.2 2.99 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.456 ' H ' HD12 ' A' ' 94' ' ' ILE . 14.8 t70 -34.8 -31.45 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 174.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.9 m -95.94 2.78 53.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.77 -0.582 . . . . 0.0 111.301 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 108' ' ' ILE . 31.9 mm 69.53 24.97 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 122.667 1.222 . . . . 0.0 109.124 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -96.78 73.95 2.67 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.929 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.768 HD12 ' HB3' ' A' ' 105' ' ' ASP . 5.0 mp -98.01 10.84 39.38 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.995 -166.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -40.18 -38.22 1.26 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 115.645 1.018 . . . . 0.0 115.645 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.74 ' HB2' ' HB2' ' A' ' 76' ' ' MET . 18.4 t70 -80.88 -51.3 8.74 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.579 0.704 . . . . 0.0 110.42 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.646 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 53.4 mt -65.09 -24.14 34.76 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.823 -174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.536 ' HG3' ' HB3' ' A' ' 110' ' ' LEU . 47.3 mt-10 -67.91 -58.38 4.66 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.07 -40.57 77.13 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.974 0.797 . . . . 0.0 112.479 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.833 HD11 ' HB2' ' A' ' 72' ' ' SER . 8.9 mp -94.65 -5.84 44.74 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.646 ' HB3' ' O ' ' A' ' 113' ' ' ILE . 2.9 pt20 -61.65 -28.31 69.3 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.79 0.805 . . . . 0.0 111.762 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.86 -16.46 65.41 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.536 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.887 HG21 HG13 ' A' ' 68' ' ' ILE . 24.1 t -86.8 -57.62 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 124.047 0.939 . . . . 0.0 111.003 -172.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.426 ' HA ' ' CB ' ' A' ' 129' ' ' ALA . 3.3 p -45.0 -14.59 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -176.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -128.6 0.53 5.53 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 118.481 -1.287 . . . . 0.0 112.045 -165.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.5 ' HB2' ' HB2' ' A' ' 125' ' ' ARG . 6.1 m-85 -90.13 130.61 41.58 Favored Pre-proline 0 N--CA 1.441 -0.883 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.43 -29.0 29.5 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.935 2.424 . . . . 0.0 112.241 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -93.86 -2.88 52.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.446 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 122' ' ' PHE . 89.8 mtt180 -125.39 11.71 8.08 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.1 tt -80.33 -36.78 16.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.08 0.943 . . . . 0.0 109.029 -171.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -85.64 -18.03 34.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.167 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 3.7 t -79.87 -19.28 48.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.565 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -85.85 -33.19 21.36 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.57 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.763 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 26.2 p -77.28 -32.31 55.43 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 119.323 -0.951 . . . . 0.0 108.926 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.867 HD22 ' HA3' ' A' ' 42' ' ' GLY . 19.2 tp -47.31 -59.41 3.21 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.663 169.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.8 m -79.09 -61.06 2.13 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.675 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.555 ' HB2' HD23 ' A' ' 116' ' ' LEU . 2.6 t90 -63.12 -51.37 66.81 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.458 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.763 ' HB2' ' O ' ' A' ' 130' ' ' THR . 27.4 mmmt -61.67 -42.43 98.91 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 121.855 -0.528 . . . . 0.0 110.986 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 36' ' ' MET . . . -57.02 -36.74 70.8 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.307 174.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.94 HD21 ' HG2' ' A' ' 76' ' ' MET . 4.6 tp -79.55 -40.74 28.79 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.826 0.822 . . . . 0.0 110.114 -175.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 139' ' ' GLY . 39.4 tt0 -79.12 -53.01 7.42 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.283 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 134' ' ' LYS . 72.3 tttt -78.87 15.63 1.05 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.878 -169.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.551 ' O ' HD12 ' A' ' 32' ' ' ILE . . . -101.08 -26.61 7.77 Favored Glycine 0 N--CA 1.424 -2.148 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.921 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.29 -33.35 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 O-C-N 122.242 -0.563 . . . . 0.0 110.295 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.901 ' HB2' ' HB1' ' A' ' 88' ' ' ALA . . . -102.19 119.16 38.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.39 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.634 ' H ' ' CD2' ' A' ' 89' ' ' LEU . 47.9 mtmt -146.55 113.09 5.96 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.731 0.301 . . . . 0.0 110.446 173.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.511 ' HG3' ' CB ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -57.11 69.89 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.221 0.534 . . . . 0.0 111.971 162.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -69.76 -22.36 63.36 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.014 0.911 . . . . 0.0 110.12 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 155.37 -23.29 0.57 Allowed Glycine 0 CA--C 1.502 -0.743 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.357 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 102.06 -69.53 0.37 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.336 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 . . . . . 0 C--N 1.319 -0.748 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.567 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.525 0.202 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -144.39 -52.1 0.31 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -127.81 88.81 2.83 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 175.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -76.46 -45.72 30.01 Favored 'General case' 0 C--O 1.241 0.656 0 O-C-N 123.973 0.796 . . . . 0.0 110.149 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.0 -73.91 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.273 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.3 t30 64.71 30.39 12.48 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 122.467 1.127 . . . . 0.0 108.739 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.598 HD12 HD12 ' A' ' 10' ' ' LEU . 34.3 tp -118.38 -12.28 9.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.764 -175.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.54 ' HA ' ' HD2' ' A' ' 11' ' ' TYR . 2.2 m-20 -58.44 -58.62 7.7 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.108 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 p -56.45 -41.04 75.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.925 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.598 HD12 HD12 ' A' ' 7' ' ' LEU . 62.6 mt -55.42 -41.69 73.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.285 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.54 ' HD2' ' HA ' ' A' ' 8' ' ' ASP . 47.9 m-85 -57.16 -51.54 68.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.322 0.582 . . . . 0.0 109.92 173.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -56.65 -39.63 74.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.51 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.5 tp60 -74.09 -35.17 64.19 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.709 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 115' ' ' ALA . 75.6 t -70.02 -45.48 76.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.69 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 66.6 mt -67.52 -23.19 29.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.1 ttt -73.2 -53.71 10.26 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.898 -0.502 . . . . 0.0 110.294 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -69.59 -44.81 70.02 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.49 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -65.6 -20.69 66.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.157 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 15' ' ' ILE . 82.8 t80 -62.94 -50.09 72.18 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 121.959 -0.463 . . . . 0.0 110.56 173.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -44.85 -29.75 0.86 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.897 173.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -122.4 82.23 46.4 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 120.885 0.374 . . . . 0.0 110.141 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.6 73.45 1.29 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.125 2.55 . . . . 0.0 113.064 -172.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.3 ttm105 -145.55 72.47 1.31 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.659 0.742 . . . . 0.0 110.168 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -105.53 64.29 0.7 Allowed 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.641 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? 179.52 163.45 0.95 Allowed 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 60' ' ' LYS . . . 144.82 153.53 5.89 Favored Glycine 0 C--O 1.218 -0.867 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.998 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.847 ' HB ' ' HB2' ' A' ' 62' ' ' GLU . 2.6 p -168.46 117.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.724 ' O ' ' HB ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -141.33 149.0 40.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.056 0.455 . . . . 0.0 111.152 178.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -107.55 104.81 14.45 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.31 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -149.75 -110.36 0.07 Allowed 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.468 0.48 . . . . 0.0 110.383 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.684 ' HB3' HD23 ' A' ' 51' ' ' LEU . 22.3 m -54.06 -74.0 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 124.79 1.306 . . . . 0.0 112.05 -171.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.712 HG13 ' HB3' ' A' ' 49' ' ' MET . 10.6 pt -134.82 136.71 51.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.779 0.8 . . . . 0.0 109.111 174.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.741 HG13 HG22 ' A' ' 48' ' ' THR . 33.8 t -117.69 105.23 17.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.842 0.829 . . . . 0.0 108.791 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.764 HG21 ' HA2' ' A' ' 139' ' ' GLY . 85.6 t -98.41 124.49 51.56 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.845 -171.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.789 ' HB3' ' HE ' ' A' ' 46' ' ' ARG . 5.4 p-10 -136.88 145.9 44.9 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.506 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.3 mmt -154.19 135.66 14.23 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.768 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.521 ' HB2' ' O ' ' A' ' 43' ' ' ASP . 22.6 p-10 -122.13 142.05 50.79 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.04 174.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.657 ' ND2' ' HA ' ' A' ' 127' ' ' LYS . 56.4 t30 -125.57 106.04 27.02 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 174.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 1.3 Cg_endo -42.85 133.02 5.7 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 125.123 3.882 . . . . 0.0 114.458 -167.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.0 m 77.12 -36.56 0.25 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.139 175.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.799 ' SG ' ' HB3' ' A' ' 127' ' ' LYS . 44.1 t -85.85 -78.61 0.27 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -171.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.613 ' HA3' HD13 ' A' ' 131' ' ' LEU . . . -102.6 11.48 56.47 Favored Glycine 0 CA--C 1.502 -0.761 0 C-N-CA 118.786 -1.673 . . . . 0.0 112.286 -166.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.58 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 18.3 t70 62.8 -90.9 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.423 0.719 . . . . 0.0 110.349 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -159.8 144.4 14.97 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 123.198 0.311 . . . . 0.0 110.466 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.42 133.92 59.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.789 ' HE ' ' HB3' ' A' ' 35' ' ' ASP . 28.8 ttm180 -134.41 109.4 8.74 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.594 HD11 ' HB1' ' A' ' 59' ' ' ALA . 11.8 tp -84.91 99.24 10.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.127 172.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.741 HG22 HG13 ' A' ' 33' ' ' VAL . 50.0 p -80.71 107.41 13.5 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 171.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.712 ' HB3' HG13 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -110.07 165.43 11.74 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -164.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 57' ' ' GLU . 8.5 tmtm? -156.33 97.21 1.75 Allowed 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -173.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.684 HD23 ' HB3' ' A' ' 31' ' ' SER . 2.6 pt? -118.85 93.82 4.23 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.62 59.26 1.76 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.373 1.082 . . . . 0.0 109.545 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 150.18 -99.44 0.19 Allowed Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.064 -1.425 . . . . 0.0 109.846 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.473 ' C ' HG12 ' A' ' 85' ' ' ILE . 2.0 t70 -134.91 24.25 3.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.442 0.639 . . . . 0.0 109.37 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.645 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.2 pp -137.31 156.07 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 C-N-CA 124.435 1.094 . . . . 0.0 108.47 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.496 HG11 ' O ' ' A' ' 80' ' ' ILE . 3.3 p -96.77 119.46 44.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 122.139 0.971 . . . . 0.0 108.551 168.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 50' ' ' LYS . 32.2 tt0 -98.03 -33.44 11.18 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.379 -171.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -146.22 147.55 31.58 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.483 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.594 ' HB1' HD11 ' A' ' 47' ' ' LEU . . . -155.82 123.09 5.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.488 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 46.8 mmtm -133.82 165.7 24.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.069 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.718 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 26.0 p90 -127.47 127.29 43.81 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.48 0.657 . . . . 0.0 111.612 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.847 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 8.8 tp10 -110.54 109.31 19.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 173.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.22 -178.62 48.59 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.518 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.58 ' O ' ' HB3' ' A' ' 43' ' ' ASP . 15.1 mm-40 -142.29 168.5 19.58 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.3 -131.62 3.36 Favored Glycine 0 C--O 1.24 0.496 0 C-N-CA 119.588 -1.291 . . . . 0.0 112.93 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.8 m -78.34 178.88 7.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.6 m -93.18 -23.96 18.39 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -79.89 -38.74 19.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 113.831 -1.532 . . . . 0.0 110.614 175.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.4 p -65.41 -43.35 90.84 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 121.946 -0.471 . . . . 0.0 110.786 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.5 ptp -62.51 -29.17 70.35 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.852 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.57 -34.51 65.17 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.643 0.589 . . . . 0.0 111.642 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.3 m -62.25 -40.51 96.44 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.761 ' HA ' ' HG2' ' A' ' 76' ' ' MET . . . -64.95 -43.08 93.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.892 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.1 m -52.42 -49.0 65.4 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 122.324 0.249 . . . . 0.0 110.653 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.474 ' HA ' ' HG2' ' A' ' 78' ' ' GLN . 4.6 mmt -66.0 -47.5 74.29 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.988 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.761 ' HG2' ' HA ' ' A' ' 73' ' ' ALA . 19.7 ptt? -59.82 -41.41 91.23 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.962 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.4 p -60.18 -35.57 75.67 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.257 -0.902 . . . . 0.0 111.052 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.474 ' HG2' ' HA ' ' A' ' 75' ' ' MET . 20.4 pt20 -88.16 -41.37 13.04 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.926 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.66 -48.63 8.14 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 121.678 0.751 . . . . 0.0 111.425 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.598 ' HB ' ' O ' ' A' ' 76' ' ' MET . 0.3 OUTLIER -71.47 -42.45 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.892 -174.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -61.7 -16.1 46.11 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.071 0.462 . . . . 0.0 111.273 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.12 43.61 1.65 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.322 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.589 ' HG3' ' HB ' ' A' ' 87' ' ' THR . 2.9 tppt? -134.42 170.45 15.73 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -105.66 175.61 5.44 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.668 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.5 mm -78.07 -35.86 20.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.173 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.12 -48.03 79.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.638 0.733 . . . . 0.0 109.557 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.589 ' HB ' ' HG3' ' A' ' 83' ' ' LYS . 1.4 m -66.2 -40.32 90.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.711 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.708 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -63.94 -41.7 97.54 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.139 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 85' ' ' ILE . 73.5 mt -66.64 -31.01 71.42 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.8 m -70.22 -44.33 68.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.154 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.584 ' HE2' ' HB2' ' A' ' 112' ' ' ASP . 13.1 tpt -60.11 -29.92 68.92 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.444 0.698 . . . . 0.0 110.4 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.51 ' OG ' ' HA ' ' A' ' 142' ' ' LYS . 71.7 p -87.92 -37.86 16.08 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.968 -175.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.627 ' HG3' ' HG2' ' A' ' 143' ' ' GLU . 61.2 tttm -67.5 -44.68 77.87 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.331 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 105' ' ' ASP . 71.8 mt -63.79 -44.75 98.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.306 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' A' ' 91' ' ' MET . 0.7 OUTLIER -53.34 -32.61 49.96 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.543 174.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.6 m -83.21 -40.34 19.77 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.8 0.333 . . . . 0.0 111.187 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -71.22 -37.57 72.04 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.799 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.1 ttt -45.28 -51.48 10.84 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.439 0.695 . . . . 0.0 112.308 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 46.5 ttp -61.03 -8.74 3.51 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -123.96 -31.82 3.34 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.908 -0.495 . . . . 0.0 110.841 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 102' ' ' LYS . . . -89.51 -25.58 27.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.769 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 23.9 tptm 84.87 -31.35 0.06 Allowed 'General case' 0 N--CA 1.478 0.97 0 O-C-N 125.044 1.085 . . . . 0.0 109.119 175.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.22 178.45 6.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.411 ' CG ' HD21 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -144.76 -108.84 0.11 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.112 0.482 . . . . 0.0 111.714 -173.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.436 ' HB2' HD13 ' A' ' 94' ' ' ILE . 20.2 t70 -109.16 107.9 18.35 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -175.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.08 3.89 0.38 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.616 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.562 ' O ' HG22 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -99.09 -18.95 17.46 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 173.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 107' ' ' SER . 6.6 tp 66.91 24.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.446 168.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.22 87.34 6.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 172.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 114' ' ' GLU . 1.1 mp -114.21 21.53 14.64 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 123.306 0.379 . . . . 0.0 111.546 -168.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -51.6 -54.52 24.26 Favored Glycine 0 C--O 1.242 0.656 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.247 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.584 ' HB2' ' HE2' ' A' ' 91' ' ' MET . 6.7 m-20 -58.04 -24.14 57.18 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.863 0.865 . . . . 0.0 111.998 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 76.3 mt -100.69 -25.09 3.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -174.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 33.7 tt0 -75.36 -54.41 7.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.53 -1.213 . . . . 0.0 111.762 -163.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.517 ' O ' HD11 ' A' ' 7' ' ' LEU . . . -49.23 -24.76 1.9 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.81 0.694 . . . . 0.0 110.818 170.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.6 mp -102.89 -3.18 26.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.472 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.429 ' HB2' ' HA ' ' A' ' 114' ' ' GLU . 7.8 tt0 -54.48 -37.19 64.98 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.187 0.595 . . . . 0.0 110.686 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.82 -18.16 66.2 Favored Glycine 0 C--O 1.216 -0.986 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.557 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.803 HG12 ' HB2' ' A' ' 129' ' ' ALA . 48.4 t -84.11 -44.71 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 O-C-N 122.283 -0.539 . . . . 0.0 112.164 -174.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 11.5 p -45.93 -25.56 0.56 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.318 0.647 . . . . 0.0 110.247 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.586 ' NZ ' ' HB2' ' A' ' 121' ' ' LYS . 3.6 ttmp? -131.71 96.51 3.97 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.996 ' H ' ' HB3' ' A' ' 125' ' ' ARG . 0.1 OUTLIER -152.34 157.06 33.91 Favored Pre-proline 0 N--CA 1.448 -0.561 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -172.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.454 ' HD2' ' CG ' ' A' ' 122' ' ' PHE . 10.8 Cg_endo -59.24 -22.85 66.95 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.705 1.603 . . . . 0.0 111.221 172.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.28 18.42 17.85 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.294 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.996 ' HB3' ' H ' ' A' ' 122' ' ' PHE . 25.6 ptt-85 -52.44 -44.5 65.52 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 124.105 0.878 . . . . 0.0 112.202 -165.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.431 ' N ' ' HG3' ' A' ' 125' ' ' ARG . 11.6 tt -85.24 -20.59 8.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -160.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.799 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 38.5 mmtm -75.97 -50.14 15.75 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.435 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.873 ' HB3' HD12 ' A' ' 68' ' ' ILE . 80.0 m -86.54 -29.11 22.92 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.256 -173.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.803 ' HB2' HG12 ' A' ' 119' ' ' VAL . . . -87.59 -29.8 20.98 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.033 -171.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 63.8 m -84.5 -41.93 16.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.613 HD13 ' HA3' ' A' ' 42' ' ' GLY . 8.4 tt -51.82 -39.41 58.7 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.942 0.401 . . . . 0.0 110.612 173.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.9 m -84.05 -42.45 16.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.697 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.459 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 2.3 t90 -53.02 -50.48 64.15 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.114 0.566 . . . . 0.0 109.816 174.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 68.2 mmtt -60.08 -42.59 94.9 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 124.68 1.238 . . . . 0.0 110.407 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.2 -41.96 63.12 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.455 0.472 . . . . 0.0 112.102 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 76' ' ' MET . 4.4 mm? -83.06 -38.45 22.52 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.534 0.683 . . . . 0.0 110.894 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.718 ' HG3' ' HB3' ' A' ' 142' ' ' LYS . 26.4 tt0 -68.69 -41.87 78.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.37 -177.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.508 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 9.3 mtpt -93.31 -0.75 56.58 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.651 -1.158 . . . . 0.0 110.063 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.764 ' HA2' HG21 ' A' ' 34' ' ' VAL . . . -79.99 -27.71 52.3 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.903 HG23 ' H ' ' A' ' 141' ' ' ALA . 16.9 m -129.89 -94.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 113.184 -1.508 . . . . 0.0 108.089 170.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.903 ' H ' HG23 ' A' ' 140' ' ' VAL . . . -166.86 153.48 8.61 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 123.563 0.745 . . . . 0.0 109.017 166.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.718 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 21.2 pttm -87.45 119.05 27.34 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.242 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.627 ' HG2' ' HG3' ' A' ' 93' ' ' LYS . 29.6 mt-10 68.02 -78.57 0.04 OUTLIER 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.259 0.624 . . . . 0.0 110.77 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -124.76 -52.11 1.69 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.334 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.0 -41.19 0.97 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.909 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.03 49.5 0.37 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.592 -0.814 . . . . 0.0 111.887 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 . . . . . 0 C--O 1.24 0.605 0 CA-C-O 120.846 0.355 . . . . 0.0 110.686 179.34 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_